{"idB": "906709_12_item7_p16_s1", "idA": "906709_11_item7_p0_s0", "sentA": "The following discussion contains forward-looking statements that involve risks and uncertainties.", "sentB": "The following table sets forth revenue by geographic area (in thousands):", "type": 2, "words": ["<tag1>", "The", "following", "discussion", "contains", "forward-looking", "statements", "that", "involve", "risks", "and", "uncertainties.", "<tag2>", "The", "following", "table", "sets", "forth", "revenue", "by", "geographic", "area", "(in", "thousands):", "<tag3>"], "wordsA": ["The", "following", "discussion", "contains", "forward-looking", "statements", "that", "involve", "risks", "and", "uncertainties."], "wordsB": ["The", "following", "table", "sets", "forth", "revenue", "by", "geographic", "area", "(in", "thousands):"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p15_s1", "idA": "906709_11_item7_p0_s2", "sentA": "Factors that could cause or contribute to such differences include, but are not limited to, those discussed in this section as well as factors described in Part I, Item 1A Risk Factors.", "sentB": "See Part I, Item 1A Risk Factors for discussion of the risks associated with the complex nature of our collaboration agreements.", "type": 2, "words": ["<tag1>", "Factors", "that", "could", "cause", "or", "contribute", "to", "such", "differences", "include,", "but", "are", "not", "limited", "to,", "those", "discussed", "in", "this", "section", "as", "well", "as", "factors", "described", "in", "Part", "I,", "Item", "1A", "Risk", "Factors.", "<tag2>", "See", "Part", "I,", "Item", "1A", "Risk", "Factors", "for", "discussion", "of", "the", "risks", "associated", "with", "the", "complex", "nature", "of", "our", "collaboration", "agreements.", "<tag3>"], "wordsA": ["Factors", "that", "could", "cause", "or", "contribute", "to", "such", "differences", "include,", "but", "are", "not", "limited", "to,", "those", "discussed", "in", "this", "section", "as", "well", "as", "factors", "described", "in", "Part", "I,", "Item", "1A", "Risk", "Factors."], "wordsB": ["See", "Part", "I,", "Item", "1A", "Risk", "Factors", "for", "discussion", "of", "the", "risks", "associated", "with", "the", "complex", "nature", "of", "our", "collaboration", "agreements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p22_s0", "idA": "906709_11_item7_p0_s2", "sentA": "Factors that could cause or contribute to such differences include, but are not limited to, those discussed in this section as well as factors described in Part I, Item 1A Risk Factors.", "sentB": "(1) Clinical Study Status definitions are provided in the chart found in Part I, Item 1.", "type": 2, "words": ["<tag1>", "Factors", "that", "could", "cause", "or", "contribute", "to", "such", "differences", "include,", "but", "are", "not", "limited", "to,", "those", "discussed", "in", "this", "section", "as", "well", "as", "factors", "described", "in", "Part", "I,", "Item", "1A", "Risk", "Factors.", "<tag2>", "(1)", "Clinical", "Study", "Status", "definitions", "are", "provided", "in", "the", "chart", "found", "in", "Part", "I,", "Item", "1.", "<tag3>"], "wordsA": ["Factors", "that", "could", "cause", "or", "contribute", "to", "such", "differences", "include,", "but", "are", "not", "limited", "to,", "those", "discussed", "in", "this", "section", "as", "well", "as", "factors", "described", "in", "Part", "I,", "Item", "1A", "Risk", "Factors."], "wordsB": ["(1)", "Clinical", "Study", "Status", "definitions", "are", "provided", "in", "the", "chart", "found", "in", "Part", "I,", "Item", "1."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p27_s1", "idA": "906709_11_item7_p10_s1", "sentA": "Our current strategy is to manufacture and supply PEGylation reagents to support our proprietary drug candidates or for third party collaborators where we have a strategic development and commercialization relationship or where we derive substantial economic benefit.", "sentB": "Furthermore, our strategy includes entering into collaborations with third parties to participate in the development and commercialization of some of our drug candidates such as those collaborations that we have already completed for NKTR-118, NKTR-119 and Amikacin Inhale.", "type": 2, "words": ["<tag1>", "Our", "current", "strategy", "is", "to", "manufacture", "and", "supply", "PEGylation", "reagents", "to", "support", "our", "proprietary", "drug", "candidates", "or", "for", "third", "party", "collaborators", "where", "we", "have", "a", "strategic", "development", "and", "commercialization", "relationship", "or", "where", "we", "derive", "substantial", "economic", "benefit.", "<tag2>", "Furthermore,", "our", "strategy", "includes", "entering", "into", "collaborations", "with", "third", "parties", "to", "participate", "in", "the", "development", "and", "commercialization", "of", "some", "of", "our", "drug", "candidates", "such", "as", "those", "collaborations", "that", "we", "have", "already", "completed", "for", "NKTR-118,", "NKTR-119", "and", "Amikacin", "Inhale.", "<tag3>"], "wordsA": ["Our", "current", "strategy", "is", "to", "manufacture", "and", "supply", "PEGylation", "reagents", "to", "support", "our", "proprietary", "drug", "candidates", "or", "for", "third", "party", "collaborators", "where", "we", "have", "a", "strategic", "development", "and", "commercialization", "relationship", "or", "where", "we", "derive", "substantial", "economic", "benefit."], "wordsB": ["Furthermore,", "our", "strategy", "includes", "entering", "into", "collaborations", "with", "third", "parties", "to", "participate", "in", "the", "development", "and", "commercialization", "of", "some", "of", "our", "drug", "candidates", "such", "as", "those", "collaborations", "that", "we", "have", "already", "completed", "for", "NKTR-118,", "NKTR-119", "and", "Amikacin", "Inhale."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p32_s3", "idA": "906709_11_item7_p10_s2", "sentA": "As a result, whenever possible, we are renegotiating or not seeking renewal of legacy manufacturing supply arrangements that do not include a strategic development or commercialization component.", "sentB": "As a result, we expect interest expense in 2012 to increase significantly from 2011.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "whenever", "possible,", "we", "are", "renegotiating", "or", "not", "seeking", "renewal", "of", "legacy", "manufacturing", "supply", "arrangements", "that", "do", "not", "include", "a", "strategic", "development", "or", "commercialization", "component.", "<tag2>", "As", "a", "result,", "we", "expect", "interest", "expense", "in", "2012", "to", "increase", "significantly", "from", "2011.", "<tag3>"], "wordsA": ["As", "a", "result,", "whenever", "possible,", "we", "are", "renegotiating", "or", "not", "seeking", "renewal", "of", "legacy", "manufacturing", "supply", "arrangements", "that", "do", "not", "include", "a", "strategic", "development", "or", "commercialization", "component."], "wordsB": ["As", "a", "result,", "we", "expect", "interest", "expense", "in", "2012", "to", "increase", "significantly", "from", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p35_s0", "idA": "906709_11_item7_p10_s3", "sentA": "For example, in October 2010 we entered into a supply, dedicated suite and manufacturing guarantee agreement with Amgen Inc. and Amgen Manufacturing, Limited, which has significantly amended economic and other terms in the non-exclusive supply and license agreement we previously entered into with Amgen in July 1995.", "sentB": "During the year ended December 31, 2010, net cash used in operating activities totaled $55.9 million, which primarily consisted of spending on operating costs and expenses and includes $7.0 million for interest payments on our convertible subordinated notes, and was partially offset by a $50.0 million upfront payment received from Amgen under the supply, dedicated suite and manufacturing guarantee agreement that we entered into with Amgen in October 2010.", "type": 2, "words": ["<tag1>", "For", "example,", "in", "October", "2010", "we", "entered", "into", "a", "supply,", "dedicated", "suite", "and", "manufacturing", "guarantee", "agreement", "with", "Amgen", "Inc.", "and", "Amgen", "Manufacturing,", "Limited,", "which", "has", "significantly", "amended", "economic", "and", "other", "terms", "in", "the", "non-exclusive", "supply", "and", "license", "agreement", "we", "previously", "entered", "into", "with", "Amgen", "in", "July", "1995.", "<tag2>", "During", "the", "year", "ended", "December", "31,", "2010,", "net", "cash", "used", "in", "operating", "activities", "totaled", "$55.9", "million,", "which", "primarily", "consisted", "of", "spending", "on", "operating", "costs", "and", "expenses", "and", "includes", "$7.0", "million", "for", "interest", "payments", "on", "our", "convertible", "subordinated", "notes,", "and", "was", "partially", "offset", "by", "a", "$50.0", "million", "upfront", "payment", "received", "from", "Amgen", "under", "the", "supply,", "dedicated", "suite", "and", "manufacturing", "guarantee", "agreement", "that", "we", "entered", "into", "with", "Amgen", "in", "October", "2010.", "<tag3>"], "wordsA": ["For", "example,", "in", "October", "2010", "we", "entered", "into", "a", "supply,", "dedicated", "suite", "and", "manufacturing", "guarantee", "agreement", "with", "Amgen", "Inc.", "and", "Amgen", "Manufacturing,", "Limited,", "which", "has", "significantly", "amended", "economic", "and", "other", "terms", "in", "the", "non-exclusive", "supply", "and", "license", "agreement", "we", "previously", "entered", "into", "with", "Amgen", "in", "July", "1995."], "wordsB": ["During", "the", "year", "ended", "December", "31,", "2010,", "net", "cash", "used", "in", "operating", "activities", "totaled", "$55.9", "million,", "which", "primarily", "consisted", "of", "spending", "on", "operating", "costs", "and", "expenses", "and", "includes", "$7.0", "million", "for", "interest", "payments", "on", "our", "convertible", "subordinated", "notes,", "and", "was", "partially", "offset", "by", "a", "$50.0", "million", "upfront", "payment", "received", "from", "Amgen", "under", "the", "supply,", "dedicated", "suite", "and", "manufacturing", "guarantee", "agreement", "that", "we", "entered", "into", "with", "Amgen", "in", "October", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p7_s4", "idA": "906709_11_item7_p10_s4", "sentA": "In addition, in December 2010 we entered into an amended manufacturing and supply agreement with Merck (through its subsidiary Schering) to provide for transfer to an alternative manufacturer and revised economics for an interim supply arrangement until that transition is completed.", "sentB": "In addition, in December 2010, we entered into an amended manufacturing and supply agreement with Merck (through its acquisition of Schering-Plough Corporation) to provide for transfer to an alternative manufacturer and revised economics for an interim supply arrangement until that transition is completed.", "type": 2, "words": ["<tag1>", "In", "addition,", "in", "December", "2010", "we", "entered", "into", "an", "amended", "manufacturing", "and", "supply", "agreement", "with", "Merck", "(through", "its", "subsidiary", "Schering)", "to", "provide", "for", "transfer", "to", "an", "alternative", "manufacturer", "and", "revised", "economics", "for", "an", "interim", "supply", "arrangement", "until", "that", "transition", "is", "completed.", "<tag2>", "In", "addition,", "in", "December", "2010,", "we", "entered", "into", "an", "amended", "manufacturing", "and", "supply", "agreement", "with", "Merck", "(through", "its", "acquisition", "of", "Schering-Plough", "Corporation)", "to", "provide", "for", "transfer", "to", "an", "alternative", "manufacturer", "and", "revised", "economics", "for", "an", "interim", "supply", "arrangement", "until", "that", "transition", "is", "completed.", "<tag3>"], "wordsA": ["In", "addition,", "in", "December", "2010", "we", "entered", "into", "an", "amended", "manufacturing", "and", "supply", "agreement", "with", "Merck", "(through", "its", "subsidiary", "Schering)", "to", "provide", "for", "transfer", "to", "an", "alternative", "manufacturer", "and", "revised", "economics", "for", "an", "interim", "supply", "arrangement", "until", "that", "transition", "is", "completed."], "wordsB": ["In", "addition,", "in", "December", "2010,", "we", "entered", "into", "an", "amended", "manufacturing", "and", "supply", "agreement", "with", "Merck", "(through", "its", "acquisition", "of", "Schering-Plough", "Corporation)", "to", "provide", "for", "transfer", "to", "an", "alternative", "manufacturer", "and", "revised", "economics", "for", "an", "interim", "supply", "arrangement", "until", "that", "transition", "is", "completed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p32_s6", "idA": "906709_11_item7_p11_s0", "sentA": "At December 31, 2010, we had approximately $315.9 million in cash, cash equivalents, and short-term investments and $240.4 million in indebtedness.", "sentB": "As of December 31, 2011, we had cash, cash equivalents and investments in marketable securities of $414.9 million and indebtedness of $239.9 million, including $215.0 million of convertible subordinated notes, $17.0 million in capital lease obligations and $7.9 million in other liabilities.", "type": 2, "words": ["<tag1>", "At", "December", "31,", "2010,", "we", "had", "approximately", "$315.9", "million", "in", "cash,", "cash", "equivalents,", "and", "short-term", "investments", "and", "$240.4", "million", "in", "indebtedness.", "<tag2>", "As", "of", "December", "31,", "2011,", "we", "had", "cash,", "cash", "equivalents", "and", "investments", "in", "marketable", "securities", "of", "$414.9", "million", "and", "indebtedness", "of", "$239.9", "million,", "including", "$215.0", "million", "of", "convertible", "subordinated", "notes,", "$17.0", "million", "in", "capital", "lease", "obligations", "and", "$7.9", "million", "in", "other", "liabilities.", "<tag3>"], "wordsA": ["At", "December", "31,", "2010,", "we", "had", "approximately", "$315.9", "million", "in", "cash,", "cash", "equivalents,", "and", "short-term", "investments", "and", "$240.4", "million", "in", "indebtedness."], "wordsB": ["As", "of", "December", "31,", "2011,", "we", "had", "cash,", "cash", "equivalents", "and", "investments", "in", "marketable", "securities", "of", "$414.9", "million", "and", "indebtedness", "of", "$239.9", "million,", "including", "$215.0", "million", "of", "convertible", "subordinated", "notes,", "$17.0", "million", "in", "capital", "lease", "obligations", "and", "$7.9", "million", "in", "other", "liabilities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p34_s17", "idA": "906709_11_item7_p11_s0", "sentA": "At December 31, 2010, we had approximately $315.9 million in cash, cash equivalents, and short-term investments and $240.4 million in indebtedness.", "sentB": "We believe that, even allowing for potential liquidity issues with respect to these securities, our remaining cash, cash equivalents, and investments will be sufficient to meet our anticipated cash needs for at least the next twelve months.", "type": 2, "words": ["<tag1>", "At", "December", "31,", "2010,", "we", "had", "approximately", "$315.9", "million", "in", "cash,", "cash", "equivalents,", "and", "short-term", "investments", "and", "$240.4", "million", "in", "indebtedness.", "<tag2>", "We", "believe", "that,", "even", "allowing", "for", "potential", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "our", "remaining", "cash,", "cash", "equivalents,", "and", "investments", "will", "be", "sufficient", "to", "meet", "our", "anticipated", "cash", "needs", "for", "at", "least", "the", "next", "twelve", "months.", "<tag3>"], "wordsA": ["At", "December", "31,", "2010,", "we", "had", "approximately", "$315.9", "million", "in", "cash,", "cash", "equivalents,", "and", "short-term", "investments", "and", "$240.4", "million", "in", "indebtedness."], "wordsB": ["We", "believe", "that,", "even", "allowing", "for", "potential", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "our", "remaining", "cash,", "cash", "equivalents,", "and", "investments", "will", "be", "sufficient", "to", "meet", "our", "anticipated", "cash", "needs", "for", "at", "least", "the", "next", "twelve", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p8_s0", "idA": "906709_11_item7_p11_s0", "sentA": "At December 31, 2010, we had approximately $315.9 million in cash, cash equivalents, and short-term investments and $240.4 million in indebtedness.", "sentB": "Key Developments and Trends in Liquidity and Capital Resources At December 31, 2011, we had approximately $414.9 million in cash, cash equivalents, and investments in marketable securities and $239.9 million in indebtedness.", "type": 2, "words": ["<tag1>", "At", "December", "31,", "2010,", "we", "had", "approximately", "$315.9", "million", "in", "cash,", "cash", "equivalents,", "and", "short-term", "investments", "and", "$240.4", "million", "in", "indebtedness.", "<tag2>", "Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "At", "December", "31,", "2011,", "we", "had", "approximately", "$414.9", "million", "in", "cash,", "cash", "equivalents,", "and", "investments", "in", "marketable", "securities", "and", "$239.9", "million", "in", "indebtedness.", "<tag3>"], "wordsA": ["At", "December", "31,", "2010,", "we", "had", "approximately", "$315.9", "million", "in", "cash,", "cash", "equivalents,", "and", "short-term", "investments", "and", "$240.4", "million", "in", "indebtedness."], "wordsB": ["Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "At", "December", "31,", "2011,", "we", "had", "approximately", "$414.9", "million", "in", "cash,", "cash", "equivalents,", "and", "investments", "in", "marketable", "securities", "and", "$239.9", "million", "in", "indebtedness."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p10_s1", "idA": "906709_11_item7_p11_s1", "sentA": "On January 24, 2011, we completed a public offering of our common stock with proceeds of approximately $220.4 million.", "sentB": "On February 29, 2012, we sold all of our rights to receive future royalty payments on CIMZIA and MIRCERA in exchange for $124.0 million.", "type": 2, "words": ["<tag1>", "On", "January", "24,", "2011,", "we", "completed", "a", "public", "offering", "of", "our", "common", "stock", "with", "proceeds", "of", "approximately", "$220.4", "million.", "<tag2>", "On", "February", "29,", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "on", "CIMZIA", "and", "MIRCERA", "in", "exchange", "for", "$124.0", "million.", "<tag3>"], "wordsA": ["On", "January", "24,", "2011,", "we", "completed", "a", "public", "offering", "of", "our", "common", "stock", "with", "proceeds", "of", "approximately", "$220.4", "million."], "wordsB": ["On", "February", "29,", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "on", "CIMZIA", "and", "MIRCERA", "in", "exchange", "for", "$124.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p32_s7", "idA": "906709_11_item7_p11_s1", "sentA": "On January 24, 2011, we completed a public offering of our common stock with proceeds of approximately $220.4 million.", "sentB": "Additionally at December 31, 2011, we had letter of credit arrangements with certain financial institutions and vendors, including our landlord, totaling $2.4 million.", "type": 2, "words": ["<tag1>", "On", "January", "24,", "2011,", "we", "completed", "a", "public", "offering", "of", "our", "common", "stock", "with", "proceeds", "of", "approximately", "$220.4", "million.", "<tag2>", "Additionally", "at", "December", "31,", "2011,", "we", "had", "letter", "of", "credit", "arrangements", "with", "certain", "financial", "institutions", "and", "vendors,", "including", "our", "landlord,", "totaling", "$2.4", "million.", "<tag3>"], "wordsA": ["On", "January", "24,", "2011,", "we", "completed", "a", "public", "offering", "of", "our", "common", "stock", "with", "proceeds", "of", "approximately", "$220.4", "million."], "wordsB": ["Additionally", "at", "December", "31,", "2011,", "we", "had", "letter", "of", "credit", "arrangements", "with", "certain", "financial", "institutions", "and", "vendors,", "including", "our", "landlord,", "totaling", "$2.4", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p34_s0", "idA": "906709_11_item7_p11_s1", "sentA": "On January 24, 2011, we completed a public offering of our common stock with proceeds of approximately $220.4 million.", "sentB": "On February 29, 2012, we sold all of our rights to receive future royalty payments on CIMZIA and MIRCERA in exchange for $124.0 million.", "type": 2, "words": ["<tag1>", "On", "January", "24,", "2011,", "we", "completed", "a", "public", "offering", "of", "our", "common", "stock", "with", "proceeds", "of", "approximately", "$220.4", "million.", "<tag2>", "On", "February", "29,", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "on", "CIMZIA", "and", "MIRCERA", "in", "exchange", "for", "$124.0", "million.", "<tag3>"], "wordsA": ["On", "January", "24,", "2011,", "we", "completed", "a", "public", "offering", "of", "our", "common", "stock", "with", "proceeds", "of", "approximately", "$220.4", "million."], "wordsB": ["On", "February", "29,", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "on", "CIMZIA", "and", "MIRCERA", "in", "exchange", "for", "$124.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p36_s2", "idA": "906709_11_item7_p11_s1", "sentA": "On January 24, 2011, we completed a public offering of our common stock with proceeds of approximately $220.4 million.", "sentB": "On January 24, 2011, we completed a public offering of our common stock with gross proceeds of approximately $220.4 million.", "type": 2, "words": ["<tag1>", "On", "January", "24,", "2011,", "we", "completed", "a", "public", "offering", "of", "our", "common", "stock", "with", "proceeds", "of", "approximately", "$220.4", "million.", "<tag2>", "On", "January", "24,", "2011,", "we", "completed", "a", "public", "offering", "of", "our", "common", "stock", "with", "gross", "proceeds", "of", "approximately", "$220.4", "million.", "<tag3>"], "wordsA": ["On", "January", "24,", "2011,", "we", "completed", "a", "public", "offering", "of", "our", "common", "stock", "with", "proceeds", "of", "approximately", "$220.4", "million."], "wordsB": ["On", "January", "24,", "2011,", "we", "completed", "a", "public", "offering", "of", "our", "common", "stock", "with", "gross", "proceeds", "of", "approximately", "$220.4", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p10_s2", "idA": "906709_11_item7_p11_s2", "sentA": "Additionally, as part of the public offering, we incurred approximately $0.6 million in legal and accounting fees, filing fees, and other offering expenses.", "sentB": "Additionally, we incurred approximately $4.5 million in transaction costs.", "type": 2, "words": ["<tag1>", "Additionally,", "as", "part", "of", "the", "public", "offering,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses.", "<tag2>", "Additionally,", "we", "incurred", "approximately", "$4.5", "million", "in", "transaction", "costs.", "<tag3>"], "wordsA": ["Additionally,", "as", "part", "of", "the", "public", "offering,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses."], "wordsB": ["Additionally,", "we", "incurred", "approximately", "$4.5", "million", "in", "transaction", "costs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p34_s1", "idA": "906709_11_item7_p11_s2", "sentA": "Additionally, as part of the public offering, we incurred approximately $0.6 million in legal and accounting fees, filing fees, and other offering expenses.", "sentB": "Additionally, we incurred approximately $4.5 million in transaction costs.", "type": 2, "words": ["<tag1>", "Additionally,", "as", "part", "of", "the", "public", "offering,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses.", "<tag2>", "Additionally,", "we", "incurred", "approximately", "$4.5", "million", "in", "transaction", "costs.", "<tag3>"], "wordsA": ["Additionally,", "as", "part", "of", "the", "public", "offering,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses."], "wordsB": ["Additionally,", "we", "incurred", "approximately", "$4.5", "million", "in", "transaction", "costs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p36_s3", "idA": "906709_11_item7_p11_s2", "sentA": "Additionally, as part of the public offering, we incurred approximately $0.6 million in legal and accounting fees, filing fees, and other offering expenses.", "sentB": "As part of the public offering, we incurred approximately $0.6 million in legal and accounting fees, filing fees, and other offering expenses.", "type": 2, "words": ["<tag1>", "Additionally,", "as", "part", "of", "the", "public", "offering,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses.", "<tag2>", "As", "part", "of", "the", "public", "offering,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses.", "<tag3>"], "wordsA": ["Additionally,", "as", "part", "of", "the", "public", "offering,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses."], "wordsB": ["As", "part", "of", "the", "public", "offering,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p34_s10", "idA": "906709_11_item7_p11_s3", "sentA": "We have $215.0 million in outstanding convertible subordinated notes due September 2012.", "sentB": "Please refer to Part I, Item 1A, Risk Factors, We may need to raise substantial additional capital to repay the $215.0 million in convertible notes due in September 2012 and fund our future operations, and we may be unable to secure such capital without dilutive financing transactions and We have substantial future capital requirements and there is a risk we may not have access to sufficient capital to meet our current business plan.", "type": 2, "words": ["<tag1>", "We", "have", "$215.0", "million", "in", "outstanding", "convertible", "subordinated", "notes", "due", "September", "2012.", "<tag2>", "Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "may", "need", "to", "raise", "substantial", "additional", "capital", "to", "repay", "the", "$215.0", "million", "in", "convertible", "notes", "due", "in", "September", "2012", "and", "fund", "our", "future", "operations,", "and", "we", "may", "be", "unable", "to", "secure", "such", "capital", "without", "dilutive", "financing", "transactions", "and", "We", "have", "substantial", "future", "capital", "requirements", "and", "there", "is", "a", "risk", "we", "may", "not", "have", "access", "to", "sufficient", "capital", "to", "meet", "our", "current", "business", "plan.", "<tag3>"], "wordsA": ["We", "have", "$215.0", "million", "in", "outstanding", "convertible", "subordinated", "notes", "due", "September", "2012."], "wordsB": ["Please", "refer", "to", "Part", "I,", "Item", "1A,", "Risk", "Factors,", "We", "may", "need", "to", "raise", "substantial", "additional", "capital", "to", "repay", "the", "$215.0", "million", "in", "convertible", "notes", "due", "in", "September", "2012", "and", "fund", "our", "future", "operations,", "and", "we", "may", "be", "unable", "to", "secure", "such", "capital", "without", "dilutive", "financing", "transactions", "and", "We", "have", "substantial", "future", "capital", "requirements", "and", "there", "is", "a", "risk", "we", "may", "not", "have", "access", "to", "sufficient", "capital", "to", "meet", "our", "current", "business", "plan."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p28_s0", "idA": "906709_11_item7_p11_s4", "sentA": "We do not have sufficient resources to fund our research and development plans and repay these convertible notes.", "sentB": "The risks and uncertainties associated with our research and development projects are discussed more fully in Item 1A Risk Factors.", "type": 2, "words": ["<tag1>", "We", "do", "not", "have", "sufficient", "resources", "to", "fund", "our", "research", "and", "development", "plans", "and", "repay", "these", "convertible", "notes.", "<tag2>", "The", "risks", "and", "uncertainties", "associated", "with", "our", "research", "and", "development", "projects", "are", "discussed", "more", "fully", "in", "Item", "1A", "Risk", "Factors.", "<tag3>"], "wordsA": ["We", "do", "not", "have", "sufficient", "resources", "to", "fund", "our", "research", "and", "development", "plans", "and", "repay", "these", "convertible", "notes."], "wordsB": ["The", "risks", "and", "uncertainties", "associated", "with", "our", "research", "and", "development", "projects", "are", "discussed", "more", "fully", "in", "Item", "1A", "Risk", "Factors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p35_s4", "idA": "906709_11_item7_p11_s4", "sentA": "We do not have sufficient resources to fund our research and development plans and repay these convertible notes.", "sentB": "Our capital expenditures increased in 2010, as we constructed the leasehold improvements for the Mission Bay Facility and completed our research and development facility in Hyderabad, India.", "type": 2, "words": ["<tag1>", "We", "do", "not", "have", "sufficient", "resources", "to", "fund", "our", "research", "and", "development", "plans", "and", "repay", "these", "convertible", "notes.", "<tag2>", "Our", "capital", "expenditures", "increased", "in", "2010,", "as", "we", "constructed", "the", "leasehold", "improvements", "for", "the", "Mission", "Bay", "Facility", "and", "completed", "our", "research", "and", "development", "facility", "in", "Hyderabad,", "India.", "<tag3>"], "wordsA": ["We", "do", "not", "have", "sufficient", "resources", "to", "fund", "our", "research", "and", "development", "plans", "and", "repay", "these", "convertible", "notes."], "wordsB": ["Our", "capital", "expenditures", "increased", "in", "2010,", "as", "we", "constructed", "the", "leasehold", "improvements", "for", "the", "Mission", "Bay", "Facility", "and", "completed", "our", "research", "and", "development", "facility", "in", "Hyderabad,", "India."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p24_s7", "idA": "906709_11_item7_p11_s6", "sentA": "We expect the Phase 3 clinical studies of NKTR-102 to require particularly significant resources because we anticipate bearing a majority or all of the development costs for that drug candidate.", "sentB": "We will be funding all of the clinical development costs for NKTR-102 without reimbursement from a collaboration partner for the foreseeable future.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "Phase", "3", "clinical", "studies", "of", "NKTR-102", "to", "require", "particularly", "significant", "resources", "because", "we", "anticipate", "bearing", "a", "majority", "or", "all", "of", "the", "development", "costs", "for", "that", "drug", "candidate.", "<tag2>", "We", "will", "be", "funding", "all", "of", "the", "clinical", "development", "costs", "for", "NKTR-102", "without", "reimbursement", "from", "a", "collaboration", "partner", "for", "the", "foreseeable", "future.", "<tag3>"], "wordsA": ["We", "expect", "the", "Phase", "3", "clinical", "studies", "of", "NKTR-102", "to", "require", "particularly", "significant", "resources", "because", "we", "anticipate", "bearing", "a", "majority", "or", "all", "of", "the", "development", "costs", "for", "that", "drug", "candidate."], "wordsB": ["We", "will", "be", "funding", "all", "of", "the", "clinical", "development", "costs", "for", "NKTR-102", "without", "reimbursement", "from", "a", "collaboration", "partner", "for", "the", "foreseeable", "future."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p24_s8", "idA": "906709_11_item7_p11_s6", "sentA": "We expect the Phase 3 clinical studies of NKTR-102 to require particularly significant resources because we anticipate bearing a majority or all of the development costs for that drug candidate.", "sentB": "The clinical development costs for NKTR-102 will be significant.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "Phase", "3", "clinical", "studies", "of", "NKTR-102", "to", "require", "particularly", "significant", "resources", "because", "we", "anticipate", "bearing", "a", "majority", "or", "all", "of", "the", "development", "costs", "for", "that", "drug", "candidate.", "<tag2>", "The", "clinical", "development", "costs", "for", "NKTR-102", "will", "be", "significant.", "<tag3>"], "wordsA": ["We", "expect", "the", "Phase", "3", "clinical", "studies", "of", "NKTR-102", "to", "require", "particularly", "significant", "resources", "because", "we", "anticipate", "bearing", "a", "majority", "or", "all", "of", "the", "development", "costs", "for", "that", "drug", "candidate."], "wordsB": ["The", "clinical", "development", "costs", "for", "NKTR-102", "will", "be", "significant."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p2_s1", "idA": "906709_11_item7_p11_s6", "sentA": "We expect the Phase 3 clinical studies of NKTR-102 to require particularly significant resources because we anticipate bearing a majority or all of the development costs for that drug candidate.", "sentB": "On March 15, 2011, AstraZeneca announced enrollment of the first patient in Phase 3 clinical studies for NKTR-118 that AstraZeneca calls the KODIAC study.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "Phase", "3", "clinical", "studies", "of", "NKTR-102", "to", "require", "particularly", "significant", "resources", "because", "we", "anticipate", "bearing", "a", "majority", "or", "all", "of", "the", "development", "costs", "for", "that", "drug", "candidate.", "<tag2>", "On", "March", "15,", "2011,", "AstraZeneca", "announced", "enrollment", "of", "the", "first", "patient", "in", "Phase", "3", "clinical", "studies", "for", "NKTR-118", "that", "AstraZeneca", "calls", "the", "KODIAC", "study.", "<tag3>"], "wordsA": ["We", "expect", "the", "Phase", "3", "clinical", "studies", "of", "NKTR-102", "to", "require", "particularly", "significant", "resources", "because", "we", "anticipate", "bearing", "a", "majority", "or", "all", "of", "the", "development", "costs", "for", "that", "drug", "candidate."], "wordsB": ["On", "March", "15,", "2011,", "AstraZeneca", "announced", "enrollment", "of", "the", "first", "patient", "in", "Phase", "3", "clinical", "studies", "for", "NKTR-118", "that", "AstraZeneca", "calls", "the", "KODIAC", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p34_s7", "idA": "906709_11_item7_p11_s6", "sentA": "We expect the Phase 3 clinical studies of NKTR-102 to require particularly significant resources because we anticipate bearing a majority or all of the development costs for that drug candidate.", "sentB": "In addition, we expect the Phase 3 clinical trials of NKTR-102 to require particularly significant resources because we anticipate bearing a majority or all of the development costs for that drug candidate.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "Phase", "3", "clinical", "studies", "of", "NKTR-102", "to", "require", "particularly", "significant", "resources", "because", "we", "anticipate", "bearing", "a", "majority", "or", "all", "of", "the", "development", "costs", "for", "that", "drug", "candidate.", "<tag2>", "In", "addition,", "we", "expect", "the", "Phase", "3", "clinical", "trials", "of", "NKTR-102", "to", "require", "particularly", "significant", "resources", "because", "we", "anticipate", "bearing", "a", "majority", "or", "all", "of", "the", "development", "costs", "for", "that", "drug", "candidate.", "<tag3>"], "wordsA": ["We", "expect", "the", "Phase", "3", "clinical", "studies", "of", "NKTR-102", "to", "require", "particularly", "significant", "resources", "because", "we", "anticipate", "bearing", "a", "majority", "or", "all", "of", "the", "development", "costs", "for", "that", "drug", "candidate."], "wordsB": ["In", "addition,", "we", "expect", "the", "Phase", "3", "clinical", "trials", "of", "NKTR-102", "to", "require", "particularly", "significant", "resources", "because", "we", "anticipate", "bearing", "a", "majority", "or", "all", "of", "the", "development", "costs", "for", "that", "drug", "candidate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p5_s8", "idA": "906709_11_item7_p11_s6", "sentA": "We expect the Phase 3 clinical studies of NKTR-102 to require particularly significant resources because we anticipate bearing a majority or all of the development costs for that drug candidate.", "sentB": "We expect to continue to make significant investments over the next two years in establishing manufacturing capability for the nebulizer device necessary to support the Phase 3 clinical study of this drug candidate and, if such study is successful and the drug candidate is approved by government health authorities, the commercial supply of the nebulizer device.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "Phase", "3", "clinical", "studies", "of", "NKTR-102", "to", "require", "particularly", "significant", "resources", "because", "we", "anticipate", "bearing", "a", "majority", "or", "all", "of", "the", "development", "costs", "for", "that", "drug", "candidate.", "<tag2>", "We", "expect", "to", "continue", "to", "make", "significant", "investments", "over", "the", "next", "two", "years", "in", "establishing", "manufacturing", "capability", "for", "the", "nebulizer", "device", "necessary", "to", "support", "the", "Phase", "3", "clinical", "study", "of", "this", "drug", "candidate", "and,", "if", "such", "study", "is", "successful", "and", "the", "drug", "candidate", "is", "approved", "by", "government", "health", "authorities,", "the", "commercial", "supply", "of", "the", "nebulizer", "device.", "<tag3>"], "wordsA": ["We", "expect", "the", "Phase", "3", "clinical", "studies", "of", "NKTR-102", "to", "require", "particularly", "significant", "resources", "because", "we", "anticipate", "bearing", "a", "majority", "or", "all", "of", "the", "development", "costs", "for", "that", "drug", "candidate."], "wordsB": ["We", "expect", "to", "continue", "to", "make", "significant", "investments", "over", "the", "next", "two", "years", "in", "establishing", "manufacturing", "capability", "for", "the", "nebulizer", "device", "necessary", "to", "support", "the", "Phase", "3", "clinical", "study", "of", "this", "drug", "candidate", "and,", "if", "such", "study", "is", "successful", "and", "the", "drug", "candidate", "is", "approved", "by", "government", "health", "authorities,", "the", "commercial", "supply", "of", "the", "nebulizer", "device."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p10_s3", "idA": "906709_11_item7_p12_s0", "sentA": "Prior to the maturity of the convertible notes, we plan to explore a number of alternatives to provide for the repayment of the notes, including restructuring the notes.", "sentB": "While the net proceeds from this transaction will fund more than 50% of the September 2012 repayment obligation for the outstanding convertible notes, we intend to pursue other financing alternatives before the convertible note maturity date which could include the sale of additional royalty interests from legacy agreements or term loan arrangements.", "type": 2, "words": ["<tag1>", "Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "notes,", "including", "restructuring", "the", "notes.", "<tag2>", "While", "the", "net", "proceeds", "from", "this", "transaction", "will", "fund", "more", "than", "50%", "of", "the", "September", "2012", "repayment", "obligation", "for", "the", "outstanding", "convertible", "notes,", "we", "intend", "to", "pursue", "other", "financing", "alternatives", "before", "the", "convertible", "note", "maturity", "date", "which", "could", "include", "the", "sale", "of", "additional", "royalty", "interests", "from", "legacy", "agreements", "or", "term", "loan", "arrangements.", "<tag3>"], "wordsA": ["Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "notes,", "including", "restructuring", "the", "notes."], "wordsB": ["While", "the", "net", "proceeds", "from", "this", "transaction", "will", "fund", "more", "than", "50%", "of", "the", "September", "2012", "repayment", "obligation", "for", "the", "outstanding", "convertible", "notes,", "we", "intend", "to", "pursue", "other", "financing", "alternatives", "before", "the", "convertible", "note", "maturity", "date", "which", "could", "include", "the", "sale", "of", "additional", "royalty", "interests", "from", "legacy", "agreements", "or", "term", "loan", "arrangements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p34_s15", "idA": "906709_11_item7_p12_s0", "sentA": "Prior to the maturity of the convertible notes, we plan to explore a number of alternatives to provide for the repayment of the notes, including restructuring the notes.", "sentB": "At December 31, 2011, the average time to maturity of the investments held in our portfolio was approximately ten months and the maturity of any single investment did not exceed twenty-four months.", "type": 2, "words": ["<tag1>", "Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "notes,", "including", "restructuring", "the", "notes.", "<tag2>", "At", "December", "31,", "2011,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "ten", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "twenty-four", "months.", "<tag3>"], "wordsA": ["Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "notes,", "including", "restructuring", "the", "notes."], "wordsB": ["At", "December", "31,", "2011,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "ten", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "twenty-four", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p34_s2", "idA": "906709_11_item7_p12_s0", "sentA": "Prior to the maturity of the convertible notes, we plan to explore a number of alternatives to provide for the repayment of the notes, including restructuring the notes.", "sentB": "While the net payments from this transaction will fund more than 50% of the September 2012 repayment obligation for the outstanding convertible notes, we intend to pursue other financing alternatives before the convertible note maturity date which could include the sale of additional royalty interests or term loan arrangements.", "type": 2, "words": ["<tag1>", "Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "notes,", "including", "restructuring", "the", "notes.", "<tag2>", "While", "the", "net", "payments", "from", "this", "transaction", "will", "fund", "more", "than", "50%", "of", "the", "September", "2012", "repayment", "obligation", "for", "the", "outstanding", "convertible", "notes,", "we", "intend", "to", "pursue", "other", "financing", "alternatives", "before", "the", "convertible", "note", "maturity", "date", "which", "could", "include", "the", "sale", "of", "additional", "royalty", "interests", "or", "term", "loan", "arrangements.", "<tag3>"], "wordsA": ["Prior", "to", "the", "maturity", "of", "the", "convertible", "notes,", "we", "plan", "to", "explore", "a", "number", "of", "alternatives", "to", "provide", "for", "the", "repayment", "of", "the", "notes,", "including", "restructuring", "the", "notes."], "wordsB": ["While", "the", "net", "payments", "from", "this", "transaction", "will", "fund", "more", "than", "50%", "of", "the", "September", "2012", "repayment", "obligation", "for", "the", "outstanding", "convertible", "notes,", "we", "intend", "to", "pursue", "other", "financing", "alternatives", "before", "the", "convertible", "note", "maturity", "date", "which", "could", "include", "the", "sale", "of", "additional", "royalty", "interests", "or", "term", "loan", "arrangements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p32_s5", "idA": "906709_11_item7_p13_s0", "sentA": "We have financed our operations primarily through revenue from product sales and royalties, development and commercialization collaboration contracts and debt and equity financings.", "sentB": "Liquidity and Capital Resources We have financed our operations primarily through revenue from product sales, royalties and research and development contracts, as well as public and private placements of debt and equity.", "type": 2, "words": ["<tag1>", "We", "have", "financed", "our", "operations", "primarily", "through", "revenue", "from", "product", "sales", "and", "royalties,", "development", "and", "commercialization", "collaboration", "contracts", "and", "debt", "and", "equity", "financings.", "<tag2>", "Liquidity", "and", "Capital", "Resources", "We", "have", "financed", "our", "operations", "primarily", "through", "revenue", "from", "product", "sales,", "royalties", "and", "research", "and", "development", "contracts,", "as", "well", "as", "public", "and", "private", "placements", "of", "debt", "and", "equity.", "<tag3>"], "wordsA": ["We", "have", "financed", "our", "operations", "primarily", "through", "revenue", "from", "product", "sales", "and", "royalties,", "development", "and", "commercialization", "collaboration", "contracts", "and", "debt", "and", "equity", "financings."], "wordsB": ["Liquidity", "and", "Capital", "Resources", "We", "have", "financed", "our", "operations", "primarily", "through", "revenue", "from", "product", "sales,", "royalties", "and", "research", "and", "development", "contracts,", "as", "well", "as", "public", "and", "private", "placements", "of", "debt", "and", "equity."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p9_s0", "idA": "906709_11_item7_p13_s0", "sentA": "We have financed our operations primarily through revenue from product sales and royalties, development and commercialization collaboration contracts and debt and equity financings.", "sentB": "Historically, we have financed our operations primarily through cash from licensing, collaboration and manufacturing agreements and public and private placements of debt and equity securities.", "type": 2, "words": ["<tag1>", "We", "have", "financed", "our", "operations", "primarily", "through", "revenue", "from", "product", "sales", "and", "royalties,", "development", "and", "commercialization", "collaboration", "contracts", "and", "debt", "and", "equity", "financings.", "<tag2>", "Historically,", "we", "have", "financed", "our", "operations", "primarily", "through", "cash", "from", "licensing,", "collaboration", "and", "manufacturing", "agreements", "and", "public", "and", "private", "placements", "of", "debt", "and", "equity", "securities.", "<tag3>"], "wordsA": ["We", "have", "financed", "our", "operations", "primarily", "through", "revenue", "from", "product", "sales", "and", "royalties,", "development", "and", "commercialization", "collaboration", "contracts", "and", "debt", "and", "equity", "financings."], "wordsB": ["Historically,", "we", "have", "financed", "our", "operations", "primarily", "through", "cash", "from", "licensing,", "collaboration", "and", "manufacturing", "agreements", "and", "public", "and", "private", "placements", "of", "debt", "and", "equity", "securities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p34_s11", "idA": "906709_11_item7_p13_s1", "sentA": "While in the past we have received a number of significant payments from license and collaboration agreements and other significant transactions, we do not currently anticipate receiving substantial payments for new transactions in the near future.", "sentB": "If we do not receive substantial milestone payments from our existing collaboration agreements, execute new high value collaboration partnerships, or if we are unable to raise additional capital in one or more financing transactions, we would be unable to continue our current level of investment in research and development.", "type": 2, "words": ["<tag1>", "While", "in", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "license", "and", "collaboration", "agreements", "and", "other", "significant", "transactions,", "we", "do", "not", "currently", "anticipate", "receiving", "substantial", "payments", "for", "new", "transactions", "in", "the", "near", "future.", "<tag2>", "If", "we", "do", "not", "receive", "substantial", "milestone", "payments", "from", "our", "existing", "collaboration", "agreements,", "execute", "new", "high", "value", "collaboration", "partnerships,", "or", "if", "we", "are", "unable", "to", "raise", "additional", "capital", "in", "one", "or", "more", "financing", "transactions,", "we", "would", "be", "unable", "to", "continue", "our", "current", "level", "of", "investment", "in", "research", "and", "development.", "<tag3>"], "wordsA": ["While", "in", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "license", "and", "collaboration", "agreements", "and", "other", "significant", "transactions,", "we", "do", "not", "currently", "anticipate", "receiving", "substantial", "payments", "for", "new", "transactions", "in", "the", "near", "future."], "wordsB": ["If", "we", "do", "not", "receive", "substantial", "milestone", "payments", "from", "our", "existing", "collaboration", "agreements,", "execute", "new", "high", "value", "collaboration", "partnerships,", "or", "if", "we", "are", "unable", "to", "raise", "additional", "capital", "in", "one", "or", "more", "financing", "transactions,", "we", "would", "be", "unable", "to", "continue", "our", "current", "level", "of", "investment", "in", "research", "and", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p9_s1", "idA": "906709_11_item7_p13_s1", "sentA": "While in the past we have received a number of significant payments from license and collaboration agreements and other significant transactions, we do not currently anticipate receiving substantial payments for new transactions in the near future.", "sentB": "While in the past we have received a number of significant payments from license and collaboration agreements and other significant transactions, we do not currently anticipate completing new transactions with substantial upfront payments in the near future.", "type": 2, "words": ["<tag1>", "While", "in", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "license", "and", "collaboration", "agreements", "and", "other", "significant", "transactions,", "we", "do", "not", "currently", "anticipate", "receiving", "substantial", "payments", "for", "new", "transactions", "in", "the", "near", "future.", "<tag2>", "While", "in", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "license", "and", "collaboration", "agreements", "and", "other", "significant", "transactions,", "we", "do", "not", "currently", "anticipate", "completing", "new", "transactions", "with", "substantial", "upfront", "payments", "in", "the", "near", "future.", "<tag3>"], "wordsA": ["While", "in", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "license", "and", "collaboration", "agreements", "and", "other", "significant", "transactions,", "we", "do", "not", "currently", "anticipate", "receiving", "substantial", "payments", "for", "new", "transactions", "in", "the", "near", "future."], "wordsB": ["While", "in", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "license", "and", "collaboration", "agreements", "and", "other", "significant", "transactions,", "we", "do", "not", "currently", "anticipate", "completing", "new", "transactions", "with", "substantial", "upfront", "payments", "in", "the", "near", "future."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p10_s4", "idA": "906709_11_item7_p13_s2", "sentA": "To date we have incurred substantial debt as a result of our issuances of subordinated notes that are convertible into our common stock.", "sentB": "Where we believe it is in the best interests of the company and our stockholders, we are pursuing financing alternatives that are not dilutive to the ownership of our common stock security holders.", "type": 2, "words": ["<tag1>", "To", "date", "we", "have", "incurred", "substantial", "debt", "as", "a", "result", "of", "our", "issuances", "of", "subordinated", "notes", "that", "are", "convertible", "into", "our", "common", "stock.", "<tag2>", "Where", "we", "believe", "it", "is", "in", "the", "best", "interests", "of", "the", "company", "and", "our", "stockholders,", "we", "are", "pursuing", "financing", "alternatives", "that", "are", "not", "dilutive", "to", "the", "ownership", "of", "our", "common", "stock", "security", "holders.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "incurred", "substantial", "debt", "as", "a", "result", "of", "our", "issuances", "of", "subordinated", "notes", "that", "are", "convertible", "into", "our", "common", "stock."], "wordsB": ["Where", "we", "believe", "it", "is", "in", "the", "best", "interests", "of", "the", "company", "and", "our", "stockholders,", "we", "are", "pursuing", "financing", "alternatives", "that", "are", "not", "dilutive", "to", "the", "ownership", "of", "our", "common", "stock", "security", "holders."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p26_s2", "idA": "906709_11_item7_p13_s2", "sentA": "To date we have incurred substantial debt as a result of our issuances of subordinated notes that are convertible into our common stock.", "sentB": "The cost and time required to complete clinical trials may vary significantly over the life of a clinical development program as a result of a variety of factors, including but not limited to:", "type": 2, "words": ["<tag1>", "To", "date", "we", "have", "incurred", "substantial", "debt", "as", "a", "result", "of", "our", "issuances", "of", "subordinated", "notes", "that", "are", "convertible", "into", "our", "common", "stock.", "<tag2>", "The", "cost", "and", "time", "required", "to", "complete", "clinical", "trials", "may", "vary", "significantly", "over", "the", "life", "of", "a", "clinical", "development", "program", "as", "a", "result", "of", "a", "variety", "of", "factors,", "including", "but", "not", "limited", "to:", "<tag3>"], "wordsA": ["To", "date", "we", "have", "incurred", "substantial", "debt", "as", "a", "result", "of", "our", "issuances", "of", "subordinated", "notes", "that", "are", "convertible", "into", "our", "common", "stock."], "wordsB": ["The", "cost", "and", "time", "required", "to", "complete", "clinical", "trials", "may", "vary", "significantly", "over", "the", "life", "of", "a", "clinical", "development", "program", "as", "a", "result", "of", "a", "variety", "of", "factors,", "including", "but", "not", "limited", "to:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p34_s16", "idA": "906709_11_item7_p13_s2", "sentA": "To date we have incurred substantial debt as a result of our issuances of subordinated notes that are convertible into our common stock.", "sentB": "To date we have not experienced any liquidity issues with respect to these securities, but should such issues arise, we may be required to hold some, or all, of these securities until maturity.", "type": 2, "words": ["<tag1>", "To", "date", "we", "have", "incurred", "substantial", "debt", "as", "a", "result", "of", "our", "issuances", "of", "subordinated", "notes", "that", "are", "convertible", "into", "our", "common", "stock.", "<tag2>", "To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "should", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "incurred", "substantial", "debt", "as", "a", "result", "of", "our", "issuances", "of", "subordinated", "notes", "that", "are", "convertible", "into", "our", "common", "stock."], "wordsB": ["To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "should", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p34_s19", "idA": "906709_11_item7_p13_s2", "sentA": "To date we have incurred substantial debt as a result of our issuances of subordinated notes that are convertible into our common stock.", "sentB": "We expect that cash flows used in operating activities, excluding upfront payments received, if any, will increase in 2012 as a result of increased spending on our proprietary research and development programs and, in particular, our BEACON study.", "type": 2, "words": ["<tag1>", "To", "date", "we", "have", "incurred", "substantial", "debt", "as", "a", "result", "of", "our", "issuances", "of", "subordinated", "notes", "that", "are", "convertible", "into", "our", "common", "stock.", "<tag2>", "We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront", "payments", "received,", "if", "any,", "will", "increase", "in", "2012", "as", "a", "result", "of", "increased", "spending", "on", "our", "proprietary", "research", "and", "development", "programs", "and,", "in", "particular,", "our", "BEACON", "study.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "incurred", "substantial", "debt", "as", "a", "result", "of", "our", "issuances", "of", "subordinated", "notes", "that", "are", "convertible", "into", "our", "common", "stock."], "wordsB": ["We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront", "payments", "received,", "if", "any,", "will", "increase", "in", "2012", "as", "a", "result", "of", "increased", "spending", "on", "our", "proprietary", "research", "and", "development", "programs", "and,", "in", "particular,", "our", "BEACON", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p34_s5", "idA": "906709_11_item7_p13_s2", "sentA": "To date we have incurred substantial debt as a result of our issuances of subordinated notes that are convertible into our common stock.", "sentB": "Where we believe it is in the best interests of the company and our stockholders, we are pursuing financing alternatives that are not dilutive to the ownership of our common stock security holders.", "type": 2, "words": ["<tag1>", "To", "date", "we", "have", "incurred", "substantial", "debt", "as", "a", "result", "of", "our", "issuances", "of", "subordinated", "notes", "that", "are", "convertible", "into", "our", "common", "stock.", "<tag2>", "Where", "we", "believe", "it", "is", "in", "the", "best", "interests", "of", "the", "company", "and", "our", "stockholders,", "we", "are", "pursuing", "financing", "alternatives", "that", "are", "not", "dilutive", "to", "the", "ownership", "of", "our", "common", "stock", "security", "holders.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "incurred", "substantial", "debt", "as", "a", "result", "of", "our", "issuances", "of", "subordinated", "notes", "that", "are", "convertible", "into", "our", "common", "stock."], "wordsB": ["Where", "we", "believe", "it", "is", "in", "the", "best", "interests", "of", "the", "company", "and", "our", "stockholders,", "we", "are", "pursuing", "financing", "alternatives", "that", "are", "not", "dilutive", "to", "the", "ownership", "of", "our", "common", "stock", "security", "holders."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p10_s7", "idA": "906709_11_item7_p13_s3", "sentA": "Our substantial debt, the market price of our securities, and the general economic climate, among other factors, could have material consequences for our financial condition and could affect our sources of short-term and long-term funding.", "sentB": "Our substantial debt, the market price of our common stock, and the general economic and equity market climate, among other factors, could have material adverse effects on our financial condition and could affect our ability to obtain short-term and long-term financing alternatives.", "type": 2, "words": ["<tag1>", "Our", "substantial", "debt,", "the", "market", "price", "of", "our", "securities,", "and", "the", "general", "economic", "climate,", "among", "other", "factors,", "could", "have", "material", "consequences", "for", "our", "financial", "condition", "and", "could", "affect", "our", "sources", "of", "short-term", "and", "long-term", "funding.", "<tag2>", "Our", "substantial", "debt,", "the", "market", "price", "of", "our", "common", "stock,", "and", "the", "general", "economic", "and", "equity", "market", "climate,", "among", "other", "factors,", "could", "have", "material", "adverse", "effects", "on", "our", "financial", "condition", "and", "could", "affect", "our", "ability", "to", "obtain", "short-term", "and", "long-term", "financing", "alternatives.", "<tag3>"], "wordsA": ["Our", "substantial", "debt,", "the", "market", "price", "of", "our", "securities,", "and", "the", "general", "economic", "climate,", "among", "other", "factors,", "could", "have", "material", "consequences", "for", "our", "financial", "condition", "and", "could", "affect", "our", "sources", "of", "short-term", "and", "long-term", "funding."], "wordsB": ["Our", "substantial", "debt,", "the", "market", "price", "of", "our", "common", "stock,", "and", "the", "general", "economic", "and", "equity", "market", "climate,", "among", "other", "factors,", "could", "have", "material", "adverse", "effects", "on", "our", "financial", "condition", "and", "could", "affect", "our", "ability", "to", "obtain", "short-term", "and", "long-term", "financing", "alternatives."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p34_s9", "idA": "906709_11_item7_p13_s3", "sentA": "Our substantial debt, the market price of our securities, and the general economic climate, among other factors, could have material consequences for our financial condition and could affect our sources of short-term and long-term funding.", "sentB": "Our substantial debt, the market price of our common stock, and the general economic and equity market climate, among other factors, could substantially weaken our financial condition and could reduce or eliminate our ability to obtain short-term and long-term financing alternatives.", "type": 2, "words": ["<tag1>", "Our", "substantial", "debt,", "the", "market", "price", "of", "our", "securities,", "and", "the", "general", "economic", "climate,", "among", "other", "factors,", "could", "have", "material", "consequences", "for", "our", "financial", "condition", "and", "could", "affect", "our", "sources", "of", "short-term", "and", "long-term", "funding.", "<tag2>", "Our", "substantial", "debt,", "the", "market", "price", "of", "our", "common", "stock,", "and", "the", "general", "economic", "and", "equity", "market", "climate,", "among", "other", "factors,", "could", "substantially", "weaken", "our", "financial", "condition", "and", "could", "reduce", "or", "eliminate", "our", "ability", "to", "obtain", "short-term", "and", "long-term", "financing", "alternatives.", "<tag3>"], "wordsA": ["Our", "substantial", "debt,", "the", "market", "price", "of", "our", "securities,", "and", "the", "general", "economic", "climate,", "among", "other", "factors,", "could", "have", "material", "consequences", "for", "our", "financial", "condition", "and", "could", "affect", "our", "sources", "of", "short-term", "and", "long-term", "funding."], "wordsB": ["Our", "substantial", "debt,", "the", "market", "price", "of", "our", "common", "stock,", "and", "the", "general", "economic", "and", "equity", "market", "climate,", "among", "other", "factors,", "could", "substantially", "weaken", "our", "financial", "condition", "and", "could", "reduce", "or", "eliminate", "our", "ability", "to", "obtain", "short-term", "and", "long-term", "financing", "alternatives."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p10_s0", "idA": "906709_11_item7_p13_s5", "sentA": "Even if we or our partners are successful, we may require additional capital to continue to fund our operations and repay our debt obligations as they become due.", "sentB": "As discussed above, the success of the KODIAC study is critical to providing cash to fund our operations and there can be no assurance as to the outcome of this study.", "type": 2, "words": ["<tag1>", "Even", "if", "we", "or", "our", "partners", "are", "successful,", "we", "may", "require", "additional", "capital", "to", "continue", "to", "fund", "our", "operations", "and", "repay", "our", "debt", "obligations", "as", "they", "become", "due.", "<tag2>", "As", "discussed", "above,", "the", "success", "of", "the", "KODIAC", "study", "is", "critical", "to", "providing", "cash", "to", "fund", "our", "operations", "and", "there", "can", "be", "no", "assurance", "as", "to", "the", "outcome", "of", "this", "study.", "<tag3>"], "wordsA": ["Even", "if", "we", "or", "our", "partners", "are", "successful,", "we", "may", "require", "additional", "capital", "to", "continue", "to", "fund", "our", "operations", "and", "repay", "our", "debt", "obligations", "as", "they", "become", "due."], "wordsB": ["As", "discussed", "above,", "the", "success", "of", "the", "KODIAC", "study", "is", "critical", "to", "providing", "cash", "to", "fund", "our", "operations", "and", "there", "can", "be", "no", "assurance", "as", "to", "the", "outcome", "of", "this", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p10_s5", "idA": "906709_11_item7_p13_s6", "sentA": "There can be no assurance that additional funds, if and when required, will be available to us on favorable terms, if at all.", "sentB": "However, if non-dilutive financing alternatives are not available to us on commercially reasonable terms or at all, we could be required to pursue dilutive equity-based financing alternatives such as an offering of convertible debt or common stock.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "additional", "funds,", "if", "and", "when", "required,", "will", "be", "available", "to", "us", "on", "favorable", "terms,", "if", "at", "all.", "<tag2>", "However,", "if", "non-dilutive", "financing", "alternatives", "are", "not", "available", "to", "us", "on", "commercially", "reasonable", "terms", "or", "at", "all,", "we", "could", "be", "required", "to", "pursue", "dilutive", "equity-based", "financing", "alternatives", "such", "as", "an", "offering", "of", "convertible", "debt", "or", "common", "stock.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "additional", "funds,", "if", "and", "when", "required,", "will", "be", "available", "to", "us", "on", "favorable", "terms,", "if", "at", "all."], "wordsB": ["However,", "if", "non-dilutive", "financing", "alternatives", "are", "not", "available", "to", "us", "on", "commercially", "reasonable", "terms", "or", "at", "all,", "we", "could", "be", "required", "to", "pursue", "dilutive", "equity-based", "financing", "alternatives", "such", "as", "an", "offering", "of", "convertible", "debt", "or", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p34_s6", "idA": "906709_11_item7_p13_s6", "sentA": "There can be no assurance that additional funds, if and when required, will be available to us on favorable terms, if at all.", "sentB": "However, if non-dilutive financing alternatives are not available to us on commercially reasonable terms or at all, we could be required to pursue dilutive equity-based financing alternatives such as an offering of convertible debt or common stock.", "type": 2, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "additional", "funds,", "if", "and", "when", "required,", "will", "be", "available", "to", "us", "on", "favorable", "terms,", "if", "at", "all.", "<tag2>", "However,", "if", "non-dilutive", "financing", "alternatives", "are", "not", "available", "to", "us", "on", "commercially", "reasonable", "terms", "or", "at", "all,", "we", "could", "be", "required", "to", "pursue", "dilutive", "equity-based", "financing", "alternatives", "such", "as", "an", "offering", "of", "convertible", "debt", "or", "common", "stock.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "additional", "funds,", "if", "and", "when", "required,", "will", "be", "available", "to", "us", "on", "favorable", "terms,", "if", "at", "all."], "wordsB": ["However,", "if", "non-dilutive", "financing", "alternatives", "are", "not", "available", "to", "us", "on", "commercially", "reasonable", "terms", "or", "at", "all,", "we", "could", "be", "required", "to", "pursue", "dilutive", "equity-based", "financing", "alternatives", "such", "as", "an", "offering", "of", "convertible", "debt", "or", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p13_s11", "idA": "906709_11_item7_p14_s0", "sentA": "Total revenue increased for the year ended December 31, 2010 compared to the year ended December 31, 2009 primarily due to the recognition of the remaining $101.4 million of the $125.0 million upfront payment received from AstraZeneca AB for NKTR-118 and NKTR-119 in the fourth quarter of 2009.", "sentB": "License, collaboration and other revenue for the year ended December 31, 2011 decreased compared to the year ended December 31, 2010 primarily due to the complete recognition as of December 31, 2010 of the $125.0 million upfront payment received in the fourth quarter of 2009 from AstraZeneca in connection with the NKTR-118 and NKTR-119 global license agreement.", "type": 2, "words": ["<tag1>", "Total", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "primarily", "due", "to", "the", "recognition", "of", "the", "remaining", "$101.4", "million", "of", "the", "$125.0", "million", "upfront", "payment", "received", "from", "AstraZeneca", "AB", "for", "NKTR-118", "and", "NKTR-119", "in", "the", "fourth", "quarter", "of", "2009.", "<tag2>", "License,", "collaboration", "and", "other", "revenue", "for", "the", "year", "ended", "December", "31,", "2011", "decreased", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "primarily", "due", "to", "the", "complete", "recognition", "as", "of", "December", "31,", "2010", "of", "the", "$125.0", "million", "upfront", "payment", "received", "in", "the", "fourth", "quarter", "of", "2009", "from", "AstraZeneca", "in", "connection", "with", "the", "NKTR-118", "and", "NKTR-119", "global", "license", "agreement.", "<tag3>"], "wordsA": ["Total", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "primarily", "due", "to", "the", "recognition", "of", "the", "remaining", "$101.4", "million", "of", "the", "$125.0", "million", "upfront", "payment", "received", "from", "AstraZeneca", "AB", "for", "NKTR-118", "and", "NKTR-119", "in", "the", "fourth", "quarter", "of", "2009."], "wordsB": ["License,", "collaboration", "and", "other", "revenue", "for", "the", "year", "ended", "December", "31,", "2011", "decreased", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "primarily", "due", "to", "the", "complete", "recognition", "as", "of", "December", "31,", "2010", "of", "the", "$125.0", "million", "upfront", "payment", "received", "in", "the", "fourth", "quarter", "of", "2009", "from", "AstraZeneca", "in", "connection", "with", "the", "NKTR-118", "and", "NKTR-119", "global", "license", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p2_s5", "idA": "906709_11_item7_p14_s0", "sentA": "Total revenue increased for the year ended December 31, 2010 compared to the year ended December 31, 2009 primarily due to the recognition of the remaining $101.4 million of the $125.0 million upfront payment received from AstraZeneca AB for NKTR-118 and NKTR-119 in the fourth quarter of 2009.", "sentB": "We will be entitled to the remaining $140.0 million of these milestones if NKTR-118 is approved by the FDA and EMA and commercial launch is achieved in the U.S. and one major country in the European Union (EU).", "type": 2, "words": ["<tag1>", "Total", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "primarily", "due", "to", "the", "recognition", "of", "the", "remaining", "$101.4", "million", "of", "the", "$125.0", "million", "upfront", "payment", "received", "from", "AstraZeneca", "AB", "for", "NKTR-118", "and", "NKTR-119", "in", "the", "fourth", "quarter", "of", "2009.", "<tag2>", "We", "will", "be", "entitled", "to", "the", "remaining", "$140.0", "million", "of", "these", "milestones", "if", "NKTR-118", "is", "approved", "by", "the", "FDA", "and", "EMA", "and", "commercial", "launch", "is", "achieved", "in", "the", "U.S.", "and", "one", "major", "country", "in", "the", "European", "Union", "(EU).", "<tag3>"], "wordsA": ["Total", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "primarily", "due", "to", "the", "recognition", "of", "the", "remaining", "$101.4", "million", "of", "the", "$125.0", "million", "upfront", "payment", "received", "from", "AstraZeneca", "AB", "for", "NKTR-118", "and", "NKTR-119", "in", "the", "fourth", "quarter", "of", "2009."], "wordsB": ["We", "will", "be", "entitled", "to", "the", "remaining", "$140.0", "million", "of", "these", "milestones", "if", "NKTR-118", "is", "approved", "by", "the", "FDA", "and", "EMA", "and", "commercial", "launch", "is", "achieved", "in", "the", "U.S.", "and", "one", "major", "country", "in", "the", "European", "Union", "(EU)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p34_s18", "idA": "906709_11_item7_p14_s0", "sentA": "Total revenue increased for the year ended December 31, 2010 compared to the year ended December 31, 2009 primarily due to the recognition of the remaining $101.4 million of the $125.0 million upfront payment received from AstraZeneca AB for NKTR-118 and NKTR-119 in the fourth quarter of 2009.", "sentB": "Cash flows from operating activities Cash flows used in operating activities for the year ended December 31, 2011 totaled $113.7 million, which includes $7.0 million for semi-annual interest payments on our convertible subordinated notes, $11.2 million of prepayments to certain vendors in our BEACON study, and $125.0 million of other net operating cash uses, partially offset by the receipt of $29.5 million from collaboration agreements, of which $16.5 million was included in accounts receivable at December 31, 2010 resulting from an upfront payment obligation arising from an amendment to one of our manufacturing and supply agreements.", "type": 2, "words": ["<tag1>", "Total", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "primarily", "due", "to", "the", "recognition", "of", "the", "remaining", "$101.4", "million", "of", "the", "$125.0", "million", "upfront", "payment", "received", "from", "AstraZeneca", "AB", "for", "NKTR-118", "and", "NKTR-119", "in", "the", "fourth", "quarter", "of", "2009.", "<tag2>", "Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2011", "totaled", "$113.7", "million,", "which", "includes", "$7.0", "million", "for", "semi-annual", "interest", "payments", "on", "our", "convertible", "subordinated", "notes,", "$11.2", "million", "of", "prepayments", "to", "certain", "vendors", "in", "our", "BEACON", "study,", "and", "$125.0", "million", "of", "other", "net", "operating", "cash", "uses,", "partially", "offset", "by", "the", "receipt", "of", "$29.5", "million", "from", "collaboration", "agreements,", "of", "which", "$16.5", "million", "was", "included", "in", "accounts", "receivable", "at", "December", "31,", "2010", "resulting", "from", "an", "upfront", "payment", "obligation", "arising", "from", "an", "amendment", "to", "one", "of", "our", "manufacturing", "and", "supply", "agreements.", "<tag3>"], "wordsA": ["Total", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "primarily", "due", "to", "the", "recognition", "of", "the", "remaining", "$101.4", "million", "of", "the", "$125.0", "million", "upfront", "payment", "received", "from", "AstraZeneca", "AB", "for", "NKTR-118", "and", "NKTR-119", "in", "the", "fourth", "quarter", "of", "2009."], "wordsB": ["Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2011", "totaled", "$113.7", "million,", "which", "includes", "$7.0", "million", "for", "semi-annual", "interest", "payments", "on", "our", "convertible", "subordinated", "notes,", "$11.2", "million", "of", "prepayments", "to", "certain", "vendors", "in", "our", "BEACON", "study,", "and", "$125.0", "million", "of", "other", "net", "operating", "cash", "uses,", "partially", "offset", "by", "the", "receipt", "of", "$29.5", "million", "from", "collaboration", "agreements,", "of", "which", "$16.5", "million", "was", "included", "in", "accounts", "receivable", "at", "December", "31,", "2010", "resulting", "from", "an", "upfront", "payment", "obligation", "arising", "from", "an", "amendment", "to", "one", "of", "our", "manufacturing", "and", "supply", "agreements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p35_s1", "idA": "906709_11_item7_p14_s0", "sentA": "Total revenue increased for the year ended December 31, 2010 compared to the year ended December 31, 2009 primarily due to the recognition of the remaining $101.4 million of the $125.0 million upfront payment received from AstraZeneca AB for NKTR-118 and NKTR-119 in the fourth quarter of 2009.", "sentB": "During the year ended December 31, 2009, net cash provided by operating activities totaled $39.7 million, which included the $125.0 million upfront payment received from AstraZeneca under the license agreement we entered into for NKTR-118 and NKTR-119 and a $31.0 million license extension payment received from Roche in December 2009.", "type": 2, "words": ["<tag1>", "Total", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "primarily", "due", "to", "the", "recognition", "of", "the", "remaining", "$101.4", "million", "of", "the", "$125.0", "million", "upfront", "payment", "received", "from", "AstraZeneca", "AB", "for", "NKTR-118", "and", "NKTR-119", "in", "the", "fourth", "quarter", "of", "2009.", "<tag2>", "During", "the", "year", "ended", "December", "31,", "2009,", "net", "cash", "provided", "by", "operating", "activities", "totaled", "$39.7", "million,", "which", "included", "the", "$125.0", "million", "upfront", "payment", "received", "from", "AstraZeneca", "under", "the", "license", "agreement", "we", "entered", "into", "for", "NKTR-118", "and", "NKTR-119", "and", "a", "$31.0", "million", "license", "extension", "payment", "received", "from", "Roche", "in", "December", "2009.", "<tag3>"], "wordsA": ["Total", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "primarily", "due", "to", "the", "recognition", "of", "the", "remaining", "$101.4", "million", "of", "the", "$125.0", "million", "upfront", "payment", "received", "from", "AstraZeneca", "AB", "for", "NKTR-118", "and", "NKTR-119", "in", "the", "fourth", "quarter", "of", "2009."], "wordsB": ["During", "the", "year", "ended", "December", "31,", "2009,", "net", "cash", "provided", "by", "operating", "activities", "totaled", "$39.7", "million,", "which", "included", "the", "$125.0", "million", "upfront", "payment", "received", "from", "AstraZeneca", "under", "the", "license", "agreement", "we", "entered", "into", "for", "NKTR-118", "and", "NKTR-119", "and", "a", "$31.0", "million", "license", "extension", "payment", "received", "from", "Roche", "in", "December", "2009."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p35_s3", "idA": "906709_11_item7_p14_s0", "sentA": "Total revenue increased for the year ended December 31, 2010 compared to the year ended December 31, 2009 primarily due to the recognition of the remaining $101.4 million of the $125.0 million upfront payment received from AstraZeneca AB for NKTR-118 and NKTR-119 in the fourth quarter of 2009.", "sentB": "Additionally, we made advanced payments on property and equipment purchases of $4.3 million in the year ended December 31, 2009.", "type": 2, "words": ["<tag1>", "Total", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "primarily", "due", "to", "the", "recognition", "of", "the", "remaining", "$101.4", "million", "of", "the", "$125.0", "million", "upfront", "payment", "received", "from", "AstraZeneca", "AB", "for", "NKTR-118", "and", "NKTR-119", "in", "the", "fourth", "quarter", "of", "2009.", "<tag2>", "Additionally,", "we", "made", "advanced", "payments", "on", "property", "and", "equipment", "purchases", "of", "$4.3", "million", "in", "the", "year", "ended", "December", "31,", "2009.", "<tag3>"], "wordsA": ["Total", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "primarily", "due", "to", "the", "recognition", "of", "the", "remaining", "$101.4", "million", "of", "the", "$125.0", "million", "upfront", "payment", "received", "from", "AstraZeneca", "AB", "for", "NKTR-118", "and", "NKTR-119", "in", "the", "fourth", "quarter", "of", "2009."], "wordsB": ["Additionally,", "we", "made", "advanced", "payments", "on", "property", "and", "equipment", "purchases", "of", "$4.3", "million", "in", "the", "year", "ended", "December", "31,", "2009."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p39_s1", "idA": "906709_11_item7_p14_s0", "sentA": "Total revenue increased for the year ended December 31, 2010 compared to the year ended December 31, 2009 primarily due to the recognition of the remaining $101.4 million of the $125.0 million upfront payment received from AstraZeneca AB for NKTR-118 and NKTR-119 in the fourth quarter of 2009.", "sentB": "We have subleased a portion of the San Carlos Facility and are currently seeking one or more subtenants for the remaining space.", "type": 2, "words": ["<tag1>", "Total", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "primarily", "due", "to", "the", "recognition", "of", "the", "remaining", "$101.4", "million", "of", "the", "$125.0", "million", "upfront", "payment", "received", "from", "AstraZeneca", "AB", "for", "NKTR-118", "and", "NKTR-119", "in", "the", "fourth", "quarter", "of", "2009.", "<tag2>", "We", "have", "subleased", "a", "portion", "of", "the", "San", "Carlos", "Facility", "and", "are", "currently", "seeking", "one", "or", "more", "subtenants", "for", "the", "remaining", "space.", "<tag3>"], "wordsA": ["Total", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "primarily", "due", "to", "the", "recognition", "of", "the", "remaining", "$101.4", "million", "of", "the", "$125.0", "million", "upfront", "payment", "received", "from", "AstraZeneca", "AB", "for", "NKTR-118", "and", "NKTR-119", "in", "the", "fourth", "quarter", "of", "2009."], "wordsB": ["We", "have", "subleased", "a", "portion", "of", "the", "San", "Carlos", "Facility", "and", "are", "currently", "seeking", "one", "or", "more", "subtenants", "for", "the", "remaining", "space."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p11_s3", "idA": "906709_11_item7_p14_s1", "sentA": "For the year ended December 31, 2010, recognition of amounts received from AstraZeneca AB represented 68% of our total revenue.", "sentB": "As a result, there may be significant variations in the timing of receipt of cash payments and our recognition of revenue.", "type": 2, "words": ["<tag1>", "For", "the", "year", "ended", "December", "31,", "2010,", "recognition", "of", "amounts", "received", "from", "AstraZeneca", "AB", "represented", "68%", "of", "our", "total", "revenue.", "<tag2>", "As", "a", "result,", "there", "may", "be", "significant", "variations", "in", "the", "timing", "of", "receipt", "of", "cash", "payments", "and", "our", "recognition", "of", "revenue.", "<tag3>"], "wordsA": ["For", "the", "year", "ended", "December", "31,", "2010,", "recognition", "of", "amounts", "received", "from", "AstraZeneca", "AB", "represented", "68%", "of", "our", "total", "revenue."], "wordsB": ["As", "a", "result,", "there", "may", "be", "significant", "variations", "in", "the", "timing", "of", "receipt", "of", "cash", "payments", "and", "our", "recognition", "of", "revenue."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p30_s0", "idA": "906709_11_item7_p14_s1", "sentA": "For the year ended December 31, 2010, recognition of amounts received from AstraZeneca AB represented 68% of our total revenue.", "sentB": "During the year ended December 31, 2010, we relocated all of our operations previously located in San Carlos, California, including our corporate headquarters, to our Mission Bay Facility in San Francisco, California.", "type": 2, "words": ["<tag1>", "For", "the", "year", "ended", "December", "31,", "2010,", "recognition", "of", "amounts", "received", "from", "AstraZeneca", "AB", "represented", "68%", "of", "our", "total", "revenue.", "<tag2>", "During", "the", "year", "ended", "December", "31,", "2010,", "we", "relocated", "all", "of", "our", "operations", "previously", "located", "in", "San", "Carlos,", "California,", "including", "our", "corporate", "headquarters,", "to", "our", "Mission", "Bay", "Facility", "in", "San", "Francisco,", "California.", "<tag3>"], "wordsA": ["For", "the", "year", "ended", "December", "31,", "2010,", "recognition", "of", "amounts", "received", "from", "AstraZeneca", "AB", "represented", "68%", "of", "our", "total", "revenue."], "wordsB": ["During", "the", "year", "ended", "December", "31,", "2010,", "we", "relocated", "all", "of", "our", "operations", "previously", "located", "in", "San", "Carlos,", "California,", "including", "our", "corporate", "headquarters,", "to", "our", "Mission", "Bay", "Facility", "in", "San", "Francisco,", "California."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p19_s3", "idA": "906709_11_item7_p15_s0", "sentA": "Total revenue decreased for the year ended December 31, 2009 compared to the year ended December 31, 2008 primarily as a result of the sale of certain of our pulmonary assets to Novartis completed on December 31, 2008 (Novartis Pulmonary Asset Sale) and lower product manufacturing volumes required by our collaboration partners.", "sentB": "However, due to the fixed price nature of certain of our significant supply agreements, we expect that gross margin will decrease in 2012 compared to 2011.", "type": 2, "words": ["<tag1>", "Total", "revenue", "decreased", "for", "the", "year", "ended", "December", "31,", "2009", "compared", "to", "the", "year", "ended", "December", "31,", "2008", "primarily", "as", "a", "result", "of", "the", "sale", "of", "certain", "of", "our", "pulmonary", "assets", "to", "Novartis", "completed", "on", "December", "31,", "2008", "(Novartis", "Pulmonary", "Asset", "Sale)", "and", "lower", "product", "manufacturing", "volumes", "required", "by", "our", "collaboration", "partners.", "<tag2>", "However,", "due", "to", "the", "fixed", "price", "nature", "of", "certain", "of", "our", "significant", "supply", "agreements,", "we", "expect", "that", "gross", "margin", "will", "decrease", "in", "2012", "compared", "to", "2011.", "<tag3>"], "wordsA": ["Total", "revenue", "decreased", "for", "the", "year", "ended", "December", "31,", "2009", "compared", "to", "the", "year", "ended", "December", "31,", "2008", "primarily", "as", "a", "result", "of", "the", "sale", "of", "certain", "of", "our", "pulmonary", "assets", "to", "Novartis", "completed", "on", "December", "31,", "2008", "(Novartis", "Pulmonary", "Asset", "Sale)", "and", "lower", "product", "manufacturing", "volumes", "required", "by", "our", "collaboration", "partners."], "wordsB": ["However,", "due", "to", "the", "fixed", "price", "nature", "of", "certain", "of", "our", "significant", "supply", "agreements,", "we", "expect", "that", "gross", "margin", "will", "decrease", "in", "2012", "compared", "to", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p20_s5", "idA": "906709_11_item7_p15_s0", "sentA": "Total revenue decreased for the year ended December 31, 2009 compared to the year ended December 31, 2008 primarily as a result of the sale of certain of our pulmonary assets to Novartis completed on December 31, 2008 (Novartis Pulmonary Asset Sale) and lower product manufacturing volumes required by our collaboration partners.", "sentB": "These expense increases were partially offset by a $5.5 million decrease in outside services, including contract research organizations, due primarily to lower expenses for the NKTR-118 and NKTR-119 programs as a result of our successful completion of Phase 2 clinical studies and collaboration with AstraZeneca pursuant to the license agreement entered into in September 2009.", "type": 2, "words": ["<tag1>", "Total", "revenue", "decreased", "for", "the", "year", "ended", "December", "31,", "2009", "compared", "to", "the", "year", "ended", "December", "31,", "2008", "primarily", "as", "a", "result", "of", "the", "sale", "of", "certain", "of", "our", "pulmonary", "assets", "to", "Novartis", "completed", "on", "December", "31,", "2008", "(Novartis", "Pulmonary", "Asset", "Sale)", "and", "lower", "product", "manufacturing", "volumes", "required", "by", "our", "collaboration", "partners.", "<tag2>", "These", "expense", "increases", "were", "partially", "offset", "by", "a", "$5.5", "million", "decrease", "in", "outside", "services,", "including", "contract", "research", "organizations,", "due", "primarily", "to", "lower", "expenses", "for", "the", "NKTR-118", "and", "NKTR-119", "programs", "as", "a", "result", "of", "our", "successful", "completion", "of", "Phase", "2", "clinical", "studies", "and", "collaboration", "with", "AstraZeneca", "pursuant", "to", "the", "license", "agreement", "entered", "into", "in", "September", "2009.", "<tag3>"], "wordsA": ["Total", "revenue", "decreased", "for", "the", "year", "ended", "December", "31,", "2009", "compared", "to", "the", "year", "ended", "December", "31,", "2008", "primarily", "as", "a", "result", "of", "the", "sale", "of", "certain", "of", "our", "pulmonary", "assets", "to", "Novartis", "completed", "on", "December", "31,", "2008", "(Novartis", "Pulmonary", "Asset", "Sale)", "and", "lower", "product", "manufacturing", "volumes", "required", "by", "our", "collaboration", "partners."], "wordsB": ["These", "expense", "increases", "were", "partially", "offset", "by", "a", "$5.5", "million", "decrease", "in", "outside", "services,", "including", "contract", "research", "organizations,", "due", "primarily", "to", "lower", "expenses", "for", "the", "NKTR-118", "and", "NKTR-119", "programs", "as", "a", "result", "of", "our", "successful", "completion", "of", "Phase", "2", "clinical", "studies", "and", "collaboration", "with", "AstraZeneca", "pursuant", "to", "the", "license", "agreement", "entered", "into", "in", "September", "2009."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p36_s0", "idA": "906709_11_item7_p15_s0", "sentA": "Total revenue decreased for the year ended December 31, 2009 compared to the year ended December 31, 2008 primarily as a result of the sale of certain of our pulmonary assets to Novartis completed on December 31, 2008 (Novartis Pulmonary Asset Sale) and lower product manufacturing volumes required by our collaboration partners.", "sentB": "On December 31, 2008, we completed the sale of certain pulmonary assets to Novartis for a purchase price of $115.0 million.", "type": 2, "words": ["<tag1>", "Total", "revenue", "decreased", "for", "the", "year", "ended", "December", "31,", "2009", "compared", "to", "the", "year", "ended", "December", "31,", "2008", "primarily", "as", "a", "result", "of", "the", "sale", "of", "certain", "of", "our", "pulmonary", "assets", "to", "Novartis", "completed", "on", "December", "31,", "2008", "(Novartis", "Pulmonary", "Asset", "Sale)", "and", "lower", "product", "manufacturing", "volumes", "required", "by", "our", "collaboration", "partners.", "<tag2>", "On", "December", "31,", "2008,", "we", "completed", "the", "sale", "of", "certain", "pulmonary", "assets", "to", "Novartis", "for", "a", "purchase", "price", "of", "$115.0", "million.", "<tag3>"], "wordsA": ["Total", "revenue", "decreased", "for", "the", "year", "ended", "December", "31,", "2009", "compared", "to", "the", "year", "ended", "December", "31,", "2008", "primarily", "as", "a", "result", "of", "the", "sale", "of", "certain", "of", "our", "pulmonary", "assets", "to", "Novartis", "completed", "on", "December", "31,", "2008", "(Novartis", "Pulmonary", "Asset", "Sale)", "and", "lower", "product", "manufacturing", "volumes", "required", "by", "our", "collaboration", "partners."], "wordsB": ["On", "December", "31,", "2008,", "we", "completed", "the", "sale", "of", "certain", "pulmonary", "assets", "to", "Novartis", "for", "a", "purchase", "price", "of", "$115.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p23_s1", "idA": "906709_11_item7_p15_s1", "sentA": "In connection with the Novartis Pulmonary Asset Sale, our collaboration agreement with Novartis for TIP was terminated and our collaboration agreement with Bayer Schering Pharma AG for Cipro Inhale was assigned to Novartis.", "sentB": "As part of the Novartis Pulmonary Asset Sale, we retained an exclusive license to this technology for the development and commercialization of this drug candidate.", "type": 2, "words": ["<tag1>", "In", "connection", "with", "the", "Novartis", "Pulmonary", "Asset", "Sale,", "our", "collaboration", "agreement", "with", "Novartis", "for", "TIP", "was", "terminated", "and", "our", "collaboration", "agreement", "with", "Bayer", "Schering", "Pharma", "AG", "for", "Cipro", "Inhale", "was", "assigned", "to", "Novartis.", "<tag2>", "As", "part", "of", "the", "Novartis", "Pulmonary", "Asset", "Sale,", "we", "retained", "an", "exclusive", "license", "to", "this", "technology", "for", "the", "development", "and", "commercialization", "of", "this", "drug", "candidate.", "<tag3>"], "wordsA": ["In", "connection", "with", "the", "Novartis", "Pulmonary", "Asset", "Sale,", "our", "collaboration", "agreement", "with", "Novartis", "for", "TIP", "was", "terminated", "and", "our", "collaboration", "agreement", "with", "Bayer", "Schering", "Pharma", "AG", "for", "Cipro", "Inhale", "was", "assigned", "to", "Novartis."], "wordsB": ["As", "part", "of", "the", "Novartis", "Pulmonary", "Asset", "Sale,", "we", "retained", "an", "exclusive", "license", "to", "this", "technology", "for", "the", "development", "and", "commercialization", "of", "this", "drug", "candidate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p13_s0", "idA": "906709_11_item7_p16_s0", "sentA": "Product sales include cost-plus and fixed price manufacturing and supply agreements with our collaboration partners.", "sentB": "Product sales Product sales include cost-plus and fixed price manufacturing and supply agreements with our collaboration partners.", "type": 2, "words": ["<tag1>", "Product", "sales", "include", "cost-plus", "and", "fixed", "price", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners.", "<tag2>", "Product", "sales", "Product", "sales", "include", "cost-plus", "and", "fixed", "price", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners.", "<tag3>"], "wordsA": ["Product", "sales", "include", "cost-plus", "and", "fixed", "price", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners."], "wordsB": ["Product", "sales", "Product", "sales", "include", "cost-plus", "and", "fixed", "price", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p13_s4", "idA": "906709_11_item7_p16_s1", "sentA": "We also receive royalty revenue from certain of our collaboration partners based on their net sales once their products are approved for commercial sale.", "sentB": "We receive royalty revenue from certain of our collaboration partners based on their net sales of commercial products.", "type": 2, "words": ["<tag1>", "We", "also", "receive", "royalty", "revenue", "from", "certain", "of", "our", "collaboration", "partners", "based", "on", "their", "net", "sales", "once", "their", "products", "are", "approved", "for", "commercial", "sale.", "<tag2>", "We", "receive", "royalty", "revenue", "from", "certain", "of", "our", "collaboration", "partners", "based", "on", "their", "net", "sales", "of", "commercial", "products.", "<tag3>"], "wordsA": ["We", "also", "receive", "royalty", "revenue", "from", "certain", "of", "our", "collaboration", "partners", "based", "on", "their", "net", "sales", "once", "their", "products", "are", "approved", "for", "commercial", "sale."], "wordsB": ["We", "receive", "royalty", "revenue", "from", "certain", "of", "our", "collaboration", "partners", "based", "on", "their", "net", "sales", "of", "commercial", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p13_s6", "idA": "906709_11_item7_p16_s2", "sentA": "Royalty revenues were $7.3 million, $5.2 million, and $3.5 million for the years ended December 31, 2010, 2009, and 2008, respectively.", "sentB": "During the years ended December 31, 2011, 2010, and 2009, we recognized $8.3 million, $5.4 million, and $2.7 million, respectively, in aggregate royalties from net sales of MIRCERA and CIMZIA .", "type": 2, "words": ["<tag1>", "Royalty", "revenues", "were", "$7.3", "million,", "$5.2", "million,", "and", "$3.5", "million", "for", "the", "years", "ended", "December", "31,", "2010,", "2009,", "and", "2008,", "respectively.", "<tag2>", "During", "the", "years", "ended", "December", "31,", "2011,", "2010,", "and", "2009,", "we", "recognized", "$8.3", "million,", "$5.4", "million,", "and", "$2.7", "million,", "respectively,", "in", "aggregate", "royalties", "from", "net", "sales", "of", "MIRCERA", "and", "CIMZIA", ".", "<tag3>"], "wordsA": ["Royalty", "revenues", "were", "$7.3", "million,", "$5.2", "million,", "and", "$3.5", "million", "for", "the", "years", "ended", "December", "31,", "2010,", "2009,", "and", "2008,", "respectively."], "wordsB": ["During", "the", "years", "ended", "December", "31,", "2011,", "2010,", "and", "2009,", "we", "recognized", "$8.3", "million,", "$5.4", "million,", "and", "$2.7", "million,", "respectively,", "in", "aggregate", "royalties", "from", "net", "sales", "of", "MIRCERA", "and", "CIMZIA", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p17_s0", "idA": "906709_11_item7_p17_s0", "sentA": "The decrease in product sales and royalties for the year ended December 31, 2010 compared to the year ended December 31, 2009 is attributable to decreased product sales of $2.7 million partially offset by increased royalty revenue of $2.1 million.", "sentB": "The decrease in revenue attributable to European countries for the year ended December 31, 2011 compared to the year ended December 31, 2010 and the increase in the year ended December 31, 2010 compared to the year ended December 31, 2009 is primarily attributable to the revenue we recognized from the AstraZeneca license agreement.", "type": 2, "words": ["<tag1>", "The", "decrease", "in", "product", "sales", "and", "royalties", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "attributable", "to", "decreased", "product", "sales", "of", "$2.7", "million", "partially", "offset", "by", "increased", "royalty", "revenue", "of", "$2.1", "million.", "<tag2>", "The", "decrease", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "and", "the", "increase", "in", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "the", "revenue", "we", "recognized", "from", "the", "AstraZeneca", "license", "agreement.", "<tag3>"], "wordsA": ["The", "decrease", "in", "product", "sales", "and", "royalties", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "attributable", "to", "decreased", "product", "sales", "of", "$2.7", "million", "partially", "offset", "by", "increased", "royalty", "revenue", "of", "$2.1", "million."], "wordsB": ["The", "decrease", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "and", "the", "increase", "in", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "the", "revenue", "we", "recognized", "from", "the", "AstraZeneca", "license", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p19_s0", "idA": "906709_11_item7_p17_s0", "sentA": "The decrease in product sales and royalties for the year ended December 31, 2010 compared to the year ended December 31, 2009 is attributable to decreased product sales of $2.7 million partially offset by increased royalty revenue of $2.1 million.", "sentB": "The decrease in cost of goods sold during the year ended December 31, 2010 compared to the year ended December 31, 2009 is primarily due to the $2.7 million decrease in product sales and the inclusion in cost of goods sold in 2009 of a $2.1 million success fee that became due to one of our former consulting firms in 2009.", "type": 2, "words": ["<tag1>", "The", "decrease", "in", "product", "sales", "and", "royalties", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "attributable", "to", "decreased", "product", "sales", "of", "$2.7", "million", "partially", "offset", "by", "increased", "royalty", "revenue", "of", "$2.1", "million.", "<tag2>", "The", "decrease", "in", "cost", "of", "goods", "sold", "during", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "due", "to", "the", "$2.7", "million", "decrease", "in", "product", "sales", "and", "the", "inclusion", "in", "cost", "of", "goods", "sold", "in", "2009", "of", "a", "$2.1", "million", "success", "fee", "that", "became", "due", "to", "one", "of", "our", "former", "consulting", "firms", "in", "2009.", "<tag3>"], "wordsA": ["The", "decrease", "in", "product", "sales", "and", "royalties", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "attributable", "to", "decreased", "product", "sales", "of", "$2.7", "million", "partially", "offset", "by", "increased", "royalty", "revenue", "of", "$2.1", "million."], "wordsB": ["The", "decrease", "in", "cost", "of", "goods", "sold", "during", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "due", "to", "the", "$2.7", "million", "decrease", "in", "product", "sales", "and", "the", "inclusion", "in", "cost", "of", "goods", "sold", "in", "2009", "of", "a", "$2.1", "million", "success", "fee", "that", "became", "due", "to", "one", "of", "our", "former", "consulting", "firms", "in", "2009."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p19_s1", "idA": "906709_11_item7_p17_s0", "sentA": "The decrease in product sales and royalties for the year ended December 31, 2010 compared to the year ended December 31, 2009 is attributable to decreased product sales of $2.7 million partially offset by increased royalty revenue of $2.1 million.", "sentB": "The increase to product gross margin during the year ended December 31, 2010 compared to the year ended December 31, 2009 is primarily attributable to the $2.1 million success fee included in cost of goods sold in 2009.", "type": 2, "words": ["<tag1>", "The", "decrease", "in", "product", "sales", "and", "royalties", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "attributable", "to", "decreased", "product", "sales", "of", "$2.7", "million", "partially", "offset", "by", "increased", "royalty", "revenue", "of", "$2.1", "million.", "<tag2>", "The", "increase", "to", "product", "gross", "margin", "during", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "the", "$2.1", "million", "success", "fee", "included", "in", "cost", "of", "goods", "sold", "in", "2009.", "<tag3>"], "wordsA": ["The", "decrease", "in", "product", "sales", "and", "royalties", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "attributable", "to", "decreased", "product", "sales", "of", "$2.7", "million", "partially", "offset", "by", "increased", "royalty", "revenue", "of", "$2.1", "million."], "wordsB": ["The", "increase", "to", "product", "gross", "margin", "during", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "the", "$2.1", "million", "success", "fee", "included", "in", "cost", "of", "goods", "sold", "in", "2009."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p20_s3", "idA": "906709_11_item7_p17_s0", "sentA": "The decrease in product sales and royalties for the year ended December 31, 2010 compared to the year ended December 31, 2009 is attributable to decreased product sales of $2.7 million partially offset by increased royalty revenue of $2.1 million.", "sentB": "The increase in research and development expense for the year ended December 31, 2010 compared to the year ended December 31, 2009 is primarily attributable to an $8.4 million increase in salaries and employee benefits due to increased headcount to support our expanded clinical development efforts and further investment in and development of proprietary drug candidates in our research and development pipeline.", "type": 2, "words": ["<tag1>", "The", "decrease", "in", "product", "sales", "and", "royalties", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "attributable", "to", "decreased", "product", "sales", "of", "$2.7", "million", "partially", "offset", "by", "increased", "royalty", "revenue", "of", "$2.1", "million.", "<tag2>", "The", "increase", "in", "research", "and", "development", "expense", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "an", "$8.4", "million", "increase", "in", "salaries", "and", "employee", "benefits", "due", "to", "increased", "headcount", "to", "support", "our", "expanded", "clinical", "development", "efforts", "and", "further", "investment", "in", "and", "development", "of", "proprietary", "drug", "candidates", "in", "our", "research", "and", "development", "pipeline.", "<tag3>"], "wordsA": ["The", "decrease", "in", "product", "sales", "and", "royalties", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "attributable", "to", "decreased", "product", "sales", "of", "$2.7", "million", "partially", "offset", "by", "increased", "royalty", "revenue", "of", "$2.1", "million."], "wordsB": ["The", "increase", "in", "research", "and", "development", "expense", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "an", "$8.4", "million", "increase", "in", "salaries", "and", "employee", "benefits", "due", "to", "increased", "headcount", "to", "support", "our", "expanded", "clinical", "development", "efforts", "and", "further", "investment", "in", "and", "development", "of", "proprietary", "drug", "candidates", "in", "our", "research", "and", "development", "pipeline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p31_s0", "idA": "906709_11_item7_p17_s0", "sentA": "The decrease in product sales and royalties for the year ended December 31, 2010 compared to the year ended December 31, 2009 is attributable to decreased product sales of $2.7 million partially offset by increased royalty revenue of $2.1 million.", "sentB": "The increase in interest income for the year ended December 31, 2011 compared to the year ended December 31, 2010 is a result of higher average cash and investment balances partially offset by the impact of lower interest rates earned on our cash, cash equivalents, and available-for-sale investments.", "type": 2, "words": ["<tag1>", "The", "decrease", "in", "product", "sales", "and", "royalties", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "attributable", "to", "decreased", "product", "sales", "of", "$2.7", "million", "partially", "offset", "by", "increased", "royalty", "revenue", "of", "$2.1", "million.", "<tag2>", "The", "increase", "in", "interest", "income", "for", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "a", "result", "of", "higher", "average", "cash", "and", "investment", "balances", "partially", "offset", "by", "the", "impact", "of", "lower", "interest", "rates", "earned", "on", "our", "cash,", "cash", "equivalents,", "and", "available-for-sale", "investments.", "<tag3>"], "wordsA": ["The", "decrease", "in", "product", "sales", "and", "royalties", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "attributable", "to", "decreased", "product", "sales", "of", "$2.7", "million", "partially", "offset", "by", "increased", "royalty", "revenue", "of", "$2.1", "million."], "wordsB": ["The", "increase", "in", "interest", "income", "for", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "a", "result", "of", "higher", "average", "cash", "and", "investment", "balances", "partially", "offset", "by", "the", "impact", "of", "lower", "interest", "rates", "earned", "on", "our", "cash,", "cash", "equivalents,", "and", "available-for-sale", "investments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p31_s1", "idA": "906709_11_item7_p17_s0", "sentA": "The decrease in product sales and royalties for the year ended December 31, 2010 compared to the year ended December 31, 2009 is attributable to decreased product sales of $2.7 million partially offset by increased royalty revenue of $2.1 million.", "sentB": "The decrease in interest income for the year ended December 31, 2010 compared to the year ended December 31, 2009 is primarily attributable to lower interest rates earned on our cash, cash equivalents, and available-for-sale investments.", "type": 2, "words": ["<tag1>", "The", "decrease", "in", "product", "sales", "and", "royalties", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "attributable", "to", "decreased", "product", "sales", "of", "$2.7", "million", "partially", "offset", "by", "increased", "royalty", "revenue", "of", "$2.1", "million.", "<tag2>", "The", "decrease", "in", "interest", "income", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "lower", "interest", "rates", "earned", "on", "our", "cash,", "cash", "equivalents,", "and", "available-for-sale", "investments.", "<tag3>"], "wordsA": ["The", "decrease", "in", "product", "sales", "and", "royalties", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "attributable", "to", "decreased", "product", "sales", "of", "$2.7", "million", "partially", "offset", "by", "increased", "royalty", "revenue", "of", "$2.1", "million."], "wordsB": ["The", "decrease", "in", "interest", "income", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "lower", "interest", "rates", "earned", "on", "our", "cash,", "cash", "equivalents,", "and", "available-for-sale", "investments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p31_s2", "idA": "906709_11_item7_p17_s0", "sentA": "The decrease in product sales and royalties for the year ended December 31, 2010 compared to the year ended December 31, 2009 is attributable to decreased product sales of $2.7 million partially offset by increased royalty revenue of $2.1 million.", "sentB": "The decrease in interest expense for the year ended December 30, 2011 compared to the year ended December 31, 2010 is primarily attributable to the complete amortization of deferred financing costs during 2010 from our 3.25% convertible subordinated notes due September 2012.", "type": 2, "words": ["<tag1>", "The", "decrease", "in", "product", "sales", "and", "royalties", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "attributable", "to", "decreased", "product", "sales", "of", "$2.7", "million", "partially", "offset", "by", "increased", "royalty", "revenue", "of", "$2.1", "million.", "<tag2>", "The", "decrease", "in", "interest", "expense", "for", "the", "year", "ended", "December", "30,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "attributable", "to", "the", "complete", "amortization", "of", "deferred", "financing", "costs", "during", "2010", "from", "our", "3.25%", "convertible", "subordinated", "notes", "due", "September", "2012.", "<tag3>"], "wordsA": ["The", "decrease", "in", "product", "sales", "and", "royalties", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "attributable", "to", "decreased", "product", "sales", "of", "$2.7", "million", "partially", "offset", "by", "increased", "royalty", "revenue", "of", "$2.1", "million."], "wordsB": ["The", "decrease", "in", "interest", "expense", "for", "the", "year", "ended", "December", "30,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "attributable", "to", "the", "complete", "amortization", "of", "deferred", "financing", "costs", "during", "2010", "from", "our", "3.25%", "convertible", "subordinated", "notes", "due", "September", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p32_s4", "idA": "906709_11_item7_p17_s0", "sentA": "The decrease in product sales and royalties for the year ended December 31, 2010 compared to the year ended December 31, 2009 is attributable to decreased product sales of $2.7 million partially offset by increased royalty revenue of $2.1 million.", "sentB": "The decrease in interest expense during the year ended December 31, 2010 compared to the year ended December 31, 2009 is primarily attributable to the complete amortization of deferred financing costs during 2010 from our 3.25% convertible subordinated notes due September 2012 and decreased interest expense from capital leases.", "type": 2, "words": ["<tag1>", "The", "decrease", "in", "product", "sales", "and", "royalties", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "attributable", "to", "decreased", "product", "sales", "of", "$2.7", "million", "partially", "offset", "by", "increased", "royalty", "revenue", "of", "$2.1", "million.", "<tag2>", "The", "decrease", "in", "interest", "expense", "during", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "the", "complete", "amortization", "of", "deferred", "financing", "costs", "during", "2010", "from", "our", "3.25%", "convertible", "subordinated", "notes", "due", "September", "2012", "and", "decreased", "interest", "expense", "from", "capital", "leases.", "<tag3>"], "wordsA": ["The", "decrease", "in", "product", "sales", "and", "royalties", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "attributable", "to", "decreased", "product", "sales", "of", "$2.7", "million", "partially", "offset", "by", "increased", "royalty", "revenue", "of", "$2.1", "million."], "wordsB": ["The", "decrease", "in", "interest", "expense", "during", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "the", "complete", "amortization", "of", "deferred", "financing", "costs", "during", "2010", "from", "our", "3.25%", "convertible", "subordinated", "notes", "due", "September", "2012", "and", "decreased", "interest", "expense", "from", "capital", "leases."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p16_s0", "idA": "906709_11_item7_p17_s1", "sentA": "The timing of shipments is based on the demand and requirements of our collaboration partners and is not ratable throughout the year.", "sentB": "Revenue by geography Revenue by geographic area is based on locations of our partners.", "type": 2, "words": ["<tag1>", "The", "timing", "of", "shipments", "is", "based", "on", "the", "demand", "and", "requirements", "of", "our", "collaboration", "partners", "and", "is", "not", "ratable", "throughout", "the", "year.", "<tag2>", "Revenue", "by", "geography", "Revenue", "by", "geographic", "area", "is", "based", "on", "locations", "of", "our", "partners.", "<tag3>"], "wordsA": ["The", "timing", "of", "shipments", "is", "based", "on", "the", "demand", "and", "requirements", "of", "our", "collaboration", "partners", "and", "is", "not", "ratable", "throughout", "the", "year."], "wordsB": ["Revenue", "by", "geography", "Revenue", "by", "geographic", "area", "is", "based", "on", "locations", "of", "our", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p13_s3", "idA": "906709_11_item7_p18_s0", "sentA": "We expect product sales and royalties to decrease in 2011 due to decreased product sales partially offset by increased royalty revenues.", "sentB": "We expect product sales to increase in 2012 compared with 2011.", "type": 2, "words": ["<tag1>", "We", "expect", "product", "sales", "and", "royalties", "to", "decrease", "in", "2011", "due", "to", "decreased", "product", "sales", "partially", "offset", "by", "increased", "royalty", "revenues.", "<tag2>", "We", "expect", "product", "sales", "to", "increase", "in", "2012", "compared", "with", "2011.", "<tag3>"], "wordsA": ["We", "expect", "product", "sales", "and", "royalties", "to", "decrease", "in", "2011", "due", "to", "decreased", "product", "sales", "partially", "offset", "by", "increased", "royalty", "revenues."], "wordsB": ["We", "expect", "product", "sales", "to", "increase", "in", "2012", "compared", "with", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p11_s0", "idA": "906709_11_item7_p19_s0", "sentA": "Lower product demand from our collaboration partners resulted in decreased product sales of approximately $7.5 million for the year ended December 31, 2009 compared to the year ended December 31, 2008.", "sentB": "Our revenue is derived from our collaboration agreements, under which we may receive product sales revenue, royalties, license fees, milestone payments or contract research payments.", "type": 2, "words": ["<tag1>", "Lower", "product", "demand", "from", "our", "collaboration", "partners", "resulted", "in", "decreased", "product", "sales", "of", "approximately", "$7.5", "million", "for", "the", "year", "ended", "December", "31,", "2009", "compared", "to", "the", "year", "ended", "December", "31,", "2008.", "<tag2>", "Our", "revenue", "is", "derived", "from", "our", "collaboration", "agreements,", "under", "which", "we", "may", "receive", "product", "sales", "revenue,", "royalties,", "license", "fees,", "milestone", "payments", "or", "contract", "research", "payments.", "<tag3>"], "wordsA": ["Lower", "product", "demand", "from", "our", "collaboration", "partners", "resulted", "in", "decreased", "product", "sales", "of", "approximately", "$7.5", "million", "for", "the", "year", "ended", "December", "31,", "2009", "compared", "to", "the", "year", "ended", "December", "31,", "2008."], "wordsB": ["Our", "revenue", "is", "derived", "from", "our", "collaboration", "agreements,", "under", "which", "we", "may", "receive", "product", "sales", "revenue,", "royalties,", "license", "fees,", "milestone", "payments", "or", "contract", "research", "payments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p13_s1", "idA": "906709_11_item7_p19_s0", "sentA": "Lower product demand from our collaboration partners resulted in decreased product sales of approximately $7.5 million for the year ended December 31, 2009 compared to the year ended December 31, 2008.", "sentB": "Product sales decreased during the years ended December 31, 2011 and 2010 compared to the prior periods primarily as a result of decreased product demand from our collaboration partners due in part to the transfer of manufacturing activities to certain collaboration partners.", "type": 2, "words": ["<tag1>", "Lower", "product", "demand", "from", "our", "collaboration", "partners", "resulted", "in", "decreased", "product", "sales", "of", "approximately", "$7.5", "million", "for", "the", "year", "ended", "December", "31,", "2009", "compared", "to", "the", "year", "ended", "December", "31,", "2008.", "<tag2>", "Product", "sales", "decreased", "during", "the", "years", "ended", "December", "31,", "2011", "and", "2010", "compared", "to", "the", "prior", "periods", "primarily", "as", "a", "result", "of", "decreased", "product", "demand", "from", "our", "collaboration", "partners", "due", "in", "part", "to", "the", "transfer", "of", "manufacturing", "activities", "to", "certain", "collaboration", "partners.", "<tag3>"], "wordsA": ["Lower", "product", "demand", "from", "our", "collaboration", "partners", "resulted", "in", "decreased", "product", "sales", "of", "approximately", "$7.5", "million", "for", "the", "year", "ended", "December", "31,", "2009", "compared", "to", "the", "year", "ended", "December", "31,", "2008."], "wordsB": ["Product", "sales", "decreased", "during", "the", "years", "ended", "December", "31,", "2011", "and", "2010", "compared", "to", "the", "prior", "periods", "primarily", "as", "a", "result", "of", "decreased", "product", "demand", "from", "our", "collaboration", "partners", "due", "in", "part", "to", "the", "transfer", "of", "manufacturing", "activities", "to", "certain", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p29_s4", "idA": "906709_11_item7_p19_s0", "sentA": "Lower product demand from our collaboration partners resulted in decreased product sales of approximately $7.5 million for the year ended December 31, 2009 compared to the year ended December 31, 2008.", "sentB": "General and administrative expenses for the year ended December 31, 2010 remained at a consistent level compared to the year ended December 31, 2009.", "type": 2, "words": ["<tag1>", "Lower", "product", "demand", "from", "our", "collaboration", "partners", "resulted", "in", "decreased", "product", "sales", "of", "approximately", "$7.5", "million", "for", "the", "year", "ended", "December", "31,", "2009", "compared", "to", "the", "year", "ended", "December", "31,", "2008.", "<tag2>", "General", "and", "administrative", "expenses", "for", "the", "year", "ended", "December", "31,", "2010", "remained", "at", "a", "consistent", "level", "compared", "to", "the", "year", "ended", "December", "31,", "2009.", "<tag3>"], "wordsA": ["Lower", "product", "demand", "from", "our", "collaboration", "partners", "resulted", "in", "decreased", "product", "sales", "of", "approximately", "$7.5", "million", "for", "the", "year", "ended", "December", "31,", "2009", "compared", "to", "the", "year", "ended", "December", "31,", "2008."], "wordsB": ["General", "and", "administrative", "expenses", "for", "the", "year", "ended", "December", "31,", "2010", "remained", "at", "a", "consistent", "level", "compared", "to", "the", "year", "ended", "December", "31,", "2009."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p36_s1", "idA": "906709_11_item7_p19_s0", "sentA": "Lower product demand from our collaboration partners resulted in decreased product sales of approximately $7.5 million for the year ended December 31, 2009 compared to the year ended December 31, 2008.", "sentB": "We paid $0.2 million in transaction costs related to the sale during the year ended December 31, 2008 and $4.4 million in transaction costs during the year ended December 31, 2009.", "type": 2, "words": ["<tag1>", "Lower", "product", "demand", "from", "our", "collaboration", "partners", "resulted", "in", "decreased", "product", "sales", "of", "approximately", "$7.5", "million", "for", "the", "year", "ended", "December", "31,", "2009", "compared", "to", "the", "year", "ended", "December", "31,", "2008.", "<tag2>", "We", "paid", "$0.2", "million", "in", "transaction", "costs", "related", "to", "the", "sale", "during", "the", "year", "ended", "December", "31,", "2008", "and", "$4.4", "million", "in", "transaction", "costs", "during", "the", "year", "ended", "December", "31,", "2009.", "<tag3>"], "wordsA": ["Lower", "product", "demand", "from", "our", "collaboration", "partners", "resulted", "in", "decreased", "product", "sales", "of", "approximately", "$7.5", "million", "for", "the", "year", "ended", "December", "31,", "2009", "compared", "to", "the", "year", "ended", "December", "31,", "2008."], "wordsB": ["We", "paid", "$0.2", "million", "in", "transaction", "costs", "related", "to", "the", "sale", "during", "the", "year", "ended", "December", "31,", "2008", "and", "$4.4", "million", "in", "transaction", "costs", "during", "the", "year", "ended", "December", "31,", "2009."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p13_s5", "idA": "906709_11_item7_p19_s1", "sentA": "For the year ended December 31, 2009, an increase in royalties of approximately $1.6 million partially offset the decrease in product sales compared to the year ended December 31, 2008.", "sentB": "Royalty revenues increased during the years ended December 31, 2011 and 2010 compared to the prior periods primarily as a result of the increase in royalties received from Roche s MIRCERA and UCB Pharma s CIMZIA product sales.", "type": 2, "words": ["<tag1>", "For", "the", "year", "ended", "December", "31,", "2009,", "an", "increase", "in", "royalties", "of", "approximately", "$1.6", "million", "partially", "offset", "the", "decrease", "in", "product", "sales", "compared", "to", "the", "year", "ended", "December", "31,", "2008.", "<tag2>", "Royalty", "revenues", "increased", "during", "the", "years", "ended", "December", "31,", "2011", "and", "2010", "compared", "to", "the", "prior", "periods", "primarily", "as", "a", "result", "of", "the", "increase", "in", "royalties", "received", "from", "Roche", "s", "MIRCERA", "and", "UCB", "Pharma", "s", "CIMZIA", "product", "sales.", "<tag3>"], "wordsA": ["For", "the", "year", "ended", "December", "31,", "2009,", "an", "increase", "in", "royalties", "of", "approximately", "$1.6", "million", "partially", "offset", "the", "decrease", "in", "product", "sales", "compared", "to", "the", "year", "ended", "December", "31,", "2008."], "wordsB": ["Royalty", "revenues", "increased", "during", "the", "years", "ended", "December", "31,", "2011", "and", "2010", "compared", "to", "the", "prior", "periods", "primarily", "as", "a", "result", "of", "the", "increase", "in", "royalties", "received", "from", "Roche", "s", "MIRCERA", "and", "UCB", "Pharma", "s", "CIMZIA", "product", "sales."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p18_s0", "idA": "906709_11_item7_p19_s1", "sentA": "For the year ended December 31, 2009, an increase in royalties of approximately $1.6 million partially offset the decrease in product sales compared to the year ended December 31, 2008.", "sentB": "The decrease in cost of goods sold during the year ended December 31, 2011 compared to the year ended December 31, 2010 is primarily due to the $2.5 million decrease in product sales in 2011 and an increase in overall commercial and proprietary manufacturing activity in 2011 compared to 2010 that resulted in decreased costs per unit.", "type": 2, "words": ["<tag1>", "For", "the", "year", "ended", "December", "31,", "2009,", "an", "increase", "in", "royalties", "of", "approximately", "$1.6", "million", "partially", "offset", "the", "decrease", "in", "product", "sales", "compared", "to", "the", "year", "ended", "December", "31,", "2008.", "<tag2>", "The", "decrease", "in", "cost", "of", "goods", "sold", "during", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "due", "to", "the", "$2.5", "million", "decrease", "in", "product", "sales", "in", "2011", "and", "an", "increase", "in", "overall", "commercial", "and", "proprietary", "manufacturing", "activity", "in", "2011", "compared", "to", "2010", "that", "resulted", "in", "decreased", "costs", "per", "unit.", "<tag3>"], "wordsA": ["For", "the", "year", "ended", "December", "31,", "2009,", "an", "increase", "in", "royalties", "of", "approximately", "$1.6", "million", "partially", "offset", "the", "decrease", "in", "product", "sales", "compared", "to", "the", "year", "ended", "December", "31,", "2008."], "wordsB": ["The", "decrease", "in", "cost", "of", "goods", "sold", "during", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "due", "to", "the", "$2.5", "million", "decrease", "in", "product", "sales", "in", "2011", "and", "an", "increase", "in", "overall", "commercial", "and", "proprietary", "manufacturing", "activity", "in", "2011", "compared", "to", "2010", "that", "resulted", "in", "decreased", "costs", "per", "unit."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p18_s1", "idA": "906709_11_item7_p19_s1", "sentA": "For the year ended December 31, 2009, an increase in royalties of approximately $1.6 million partially offset the decrease in product sales compared to the year ended December 31, 2008.", "sentB": "The increase in product gross margin during the year ended December 31, 2011 compared to the year ended December 31, 2010 is primarily due to the different mix of products sold and the decreased costs per unit in 2011 resulting from increased manufacturing activity.", "type": 2, "words": ["<tag1>", "For", "the", "year", "ended", "December", "31,", "2009,", "an", "increase", "in", "royalties", "of", "approximately", "$1.6", "million", "partially", "offset", "the", "decrease", "in", "product", "sales", "compared", "to", "the", "year", "ended", "December", "31,", "2008.", "<tag2>", "The", "increase", "in", "product", "gross", "margin", "during", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "due", "to", "the", "different", "mix", "of", "products", "sold", "and", "the", "decreased", "costs", "per", "unit", "in", "2011", "resulting", "from", "increased", "manufacturing", "activity.", "<tag3>"], "wordsA": ["For", "the", "year", "ended", "December", "31,", "2009,", "an", "increase", "in", "royalties", "of", "approximately", "$1.6", "million", "partially", "offset", "the", "decrease", "in", "product", "sales", "compared", "to", "the", "year", "ended", "December", "31,", "2008."], "wordsB": ["The", "increase", "in", "product", "gross", "margin", "during", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "due", "to", "the", "different", "mix", "of", "products", "sold", "and", "the", "decreased", "costs", "per", "unit", "in", "2011", "resulting", "from", "increased", "manufacturing", "activity."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p29_s1", "idA": "906709_11_item7_p19_s1", "sentA": "For the year ended December 31, 2009, an increase in royalties of approximately $1.6 million partially offset the decrease in product sales compared to the year ended December 31, 2008.", "sentB": "For the year ended December 31, 2011 compared to the year ended December 31, 2010, general and administrative expense increased by $2.7 million due to a payment obligation related to the settlement of a commercial litigation matter.", "type": 2, "words": ["<tag1>", "For", "the", "year", "ended", "December", "31,", "2009,", "an", "increase", "in", "royalties", "of", "approximately", "$1.6", "million", "partially", "offset", "the", "decrease", "in", "product", "sales", "compared", "to", "the", "year", "ended", "December", "31,", "2008.", "<tag2>", "For", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010,", "general", "and", "administrative", "expense", "increased", "by", "$2.7", "million", "due", "to", "a", "payment", "obligation", "related", "to", "the", "settlement", "of", "a", "commercial", "litigation", "matter.", "<tag3>"], "wordsA": ["For", "the", "year", "ended", "December", "31,", "2009,", "an", "increase", "in", "royalties", "of", "approximately", "$1.6", "million", "partially", "offset", "the", "decrease", "in", "product", "sales", "compared", "to", "the", "year", "ended", "December", "31,", "2008."], "wordsB": ["For", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010,", "general", "and", "administrative", "expense", "increased", "by", "$2.7", "million", "due", "to", "a", "payment", "obligation", "related", "to", "the", "settlement", "of", "a", "commercial", "litigation", "matter."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p0_s1", "idA": "906709_11_item7_p1_s1", "sentA": "Our current proprietary product pipeline is comprised of drug candidates across a number of therapeutic areas, including oncology, pain, anti-infectives, anti-viral and immunology.", "sentB": "Our current proprietary pipeline is comprised of drug candidates across a number of therapeutic areas including oncology, pain, anti-infectives, anti-viral and immunology.", "type": 2, "words": ["<tag1>", "Our", "current", "proprietary", "product", "pipeline", "is", "comprised", "of", "drug", "candidates", "across", "a", "number", "of", "therapeutic", "areas,", "including", "oncology,", "pain,", "anti-infectives,", "anti-viral", "and", "immunology.", "<tag2>", "Our", "current", "proprietary", "pipeline", "is", "comprised", "of", "drug", "candidates", "across", "a", "number", "of", "therapeutic", "areas", "including", "oncology,", "pain,", "anti-infectives,", "anti-viral", "and", "immunology.", "<tag3>"], "wordsA": ["Our", "current", "proprietary", "product", "pipeline", "is", "comprised", "of", "drug", "candidates", "across", "a", "number", "of", "therapeutic", "areas,", "including", "oncology,", "pain,", "anti-infectives,", "anti-viral", "and", "immunology."], "wordsB": ["Our", "current", "proprietary", "pipeline", "is", "comprised", "of", "drug", "candidates", "across", "a", "number", "of", "therapeutic", "areas", "including", "oncology,", "pain,", "anti-infectives,", "anti-viral", "and", "immunology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p12_s1", "idA": "906709_11_item7_p1_s2", "sentA": "Our research and development activities involve small molecule drugs, peptides and other potential biologic drug candidates.", "sentB": "Given the uncertainties in research and development collaborations, significant judgment is required by management to determine the performance periods.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "other", "potential", "biologic", "drug", "candidates.", "<tag2>", "Given", "the", "uncertainties", "in", "research", "and", "development", "collaborations,", "significant", "judgment", "is", "required", "by", "management", "to", "determine", "the", "performance", "periods.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "other", "potential", "biologic", "drug", "candidates."], "wordsB": ["Given", "the", "uncertainties", "in", "research", "and", "development", "collaborations,", "significant", "judgment", "is", "required", "by", "management", "to", "determine", "the", "performance", "periods."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p25_s4", "idA": "906709_11_item7_p1_s2", "sentA": "Our research and development activities involve small molecule drugs, peptides and other potential biologic drug candidates.", "sentB": "We do not expect to have any significant future research and development costs associated with NKTR-118 and NKTR-119 as AstraZeneca is responsible for all further development and commercialization costs for these drug candidates.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "other", "potential", "biologic", "drug", "candidates.", "<tag2>", "We", "do", "not", "expect", "to", "have", "any", "significant", "future", "research", "and", "development", "costs", "associated", "with", "NKTR-118", "and", "NKTR-119", "as", "AstraZeneca", "is", "responsible", "for", "all", "further", "development", "and", "commercialization", "costs", "for", "these", "drug", "candidates.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "other", "potential", "biologic", "drug", "candidates."], "wordsB": ["We", "do", "not", "expect", "to", "have", "any", "significant", "future", "research", "and", "development", "costs", "associated", "with", "NKTR-118", "and", "NKTR-119", "as", "AstraZeneca", "is", "responsible", "for", "all", "further", "development", "and", "commercialization", "costs", "for", "these", "drug", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p2_s0", "idA": "906709_11_item7_p1_s2", "sentA": "Our research and development activities involve small molecule drugs, peptides and other potential biologic drug candidates.", "sentB": "NKTR-119 is an early stage research and development program that is designed to combine various opioids with NKTR-118.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "other", "potential", "biologic", "drug", "candidates.", "<tag2>", "NKTR-119", "is", "an", "early", "stage", "research", "and", "development", "program", "that", "is", "designed", "to", "combine", "various", "opioids", "with", "NKTR-118.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "other", "potential", "biologic", "drug", "candidates."], "wordsB": ["NKTR-119", "is", "an", "early", "stage", "research", "and", "development", "program", "that", "is", "designed", "to", "combine", "various", "opioids", "with", "NKTR-118."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p13_s9", "idA": "906709_11_item7_p20_s0", "sentA": "License, collaboration and other revenue includes amortization of upfront payments and performance milestone payments received in connection with our license and collaboration agreements and reimbursed research and development expenses.", "sentB": "License, collaboration and other revenue License, collaboration and other revenue includes amortization of upfront payments and milestone payments received in connection with our license and collaboration agreements and reimbursed research and development expenses.", "type": 2, "words": ["<tag1>", "License,", "collaboration", "and", "other", "revenue", "includes", "amortization", "of", "upfront", "payments", "and", "performance", "milestone", "payments", "received", "in", "connection", "with", "our", "license", "and", "collaboration", "agreements", "and", "reimbursed", "research", "and", "development", "expenses.", "<tag2>", "License,", "collaboration", "and", "other", "revenue", "License,", "collaboration", "and", "other", "revenue", "includes", "amortization", "of", "upfront", "payments", "and", "milestone", "payments", "received", "in", "connection", "with", "our", "license", "and", "collaboration", "agreements", "and", "reimbursed", "research", "and", "development", "expenses.", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "revenue", "includes", "amortization", "of", "upfront", "payments", "and", "performance", "milestone", "payments", "received", "in", "connection", "with", "our", "license", "and", "collaboration", "agreements", "and", "reimbursed", "research", "and", "development", "expenses."], "wordsB": ["License,", "collaboration", "and", "other", "revenue", "License,", "collaboration", "and", "other", "revenue", "includes", "amortization", "of", "upfront", "payments", "and", "milestone", "payments", "received", "in", "connection", "with", "our", "license", "and", "collaboration", "agreements", "and", "reimbursed", "research", "and", "development", "expenses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p13_s10", "idA": "906709_11_item7_p20_s1", "sentA": "The level of license, collaboration and other revenues depends in part upon the estimated amortization period of the upfront and milestone payments, the achievement of future milestones, the continuation of existing collaborations, the amount of reimbursed research and development work, and the signing of new collaborations.", "sentB": "The level of license, collaboration and other revenue depends in part upon the estimated amortization period of the upfront payments, the achievement of milestones, the continuation of existing collaborations, the amount of reimbursed research and development work, and entering into new collaboration agreements, if any.", "type": 2, "words": ["<tag1>", "The", "level", "of", "license,", "collaboration", "and", "other", "revenues", "depends", "in", "part", "upon", "the", "estimated", "amortization", "period", "of", "the", "upfront", "and", "milestone", "payments,", "the", "achievement", "of", "future", "milestones,", "the", "continuation", "of", "existing", "collaborations,", "the", "amount", "of", "reimbursed", "research", "and", "development", "work,", "and", "the", "signing", "of", "new", "collaborations.", "<tag2>", "The", "level", "of", "license,", "collaboration", "and", "other", "revenue", "depends", "in", "part", "upon", "the", "estimated", "amortization", "period", "of", "the", "upfront", "payments,", "the", "achievement", "of", "milestones,", "the", "continuation", "of", "existing", "collaborations,", "the", "amount", "of", "reimbursed", "research", "and", "development", "work,", "and", "entering", "into", "new", "collaboration", "agreements,", "if", "any.", "<tag3>"], "wordsA": ["The", "level", "of", "license,", "collaboration", "and", "other", "revenues", "depends", "in", "part", "upon", "the", "estimated", "amortization", "period", "of", "the", "upfront", "and", "milestone", "payments,", "the", "achievement", "of", "future", "milestones,", "the", "continuation", "of", "existing", "collaborations,", "the", "amount", "of", "reimbursed", "research", "and", "development", "work,", "and", "the", "signing", "of", "new", "collaborations."], "wordsB": ["The", "level", "of", "license,", "collaboration", "and", "other", "revenue", "depends", "in", "part", "upon", "the", "estimated", "amortization", "period", "of", "the", "upfront", "payments,", "the", "achievement", "of", "milestones,", "the", "continuation", "of", "existing", "collaborations,", "the", "amount", "of", "reimbursed", "research", "and", "development", "work,", "and", "entering", "into", "new", "collaboration", "agreements,", "if", "any."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p20_s2", "idA": "906709_11_item7_p21_s0", "sentA": "For the year ended December 31, 2010, the increase in license, collaboration and other revenue compared to the year ended December 31, 2009 is primarily attributable to recognition of the upfront payment received from AstraZeneca for NKTR-118 and NKTR-119 in the fourth quarter of 2009, contract research and other revenue from AstraZeneca, and the recognition of the license extension option payment received from Roche in December 2009.", "sentB": "The increase in research and development expense for the year ended December 31, 2011 compared to the year ended December 31, 2010 is primarily attributable to a $7.5 million increase in direct research and development program costs and related materials costs, a $3.0 million increase in salaries and employee benefits resulting from increased headcount to support our expanded clinical efforts, and a $6.3 million increase in support and facilities-related costs, which includes increased non-cash depreciation and non-cash rent expenses related to our new facility in the Mission Bay Area of San Francisco, California (Mission Bay Facility).", "type": 2, "words": ["<tag1>", "For", "the", "year", "ended", "December", "31,", "2010,", "the", "increase", "in", "license,", "collaboration", "and", "other", "revenue", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "recognition", "of", "the", "upfront", "payment", "received", "from", "AstraZeneca", "for", "NKTR-118", "and", "NKTR-119", "in", "the", "fourth", "quarter", "of", "2009,", "contract", "research", "and", "other", "revenue", "from", "AstraZeneca,", "and", "the", "recognition", "of", "the", "license", "extension", "option", "payment", "received", "from", "Roche", "in", "December", "2009.", "<tag2>", "The", "increase", "in", "research", "and", "development", "expense", "for", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "attributable", "to", "a", "$7.5", "million", "increase", "in", "direct", "research", "and", "development", "program", "costs", "and", "related", "materials", "costs,", "a", "$3.0", "million", "increase", "in", "salaries", "and", "employee", "benefits", "resulting", "from", "increased", "headcount", "to", "support", "our", "expanded", "clinical", "efforts,", "and", "a", "$6.3", "million", "increase", "in", "support", "and", "facilities-related", "costs,", "which", "includes", "increased", "non-cash", "depreciation", "and", "non-cash", "rent", "expenses", "related", "to", "our", "new", "facility", "in", "the", "Mission", "Bay", "Area", "of", "San", "Francisco,", "California", "(Mission", "Bay", "Facility).", "<tag3>"], "wordsA": ["For", "the", "year", "ended", "December", "31,", "2010,", "the", "increase", "in", "license,", "collaboration", "and", "other", "revenue", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "recognition", "of", "the", "upfront", "payment", "received", "from", "AstraZeneca", "for", "NKTR-118", "and", "NKTR-119", "in", "the", "fourth", "quarter", "of", "2009,", "contract", "research", "and", "other", "revenue", "from", "AstraZeneca,", "and", "the", "recognition", "of", "the", "license", "extension", "option", "payment", "received", "from", "Roche", "in", "December", "2009."], "wordsB": ["The", "increase", "in", "research", "and", "development", "expense", "for", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "attributable", "to", "a", "$7.5", "million", "increase", "in", "direct", "research", "and", "development", "program", "costs", "and", "related", "materials", "costs,", "a", "$3.0", "million", "increase", "in", "salaries", "and", "employee", "benefits", "resulting", "from", "increased", "headcount", "to", "support", "our", "expanded", "clinical", "efforts,", "and", "a", "$6.3", "million", "increase", "in", "support", "and", "facilities-related", "costs,", "which", "includes", "increased", "non-cash", "depreciation", "and", "non-cash", "rent", "expenses", "related", "to", "our", "new", "facility", "in", "the", "Mission", "Bay", "Area", "of", "San", "Francisco,", "California", "(Mission", "Bay", "Facility)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p35_s2", "idA": "906709_11_item7_p21_s1", "sentA": "Under the AstraZeneca license agreement and related technology transfer agreement, we recognized $101.4 million and $23.6 million of the $125.0 million upfront payment and $6.5 million and $1.5 million of contract research and other revenue for the years ended December 31, 2010 and 2009, respectively.", "sentB": "Cash flows from investing activities We purchased $9.7 million, $31.5 million, and $16.4 million of property and equipment in the years ended December 31, 2011, 2010, and 2009, respectively.", "type": 2, "words": ["<tag1>", "Under", "the", "AstraZeneca", "license", "agreement", "and", "related", "technology", "transfer", "agreement,", "we", "recognized", "$101.4", "million", "and", "$23.6", "million", "of", "the", "$125.0", "million", "upfront", "payment", "and", "$6.5", "million", "and", "$1.5", "million", "of", "contract", "research", "and", "other", "revenue", "for", "the", "years", "ended", "December", "31,", "2010", "and", "2009,", "respectively.", "<tag2>", "Cash", "flows", "from", "investing", "activities", "We", "purchased", "$9.7", "million,", "$31.5", "million,", "and", "$16.4", "million", "of", "property", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2011,", "2010,", "and", "2009,", "respectively.", "<tag3>"], "wordsA": ["Under", "the", "AstraZeneca", "license", "agreement", "and", "related", "technology", "transfer", "agreement,", "we", "recognized", "$101.4", "million", "and", "$23.6", "million", "of", "the", "$125.0", "million", "upfront", "payment", "and", "$6.5", "million", "and", "$1.5", "million", "of", "contract", "research", "and", "other", "revenue", "for", "the", "years", "ended", "December", "31,", "2010", "and", "2009,", "respectively."], "wordsB": ["Cash", "flows", "from", "investing", "activities", "We", "purchased", "$9.7", "million,", "$31.5", "million,", "and", "$16.4", "million", "of", "property", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2011,", "2010,", "and", "2009,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p36_s4", "idA": "906709_11_item7_p21_s2", "sentA": "We recognized $5.1 million and $0.2 million, respectively, of the $31.0 million license extension option payment from Roche for the years ended December 31, 2010 and 2009, respectively.", "sentB": "We received proceeds from issuance of common stock related to our employee option and stock purchase plans of $4.5 million, $8.9 million, and $4.8 million in the years ended December 31, 2011, 2010, and 2009, respectively.", "type": 2, "words": ["<tag1>", "We", "recognized", "$5.1", "million", "and", "$0.2", "million,", "respectively,", "of", "the", "$31.0", "million", "license", "extension", "option", "payment", "from", "Roche", "for", "the", "years", "ended", "December", "31,", "2010", "and", "2009,", "respectively.", "<tag2>", "We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$4.5", "million,", "$8.9", "million,", "and", "$4.8", "million", "in", "the", "years", "ended", "December", "31,", "2011,", "2010,", "and", "2009,", "respectively.", "<tag3>"], "wordsA": ["We", "recognized", "$5.1", "million", "and", "$0.2", "million,", "respectively,", "of", "the", "$31.0", "million", "license", "extension", "option", "payment", "from", "Roche", "for", "the", "years", "ended", "December", "31,", "2010", "and", "2009,", "respectively."], "wordsB": ["We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$4.5", "million,", "$8.9", "million,", "and", "$4.8", "million", "in", "the", "years", "ended", "December", "31,", "2011,", "2010,", "and", "2009,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p40_s1", "idA": "906709_11_item7_p22_s1", "sentA": "In addition, 2008 included revenue related to a new intellectual property license agreement we entered into with Roche and higher revenue from Bayer under our collaboration agreement for BAY41-6551.", "sentB": "Under the terms of the sublease we entered into with Pfizer Inc. on September 30, 2009 for the Mission Bay Facility, we will begin making non-cancelable lease payments in 2014.", "type": 2, "words": ["<tag1>", "In", "addition,", "2008", "included", "revenue", "related", "to", "a", "new", "intellectual", "property", "license", "agreement", "we", "entered", "into", "with", "Roche", "and", "higher", "revenue", "from", "Bayer", "under", "our", "collaboration", "agreement", "for", "BAY41-6551.", "<tag2>", "Under", "the", "terms", "of", "the", "sublease", "we", "entered", "into", "with", "Pfizer", "Inc.", "on", "September", "30,", "2009", "for", "the", "Mission", "Bay", "Facility,", "we", "will", "begin", "making", "non-cancelable", "lease", "payments", "in", "2014.", "<tag3>"], "wordsA": ["In", "addition,", "2008", "included", "revenue", "related", "to", "a", "new", "intellectual", "property", "license", "agreement", "we", "entered", "into", "with", "Roche", "and", "higher", "revenue", "from", "Bayer", "under", "our", "collaboration", "agreement", "for", "BAY41-6551."], "wordsB": ["Under", "the", "terms", "of", "the", "sublease", "we", "entered", "into", "with", "Pfizer", "Inc.", "on", "September", "30,", "2009", "for", "the", "Mission", "Bay", "Facility,", "we", "will", "begin", "making", "non-cancelable", "lease", "payments", "in", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p13_s12", "idA": "906709_11_item7_p22_s2", "sentA": "This decrease is partially off-set by $25.1 million in revenue recognized related to our agreement with AstraZeneca for NKTR-118 and NKTR-119.", "sentB": "This decrease was partially offset by the recognition of a $5.0 million license fee, $6.0 million in milestones earned under existing collaboration agreements, and increases in revenue recognized in 2011 from upfront payments received by us during 2010.", "type": 2, "words": ["<tag1>", "This", "decrease", "is", "partially", "off-set", "by", "$25.1", "million", "in", "revenue", "recognized", "related", "to", "our", "agreement", "with", "AstraZeneca", "for", "NKTR-118", "and", "NKTR-119.", "<tag2>", "This", "decrease", "was", "partially", "offset", "by", "the", "recognition", "of", "a", "$5.0", "million", "license", "fee,", "$6.0", "million", "in", "milestones", "earned", "under", "existing", "collaboration", "agreements,", "and", "increases", "in", "revenue", "recognized", "in", "2011", "from", "upfront", "payments", "received", "by", "us", "during", "2010.", "<tag3>"], "wordsA": ["This", "decrease", "is", "partially", "off-set", "by", "$25.1", "million", "in", "revenue", "recognized", "related", "to", "our", "agreement", "with", "AstraZeneca", "for", "NKTR-118", "and", "NKTR-119."], "wordsB": ["This", "decrease", "was", "partially", "offset", "by", "the", "recognition", "of", "a", "$5.0", "million", "license", "fee,", "$6.0", "million", "in", "milestones", "earned", "under", "existing", "collaboration", "agreements,", "and", "increases", "in", "revenue", "recognized", "in", "2011", "from", "upfront", "payments", "received", "by", "us", "during", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p1_s5", "idA": "906709_11_item7_p22_s2", "sentA": "This decrease is partially off-set by $25.1 million in revenue recognized related to our agreement with AstraZeneca for NKTR-118 and NKTR-119.", "sentB": "We are a party to an exclusive worldwide license agreement with AstraZeneca for the global development and commercialization of NKTR-118 and NKTR-119.", "type": 2, "words": ["<tag1>", "This", "decrease", "is", "partially", "off-set", "by", "$25.1", "million", "in", "revenue", "recognized", "related", "to", "our", "agreement", "with", "AstraZeneca", "for", "NKTR-118", "and", "NKTR-119.", "<tag2>", "We", "are", "a", "party", "to", "an", "exclusive", "worldwide", "license", "agreement", "with", "AstraZeneca", "for", "the", "global", "development", "and", "commercialization", "of", "NKTR-118", "and", "NKTR-119.", "<tag3>"], "wordsA": ["This", "decrease", "is", "partially", "off-set", "by", "$25.1", "million", "in", "revenue", "recognized", "related", "to", "our", "agreement", "with", "AstraZeneca", "for", "NKTR-118", "and", "NKTR-119."], "wordsB": ["We", "are", "a", "party", "to", "an", "exclusive", "worldwide", "license", "agreement", "with", "AstraZeneca", "for", "the", "global", "development", "and", "commercialization", "of", "NKTR-118", "and", "NKTR-119."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p13_s13", "idA": "906709_11_item7_p23_s0", "sentA": "We expect license, collaboration and other revenue to substantially decrease in 2011 due to the complete recognition as of December 31, 2010 of the upfront payment we received under the AstraZeneca license agreement.", "sentB": "We expect license, collaboration and other revenue in 2012 to be consistent with 2011.", "type": 2, "words": ["<tag1>", "We", "expect", "license,", "collaboration", "and", "other", "revenue", "to", "substantially", "decrease", "in", "2011", "due", "to", "the", "complete", "recognition", "as", "of", "December", "31,", "2010", "of", "the", "upfront", "payment", "we", "received", "under", "the", "AstraZeneca", "license", "agreement.", "<tag2>", "We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2012", "to", "be", "consistent", "with", "2011.", "<tag3>"], "wordsA": ["We", "expect", "license,", "collaboration", "and", "other", "revenue", "to", "substantially", "decrease", "in", "2011", "due", "to", "the", "complete", "recognition", "as", "of", "December", "31,", "2010", "of", "the", "upfront", "payment", "we", "received", "under", "the", "AstraZeneca", "license", "agreement."], "wordsB": ["We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2012", "to", "be", "consistent", "with", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p25_s8", "idA": "906709_11_item7_p24_s0", "sentA": "The timing and future success of our drug development programs and those of our collaboration partners are subject to a number of risks and uncertainties.", "sentB": "Our expenditures on current and future preclinical and clinical development programs are subject to numerous uncertainties in timing and cost to completion.", "type": 2, "words": ["<tag1>", "The", "timing", "and", "future", "success", "of", "our", "drug", "development", "programs", "and", "those", "of", "our", "collaboration", "partners", "are", "subject", "to", "a", "number", "of", "risks", "and", "uncertainties.", "<tag2>", "Our", "expenditures", "on", "current", "and", "future", "preclinical", "and", "clinical", "development", "programs", "are", "subject", "to", "numerous", "uncertainties", "in", "timing", "and", "cost", "to", "completion.", "<tag3>"], "wordsA": ["The", "timing", "and", "future", "success", "of", "our", "drug", "development", "programs", "and", "those", "of", "our", "collaboration", "partners", "are", "subject", "to", "a", "number", "of", "risks", "and", "uncertainties."], "wordsB": ["Our", "expenditures", "on", "current", "and", "future", "preclinical", "and", "clinical", "development", "programs", "are", "subject", "to", "numerous", "uncertainties", "in", "timing", "and", "cost", "to", "completion."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p27_s3", "idA": "906709_11_item7_p24_s0", "sentA": "The timing and future success of our drug development programs and those of our collaboration partners are subject to a number of risks and uncertainties.", "sentB": "We cannot forecast with any degree of certainty which of our drug candidates will be subject to future collaborations or how such arrangements would affect our development plans or capital requirements.", "type": 2, "words": ["<tag1>", "The", "timing", "and", "future", "success", "of", "our", "drug", "development", "programs", "and", "those", "of", "our", "collaboration", "partners", "are", "subject", "to", "a", "number", "of", "risks", "and", "uncertainties.", "<tag2>", "We", "cannot", "forecast", "with", "any", "degree", "of", "certainty", "which", "of", "our", "drug", "candidates", "will", "be", "subject", "to", "future", "collaborations", "or", "how", "such", "arrangements", "would", "affect", "our", "development", "plans", "or", "capital", "requirements.", "<tag3>"], "wordsA": ["The", "timing", "and", "future", "success", "of", "our", "drug", "development", "programs", "and", "those", "of", "our", "collaboration", "partners", "are", "subject", "to", "a", "number", "of", "risks", "and", "uncertainties."], "wordsB": ["We", "cannot", "forecast", "with", "any", "degree", "of", "certainty", "which", "of", "our", "drug", "candidates", "will", "be", "subject", "to", "future", "collaborations", "or", "how", "such", "arrangements", "would", "affect", "our", "development", "plans", "or", "capital", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p1_s3", "idA": "906709_11_item7_p2_s3", "sentA": "Our objective is to apply our advanced polymer conjugate technology platform to create new drugs in multiple therapeutic areas.", "sentB": "Our objective is to apply our advanced polymer conjugate technology platform to create new drug candidates in multiple therapeutic areas that address large potential markets.", "type": 2, "words": ["<tag1>", "Our", "objective", "is", "to", "apply", "our", "advanced", "polymer", "conjugate", "technology", "platform", "to", "create", "new", "drugs", "in", "multiple", "therapeutic", "areas.", "<tag2>", "Our", "objective", "is", "to", "apply", "our", "advanced", "polymer", "conjugate", "technology", "platform", "to", "create", "new", "drug", "candidates", "in", "multiple", "therapeutic", "areas", "that", "address", "large", "potential", "markets.", "<tag3>"], "wordsA": ["Our", "objective", "is", "to", "apply", "our", "advanced", "polymer", "conjugate", "technology", "platform", "to", "create", "new", "drugs", "in", "multiple", "therapeutic", "areas."], "wordsB": ["Our", "objective", "is", "to", "apply", "our", "advanced", "polymer", "conjugate", "technology", "platform", "to", "create", "new", "drug", "candidates", "in", "multiple", "therapeutic", "areas", "that", "address", "large", "potential", "markets."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p25_s6", "idA": "906709_11_item7_p2_s3", "sentA": "Our objective is to apply our advanced polymer conjugate technology platform to create new drugs in multiple therapeutic areas.", "sentB": "Our discovery research organization is identifying new drug candidates by applying our technology platform to a wide range of molecule classes, including small molecules and large proteins, peptides and antibodies, across multiple therapeutic areas.", "type": 2, "words": ["<tag1>", "Our", "objective", "is", "to", "apply", "our", "advanced", "polymer", "conjugate", "technology", "platform", "to", "create", "new", "drugs", "in", "multiple", "therapeutic", "areas.", "<tag2>", "Our", "discovery", "research", "organization", "is", "identifying", "new", "drug", "candidates", "by", "applying", "our", "technology", "platform", "to", "a", "wide", "range", "of", "molecule", "classes,", "including", "small", "molecules", "and", "large", "proteins,", "peptides", "and", "antibodies,", "across", "multiple", "therapeutic", "areas.", "<tag3>"], "wordsA": ["Our", "objective", "is", "to", "apply", "our", "advanced", "polymer", "conjugate", "technology", "platform", "to", "create", "new", "drugs", "in", "multiple", "therapeutic", "areas."], "wordsB": ["Our", "discovery", "research", "organization", "is", "identifying", "new", "drug", "candidates", "by", "applying", "our", "technology", "platform", "to", "a", "wide", "range", "of", "molecule", "classes,", "including", "small", "molecules", "and", "large", "proteins,", "peptides", "and", "antibodies,", "across", "multiple", "therapeutic", "areas."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p25_s2", "idA": "906709_11_item7_p3_s0", "sentA": "During 2010, we continued to make substantial investments to advance our pipeline of drug candidates from early stage discovery research through clinical development.", "sentB": "In addition, we plan to continue to make substantial investments to support the clinical and commercial manufacturing preparation and scale-up for the nebulizer devices to supply Bayer for the Amikacin Inhale program.", "type": 2, "words": ["<tag1>", "During", "2010,", "we", "continued", "to", "make", "substantial", "investments", "to", "advance", "our", "pipeline", "of", "drug", "candidates", "from", "early", "stage", "discovery", "research", "through", "clinical", "development.", "<tag2>", "In", "addition,", "we", "plan", "to", "continue", "to", "make", "substantial", "investments", "to", "support", "the", "clinical", "and", "commercial", "manufacturing", "preparation", "and", "scale-up", "for", "the", "nebulizer", "devices", "to", "supply", "Bayer", "for", "the", "Amikacin", "Inhale", "program.", "<tag3>"], "wordsA": ["During", "2010,", "we", "continued", "to", "make", "substantial", "investments", "to", "advance", "our", "pipeline", "of", "drug", "candidates", "from", "early", "stage", "discovery", "research", "through", "clinical", "development."], "wordsB": ["In", "addition,", "we", "plan", "to", "continue", "to", "make", "substantial", "investments", "to", "support", "the", "clinical", "and", "commercial", "manufacturing", "preparation", "and", "scale-up", "for", "the", "nebulizer", "devices", "to", "supply", "Bayer", "for", "the", "Amikacin", "Inhale", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p25_s5", "idA": "906709_11_item7_p3_s0", "sentA": "During 2010, we continued to make substantial investments to advance our pipeline of drug candidates from early stage discovery research through clinical development.", "sentB": "In addition to our drug candidates that we plan to have in clinical development during 2012 and beyond, we believe it is vitally important to continue our substantial investment in a diverse pipeline of new drug candidates to continue to build on the value of our business.", "type": 2, "words": ["<tag1>", "During", "2010,", "we", "continued", "to", "make", "substantial", "investments", "to", "advance", "our", "pipeline", "of", "drug", "candidates", "from", "early", "stage", "discovery", "research", "through", "clinical", "development.", "<tag2>", "In", "addition", "to", "our", "drug", "candidates", "that", "we", "plan", "to", "have", "in", "clinical", "development", "during", "2012", "and", "beyond,", "we", "believe", "it", "is", "vitally", "important", "to", "continue", "our", "substantial", "investment", "in", "a", "diverse", "pipeline", "of", "new", "drug", "candidates", "to", "continue", "to", "build", "on", "the", "value", "of", "our", "business.", "<tag3>"], "wordsA": ["During", "2010,", "we", "continued", "to", "make", "substantial", "investments", "to", "advance", "our", "pipeline", "of", "drug", "candidates", "from", "early", "stage", "discovery", "research", "through", "clinical", "development."], "wordsB": ["In", "addition", "to", "our", "drug", "candidates", "that", "we", "plan", "to", "have", "in", "clinical", "development", "during", "2012", "and", "beyond,", "we", "believe", "it", "is", "vitally", "important", "to", "continue", "our", "substantial", "investment", "in", "a", "diverse", "pipeline", "of", "new", "drug", "candidates", "to", "continue", "to", "build", "on", "the", "value", "of", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p26_s0", "idA": "906709_11_item7_p3_s0", "sentA": "During 2010, we continued to make substantial investments to advance our pipeline of drug candidates from early stage discovery research through clinical development.", "sentB": "In order to advance our drug candidates through clinical development, the drug candidates are tested in numerous preclinical safety, toxicology and efficacy studies.", "type": 2, "words": ["<tag1>", "During", "2010,", "we", "continued", "to", "make", "substantial", "investments", "to", "advance", "our", "pipeline", "of", "drug", "candidates", "from", "early", "stage", "discovery", "research", "through", "clinical", "development.", "<tag2>", "In", "order", "to", "advance", "our", "drug", "candidates", "through", "clinical", "development,", "the", "drug", "candidates", "are", "tested", "in", "numerous", "preclinical", "safety,", "toxicology", "and", "efficacy", "studies.", "<tag3>"], "wordsA": ["During", "2010,", "we", "continued", "to", "make", "substantial", "investments", "to", "advance", "our", "pipeline", "of", "drug", "candidates", "from", "early", "stage", "discovery", "research", "through", "clinical", "development."], "wordsB": ["In", "order", "to", "advance", "our", "drug", "candidates", "through", "clinical", "development,", "the", "drug", "candidates", "are", "tested", "in", "numerous", "preclinical", "safety,", "toxicology", "and", "efficacy", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p8_s3", "idA": "906709_11_item7_p3_s0", "sentA": "During 2010, we continued to make substantial investments to advance our pipeline of drug candidates from early stage discovery research through clinical development.", "sentB": "We expect the clinical development of our proprietary drug candidates including NKTR-102, NKTR-061, NKTR-181, and NKTR-192 will continue to require significant investments in order to advance through the clinic with the objective of entering into a collaboration partnership or obtaining regulatory approval.", "type": 2, "words": ["<tag1>", "During", "2010,", "we", "continued", "to", "make", "substantial", "investments", "to", "advance", "our", "pipeline", "of", "drug", "candidates", "from", "early", "stage", "discovery", "research", "through", "clinical", "development.", "<tag2>", "We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates", "including", "NKTR-102,", "NKTR-061,", "NKTR-181,", "and", "NKTR-192", "will", "continue", "to", "require", "significant", "investments", "in", "order", "to", "advance", "through", "the", "clinic", "with", "the", "objective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval.", "<tag3>"], "wordsA": ["During", "2010,", "we", "continued", "to", "make", "substantial", "investments", "to", "advance", "our", "pipeline", "of", "drug", "candidates", "from", "early", "stage", "discovery", "research", "through", "clinical", "development."], "wordsB": ["We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates", "including", "NKTR-102,", "NKTR-061,", "NKTR-181,", "and", "NKTR-192", "will", "continue", "to", "require", "significant", "investments", "in", "order", "to", "advance", "through", "the", "clinic", "with", "the", "objective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p4_s2", "idA": "906709_11_item7_p4_s0", "sentA": "In 2010, we continued to advance Phase 2 clinical trials for NKTR-102 (topoisomerase I inhibitor-polymer conjugate) in platinum resistant/refractory ovarian cancer, metastatic breast cancer and metastatic colorectal cancer.", "sentB": "The BEACON study is scheduled to enroll approximately 840 patients with metastatic breast cancer.", "type": 2, "words": ["<tag1>", "In", "2010,", "we", "continued", "to", "advance", "Phase", "2", "clinical", "trials", "for", "NKTR-102", "(topoisomerase", "I", "inhibitor-polymer", "conjugate)", "in", "platinum", "resistant/refractory", "ovarian", "cancer,", "metastatic", "breast", "cancer", "and", "metastatic", "colorectal", "cancer.", "<tag2>", "The", "BEACON", "study", "is", "scheduled", "to", "enroll", "approximately", "840", "patients", "with", "metastatic", "breast", "cancer.", "<tag3>"], "wordsA": ["In", "2010,", "we", "continued", "to", "advance", "Phase", "2", "clinical", "trials", "for", "NKTR-102", "(topoisomerase", "I", "inhibitor-polymer", "conjugate)", "in", "platinum", "resistant/refractory", "ovarian", "cancer,", "metastatic", "breast", "cancer", "and", "metastatic", "colorectal", "cancer."], "wordsB": ["The", "BEACON", "study", "is", "scheduled", "to", "enroll", "approximately", "840", "patients", "with", "metastatic", "breast", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p24_s3", "idA": "906709_11_item7_p4_s1", "sentA": "The Phase 2 clinical trial in metastatic breast cancer patients was fully enrolled in 2010 with patients continuing in the study into 2011.", "sentB": "We plan to continue to advance NKTR-102 in the BEACON study (metastatic breast cancer) and in Phase 2 clinical studies in ovarian and colorectal cancers.", "type": 2, "words": ["<tag1>", "The", "Phase", "2", "clinical", "trial", "in", "metastatic", "breast", "cancer", "patients", "was", "fully", "enrolled", "in", "2010", "with", "patients", "continuing", "in", "the", "study", "into", "2011.", "<tag2>", "We", "plan", "to", "continue", "to", "advance", "NKTR-102", "in", "the", "BEACON", "study", "(metastatic", "breast", "cancer)", "and", "in", "Phase", "2", "clinical", "studies", "in", "ovarian", "and", "colorectal", "cancers.", "<tag3>"], "wordsA": ["The", "Phase", "2", "clinical", "trial", "in", "metastatic", "breast", "cancer", "patients", "was", "fully", "enrolled", "in", "2010", "with", "patients", "continuing", "in", "the", "study", "into", "2011."], "wordsB": ["We", "plan", "to", "continue", "to", "advance", "NKTR-102", "in", "the", "BEACON", "study", "(metastatic", "breast", "cancer)", "and", "in", "Phase", "2", "clinical", "studies", "in", "ovarian", "and", "colorectal", "cancers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p5_s2", "idA": "906709_11_item7_p4_s1", "sentA": "The Phase 2 clinical trial in metastatic breast cancer patients was fully enrolled in 2010 with patients continuing in the study into 2011.", "sentB": "As of February 2012, approximately 94 of the planned 110 patients had been enrolled in the study.", "type": 2, "words": ["<tag1>", "The", "Phase", "2", "clinical", "trial", "in", "metastatic", "breast", "cancer", "patients", "was", "fully", "enrolled", "in", "2010", "with", "patients", "continuing", "in", "the", "study", "into", "2011.", "<tag2>", "As", "of", "February", "2012,", "approximately", "94", "of", "the", "planned", "110", "patients", "had", "been", "enrolled", "in", "the", "study.", "<tag3>"], "wordsA": ["The", "Phase", "2", "clinical", "trial", "in", "metastatic", "breast", "cancer", "patients", "was", "fully", "enrolled", "in", "2010", "with", "patients", "continuing", "in", "the", "study", "into", "2011."], "wordsB": ["As", "of", "February", "2012,", "approximately", "94", "of", "the", "planned", "110", "patients", "had", "been", "enrolled", "in", "the", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p5_s1", "idA": "906709_11_item7_p4_s2", "sentA": "In 2010, we expanded the Phase 2 clinical trial by 50 patients in platinum resistant/refractory ovarian cancer patients and on March 1, 2011, we announced that we intended to further expand this study by up to 60 additional patients.", "sentB": "In November 2011, we announced that enrollment in this expanded Phase 2 study was slower than anticipated because of a shortage of Doxil related to serious manufacturing issues being experienced by the manufacturer and supplier of Doxil .", "type": 2, "words": ["<tag1>", "In", "2010,", "we", "expanded", "the", "Phase", "2", "clinical", "trial", "by", "50", "patients", "in", "platinum", "resistant/refractory", "ovarian", "cancer", "patients", "and", "on", "March", "1,", "2011,", "we", "announced", "that", "we", "intended", "to", "further", "expand", "this", "study", "by", "up", "to", "60", "additional", "patients.", "<tag2>", "In", "November", "2011,", "we", "announced", "that", "enrollment", "in", "this", "expanded", "Phase", "2", "study", "was", "slower", "than", "anticipated", "because", "of", "a", "shortage", "of", "Doxil", "related", "to", "serious", "manufacturing", "issues", "being", "experienced", "by", "the", "manufacturer", "and", "supplier", "of", "Doxil", ".", "<tag3>"], "wordsA": ["In", "2010,", "we", "expanded", "the", "Phase", "2", "clinical", "trial", "by", "50", "patients", "in", "platinum", "resistant/refractory", "ovarian", "cancer", "patients", "and", "on", "March", "1,", "2011,", "we", "announced", "that", "we", "intended", "to", "further", "expand", "this", "study", "by", "up", "to", "60", "additional", "patients."], "wordsB": ["In", "November", "2011,", "we", "announced", "that", "enrollment", "in", "this", "expanded", "Phase", "2", "study", "was", "slower", "than", "anticipated", "because", "of", "a", "shortage", "of", "Doxil", "related", "to", "serious", "manufacturing", "issues", "being", "experienced", "by", "the", "manufacturer", "and", "supplier", "of", "Doxil", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p35_s5", "idA": "906709_11_item7_p4_s3", "sentA": "We expect this expansion trial to continue to enroll in 2011.", "sentB": "We expect our capital expenditures in 2012 to be consistent with 2011.", "type": 2, "words": ["<tag1>", "We", "expect", "this", "expansion", "trial", "to", "continue", "to", "enroll", "in", "2011.", "<tag2>", "We", "expect", "our", "capital", "expenditures", "in", "2012", "to", "be", "consistent", "with", "2011.", "<tag3>"], "wordsA": ["We", "expect", "this", "expansion", "trial", "to", "continue", "to", "enroll", "in", "2011."], "wordsB": ["We", "expect", "our", "capital", "expenditures", "in", "2012", "to", "be", "consistent", "with", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p24_s4", "idA": "906709_11_item7_p4_s4", "sentA": "The Phase 2 clinical study in metastatic colorectal cancer patients is still enrolling.", "sentB": "Our expanded Phase 2 clinical study in platinum resistant/refractory ovarian cancer patients is expected to continue throughout 2012.", "type": 2, "words": ["<tag1>", "The", "Phase", "2", "clinical", "study", "in", "metastatic", "colorectal", "cancer", "patients", "is", "still", "enrolling.", "<tag2>", "Our", "expanded", "Phase", "2", "clinical", "study", "in", "platinum", "resistant/refractory", "ovarian", "cancer", "patients", "is", "expected", "to", "continue", "throughout", "2012.", "<tag3>"], "wordsA": ["The", "Phase", "2", "clinical", "study", "in", "metastatic", "colorectal", "cancer", "patients", "is", "still", "enrolling."], "wordsB": ["Our", "expanded", "Phase", "2", "clinical", "study", "in", "platinum", "resistant/refractory", "ovarian", "cancer", "patients", "is", "expected", "to", "continue", "throughout", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p24_s6", "idA": "906709_11_item7_p4_s4", "sentA": "The Phase 2 clinical study in metastatic colorectal cancer patients is still enrolling.", "sentB": "At the same time, we continue to advance the Phase 2 clinical study for NKTR-102 in colorectal cancer patients.", "type": 2, "words": ["<tag1>", "The", "Phase", "2", "clinical", "study", "in", "metastatic", "colorectal", "cancer", "patients", "is", "still", "enrolling.", "<tag2>", "At", "the", "same", "time,", "we", "continue", "to", "advance", "the", "Phase", "2", "clinical", "study", "for", "NKTR-102", "in", "colorectal", "cancer", "patients.", "<tag3>"], "wordsA": ["The", "Phase", "2", "clinical", "study", "in", "metastatic", "colorectal", "cancer", "patients", "is", "still", "enrolling."], "wordsB": ["At", "the", "same", "time,", "we", "continue", "to", "advance", "the", "Phase", "2", "clinical", "study", "for", "NKTR-102", "in", "colorectal", "cancer", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p4_s0", "idA": "906709_11_item7_p5_s1", "sentA": "We are currently planning a comparative Phase 3 clinical study for NKTR-102 in metastatic breast cancer and plan to start this study in late 2011.", "sentB": "Our second most advanced drug candidate, NKTR-102, is a next-generation topoisomerase I inhibitor, currently being evaluated as a single-agent therapy in a Phase 3 open-label, randomized, multicenter clinical study in patients with metastatic breast cancer.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "planning", "a", "comparative", "Phase", "3", "clinical", "study", "for", "NKTR-102", "in", "metastatic", "breast", "cancer", "and", "plan", "to", "start", "this", "study", "in", "late", "2011.", "<tag2>", "Our", "second", "most", "advanced", "drug", "candidate,", "NKTR-102,", "is", "a", "next-generation", "topoisomerase", "I", "inhibitor,", "currently", "being", "evaluated", "as", "a", "single-agent", "therapy", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "in", "patients", "with", "metastatic", "breast", "cancer.", "<tag3>"], "wordsA": ["We", "are", "currently", "planning", "a", "comparative", "Phase", "3", "clinical", "study", "for", "NKTR-102", "in", "metastatic", "breast", "cancer", "and", "plan", "to", "start", "this", "study", "in", "late", "2011."], "wordsB": ["Our", "second", "most", "advanced", "drug", "candidate,", "NKTR-102,", "is", "a", "next-generation", "topoisomerase", "I", "inhibitor,", "currently", "being", "evaluated", "as", "a", "single-agent", "therapy", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "in", "patients", "with", "metastatic", "breast", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p4_s1", "idA": "906709_11_item7_p5_s1", "sentA": "We are currently planning a comparative Phase 3 clinical study for NKTR-102 in metastatic breast cancer and plan to start this study in late 2011.", "sentB": "This Phase 3 clinical study, which we call the BEACON study (BrEAst Cancer Outcomes with NKTR-102), was initiated by us in December 2011.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "planning", "a", "comparative", "Phase", "3", "clinical", "study", "for", "NKTR-102", "in", "metastatic", "breast", "cancer", "and", "plan", "to", "start", "this", "study", "in", "late", "2011.", "<tag2>", "This", "Phase", "3", "clinical", "study,", "which", "we", "call", "the", "BEACON", "study", "(BrEAst", "Cancer", "Outcomes", "with", "NKTR-102),", "was", "initiated", "by", "us", "in", "December", "2011.", "<tag3>"], "wordsA": ["We", "are", "currently", "planning", "a", "comparative", "Phase", "3", "clinical", "study", "for", "NKTR-102", "in", "metastatic", "breast", "cancer", "and", "plan", "to", "start", "this", "study", "in", "late", "2011."], "wordsB": ["This", "Phase", "3", "clinical", "study,", "which", "we", "call", "the", "BEACON", "study", "(BrEAst", "Cancer", "Outcomes", "with", "NKTR-102),", "was", "initiated", "by", "us", "in", "December", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p4_s4", "idA": "906709_11_item7_p5_s1", "sentA": "We are currently planning a comparative Phase 3 clinical study for NKTR-102 in metastatic breast cancer and plan to start this study in late 2011.", "sentB": "In the first quarter of 2012, we are also completing an expanded Phase 2 clinical study for NKTR-102 in patients with platinum-resistant ovarian cancer.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "planning", "a", "comparative", "Phase", "3", "clinical", "study", "for", "NKTR-102", "in", "metastatic", "breast", "cancer", "and", "plan", "to", "start", "this", "study", "in", "late", "2011.", "<tag2>", "In", "the", "first", "quarter", "of", "2012,", "we", "are", "also", "completing", "an", "expanded", "Phase", "2", "clinical", "study", "for", "NKTR-102", "in", "patients", "with", "platinum-resistant", "ovarian", "cancer.", "<tag3>"], "wordsA": ["We", "are", "currently", "planning", "a", "comparative", "Phase", "3", "clinical", "study", "for", "NKTR-102", "in", "metastatic", "breast", "cancer", "and", "plan", "to", "start", "this", "study", "in", "late", "2011."], "wordsB": ["In", "the", "first", "quarter", "of", "2012,", "we", "are", "also", "completing", "an", "expanded", "Phase", "2", "clinical", "study", "for", "NKTR-102", "in", "patients", "with", "platinum-resistant", "ovarian", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p5_s4", "idA": "906709_11_item7_p5_s1", "sentA": "We are currently planning a comparative Phase 3 clinical study for NKTR-102 in metastatic breast cancer and plan to start this study in late 2011.", "sentB": "Results from this study and communication with government health authorities in both the United States and EU, will guide our future development and regulatory strategy for NKTR-102 in ovarian cancer.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "planning", "a", "comparative", "Phase", "3", "clinical", "study", "for", "NKTR-102", "in", "metastatic", "breast", "cancer", "and", "plan", "to", "start", "this", "study", "in", "late", "2011.", "<tag2>", "Results", "from", "this", "study", "and", "communication", "with", "government", "health", "authorities", "in", "both", "the", "United", "States", "and", "EU,", "will", "guide", "our", "future", "development", "and", "regulatory", "strategy", "for", "NKTR-102", "in", "ovarian", "cancer.", "<tag3>"], "wordsA": ["We", "are", "currently", "planning", "a", "comparative", "Phase", "3", "clinical", "study", "for", "NKTR-102", "in", "metastatic", "breast", "cancer", "and", "plan", "to", "start", "this", "study", "in", "late", "2011."], "wordsB": ["Results", "from", "this", "study", "and", "communication", "with", "government", "health", "authorities", "in", "both", "the", "United", "States", "and", "EU,", "will", "guide", "our", "future", "development", "and", "regulatory", "strategy", "for", "NKTR-102", "in", "ovarian", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p24_s5", "idA": "906709_11_item7_p5_s3", "sentA": "The size, scope and timing of our investment in a comparative Phase 3 clinical study in platinum resistant/refractory ovarian cancer will depend upon a number of important variables including our evaluation of the expanded Phase 2 study results, discussions with health authorities and key opinion leaders, evolving regulatory standards and requirements, and the estimated cost of these studies.", "sentB": "Based on our compilation and review of preliminary interim results in the expanded Phase 2 study in ovarian cancer and our communications with government health authorities, we will decide the future of our clinical development efforts in this indication.", "type": 2, "words": ["<tag1>", "The", "size,", "scope", "and", "timing", "of", "our", "investment", "in", "a", "comparative", "Phase", "3", "clinical", "study", "in", "platinum", "resistant/refractory", "ovarian", "cancer", "will", "depend", "upon", "a", "number", "of", "important", "variables", "including", "our", "evaluation", "of", "the", "expanded", "Phase", "2", "study", "results,", "discussions", "with", "health", "authorities", "and", "key", "opinion", "leaders,", "evolving", "regulatory", "standards", "and", "requirements,", "and", "the", "estimated", "cost", "of", "these", "studies.", "<tag2>", "Based", "on", "our", "compilation", "and", "review", "of", "preliminary", "interim", "results", "in", "the", "expanded", "Phase", "2", "study", "in", "ovarian", "cancer", "and", "our", "communications", "with", "government", "health", "authorities,", "we", "will", "decide", "the", "future", "of", "our", "clinical", "development", "efforts", "in", "this", "indication.", "<tag3>"], "wordsA": ["The", "size,", "scope", "and", "timing", "of", "our", "investment", "in", "a", "comparative", "Phase", "3", "clinical", "study", "in", "platinum", "resistant/refractory", "ovarian", "cancer", "will", "depend", "upon", "a", "number", "of", "important", "variables", "including", "our", "evaluation", "of", "the", "expanded", "Phase", "2", "study", "results,", "discussions", "with", "health", "authorities", "and", "key", "opinion", "leaders,", "evolving", "regulatory", "standards", "and", "requirements,", "and", "the", "estimated", "cost", "of", "these", "studies."], "wordsB": ["Based", "on", "our", "compilation", "and", "review", "of", "preliminary", "interim", "results", "in", "the", "expanded", "Phase", "2", "study", "in", "ovarian", "cancer", "and", "our", "communications", "with", "government", "health", "authorities,", "we", "will", "decide", "the", "future", "of", "our", "clinical", "development", "efforts", "in", "this", "indication."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p24_s2", "idA": "906709_11_item7_p5_s4", "sentA": "We anticipate our Phase 3 development plans for NKTR-102 to require substantial investment over the next several years.", "sentB": "We expect research and development expense to substantially increase over the next several years.", "type": 2, "words": ["<tag1>", "We", "anticipate", "our", "Phase", "3", "development", "plans", "for", "NKTR-102", "to", "require", "substantial", "investment", "over", "the", "next", "several", "years.", "<tag2>", "We", "expect", "research", "and", "development", "expense", "to", "substantially", "increase", "over", "the", "next", "several", "years.", "<tag3>"], "wordsA": ["We", "anticipate", "our", "Phase", "3", "development", "plans", "for", "NKTR-102", "to", "require", "substantial", "investment", "over", "the", "next", "several", "years."], "wordsB": ["We", "expect", "research", "and", "development", "expense", "to", "substantially", "increase", "over", "the", "next", "several", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p25_s7", "idA": "906709_11_item7_p5_s4", "sentA": "We anticipate our Phase 3 development plans for NKTR-102 to require substantial investment over the next several years.", "sentB": "We plan to continue to advance our most promising early research drug candidates into preclinical development with the objective to advance these early stage research programs to human clinical studies over the next several years.", "type": 2, "words": ["<tag1>", "We", "anticipate", "our", "Phase", "3", "development", "plans", "for", "NKTR-102", "to", "require", "substantial", "investment", "over", "the", "next", "several", "years.", "<tag2>", "We", "plan", "to", "continue", "to", "advance", "our", "most", "promising", "early", "research", "drug", "candidates", "into", "preclinical", "development", "with", "the", "objective", "to", "advance", "these", "early", "stage", "research", "programs", "to", "human", "clinical", "studies", "over", "the", "next", "several", "years.", "<tag3>"], "wordsA": ["We", "anticipate", "our", "Phase", "3", "development", "plans", "for", "NKTR-102", "to", "require", "substantial", "investment", "over", "the", "next", "several", "years."], "wordsB": ["We", "plan", "to", "continue", "to", "advance", "our", "most", "promising", "early", "research", "drug", "candidates", "into", "preclinical", "development", "with", "the", "objective", "to", "advance", "these", "early", "stage", "research", "programs", "to", "human", "clinical", "studies", "over", "the", "next", "several", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p4_s3", "idA": "906709_11_item7_p5_s4", "sentA": "We anticipate our Phase 3 development plans for NKTR-102 to require substantial investment over the next several years.", "sentB": "The BEACON study will require a substantial investment over the next three years.", "type": 2, "words": ["<tag1>", "We", "anticipate", "our", "Phase", "3", "development", "plans", "for", "NKTR-102", "to", "require", "substantial", "investment", "over", "the", "next", "several", "years.", "<tag2>", "The", "BEACON", "study", "will", "require", "a", "substantial", "investment", "over", "the", "next", "three", "years.", "<tag3>"], "wordsA": ["We", "anticipate", "our", "Phase", "3", "development", "plans", "for", "NKTR-102", "to", "require", "substantial", "investment", "over", "the", "next", "several", "years."], "wordsB": ["The", "BEACON", "study", "will", "require", "a", "substantial", "investment", "over", "the", "next", "three", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p5_s9", "idA": "906709_11_item7_p6_s0", "sentA": "Our focus on research and clinical development requires substantial investments that continue to increase as we advance each drug candidate through each phase of the development cycle.", "sentB": "While the late stage clinical development programs described above are key elements of the future success of our company, we believe it is critically important that we continue to make substantial investments in our earlier stage drug candidate pipeline.", "type": 2, "words": ["<tag1>", "Our", "focus", "on", "research", "and", "clinical", "development", "requires", "substantial", "investments", "that", "continue", "to", "increase", "as", "we", "advance", "each", "drug", "candidate", "through", "each", "phase", "of", "the", "development", "cycle.", "<tag2>", "While", "the", "late", "stage", "clinical", "development", "programs", "described", "above", "are", "key", "elements", "of", "the", "future", "success", "of", "our", "company,", "we", "believe", "it", "is", "critically", "important", "that", "we", "continue", "to", "make", "substantial", "investments", "in", "our", "earlier", "stage", "drug", "candidate", "pipeline.", "<tag3>"], "wordsA": ["Our", "focus", "on", "research", "and", "clinical", "development", "requires", "substantial", "investments", "that", "continue", "to", "increase", "as", "we", "advance", "each", "drug", "candidate", "through", "each", "phase", "of", "the", "development", "cycle."], "wordsB": ["While", "the", "late", "stage", "clinical", "development", "programs", "described", "above", "are", "key", "elements", "of", "the", "future", "success", "of", "our", "company,", "we", "believe", "it", "is", "critically", "important", "that", "we", "continue", "to", "make", "substantial", "investments", "in", "our", "earlier", "stage", "drug", "candidate", "pipeline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p25_s0", "idA": "906709_11_item7_p6_s2", "sentA": "For example, we plan to start a Phase 1 clinical study for NKTR-181 in the first half of 2011.", "sentB": "In addition to our NKTR-102 development activities, in 2012, we plan to initiate a Phase 2 clinical study for NKTR-181 that we expect to complete in 2013.", "type": 2, "words": ["<tag1>", "For", "example,", "we", "plan", "to", "start", "a", "Phase", "1", "clinical", "study", "for", "NKTR-181", "in", "the", "first", "half", "of", "2011.", "<tag2>", "In", "addition", "to", "our", "NKTR-102", "development", "activities,", "in", "2012,", "we", "plan", "to", "initiate", "a", "Phase", "2", "clinical", "study", "for", "NKTR-181", "that", "we", "expect", "to", "complete", "in", "2013.", "<tag3>"], "wordsA": ["For", "example,", "we", "plan", "to", "start", "a", "Phase", "1", "clinical", "study", "for", "NKTR-181", "in", "the", "first", "half", "of", "2011."], "wordsB": ["In", "addition", "to", "our", "NKTR-102", "development", "activities,", "in", "2012,", "we", "plan", "to", "initiate", "a", "Phase", "2", "clinical", "study", "for", "NKTR-181", "that", "we", "expect", "to", "complete", "in", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p25_s1", "idA": "906709_11_item7_p6_s2", "sentA": "For example, we plan to start a Phase 1 clinical study for NKTR-181 in the first half of 2011.", "sentB": "We also plan to invest in an initial Phase 1 clinical study for NKTR-192 that we expect to complete in 2012.", "type": 2, "words": ["<tag1>", "For", "example,", "we", "plan", "to", "start", "a", "Phase", "1", "clinical", "study", "for", "NKTR-181", "in", "the", "first", "half", "of", "2011.", "<tag2>", "We", "also", "plan", "to", "invest", "in", "an", "initial", "Phase", "1", "clinical", "study", "for", "NKTR-192", "that", "we", "expect", "to", "complete", "in", "2012.", "<tag3>"], "wordsA": ["For", "example,", "we", "plan", "to", "start", "a", "Phase", "1", "clinical", "study", "for", "NKTR-181", "in", "the", "first", "half", "of", "2011."], "wordsB": ["We", "also", "plan", "to", "invest", "in", "an", "initial", "Phase", "1", "clinical", "study", "for", "NKTR-192", "that", "we", "expect", "to", "complete", "in", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p5_s10", "idA": "906709_11_item7_p6_s2", "sentA": "For example, we plan to start a Phase 1 clinical study for NKTR-181 in the first half of 2011.", "sentB": "For example, we plan to advance NKTR-181 into Phase 2 clinical trials in 2012 and we also plan to file an investigational new drug application (IND) for NKTR-192 in 2012.", "type": 2, "words": ["<tag1>", "For", "example,", "we", "plan", "to", "start", "a", "Phase", "1", "clinical", "study", "for", "NKTR-181", "in", "the", "first", "half", "of", "2011.", "<tag2>", "For", "example,", "we", "plan", "to", "advance", "NKTR-181", "into", "Phase", "2", "clinical", "trials", "in", "2012", "and", "we", "also", "plan", "to", "file", "an", "investigational", "new", "drug", "application", "(IND)", "for", "NKTR-192", "in", "2012.", "<tag3>"], "wordsA": ["For", "example,", "we", "plan", "to", "start", "a", "Phase", "1", "clinical", "study", "for", "NKTR-181", "in", "the", "first", "half", "of", "2011."], "wordsB": ["For", "example,", "we", "plan", "to", "advance", "NKTR-181", "into", "Phase", "2", "clinical", "trials", "in", "2012", "and", "we", "also", "plan", "to", "file", "an", "investigational", "new", "drug", "application", "(IND)", "for", "NKTR-192", "in", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p5_s6", "idA": "906709_11_item7_p6_s2", "sentA": "For example, we plan to start a Phase 1 clinical study for NKTR-181 in the first half of 2011.", "sentB": "Preparations for a Phase 3 clinical study, which we currently expect to start in the second half of 2012, are continuing.", "type": 2, "words": ["<tag1>", "For", "example,", "we", "plan", "to", "start", "a", "Phase", "1", "clinical", "study", "for", "NKTR-181", "in", "the", "first", "half", "of", "2011.", "<tag2>", "Preparations", "for", "a", "Phase", "3", "clinical", "study,", "which", "we", "currently", "expect", "to", "start", "in", "the", "second", "half", "of", "2012,", "are", "continuing.", "<tag3>"], "wordsA": ["For", "example,", "we", "plan", "to", "start", "a", "Phase", "1", "clinical", "study", "for", "NKTR-181", "in", "the", "first", "half", "of", "2011."], "wordsB": ["Preparations", "for", "a", "Phase", "3", "clinical", "study,", "which", "we", "currently", "expect", "to", "start", "in", "the", "second", "half", "of", "2012,", "are", "continuing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p3_s1", "idA": "906709_11_item7_p7_s0", "sentA": "drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval and the timing and outcome of clinical trial results is extremely difficult to predict.", "sentB": "Therefore, the results from the KODIAC study, the timing and outcome of approval review of NKTR-118 by the FDA and EMA, the timing of the commercial launch of NKTR-118 (if approved), and the level of NKTR-118 sales, will have a significant impact on our financial condition and future business prospects.", "type": 2, "words": ["<tag1>", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "outcome", "of", "clinical", "trial", "results", "is", "extremely", "difficult", "to", "predict.", "<tag2>", "Therefore,", "the", "results", "from", "the", "KODIAC", "study,", "the", "timing", "and", "outcome", "of", "approval", "review", "of", "NKTR-118", "by", "the", "FDA", "and", "EMA,", "the", "timing", "of", "the", "commercial", "launch", "of", "NKTR-118", "(if", "approved),", "and", "the", "level", "of", "NKTR-118", "sales,", "will", "have", "a", "significant", "impact", "on", "our", "financial", "condition", "and", "future", "business", "prospects.", "<tag3>"], "wordsA": ["drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "outcome", "of", "clinical", "trial", "results", "is", "extremely", "difficult", "to", "predict."], "wordsB": ["Therefore,", "the", "results", "from", "the", "KODIAC", "study,", "the", "timing", "and", "outcome", "of", "approval", "review", "of", "NKTR-118", "by", "the", "FDA", "and", "EMA,", "the", "timing", "of", "the", "commercial", "launch", "of", "NKTR-118", "(if", "approved),", "and", "the", "level", "of", "NKTR-118", "sales,", "will", "have", "a", "significant", "impact", "on", "our", "financial", "condition", "and", "future", "business", "prospects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p6_s0", "idA": "906709_11_item7_p7_s0", "sentA": "drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval and the timing and outcome of clinical trial results is extremely difficult to predict.", "sentB": "While we believe that our substantial investment in research and development has the potential to create significant value if one or more of our drug candidates demonstrates positive clinical results and/or receives regulatory approval in one or more major markets, drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval and the timing and outcome of clinical trial results is extremely difficult to predict.", "type": 2, "words": ["<tag1>", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "outcome", "of", "clinical", "trial", "results", "is", "extremely", "difficult", "to", "predict.", "<tag2>", "While", "we", "believe", "that", "our", "substantial", "investment", "in", "research", "and", "development", "has", "the", "potential", "to", "create", "significant", "value", "if", "one", "or", "more", "of", "our", "drug", "candidates", "demonstrates", "positive", "clinical", "results", "and/or", "receives", "regulatory", "approval", "in", "one", "or", "more", "major", "markets,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "outcome", "of", "clinical", "trial", "results", "is", "extremely", "difficult", "to", "predict.", "<tag3>"], "wordsA": ["drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "outcome", "of", "clinical", "trial", "results", "is", "extremely", "difficult", "to", "predict."], "wordsB": ["While", "we", "believe", "that", "our", "substantial", "investment", "in", "research", "and", "development", "has", "the", "potential", "to", "create", "significant", "value", "if", "one", "or", "more", "of", "our", "drug", "candidates", "demonstrates", "positive", "clinical", "results", "and/or", "receives", "regulatory", "approval", "in", "one", "or", "more", "major", "markets,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "outcome", "of", "clinical", "trial", "results", "is", "extremely", "difficult", "to", "predict."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p25_s3", "idA": "906709_11_item7_p8_s1", "sentA": "In particular, the future clinical and commercial success or failure of our collaboration with AstraZeneca for NKTR-118 and NKTR-119 and our collaboration with Bayer for Amikacin Inhale will have a material impact on our business and financial condition over the next several years.", "sentB": "Under our collaboration agreement with Bayer, we are responsible for all clinical and commercial supply of the nebulizer devices for Amikacin Inhale.", "type": 2, "words": ["<tag1>", "In", "particular,", "the", "future", "clinical", "and", "commercial", "success", "or", "failure", "of", "our", "collaboration", "with", "AstraZeneca", "for", "NKTR-118", "and", "NKTR-119", "and", "our", "collaboration", "with", "Bayer", "for", "Amikacin", "Inhale", "will", "have", "a", "material", "impact", "on", "our", "business", "and", "financial", "condition", "over", "the", "next", "several", "years.", "<tag2>", "Under", "our", "collaboration", "agreement", "with", "Bayer,", "we", "are", "responsible", "for", "all", "clinical", "and", "commercial", "supply", "of", "the", "nebulizer", "devices", "for", "Amikacin", "Inhale.", "<tag3>"], "wordsA": ["In", "particular,", "the", "future", "clinical", "and", "commercial", "success", "or", "failure", "of", "our", "collaboration", "with", "AstraZeneca", "for", "NKTR-118", "and", "NKTR-119", "and", "our", "collaboration", "with", "Bayer", "for", "Amikacin", "Inhale", "will", "have", "a", "material", "impact", "on", "our", "business", "and", "financial", "condition", "over", "the", "next", "several", "years."], "wordsB": ["Under", "our", "collaboration", "agreement", "with", "Bayer,", "we", "are", "responsible", "for", "all", "clinical", "and", "commercial", "supply", "of", "the", "nebulizer", "devices", "for", "Amikacin", "Inhale."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p2_s3", "idA": "906709_11_item7_p8_s1", "sentA": "In particular, the future clinical and commercial success or failure of our collaboration with AstraZeneca for NKTR-118 and NKTR-119 and our collaboration with Bayer for Amikacin Inhale will have a material impact on our business and financial condition over the next several years.", "sentB": "The outcome of the KODIAC study will have a substantial impact on our financial condition as we are entitled to $235.0 million in regulatory filing and commercial launch milestones.", "type": 2, "words": ["<tag1>", "In", "particular,", "the", "future", "clinical", "and", "commercial", "success", "or", "failure", "of", "our", "collaboration", "with", "AstraZeneca", "for", "NKTR-118", "and", "NKTR-119", "and", "our", "collaboration", "with", "Bayer", "for", "Amikacin", "Inhale", "will", "have", "a", "material", "impact", "on", "our", "business", "and", "financial", "condition", "over", "the", "next", "several", "years.", "<tag2>", "The", "outcome", "of", "the", "KODIAC", "study", "will", "have", "a", "substantial", "impact", "on", "our", "financial", "condition", "as", "we", "are", "entitled", "to", "$235.0", "million", "in", "regulatory", "filing", "and", "commercial", "launch", "milestones.", "<tag3>"], "wordsA": ["In", "particular,", "the", "future", "clinical", "and", "commercial", "success", "or", "failure", "of", "our", "collaboration", "with", "AstraZeneca", "for", "NKTR-118", "and", "NKTR-119", "and", "our", "collaboration", "with", "Bayer", "for", "Amikacin", "Inhale", "will", "have", "a", "material", "impact", "on", "our", "business", "and", "financial", "condition", "over", "the", "next", "several", "years."], "wordsB": ["The", "outcome", "of", "the", "KODIAC", "study", "will", "have", "a", "substantial", "impact", "on", "our", "financial", "condition", "as", "we", "are", "entitled", "to", "$235.0", "million", "in", "regulatory", "filing", "and", "commercial", "launch", "milestones."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_12_item7_p5_s5", "idA": "906709_11_item7_p8_s1", "sentA": "In particular, the future clinical and commercial success or failure of our collaboration with AstraZeneca for NKTR-118 and NKTR-119 and our collaboration with Bayer for Amikacin Inhale will have a material impact on our business and financial condition over the next several years.", "sentB": "We also have a significant collaboration with Bayer Healthcare LLC (Bayer) for Amikacin Inhale, an inhaled solution of amikacin, an aminoglycoside antibiotic, that has completed Phase 2 development.", "type": 2, "words": ["<tag1>", "In", "particular,", "the", "future", "clinical", "and", "commercial", "success", "or", "failure", "of", "our", "collaboration", "with", "AstraZeneca", "for", "NKTR-118", "and", "NKTR-119", "and", "our", "collaboration", "with", "Bayer", "for", "Amikacin", "Inhale", "will", "have", "a", "material", "impact", "on", "our", "business", "and", "financial", "condition", "over", "the", "next", "several", "years.", "<tag2>", "We", "also", "have", "a", "significant", "collaboration", "with", "Bayer", "Healthcare", "LLC", "(Bayer)", "for", "Amikacin", "Inhale,", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic,", "that", "has", "completed", "Phase", "2", "development.", "<tag3>"], "wordsA": ["In", "particular,", "the", "future", "clinical", "and", "commercial", "success", "or", "failure", "of", "our", "collaboration", "with", "AstraZeneca", "for", "NKTR-118", "and", "NKTR-119", "and", "our", "collaboration", "with", "Bayer", "for", "Amikacin", "Inhale", "will", "have", "a", "material", "impact", "on", "our", "business", "and", "financial", "condition", "over", "the", "next", "several", "years."], "wordsB": ["We", "also", "have", "a", "significant", "collaboration", "with", "Bayer", "Healthcare", "LLC", "(Bayer)", "for", "Amikacin", "Inhale,", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic,", "that", "has", "completed", "Phase", "2", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p0_s0", "idA": "906709_12_item7_p0_s0", "sentA": "We are a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize our PEGylation and advanced polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients.", "sentB": "We are a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize our PEGylation and advanced polymer conjugate technology platforms, which are designed to enable the development of new molecular entities that target known mechanisms of action.", "type": 2, "words": ["<tag1>", "We", "are", "a", "clinical-stage", "biopharmaceutical", "company", "developing", "a", "pipeline", "of", "drug", "candidates", "that", "utilize", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "technology", "platforms,", "which", "are", "designed", "to", "improve", "the", "benefits", "of", "drugs", "for", "patients.", "<tag2>", "We", "are", "a", "clinical-stage", "biopharmaceutical", "company", "developing", "a", "pipeline", "of", "drug", "candidates", "that", "utilize", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "technology", "platforms,", "which", "are", "designed", "to", "enable", "the", "development", "of", "new", "molecular", "entities", "that", "target", "known", "mechanisms", "of", "action.", "<tag3>"], "wordsA": ["We", "are", "a", "clinical-stage", "biopharmaceutical", "company", "developing", "a", "pipeline", "of", "drug", "candidates", "that", "utilize", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "technology", "platforms,", "which", "are", "designed", "to", "improve", "the", "benefits", "of", "drugs", "for", "patients."], "wordsB": ["We", "are", "a", "clinical-stage", "biopharmaceutical", "company", "developing", "a", "pipeline", "of", "drug", "candidates", "that", "utilize", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "technology", "platforms,", "which", "are", "designed", "to", "enable", "the", "development", "of", "new", "molecular", "entities", "that", "target", "known", "mechanisms", "of", "action."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p0_s1", "idA": "906709_12_item7_p0_s1", "sentA": "Our current proprietary pipeline is comprised of drug candidates across a number of therapeutic areas including oncology, pain, anti-infectives, anti-viral and immunology.", "sentB": "Our current proprietary pipeline is comprised of drug candidates across a number of therapeutic areas including oncology, pain, anti-infectives, and immunology.", "type": 2, "words": ["<tag1>", "Our", "current", "proprietary", "pipeline", "is", "comprised", "of", "drug", "candidates", "across", "a", "number", "of", "therapeutic", "areas", "including", "oncology,", "pain,", "anti-infectives,", "anti-viral", "and", "immunology.", "<tag2>", "Our", "current", "proprietary", "pipeline", "is", "comprised", "of", "drug", "candidates", "across", "a", "number", "of", "therapeutic", "areas", "including", "oncology,", "pain,", "anti-infectives,", "and", "immunology.", "<tag3>"], "wordsA": ["Our", "current", "proprietary", "pipeline", "is", "comprised", "of", "drug", "candidates", "across", "a", "number", "of", "therapeutic", "areas", "including", "oncology,", "pain,", "anti-infectives,", "anti-viral", "and", "immunology."], "wordsB": ["Our", "current", "proprietary", "pipeline", "is", "comprised", "of", "drug", "candidates", "across", "a", "number", "of", "therapeutic", "areas", "including", "oncology,", "pain,", "anti-infectives,", "and", "immunology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p0_s2", "idA": "906709_12_item7_p0_s2", "sentA": "Our research and development activities involve small molecule drugs, peptides and other potential biologic drug candidates.", "sentB": "Our research and development activities involve small molecule drugs, peptides and other biologic drug candidates.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "other", "potential", "biologic", "drug", "candidates.", "<tag2>", "Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "other", "biologic", "drug", "candidates.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "other", "potential", "biologic", "drug", "candidates."], "wordsB": ["Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "other", "biologic", "drug", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p65_s2", "idA": "906709_12_item7_p0_s2", "sentA": "Our research and development activities involve small molecule drugs, peptides and other potential biologic drug candidates.", "sentB": "Advance payments for goods or services that will be used or rendered for future research and development activities are capitalized as prepaid expenses and recognized as expense as the related goods are delivered or the related services are performed.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "other", "potential", "biologic", "drug", "candidates.", "<tag2>", "Advance", "payments", "for", "goods", "or", "services", "that", "will", "be", "used", "or", "rendered", "for", "future", "research", "and", "development", "activities", "are", "capitalized", "as", "prepaid", "expenses", "and", "recognized", "as", "expense", "as", "the", "related", "goods", "are", "delivered", "or", "the", "related", "services", "are", "performed.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "other", "potential", "biologic", "drug", "candidates."], "wordsB": ["Advance", "payments", "for", "goods", "or", "services", "that", "will", "be", "used", "or", "rendered", "for", "future", "research", "and", "development", "activities", "are", "capitalized", "as", "prepaid", "expenses", "and", "recognized", "as", "expense", "as", "the", "related", "goods", "are", "delivered", "or", "the", "related", "services", "are", "performed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p0_s3", "idA": "906709_12_item7_p0_s3", "sentA": "We create our innovative drug candidates by using our proprietary advanced polymer conjugate technologies and expertise to modify the chemical structure of drugs to create new molecular entities.", "sentB": "We create innovative drug candidates by using our proprietary advanced polymer conjugate technologies and expertise to modify the chemical structure of pharmacophores to create new molecular entities.", "type": 2, "words": ["<tag1>", "We", "create", "our", "innovative", "drug", "candidates", "by", "using", "our", "proprietary", "advanced", "polymer", "conjugate", "technologies", "and", "expertise", "to", "modify", "the", "chemical", "structure", "of", "drugs", "to", "create", "new", "molecular", "entities.", "<tag2>", "We", "create", "innovative", "drug", "candidates", "by", "using", "our", "proprietary", "advanced", "polymer", "conjugate", "technologies", "and", "expertise", "to", "modify", "the", "chemical", "structure", "of", "pharmacophores", "to", "create", "new", "molecular", "entities.", "<tag3>"], "wordsA": ["We", "create", "our", "innovative", "drug", "candidates", "by", "using", "our", "proprietary", "advanced", "polymer", "conjugate", "technologies", "and", "expertise", "to", "modify", "the", "chemical", "structure", "of", "drugs", "to", "create", "new", "molecular", "entities."], "wordsB": ["We", "create", "innovative", "drug", "candidates", "by", "using", "our", "proprietary", "advanced", "polymer", "conjugate", "technologies", "and", "expertise", "to", "modify", "the", "chemical", "structure", "of", "pharmacophores", "to", "create", "new", "molecular", "entities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p53_s7", "idA": "906709_12_item7_p10_s0", "sentA": "As discussed above, the success of the KODIAC study is critical to providing cash to fund our operations and there can be no assurance as to the outcome of this study.", "sentB": "Even if we or our partners are successful, we may require additional capital to continue to fund our operations and repay our debt obligations as they become due.", "type": 2, "words": ["<tag1>", "As", "discussed", "above,", "the", "success", "of", "the", "KODIAC", "study", "is", "critical", "to", "providing", "cash", "to", "fund", "our", "operations", "and", "there", "can", "be", "no", "assurance", "as", "to", "the", "outcome", "of", "this", "study.", "<tag2>", "Even", "if", "we", "or", "our", "partners", "are", "successful,", "we", "may", "require", "additional", "capital", "to", "continue", "to", "fund", "our", "operations", "and", "repay", "our", "debt", "obligations", "as", "they", "become", "due.", "<tag3>"], "wordsA": ["As", "discussed", "above,", "the", "success", "of", "the", "KODIAC", "study", "is", "critical", "to", "providing", "cash", "to", "fund", "our", "operations", "and", "there", "can", "be", "no", "assurance", "as", "to", "the", "outcome", "of", "this", "study."], "wordsB": ["Even", "if", "we", "or", "our", "partners", "are", "successful,", "we", "may", "require", "additional", "capital", "to", "continue", "to", "fund", "our", "operations", "and", "repay", "our", "debt", "obligations", "as", "they", "become", "due."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p53_s8", "idA": "906709_12_item7_p10_s0", "sentA": "As discussed above, the success of the KODIAC study is critical to providing cash to fund our operations and there can be no assurance as to the outcome of this study.", "sentB": "There can be no assurance that additional funds, if and when required, will be available to us on favorable terms, if at all.", "type": 2, "words": ["<tag1>", "As", "discussed", "above,", "the", "success", "of", "the", "KODIAC", "study", "is", "critical", "to", "providing", "cash", "to", "fund", "our", "operations", "and", "there", "can", "be", "no", "assurance", "as", "to", "the", "outcome", "of", "this", "study.", "<tag2>", "There", "can", "be", "no", "assurance", "that", "additional", "funds,", "if", "and", "when", "required,", "will", "be", "available", "to", "us", "on", "favorable", "terms,", "if", "at", "all.", "<tag3>"], "wordsA": ["As", "discussed", "above,", "the", "success", "of", "the", "KODIAC", "study", "is", "critical", "to", "providing", "cash", "to", "fund", "our", "operations", "and", "there", "can", "be", "no", "assurance", "as", "to", "the", "outcome", "of", "this", "study."], "wordsB": ["There", "can", "be", "no", "assurance", "that", "additional", "funds,", "if", "and", "when", "required,", "will", "be", "available", "to", "us", "on", "favorable", "terms,", "if", "at", "all."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p6_s0", "idA": "906709_12_item7_p10_s0", "sentA": "As discussed above, the success of the KODIAC study is critical to providing cash to fund our operations and there can be no assurance as to the outcome of this study.", "sentB": "result, the outcome of AstraZeneca s determination to make regulatory filings for naloxegol with the FDA and EMA is critical to our financial position in 2013 as well as our future business prospects as a result of the significant economic stake that we have in success of the potential commercialization of naloxegol.", "type": 2, "words": ["<tag1>", "As", "discussed", "above,", "the", "success", "of", "the", "KODIAC", "study", "is", "critical", "to", "providing", "cash", "to", "fund", "our", "operations", "and", "there", "can", "be", "no", "assurance", "as", "to", "the", "outcome", "of", "this", "study.", "<tag2>", "result,", "the", "outcome", "of", "AstraZeneca", "s", "determination", "to", "make", "regulatory", "filings", "for", "naloxegol", "with", "the", "FDA", "and", "EMA", "is", "critical", "to", "our", "financial", "position", "in", "2013", "as", "well", "as", "our", "future", "business", "prospects", "as", "a", "result", "of", "the", "significant", "economic", "stake", "that", "we", "have", "in", "success", "of", "the", "potential", "commercialization", "of", "naloxegol.", "<tag3>"], "wordsA": ["As", "discussed", "above,", "the", "success", "of", "the", "KODIAC", "study", "is", "critical", "to", "providing", "cash", "to", "fund", "our", "operations", "and", "there", "can", "be", "no", "assurance", "as", "to", "the", "outcome", "of", "this", "study."], "wordsB": ["result,", "the", "outcome", "of", "AstraZeneca", "s", "determination", "to", "make", "regulatory", "filings", "for", "naloxegol", "with", "the", "FDA", "and", "EMA", "is", "critical", "to", "our", "financial", "position", "in", "2013", "as", "well", "as", "our", "future", "business", "prospects", "as", "a", "result", "of", "the", "significant", "economic", "stake", "that", "we", "have", "in", "success", "of", "the", "potential", "commercialization", "of", "naloxegol."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p47_s4", "idA": "906709_12_item7_p10_s1", "sentA": "On February 29, 2012, we sold all of our rights to receive future royalty payments on CIMZIA and MIRCERA in exchange for $124.0 million.", "sentB": "Cash flows used in financing activities On February 24, 2012, we sold all of our rights to receive future royalty payments on CIMZIA and MIRCERA in exchange for $124.0 million.", "type": 2, "words": ["<tag1>", "On", "February", "29,", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "on", "CIMZIA", "and", "MIRCERA", "in", "exchange", "for", "$124.0", "million.", "<tag2>", "Cash", "flows", "used", "in", "financing", "activities", "On", "February", "24,", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "on", "CIMZIA", "and", "MIRCERA", "in", "exchange", "for", "$124.0", "million.", "<tag3>"], "wordsA": ["On", "February", "29,", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "on", "CIMZIA", "and", "MIRCERA", "in", "exchange", "for", "$124.0", "million."], "wordsB": ["Cash", "flows", "used", "in", "financing", "activities", "On", "February", "24,", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "on", "CIMZIA", "and", "MIRCERA", "in", "exchange", "for", "$124.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p47_s7", "idA": "906709_12_item7_p10_s2", "sentA": "Additionally, we incurred approximately $4.5 million in transaction costs.", "sentB": "As part of this transaction, we incurred approximately $4.5 million in issuance costs.", "type": 2, "words": ["<tag1>", "Additionally,", "we", "incurred", "approximately", "$4.5", "million", "in", "transaction", "costs.", "<tag2>", "As", "part", "of", "this", "transaction,", "we", "incurred", "approximately", "$4.5", "million", "in", "issuance", "costs.", "<tag3>"], "wordsA": ["Additionally,", "we", "incurred", "approximately", "$4.5", "million", "in", "transaction", "costs."], "wordsB": ["As", "part", "of", "this", "transaction,", "we", "incurred", "approximately", "$4.5", "million", "in", "issuance", "costs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p53_s5", "idA": "906709_12_item7_p10_s7", "sentA": "Our substantial debt, the market price of our common stock, and the general economic and equity market climate, among other factors, could have material adverse effects on our financial condition and could affect our ability to obtain short-term and long-term financing alternatives.", "sentB": "Our substantial debt, the market price of our securities, and the general economic climate, among other factors, could have material consequences for our financial condition and could affect our sources of short-term and long-term funding.", "type": 2, "words": ["<tag1>", "Our", "substantial", "debt,", "the", "market", "price", "of", "our", "common", "stock,", "and", "the", "general", "economic", "and", "equity", "market", "climate,", "among", "other", "factors,", "could", "have", "material", "adverse", "effects", "on", "our", "financial", "condition", "and", "could", "affect", "our", "ability", "to", "obtain", "short-term", "and", "long-term", "financing", "alternatives.", "<tag2>", "Our", "substantial", "debt,", "the", "market", "price", "of", "our", "securities,", "and", "the", "general", "economic", "climate,", "among", "other", "factors,", "could", "have", "material", "consequences", "for", "our", "financial", "condition", "and", "could", "affect", "our", "sources", "of", "short-term", "and", "long-term", "funding.", "<tag3>"], "wordsA": ["Our", "substantial", "debt,", "the", "market", "price", "of", "our", "common", "stock,", "and", "the", "general", "economic", "and", "equity", "market", "climate,", "among", "other", "factors,", "could", "have", "material", "adverse", "effects", "on", "our", "financial", "condition", "and", "could", "affect", "our", "ability", "to", "obtain", "short-term", "and", "long-term", "financing", "alternatives."], "wordsB": ["Our", "substantial", "debt,", "the", "market", "price", "of", "our", "securities,", "and", "the", "general", "economic", "climate,", "among", "other", "factors,", "could", "have", "material", "consequences", "for", "our", "financial", "condition", "and", "could", "affect", "our", "sources", "of", "short-term", "and", "long-term", "funding."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p19_s2", "idA": "906709_12_item7_p11_s2", "sentA": "Upfront fees received for license and collaborative agreements are recognized ratably over our expected performance period under the arrangement.", "sentB": "The amount of upfront fees received under our license and collaboration agreements allocated to continuing obligations, such as manufacturing and supply commitments, are recognized ratably over our expected performance period under the arrangement.", "type": 2, "words": ["<tag1>", "Upfront", "fees", "received", "for", "license", "and", "collaborative", "agreements", "are", "recognized", "ratably", "over", "our", "expected", "performance", "period", "under", "the", "arrangement.", "<tag2>", "The", "amount", "of", "upfront", "fees", "received", "under", "our", "license", "and", "collaboration", "agreements", "allocated", "to", "continuing", "obligations,", "such", "as", "manufacturing", "and", "supply", "commitments,", "are", "recognized", "ratably", "over", "our", "expected", "performance", "period", "under", "the", "arrangement.", "<tag3>"], "wordsA": ["Upfront", "fees", "received", "for", "license", "and", "collaborative", "agreements", "are", "recognized", "ratably", "over", "our", "expected", "performance", "period", "under", "the", "arrangement."], "wordsB": ["The", "amount", "of", "upfront", "fees", "received", "under", "our", "license", "and", "collaboration", "agreements", "allocated", "to", "continuing", "obligations,", "such", "as", "manufacturing", "and", "supply", "commitments,", "are", "recognized", "ratably", "over", "our", "expected", "performance", "period", "under", "the", "arrangement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p57_s0", "idA": "906709_12_item7_p11_s2", "sentA": "Upfront fees received for license and collaborative agreements are recognized ratably over our expected performance period under the arrangement.", "sentB": "Upfront fees are recognized ratably over the expected performance period under each arrangement.", "type": 2, "words": ["<tag1>", "Upfront", "fees", "received", "for", "license", "and", "collaborative", "agreements", "are", "recognized", "ratably", "over", "our", "expected", "performance", "period", "under", "the", "arrangement.", "<tag2>", "Upfront", "fees", "are", "recognized", "ratably", "over", "the", "expected", "performance", "period", "under", "each", "arrangement.", "<tag3>"], "wordsA": ["Upfront", "fees", "received", "for", "license", "and", "collaborative", "agreements", "are", "recognized", "ratably", "over", "our", "expected", "performance", "period", "under", "the", "arrangement."], "wordsB": ["Upfront", "fees", "are", "recognized", "ratably", "over", "the", "expected", "performance", "period", "under", "each", "arrangement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p19_s4", "idA": "906709_12_item7_p12_s0", "sentA": "Management makes its best estimate of the period over which we expect to fulfill our performance obligations.", "sentB": "We make our best estimate of the period over which we expect to fulfill our performance obligations.", "type": 2, "words": ["<tag1>", "Management", "makes", "its", "best", "estimate", "of", "the", "period", "over", "which", "we", "expect", "to", "fulfill", "our", "performance", "obligations.", "<tag2>", "We", "make", "our", "best", "estimate", "of", "the", "period", "over", "which", "we", "expect", "to", "fulfill", "our", "performance", "obligations.", "<tag3>"], "wordsA": ["Management", "makes", "its", "best", "estimate", "of", "the", "period", "over", "which", "we", "expect", "to", "fulfill", "our", "performance", "obligations."], "wordsB": ["We", "make", "our", "best", "estimate", "of", "the", "period", "over", "which", "we", "expect", "to", "fulfill", "our", "performance", "obligations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p57_s1", "idA": "906709_12_item7_p12_s0", "sentA": "Management makes its best estimate of the period over which we expect to fulfill our performance obligations.", "sentB": "Management makes its best estimate of the period over which we expect to fulfill our performance obligations, which may include technology transfer assistance, clinical development activities, or manufacturing activities through the completion of clinical development or the termination or expiration of the collaboration agreement.", "type": 2, "words": ["<tag1>", "Management", "makes", "its", "best", "estimate", "of", "the", "period", "over", "which", "we", "expect", "to", "fulfill", "our", "performance", "obligations.", "<tag2>", "Management", "makes", "its", "best", "estimate", "of", "the", "period", "over", "which", "we", "expect", "to", "fulfill", "our", "performance", "obligations,", "which", "may", "include", "technology", "transfer", "assistance,", "clinical", "development", "activities,", "or", "manufacturing", "activities", "through", "the", "completion", "of", "clinical", "development", "or", "the", "termination", "or", "expiration", "of", "the", "collaboration", "agreement.", "<tag3>"], "wordsA": ["Management", "makes", "its", "best", "estimate", "of", "the", "period", "over", "which", "we", "expect", "to", "fulfill", "our", "performance", "obligations."], "wordsB": ["Management", "makes", "its", "best", "estimate", "of", "the", "period", "over", "which", "we", "expect", "to", "fulfill", "our", "performance", "obligations,", "which", "may", "include", "technology", "transfer", "assistance,", "clinical", "development", "activities,", "or", "manufacturing", "activities", "through", "the", "completion", "of", "clinical", "development", "or", "the", "termination", "or", "expiration", "of", "the", "collaboration", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p59_s0", "idA": "906709_12_item7_p12_s0", "sentA": "Management makes its best estimate of the period over which we expect to fulfill our performance obligations.", "sentB": "For our collaboration agreements, our performance obligations may span the life of the agreement.", "type": 2, "words": ["<tag1>", "Management", "makes", "its", "best", "estimate", "of", "the", "period", "over", "which", "we", "expect", "to", "fulfill", "our", "performance", "obligations.", "<tag2>", "For", "our", "collaboration", "agreements,", "our", "performance", "obligations", "may", "span", "the", "life", "of", "the", "agreement.", "<tag3>"], "wordsA": ["Management", "makes", "its", "best", "estimate", "of", "the", "period", "over", "which", "we", "expect", "to", "fulfill", "our", "performance", "obligations."], "wordsB": ["For", "our", "collaboration", "agreements,", "our", "performance", "obligations", "may", "span", "the", "life", "of", "the", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p19_s5", "idA": "906709_12_item7_p12_s1", "sentA": "Given the uncertainties in research and development collaborations, significant judgment is required by management to determine the performance periods.", "sentB": "Given the uncertainties in research and development collaborations, significant judgment is required by us to determine the performance periods.", "type": 2, "words": ["<tag1>", "Given", "the", "uncertainties", "in", "research", "and", "development", "collaborations,", "significant", "judgment", "is", "required", "by", "management", "to", "determine", "the", "performance", "periods.", "<tag2>", "Given", "the", "uncertainties", "in", "research", "and", "development", "collaborations,", "significant", "judgment", "is", "required", "by", "us", "to", "determine", "the", "performance", "periods.", "<tag3>"], "wordsA": ["Given", "the", "uncertainties", "in", "research", "and", "development", "collaborations,", "significant", "judgment", "is", "required", "by", "management", "to", "determine", "the", "performance", "periods."], "wordsB": ["Given", "the", "uncertainties", "in", "research", "and", "development", "collaborations,", "significant", "judgment", "is", "required", "by", "us", "to", "determine", "the", "performance", "periods."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p57_s2", "idA": "906709_12_item7_p12_s1", "sentA": "Given the uncertainties in research and development collaborations, significant judgment is required by management to determine the performance periods.", "sentB": "Given the complexities and uncertainties of collaboration arrangements, significant judgment is required by management to determine the duration of the performance period.", "type": 2, "words": ["<tag1>", "Given", "the", "uncertainties", "in", "research", "and", "development", "collaborations,", "significant", "judgment", "is", "required", "by", "management", "to", "determine", "the", "performance", "periods.", "<tag2>", "Given", "the", "complexities", "and", "uncertainties", "of", "collaboration", "arrangements,", "significant", "judgment", "is", "required", "by", "management", "to", "determine", "the", "duration", "of", "the", "performance", "period.", "<tag3>"], "wordsA": ["Given", "the", "uncertainties", "in", "research", "and", "development", "collaborations,", "significant", "judgment", "is", "required", "by", "management", "to", "determine", "the", "performance", "periods."], "wordsB": ["Given", "the", "complexities", "and", "uncertainties", "of", "collaboration", "arrangements,", "significant", "judgment", "is", "required", "by", "management", "to", "determine", "the", "duration", "of", "the", "performance", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p20_s0", "idA": "906709_12_item7_p13_s0", "sentA": "Product sales Product sales include cost-plus and fixed price manufacturing and supply agreements with our collaboration partners.", "sentB": "Product sales Product sales include fixed price and cost-plus manufacturing and supply agreements with our collaboration partners.", "type": 2, "words": ["<tag1>", "Product", "sales", "Product", "sales", "include", "cost-plus", "and", "fixed", "price", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners.", "<tag2>", "Product", "sales", "Product", "sales", "include", "fixed", "price", "and", "cost-plus", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners.", "<tag3>"], "wordsA": ["Product", "sales", "Product", "sales", "include", "cost-plus", "and", "fixed", "price", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners."], "wordsB": ["Product", "sales", "Product", "sales", "include", "fixed", "price", "and", "cost-plus", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p61_s1", "idA": "906709_12_item7_p13_s0", "sentA": "Product sales Product sales include cost-plus and fixed price manufacturing and supply agreements with our collaboration partners.", "sentB": "As of December 31, 2012, we also had $90.4 million of deferred upfront fees related to seven license, manufacturing and supply agreements that are being amortized over periods from 5 to 10 years.", "type": 2, "words": ["<tag1>", "Product", "sales", "Product", "sales", "include", "cost-plus", "and", "fixed", "price", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners.", "<tag2>", "As", "of", "December", "31,", "2012,", "we", "also", "had", "$90.4", "million", "of", "deferred", "upfront", "fees", "related", "to", "seven", "license,", "manufacturing", "and", "supply", "agreements", "that", "are", "being", "amortized", "over", "periods", "from", "5", "to", "10", "years.", "<tag3>"], "wordsA": ["Product", "sales", "Product", "sales", "include", "cost-plus", "and", "fixed", "price", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners."], "wordsB": ["As", "of", "December", "31,", "2012,", "we", "also", "had", "$90.4", "million", "of", "deferred", "upfront", "fees", "related", "to", "seven", "license,", "manufacturing", "and", "supply", "agreements", "that", "are", "being", "amortized", "over", "periods", "from", "5", "to", "10", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p20_s1", "idA": "906709_12_item7_p13_s1", "sentA": "Product sales decreased during the years ended December 31, 2011 and 2010 compared to the prior periods primarily as a result of decreased product demand from our collaboration partners due in part to the transfer of manufacturing activities to certain collaboration partners.", "sentB": "Product sales increased during the year ended December 31, 2012 compared to the year ended December 31, 2011 as a result of increased product demand from a number of our collaboration partners.", "type": 2, "words": ["<tag1>", "Product", "sales", "decreased", "during", "the", "years", "ended", "December", "31,", "2011", "and", "2010", "compared", "to", "the", "prior", "periods", "primarily", "as", "a", "result", "of", "decreased", "product", "demand", "from", "our", "collaboration", "partners", "due", "in", "part", "to", "the", "transfer", "of", "manufacturing", "activities", "to", "certain", "collaboration", "partners.", "<tag2>", "Product", "sales", "increased", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "as", "a", "result", "of", "increased", "product", "demand", "from", "a", "number", "of", "our", "collaboration", "partners.", "<tag3>"], "wordsA": ["Product", "sales", "decreased", "during", "the", "years", "ended", "December", "31,", "2011", "and", "2010", "compared", "to", "the", "prior", "periods", "primarily", "as", "a", "result", "of", "decreased", "product", "demand", "from", "our", "collaboration", "partners", "due", "in", "part", "to", "the", "transfer", "of", "manufacturing", "activities", "to", "certain", "collaboration", "partners."], "wordsB": ["Product", "sales", "increased", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "as", "a", "result", "of", "increased", "product", "demand", "from", "a", "number", "of", "our", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p20_s2", "idA": "906709_12_item7_p13_s1", "sentA": "Product sales decreased during the years ended December 31, 2011 and 2010 compared to the prior periods primarily as a result of decreased product demand from our collaboration partners due in part to the transfer of manufacturing activities to certain collaboration partners.", "sentB": "Product sales decreased during the year ended December 31, 2011 compared to the year ended December 31, 2010 due in part to the transfer of manufacturing activities to certain collaboration partners.", "type": 2, "words": ["<tag1>", "Product", "sales", "decreased", "during", "the", "years", "ended", "December", "31,", "2011", "and", "2010", "compared", "to", "the", "prior", "periods", "primarily", "as", "a", "result", "of", "decreased", "product", "demand", "from", "our", "collaboration", "partners", "due", "in", "part", "to", "the", "transfer", "of", "manufacturing", "activities", "to", "certain", "collaboration", "partners.", "<tag2>", "Product", "sales", "decreased", "during", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "due", "in", "part", "to", "the", "transfer", "of", "manufacturing", "activities", "to", "certain", "collaboration", "partners.", "<tag3>"], "wordsA": ["Product", "sales", "decreased", "during", "the", "years", "ended", "December", "31,", "2011", "and", "2010", "compared", "to", "the", "prior", "periods", "primarily", "as", "a", "result", "of", "decreased", "product", "demand", "from", "our", "collaboration", "partners", "due", "in", "part", "to", "the", "transfer", "of", "manufacturing", "activities", "to", "certain", "collaboration", "partners."], "wordsB": ["Product", "sales", "decreased", "during", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "due", "in", "part", "to", "the", "transfer", "of", "manufacturing", "activities", "to", "certain", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p68_s0", "idA": "906709_12_item7_p13_s10", "sentA": "The level of license, collaboration and other revenue depends in part upon the estimated amortization period of the upfront payments, the achievement of milestones, the continuation of existing collaborations, the amount of reimbursed research and development work, and entering into new collaboration agreements, if any.", "sentB": "In addition, for awards that vest upon the achievement of performance milestones, we estimate the vesting period based on our evaluation of the probability of achievement of each respective milestone and the related estimated date of achievement.", "type": 2, "words": ["<tag1>", "The", "level", "of", "license,", "collaboration", "and", "other", "revenue", "depends", "in", "part", "upon", "the", "estimated", "amortization", "period", "of", "the", "upfront", "payments,", "the", "achievement", "of", "milestones,", "the", "continuation", "of", "existing", "collaborations,", "the", "amount", "of", "reimbursed", "research", "and", "development", "work,", "and", "entering", "into", "new", "collaboration", "agreements,", "if", "any.", "<tag2>", "In", "addition,", "for", "awards", "that", "vest", "upon", "the", "achievement", "of", "performance", "milestones,", "we", "estimate", "the", "vesting", "period", "based", "on", "our", "evaluation", "of", "the", "probability", "of", "achievement", "of", "each", "respective", "milestone", "and", "the", "related", "estimated", "date", "of", "achievement.", "<tag3>"], "wordsA": ["The", "level", "of", "license,", "collaboration", "and", "other", "revenue", "depends", "in", "part", "upon", "the", "estimated", "amortization", "period", "of", "the", "upfront", "payments,", "the", "achievement", "of", "milestones,", "the", "continuation", "of", "existing", "collaborations,", "the", "amount", "of", "reimbursed", "research", "and", "development", "work,", "and", "entering", "into", "new", "collaboration", "agreements,", "if", "any."], "wordsB": ["In", "addition,", "for", "awards", "that", "vest", "upon", "the", "achievement", "of", "performance", "milestones,", "we", "estimate", "the", "vesting", "period", "based", "on", "our", "evaluation", "of", "the", "probability", "of", "achievement", "of", "each", "respective", "milestone", "and", "the", "related", "estimated", "date", "of", "achievement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p69_s3", "idA": "906709_12_item7_p13_s10", "sentA": "The level of license, collaboration and other revenue depends in part upon the estimated amortization period of the upfront payments, the achievement of milestones, the continuation of existing collaborations, the amount of reimbursed research and development work, and entering into new collaboration agreements, if any.", "sentB": "Our estimate of the interest rate under the agreement is based on the amount of royalty payments to be received by RPI over the life of the arrangement and payments we may be required to make to RPI under the agreement, if any.", "type": 2, "words": ["<tag1>", "The", "level", "of", "license,", "collaboration", "and", "other", "revenue", "depends", "in", "part", "upon", "the", "estimated", "amortization", "period", "of", "the", "upfront", "payments,", "the", "achievement", "of", "milestones,", "the", "continuation", "of", "existing", "collaborations,", "the", "amount", "of", "reimbursed", "research", "and", "development", "work,", "and", "entering", "into", "new", "collaboration", "agreements,", "if", "any.", "<tag2>", "Our", "estimate", "of", "the", "interest", "rate", "under", "the", "agreement", "is", "based", "on", "the", "amount", "of", "royalty", "payments", "to", "be", "received", "by", "RPI", "over", "the", "life", "of", "the", "arrangement", "and", "payments", "we", "may", "be", "required", "to", "make", "to", "RPI", "under", "the", "agreement,", "if", "any.", "<tag3>"], "wordsA": ["The", "level", "of", "license,", "collaboration", "and", "other", "revenue", "depends", "in", "part", "upon", "the", "estimated", "amortization", "period", "of", "the", "upfront", "payments,", "the", "achievement", "of", "milestones,", "the", "continuation", "of", "existing", "collaborations,", "the", "amount", "of", "reimbursed", "research", "and", "development", "work,", "and", "entering", "into", "new", "collaboration", "agreements,", "if", "any."], "wordsB": ["Our", "estimate", "of", "the", "interest", "rate", "under", "the", "agreement", "is", "based", "on", "the", "amount", "of", "royalty", "payments", "to", "be", "received", "by", "RPI", "over", "the", "life", "of", "the", "arrangement", "and", "payments", "we", "may", "be", "required", "to", "make", "to", "RPI", "under", "the", "agreement,", "if", "any."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p21_s8", "idA": "906709_12_item7_p13_s11", "sentA": "License, collaboration and other revenue for the year ended December 31, 2011 decreased compared to the year ended December 31, 2010 primarily due to the complete recognition as of December 31, 2010 of the $125.0 million upfront payment received in the fourth quarter of 2009 from AstraZeneca in connection with the NKTR-118 and NKTR-119 global license agreement.", "sentB": "License, collaboration and other revenue for the year ended December 31, 2012 decreased compared to the year ended December 31, 2011 primarily due to the recognition in 2011 of a $5.0 million license fee from an agreement signed in September 2011.", "type": 2, "words": ["<tag1>", "License,", "collaboration", "and", "other", "revenue", "for", "the", "year", "ended", "December", "31,", "2011", "decreased", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "primarily", "due", "to", "the", "complete", "recognition", "as", "of", "December", "31,", "2010", "of", "the", "$125.0", "million", "upfront", "payment", "received", "in", "the", "fourth", "quarter", "of", "2009", "from", "AstraZeneca", "in", "connection", "with", "the", "NKTR-118", "and", "NKTR-119", "global", "license", "agreement.", "<tag2>", "License,", "collaboration", "and", "other", "revenue", "for", "the", "year", "ended", "December", "31,", "2012", "decreased", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "primarily", "due", "to", "the", "recognition", "in", "2011", "of", "a", "$5.0", "million", "license", "fee", "from", "an", "agreement", "signed", "in", "September", "2011.", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "revenue", "for", "the", "year", "ended", "December", "31,", "2011", "decreased", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "primarily", "due", "to", "the", "complete", "recognition", "as", "of", "December", "31,", "2010", "of", "the", "$125.0", "million", "upfront", "payment", "received", "in", "the", "fourth", "quarter", "of", "2009", "from", "AstraZeneca", "in", "connection", "with", "the", "NKTR-118", "and", "NKTR-119", "global", "license", "agreement."], "wordsB": ["License,", "collaboration", "and", "other", "revenue", "for", "the", "year", "ended", "December", "31,", "2012", "decreased", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "primarily", "due", "to", "the", "recognition", "in", "2011", "of", "a", "$5.0", "million", "license", "fee", "from", "an", "agreement", "signed", "in", "September", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p21_s9", "idA": "906709_12_item7_p13_s12", "sentA": "This decrease was partially offset by the recognition of a $5.0 million license fee, $6.0 million in milestones earned under existing collaboration agreements, and increases in revenue recognized in 2011 from upfront payments received by us during 2010.", "sentB": "This decrease was partially offset by the recognition of the $5.0 million license fee noted above, $6.0 million in milestones earned under existing collaboration agreements, and increases in revenue recognized in 2011 from upfront payments received by us during 2010.", "type": 2, "words": ["<tag1>", "This", "decrease", "was", "partially", "offset", "by", "the", "recognition", "of", "a", "$5.0", "million", "license", "fee,", "$6.0", "million", "in", "milestones", "earned", "under", "existing", "collaboration", "agreements,", "and", "increases", "in", "revenue", "recognized", "in", "2011", "from", "upfront", "payments", "received", "by", "us", "during", "2010.", "<tag2>", "This", "decrease", "was", "partially", "offset", "by", "the", "recognition", "of", "the", "$5.0", "million", "license", "fee", "noted", "above,", "$6.0", "million", "in", "milestones", "earned", "under", "existing", "collaboration", "agreements,", "and", "increases", "in", "revenue", "recognized", "in", "2011", "from", "upfront", "payments", "received", "by", "us", "during", "2010.", "<tag3>"], "wordsA": ["This", "decrease", "was", "partially", "offset", "by", "the", "recognition", "of", "a", "$5.0", "million", "license", "fee,", "$6.0", "million", "in", "milestones", "earned", "under", "existing", "collaboration", "agreements,", "and", "increases", "in", "revenue", "recognized", "in", "2011", "from", "upfront", "payments", "received", "by", "us", "during", "2010."], "wordsB": ["This", "decrease", "was", "partially", "offset", "by", "the", "recognition", "of", "the", "$5.0", "million", "license", "fee", "noted", "above,", "$6.0", "million", "in", "milestones", "earned", "under", "existing", "collaboration", "agreements,", "and", "increases", "in", "revenue", "recognized", "in", "2011", "from", "upfront", "payments", "received", "by", "us", "during", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p21_s10", "idA": "906709_12_item7_p13_s13", "sentA": "We expect license, collaboration and other revenue in 2012 to be consistent with 2011.", "sentB": "We expect license, collaboration and other revenue in 2013 to increase as compared to 2012 primarily as a result of the recognition of milestones under existing collaboration agreements.", "type": 2, "words": ["<tag1>", "We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2012", "to", "be", "consistent", "with", "2011.", "<tag2>", "We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2013", "to", "increase", "as", "compared", "to", "2012", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "milestones", "under", "existing", "collaboration", "agreements.", "<tag3>"], "wordsA": ["We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2012", "to", "be", "consistent", "with", "2011."], "wordsB": ["We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2013", "to", "increase", "as", "compared", "to", "2012", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "milestones", "under", "existing", "collaboration", "agreements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p21_s12", "idA": "906709_12_item7_p13_s13", "sentA": "We expect license, collaboration and other revenue in 2012 to be consistent with 2011.", "sentB": "If these filings occur in 2013, our license, collaboration and other revenue in 2013 will increase significantly from 2012.", "type": 2, "words": ["<tag1>", "We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2012", "to", "be", "consistent", "with", "2011.", "<tag2>", "If", "these", "filings", "occur", "in", "2013,", "our", "license,", "collaboration", "and", "other", "revenue", "in", "2013", "will", "increase", "significantly", "from", "2012.", "<tag3>"], "wordsA": ["We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2012", "to", "be", "consistent", "with", "2011."], "wordsB": ["If", "these", "filings", "occur", "in", "2013,", "our", "license,", "collaboration", "and", "other", "revenue", "in", "2013", "will", "increase", "significantly", "from", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p20_s3", "idA": "906709_12_item7_p13_s2", "sentA": "The timing of shipments is based on the demand and requirements of our collaboration partners and is not ratable throughout the year.", "sentB": "The timing of shipments is based solely on the demand and requirements of our collaboration partners and is not ratable throughout the year.", "type": 2, "words": ["<tag1>", "The", "timing", "of", "shipments", "is", "based", "on", "the", "demand", "and", "requirements", "of", "our", "collaboration", "partners", "and", "is", "not", "ratable", "throughout", "the", "year.", "<tag2>", "The", "timing", "of", "shipments", "is", "based", "solely", "on", "the", "demand", "and", "requirements", "of", "our", "collaboration", "partners", "and", "is", "not", "ratable", "throughout", "the", "year.", "<tag3>"], "wordsA": ["The", "timing", "of", "shipments", "is", "based", "on", "the", "demand", "and", "requirements", "of", "our", "collaboration", "partners", "and", "is", "not", "ratable", "throughout", "the", "year."], "wordsB": ["The", "timing", "of", "shipments", "is", "based", "solely", "on", "the", "demand", "and", "requirements", "of", "our", "collaboration", "partners", "and", "is", "not", "ratable", "throughout", "the", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p20_s4", "idA": "906709_12_item7_p13_s3", "sentA": "We expect product sales to increase in 2012 compared with 2011.", "sentB": "We expect product sales to increase in 2013 as compared to 2012.", "type": 2, "words": ["<tag1>", "We", "expect", "product", "sales", "to", "increase", "in", "2012", "compared", "with", "2011.", "<tag2>", "We", "expect", "product", "sales", "to", "increase", "in", "2013", "as", "compared", "to", "2012.", "<tag3>"], "wordsA": ["We", "expect", "product", "sales", "to", "increase", "in", "2012", "compared", "with", "2011."], "wordsB": ["We", "expect", "product", "sales", "to", "increase", "in", "2013", "as", "compared", "to", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p21_s5", "idA": "906709_12_item7_p13_s3", "sentA": "We expect product sales to increase in 2012 compared with 2011.", "sentB": "We expect non cash royalties from net sales of CIMZIA and MIRCERA to increase in 2013 as compared to 2012.", "type": 2, "words": ["<tag1>", "We", "expect", "product", "sales", "to", "increase", "in", "2012", "compared", "with", "2011.", "<tag2>", "We", "expect", "non", "cash", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "to", "increase", "in", "2013", "as", "compared", "to", "2012.", "<tag3>"], "wordsA": ["We", "expect", "product", "sales", "to", "increase", "in", "2012", "compared", "with", "2011."], "wordsB": ["We", "expect", "non", "cash", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "to", "increase", "in", "2013", "as", "compared", "to", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p20_s6", "idA": "906709_12_item7_p13_s5", "sentA": "Royalty revenues increased during the years ended December 31, 2011 and 2010 compared to the prior periods primarily as a result of the increase in royalties received from Roche s MIRCERA and UCB Pharma s CIMZIA product sales.", "sentB": "Royalty revenues decreased during the year ended December 31, 2012 compared to the year ended December 31, 2011 primarily as a result of the sale of the royalties we receive from UCB s CIMZIA and Roche s MIRCERA product sales as is further described below.", "type": 2, "words": ["<tag1>", "Royalty", "revenues", "increased", "during", "the", "years", "ended", "December", "31,", "2011", "and", "2010", "compared", "to", "the", "prior", "periods", "primarily", "as", "a", "result", "of", "the", "increase", "in", "royalties", "received", "from", "Roche", "s", "MIRCERA", "and", "UCB", "Pharma", "s", "CIMZIA", "product", "sales.", "<tag2>", "Royalty", "revenues", "decreased", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "primarily", "as", "a", "result", "of", "the", "sale", "of", "the", "royalties", "we", "receive", "from", "UCB", "s", "CIMZIA", "and", "Roche", "s", "MIRCERA", "product", "sales", "as", "is", "further", "described", "below.", "<tag3>"], "wordsA": ["Royalty", "revenues", "increased", "during", "the", "years", "ended", "December", "31,", "2011", "and", "2010", "compared", "to", "the", "prior", "periods", "primarily", "as", "a", "result", "of", "the", "increase", "in", "royalties", "received", "from", "Roche", "s", "MIRCERA", "and", "UCB", "Pharma", "s", "CIMZIA", "product", "sales."], "wordsB": ["Royalty", "revenues", "decreased", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "primarily", "as", "a", "result", "of", "the", "sale", "of", "the", "royalties", "we", "receive", "from", "UCB", "s", "CIMZIA", "and", "Roche", "s", "MIRCERA", "product", "sales", "as", "is", "further", "described", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p20_s7", "idA": "906709_12_item7_p13_s5", "sentA": "Royalty revenues increased during the years ended December 31, 2011 and 2010 compared to the prior periods primarily as a result of the increase in royalties received from Roche s MIRCERA and UCB Pharma s CIMZIA product sales.", "sentB": "Royalty revenues increased during the year ended December 31, 2011 as compared to the year ended December 31, 2010 primarily as a result of the increase in royalties received from net sales of CIMZIA and MIRCERA .", "type": 2, "words": ["<tag1>", "Royalty", "revenues", "increased", "during", "the", "years", "ended", "December", "31,", "2011", "and", "2010", "compared", "to", "the", "prior", "periods", "primarily", "as", "a", "result", "of", "the", "increase", "in", "royalties", "received", "from", "Roche", "s", "MIRCERA", "and", "UCB", "Pharma", "s", "CIMZIA", "product", "sales.", "<tag2>", "Royalty", "revenues", "increased", "during", "the", "year", "ended", "December", "31,", "2011", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "primarily", "as", "a", "result", "of", "the", "increase", "in", "royalties", "received", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", ".", "<tag3>"], "wordsA": ["Royalty", "revenues", "increased", "during", "the", "years", "ended", "December", "31,", "2011", "and", "2010", "compared", "to", "the", "prior", "periods", "primarily", "as", "a", "result", "of", "the", "increase", "in", "royalties", "received", "from", "Roche", "s", "MIRCERA", "and", "UCB", "Pharma", "s", "CIMZIA", "product", "sales."], "wordsB": ["Royalty", "revenues", "increased", "during", "the", "year", "ended", "December", "31,", "2011", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "primarily", "as", "a", "result", "of", "the", "increase", "in", "royalties", "received", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p21_s0", "idA": "906709_12_item7_p13_s6", "sentA": "During the years ended December 31, 2011, 2010, and 2009, we recognized $8.3 million, $5.4 million, and $2.7 million, respectively, in aggregate royalties from net sales of MIRCERA and CIMZIA .", "sentB": "During the years ended December 31, 2011 and 2010, we recognized $8.3 million and $5.4 million, respectively, in aggregate royalties from net sales of CIMZIA and MIRCERA .", "type": 2, "words": ["<tag1>", "During", "the", "years", "ended", "December", "31,", "2011,", "2010,", "and", "2009,", "we", "recognized", "$8.3", "million,", "$5.4", "million,", "and", "$2.7", "million,", "respectively,", "in", "aggregate", "royalties", "from", "net", "sales", "of", "MIRCERA", "and", "CIMZIA", ".", "<tag2>", "During", "the", "years", "ended", "December", "31,", "2011", "and", "2010,", "we", "recognized", "$8.3", "million", "and", "$5.4", "million,", "respectively,", "in", "aggregate", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", ".", "<tag3>"], "wordsA": ["During", "the", "years", "ended", "December", "31,", "2011,", "2010,", "and", "2009,", "we", "recognized", "$8.3", "million,", "$5.4", "million,", "and", "$2.7", "million,", "respectively,", "in", "aggregate", "royalties", "from", "net", "sales", "of", "MIRCERA", "and", "CIMZIA", "."], "wordsB": ["During", "the", "years", "ended", "December", "31,", "2011", "and", "2010,", "we", "recognized", "$8.3", "million", "and", "$5.4", "million,", "respectively,", "in", "aggregate", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p21_s4", "idA": "906709_12_item7_p13_s6", "sentA": "During the years ended December 31, 2011, 2010, and 2009, we recognized $8.3 million, $5.4 million, and $2.7 million, respectively, in aggregate royalties from net sales of MIRCERA and CIMZIA .", "sentB": "During the year ended December 31, 2012, we recognized $13.5 million in aggregate royalties from net sales of CIMZIA and MIRCERA , of which the $2.7 million recognized in the three months ended March 31, 2012 was retained by us as these amounts resulted from product sales in the fourth quarter of 2011 and the $10.8 million recognized in the nine months ended December 31, 2012 was remitted directly to the purchaser as these amounts resulted from product sales in the first three quarters of 2012.", "type": 2, "words": ["<tag1>", "During", "the", "years", "ended", "December", "31,", "2011,", "2010,", "and", "2009,", "we", "recognized", "$8.3", "million,", "$5.4", "million,", "and", "$2.7", "million,", "respectively,", "in", "aggregate", "royalties", "from", "net", "sales", "of", "MIRCERA", "and", "CIMZIA", ".", "<tag2>", "During", "the", "year", "ended", "December", "31,", "2012,", "we", "recognized", "$13.5", "million", "in", "aggregate", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", ",", "of", "which", "the", "$2.7", "million", "recognized", "in", "the", "three", "months", "ended", "March", "31,", "2012", "was", "retained", "by", "us", "as", "these", "amounts", "resulted", "from", "product", "sales", "in", "the", "fourth", "quarter", "of", "2011", "and", "the", "$10.8", "million", "recognized", "in", "the", "nine", "months", "ended", "December", "31,", "2012", "was", "remitted", "directly", "to", "the", "purchaser", "as", "these", "amounts", "resulted", "from", "product", "sales", "in", "the", "first", "three", "quarters", "of", "2012.", "<tag3>"], "wordsA": ["During", "the", "years", "ended", "December", "31,", "2011,", "2010,", "and", "2009,", "we", "recognized", "$8.3", "million,", "$5.4", "million,", "and", "$2.7", "million,", "respectively,", "in", "aggregate", "royalties", "from", "net", "sales", "of", "MIRCERA", "and", "CIMZIA", "."], "wordsB": ["During", "the", "year", "ended", "December", "31,", "2012,", "we", "recognized", "$13.5", "million", "in", "aggregate", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", ",", "of", "which", "the", "$2.7", "million", "recognized", "in", "the", "three", "months", "ended", "March", "31,", "2012", "was", "retained", "by", "us", "as", "these", "amounts", "resulted", "from", "product", "sales", "in", "the", "fourth", "quarter", "of", "2011", "and", "the", "$10.8", "million", "recognized", "in", "the", "nine", "months", "ended", "December", "31,", "2012", "was", "remitted", "directly", "to", "the", "purchaser", "as", "these", "amounts", "resulted", "from", "product", "sales", "in", "the", "first", "three", "quarters", "of", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p69_s0", "idA": "906709_12_item7_p13_s7", "sentA": "As noted above, in February 2012, we sold all of our rights to receive future royalty payments on CIMZIA and MIRCERA .", "sentB": "In February 2012, we sold all of our rights to receive future royalty payments from sales of the CIMZIA and MIRCERA drug products marketed by UCB and Roche, respectively.", "type": 2, "words": ["<tag1>", "As", "noted", "above,", "in", "February", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "on", "CIMZIA", "and", "MIRCERA", ".", "<tag2>", "In", "February", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "from", "sales", "of", "the", "CIMZIA", "and", "MIRCERA", "drug", "products", "marketed", "by", "UCB", "and", "Roche,", "respectively.", "<tag3>"], "wordsA": ["As", "noted", "above,", "in", "February", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "on", "CIMZIA", "and", "MIRCERA", "."], "wordsB": ["In", "February", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "from", "sales", "of", "the", "CIMZIA", "and", "MIRCERA", "drug", "products", "marketed", "by", "UCB", "and", "Roche,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p70_s0", "idA": "906709_12_item7_p13_s7", "sentA": "As noted above, in February 2012, we sold all of our rights to receive future royalty payments on CIMZIA and MIRCERA .", "sentB": "There are a number of factors that could materially affect the amount and timing of royalty payments from CIMZIA and MIRCERA , most of which are not within our control.", "type": 2, "words": ["<tag1>", "As", "noted", "above,", "in", "February", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "on", "CIMZIA", "and", "MIRCERA", ".", "<tag2>", "There", "are", "a", "number", "of", "factors", "that", "could", "materially", "affect", "the", "amount", "and", "timing", "of", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "most", "of", "which", "are", "not", "within", "our", "control.", "<tag3>"], "wordsA": ["As", "noted", "above,", "in", "February", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "on", "CIMZIA", "and", "MIRCERA", "."], "wordsB": ["There", "are", "a", "number", "of", "factors", "that", "could", "materially", "affect", "the", "amount", "and", "timing", "of", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "most", "of", "which", "are", "not", "within", "our", "control."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p21_s2", "idA": "906709_12_item7_p13_s8", "sentA": "However, although any future CIMZIA and MIRCERA royalties will go directly to the purchaser of these royalty interests, as this transaction will be recorded as a liability that amortizes over the life of the estimated royalty payment period, we will continue to recognize the royalties as revenue, which we expect to increase in 2012.", "sentB": "As described in Note 7 to our Consolidated Financial Statements, this royalty sale transaction has been recorded as a liability that amortizes over the estimated royalty payment period.", "type": 2, "words": ["<tag1>", "However,", "although", "any", "future", "CIMZIA", "and", "MIRCERA", "royalties", "will", "go", "directly", "to", "the", "purchaser", "of", "these", "royalty", "interests,", "as", "this", "transaction", "will", "be", "recorded", "as", "a", "liability", "that", "amortizes", "over", "the", "life", "of", "the", "estimated", "royalty", "payment", "period,", "we", "will", "continue", "to", "recognize", "the", "royalties", "as", "revenue,", "which", "we", "expect", "to", "increase", "in", "2012.", "<tag2>", "As", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "sale", "transaction", "has", "been", "recorded", "as", "a", "liability", "that", "amortizes", "over", "the", "estimated", "royalty", "payment", "period.", "<tag3>"], "wordsA": ["However,", "although", "any", "future", "CIMZIA", "and", "MIRCERA", "royalties", "will", "go", "directly", "to", "the", "purchaser", "of", "these", "royalty", "interests,", "as", "this", "transaction", "will", "be", "recorded", "as", "a", "liability", "that", "amortizes", "over", "the", "life", "of", "the", "estimated", "royalty", "payment", "period,", "we", "will", "continue", "to", "recognize", "the", "royalties", "as", "revenue,", "which", "we", "expect", "to", "increase", "in", "2012."], "wordsB": ["As", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "sale", "transaction", "has", "been", "recorded", "as", "a", "liability", "that", "amortizes", "over", "the", "estimated", "royalty", "payment", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p21_s3", "idA": "906709_12_item7_p13_s8", "sentA": "However, although any future CIMZIA and MIRCERA royalties will go directly to the purchaser of these royalty interests, as this transaction will be recorded as a liability that amortizes over the life of the estimated royalty payment period, we will continue to recognize the royalties as revenue, which we expect to increase in 2012.", "sentB": "As a result of this liability accounting, even though the royalties from UCB and Roche are remitted directly to the purchaser, we will continue to record revenue for these royalties.", "type": 2, "words": ["<tag1>", "However,", "although", "any", "future", "CIMZIA", "and", "MIRCERA", "royalties", "will", "go", "directly", "to", "the", "purchaser", "of", "these", "royalty", "interests,", "as", "this", "transaction", "will", "be", "recorded", "as", "a", "liability", "that", "amortizes", "over", "the", "life", "of", "the", "estimated", "royalty", "payment", "period,", "we", "will", "continue", "to", "recognize", "the", "royalties", "as", "revenue,", "which", "we", "expect", "to", "increase", "in", "2012.", "<tag2>", "As", "a", "result", "of", "this", "liability", "accounting,", "even", "though", "the", "royalties", "from", "UCB", "and", "Roche", "are", "remitted", "directly", "to", "the", "purchaser,", "we", "will", "continue", "to", "record", "revenue", "for", "these", "royalties.", "<tag3>"], "wordsA": ["However,", "although", "any", "future", "CIMZIA", "and", "MIRCERA", "royalties", "will", "go", "directly", "to", "the", "purchaser", "of", "these", "royalty", "interests,", "as", "this", "transaction", "will", "be", "recorded", "as", "a", "liability", "that", "amortizes", "over", "the", "life", "of", "the", "estimated", "royalty", "payment", "period,", "we", "will", "continue", "to", "recognize", "the", "royalties", "as", "revenue,", "which", "we", "expect", "to", "increase", "in", "2012."], "wordsB": ["As", "a", "result", "of", "this", "liability", "accounting,", "even", "though", "the", "royalties", "from", "UCB", "and", "Roche", "are", "remitted", "directly", "to", "the", "purchaser,", "we", "will", "continue", "to", "record", "revenue", "for", "these", "royalties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p40_s6", "idA": "906709_12_item7_p13_s8", "sentA": "However, although any future CIMZIA and MIRCERA royalties will go directly to the purchaser of these royalty interests, as this transaction will be recorded as a liability that amortizes over the life of the estimated royalty payment period, we will continue to recognize the royalties as revenue, which we expect to increase in 2012.", "sentB": "As described in Note 7 to our Consolidated Financial Statements, this royalty sale transaction has been recorded as a liability that amortizes over the estimated royalty payment period as CIMZIA and MIRCERA royalties are remitted directly to the purchaser.", "type": 2, "words": ["<tag1>", "However,", "although", "any", "future", "CIMZIA", "and", "MIRCERA", "royalties", "will", "go", "directly", "to", "the", "purchaser", "of", "these", "royalty", "interests,", "as", "this", "transaction", "will", "be", "recorded", "as", "a", "liability", "that", "amortizes", "over", "the", "life", "of", "the", "estimated", "royalty", "payment", "period,", "we", "will", "continue", "to", "recognize", "the", "royalties", "as", "revenue,", "which", "we", "expect", "to", "increase", "in", "2012.", "<tag2>", "As", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "sale", "transaction", "has", "been", "recorded", "as", "a", "liability", "that", "amortizes", "over", "the", "estimated", "royalty", "payment", "period", "as", "CIMZIA", "and", "MIRCERA", "royalties", "are", "remitted", "directly", "to", "the", "purchaser.", "<tag3>"], "wordsA": ["However,", "although", "any", "future", "CIMZIA", "and", "MIRCERA", "royalties", "will", "go", "directly", "to", "the", "purchaser", "of", "these", "royalty", "interests,", "as", "this", "transaction", "will", "be", "recorded", "as", "a", "liability", "that", "amortizes", "over", "the", "life", "of", "the", "estimated", "royalty", "payment", "period,", "we", "will", "continue", "to", "recognize", "the", "royalties", "as", "revenue,", "which", "we", "expect", "to", "increase", "in", "2012."], "wordsB": ["As", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "sale", "transaction", "has", "been", "recorded", "as", "a", "liability", "that", "amortizes", "over", "the", "estimated", "royalty", "payment", "period", "as", "CIMZIA", "and", "MIRCERA", "royalties", "are", "remitted", "directly", "to", "the", "purchaser."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p70_s1", "idA": "906709_12_item7_p13_s8", "sentA": "However, although any future CIMZIA and MIRCERA royalties will go directly to the purchaser of these royalty interests, as this transaction will be recorded as a liability that amortizes over the life of the estimated royalty payment period, we will continue to recognize the royalties as revenue, which we expect to increase in 2012.", "sentB": "Such factors include, but are not limited to, changing standards of care, the introduction of competing products, manufacturing or other delays, biosimilar competition, intellectual property matters, adverse events that result in health authority imposed restrictions on the use of the drug products, and other events or circumstances that result in reduced royalty payments from CIMZIA and MIRCERA , all of which would result in a reduction of non-cash royalty revenues and non-cash interest expense over the life of the Royalty Obligation.", "type": 2, "words": ["<tag1>", "However,", "although", "any", "future", "CIMZIA", "and", "MIRCERA", "royalties", "will", "go", "directly", "to", "the", "purchaser", "of", "these", "royalty", "interests,", "as", "this", "transaction", "will", "be", "recorded", "as", "a", "liability", "that", "amortizes", "over", "the", "life", "of", "the", "estimated", "royalty", "payment", "period,", "we", "will", "continue", "to", "recognize", "the", "royalties", "as", "revenue,", "which", "we", "expect", "to", "increase", "in", "2012.", "<tag2>", "Such", "factors", "include,", "but", "are", "not", "limited", "to,", "changing", "standards", "of", "care,", "the", "introduction", "of", "competing", "products,", "manufacturing", "or", "other", "delays,", "biosimilar", "competition,", "intellectual", "property", "matters,", "adverse", "events", "that", "result", "in", "health", "authority", "imposed", "restrictions", "on", "the", "use", "of", "the", "drug", "products,", "and", "other", "events", "or", "circumstances", "that", "result", "in", "reduced", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "all", "of", "which", "would", "result", "in", "a", "reduction", "of", "non-cash", "royalty", "revenues", "and", "non-cash", "interest", "expense", "over", "the", "life", "of", "the", "Royalty", "Obligation.", "<tag3>"], "wordsA": ["However,", "although", "any", "future", "CIMZIA", "and", "MIRCERA", "royalties", "will", "go", "directly", "to", "the", "purchaser", "of", "these", "royalty", "interests,", "as", "this", "transaction", "will", "be", "recorded", "as", "a", "liability", "that", "amortizes", "over", "the", "life", "of", "the", "estimated", "royalty", "payment", "period,", "we", "will", "continue", "to", "recognize", "the", "royalties", "as", "revenue,", "which", "we", "expect", "to", "increase", "in", "2012."], "wordsB": ["Such", "factors", "include,", "but", "are", "not", "limited", "to,", "changing", "standards", "of", "care,", "the", "introduction", "of", "competing", "products,", "manufacturing", "or", "other", "delays,", "biosimilar", "competition,", "intellectual", "property", "matters,", "adverse", "events", "that", "result", "in", "health", "authority", "imposed", "restrictions", "on", "the", "use", "of", "the", "drug", "products,", "and", "other", "events", "or", "circumstances", "that", "result", "in", "reduced", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "all", "of", "which", "would", "result", "in", "a", "reduction", "of", "non-cash", "royalty", "revenues", "and", "non-cash", "interest", "expense", "over", "the", "life", "of", "the", "Royalty", "Obligation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p70_s2", "idA": "906709_12_item7_p13_s8", "sentA": "However, although any future CIMZIA and MIRCERA royalties will go directly to the purchaser of these royalty interests, as this transaction will be recorded as a liability that amortizes over the life of the estimated royalty payment period, we will continue to recognize the royalties as revenue, which we expect to increase in 2012.", "sentB": "Conversely, if sales of CIMZIA and MIRCERA are higher than expected, non-cash royalty revenues and non-cash interest expense would also be greater over the term of the Royalty Obligation.", "type": 2, "words": ["<tag1>", "However,", "although", "any", "future", "CIMZIA", "and", "MIRCERA", "royalties", "will", "go", "directly", "to", "the", "purchaser", "of", "these", "royalty", "interests,", "as", "this", "transaction", "will", "be", "recorded", "as", "a", "liability", "that", "amortizes", "over", "the", "life", "of", "the", "estimated", "royalty", "payment", "period,", "we", "will", "continue", "to", "recognize", "the", "royalties", "as", "revenue,", "which", "we", "expect", "to", "increase", "in", "2012.", "<tag2>", "Conversely,", "if", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "higher", "than", "expected,", "non-cash", "royalty", "revenues", "and", "non-cash", "interest", "expense", "would", "also", "be", "greater", "over", "the", "term", "of", "the", "Royalty", "Obligation.", "<tag3>"], "wordsA": ["However,", "although", "any", "future", "CIMZIA", "and", "MIRCERA", "royalties", "will", "go", "directly", "to", "the", "purchaser", "of", "these", "royalty", "interests,", "as", "this", "transaction", "will", "be", "recorded", "as", "a", "liability", "that", "amortizes", "over", "the", "life", "of", "the", "estimated", "royalty", "payment", "period,", "we", "will", "continue", "to", "recognize", "the", "royalties", "as", "revenue,", "which", "we", "expect", "to", "increase", "in", "2012."], "wordsB": ["Conversely,", "if", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "higher", "than", "expected,", "non-cash", "royalty", "revenues", "and", "non-cash", "interest", "expense", "would", "also", "be", "greater", "over", "the", "term", "of", "the", "Royalty", "Obligation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p55_s0", "idA": "906709_12_item7_p13_s9", "sentA": "License, collaboration and other revenue License, collaboration and other revenue includes amortization of upfront payments and milestone payments received in connection with our license and collaboration agreements and reimbursed research and development expenses.", "sentB": "Revenue Recognition License, collaboration and other research revenue is recognized based on the facts and circumstances of each contractual agreement and includes amortization of upfront fees.", "type": 2, "words": ["<tag1>", "License,", "collaboration", "and", "other", "revenue", "License,", "collaboration", "and", "other", "revenue", "includes", "amortization", "of", "upfront", "payments", "and", "milestone", "payments", "received", "in", "connection", "with", "our", "license", "and", "collaboration", "agreements", "and", "reimbursed", "research", "and", "development", "expenses.", "<tag2>", "Revenue", "Recognition", "License,", "collaboration", "and", "other", "research", "revenue", "is", "recognized", "based", "on", "the", "facts", "and", "circumstances", "of", "each", "contractual", "agreement", "and", "includes", "amortization", "of", "upfront", "fees.", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "revenue", "License,", "collaboration", "and", "other", "revenue", "includes", "amortization", "of", "upfront", "payments", "and", "milestone", "payments", "received", "in", "connection", "with", "our", "license", "and", "collaboration", "agreements", "and", "reimbursed", "research", "and", "development", "expenses."], "wordsB": ["Revenue", "Recognition", "License,", "collaboration", "and", "other", "research", "revenue", "is", "recognized", "based", "on", "the", "facts", "and", "circumstances", "of", "each", "contractual", "agreement", "and", "includes", "amortization", "of", "upfront", "fees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p40_s1", "idA": "906709_12_item7_p14_s1", "sentA": "Under the AstraZeneca license agreement and related technology transfer agreement, we recognized $101.4 million and $23.6 million of the $125.0 million upfront payment and $6.5 million and $1.5 million of contract research and other revenue for the years ended December 31, 2010 and 2009, respectively.", "sentB": "On July 11, 2012, we issued $125.0 million of 12% senior secured notes maturing on July 15, 2017.", "type": 2, "words": ["<tag1>", "Under", "the", "AstraZeneca", "license", "agreement", "and", "related", "technology", "transfer", "agreement,", "we", "recognized", "$101.4", "million", "and", "$23.6", "million", "of", "the", "$125.0", "million", "upfront", "payment", "and", "$6.5", "million", "and", "$1.5", "million", "of", "contract", "research", "and", "other", "revenue", "for", "the", "years", "ended", "December", "31,", "2010", "and", "2009,", "respectively.", "<tag2>", "On", "July", "11,", "2012,", "we", "issued", "$125.0", "million", "of", "12%", "senior", "secured", "notes", "maturing", "on", "July", "15,", "2017.", "<tag3>"], "wordsA": ["Under", "the", "AstraZeneca", "license", "agreement", "and", "related", "technology", "transfer", "agreement,", "we", "recognized", "$101.4", "million", "and", "$23.6", "million", "of", "the", "$125.0", "million", "upfront", "payment", "and", "$6.5", "million", "and", "$1.5", "million", "of", "contract", "research", "and", "other", "revenue", "for", "the", "years", "ended", "December", "31,", "2010", "and", "2009,", "respectively."], "wordsB": ["On", "July", "11,", "2012,", "we", "issued", "$125.0", "million", "of", "12%", "senior", "secured", "notes", "maturing", "on", "July", "15,", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p12_s0", "idA": "906709_12_item7_p15_s0", "sentA": "The timing and future success of our drug development programs and those of our collaboration partners are subject to a number of risks and uncertainties.", "sentB": "If BAX 855 is approved by health authorities and is successfully commercialized by Baxter, this would represent a substantial royalty revenue opportunity for us, subject to significant risks and uncertainties relating to regulatory approval with health authorities and subsequent commercial success.", "type": 2, "words": ["<tag1>", "The", "timing", "and", "future", "success", "of", "our", "drug", "development", "programs", "and", "those", "of", "our", "collaboration", "partners", "are", "subject", "to", "a", "number", "of", "risks", "and", "uncertainties.", "<tag2>", "If", "BAX", "855", "is", "approved", "by", "health", "authorities", "and", "is", "successfully", "commercialized", "by", "Baxter,", "this", "would", "represent", "a", "substantial", "royalty", "revenue", "opportunity", "for", "us,", "subject", "to", "significant", "risks", "and", "uncertainties", "relating", "to", "regulatory", "approval", "with", "health", "authorities", "and", "subsequent", "commercial", "success.", "<tag3>"], "wordsA": ["The", "timing", "and", "future", "success", "of", "our", "drug", "development", "programs", "and", "those", "of", "our", "collaboration", "partners", "are", "subject", "to", "a", "number", "of", "risks", "and", "uncertainties."], "wordsB": ["If", "BAX", "855", "is", "approved", "by", "health", "authorities", "and", "is", "successfully", "commercialized", "by", "Baxter,", "this", "would", "represent", "a", "substantial", "royalty", "revenue", "opportunity", "for", "us,", "subject", "to", "significant", "risks", "and", "uncertainties", "relating", "to", "regulatory", "approval", "with", "health", "authorities", "and", "subsequent", "commercial", "success."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p17_s6", "idA": "906709_12_item7_p15_s0", "sentA": "The timing and future success of our drug development programs and those of our collaboration partners are subject to a number of risks and uncertainties.", "sentB": "The availability and terms of various financing alternatives substantially depend on the success or failure of our drug development programs including naloxegol, etirinotecan pegol, BAX 855, Amikacin Inhale, NKTR-181, and NKTR-192.", "type": 2, "words": ["<tag1>", "The", "timing", "and", "future", "success", "of", "our", "drug", "development", "programs", "and", "those", "of", "our", "collaboration", "partners", "are", "subject", "to", "a", "number", "of", "risks", "and", "uncertainties.", "<tag2>", "The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "the", "success", "or", "failure", "of", "our", "drug", "development", "programs", "including", "naloxegol,", "etirinotecan", "pegol,", "BAX", "855,", "Amikacin", "Inhale,", "NKTR-181,", "and", "NKTR-192.", "<tag3>"], "wordsA": ["The", "timing", "and", "future", "success", "of", "our", "drug", "development", "programs", "and", "those", "of", "our", "collaboration", "partners", "are", "subject", "to", "a", "number", "of", "risks", "and", "uncertainties."], "wordsB": ["The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "the", "success", "or", "failure", "of", "our", "drug", "development", "programs", "including", "naloxegol,", "etirinotecan", "pegol,", "BAX", "855,", "Amikacin", "Inhale,", "NKTR-181,", "and", "NKTR-192."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p44_s2", "idA": "906709_12_item7_p15_s0", "sentA": "The timing and future success of our drug development programs and those of our collaboration partners are subject to a number of risks and uncertainties.", "sentB": "The availability and terms of various financing alternatives substantially depend on the success or failure of our drug development programs including naloxegol, BAX 855, Amikacin Inhale, etirinotecan pegol, NKTR-181, and NKTR-192.", "type": 2, "words": ["<tag1>", "The", "timing", "and", "future", "success", "of", "our", "drug", "development", "programs", "and", "those", "of", "our", "collaboration", "partners", "are", "subject", "to", "a", "number", "of", "risks", "and", "uncertainties.", "<tag2>", "The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "the", "success", "or", "failure", "of", "our", "drug", "development", "programs", "including", "naloxegol,", "BAX", "855,", "Amikacin", "Inhale,", "etirinotecan", "pegol,", "NKTR-181,", "and", "NKTR-192.", "<tag3>"], "wordsA": ["The", "timing", "and", "future", "success", "of", "our", "drug", "development", "programs", "and", "those", "of", "our", "collaboration", "partners", "are", "subject", "to", "a", "number", "of", "risks", "and", "uncertainties."], "wordsB": ["The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "the", "success", "or", "failure", "of", "our", "drug", "development", "programs", "including", "naloxegol,", "BAX", "855,", "Amikacin", "Inhale,", "etirinotecan", "pegol,", "NKTR-181,", "and", "NKTR-192."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p65_s0", "idA": "906709_12_item7_p15_s1", "sentA": "See Part I, Item 1A Risk Factors for discussion of the risks associated with the complex nature of our collaboration agreements.", "sentB": "We generally accrue costs associated with the treatment phase of clinical studies based on the total estimated cost of the treatment phase on a per patient basis and we expense the per patient cost ratably based on patient enrollment in the studies.", "type": 2, "words": ["<tag1>", "See", "Part", "I,", "Item", "1A", "Risk", "Factors", "for", "discussion", "of", "the", "risks", "associated", "with", "the", "complex", "nature", "of", "our", "collaboration", "agreements.", "<tag2>", "We", "generally", "accrue", "costs", "associated", "with", "the", "treatment", "phase", "of", "clinical", "studies", "based", "on", "the", "total", "estimated", "cost", "of", "the", "treatment", "phase", "on", "a", "per", "patient", "basis", "and", "we", "expense", "the", "per", "patient", "cost", "ratably", "based", "on", "patient", "enrollment", "in", "the", "studies.", "<tag3>"], "wordsA": ["See", "Part", "I,", "Item", "1A", "Risk", "Factors", "for", "discussion", "of", "the", "risks", "associated", "with", "the", "complex", "nature", "of", "our", "collaboration", "agreements."], "wordsB": ["We", "generally", "accrue", "costs", "associated", "with", "the", "treatment", "phase", "of", "clinical", "studies", "based", "on", "the", "total", "estimated", "cost", "of", "the", "treatment", "phase", "on", "a", "per", "patient", "basis", "and", "we", "expense", "the", "per", "patient", "cost", "ratably", "based", "on", "patient", "enrollment", "in", "the", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p23_s1", "idA": "906709_12_item7_p17_s0", "sentA": "The decrease in revenue attributable to European countries for the year ended December 31, 2011 compared to the year ended December 31, 2010 and the increase in the year ended December 31, 2010 compared to the year ended December 31, 2009 is primarily attributable to the revenue we recognized from the AstraZeneca license agreement.", "sentB": "The following table sets forth revenue by geographic area (in thousands): The increase in revenue attributable to European countries for the year ended December 31, 2012 compared to the year ended December 31, 2011 is primarily attributable to increased product sales and royalty revenues from our existing European collaboration partners.", "type": 2, "words": ["<tag1>", "The", "decrease", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "and", "the", "increase", "in", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "the", "revenue", "we", "recognized", "from", "the", "AstraZeneca", "license", "agreement.", "<tag2>", "The", "following", "table", "sets", "forth", "revenue", "by", "geographic", "area", "(in", "thousands):", "The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "attributable", "to", "increased", "product", "sales", "and", "royalty", "revenues", "from", "our", "existing", "European", "collaboration", "partners.", "<tag3>"], "wordsA": ["The", "decrease", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "and", "the", "increase", "in", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "the", "revenue", "we", "recognized", "from", "the", "AstraZeneca", "license", "agreement."], "wordsB": ["The", "following", "table", "sets", "forth", "revenue", "by", "geographic", "area", "(in", "thousands):", "The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "attributable", "to", "increased", "product", "sales", "and", "royalty", "revenues", "from", "our", "existing", "European", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p23_s2", "idA": "906709_12_item7_p17_s0", "sentA": "The decrease in revenue attributable to European countries for the year ended December 31, 2011 compared to the year ended December 31, 2010 and the increase in the year ended December 31, 2010 compared to the year ended December 31, 2009 is primarily attributable to the revenue we recognized from the AstraZeneca license agreement.", "sentB": "The decrease in revenue attributable to European countries for the year ended December 31, 2011 compared to the year ended December 31, 2010 is primarily attributable to the revenue we recognized in 2010 from the AstraZeneca license agreement.", "type": 2, "words": ["<tag1>", "The", "decrease", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "and", "the", "increase", "in", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "the", "revenue", "we", "recognized", "from", "the", "AstraZeneca", "license", "agreement.", "<tag2>", "The", "decrease", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "attributable", "to", "the", "revenue", "we", "recognized", "in", "2010", "from", "the", "AstraZeneca", "license", "agreement.", "<tag3>"], "wordsA": ["The", "decrease", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "and", "the", "increase", "in", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "the", "revenue", "we", "recognized", "from", "the", "AstraZeneca", "license", "agreement."], "wordsB": ["The", "decrease", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "attributable", "to", "the", "revenue", "we", "recognized", "in", "2010", "from", "the", "AstraZeneca", "license", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p40_s4", "idA": "906709_12_item7_p17_s0", "sentA": "The decrease in revenue attributable to European countries for the year ended December 31, 2011 compared to the year ended December 31, 2010 and the increase in the year ended December 31, 2010 compared to the year ended December 31, 2009 is primarily attributable to the revenue we recognized from the AstraZeneca license agreement.", "sentB": "The increase in non-cash interest expense on liability related to sale of future royalties for the year ended December 31, 2012 compared to the year ended December 31, 2011 is attributable to the royalty sale transaction that we completed in 2012.", "type": 2, "words": ["<tag1>", "The", "decrease", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "and", "the", "increase", "in", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "the", "revenue", "we", "recognized", "from", "the", "AstraZeneca", "license", "agreement.", "<tag2>", "The", "increase", "in", "non-cash", "interest", "expense", "on", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "royalty", "sale", "transaction", "that", "we", "completed", "in", "2012.", "<tag3>"], "wordsA": ["The", "decrease", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "and", "the", "increase", "in", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "the", "revenue", "we", "recognized", "from", "the", "AstraZeneca", "license", "agreement."], "wordsB": ["The", "increase", "in", "non-cash", "interest", "expense", "on", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "royalty", "sale", "transaction", "that", "we", "completed", "in", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p24_s0", "idA": "906709_12_item7_p18_s0", "sentA": "The decrease in cost of goods sold during the year ended December 31, 2011 compared to the year ended December 31, 2010 is primarily due to the $2.5 million decrease in product sales in 2011 and an increase in overall commercial and proprietary manufacturing activity in 2011 compared to 2010 that resulted in decreased costs per unit.", "sentB": "Cost of goods sold increased during the year ended December 31, 2012 compared to the year ended December 31, 2011 primarily due to the $10.5 million increase in product sales in 2012.", "type": 2, "words": ["<tag1>", "The", "decrease", "in", "cost", "of", "goods", "sold", "during", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "due", "to", "the", "$2.5", "million", "decrease", "in", "product", "sales", "in", "2011", "and", "an", "increase", "in", "overall", "commercial", "and", "proprietary", "manufacturing", "activity", "in", "2011", "compared", "to", "2010", "that", "resulted", "in", "decreased", "costs", "per", "unit.", "<tag2>", "Cost", "of", "goods", "sold", "increased", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "primarily", "due", "to", "the", "$10.5", "million", "increase", "in", "product", "sales", "in", "2012.", "<tag3>"], "wordsA": ["The", "decrease", "in", "cost", "of", "goods", "sold", "during", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "due", "to", "the", "$2.5", "million", "decrease", "in", "product", "sales", "in", "2011", "and", "an", "increase", "in", "overall", "commercial", "and", "proprietary", "manufacturing", "activity", "in", "2011", "compared", "to", "2010", "that", "resulted", "in", "decreased", "costs", "per", "unit."], "wordsB": ["Cost", "of", "goods", "sold", "increased", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "primarily", "due", "to", "the", "$10.5", "million", "increase", "in", "product", "sales", "in", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p24_s1", "idA": "906709_12_item7_p18_s1", "sentA": "The increase in product gross margin during the year ended December 31, 2011 compared to the year ended December 31, 2010 is primarily due to the different mix of products sold and the decreased costs per unit in 2011 resulting from increased manufacturing activity.", "sentB": "The increase in product gross margin during the year ended December 31, 2012 compared to the year ended December 31, 2011 is primarily due to the decreased cost per unit in 2012 resulting from increased manufacturing activity, resulting in improved overhead absorption.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "product", "gross", "margin", "during", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "due", "to", "the", "different", "mix", "of", "products", "sold", "and", "the", "decreased", "costs", "per", "unit", "in", "2011", "resulting", "from", "increased", "manufacturing", "activity.", "<tag2>", "The", "increase", "in", "product", "gross", "margin", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "due", "to", "the", "decreased", "cost", "per", "unit", "in", "2012", "resulting", "from", "increased", "manufacturing", "activity,", "resulting", "in", "improved", "overhead", "absorption.", "<tag3>"], "wordsA": ["The", "increase", "in", "product", "gross", "margin", "during", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "due", "to", "the", "different", "mix", "of", "products", "sold", "and", "the", "decreased", "costs", "per", "unit", "in", "2011", "resulting", "from", "increased", "manufacturing", "activity."], "wordsB": ["The", "increase", "in", "product", "gross", "margin", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "due", "to", "the", "decreased", "cost", "per", "unit", "in", "2012", "resulting", "from", "increased", "manufacturing", "activity,", "resulting", "in", "improved", "overhead", "absorption."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p24_s4", "idA": "906709_12_item7_p19_s2", "sentA": "As a result of the fixed cost base associated with our manufacturing activities, we expect product gross margin to fluctuate in future periods depending on the level of manufacturing orders from our customers.", "sentB": "We expect product gross margin to fluctuate in future periods depending on the level and mix of manufacturing orders from our customers due to the fixed cost base associated with our manufacturing activities.", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "the", "fixed", "cost", "base", "associated", "with", "our", "manufacturing", "activities,", "we", "expect", "product", "gross", "margin", "to", "fluctuate", "in", "future", "periods", "depending", "on", "the", "level", "of", "manufacturing", "orders", "from", "our", "customers.", "<tag2>", "We", "expect", "product", "gross", "margin", "to", "fluctuate", "in", "future", "periods", "depending", "on", "the", "level", "and", "mix", "of", "manufacturing", "orders", "from", "our", "customers", "due", "to", "the", "fixed", "cost", "base", "associated", "with", "our", "manufacturing", "activities.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "the", "fixed", "cost", "base", "associated", "with", "our", "manufacturing", "activities,", "we", "expect", "product", "gross", "margin", "to", "fluctuate", "in", "future", "periods", "depending", "on", "the", "level", "of", "manufacturing", "orders", "from", "our", "customers."], "wordsB": ["We", "expect", "product", "gross", "margin", "to", "fluctuate", "in", "future", "periods", "depending", "on", "the", "level", "and", "mix", "of", "manufacturing", "orders", "from", "our", "customers", "due", "to", "the", "fixed", "cost", "base", "associated", "with", "our", "manufacturing", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p9_s6", "idA": "906709_12_item7_p1_s1", "sentA": "Additionally, we may utilize established pharmacologic targets to engineer a new drug candidate relying on a combination of the known properties of these targets and our proprietary polymer chemistry technology and expertise.", "sentB": "Under the terms of this collaboration, we are providing a license to our intellectual property and our PEGylation technology and expertise.", "type": 2, "words": ["<tag1>", "Additionally,", "we", "may", "utilize", "established", "pharmacologic", "targets", "to", "engineer", "a", "new", "drug", "candidate", "relying", "on", "a", "combination", "of", "the", "known", "properties", "of", "these", "targets", "and", "our", "proprietary", "polymer", "chemistry", "technology", "and", "expertise.", "<tag2>", "Under", "the", "terms", "of", "this", "collaboration,", "we", "are", "providing", "a", "license", "to", "our", "intellectual", "property", "and", "our", "PEGylation", "technology", "and", "expertise.", "<tag3>"], "wordsA": ["Additionally,", "we", "may", "utilize", "established", "pharmacologic", "targets", "to", "engineer", "a", "new", "drug", "candidate", "relying", "on", "a", "combination", "of", "the", "known", "properties", "of", "these", "targets", "and", "our", "proprietary", "polymer", "chemistry", "technology", "and", "expertise."], "wordsB": ["Under", "the", "terms", "of", "this", "collaboration,", "we", "are", "providing", "a", "license", "to", "our", "intellectual", "property", "and", "our", "PEGylation", "technology", "and", "expertise."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p2_s0", "idA": "906709_12_item7_p1_s2", "sentA": "Our drug candidates are designed to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability, metabolism or distribution of drugs and improve the overall benefits and use of a drug for the patient.", "sentB": "Our drug candidates are designed to improve the overall benefits and use of a drug for patients by improving the metabolism, distribution, pharmacokinetics, pharmacodynamics, half-life and/or bioavailability of drugs.", "type": 2, "words": ["<tag1>", "Our", "drug", "candidates", "are", "designed", "to", "improve", "the", "pharmacokinetics,", "pharmacodynamics,", "half-life,", "bioavailability,", "metabolism", "or", "distribution", "of", "drugs", "and", "improve", "the", "overall", "benefits", "and", "use", "of", "a", "drug", "for", "the", "patient.", "<tag2>", "Our", "drug", "candidates", "are", "designed", "to", "improve", "the", "overall", "benefits", "and", "use", "of", "a", "drug", "for", "patients", "by", "improving", "the", "metabolism,", "distribution,", "pharmacokinetics,", "pharmacodynamics,", "half-life", "and/or", "bioavailability", "of", "drugs.", "<tag3>"], "wordsA": ["Our", "drug", "candidates", "are", "designed", "to", "improve", "the", "pharmacokinetics,", "pharmacodynamics,", "half-life,", "bioavailability,", "metabolism", "or", "distribution", "of", "drugs", "and", "improve", "the", "overall", "benefits", "and", "use", "of", "a", "drug", "for", "the", "patient."], "wordsB": ["Our", "drug", "candidates", "are", "designed", "to", "improve", "the", "overall", "benefits", "and", "use", "of", "a", "drug", "for", "patients", "by", "improving", "the", "metabolism,", "distribution,", "pharmacokinetics,", "pharmacodynamics,", "half-life", "and/or", "bioavailability", "of", "drugs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p3_s0", "idA": "906709_12_item7_p1_s4", "sentA": "Our most advanced proprietary product candidate, NKTR-118, is a peripheral opioid antagonist that is currently being evaluated for the treatment of opioid-induced constipation.", "sentB": "Our most advanced proprietary product candidate, naloxegol (formerly known as NKTR-118), is a peripheral opioid antagonist which has completed Phase 3 clinical studies for the treatment of opioid-induced constipation (OIC).", "type": 2, "words": ["<tag1>", "Our", "most", "advanced", "proprietary", "product", "candidate,", "NKTR-118,", "is", "a", "peripheral", "opioid", "antagonist", "that", "is", "currently", "being", "evaluated", "for", "the", "treatment", "of", "opioid-induced", "constipation.", "<tag2>", "Our", "most", "advanced", "proprietary", "product", "candidate,", "naloxegol", "(formerly", "known", "as", "NKTR-118),", "is", "a", "peripheral", "opioid", "antagonist", "which", "has", "completed", "Phase", "3", "clinical", "studies", "for", "the", "treatment", "of", "opioid-induced", "constipation", "(OIC).", "<tag3>"], "wordsA": ["Our", "most", "advanced", "proprietary", "product", "candidate,", "NKTR-118,", "is", "a", "peripheral", "opioid", "antagonist", "that", "is", "currently", "being", "evaluated", "for", "the", "treatment", "of", "opioid-induced", "constipation."], "wordsB": ["Our", "most", "advanced", "proprietary", "product", "candidate,", "naloxegol", "(formerly", "known", "as", "NKTR-118),", "is", "a", "peripheral", "opioid", "antagonist", "which", "has", "completed", "Phase", "3", "clinical", "studies", "for", "the", "treatment", "of", "opioid-induced", "constipation", "(OIC)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p3_s1", "idA": "906709_12_item7_p1_s5", "sentA": "We are a party to an exclusive worldwide license agreement with AstraZeneca for the global development and commercialization of NKTR-118 and NKTR-119.", "sentB": "We are a party to an exclusive worldwide license agreement with AstraZeneca for the global development and commercialization of naloxegol and naloxegol fixed-dose combination products (formerly known as NKTR-119).", "type": 2, "words": ["<tag1>", "We", "are", "a", "party", "to", "an", "exclusive", "worldwide", "license", "agreement", "with", "AstraZeneca", "for", "the", "global", "development", "and", "commercialization", "of", "NKTR-118", "and", "NKTR-119.", "<tag2>", "We", "are", "a", "party", "to", "an", "exclusive", "worldwide", "license", "agreement", "with", "AstraZeneca", "for", "the", "global", "development", "and", "commercialization", "of", "naloxegol", "and", "naloxegol", "fixed-dose", "combination", "products", "(formerly", "known", "as", "NKTR-119).", "<tag3>"], "wordsA": ["We", "are", "a", "party", "to", "an", "exclusive", "worldwide", "license", "agreement", "with", "AstraZeneca", "for", "the", "global", "development", "and", "commercialization", "of", "NKTR-118", "and", "NKTR-119."], "wordsB": ["We", "are", "a", "party", "to", "an", "exclusive", "worldwide", "license", "agreement", "with", "AstraZeneca", "for", "the", "global", "development", "and", "commercialization", "of", "naloxegol", "and", "naloxegol", "fixed-dose", "combination", "products", "(formerly", "known", "as", "NKTR-119)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p25_s0", "idA": "906709_12_item7_p20_s0", "sentA": "Research and development expense consists primarily of personnel costs, including salaries, benefits, and stock-based compensation, clinical study costs, direct costs of outside research, materials, supplies, licenses and fees.", "sentB": "Research and development expense consists primarily of personnel costs (including salaries, benefits, and stock-based compensation), clinical study costs, direct costs of outside research conducted by clinical research organizations, materials, supplies, licenses and fees.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expense", "consists", "primarily", "of", "personnel", "costs,", "including", "salaries,", "benefits,", "and", "stock-based", "compensation,", "clinical", "study", "costs,", "direct", "costs", "of", "outside", "research,", "materials,", "supplies,", "licenses", "and", "fees.", "<tag2>", "Research", "and", "development", "expense", "consists", "primarily", "of", "personnel", "costs", "(including", "salaries,", "benefits,", "and", "stock-based", "compensation),", "clinical", "study", "costs,", "direct", "costs", "of", "outside", "research", "conducted", "by", "clinical", "research", "organizations,", "materials,", "supplies,", "licenses", "and", "fees.", "<tag3>"], "wordsA": ["Research", "and", "development", "expense", "consists", "primarily", "of", "personnel", "costs,", "including", "salaries,", "benefits,", "and", "stock-based", "compensation,", "clinical", "study", "costs,", "direct", "costs", "of", "outside", "research,", "materials,", "supplies,", "licenses", "and", "fees."], "wordsB": ["Research", "and", "development", "expense", "consists", "primarily", "of", "personnel", "costs", "(including", "salaries,", "benefits,", "and", "stock-based", "compensation),", "clinical", "study", "costs,", "direct", "costs", "of", "outside", "research", "conducted", "by", "clinical", "research", "organizations,", "materials,", "supplies,", "licenses", "and", "fees."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p25_s4", "idA": "906709_12_item7_p20_s2", "sentA": "The increase in research and development expense for the year ended December 31, 2011 compared to the year ended December 31, 2010 is primarily attributable to a $7.5 million increase in direct research and development program costs and related materials costs, a $3.0 million increase in salaries and employee benefits resulting from increased headcount to support our expanded clinical efforts, and a $6.3 million increase in support and facilities-related costs, which includes increased non-cash depreciation and non-cash rent expenses related to our new facility in the Mission Bay Area of San Francisco, California (Mission Bay Facility).", "sentB": "The increase in research and development expense for the year ended December 31, 2011 compared to the year ended December 31, 2010 is primarily attributable to a $7.5 million increase in direct research and development program and materials costs, a $3.0 million increase in salaries and employee benefits, and a $6.3 million increase in support and facilities-related costs, which includes increased non-cash depreciation and non-cash rent expenses related to the move to our facility in the Mission Bay Area of San Francisco, California (Mission Bay Facility) at the end of 2010.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "research", "and", "development", "expense", "for", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "attributable", "to", "a", "$7.5", "million", "increase", "in", "direct", "research", "and", "development", "program", "costs", "and", "related", "materials", "costs,", "a", "$3.0", "million", "increase", "in", "salaries", "and", "employee", "benefits", "resulting", "from", "increased", "headcount", "to", "support", "our", "expanded", "clinical", "efforts,", "and", "a", "$6.3", "million", "increase", "in", "support", "and", "facilities-related", "costs,", "which", "includes", "increased", "non-cash", "depreciation", "and", "non-cash", "rent", "expenses", "related", "to", "our", "new", "facility", "in", "the", "Mission", "Bay", "Area", "of", "San", "Francisco,", "California", "(Mission", "Bay", "Facility).", "<tag2>", "The", "increase", "in", "research", "and", "development", "expense", "for", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "attributable", "to", "a", "$7.5", "million", "increase", "in", "direct", "research", "and", "development", "program", "and", "materials", "costs,", "a", "$3.0", "million", "increase", "in", "salaries", "and", "employee", "benefits,", "and", "a", "$6.3", "million", "increase", "in", "support", "and", "facilities-related", "costs,", "which", "includes", "increased", "non-cash", "depreciation", "and", "non-cash", "rent", "expenses", "related", "to", "the", "move", "to", "our", "facility", "in", "the", "Mission", "Bay", "Area", "of", "San", "Francisco,", "California", "(Mission", "Bay", "Facility)", "at", "the", "end", "of", "2010.", "<tag3>"], "wordsA": ["The", "increase", "in", "research", "and", "development", "expense", "for", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "attributable", "to", "a", "$7.5", "million", "increase", "in", "direct", "research", "and", "development", "program", "costs", "and", "related", "materials", "costs,", "a", "$3.0", "million", "increase", "in", "salaries", "and", "employee", "benefits", "resulting", "from", "increased", "headcount", "to", "support", "our", "expanded", "clinical", "efforts,", "and", "a", "$6.3", "million", "increase", "in", "support", "and", "facilities-related", "costs,", "which", "includes", "increased", "non-cash", "depreciation", "and", "non-cash", "rent", "expenses", "related", "to", "our", "new", "facility", "in", "the", "Mission", "Bay", "Area", "of", "San", "Francisco,", "California", "(Mission", "Bay", "Facility)."], "wordsB": ["The", "increase", "in", "research", "and", "development", "expense", "for", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "attributable", "to", "a", "$7.5", "million", "increase", "in", "direct", "research", "and", "development", "program", "and", "materials", "costs,", "a", "$3.0", "million", "increase", "in", "salaries", "and", "employee", "benefits,", "and", "a", "$6.3", "million", "increase", "in", "support", "and", "facilities-related", "costs,", "which", "includes", "increased", "non-cash", "depreciation", "and", "non-cash", "rent", "expenses", "related", "to", "the", "move", "to", "our", "facility", "in", "the", "Mission", "Bay", "Area", "of", "San", "Francisco,", "California", "(Mission", "Bay", "Facility)", "at", "the", "end", "of", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p25_s2", "idA": "906709_12_item7_p20_s3", "sentA": "The increase in research and development expense for the year ended December 31, 2010 compared to the year ended December 31, 2009 is primarily attributable to an $8.4 million increase in salaries and employee benefits due to increased headcount to support our expanded clinical development efforts and further investment in and development of proprietary drug candidates in our research and development pipeline.", "sentB": "The increase in research and development expense for the year ended December 31, 2012 compared to the year ended December 31, 2011 is primarily attributable to the $15.2 million increase in direct research and development program costs, a substantial portion of which is attributable to the etirinotecan pegol (NKTR-102) Phase 3 BEACON clinical study initiated in December 2011 as well as the NKTR-181 Phase 2 clinical study initiated in July 2012.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "research", "and", "development", "expense", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "an", "$8.4", "million", "increase", "in", "salaries", "and", "employee", "benefits", "due", "to", "increased", "headcount", "to", "support", "our", "expanded", "clinical", "development", "efforts", "and", "further", "investment", "in", "and", "development", "of", "proprietary", "drug", "candidates", "in", "our", "research", "and", "development", "pipeline.", "<tag2>", "The", "increase", "in", "research", "and", "development", "expense", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "attributable", "to", "the", "$15.2", "million", "increase", "in", "direct", "research", "and", "development", "program", "costs,", "a", "substantial", "portion", "of", "which", "is", "attributable", "to", "the", "etirinotecan", "pegol", "(NKTR-102)", "Phase", "3", "BEACON", "clinical", "study", "initiated", "in", "December", "2011", "as", "well", "as", "the", "NKTR-181", "Phase", "2", "clinical", "study", "initiated", "in", "July", "2012.", "<tag3>"], "wordsA": ["The", "increase", "in", "research", "and", "development", "expense", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "an", "$8.4", "million", "increase", "in", "salaries", "and", "employee", "benefits", "due", "to", "increased", "headcount", "to", "support", "our", "expanded", "clinical", "development", "efforts", "and", "further", "investment", "in", "and", "development", "of", "proprietary", "drug", "candidates", "in", "our", "research", "and", "development", "pipeline."], "wordsB": ["The", "increase", "in", "research", "and", "development", "expense", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "attributable", "to", "the", "$15.2", "million", "increase", "in", "direct", "research", "and", "development", "program", "costs,", "a", "substantial", "portion", "of", "which", "is", "attributable", "to", "the", "etirinotecan", "pegol", "(NKTR-102)", "Phase", "3", "BEACON", "clinical", "study", "initiated", "in", "December", "2011", "as", "well", "as", "the", "NKTR-181", "Phase", "2", "clinical", "study", "initiated", "in", "July", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p25_s3", "idA": "906709_12_item7_p20_s3", "sentA": "The increase in research and development expense for the year ended December 31, 2010 compared to the year ended December 31, 2009 is primarily attributable to an $8.4 million increase in salaries and employee benefits due to increased headcount to support our expanded clinical development efforts and further investment in and development of proprietary drug candidates in our research and development pipeline.", "sentB": "In addition, research and development expense increased due to a $6.2 million increase in salaries and employee benefits resulting from increased headcount to support our expanded clinical development activities.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "research", "and", "development", "expense", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "an", "$8.4", "million", "increase", "in", "salaries", "and", "employee", "benefits", "due", "to", "increased", "headcount", "to", "support", "our", "expanded", "clinical", "development", "efforts", "and", "further", "investment", "in", "and", "development", "of", "proprietary", "drug", "candidates", "in", "our", "research", "and", "development", "pipeline.", "<tag2>", "In", "addition,", "research", "and", "development", "expense", "increased", "due", "to", "a", "$6.2", "million", "increase", "in", "salaries", "and", "employee", "benefits", "resulting", "from", "increased", "headcount", "to", "support", "our", "expanded", "clinical", "development", "activities.", "<tag3>"], "wordsA": ["The", "increase", "in", "research", "and", "development", "expense", "for", "the", "year", "ended", "December", "31,", "2010", "compared", "to", "the", "year", "ended", "December", "31,", "2009", "is", "primarily", "attributable", "to", "an", "$8.4", "million", "increase", "in", "salaries", "and", "employee", "benefits", "due", "to", "increased", "headcount", "to", "support", "our", "expanded", "clinical", "development", "efforts", "and", "further", "investment", "in", "and", "development", "of", "proprietary", "drug", "candidates", "in", "our", "research", "and", "development", "pipeline."], "wordsB": ["In", "addition,", "research", "and", "development", "expense", "increased", "due", "to", "a", "$6.2", "million", "increase", "in", "salaries", "and", "employee", "benefits", "resulting", "from", "increased", "headcount", "to", "support", "our", "expanded", "clinical", "development", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p26_s0", "idA": "906709_12_item7_p21_s0", "sentA": "We utilize our employee and infrastructure resources across multiple development projects as well as our research programs directed towards identifying drug candidates based on our technology platform.", "sentB": "We utilize our employee and infrastructure resources across multiple development and research programs.", "type": 2, "words": ["<tag1>", "We", "utilize", "our", "employee", "and", "infrastructure", "resources", "across", "multiple", "development", "projects", "as", "well", "as", "our", "research", "programs", "directed", "towards", "identifying", "drug", "candidates", "based", "on", "our", "technology", "platform.", "<tag2>", "We", "utilize", "our", "employee", "and", "infrastructure", "resources", "across", "multiple", "development", "and", "research", "programs.", "<tag3>"], "wordsA": ["We", "utilize", "our", "employee", "and", "infrastructure", "resources", "across", "multiple", "development", "projects", "as", "well", "as", "our", "research", "programs", "directed", "towards", "identifying", "drug", "candidates", "based", "on", "our", "technology", "platform."], "wordsB": ["We", "utilize", "our", "employee", "and", "infrastructure", "resources", "across", "multiple", "development", "and", "research", "programs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p67_s3", "idA": "906709_12_item7_p21_s0", "sentA": "We utilize our employee and infrastructure resources across multiple development projects as well as our research programs directed towards identifying drug candidates based on our technology platform.", "sentB": "Circumstances may change and additional data may become available over time, which could result in changes to the assumptions and methodologies, and which could materially impact our fair value determination, as well as our stock-based compensation expense.", "type": 2, "words": ["<tag1>", "We", "utilize", "our", "employee", "and", "infrastructure", "resources", "across", "multiple", "development", "projects", "as", "well", "as", "our", "research", "programs", "directed", "towards", "identifying", "drug", "candidates", "based", "on", "our", "technology", "platform.", "<tag2>", "Circumstances", "may", "change", "and", "additional", "data", "may", "become", "available", "over", "time,", "which", "could", "result", "in", "changes", "to", "the", "assumptions", "and", "methodologies,", "and", "which", "could", "materially", "impact", "our", "fair", "value", "determination,", "as", "well", "as", "our", "stock-based", "compensation", "expense.", "<tag3>"], "wordsA": ["We", "utilize", "our", "employee", "and", "infrastructure", "resources", "across", "multiple", "development", "projects", "as", "well", "as", "our", "research", "programs", "directed", "towards", "identifying", "drug", "candidates", "based", "on", "our", "technology", "platform."], "wordsB": ["Circumstances", "may", "change", "and", "additional", "data", "may", "become", "available", "over", "time,", "which", "could", "result", "in", "changes", "to", "the", "assumptions", "and", "methodologies,", "and", "which", "could", "materially", "impact", "our", "fair", "value", "determination,", "as", "well", "as", "our", "stock-based", "compensation", "expense."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p27_s0", "idA": "906709_12_item7_p21_s1", "sentA": "The following table shows expenses incurred for preclinical study support, contract manufacturing for clinical supplies, clinical and regulatory services provided by third parties and direct materials costs for each of our drug candidates.", "sentB": "The following table shows expenses incurred for preclinical study support, clinical supplies, clinical and regulatory services provided by third parties and direct materials costs for each of our drug candidates.", "type": 2, "words": ["<tag1>", "The", "following", "table", "shows", "expenses", "incurred", "for", "preclinical", "study", "support,", "contract", "manufacturing", "for", "clinical", "supplies,", "clinical", "and", "regulatory", "services", "provided", "by", "third", "parties", "and", "direct", "materials", "costs", "for", "each", "of", "our", "drug", "candidates.", "<tag2>", "The", "following", "table", "shows", "expenses", "incurred", "for", "preclinical", "study", "support,", "clinical", "supplies,", "clinical", "and", "regulatory", "services", "provided", "by", "third", "parties", "and", "direct", "materials", "costs", "for", "each", "of", "our", "drug", "candidates.", "<tag3>"], "wordsA": ["The", "following", "table", "shows", "expenses", "incurred", "for", "preclinical", "study", "support,", "contract", "manufacturing", "for", "clinical", "supplies,", "clinical", "and", "regulatory", "services", "provided", "by", "third", "parties", "and", "direct", "materials", "costs", "for", "each", "of", "our", "drug", "candidates."], "wordsB": ["The", "following", "table", "shows", "expenses", "incurred", "for", "preclinical", "study", "support,", "clinical", "supplies,", "clinical", "and", "regulatory", "services", "provided", "by", "third", "parties", "and", "direct", "materials", "costs", "for", "each", "of", "our", "drug", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p63_s0", "idA": "906709_12_item7_p21_s1", "sentA": "The following table shows expenses incurred for preclinical study support, contract manufacturing for clinical supplies, clinical and regulatory services provided by third parties and direct materials costs for each of our drug candidates.", "sentB": "Clinical Trial Accruals We record accruals for the estimated costs of our clinical study activities performed by third parties.", "type": 2, "words": ["<tag1>", "The", "following", "table", "shows", "expenses", "incurred", "for", "preclinical", "study", "support,", "contract", "manufacturing", "for", "clinical", "supplies,", "clinical", "and", "regulatory", "services", "provided", "by", "third", "parties", "and", "direct", "materials", "costs", "for", "each", "of", "our", "drug", "candidates.", "<tag2>", "Clinical", "Trial", "Accruals", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "study", "activities", "performed", "by", "third", "parties.", "<tag3>"], "wordsA": ["The", "following", "table", "shows", "expenses", "incurred", "for", "preclinical", "study", "support,", "contract", "manufacturing", "for", "clinical", "supplies,", "clinical", "and", "regulatory", "services", "provided", "by", "third", "parties", "and", "direct", "materials", "costs", "for", "each", "of", "our", "drug", "candidates."], "wordsB": ["Clinical", "Trial", "Accruals", "We", "record", "accruals", "for", "the", "estimated", "costs", "of", "our", "clinical", "study", "activities", "performed", "by", "third", "parties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p30_s0", "idA": "906709_12_item7_p23_s0", "sentA": "(3) Partnered with Bayer Healthcare LLC in August 2007.", "sentB": "(3) We partnered this program with Bayer Healthcare LLC in August 2007.", "type": 2, "words": ["<tag1>", "(3)", "Partnered", "with", "Bayer", "Healthcare", "LLC", "in", "August", "2007.", "<tag2>", "(3)", "We", "partnered", "this", "program", "with", "Bayer", "Healthcare", "LLC", "in", "August", "2007.", "<tag3>"], "wordsA": ["(3)", "Partnered", "with", "Bayer", "Healthcare", "LLC", "in", "August", "2007."], "wordsB": ["(3)", "We", "partnered", "this", "program", "with", "Bayer", "Healthcare", "LLC", "in", "August", "2007."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p9_s1", "idA": "906709_12_item7_p23_s0", "sentA": "(3) Partnered with Bayer Healthcare LLC in August 2007.", "sentB": "We originally developed the liquid aerosol inhalation platform and Amikacin Inhale and entered into a collaboration agreement with Bayer in August 2007 to further advance the drug candidate s development and potential commercialization.", "type": 2, "words": ["<tag1>", "(3)", "Partnered", "with", "Bayer", "Healthcare", "LLC", "in", "August", "2007.", "<tag2>", "We", "originally", "developed", "the", "liquid", "aerosol", "inhalation", "platform", "and", "Amikacin", "Inhale", "and", "entered", "into", "a", "collaboration", "agreement", "with", "Bayer", "in", "August", "2007", "to", "further", "advance", "the", "drug", "candidate", "s", "development", "and", "potential", "commercialization.", "<tag3>"], "wordsA": ["(3)", "Partnered", "with", "Bayer", "Healthcare", "LLC", "in", "August", "2007."], "wordsB": ["We", "originally", "developed", "the", "liquid", "aerosol", "inhalation", "platform", "and", "Amikacin", "Inhale", "and", "entered", "into", "a", "collaboration", "agreement", "with", "Bayer", "in", "August", "2007", "to", "further", "advance", "the", "drug", "candidate", "s", "development", "and", "potential", "commercialization."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p30_s1", "idA": "906709_12_item7_p23_s1", "sentA": "As part of the Novartis Pulmonary Asset Sale, we retained an exclusive license to this technology for the development and commercialization of this drug candidate.", "sentB": "As part of the Novartis Pulmonary Asset Sale in 2008, we retained an exclusive license to this technology for the development and commercialization of this drug candidate.", "type": 2, "words": ["<tag1>", "As", "part", "of", "the", "Novartis", "Pulmonary", "Asset", "Sale,", "we", "retained", "an", "exclusive", "license", "to", "this", "technology", "for", "the", "development", "and", "commercialization", "of", "this", "drug", "candidate.", "<tag2>", "As", "part", "of", "the", "Novartis", "Pulmonary", "Asset", "Sale", "in", "2008,", "we", "retained", "an", "exclusive", "license", "to", "this", "technology", "for", "the", "development", "and", "commercialization", "of", "this", "drug", "candidate.", "<tag3>"], "wordsA": ["As", "part", "of", "the", "Novartis", "Pulmonary", "Asset", "Sale,", "we", "retained", "an", "exclusive", "license", "to", "this", "technology", "for", "the", "development", "and", "commercialization", "of", "this", "drug", "candidate."], "wordsB": ["As", "part", "of", "the", "Novartis", "Pulmonary", "Asset", "Sale", "in", "2008,", "we", "retained", "an", "exclusive", "license", "to", "this", "technology", "for", "the", "development", "and", "commercialization", "of", "this", "drug", "candidate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p31_s0", "idA": "906709_12_item7_p24_s0", "sentA": "(4) Partnered with AstraZeneca in 2009.", "sentB": "(4) We partnered this program with AstraZeneca AB (AstraZeneca) in 2009.", "type": 2, "words": ["<tag1>", "(4)", "Partnered", "with", "AstraZeneca", "in", "2009.", "<tag2>", "(4)", "We", "partnered", "this", "program", "with", "AstraZeneca", "AB", "(AstraZeneca)", "in", "2009.", "<tag3>"], "wordsA": ["(4)", "Partnered", "with", "AstraZeneca", "in", "2009."], "wordsB": ["(4)", "We", "partnered", "this", "program", "with", "AstraZeneca", "AB", "(AstraZeneca)", "in", "2009."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p32_s7", "idA": "906709_12_item7_p24_s10", "sentA": "We are unable to estimate the dates or costs to complete the clinical development efforts for the ovarian and colorectal cancer indications in which we are studying NKTR-102.", "sentB": "We are unable to estimate the timing or costs to complete the clinical development for etirinotecan pegol across all the potential oncology indications.", "type": 2, "words": ["<tag1>", "We", "are", "unable", "to", "estimate", "the", "dates", "or", "costs", "to", "complete", "the", "clinical", "development", "efforts", "for", "the", "ovarian", "and", "colorectal", "cancer", "indications", "in", "which", "we", "are", "studying", "NKTR-102.", "<tag2>", "We", "are", "unable", "to", "estimate", "the", "timing", "or", "costs", "to", "complete", "the", "clinical", "development", "for", "etirinotecan", "pegol", "across", "all", "the", "potential", "oncology", "indications.", "<tag3>"], "wordsA": ["We", "are", "unable", "to", "estimate", "the", "dates", "or", "costs", "to", "complete", "the", "clinical", "development", "efforts", "for", "the", "ovarian", "and", "colorectal", "cancer", "indications", "in", "which", "we", "are", "studying", "NKTR-102."], "wordsB": ["We", "are", "unable", "to", "estimate", "the", "timing", "or", "costs", "to", "complete", "the", "clinical", "development", "for", "etirinotecan", "pegol", "across", "all", "the", "potential", "oncology", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p32_s0", "idA": "906709_12_item7_p24_s2", "sentA": "We expect research and development expense to substantially increase over the next several years.", "sentB": "We expect research and development expense to increase in 2013 as compared to 2012 and to continue at or above the 2012 level for the next several years.", "type": 2, "words": ["<tag1>", "We", "expect", "research", "and", "development", "expense", "to", "substantially", "increase", "over", "the", "next", "several", "years.", "<tag2>", "We", "expect", "research", "and", "development", "expense", "to", "increase", "in", "2013", "as", "compared", "to", "2012", "and", "to", "continue", "at", "or", "above", "the", "2012", "level", "for", "the", "next", "several", "years.", "<tag3>"], "wordsA": ["We", "expect", "research", "and", "development", "expense", "to", "substantially", "increase", "over", "the", "next", "several", "years."], "wordsB": ["We", "expect", "research", "and", "development", "expense", "to", "increase", "in", "2013", "as", "compared", "to", "2012", "and", "to", "continue", "at", "or", "above", "the", "2012", "level", "for", "the", "next", "several", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p32_s1", "idA": "906709_12_item7_p24_s3", "sentA": "We plan to continue to advance NKTR-102 in the BEACON study (metastatic breast cancer) and in Phase 2 clinical studies in ovarian and colorectal cancers.", "sentB": "We plan to continue to advance etirinotecan pegol in the Phase 3 BEACON study for metastatic breast cancer for which we expect patient enrollment to continue throughout 2013 and the clinical study to continue through 2014.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "continue", "to", "advance", "NKTR-102", "in", "the", "BEACON", "study", "(metastatic", "breast", "cancer)", "and", "in", "Phase", "2", "clinical", "studies", "in", "ovarian", "and", "colorectal", "cancers.", "<tag2>", "We", "plan", "to", "continue", "to", "advance", "etirinotecan", "pegol", "in", "the", "Phase", "3", "BEACON", "study", "for", "metastatic", "breast", "cancer", "for", "which", "we", "expect", "patient", "enrollment", "to", "continue", "throughout", "2013", "and", "the", "clinical", "study", "to", "continue", "through", "2014.", "<tag3>"], "wordsA": ["We", "plan", "to", "continue", "to", "advance", "NKTR-102", "in", "the", "BEACON", "study", "(metastatic", "breast", "cancer)", "and", "in", "Phase", "2", "clinical", "studies", "in", "ovarian", "and", "colorectal", "cancers."], "wordsB": ["We", "plan", "to", "continue", "to", "advance", "etirinotecan", "pegol", "in", "the", "Phase", "3", "BEACON", "study", "for", "metastatic", "breast", "cancer", "for", "which", "we", "expect", "patient", "enrollment", "to", "continue", "throughout", "2013", "and", "the", "clinical", "study", "to", "continue", "through", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p32_s10", "idA": "906709_12_item7_p24_s3", "sentA": "We plan to continue to advance NKTR-102 in the BEACON study (metastatic breast cancer) and in Phase 2 clinical studies in ovarian and colorectal cancers.", "sentB": "We also plan to continue to advance the development of NKTR-192.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "continue", "to", "advance", "NKTR-102", "in", "the", "BEACON", "study", "(metastatic", "breast", "cancer)", "and", "in", "Phase", "2", "clinical", "studies", "in", "ovarian", "and", "colorectal", "cancers.", "<tag2>", "We", "also", "plan", "to", "continue", "to", "advance", "the", "development", "of", "NKTR-192.", "<tag3>"], "wordsA": ["We", "plan", "to", "continue", "to", "advance", "NKTR-102", "in", "the", "BEACON", "study", "(metastatic", "breast", "cancer)", "and", "in", "Phase", "2", "clinical", "studies", "in", "ovarian", "and", "colorectal", "cancers."], "wordsB": ["We", "also", "plan", "to", "continue", "to", "advance", "the", "development", "of", "NKTR-192."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p53_s3", "idA": "906709_12_item7_p24_s3", "sentA": "We plan to continue to advance NKTR-102 in the BEACON study (metastatic breast cancer) and in Phase 2 clinical studies in ovarian and colorectal cancers.", "sentB": "We plan to continue to invest in the advancement of our research and development drug candidate pipeline and our future cash requirements will depend upon the timing and results of these investments.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "continue", "to", "advance", "NKTR-102", "in", "the", "BEACON", "study", "(metastatic", "breast", "cancer)", "and", "in", "Phase", "2", "clinical", "studies", "in", "ovarian", "and", "colorectal", "cancers.", "<tag2>", "We", "plan", "to", "continue", "to", "invest", "in", "the", "advancement", "of", "our", "research", "and", "development", "drug", "candidate", "pipeline", "and", "our", "future", "cash", "requirements", "will", "depend", "upon", "the", "timing", "and", "results", "of", "these", "investments.", "<tag3>"], "wordsA": ["We", "plan", "to", "continue", "to", "advance", "NKTR-102", "in", "the", "BEACON", "study", "(metastatic", "breast", "cancer)", "and", "in", "Phase", "2", "clinical", "studies", "in", "ovarian", "and", "colorectal", "cancers."], "wordsB": ["We", "plan", "to", "continue", "to", "invest", "in", "the", "advancement", "of", "our", "research", "and", "development", "drug", "candidate", "pipeline", "and", "our", "future", "cash", "requirements", "will", "depend", "upon", "the", "timing", "and", "results", "of", "these", "investments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p32_s3", "idA": "906709_12_item7_p24_s6", "sentA": "At the same time, we continue to advance the Phase 2 clinical study for NKTR-102 in colorectal cancer patients.", "sentB": "At the same time, we continue to advance the Phase 2 clinical study for etirinotecan pegol in colorectal cancer patients.", "type": 2, "words": ["<tag1>", "At", "the", "same", "time,", "we", "continue", "to", "advance", "the", "Phase", "2", "clinical", "study", "for", "NKTR-102", "in", "colorectal", "cancer", "patients.", "<tag2>", "At", "the", "same", "time,", "we", "continue", "to", "advance", "the", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "colorectal", "cancer", "patients.", "<tag3>"], "wordsA": ["At", "the", "same", "time,", "we", "continue", "to", "advance", "the", "Phase", "2", "clinical", "study", "for", "NKTR-102", "in", "colorectal", "cancer", "patients."], "wordsB": ["At", "the", "same", "time,", "we", "continue", "to", "advance", "the", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "colorectal", "cancer", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p32_s4", "idA": "906709_12_item7_p24_s7", "sentA": "We will be funding all of the clinical development costs for NKTR-102 without reimbursement from a collaboration partner for the foreseeable future.", "sentB": "Our current plan is to fund all of the clinical development costs for etirinotecan pegol for the foreseeable future without reimbursement from a collaboration partner.", "type": 2, "words": ["<tag1>", "We", "will", "be", "funding", "all", "of", "the", "clinical", "development", "costs", "for", "NKTR-102", "without", "reimbursement", "from", "a", "collaboration", "partner", "for", "the", "foreseeable", "future.", "<tag2>", "Our", "current", "plan", "is", "to", "fund", "all", "of", "the", "clinical", "development", "costs", "for", "etirinotecan", "pegol", "for", "the", "foreseeable", "future", "without", "reimbursement", "from", "a", "collaboration", "partner.", "<tag3>"], "wordsA": ["We", "will", "be", "funding", "all", "of", "the", "clinical", "development", "costs", "for", "NKTR-102", "without", "reimbursement", "from", "a", "collaboration", "partner", "for", "the", "foreseeable", "future."], "wordsB": ["Our", "current", "plan", "is", "to", "fund", "all", "of", "the", "clinical", "development", "costs", "for", "etirinotecan", "pegol", "for", "the", "foreseeable", "future", "without", "reimbursement", "from", "a", "collaboration", "partner."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p32_s5", "idA": "906709_12_item7_p24_s8", "sentA": "The clinical development costs for NKTR-102 will be significant.", "sentB": "The clinical development costs for the BEACON clinical study will continue to be significant.", "type": 2, "words": ["<tag1>", "The", "clinical", "development", "costs", "for", "NKTR-102", "will", "be", "significant.", "<tag2>", "The", "clinical", "development", "costs", "for", "the", "BEACON", "clinical", "study", "will", "continue", "to", "be", "significant.", "<tag3>"], "wordsA": ["The", "clinical", "development", "costs", "for", "NKTR-102", "will", "be", "significant."], "wordsB": ["The", "clinical", "development", "costs", "for", "the", "BEACON", "clinical", "study", "will", "continue", "to", "be", "significant."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p32_s6", "idA": "906709_12_item7_p24_s9", "sentA": "Although we are still in the early stages of the BEACON study, we estimate that the total third party and direct material costs over the life of the BEACON study will range from approximately $110.0 million to $120.0 million, of which $14.0 million was paid as of December 31, 2011, and that it will be completed around the end of 2014.", "sentB": "We estimate that the total third party and direct material costs over the life of the BEACON study will range from approximately $110.0 million to $120.0 million, of which $26.0 million was incurred through the end of 2012.", "type": 2, "words": ["<tag1>", "Although", "we", "are", "still", "in", "the", "early", "stages", "of", "the", "BEACON", "study,", "we", "estimate", "that", "the", "total", "third", "party", "and", "direct", "material", "costs", "over", "the", "life", "of", "the", "BEACON", "study", "will", "range", "from", "approximately", "$110.0", "million", "to", "$120.0", "million,", "of", "which", "$14.0", "million", "was", "paid", "as", "of", "December", "31,", "2011,", "and", "that", "it", "will", "be", "completed", "around", "the", "end", "of", "2014.", "<tag2>", "We", "estimate", "that", "the", "total", "third", "party", "and", "direct", "material", "costs", "over", "the", "life", "of", "the", "BEACON", "study", "will", "range", "from", "approximately", "$110.0", "million", "to", "$120.0", "million,", "of", "which", "$26.0", "million", "was", "incurred", "through", "the", "end", "of", "2012.", "<tag3>"], "wordsA": ["Although", "we", "are", "still", "in", "the", "early", "stages", "of", "the", "BEACON", "study,", "we", "estimate", "that", "the", "total", "third", "party", "and", "direct", "material", "costs", "over", "the", "life", "of", "the", "BEACON", "study", "will", "range", "from", "approximately", "$110.0", "million", "to", "$120.0", "million,", "of", "which", "$14.0", "million", "was", "paid", "as", "of", "December", "31,", "2011,", "and", "that", "it", "will", "be", "completed", "around", "the", "end", "of", "2014."], "wordsB": ["We", "estimate", "that", "the", "total", "third", "party", "and", "direct", "material", "costs", "over", "the", "life", "of", "the", "BEACON", "study", "will", "range", "from", "approximately", "$110.0", "million", "to", "$120.0", "million,", "of", "which", "$26.0", "million", "was", "incurred", "through", "the", "end", "of", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p13_s1", "idA": "906709_12_item7_p25_s0", "sentA": "In addition to our NKTR-102 development activities, in 2012, we plan to initiate a Phase 2 clinical study for NKTR-181 that we expect to complete in 2013.", "sentB": "For example, in April 2012 we advanced NKTR-192, our short-acting opioid drug candidate, into Phase 1 clinical studies and in July 2012 we advanced NKTR-181 into a Phase 2 clinical study and plan to conduct a human abuse liability study for NKTR-181 in the first half of 2013.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "our", "NKTR-102", "development", "activities,", "in", "2012,", "we", "plan", "to", "initiate", "a", "Phase", "2", "clinical", "study", "for", "NKTR-181", "that", "we", "expect", "to", "complete", "in", "2013.", "<tag2>", "For", "example,", "in", "April", "2012", "we", "advanced", "NKTR-192,", "our", "short-acting", "opioid", "drug", "candidate,", "into", "Phase", "1", "clinical", "studies", "and", "in", "July", "2012", "we", "advanced", "NKTR-181", "into", "a", "Phase", "2", "clinical", "study", "and", "plan", "to", "conduct", "a", "human", "abuse", "liability", "study", "for", "NKTR-181", "in", "the", "first", "half", "of", "2013.", "<tag3>"], "wordsA": ["In", "addition", "to", "our", "NKTR-102", "development", "activities,", "in", "2012,", "we", "plan", "to", "initiate", "a", "Phase", "2", "clinical", "study", "for", "NKTR-181", "that", "we", "expect", "to", "complete", "in", "2013."], "wordsB": ["For", "example,", "in", "April", "2012", "we", "advanced", "NKTR-192,", "our", "short-acting", "opioid", "drug", "candidate,", "into", "Phase", "1", "clinical", "studies", "and", "in", "July", "2012", "we", "advanced", "NKTR-181", "into", "a", "Phase", "2", "clinical", "study", "and", "plan", "to", "conduct", "a", "human", "abuse", "liability", "study", "for", "NKTR-181", "in", "the", "first", "half", "of", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p32_s8", "idA": "906709_12_item7_p25_s0", "sentA": "In addition to our NKTR-102 development activities, in 2012, we plan to initiate a Phase 2 clinical study for NKTR-181 that we expect to complete in 2013.", "sentB": "In addition to our etirinotecan pegol development activities, in 2013, we plan to continue to enroll the ongoing Phase 2 clinical study for NKTR-181 and also initiate and complete a human abuse liability study for NKTR-181.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "our", "NKTR-102", "development", "activities,", "in", "2012,", "we", "plan", "to", "initiate", "a", "Phase", "2", "clinical", "study", "for", "NKTR-181", "that", "we", "expect", "to", "complete", "in", "2013.", "<tag2>", "In", "addition", "to", "our", "etirinotecan", "pegol", "development", "activities,", "in", "2013,", "we", "plan", "to", "continue", "to", "enroll", "the", "ongoing", "Phase", "2", "clinical", "study", "for", "NKTR-181", "and", "also", "initiate", "and", "complete", "a", "human", "abuse", "liability", "study", "for", "NKTR-181.", "<tag3>"], "wordsA": ["In", "addition", "to", "our", "NKTR-102", "development", "activities,", "in", "2012,", "we", "plan", "to", "initiate", "a", "Phase", "2", "clinical", "study", "for", "NKTR-181", "that", "we", "expect", "to", "complete", "in", "2013."], "wordsB": ["In", "addition", "to", "our", "etirinotecan", "pegol", "development", "activities,", "in", "2013,", "we", "plan", "to", "continue", "to", "enroll", "the", "ongoing", "Phase", "2", "clinical", "study", "for", "NKTR-181", "and", "also", "initiate", "and", "complete", "a", "human", "abuse", "liability", "study", "for", "NKTR-181."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p32_s9", "idA": "906709_12_item7_p25_s0", "sentA": "In addition to our NKTR-102 development activities, in 2012, we plan to initiate a Phase 2 clinical study for NKTR-181 that we expect to complete in 2013.", "sentB": "Further, if the Phase 2 clinical results are successful, we plan to begin preparations for the commencement of Phase 3 clinical studies for NKTR-181.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "our", "NKTR-102", "development", "activities,", "in", "2012,", "we", "plan", "to", "initiate", "a", "Phase", "2", "clinical", "study", "for", "NKTR-181", "that", "we", "expect", "to", "complete", "in", "2013.", "<tag2>", "Further,", "if", "the", "Phase", "2", "clinical", "results", "are", "successful,", "we", "plan", "to", "begin", "preparations", "for", "the", "commencement", "of", "Phase", "3", "clinical", "studies", "for", "NKTR-181.", "<tag3>"], "wordsA": ["In", "addition", "to", "our", "NKTR-102", "development", "activities,", "in", "2012,", "we", "plan", "to", "initiate", "a", "Phase", "2", "clinical", "study", "for", "NKTR-181", "that", "we", "expect", "to", "complete", "in", "2013."], "wordsB": ["Further,", "if", "the", "Phase", "2", "clinical", "results", "are", "successful,", "we", "plan", "to", "begin", "preparations", "for", "the", "commencement", "of", "Phase", "3", "clinical", "studies", "for", "NKTR-181."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p10_s0", "idA": "906709_12_item7_p25_s3", "sentA": "Under our collaboration agreement with Bayer, we are responsible for all clinical and commercial supply of the nebulizer devices for Amikacin Inhale.", "sentB": "Baxter is responsible for all clinical development.", "type": 2, "words": ["<tag1>", "Under", "our", "collaboration", "agreement", "with", "Bayer,", "we", "are", "responsible", "for", "all", "clinical", "and", "commercial", "supply", "of", "the", "nebulizer", "devices", "for", "Amikacin", "Inhale.", "<tag2>", "Baxter", "is", "responsible", "for", "all", "clinical", "development.", "<tag3>"], "wordsA": ["Under", "our", "collaboration", "agreement", "with", "Bayer,", "we", "are", "responsible", "for", "all", "clinical", "and", "commercial", "supply", "of", "the", "nebulizer", "devices", "for", "Amikacin", "Inhale."], "wordsB": ["Baxter", "is", "responsible", "for", "all", "clinical", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p32_s13", "idA": "906709_12_item7_p25_s3", "sentA": "Under our collaboration agreement with Bayer, we are responsible for all clinical and commercial supply of the nebulizer devices for Amikacin Inhale.", "sentB": "Under our collaboration agreement with Bayer, we are responsible for all clinical and commercial supply of the nebulizer devices for this drug candidate.", "type": 2, "words": ["<tag1>", "Under", "our", "collaboration", "agreement", "with", "Bayer,", "we", "are", "responsible", "for", "all", "clinical", "and", "commercial", "supply", "of", "the", "nebulizer", "devices", "for", "Amikacin", "Inhale.", "<tag2>", "Under", "our", "collaboration", "agreement", "with", "Bayer,", "we", "are", "responsible", "for", "all", "clinical", "and", "commercial", "supply", "of", "the", "nebulizer", "devices", "for", "this", "drug", "candidate.", "<tag3>"], "wordsA": ["Under", "our", "collaboration", "agreement", "with", "Bayer,", "we", "are", "responsible", "for", "all", "clinical", "and", "commercial", "supply", "of", "the", "nebulizer", "devices", "for", "Amikacin", "Inhale."], "wordsB": ["Under", "our", "collaboration", "agreement", "with", "Bayer,", "we", "are", "responsible", "for", "all", "clinical", "and", "commercial", "supply", "of", "the", "nebulizer", "devices", "for", "this", "drug", "candidate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p32_s14", "idA": "906709_12_item7_p25_s4", "sentA": "We do not expect to have any significant future research and development costs associated with NKTR-118 and NKTR-119 as AstraZeneca is responsible for all further development and commercialization costs for these drug candidates.", "sentB": "We do not expect to have any significant future research and development costs associated with naloxegol or the naloxegol fixed-dose combination products as AstraZeneca is responsible for all further development and commercialization costs for these drug candidates.", "type": 2, "words": ["<tag1>", "We", "do", "not", "expect", "to", "have", "any", "significant", "future", "research", "and", "development", "costs", "associated", "with", "NKTR-118", "and", "NKTR-119", "as", "AstraZeneca", "is", "responsible", "for", "all", "further", "development", "and", "commercialization", "costs", "for", "these", "drug", "candidates.", "<tag2>", "We", "do", "not", "expect", "to", "have", "any", "significant", "future", "research", "and", "development", "costs", "associated", "with", "naloxegol", "or", "the", "naloxegol", "fixed-dose", "combination", "products", "as", "AstraZeneca", "is", "responsible", "for", "all", "further", "development", "and", "commercialization", "costs", "for", "these", "drug", "candidates.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "to", "have", "any", "significant", "future", "research", "and", "development", "costs", "associated", "with", "NKTR-118", "and", "NKTR-119", "as", "AstraZeneca", "is", "responsible", "for", "all", "further", "development", "and", "commercialization", "costs", "for", "these", "drug", "candidates."], "wordsB": ["We", "do", "not", "expect", "to", "have", "any", "significant", "future", "research", "and", "development", "costs", "associated", "with", "naloxegol", "or", "the", "naloxegol", "fixed-dose", "combination", "products", "as", "AstraZeneca", "is", "responsible", "for", "all", "further", "development", "and", "commercialization", "costs", "for", "these", "drug", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p32_s15", "idA": "906709_12_item7_p25_s5", "sentA": "In addition to our drug candidates that we plan to have in clinical development during 2012 and beyond, we believe it is vitally important to continue our substantial investment in a diverse pipeline of new drug candidates to continue to build on the value of our business.", "sentB": "In addition to our drug candidates that we plan to have in clinical development during 2013 and beyond, we believe it is vitally important to continue our substantial investment in a diverse pipeline of new drug candidates to continue to build the value of our drug candidate pipeline and our business.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "our", "drug", "candidates", "that", "we", "plan", "to", "have", "in", "clinical", "development", "during", "2012", "and", "beyond,", "we", "believe", "it", "is", "vitally", "important", "to", "continue", "our", "substantial", "investment", "in", "a", "diverse", "pipeline", "of", "new", "drug", "candidates", "to", "continue", "to", "build", "on", "the", "value", "of", "our", "business.", "<tag2>", "In", "addition", "to", "our", "drug", "candidates", "that", "we", "plan", "to", "have", "in", "clinical", "development", "during", "2013", "and", "beyond,", "we", "believe", "it", "is", "vitally", "important", "to", "continue", "our", "substantial", "investment", "in", "a", "diverse", "pipeline", "of", "new", "drug", "candidates", "to", "continue", "to", "build", "the", "value", "of", "our", "drug", "candidate", "pipeline", "and", "our", "business.", "<tag3>"], "wordsA": ["In", "addition", "to", "our", "drug", "candidates", "that", "we", "plan", "to", "have", "in", "clinical", "development", "during", "2012", "and", "beyond,", "we", "believe", "it", "is", "vitally", "important", "to", "continue", "our", "substantial", "investment", "in", "a", "diverse", "pipeline", "of", "new", "drug", "candidates", "to", "continue", "to", "build", "on", "the", "value", "of", "our", "business."], "wordsB": ["In", "addition", "to", "our", "drug", "candidates", "that", "we", "plan", "to", "have", "in", "clinical", "development", "during", "2013", "and", "beyond,", "we", "believe", "it", "is", "vitally", "important", "to", "continue", "our", "substantial", "investment", "in", "a", "diverse", "pipeline", "of", "new", "drug", "candidates", "to", "continue", "to", "build", "the", "value", "of", "our", "drug", "candidate", "pipeline", "and", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p32_s16", "idA": "906709_12_item7_p25_s6", "sentA": "Our discovery research organization is identifying new drug candidates by applying our technology platform to a wide range of molecule classes, including small molecules and large proteins, peptides and antibodies, across multiple therapeutic areas.", "sentB": "Our discovery research organization is identifying new drug candidates by applying our pegylation technology platform to a wide range of molecule classes, including small molecules and large proteins, peptides and antibodies, across multiple therapeutic areas.", "type": 2, "words": ["<tag1>", "Our", "discovery", "research", "organization", "is", "identifying", "new", "drug", "candidates", "by", "applying", "our", "technology", "platform", "to", "a", "wide", "range", "of", "molecule", "classes,", "including", "small", "molecules", "and", "large", "proteins,", "peptides", "and", "antibodies,", "across", "multiple", "therapeutic", "areas.", "<tag2>", "Our", "discovery", "research", "organization", "is", "identifying", "new", "drug", "candidates", "by", "applying", "our", "pegylation", "technology", "platform", "to", "a", "wide", "range", "of", "molecule", "classes,", "including", "small", "molecules", "and", "large", "proteins,", "peptides", "and", "antibodies,", "across", "multiple", "therapeutic", "areas.", "<tag3>"], "wordsA": ["Our", "discovery", "research", "organization", "is", "identifying", "new", "drug", "candidates", "by", "applying", "our", "technology", "platform", "to", "a", "wide", "range", "of", "molecule", "classes,", "including", "small", "molecules", "and", "large", "proteins,", "peptides", "and", "antibodies,", "across", "multiple", "therapeutic", "areas."], "wordsB": ["Our", "discovery", "research", "organization", "is", "identifying", "new", "drug", "candidates", "by", "applying", "our", "pegylation", "technology", "platform", "to", "a", "wide", "range", "of", "molecule", "classes,", "including", "small", "molecules", "and", "large", "proteins,", "peptides", "and", "antibodies,", "across", "multiple", "therapeutic", "areas."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p33_s0", "idA": "906709_12_item7_p26_s0", "sentA": "In order to advance our drug candidates through clinical development, the drug candidates are tested in numerous preclinical safety, toxicology and efficacy studies.", "sentB": "In order to advance our drug candidates through clinical development, each drug candidate must be tested in numerous preclinical safety, toxicology and efficacy studies.", "type": 2, "words": ["<tag1>", "In", "order", "to", "advance", "our", "drug", "candidates", "through", "clinical", "development,", "the", "drug", "candidates", "are", "tested", "in", "numerous", "preclinical", "safety,", "toxicology", "and", "efficacy", "studies.", "<tag2>", "In", "order", "to", "advance", "our", "drug", "candidates", "through", "clinical", "development,", "each", "drug", "candidate", "must", "be", "tested", "in", "numerous", "preclinical", "safety,", "toxicology", "and", "efficacy", "studies.", "<tag3>"], "wordsA": ["In", "order", "to", "advance", "our", "drug", "candidates", "through", "clinical", "development,", "the", "drug", "candidates", "are", "tested", "in", "numerous", "preclinical", "safety,", "toxicology", "and", "efficacy", "studies."], "wordsB": ["In", "order", "to", "advance", "our", "drug", "candidates", "through", "clinical", "development,", "each", "drug", "candidate", "must", "be", "tested", "in", "numerous", "preclinical", "safety,", "toxicology", "and", "efficacy", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p34_s1", "idA": "906709_12_item7_p27_s1", "sentA": "Furthermore, our strategy includes entering into collaborations with third parties to participate in the development and commercialization of some of our drug candidates such as those collaborations that we have already completed for NKTR-118, NKTR-119 and Amikacin Inhale.", "sentB": "Furthermore, our strategy includes the potential of entering into collaborations with third parties to participate in the development and commercialization of some of our drug candidates such as those collaborations that we have already completed for naloxegol and Amikacin Inhale.", "type": 2, "words": ["<tag1>", "Furthermore,", "our", "strategy", "includes", "entering", "into", "collaborations", "with", "third", "parties", "to", "participate", "in", "the", "development", "and", "commercialization", "of", "some", "of", "our", "drug", "candidates", "such", "as", "those", "collaborations", "that", "we", "have", "already", "completed", "for", "NKTR-118,", "NKTR-119", "and", "Amikacin", "Inhale.", "<tag2>", "Furthermore,", "our", "strategy", "includes", "the", "potential", "of", "entering", "into", "collaborations", "with", "third", "parties", "to", "participate", "in", "the", "development", "and", "commercialization", "of", "some", "of", "our", "drug", "candidates", "such", "as", "those", "collaborations", "that", "we", "have", "already", "completed", "for", "naloxegol", "and", "Amikacin", "Inhale.", "<tag3>"], "wordsA": ["Furthermore,", "our", "strategy", "includes", "entering", "into", "collaborations", "with", "third", "parties", "to", "participate", "in", "the", "development", "and", "commercialization", "of", "some", "of", "our", "drug", "candidates", "such", "as", "those", "collaborations", "that", "we", "have", "already", "completed", "for", "NKTR-118,", "NKTR-119", "and", "Amikacin", "Inhale."], "wordsB": ["Furthermore,", "our", "strategy", "includes", "the", "potential", "of", "entering", "into", "collaborations", "with", "third", "parties", "to", "participate", "in", "the", "development", "and", "commercialization", "of", "some", "of", "our", "drug", "candidates", "such", "as", "those", "collaborations", "that", "we", "have", "already", "completed", "for", "naloxegol", "and", "Amikacin", "Inhale."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p35_s0", "idA": "906709_12_item7_p28_s1", "sentA": "Other than for the BEACON study, due to the uncertainties discussed above, we are unable to determine with any degree of certainty the duration and completion costs of our research and development projects, anticipated completion dates or when and to what extent we will receive cash inflows from a collaboration arrangement or the commercialization of a drug candidate.", "sentB": "As a result of the uncertainties discussed above, we are unable to determine with any degree of certainty the duration and completion costs of our research and development projects, anticipated completion dates or when and to what extent we will receive cash inflows from a collaboration arrangement or the commercialization of a drug candidate.", "type": 2, "words": ["<tag1>", "Other", "than", "for", "the", "BEACON", "study,", "due", "to", "the", "uncertainties", "discussed", "above,", "we", "are", "unable", "to", "determine", "with", "any", "degree", "of", "certainty", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects,", "anticipated", "completion", "dates", "or", "when", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "a", "collaboration", "arrangement", "or", "the", "commercialization", "of", "a", "drug", "candidate.", "<tag2>", "As", "a", "result", "of", "the", "uncertainties", "discussed", "above,", "we", "are", "unable", "to", "determine", "with", "any", "degree", "of", "certainty", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects,", "anticipated", "completion", "dates", "or", "when", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "a", "collaboration", "arrangement", "or", "the", "commercialization", "of", "a", "drug", "candidate.", "<tag3>"], "wordsA": ["Other", "than", "for", "the", "BEACON", "study,", "due", "to", "the", "uncertainties", "discussed", "above,", "we", "are", "unable", "to", "determine", "with", "any", "degree", "of", "certainty", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects,", "anticipated", "completion", "dates", "or", "when", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "a", "collaboration", "arrangement", "or", "the", "commercialization", "of", "a", "drug", "candidate."], "wordsB": ["As", "a", "result", "of", "the", "uncertainties", "discussed", "above,", "we", "are", "unable", "to", "determine", "with", "any", "degree", "of", "certainty", "the", "duration", "and", "completion", "costs", "of", "our", "research", "and", "development", "projects,", "anticipated", "completion", "dates", "or", "when", "and", "to", "what", "extent", "we", "will", "receive", "cash", "inflows", "from", "a", "collaboration", "arrangement", "or", "the", "commercialization", "of", "a", "drug", "candidate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p36_s0", "idA": "906709_12_item7_p29_s0", "sentA": "General and administrative expenses are associated with administrative staffing, business development, finance, marketing, and legal.", "sentB": "General and administrative expense includes the cost of administrative staffing, business development, marketing, finance, human resources and legal activities.", "type": 2, "words": ["<tag1>", "General", "and", "administrative", "expenses", "are", "associated", "with", "administrative", "staffing,", "business", "development,", "finance,", "marketing,", "and", "legal.", "<tag2>", "General", "and", "administrative", "expense", "includes", "the", "cost", "of", "administrative", "staffing,", "business", "development,", "marketing,", "finance,", "human", "resources", "and", "legal", "activities.", "<tag3>"], "wordsA": ["General", "and", "administrative", "expenses", "are", "associated", "with", "administrative", "staffing,", "business", "development,", "finance,", "marketing,", "and", "legal."], "wordsB": ["General", "and", "administrative", "expense", "includes", "the", "cost", "of", "administrative", "staffing,", "business", "development,", "marketing,", "finance,", "human", "resources", "and", "legal", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p36_s1", "idA": "906709_12_item7_p29_s1", "sentA": "For the year ended December 31, 2011 compared to the year ended December 31, 2010, general and administrative expense increased by $2.7 million due to a payment obligation related to the settlement of a commercial litigation matter.", "sentB": "General and administrative expense decreased during the year ended December 31, 2012 compared to the year ended December 31, 2011 primarily as a result of a $2.7 million payment obligation incurred in 2011 related to the settlement of a commercial litigation matter as well as a $2.1 million decrease in non-cash stock-based compensation expense in 2012 as compared to 2011.", "type": 2, "words": ["<tag1>", "For", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010,", "general", "and", "administrative", "expense", "increased", "by", "$2.7", "million", "due", "to", "a", "payment", "obligation", "related", "to", "the", "settlement", "of", "a", "commercial", "litigation", "matter.", "<tag2>", "General", "and", "administrative", "expense", "decreased", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "primarily", "as", "a", "result", "of", "a", "$2.7", "million", "payment", "obligation", "incurred", "in", "2011", "related", "to", "the", "settlement", "of", "a", "commercial", "litigation", "matter", "as", "well", "as", "a", "$2.1", "million", "decrease", "in", "non-cash", "stock-based", "compensation", "expense", "in", "2012", "as", "compared", "to", "2011.", "<tag3>"], "wordsA": ["For", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010,", "general", "and", "administrative", "expense", "increased", "by", "$2.7", "million", "due", "to", "a", "payment", "obligation", "related", "to", "the", "settlement", "of", "a", "commercial", "litigation", "matter."], "wordsB": ["General", "and", "administrative", "expense", "decreased", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "primarily", "as", "a", "result", "of", "a", "$2.7", "million", "payment", "obligation", "incurred", "in", "2011", "related", "to", "the", "settlement", "of", "a", "commercial", "litigation", "matter", "as", "well", "as", "a", "$2.1", "million", "decrease", "in", "non-cash", "stock-based", "compensation", "expense", "in", "2012", "as", "compared", "to", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p36_s4", "idA": "906709_12_item7_p29_s3", "sentA": "In 2012, after excluding the impact of the 2011 commercial litigation settlement, we expect general and administrative expenses to increase modestly compared to 2011.", "sentB": "In 2013, we expect general and administrative expenses to increase modestly compared to 2012.", "type": 2, "words": ["<tag1>", "In", "2012,", "after", "excluding", "the", "impact", "of", "the", "2011", "commercial", "litigation", "settlement,", "we", "expect", "general", "and", "administrative", "expenses", "to", "increase", "modestly", "compared", "to", "2011.", "<tag2>", "In", "2013,", "we", "expect", "general", "and", "administrative", "expenses", "to", "increase", "modestly", "compared", "to", "2012.", "<tag3>"], "wordsA": ["In", "2012,", "after", "excluding", "the", "impact", "of", "the", "2011", "commercial", "litigation", "settlement,", "we", "expect", "general", "and", "administrative", "expenses", "to", "increase", "modestly", "compared", "to", "2011."], "wordsB": ["In", "2013,", "we", "expect", "general", "and", "administrative", "expenses", "to", "increase", "modestly", "compared", "to", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p39_s0", "idA": "906709_12_item7_p29_s4", "sentA": "General and administrative expenses for the year ended December 31, 2010 remained at a consistent level compared to the year ended December 31, 2009.", "sentB": "Interest income for the year ended December 31, 2012 was consistent with the year ended December 31, 2011.", "type": 2, "words": ["<tag1>", "General", "and", "administrative", "expenses", "for", "the", "year", "ended", "December", "31,", "2010", "remained", "at", "a", "consistent", "level", "compared", "to", "the", "year", "ended", "December", "31,", "2009.", "<tag2>", "Interest", "income", "for", "the", "year", "ended", "December", "31,", "2012", "was", "consistent", "with", "the", "year", "ended", "December", "31,", "2011.", "<tag3>"], "wordsA": ["General", "and", "administrative", "expenses", "for", "the", "year", "ended", "December", "31,", "2010", "remained", "at", "a", "consistent", "level", "compared", "to", "the", "year", "ended", "December", "31,", "2009."], "wordsB": ["Interest", "income", "for", "the", "year", "ended", "December", "31,", "2012", "was", "consistent", "with", "the", "year", "ended", "December", "31,", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p62_s1", "idA": "906709_12_item7_p29_s4", "sentA": "General and administrative expenses for the year ended December 31, 2010 remained at a consistent level compared to the year ended December 31, 2009.", "sentB": "In the year ended December 31, 2012, we entered into our first arrangement that requires accounting under this guidance.", "type": 2, "words": ["<tag1>", "General", "and", "administrative", "expenses", "for", "the", "year", "ended", "December", "31,", "2010", "remained", "at", "a", "consistent", "level", "compared", "to", "the", "year", "ended", "December", "31,", "2009.", "<tag2>", "In", "the", "year", "ended", "December", "31,", "2012,", "we", "entered", "into", "our", "first", "arrangement", "that", "requires", "accounting", "under", "this", "guidance.", "<tag3>"], "wordsA": ["General", "and", "administrative", "expenses", "for", "the", "year", "ended", "December", "31,", "2010", "remained", "at", "a", "consistent", "level", "compared", "to", "the", "year", "ended", "December", "31,", "2009."], "wordsB": ["In", "the", "year", "ended", "December", "31,", "2012,", "we", "entered", "into", "our", "first", "arrangement", "that", "requires", "accounting", "under", "this", "guidance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p4_s0", "idA": "906709_12_item7_p2_s2", "sentA": "This Phase 3 clinical program is designed to investigate the safety and efficacy of NKTR-118 as a medicine to relieve opioid-induced constipation, a common side effect of prescription opioids when used for chronic pain management.", "sentB": "The core Phase 3 clinical development program for naloxegol, which AstraZeneca calls the KODIAC program, is comprised of four clinical trials which are designed to investigate the safety and efficacy of naloxegol for the treatment of OIC in patients with non-cancer related pain.", "type": 2, "words": ["<tag1>", "This", "Phase", "3", "clinical", "program", "is", "designed", "to", "investigate", "the", "safety", "and", "efficacy", "of", "NKTR-118", "as", "a", "medicine", "to", "relieve", "opioid-induced", "constipation,", "a", "common", "side", "effect", "of", "prescription", "opioids", "when", "used", "for", "chronic", "pain", "management.", "<tag2>", "The", "core", "Phase", "3", "clinical", "development", "program", "for", "naloxegol,", "which", "AstraZeneca", "calls", "the", "KODIAC", "program,", "is", "comprised", "of", "four", "clinical", "trials", "which", "are", "designed", "to", "investigate", "the", "safety", "and", "efficacy", "of", "naloxegol", "for", "the", "treatment", "of", "OIC", "in", "patients", "with", "non-cancer", "related", "pain.", "<tag3>"], "wordsA": ["This", "Phase", "3", "clinical", "program", "is", "designed", "to", "investigate", "the", "safety", "and", "efficacy", "of", "NKTR-118", "as", "a", "medicine", "to", "relieve", "opioid-induced", "constipation,", "a", "common", "side", "effect", "of", "prescription", "opioids", "when", "used", "for", "chronic", "pain", "management."], "wordsB": ["The", "core", "Phase", "3", "clinical", "development", "program", "for", "naloxegol,", "which", "AstraZeneca", "calls", "the", "KODIAC", "program,", "is", "comprised", "of", "four", "clinical", "trials", "which", "are", "designed", "to", "investigate", "the", "safety", "and", "efficacy", "of", "naloxegol", "for", "the", "treatment", "of", "OIC", "in", "patients", "with", "non-cancer", "related", "pain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p9_s3", "idA": "906709_12_item7_p2_s2", "sentA": "This Phase 3 clinical program is designed to investigate the safety and efficacy of NKTR-118 as a medicine to relieve opioid-induced constipation, a common side effect of prescription opioids when used for chronic pain management.", "sentB": "The Phase 3 clinical program is expected to be initiated by Bayer in March 2013.", "type": 2, "words": ["<tag1>", "This", "Phase", "3", "clinical", "program", "is", "designed", "to", "investigate", "the", "safety", "and", "efficacy", "of", "NKTR-118", "as", "a", "medicine", "to", "relieve", "opioid-induced", "constipation,", "a", "common", "side", "effect", "of", "prescription", "opioids", "when", "used", "for", "chronic", "pain", "management.", "<tag2>", "The", "Phase", "3", "clinical", "program", "is", "expected", "to", "be", "initiated", "by", "Bayer", "in", "March", "2013.", "<tag3>"], "wordsA": ["This", "Phase", "3", "clinical", "program", "is", "designed", "to", "investigate", "the", "safety", "and", "efficacy", "of", "NKTR-118", "as", "a", "medicine", "to", "relieve", "opioid-induced", "constipation,", "a", "common", "side", "effect", "of", "prescription", "opioids", "when", "used", "for", "chronic", "pain", "management."], "wordsB": ["The", "Phase", "3", "clinical", "program", "is", "expected", "to", "be", "initiated", "by", "Bayer", "in", "March", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p17_s8", "idA": "906709_12_item7_p2_s3", "sentA": "The outcome of the KODIAC study will have a substantial impact on our financial condition as we are entitled to $235.0 million in regulatory filing and commercial launch milestones.", "sentB": "In particular, we are entitled to up to $235.0 million of regulatory and commercial launch milestones under our license agreement with AstraZeneca, $95.0 million of which is related to AstraZeneca submitting regulatory approval filings for naloxegol with the FDA and with the EMA.", "type": 2, "words": ["<tag1>", "The", "outcome", "of", "the", "KODIAC", "study", "will", "have", "a", "substantial", "impact", "on", "our", "financial", "condition", "as", "we", "are", "entitled", "to", "$235.0", "million", "in", "regulatory", "filing", "and", "commercial", "launch", "milestones.", "<tag2>", "In", "particular,", "we", "are", "entitled", "to", "up", "to", "$235.0", "million", "of", "regulatory", "and", "commercial", "launch", "milestones", "under", "our", "license", "agreement", "with", "AstraZeneca,", "$95.0", "million", "of", "which", "is", "related", "to", "AstraZeneca", "submitting", "regulatory", "approval", "filings", "for", "naloxegol", "with", "the", "FDA", "and", "with", "the", "EMA.", "<tag3>"], "wordsA": ["The", "outcome", "of", "the", "KODIAC", "study", "will", "have", "a", "substantial", "impact", "on", "our", "financial", "condition", "as", "we", "are", "entitled", "to", "$235.0", "million", "in", "regulatory", "filing", "and", "commercial", "launch", "milestones."], "wordsB": ["In", "particular,", "we", "are", "entitled", "to", "up", "to", "$235.0", "million", "of", "regulatory", "and", "commercial", "launch", "milestones", "under", "our", "license", "agreement", "with", "AstraZeneca,", "$95.0", "million", "of", "which", "is", "related", "to", "AstraZeneca", "submitting", "regulatory", "approval", "filings", "for", "naloxegol", "with", "the", "FDA", "and", "with", "the", "EMA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p44_s4", "idA": "906709_12_item7_p2_s3", "sentA": "The outcome of the KODIAC study will have a substantial impact on our financial condition as we are entitled to $235.0 million in regulatory filing and commercial launch milestones.", "sentB": "In particular, we are entitled to up to $235.0 million of regulatory and commercial launch milestones under our license agreement with AstraZeneca, $95.0 million of which is related to AstraZeneca submitting regulatory approval filings for naloxegol with the FDA and with the EMA.", "type": 2, "words": ["<tag1>", "The", "outcome", "of", "the", "KODIAC", "study", "will", "have", "a", "substantial", "impact", "on", "our", "financial", "condition", "as", "we", "are", "entitled", "to", "$235.0", "million", "in", "regulatory", "filing", "and", "commercial", "launch", "milestones.", "<tag2>", "In", "particular,", "we", "are", "entitled", "to", "up", "to", "$235.0", "million", "of", "regulatory", "and", "commercial", "launch", "milestones", "under", "our", "license", "agreement", "with", "AstraZeneca,", "$95.0", "million", "of", "which", "is", "related", "to", "AstraZeneca", "submitting", "regulatory", "approval", "filings", "for", "naloxegol", "with", "the", "FDA", "and", "with", "the", "EMA.", "<tag3>"], "wordsA": ["The", "outcome", "of", "the", "KODIAC", "study", "will", "have", "a", "substantial", "impact", "on", "our", "financial", "condition", "as", "we", "are", "entitled", "to", "$235.0", "million", "in", "regulatory", "filing", "and", "commercial", "launch", "milestones."], "wordsB": ["In", "particular,", "we", "are", "entitled", "to", "up", "to", "$235.0", "million", "of", "regulatory", "and", "commercial", "launch", "milestones", "under", "our", "license", "agreement", "with", "AstraZeneca,", "$95.0", "million", "of", "which", "is", "related", "to", "AstraZeneca", "submitting", "regulatory", "approval", "filings", "for", "naloxegol", "with", "the", "FDA", "and", "with", "the", "EMA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p4_s1", "idA": "906709_12_item7_p2_s3", "sentA": "The outcome of the KODIAC study will have a substantial impact on our financial condition as we are entitled to $235.0 million in regulatory filing and commercial launch milestones.", "sentB": "The outcome and timing of the naloxegol development program will have a substantial impact on our financial condition as we are entitled to up to $95 million in regulatory filing milestones and $140 million in commercial launch milestones.", "type": 2, "words": ["<tag1>", "The", "outcome", "of", "the", "KODIAC", "study", "will", "have", "a", "substantial", "impact", "on", "our", "financial", "condition", "as", "we", "are", "entitled", "to", "$235.0", "million", "in", "regulatory", "filing", "and", "commercial", "launch", "milestones.", "<tag2>", "The", "outcome", "and", "timing", "of", "the", "naloxegol", "development", "program", "will", "have", "a", "substantial", "impact", "on", "our", "financial", "condition", "as", "we", "are", "entitled", "to", "up", "to", "$95", "million", "in", "regulatory", "filing", "milestones", "and", "$140", "million", "in", "commercial", "launch", "milestones.", "<tag3>"], "wordsA": ["The", "outcome", "of", "the", "KODIAC", "study", "will", "have", "a", "substantial", "impact", "on", "our", "financial", "condition", "as", "we", "are", "entitled", "to", "$235.0", "million", "in", "regulatory", "filing", "and", "commercial", "launch", "milestones."], "wordsB": ["The", "outcome", "and", "timing", "of", "the", "naloxegol", "development", "program", "will", "have", "a", "substantial", "impact", "on", "our", "financial", "condition", "as", "we", "are", "entitled", "to", "up", "to", "$95", "million", "in", "regulatory", "filing", "milestones", "and", "$140", "million", "in", "commercial", "launch", "milestones."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p21_s11", "idA": "906709_12_item7_p2_s4", "sentA": "If the KODIAC study is successful and AstraZeneca files for regulatory approval with the FDA and the European Medicines Agency (EMA), Nektar will be entitled to $95.0 million of these milestones.", "sentB": "In the event regulatory approval filings for naloxegol are submitted by AstraZeneca and accepted by the FDA and by the EMA, we would be entitled to $95.0 million in milestone payments.", "type": 2, "words": ["<tag1>", "If", "the", "KODIAC", "study", "is", "successful", "and", "AstraZeneca", "files", "for", "regulatory", "approval", "with", "the", "FDA", "and", "the", "European", "Medicines", "Agency", "(EMA),", "Nektar", "will", "be", "entitled", "to", "$95.0", "million", "of", "these", "milestones.", "<tag2>", "In", "the", "event", "regulatory", "approval", "filings", "for", "naloxegol", "are", "submitted", "by", "AstraZeneca", "and", "accepted", "by", "the", "FDA", "and", "by", "the", "EMA,", "we", "would", "be", "entitled", "to", "$95.0", "million", "in", "milestone", "payments.", "<tag3>"], "wordsA": ["If", "the", "KODIAC", "study", "is", "successful", "and", "AstraZeneca", "files", "for", "regulatory", "approval", "with", "the", "FDA", "and", "the", "European", "Medicines", "Agency", "(EMA),", "Nektar", "will", "be", "entitled", "to", "$95.0", "million", "of", "these", "milestones."], "wordsB": ["In", "the", "event", "regulatory", "approval", "filings", "for", "naloxegol", "are", "submitted", "by", "AstraZeneca", "and", "accepted", "by", "the", "FDA", "and", "by", "the", "EMA,", "we", "would", "be", "entitled", "to", "$95.0", "million", "in", "milestone", "payments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p5_s3", "idA": "906709_12_item7_p2_s4", "sentA": "If the KODIAC study is successful and AstraZeneca files for regulatory approval with the FDA and the European Medicines Agency (EMA), Nektar will be entitled to $95.0 million of these milestones.", "sentB": "In the event regulatory approval filings are submitted by AstraZeneca and accepted by the U.S. Food and Drug Administration (FDA) and by the European Medicines Agency (EMA), we would be entitled to receive $95.0 million in milestone payments.", "type": 2, "words": ["<tag1>", "If", "the", "KODIAC", "study", "is", "successful", "and", "AstraZeneca", "files", "for", "regulatory", "approval", "with", "the", "FDA", "and", "the", "European", "Medicines", "Agency", "(EMA),", "Nektar", "will", "be", "entitled", "to", "$95.0", "million", "of", "these", "milestones.", "<tag2>", "In", "the", "event", "regulatory", "approval", "filings", "are", "submitted", "by", "AstraZeneca", "and", "accepted", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA)", "and", "by", "the", "European", "Medicines", "Agency", "(EMA),", "we", "would", "be", "entitled", "to", "receive", "$95.0", "million", "in", "milestone", "payments.", "<tag3>"], "wordsA": ["If", "the", "KODIAC", "study", "is", "successful", "and", "AstraZeneca", "files", "for", "regulatory", "approval", "with", "the", "FDA", "and", "the", "European", "Medicines", "Agency", "(EMA),", "Nektar", "will", "be", "entitled", "to", "$95.0", "million", "of", "these", "milestones."], "wordsB": ["In", "the", "event", "regulatory", "approval", "filings", "are", "submitted", "by", "AstraZeneca", "and", "accepted", "by", "the", "U.S.", "Food", "and", "Drug", "Administration", "(FDA)", "and", "by", "the", "European", "Medicines", "Agency", "(EMA),", "we", "would", "be", "entitled", "to", "receive", "$95.0", "million", "in", "milestone", "payments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p5_s2", "idA": "906709_12_item7_p2_s5", "sentA": "We will be entitled to the remaining $140.0 million of these milestones if NKTR-118 is approved by the FDA and EMA and commercial launch is achieved in the U.S. and one major country in the European Union (EU).", "sentB": "AstraZeneca has stated that it plans to submit an NDA filing in the U.S. and a marketing authorization application (MAA) filing in the E.U. in the third quarter of 2013, pending AstraZeneca s final preparation of the registration package and a pre-NDA meeting with the FDA.", "type": 2, "words": ["<tag1>", "We", "will", "be", "entitled", "to", "the", "remaining", "$140.0", "million", "of", "these", "milestones", "if", "NKTR-118", "is", "approved", "by", "the", "FDA", "and", "EMA", "and", "commercial", "launch", "is", "achieved", "in", "the", "U.S.", "and", "one", "major", "country", "in", "the", "European", "Union", "(EU).", "<tag2>", "AstraZeneca", "has", "stated", "that", "it", "plans", "to", "submit", "an", "NDA", "filing", "in", "the", "U.S.", "and", "a", "marketing", "authorization", "application", "(MAA)", "filing", "in", "the", "E.U.", "in", "the", "third", "quarter", "of", "2013,", "pending", "AstraZeneca", "s", "final", "preparation", "of", "the", "registration", "package", "and", "a", "pre-NDA", "meeting", "with", "the", "FDA.", "<tag3>"], "wordsA": ["We", "will", "be", "entitled", "to", "the", "remaining", "$140.0", "million", "of", "these", "milestones", "if", "NKTR-118", "is", "approved", "by", "the", "FDA", "and", "EMA", "and", "commercial", "launch", "is", "achieved", "in", "the", "U.S.", "and", "one", "major", "country", "in", "the", "European", "Union", "(EU)."], "wordsB": ["AstraZeneca", "has", "stated", "that", "it", "plans", "to", "submit", "an", "NDA", "filing", "in", "the", "U.S.", "and", "a", "marketing", "authorization", "application", "(MAA)", "filing", "in", "the", "E.U.", "in", "the", "third", "quarter", "of", "2013,", "pending", "AstraZeneca", "s", "final", "preparation", "of", "the", "registration", "package", "and", "a", "pre-NDA", "meeting", "with", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p37_s1", "idA": "906709_12_item7_p30_s1", "sentA": "We determined that the carrying value of the San Carlos facility exceeded its fair value based on a discounted cash flow model and an impairment charge of $12.6 million was recognized as a result.", "sentB": "As a result, we concluded that the combined carrying value of the land and building exceeded fair value and we recorded an impairment loss of $1.7 million in March 2012.", "type": 2, "words": ["<tag1>", "We", "determined", "that", "the", "carrying", "value", "of", "the", "San", "Carlos", "facility", "exceeded", "its", "fair", "value", "based", "on", "a", "discounted", "cash", "flow", "model", "and", "an", "impairment", "charge", "of", "$12.6", "million", "was", "recognized", "as", "a", "result.", "<tag2>", "As", "a", "result,", "we", "concluded", "that", "the", "combined", "carrying", "value", "of", "the", "land", "and", "building", "exceeded", "fair", "value", "and", "we", "recorded", "an", "impairment", "loss", "of", "$1.7", "million", "in", "March", "2012.", "<tag3>"], "wordsA": ["We", "determined", "that", "the", "carrying", "value", "of", "the", "San", "Carlos", "facility", "exceeded", "its", "fair", "value", "based", "on", "a", "discounted", "cash", "flow", "model", "and", "an", "impairment", "charge", "of", "$12.6", "million", "was", "recognized", "as", "a", "result."], "wordsB": ["As", "a", "result,", "we", "concluded", "that", "the", "combined", "carrying", "value", "of", "the", "land", "and", "building", "exceeded", "fair", "value", "and", "we", "recorded", "an", "impairment", "loss", "of", "$1.7", "million", "in", "March", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p66_s1", "idA": "906709_12_item7_p30_s1", "sentA": "We determined that the carrying value of the San Carlos facility exceeded its fair value based on a discounted cash flow model and an impairment charge of $12.6 million was recognized as a result.", "sentB": "We expense the estimated fair value of each award, as adjusted by the estimated historical forfeiture rate, ratably over the expected service period of the award.", "type": 2, "words": ["<tag1>", "We", "determined", "that", "the", "carrying", "value", "of", "the", "San", "Carlos", "facility", "exceeded", "its", "fair", "value", "based", "on", "a", "discounted", "cash", "flow", "model", "and", "an", "impairment", "charge", "of", "$12.6", "million", "was", "recognized", "as", "a", "result.", "<tag2>", "We", "expense", "the", "estimated", "fair", "value", "of", "each", "award,", "as", "adjusted", "by", "the", "estimated", "historical", "forfeiture", "rate,", "ratably", "over", "the", "expected", "service", "period", "of", "the", "award.", "<tag3>"], "wordsA": ["We", "determined", "that", "the", "carrying", "value", "of", "the", "San", "Carlos", "facility", "exceeded", "its", "fair", "value", "based", "on", "a", "discounted", "cash", "flow", "model", "and", "an", "impairment", "charge", "of", "$12.6", "million", "was", "recognized", "as", "a", "result."], "wordsB": ["We", "expense", "the", "estimated", "fair", "value", "of", "each", "award,", "as", "adjusted", "by", "the", "estimated", "historical", "forfeiture", "rate,", "ratably", "over", "the", "expected", "service", "period", "of", "the", "award."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p20_s8", "idA": "906709_12_item7_p31_s2", "sentA": "The decrease in interest expense for the year ended December 30, 2011 compared to the year ended December 31, 2010 is primarily attributable to the complete amortization of deferred financing costs during 2010 from our 3.25% convertible subordinated notes due September 2012.", "sentB": "We expect royalties to decrease in 2013 as compared to 2012.", "type": 2, "words": ["<tag1>", "The", "decrease", "in", "interest", "expense", "for", "the", "year", "ended", "December", "30,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "attributable", "to", "the", "complete", "amortization", "of", "deferred", "financing", "costs", "during", "2010", "from", "our", "3.25%", "convertible", "subordinated", "notes", "due", "September", "2012.", "<tag2>", "We", "expect", "royalties", "to", "decrease", "in", "2013", "as", "compared", "to", "2012.", "<tag3>"], "wordsA": ["The", "decrease", "in", "interest", "expense", "for", "the", "year", "ended", "December", "30,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "attributable", "to", "the", "complete", "amortization", "of", "deferred", "financing", "costs", "during", "2010", "from", "our", "3.25%", "convertible", "subordinated", "notes", "due", "September", "2012."], "wordsB": ["We", "expect", "royalties", "to", "decrease", "in", "2013", "as", "compared", "to", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p40_s0", "idA": "906709_12_item7_p31_s2", "sentA": "The decrease in interest expense for the year ended December 30, 2011 compared to the year ended December 31, 2010 is primarily attributable to the complete amortization of deferred financing costs during 2010 from our 3.25% convertible subordinated notes due September 2012.", "sentB": "The increase in interest expense for the year ended December 31, 2012 compared to the year ended December 31, 2011 is attributable to the interest expense recorded on the senior secured notes we issued in 2012.", "type": 2, "words": ["<tag1>", "The", "decrease", "in", "interest", "expense", "for", "the", "year", "ended", "December", "30,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "attributable", "to", "the", "complete", "amortization", "of", "deferred", "financing", "costs", "during", "2010", "from", "our", "3.25%", "convertible", "subordinated", "notes", "due", "September", "2012.", "<tag2>", "The", "increase", "in", "interest", "expense", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "interest", "expense", "recorded", "on", "the", "senior", "secured", "notes", "we", "issued", "in", "2012.", "<tag3>"], "wordsA": ["The", "decrease", "in", "interest", "expense", "for", "the", "year", "ended", "December", "30,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "attributable", "to", "the", "complete", "amortization", "of", "deferred", "financing", "costs", "during", "2010", "from", "our", "3.25%", "convertible", "subordinated", "notes", "due", "September", "2012."], "wordsB": ["The", "increase", "in", "interest", "expense", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "interest", "expense", "recorded", "on", "the", "senior", "secured", "notes", "we", "issued", "in", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p41_s1", "idA": "906709_12_item7_p31_s2", "sentA": "The decrease in interest expense for the year ended December 30, 2011 compared to the year ended December 31, 2010 is primarily attributable to the complete amortization of deferred financing costs during 2010 from our 3.25% convertible subordinated notes due September 2012.", "sentB": "The decrease in interest expense for the year ended December 30, 2011 compared to the year ended December 31, 2010 is primarily attributable to the complete amortization of deferred financing costs during 2010 relating to our 3.25% convertible subordinated notes that matured in September 2012.", "type": 2, "words": ["<tag1>", "The", "decrease", "in", "interest", "expense", "for", "the", "year", "ended", "December", "30,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "attributable", "to", "the", "complete", "amortization", "of", "deferred", "financing", "costs", "during", "2010", "from", "our", "3.25%", "convertible", "subordinated", "notes", "due", "September", "2012.", "<tag2>", "The", "decrease", "in", "interest", "expense", "for", "the", "year", "ended", "December", "30,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "attributable", "to", "the", "complete", "amortization", "of", "deferred", "financing", "costs", "during", "2010", "relating", "to", "our", "3.25%", "convertible", "subordinated", "notes", "that", "matured", "in", "September", "2012.", "<tag3>"], "wordsA": ["The", "decrease", "in", "interest", "expense", "for", "the", "year", "ended", "December", "30,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "attributable", "to", "the", "complete", "amortization", "of", "deferred", "financing", "costs", "during", "2010", "from", "our", "3.25%", "convertible", "subordinated", "notes", "due", "September", "2012."], "wordsB": ["The", "decrease", "in", "interest", "expense", "for", "the", "year", "ended", "December", "30,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "primarily", "attributable", "to", "the", "complete", "amortization", "of", "deferred", "financing", "costs", "during", "2010", "relating", "to", "our", "3.25%", "convertible", "subordinated", "notes", "that", "matured", "in", "September", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p21_s1", "idA": "906709_12_item7_p32_s0", "sentA": "As noted above, in February 2012, we sold all of our rights to receive future royalty payments on CIMZIA and MIRCERA .", "sentB": "In February 2012, we sold all of our rights to receive future royalty payments on CIMZIA and MIRCERA effective for all periods from January 1, 2012 through the life of the royalty obligation.", "type": 2, "words": ["<tag1>", "As", "noted", "above,", "in", "February", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "on", "CIMZIA", "and", "MIRCERA", ".", "<tag2>", "In", "February", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "on", "CIMZIA", "and", "MIRCERA", "effective", "for", "all", "periods", "from", "January", "1,", "2012", "through", "the", "life", "of", "the", "royalty", "obligation.", "<tag3>"], "wordsA": ["As", "noted", "above,", "in", "February", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "on", "CIMZIA", "and", "MIRCERA", "."], "wordsB": ["In", "February", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "on", "CIMZIA", "and", "MIRCERA", "effective", "for", "all", "periods", "from", "January", "1,", "2012", "through", "the", "life", "of", "the", "royalty", "obligation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p69_s1", "idA": "906709_12_item7_p32_s1", "sentA": "Although we are required to make payments to the purchaser of these rights only in certain situations, this transaction will be recorded as a liability.", "sentB": "Although we are required to make payments to the purchaser only in certain situations, including the event of our breach of a representation, warranty or covenant in the Purchase and Sale Agreement that gives rise to a liability in accordance with the terms and conditions of such agreement, this royalty sale transaction was recorded as a liability (Royalty Obligation) that we will amortize using the interest method over the estimated life of the Purchase and Sale Agreement.", "type": 2, "words": ["<tag1>", "Although", "we", "are", "required", "to", "make", "payments", "to", "the", "purchaser", "of", "these", "rights", "only", "in", "certain", "situations,", "this", "transaction", "will", "be", "recorded", "as", "a", "liability.", "<tag2>", "Although", "we", "are", "required", "to", "make", "payments", "to", "the", "purchaser", "only", "in", "certain", "situations,", "including", "the", "event", "of", "our", "breach", "of", "a", "representation,", "warranty", "or", "covenant", "in", "the", "Purchase", "and", "Sale", "Agreement", "that", "gives", "rise", "to", "a", "liability", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "such", "agreement,", "this", "royalty", "sale", "transaction", "was", "recorded", "as", "a", "liability", "(Royalty", "Obligation)", "that", "we", "will", "amortize", "using", "the", "interest", "method", "over", "the", "estimated", "life", "of", "the", "Purchase", "and", "Sale", "Agreement.", "<tag3>"], "wordsA": ["Although", "we", "are", "required", "to", "make", "payments", "to", "the", "purchaser", "of", "these", "rights", "only", "in", "certain", "situations,", "this", "transaction", "will", "be", "recorded", "as", "a", "liability."], "wordsB": ["Although", "we", "are", "required", "to", "make", "payments", "to", "the", "purchaser", "only", "in", "certain", "situations,", "including", "the", "event", "of", "our", "breach", "of", "a", "representation,", "warranty", "or", "covenant", "in", "the", "Purchase", "and", "Sale", "Agreement", "that", "gives", "rise", "to", "a", "liability", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "such", "agreement,", "this", "royalty", "sale", "transaction", "was", "recorded", "as", "a", "liability", "(Royalty", "Obligation)", "that", "we", "will", "amortize", "using", "the", "interest", "method", "over", "the", "estimated", "life", "of", "the", "Purchase", "and", "Sale", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p40_s7", "idA": "906709_12_item7_p32_s2", "sentA": "While we do not anticipate making any cash payments representing interest, we will impute interest on the transaction and record interest expense at the effective interest rate of approximately 17%.", "sentB": "We impute interest on the transaction and record interest expense at the effective interest rate, which we currently estimated to be approximately 17%.", "type": 2, "words": ["<tag1>", "While", "we", "do", "not", "anticipate", "making", "any", "cash", "payments", "representing", "interest,", "we", "will", "impute", "interest", "on", "the", "transaction", "and", "record", "interest", "expense", "at", "the", "effective", "interest", "rate", "of", "approximately", "17%.", "<tag2>", "We", "impute", "interest", "on", "the", "transaction", "and", "record", "interest", "expense", "at", "the", "effective", "interest", "rate,", "which", "we", "currently", "estimated", "to", "be", "approximately", "17%.", "<tag3>"], "wordsA": ["While", "we", "do", "not", "anticipate", "making", "any", "cash", "payments", "representing", "interest,", "we", "will", "impute", "interest", "on", "the", "transaction", "and", "record", "interest", "expense", "at", "the", "effective", "interest", "rate", "of", "approximately", "17%."], "wordsB": ["We", "impute", "interest", "on", "the", "transaction", "and", "record", "interest", "expense", "at", "the", "effective", "interest", "rate,", "which", "we", "currently", "estimated", "to", "be", "approximately", "17%."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p69_s2", "idA": "906709_12_item7_p32_s2", "sentA": "While we do not anticipate making any cash payments representing interest, we will impute interest on the transaction and record interest expense at the effective interest rate of approximately 17%.", "sentB": "As a result, we impute interest on the transaction and record interest expense at the estimated interest rate.", "type": 2, "words": ["<tag1>", "While", "we", "do", "not", "anticipate", "making", "any", "cash", "payments", "representing", "interest,", "we", "will", "impute", "interest", "on", "the", "transaction", "and", "record", "interest", "expense", "at", "the", "effective", "interest", "rate", "of", "approximately", "17%.", "<tag2>", "As", "a", "result,", "we", "impute", "interest", "on", "the", "transaction", "and", "record", "interest", "expense", "at", "the", "estimated", "interest", "rate.", "<tag3>"], "wordsA": ["While", "we", "do", "not", "anticipate", "making", "any", "cash", "payments", "representing", "interest,", "we", "will", "impute", "interest", "on", "the", "transaction", "and", "record", "interest", "expense", "at", "the", "effective", "interest", "rate", "of", "approximately", "17%."], "wordsB": ["As", "a", "result,", "we", "impute", "interest", "on", "the", "transaction", "and", "record", "interest", "expense", "at", "the", "estimated", "interest", "rate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p40_s9", "idA": "906709_12_item7_p32_s3", "sentA": "As a result, we expect interest expense in 2012 to increase significantly from 2011.", "sentB": "As a result, future interest rates could differ significantly and any such change in interest rate will be adjusted prospectively.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "we", "expect", "interest", "expense", "in", "2012", "to", "increase", "significantly", "from", "2011.", "<tag2>", "As", "a", "result,", "future", "interest", "rates", "could", "differ", "significantly", "and", "any", "such", "change", "in", "interest", "rate", "will", "be", "adjusted", "prospectively.", "<tag3>"], "wordsA": ["As", "a", "result,", "we", "expect", "interest", "expense", "in", "2012", "to", "increase", "significantly", "from", "2011."], "wordsB": ["As", "a", "result,", "future", "interest", "rates", "could", "differ", "significantly", "and", "any", "such", "change", "in", "interest", "rate", "will", "be", "adjusted", "prospectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p41_s0", "idA": "906709_12_item7_p32_s3", "sentA": "As a result, we expect interest expense in 2012 to increase significantly from 2011.", "sentB": "As a result of the timing of the royalty sale transaction and the issuance of the senior secured notes in 2012, we expect interest expense and non-cash interest expense to increase in 2013 as compared to 2012.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "we", "expect", "interest", "expense", "in", "2012", "to", "increase", "significantly", "from", "2011.", "<tag2>", "As", "a", "result", "of", "the", "timing", "of", "the", "royalty", "sale", "transaction", "and", "the", "issuance", "of", "the", "senior", "secured", "notes", "in", "2012,", "we", "expect", "interest", "expense", "and", "non-cash", "interest", "expense", "to", "increase", "in", "2013", "as", "compared", "to", "2012.", "<tag3>"], "wordsA": ["As", "a", "result,", "we", "expect", "interest", "expense", "in", "2012", "to", "increase", "significantly", "from", "2011."], "wordsB": ["As", "a", "result", "of", "the", "timing", "of", "the", "royalty", "sale", "transaction", "and", "the", "issuance", "of", "the", "senior", "secured", "notes", "in", "2012,", "we", "expect", "interest", "expense", "and", "non-cash", "interest", "expense", "to", "increase", "in", "2013", "as", "compared", "to", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p17_s1", "idA": "906709_12_item7_p32_s6", "sentA": "As of December 31, 2011, we had cash, cash equivalents and investments in marketable securities of $414.9 million and indebtedness of $239.9 million, including $215.0 million of convertible subordinated notes, $17.0 million in capital lease obligations and $7.9 million in other liabilities.", "sentB": "As of December 31, 2012, we had at least twelve months of working capital to fund our current business plans.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2011,", "we", "had", "cash,", "cash", "equivalents", "and", "investments", "in", "marketable", "securities", "of", "$414.9", "million", "and", "indebtedness", "of", "$239.9", "million,", "including", "$215.0", "million", "of", "convertible", "subordinated", "notes,", "$17.0", "million", "in", "capital", "lease", "obligations", "and", "$7.9", "million", "in", "other", "liabilities.", "<tag2>", "As", "of", "December", "31,", "2012,", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2011,", "we", "had", "cash,", "cash", "equivalents", "and", "investments", "in", "marketable", "securities", "of", "$414.9", "million", "and", "indebtedness", "of", "$239.9", "million,", "including", "$215.0", "million", "of", "convertible", "subordinated", "notes,", "$17.0", "million", "in", "capital", "lease", "obligations", "and", "$7.9", "million", "in", "other", "liabilities."], "wordsB": ["As", "of", "December", "31,", "2012,", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p41_s3", "idA": "906709_12_item7_p32_s6", "sentA": "As of December 31, 2011, we had cash, cash equivalents and investments in marketable securities of $414.9 million and indebtedness of $239.9 million, including $215.0 million of convertible subordinated notes, $17.0 million in capital lease obligations and $7.9 million in other liabilities.", "sentB": "As of December 31, 2012, we had cash, cash equivalents and investments in marketable securities of $302.2 million and indebtedness of $149.0 million.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2011,", "we", "had", "cash,", "cash", "equivalents", "and", "investments", "in", "marketable", "securities", "of", "$414.9", "million", "and", "indebtedness", "of", "$239.9", "million,", "including", "$215.0", "million", "of", "convertible", "subordinated", "notes,", "$17.0", "million", "in", "capital", "lease", "obligations", "and", "$7.9", "million", "in", "other", "liabilities.", "<tag2>", "As", "of", "December", "31,", "2012,", "we", "had", "cash,", "cash", "equivalents", "and", "investments", "in", "marketable", "securities", "of", "$302.2", "million", "and", "indebtedness", "of", "$149.0", "million.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2011,", "we", "had", "cash,", "cash", "equivalents", "and", "investments", "in", "marketable", "securities", "of", "$414.9", "million", "and", "indebtedness", "of", "$239.9", "million,", "including", "$215.0", "million", "of", "convertible", "subordinated", "notes,", "$17.0", "million", "in", "capital", "lease", "obligations", "and", "$7.9", "million", "in", "other", "liabilities."], "wordsB": ["As", "of", "December", "31,", "2012,", "we", "had", "cash,", "cash", "equivalents", "and", "investments", "in", "marketable", "securities", "of", "$302.2", "million", "and", "indebtedness", "of", "$149.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p43_s1", "idA": "906709_12_item7_p32_s6", "sentA": "As of December 31, 2011, we had cash, cash equivalents and investments in marketable securities of $414.9 million and indebtedness of $239.9 million, including $215.0 million of convertible subordinated notes, $17.0 million in capital lease obligations and $7.9 million in other liabilities.", "sentB": "As of December 31, 2012, we had at least twelve months of working capital to fund our current business plans.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2011,", "we", "had", "cash,", "cash", "equivalents", "and", "investments", "in", "marketable", "securities", "of", "$414.9", "million", "and", "indebtedness", "of", "$239.9", "million,", "including", "$215.0", "million", "of", "convertible", "subordinated", "notes,", "$17.0", "million", "in", "capital", "lease", "obligations", "and", "$7.9", "million", "in", "other", "liabilities.", "<tag2>", "As", "of", "December", "31,", "2012,", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2011,", "we", "had", "cash,", "cash", "equivalents", "and", "investments", "in", "marketable", "securities", "of", "$414.9", "million", "and", "indebtedness", "of", "$239.9", "million,", "including", "$215.0", "million", "of", "convertible", "subordinated", "notes,", "$17.0", "million", "in", "capital", "lease", "obligations", "and", "$7.9", "million", "in", "other", "liabilities."], "wordsB": ["As", "of", "December", "31,", "2012,", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p58_s0", "idA": "906709_12_item7_p32_s6", "sentA": "As of December 31, 2011, we had cash, cash equivalents and investments in marketable securities of $414.9 million and indebtedness of $239.9 million, including $215.0 million of convertible subordinated notes, $17.0 million in capital lease obligations and $7.9 million in other liabilities.", "sentB": "As of December 31, 2012, we had $25.8 million of deferred upfront fees related to two collaboration agreements that are being amortized over 11 to 14 years, or an average of 12.5 years.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2011,", "we", "had", "cash,", "cash", "equivalents", "and", "investments", "in", "marketable", "securities", "of", "$414.9", "million", "and", "indebtedness", "of", "$239.9", "million,", "including", "$215.0", "million", "of", "convertible", "subordinated", "notes,", "$17.0", "million", "in", "capital", "lease", "obligations", "and", "$7.9", "million", "in", "other", "liabilities.", "<tag2>", "As", "of", "December", "31,", "2012,", "we", "had", "$25.8", "million", "of", "deferred", "upfront", "fees", "related", "to", "two", "collaboration", "agreements", "that", "are", "being", "amortized", "over", "11", "to", "14", "years,", "or", "an", "average", "of", "12.5", "years.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2011,", "we", "had", "cash,", "cash", "equivalents", "and", "investments", "in", "marketable", "securities", "of", "$414.9", "million", "and", "indebtedness", "of", "$239.9", "million,", "including", "$215.0", "million", "of", "convertible", "subordinated", "notes,", "$17.0", "million", "in", "capital", "lease", "obligations", "and", "$7.9", "million", "in", "other", "liabilities."], "wordsB": ["As", "of", "December", "31,", "2012,", "we", "had", "$25.8", "million", "of", "deferred", "upfront", "fees", "related", "to", "two", "collaboration", "agreements", "that", "are", "being", "amortized", "over", "11", "to", "14", "years,", "or", "an", "average", "of", "12.5", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p38_s2", "idA": "906709_12_item7_p32_s7", "sentA": "Additionally at December 31, 2011, we had letter of credit arrangements with certain financial institutions and vendors, including our landlord, totaling $2.4 million.", "sentB": "As of December 31, 2012, the remaining net book value of these assets is $1.4 million.", "type": 2, "words": ["<tag1>", "Additionally", "at", "December", "31,", "2011,", "we", "had", "letter", "of", "credit", "arrangements", "with", "certain", "financial", "institutions", "and", "vendors,", "including", "our", "landlord,", "totaling", "$2.4", "million.", "<tag2>", "As", "of", "December", "31,", "2012,", "the", "remaining", "net", "book", "value", "of", "these", "assets", "is", "$1.4", "million.", "<tag3>"], "wordsA": ["Additionally", "at", "December", "31,", "2011,", "we", "had", "letter", "of", "credit", "arrangements", "with", "certain", "financial", "institutions", "and", "vendors,", "including", "our", "landlord,", "totaling", "$2.4", "million."], "wordsB": ["As", "of", "December", "31,", "2012,", "the", "remaining", "net", "book", "value", "of", "these", "assets", "is", "$1.4", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p42_s4", "idA": "906709_12_item7_p32_s7", "sentA": "Additionally at December 31, 2011, we had letter of credit arrangements with certain financial institutions and vendors, including our landlord, totaling $2.4 million.", "sentB": "Additionally at December 31, 2012, we had letter of credit arrangements with certain financial institutions and vendors, including our landlord, totaling $2.4 million.", "type": 2, "words": ["<tag1>", "Additionally", "at", "December", "31,", "2011,", "we", "had", "letter", "of", "credit", "arrangements", "with", "certain", "financial", "institutions", "and", "vendors,", "including", "our", "landlord,", "totaling", "$2.4", "million.", "<tag2>", "Additionally", "at", "December", "31,", "2012,", "we", "had", "letter", "of", "credit", "arrangements", "with", "certain", "financial", "institutions", "and", "vendors,", "including", "our", "landlord,", "totaling", "$2.4", "million.", "<tag3>"], "wordsA": ["Additionally", "at", "December", "31,", "2011,", "we", "had", "letter", "of", "credit", "arrangements", "with", "certain", "financial", "institutions", "and", "vendors,", "including", "our", "landlord,", "totaling", "$2.4", "million."], "wordsB": ["Additionally", "at", "December", "31,", "2012,", "we", "had", "letter", "of", "credit", "arrangements", "with", "certain", "financial", "institutions", "and", "vendors,", "including", "our", "landlord,", "totaling", "$2.4", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p42_s5", "idA": "906709_12_item7_p32_s8", "sentA": "These letters of credit will expire during 2012 and are secured by investments of similar amounts.", "sentB": "These letters of credit will expire during 2013 and are secured by investments of similar amounts.", "type": 2, "words": ["<tag1>", "These", "letters", "of", "credit", "will", "expire", "during", "2012", "and", "are", "secured", "by", "investments", "of", "similar", "amounts.", "<tag2>", "These", "letters", "of", "credit", "will", "expire", "during", "2013", "and", "are", "secured", "by", "investments", "of", "similar", "amounts.", "<tag3>"], "wordsA": ["These", "letters", "of", "credit", "will", "expire", "during", "2012", "and", "are", "secured", "by", "investments", "of", "similar", "amounts."], "wordsB": ["These", "letters", "of", "credit", "will", "expire", "during", "2013", "and", "are", "secured", "by", "investments", "of", "similar", "amounts."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p17_s3", "idA": "906709_12_item7_p33_s0", "sentA": "We have no material credit facility or other material committed sources of capital.", "sentB": "However, we have no credit facility or any other sources of committed capital.", "type": 2, "words": ["<tag1>", "We", "have", "no", "material", "credit", "facility", "or", "other", "material", "committed", "sources", "of", "capital.", "<tag2>", "However,", "we", "have", "no", "credit", "facility", "or", "any", "other", "sources", "of", "committed", "capital.", "<tag3>"], "wordsA": ["We", "have", "no", "material", "credit", "facility", "or", "other", "material", "committed", "sources", "of", "capital."], "wordsB": ["However,", "we", "have", "no", "credit", "facility", "or", "any", "other", "sources", "of", "committed", "capital."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p43_s3", "idA": "906709_12_item7_p33_s0", "sentA": "We have no material credit facility or other material committed sources of capital.", "sentB": "However, we have no credit facility or any other sources of committed capital.", "type": 2, "words": ["<tag1>", "We", "have", "no", "material", "credit", "facility", "or", "other", "material", "committed", "sources", "of", "capital.", "<tag2>", "However,", "we", "have", "no", "credit", "facility", "or", "any", "other", "sources", "of", "committed", "capital.", "<tag3>"], "wordsA": ["We", "have", "no", "material", "credit", "facility", "or", "other", "material", "committed", "sources", "of", "capital."], "wordsB": ["However,", "we", "have", "no", "credit", "facility", "or", "any", "other", "sources", "of", "committed", "capital."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p47_s6", "idA": "906709_12_item7_p34_s0", "sentA": "On February 29, 2012, we sold all of our rights to receive future royalty payments on CIMZIA and MIRCERA in exchange for $124.0 million.", "sentB": "On July 11, 2012, we issued $125.0 million of senior secured notes maturing on July 15, 2017.", "type": 2, "words": ["<tag1>", "On", "February", "29,", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "on", "CIMZIA", "and", "MIRCERA", "in", "exchange", "for", "$124.0", "million.", "<tag2>", "On", "July", "11,", "2012,", "we", "issued", "$125.0", "million", "of", "senior", "secured", "notes", "maturing", "on", "July", "15,", "2017.", "<tag3>"], "wordsA": ["On", "February", "29,", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "on", "CIMZIA", "and", "MIRCERA", "in", "exchange", "for", "$124.0", "million."], "wordsB": ["On", "July", "11,", "2012,", "we", "issued", "$125.0", "million", "of", "senior", "secured", "notes", "maturing", "on", "July", "15,", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p42_s2", "idA": "906709_12_item7_p34_s1", "sentA": "Additionally, we incurred approximately $4.5 million in transaction costs.", "sentB": "As a result of these transactions, we received cash of $82.5 million, less approximately $4.5 million in transaction costs, of which $25.0 million is required to be maintained in a restricted account until July 1, 2015.", "type": 2, "words": ["<tag1>", "Additionally,", "we", "incurred", "approximately", "$4.5", "million", "in", "transaction", "costs.", "<tag2>", "As", "a", "result", "of", "these", "transactions,", "we", "received", "cash", "of", "$82.5", "million,", "less", "approximately", "$4.5", "million", "in", "transaction", "costs,", "of", "which", "$25.0", "million", "is", "required", "to", "be", "maintained", "in", "a", "restricted", "account", "until", "July", "1,", "2015.", "<tag3>"], "wordsA": ["Additionally,", "we", "incurred", "approximately", "$4.5", "million", "in", "transaction", "costs."], "wordsB": ["As", "a", "result", "of", "these", "transactions,", "we", "received", "cash", "of", "$82.5", "million,", "less", "approximately", "$4.5", "million", "in", "transaction", "costs,", "of", "which", "$25.0", "million", "is", "required", "to", "be", "maintained", "in", "a", "restricted", "account", "until", "July", "1,", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p47_s5", "idA": "906709_12_item7_p34_s1", "sentA": "Additionally, we incurred approximately $4.5 million in transaction costs.", "sentB": "As part of this sale, we incurred approximately $4.4 million in transaction costs.", "type": 2, "words": ["<tag1>", "Additionally,", "we", "incurred", "approximately", "$4.5", "million", "in", "transaction", "costs.", "<tag2>", "As", "part", "of", "this", "sale,", "we", "incurred", "approximately", "$4.4", "million", "in", "transaction", "costs.", "<tag3>"], "wordsA": ["Additionally,", "we", "incurred", "approximately", "$4.5", "million", "in", "transaction", "costs."], "wordsB": ["As", "part", "of", "this", "sale,", "we", "incurred", "approximately", "$4.4", "million", "in", "transaction", "costs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p17_s10", "idA": "906709_12_item7_p34_s11", "sentA": "If we do not receive substantial milestone payments from our existing collaboration agreements, execute new high value collaboration partnerships, or if we are unable to raise additional capital in one or more financing transactions, we would be unable to continue our current level of investment in research and development.", "sentB": "In the event we do not enter into any new collaboration partnerships with significant up-front payments or do not receive the naloxegol regulatory milestone payments in 2013, we would likely be required to pursue financing alternatives.", "type": 2, "words": ["<tag1>", "If", "we", "do", "not", "receive", "substantial", "milestone", "payments", "from", "our", "existing", "collaboration", "agreements,", "execute", "new", "high", "value", "collaboration", "partnerships,", "or", "if", "we", "are", "unable", "to", "raise", "additional", "capital", "in", "one", "or", "more", "financing", "transactions,", "we", "would", "be", "unable", "to", "continue", "our", "current", "level", "of", "investment", "in", "research", "and", "development.", "<tag2>", "In", "the", "event", "we", "do", "not", "enter", "into", "any", "new", "collaboration", "partnerships", "with", "significant", "up-front", "payments", "or", "do", "not", "receive", "the", "naloxegol", "regulatory", "milestone", "payments", "in", "2013,", "we", "would", "likely", "be", "required", "to", "pursue", "financing", "alternatives.", "<tag3>"], "wordsA": ["If", "we", "do", "not", "receive", "substantial", "milestone", "payments", "from", "our", "existing", "collaboration", "agreements,", "execute", "new", "high", "value", "collaboration", "partnerships,", "or", "if", "we", "are", "unable", "to", "raise", "additional", "capital", "in", "one", "or", "more", "financing", "transactions,", "we", "would", "be", "unable", "to", "continue", "our", "current", "level", "of", "investment", "in", "research", "and", "development."], "wordsB": ["In", "the", "event", "we", "do", "not", "enter", "into", "any", "new", "collaboration", "partnerships", "with", "significant", "up-front", "payments", "or", "do", "not", "receive", "the", "naloxegol", "regulatory", "milestone", "payments", "in", "2013,", "we", "would", "likely", "be", "required", "to", "pursue", "financing", "alternatives."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p44_s6", "idA": "906709_12_item7_p34_s11", "sentA": "If we do not receive substantial milestone payments from our existing collaboration agreements, execute new high value collaboration partnerships, or if we are unable to raise additional capital in one or more financing transactions, we would be unable to continue our current level of investment in research and development.", "sentB": "In the event we do not enter into any new collaboration partnerships with significant up-front payments or do not receive the naloxegol regulatory milestone payments in 2013, we would likely be required to pursue financing alternatives.", "type": 2, "words": ["<tag1>", "If", "we", "do", "not", "receive", "substantial", "milestone", "payments", "from", "our", "existing", "collaboration", "agreements,", "execute", "new", "high", "value", "collaboration", "partnerships,", "or", "if", "we", "are", "unable", "to", "raise", "additional", "capital", "in", "one", "or", "more", "financing", "transactions,", "we", "would", "be", "unable", "to", "continue", "our", "current", "level", "of", "investment", "in", "research", "and", "development.", "<tag2>", "In", "the", "event", "we", "do", "not", "enter", "into", "any", "new", "collaboration", "partnerships", "with", "significant", "up-front", "payments", "or", "do", "not", "receive", "the", "naloxegol", "regulatory", "milestone", "payments", "in", "2013,", "we", "would", "likely", "be", "required", "to", "pursue", "financing", "alternatives.", "<tag3>"], "wordsA": ["If", "we", "do", "not", "receive", "substantial", "milestone", "payments", "from", "our", "existing", "collaboration", "agreements,", "execute", "new", "high", "value", "collaboration", "partnerships,", "or", "if", "we", "are", "unable", "to", "raise", "additional", "capital", "in", "one", "or", "more", "financing", "transactions,", "we", "would", "be", "unable", "to", "continue", "our", "current", "level", "of", "investment", "in", "research", "and", "development."], "wordsB": ["In", "the", "event", "we", "do", "not", "enter", "into", "any", "new", "collaboration", "partnerships", "with", "significant", "up-front", "payments", "or", "do", "not", "receive", "the", "naloxegol", "regulatory", "milestone", "payments", "in", "2013,", "we", "would", "likely", "be", "required", "to", "pursue", "financing", "alternatives."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p45_s0", "idA": "906709_12_item7_p34_s12", "sentA": "Due to the potential for continued uncertainty in the credit markets in 2012, we may experience reduced liquidity with respect to some of our investments in marketable securities.", "sentB": "Due to the potential for continued uncertainty in the credit markets in 2013 and thereafter, we may experience reduced liquidity with respect to some of our investments in marketable securities.", "type": 2, "words": ["<tag1>", "Due", "to", "the", "potential", "for", "continued", "uncertainty", "in", "the", "credit", "markets", "in", "2012,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities.", "<tag2>", "Due", "to", "the", "potential", "for", "continued", "uncertainty", "in", "the", "credit", "markets", "in", "2013", "and", "thereafter,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities.", "<tag3>"], "wordsA": ["Due", "to", "the", "potential", "for", "continued", "uncertainty", "in", "the", "credit", "markets", "in", "2012,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities."], "wordsB": ["Due", "to", "the", "potential", "for", "continued", "uncertainty", "in", "the", "credit", "markets", "in", "2013", "and", "thereafter,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p45_s2", "idA": "906709_12_item7_p34_s14", "sentA": "However, if the need arose to liquidate such securities before maturity, we may experience losses on liquidation.", "sentB": "However, if the need arises to liquidate such securities before maturity, we may experience losses on liquidation.", "type": 2, "words": ["<tag1>", "However,", "if", "the", "need", "arose", "to", "liquidate", "such", "securities", "before", "maturity,", "we", "may", "experience", "losses", "on", "liquidation.", "<tag2>", "However,", "if", "the", "need", "arises", "to", "liquidate", "such", "securities", "before", "maturity,", "we", "may", "experience", "losses", "on", "liquidation.", "<tag3>"], "wordsA": ["However,", "if", "the", "need", "arose", "to", "liquidate", "such", "securities", "before", "maturity,", "we", "may", "experience", "losses", "on", "liquidation."], "wordsB": ["However,", "if", "the", "need", "arises", "to", "liquidate", "such", "securities", "before", "maturity,", "we", "may", "experience", "losses", "on", "liquidation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p45_s3", "idA": "906709_12_item7_p34_s15", "sentA": "At December 31, 2011, the average time to maturity of the investments held in our portfolio was approximately ten months and the maturity of any single investment did not exceed twenty-four months.", "sentB": "At December 31, 2012, the average time to maturity of the investments held in our portfolio was approximately four months and the maturity of any single investment did not exceed two years.", "type": 2, "words": ["<tag1>", "At", "December", "31,", "2011,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "ten", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "twenty-four", "months.", "<tag2>", "At", "December", "31,", "2012,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "four", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "two", "years.", "<tag3>"], "wordsA": ["At", "December", "31,", "2011,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "ten", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "twenty-four", "months."], "wordsB": ["At", "December", "31,", "2012,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "four", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "two", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p16_s2", "idA": "906709_12_item7_p34_s16", "sentA": "To date we have not experienced any liquidity issues with respect to these securities, but should such issues arise, we may be required to hold some, or all, of these securities until maturity.", "sentB": "As is further described in Note 7, this royalty obligation liability will not be settled in cash, but we may be required to make a payment of up to $7.0 million in 2014 if the worldwide net sales thresholds of MIRCERA in 2013 are not met.", "type": 2, "words": ["<tag1>", "To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "should", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity.", "<tag2>", "As", "is", "further", "described", "in", "Note", "7,", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash,", "but", "we", "may", "be", "required", "to", "make", "a", "payment", "of", "up", "to", "$7.0", "million", "in", "2014", "if", "the", "worldwide", "net", "sales", "thresholds", "of", "MIRCERA", "in", "2013", "are", "not", "met.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "should", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity."], "wordsB": ["As", "is", "further", "described", "in", "Note", "7,", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash,", "but", "we", "may", "be", "required", "to", "make", "a", "payment", "of", "up", "to", "$7.0", "million", "in", "2014", "if", "the", "worldwide", "net", "sales", "thresholds", "of", "MIRCERA", "in", "2013", "are", "not", "met."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p41_s5", "idA": "906709_12_item7_p34_s16", "sentA": "To date we have not experienced any liquidity issues with respect to these securities, but should such issues arise, we may be required to hold some, or all, of these securities until maturity.", "sentB": "As is further described in Note 7 to our Consolidated Financial Statements, this royalty obligation liability will not be settled in cash, but we may be required to make a payment of up to $7.0 million in 2014 if the worldwide net sales thresholds of MIRCERA in 2013 are not met.", "type": 2, "words": ["<tag1>", "To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "should", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity.", "<tag2>", "As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash,", "but", "we", "may", "be", "required", "to", "make", "a", "payment", "of", "up", "to", "$7.0", "million", "in", "2014", "if", "the", "worldwide", "net", "sales", "thresholds", "of", "MIRCERA", "in", "2013", "are", "not", "met.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "should", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity."], "wordsB": ["As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash,", "but", "we", "may", "be", "required", "to", "make", "a", "payment", "of", "up", "to", "$7.0", "million", "in", "2014", "if", "the", "worldwide", "net", "sales", "thresholds", "of", "MIRCERA", "in", "2013", "are", "not", "met."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p45_s4", "idA": "906709_12_item7_p34_s16", "sentA": "To date we have not experienced any liquidity issues with respect to these securities, but should such issues arise, we may be required to hold some, or all, of these securities until maturity.", "sentB": "To date we have not experienced any liquidity issues with respect to these securities, but if such issues arise, we may be required to hold some, or all, of these securities until maturity.", "type": 2, "words": ["<tag1>", "To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "should", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity.", "<tag2>", "To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "if", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "should", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity."], "wordsB": ["To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "if", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p46_s0", "idA": "906709_12_item7_p34_s18", "sentA": "Cash flows from operating activities Cash flows used in operating activities for the year ended December 31, 2011 totaled $113.7 million, which includes $7.0 million for semi-annual interest payments on our convertible subordinated notes, $11.2 million of prepayments to certain vendors in our BEACON study, and $125.0 million of other net operating cash uses, partially offset by the receipt of $29.5 million from collaboration agreements, of which $16.5 million was included in accounts receivable at December 31, 2010 resulting from an upfront payment obligation arising from an amendment to one of our manufacturing and supply agreements.", "sentB": "Cash flows from operating activities Cash flows used in operating activities for the year ended December 31, 2012 totaled $129.8 million, which includes $148.3 million of net operating cash uses, partially offset by the receipt of $18.5 million from collaboration agreements.", "type": 2, "words": ["<tag1>", "Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2011", "totaled", "$113.7", "million,", "which", "includes", "$7.0", "million", "for", "semi-annual", "interest", "payments", "on", "our", "convertible", "subordinated", "notes,", "$11.2", "million", "of", "prepayments", "to", "certain", "vendors", "in", "our", "BEACON", "study,", "and", "$125.0", "million", "of", "other", "net", "operating", "cash", "uses,", "partially", "offset", "by", "the", "receipt", "of", "$29.5", "million", "from", "collaboration", "agreements,", "of", "which", "$16.5", "million", "was", "included", "in", "accounts", "receivable", "at", "December", "31,", "2010", "resulting", "from", "an", "upfront", "payment", "obligation", "arising", "from", "an", "amendment", "to", "one", "of", "our", "manufacturing", "and", "supply", "agreements.", "<tag2>", "Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2012", "totaled", "$129.8", "million,", "which", "includes", "$148.3", "million", "of", "net", "operating", "cash", "uses,", "partially", "offset", "by", "the", "receipt", "of", "$18.5", "million", "from", "collaboration", "agreements.", "<tag3>"], "wordsA": ["Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2011", "totaled", "$113.7", "million,", "which", "includes", "$7.0", "million", "for", "semi-annual", "interest", "payments", "on", "our", "convertible", "subordinated", "notes,", "$11.2", "million", "of", "prepayments", "to", "certain", "vendors", "in", "our", "BEACON", "study,", "and", "$125.0", "million", "of", "other", "net", "operating", "cash", "uses,", "partially", "offset", "by", "the", "receipt", "of", "$29.5", "million", "from", "collaboration", "agreements,", "of", "which", "$16.5", "million", "was", "included", "in", "accounts", "receivable", "at", "December", "31,", "2010", "resulting", "from", "an", "upfront", "payment", "obligation", "arising", "from", "an", "amendment", "to", "one", "of", "our", "manufacturing", "and", "supply", "agreements."], "wordsB": ["Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2012", "totaled", "$129.8", "million,", "which", "includes", "$148.3", "million", "of", "net", "operating", "cash", "uses,", "partially", "offset", "by", "the", "receipt", "of", "$18.5", "million", "from", "collaboration", "agreements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p46_s3", "idA": "906709_12_item7_p34_s18", "sentA": "Cash flows from operating activities Cash flows used in operating activities for the year ended December 31, 2011 totaled $113.7 million, which includes $7.0 million for semi-annual interest payments on our convertible subordinated notes, $11.2 million of prepayments to certain vendors in our BEACON study, and $125.0 million of other net operating cash uses, partially offset by the receipt of $29.5 million from collaboration agreements, of which $16.5 million was included in accounts receivable at December 31, 2010 resulting from an upfront payment obligation arising from an amendment to one of our manufacturing and supply agreements.", "sentB": "Cash flows used in operating activities for the year ended December 31, 2011 totaled $113.7 million, which includes $7.0 million for semi-annual interest payments on our convertible subordinated notes, $11.2 million of prepayments to certain vendors in our BEACON study, and $125.0 million of other net operating cash uses, partially offset by the receipt of $29.5 million from collaboration agreements, of which $16.5 million was included in accounts receivable at December 31, 2010 resulting from an upfront payment obligation arising from an amendment to one of our manufacturing and supply agreements.", "type": 2, "words": ["<tag1>", "Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2011", "totaled", "$113.7", "million,", "which", "includes", "$7.0", "million", "for", "semi-annual", "interest", "payments", "on", "our", "convertible", "subordinated", "notes,", "$11.2", "million", "of", "prepayments", "to", "certain", "vendors", "in", "our", "BEACON", "study,", "and", "$125.0", "million", "of", "other", "net", "operating", "cash", "uses,", "partially", "offset", "by", "the", "receipt", "of", "$29.5", "million", "from", "collaboration", "agreements,", "of", "which", "$16.5", "million", "was", "included", "in", "accounts", "receivable", "at", "December", "31,", "2010", "resulting", "from", "an", "upfront", "payment", "obligation", "arising", "from", "an", "amendment", "to", "one", "of", "our", "manufacturing", "and", "supply", "agreements.", "<tag2>", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2011", "totaled", "$113.7", "million,", "which", "includes", "$7.0", "million", "for", "semi-annual", "interest", "payments", "on", "our", "convertible", "subordinated", "notes,", "$11.2", "million", "of", "prepayments", "to", "certain", "vendors", "in", "our", "BEACON", "study,", "and", "$125.0", "million", "of", "other", "net", "operating", "cash", "uses,", "partially", "offset", "by", "the", "receipt", "of", "$29.5", "million", "from", "collaboration", "agreements,", "of", "which", "$16.5", "million", "was", "included", "in", "accounts", "receivable", "at", "December", "31,", "2010", "resulting", "from", "an", "upfront", "payment", "obligation", "arising", "from", "an", "amendment", "to", "one", "of", "our", "manufacturing", "and", "supply", "agreements.", "<tag3>"], "wordsA": ["Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2011", "totaled", "$113.7", "million,", "which", "includes", "$7.0", "million", "for", "semi-annual", "interest", "payments", "on", "our", "convertible", "subordinated", "notes,", "$11.2", "million", "of", "prepayments", "to", "certain", "vendors", "in", "our", "BEACON", "study,", "and", "$125.0", "million", "of", "other", "net", "operating", "cash", "uses,", "partially", "offset", "by", "the", "receipt", "of", "$29.5", "million", "from", "collaboration", "agreements,", "of", "which", "$16.5", "million", "was", "included", "in", "accounts", "receivable", "at", "December", "31,", "2010", "resulting", "from", "an", "upfront", "payment", "obligation", "arising", "from", "an", "amendment", "to", "one", "of", "our", "manufacturing", "and", "supply", "agreements."], "wordsB": ["Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2011", "totaled", "$113.7", "million,", "which", "includes", "$7.0", "million", "for", "semi-annual", "interest", "payments", "on", "our", "convertible", "subordinated", "notes,", "$11.2", "million", "of", "prepayments", "to", "certain", "vendors", "in", "our", "BEACON", "study,", "and", "$125.0", "million", "of", "other", "net", "operating", "cash", "uses,", "partially", "offset", "by", "the", "receipt", "of", "$29.5", "million", "from", "collaboration", "agreements,", "of", "which", "$16.5", "million", "was", "included", "in", "accounts", "receivable", "at", "December", "31,", "2010", "resulting", "from", "an", "upfront", "payment", "obligation", "arising", "from", "an", "amendment", "to", "one", "of", "our", "manufacturing", "and", "supply", "agreements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p46_s2", "idA": "906709_12_item7_p34_s19", "sentA": "We expect that cash flows used in operating activities, excluding upfront payments received, if any, will increase in 2012 as a result of increased spending on our proprietary research and development programs and, in particular, our BEACON study.", "sentB": "We expect that cash flows used in operating activities, excluding upfront and milestone payments received, if any, will increase in 2013 as a result of increased spending on our proprietary research and development programs, in particular, our BEACON study.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront", "payments", "received,", "if", "any,", "will", "increase", "in", "2012", "as", "a", "result", "of", "increased", "spending", "on", "our", "proprietary", "research", "and", "development", "programs", "and,", "in", "particular,", "our", "BEACON", "study.", "<tag2>", "We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront", "and", "milestone", "payments", "received,", "if", "any,", "will", "increase", "in", "2013", "as", "a", "result", "of", "increased", "spending", "on", "our", "proprietary", "research", "and", "development", "programs,", "in", "particular,", "our", "BEACON", "study.", "<tag3>"], "wordsA": ["We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront", "payments", "received,", "if", "any,", "will", "increase", "in", "2012", "as", "a", "result", "of", "increased", "spending", "on", "our", "proprietary", "research", "and", "development", "programs", "and,", "in", "particular,", "our", "BEACON", "study."], "wordsB": ["We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront", "and", "milestone", "payments", "received,", "if", "any,", "will", "increase", "in", "2013", "as", "a", "result", "of", "increased", "spending", "on", "our", "proprietary", "research", "and", "development", "programs,", "in", "particular,", "our", "BEACON", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p64_s0", "idA": "906709_12_item7_p34_s4", "sentA": "We will evaluate financing alternatives, if any, in light of the then-existing market conditions.", "sentB": "estimated duration of the start-up and reporting phases.", "type": 2, "words": ["<tag1>", "We", "will", "evaluate", "financing", "alternatives,", "if", "any,", "in", "light", "of", "the", "then-existing", "market", "conditions.", "<tag2>", "estimated", "duration", "of", "the", "start-up", "and", "reporting", "phases.", "<tag3>"], "wordsA": ["We", "will", "evaluate", "financing", "alternatives,", "if", "any,", "in", "light", "of", "the", "then-existing", "market", "conditions."], "wordsB": ["estimated", "duration", "of", "the", "start-up", "and", "reporting", "phases."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p18_s0", "idA": "906709_12_item7_p34_s5", "sentA": "Where we believe it is in the best interests of the company and our stockholders, we are pursuing financing alternatives that are not dilutive to the ownership of our common stock security holders.", "sentB": "In the event we determine to explore financing alternatives, our objective would be to first pursue financing alternatives that are not dilutive to the ownership of our common stock security holders.", "type": 2, "words": ["<tag1>", "Where", "we", "believe", "it", "is", "in", "the", "best", "interests", "of", "the", "company", "and", "our", "stockholders,", "we", "are", "pursuing", "financing", "alternatives", "that", "are", "not", "dilutive", "to", "the", "ownership", "of", "our", "common", "stock", "security", "holders.", "<tag2>", "In", "the", "event", "we", "determine", "to", "explore", "financing", "alternatives,", "our", "objective", "would", "be", "to", "first", "pursue", "financing", "alternatives", "that", "are", "not", "dilutive", "to", "the", "ownership", "of", "our", "common", "stock", "security", "holders.", "<tag3>"], "wordsA": ["Where", "we", "believe", "it", "is", "in", "the", "best", "interests", "of", "the", "company", "and", "our", "stockholders,", "we", "are", "pursuing", "financing", "alternatives", "that", "are", "not", "dilutive", "to", "the", "ownership", "of", "our", "common", "stock", "security", "holders."], "wordsB": ["In", "the", "event", "we", "determine", "to", "explore", "financing", "alternatives,", "our", "objective", "would", "be", "to", "first", "pursue", "financing", "alternatives", "that", "are", "not", "dilutive", "to", "the", "ownership", "of", "our", "common", "stock", "security", "holders."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p44_s7", "idA": "906709_12_item7_p34_s5", "sentA": "Where we believe it is in the best interests of the company and our stockholders, we are pursuing financing alternatives that are not dilutive to the ownership of our common stock security holders.", "sentB": "In the event we determine to explore financing alternatives, our objective would be to first pursue financing alternatives that are not dilutive to the ownership of our common stock security holders.", "type": 2, "words": ["<tag1>", "Where", "we", "believe", "it", "is", "in", "the", "best", "interests", "of", "the", "company", "and", "our", "stockholders,", "we", "are", "pursuing", "financing", "alternatives", "that", "are", "not", "dilutive", "to", "the", "ownership", "of", "our", "common", "stock", "security", "holders.", "<tag2>", "In", "the", "event", "we", "determine", "to", "explore", "financing", "alternatives,", "our", "objective", "would", "be", "to", "first", "pursue", "financing", "alternatives", "that", "are", "not", "dilutive", "to", "the", "ownership", "of", "our", "common", "stock", "security", "holders.", "<tag3>"], "wordsA": ["Where", "we", "believe", "it", "is", "in", "the", "best", "interests", "of", "the", "company", "and", "our", "stockholders,", "we", "are", "pursuing", "financing", "alternatives", "that", "are", "not", "dilutive", "to", "the", "ownership", "of", "our", "common", "stock", "security", "holders."], "wordsB": ["In", "the", "event", "we", "determine", "to", "explore", "financing", "alternatives,", "our", "objective", "would", "be", "to", "first", "pursue", "financing", "alternatives", "that", "are", "not", "dilutive", "to", "the", "ownership", "of", "our", "common", "stock", "security", "holders."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p67_s1", "idA": "906709_12_item7_p34_s5", "sentA": "Where we believe it is in the best interests of the company and our stockholders, we are pursuing financing alternatives that are not dilutive to the ownership of our common stock security holders.", "sentB": "Because our employee stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect fair value estimates, in management s opinion, the existing models may not provide a reliable single measure of the fair value of our employee stock options or common stock purchased under our employee stock purchase plan.", "type": 2, "words": ["<tag1>", "Where", "we", "believe", "it", "is", "in", "the", "best", "interests", "of", "the", "company", "and", "our", "stockholders,", "we", "are", "pursuing", "financing", "alternatives", "that", "are", "not", "dilutive", "to", "the", "ownership", "of", "our", "common", "stock", "security", "holders.", "<tag2>", "Because", "our", "employee", "stock", "options", "have", "characteristics", "significantly", "different", "from", "those", "of", "traded", "options,", "and", "because", "changes", "in", "the", "subjective", "input", "assumptions", "can", "materially", "affect", "fair", "value", "estimates,", "in", "management", "s", "opinion,", "the", "existing", "models", "may", "not", "provide", "a", "reliable", "single", "measure", "of", "the", "fair", "value", "of", "our", "employee", "stock", "options", "or", "common", "stock", "purchased", "under", "our", "employee", "stock", "purchase", "plan.", "<tag3>"], "wordsA": ["Where", "we", "believe", "it", "is", "in", "the", "best", "interests", "of", "the", "company", "and", "our", "stockholders,", "we", "are", "pursuing", "financing", "alternatives", "that", "are", "not", "dilutive", "to", "the", "ownership", "of", "our", "common", "stock", "security", "holders."], "wordsB": ["Because", "our", "employee", "stock", "options", "have", "characteristics", "significantly", "different", "from", "those", "of", "traded", "options,", "and", "because", "changes", "in", "the", "subjective", "input", "assumptions", "can", "materially", "affect", "fair", "value", "estimates,", "in", "management", "s", "opinion,", "the", "existing", "models", "may", "not", "provide", "a", "reliable", "single", "measure", "of", "the", "fair", "value", "of", "our", "employee", "stock", "options", "or", "common", "stock", "purchased", "under", "our", "employee", "stock", "purchase", "plan."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p54_s3", "idA": "906709_12_item7_p34_s9", "sentA": "Our substantial debt, the market price of our common stock, and the general economic and equity market climate, among other factors, could substantially weaken our financial condition and could reduce or eliminate our ability to obtain short-term and long-term financing alternatives.", "sentB": "We have determined that for the periods reported in this report, the following accounting policies and estimates are critical in understanding our financial condition and results of our operations.", "type": 2, "words": ["<tag1>", "Our", "substantial", "debt,", "the", "market", "price", "of", "our", "common", "stock,", "and", "the", "general", "economic", "and", "equity", "market", "climate,", "among", "other", "factors,", "could", "substantially", "weaken", "our", "financial", "condition", "and", "could", "reduce", "or", "eliminate", "our", "ability", "to", "obtain", "short-term", "and", "long-term", "financing", "alternatives.", "<tag2>", "We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations.", "<tag3>"], "wordsA": ["Our", "substantial", "debt,", "the", "market", "price", "of", "our", "common", "stock,", "and", "the", "general", "economic", "and", "equity", "market", "climate,", "among", "other", "factors,", "could", "substantially", "weaken", "our", "financial", "condition", "and", "could", "reduce", "or", "eliminate", "our", "ability", "to", "obtain", "short-term", "and", "long-term", "financing", "alternatives."], "wordsB": ["We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p47_s0", "idA": "906709_12_item7_p35_s0", "sentA": "During the year ended December 31, 2010, net cash used in operating activities totaled $55.9 million, which primarily consisted of spending on operating costs and expenses and includes $7.0 million for interest payments on our convertible subordinated notes, and was partially offset by a $50.0 million upfront payment received from Amgen under the supply, dedicated suite and manufacturing guarantee agreement that we entered into with Amgen in October 2010.", "sentB": "on our convertible subordinated notes, and was partially offset by a $50.0 million upfront payment received from Amgen under the supply, dedicated suite and manufacturing guarantee agreement that we entered into with Amgen in October 2010.", "type": 2, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2010,", "net", "cash", "used", "in", "operating", "activities", "totaled", "$55.9", "million,", "which", "primarily", "consisted", "of", "spending", "on", "operating", "costs", "and", "expenses", "and", "includes", "$7.0", "million", "for", "interest", "payments", "on", "our", "convertible", "subordinated", "notes,", "and", "was", "partially", "offset", "by", "a", "$50.0", "million", "upfront", "payment", "received", "from", "Amgen", "under", "the", "supply,", "dedicated", "suite", "and", "manufacturing", "guarantee", "agreement", "that", "we", "entered", "into", "with", "Amgen", "in", "October", "2010.", "<tag2>", "on", "our", "convertible", "subordinated", "notes,", "and", "was", "partially", "offset", "by", "a", "$50.0", "million", "upfront", "payment", "received", "from", "Amgen", "under", "the", "supply,", "dedicated", "suite", "and", "manufacturing", "guarantee", "agreement", "that", "we", "entered", "into", "with", "Amgen", "in", "October", "2010.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2010,", "net", "cash", "used", "in", "operating", "activities", "totaled", "$55.9", "million,", "which", "primarily", "consisted", "of", "spending", "on", "operating", "costs", "and", "expenses", "and", "includes", "$7.0", "million", "for", "interest", "payments", "on", "our", "convertible", "subordinated", "notes,", "and", "was", "partially", "offset", "by", "a", "$50.0", "million", "upfront", "payment", "received", "from", "Amgen", "under", "the", "supply,", "dedicated", "suite", "and", "manufacturing", "guarantee", "agreement", "that", "we", "entered", "into", "with", "Amgen", "in", "October", "2010."], "wordsB": ["on", "our", "convertible", "subordinated", "notes,", "and", "was", "partially", "offset", "by", "a", "$50.0", "million", "upfront", "payment", "received", "from", "Amgen", "under", "the", "supply,", "dedicated", "suite", "and", "manufacturing", "guarantee", "agreement", "that", "we", "entered", "into", "with", "Amgen", "in", "October", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p47_s1", "idA": "906709_12_item7_p35_s2", "sentA": "Cash flows from investing activities We purchased $9.7 million, $31.5 million, and $16.4 million of property and equipment in the years ended December 31, 2011, 2010, and 2009, respectively.", "sentB": "Cash flows from investing activities We purchased $10.6 million, $9.7 million, and $31.5 million of property and equipment in the years ended December 31, 2012, 2011, and 2010, respectively.", "type": 2, "words": ["<tag1>", "Cash", "flows", "from", "investing", "activities", "We", "purchased", "$9.7", "million,", "$31.5", "million,", "and", "$16.4", "million", "of", "property", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2011,", "2010,", "and", "2009,", "respectively.", "<tag2>", "Cash", "flows", "from", "investing", "activities", "We", "purchased", "$10.6", "million,", "$9.7", "million,", "and", "$31.5", "million", "of", "property", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2012,", "2011,", "and", "2010,", "respectively.", "<tag3>"], "wordsA": ["Cash", "flows", "from", "investing", "activities", "We", "purchased", "$9.7", "million,", "$31.5", "million,", "and", "$16.4", "million", "of", "property", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2011,", "2010,", "and", "2009,", "respectively."], "wordsB": ["Cash", "flows", "from", "investing", "activities", "We", "purchased", "$10.6", "million,", "$9.7", "million,", "and", "$31.5", "million", "of", "property", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2012,", "2011,", "and", "2010,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p37_s2", "idA": "906709_12_item7_p35_s3", "sentA": "Additionally, we made advanced payments on property and equipment purchases of $4.3 million in the year ended December 31, 2009.", "sentB": "No further impairment losses were recorded in the year ended December 31, 2012, however, until we dispose of these assets, we will update our analysis of their fair value on a regular basis and such updates could result in further impairment charges in future periods.", "type": 2, "words": ["<tag1>", "Additionally,", "we", "made", "advanced", "payments", "on", "property", "and", "equipment", "purchases", "of", "$4.3", "million", "in", "the", "year", "ended", "December", "31,", "2009.", "<tag2>", "No", "further", "impairment", "losses", "were", "recorded", "in", "the", "year", "ended", "December", "31,", "2012,", "however,", "until", "we", "dispose", "of", "these", "assets,", "we", "will", "update", "our", "analysis", "of", "their", "fair", "value", "on", "a", "regular", "basis", "and", "such", "updates", "could", "result", "in", "further", "impairment", "charges", "in", "future", "periods.", "<tag3>"], "wordsA": ["Additionally,", "we", "made", "advanced", "payments", "on", "property", "and", "equipment", "purchases", "of", "$4.3", "million", "in", "the", "year", "ended", "December", "31,", "2009."], "wordsB": ["No", "further", "impairment", "losses", "were", "recorded", "in", "the", "year", "ended", "December", "31,", "2012,", "however,", "until", "we", "dispose", "of", "these", "assets,", "we", "will", "update", "our", "analysis", "of", "their", "fair", "value", "on", "a", "regular", "basis", "and", "such", "updates", "could", "result", "in", "further", "impairment", "charges", "in", "future", "periods."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p71_s0", "idA": "906709_12_item7_p35_s3", "sentA": "Additionally, we made advanced payments on property and equipment purchases of $4.3 million in the year ended December 31, 2009.", "sentB": "current estimate of 17%, the non-cash interest expense recognized in the year ended December 31, 2012 would have increased by $1.2 million.", "type": 2, "words": ["<tag1>", "Additionally,", "we", "made", "advanced", "payments", "on", "property", "and", "equipment", "purchases", "of", "$4.3", "million", "in", "the", "year", "ended", "December", "31,", "2009.", "<tag2>", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2012", "would", "have", "increased", "by", "$1.2", "million.", "<tag3>"], "wordsA": ["Additionally,", "we", "made", "advanced", "payments", "on", "property", "and", "equipment", "purchases", "of", "$4.3", "million", "in", "the", "year", "ended", "December", "31,", "2009."], "wordsB": ["current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2012", "would", "have", "increased", "by", "$1.2", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p47_s2", "idA": "906709_12_item7_p35_s4", "sentA": "Our capital expenditures increased in 2010, as we constructed the leasehold improvements for the Mission Bay Facility and completed our research and development facility in Hyderabad, India.", "sentB": "Our capital expenditures were higher in 2010 as we constructed the leasehold improvements for the Mission Bay Facility and completed our research and development facility in Hyderabad, India.", "type": 2, "words": ["<tag1>", "Our", "capital", "expenditures", "increased", "in", "2010,", "as", "we", "constructed", "the", "leasehold", "improvements", "for", "the", "Mission", "Bay", "Facility", "and", "completed", "our", "research", "and", "development", "facility", "in", "Hyderabad,", "India.", "<tag2>", "Our", "capital", "expenditures", "were", "higher", "in", "2010", "as", "we", "constructed", "the", "leasehold", "improvements", "for", "the", "Mission", "Bay", "Facility", "and", "completed", "our", "research", "and", "development", "facility", "in", "Hyderabad,", "India.", "<tag3>"], "wordsA": ["Our", "capital", "expenditures", "increased", "in", "2010,", "as", "we", "constructed", "the", "leasehold", "improvements", "for", "the", "Mission", "Bay", "Facility", "and", "completed", "our", "research", "and", "development", "facility", "in", "Hyderabad,", "India."], "wordsB": ["Our", "capital", "expenditures", "were", "higher", "in", "2010", "as", "we", "constructed", "the", "leasehold", "improvements", "for", "the", "Mission", "Bay", "Facility", "and", "completed", "our", "research", "and", "development", "facility", "in", "Hyderabad,", "India."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p47_s3", "idA": "906709_12_item7_p35_s5", "sentA": "We expect our capital expenditures in 2012 to be consistent with 2011.", "sentB": "We expect our capital expenditures in 2013 to be consistent with 2012.", "type": 2, "words": ["<tag1>", "We", "expect", "our", "capital", "expenditures", "in", "2012", "to", "be", "consistent", "with", "2011.", "<tag2>", "We", "expect", "our", "capital", "expenditures", "in", "2013", "to", "be", "consistent", "with", "2012.", "<tag3>"], "wordsA": ["We", "expect", "our", "capital", "expenditures", "in", "2012", "to", "be", "consistent", "with", "2011."], "wordsB": ["We", "expect", "our", "capital", "expenditures", "in", "2013", "to", "be", "consistent", "with", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p37_s3", "idA": "906709_12_item7_p36_s0", "sentA": "On December 31, 2008, we completed the sale of certain pulmonary assets to Novartis for a purchase price of $115.0 million.", "sentB": "As of December 31, 2012, the remaining net book value of these assets is $2.8 million.", "type": 2, "words": ["<tag1>", "On", "December", "31,", "2008,", "we", "completed", "the", "sale", "of", "certain", "pulmonary", "assets", "to", "Novartis", "for", "a", "purchase", "price", "of", "$115.0", "million.", "<tag2>", "As", "of", "December", "31,", "2012,", "the", "remaining", "net", "book", "value", "of", "these", "assets", "is", "$2.8", "million.", "<tag3>"], "wordsA": ["On", "December", "31,", "2008,", "we", "completed", "the", "sale", "of", "certain", "pulmonary", "assets", "to", "Novartis", "for", "a", "purchase", "price", "of", "$115.0", "million."], "wordsB": ["As", "of", "December", "31,", "2012,", "the", "remaining", "net", "book", "value", "of", "these", "assets", "is", "$2.8", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p16_s1", "idA": "906709_12_item7_p36_s1", "sentA": "We paid $0.2 million in transaction costs related to the sale during the year ended December 31, 2008 and $4.4 million in transaction costs during the year ended December 31, 2009.", "sentB": "The indebtedness includes $125.0 million in aggregate principal amount of 12.0% senior secured notes due July 15, 2017 which we issued during the three months ended September 30, 2012, but excludes our long-term liability relating to the sale of future royalties under the Purchase and Sale Agreement with RPI Finance Trust (RPI).", "type": 2, "words": ["<tag1>", "We", "paid", "$0.2", "million", "in", "transaction", "costs", "related", "to", "the", "sale", "during", "the", "year", "ended", "December", "31,", "2008", "and", "$4.4", "million", "in", "transaction", "costs", "during", "the", "year", "ended", "December", "31,", "2009.", "<tag2>", "The", "indebtedness", "includes", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "15,", "2017", "which", "we", "issued", "during", "the", "three", "months", "ended", "September", "30,", "2012,", "but", "excludes", "our", "long-term", "liability", "relating", "to", "the", "sale", "of", "future", "royalties", "under", "the", "Purchase", "and", "Sale", "Agreement", "with", "RPI", "Finance", "Trust", "(RPI).", "<tag3>"], "wordsA": ["We", "paid", "$0.2", "million", "in", "transaction", "costs", "related", "to", "the", "sale", "during", "the", "year", "ended", "December", "31,", "2008", "and", "$4.4", "million", "in", "transaction", "costs", "during", "the", "year", "ended", "December", "31,", "2009."], "wordsB": ["The", "indebtedness", "includes", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "15,", "2017", "which", "we", "issued", "during", "the", "three", "months", "ended", "September", "30,", "2012,", "but", "excludes", "our", "long-term", "liability", "relating", "to", "the", "sale", "of", "future", "royalties", "under", "the", "Purchase", "and", "Sale", "Agreement", "with", "RPI", "Finance", "Trust", "(RPI)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p29_s0", "idA": "906709_12_item7_p36_s1", "sentA": "We paid $0.2 million in transaction costs related to the sale during the year ended December 31, 2008 and $4.4 million in transaction costs during the year ended December 31, 2009.", "sentB": "In addition, during the year ended December 31, 2011, we made $11.2 million of prepayments to certain vendors in our BEACON study.", "type": 2, "words": ["<tag1>", "We", "paid", "$0.2", "million", "in", "transaction", "costs", "related", "to", "the", "sale", "during", "the", "year", "ended", "December", "31,", "2008", "and", "$4.4", "million", "in", "transaction", "costs", "during", "the", "year", "ended", "December", "31,", "2009.", "<tag2>", "In", "addition,", "during", "the", "year", "ended", "December", "31,", "2011,", "we", "made", "$11.2", "million", "of", "prepayments", "to", "certain", "vendors", "in", "our", "BEACON", "study.", "<tag3>"], "wordsA": ["We", "paid", "$0.2", "million", "in", "transaction", "costs", "related", "to", "the", "sale", "during", "the", "year", "ended", "December", "31,", "2008", "and", "$4.4", "million", "in", "transaction", "costs", "during", "the", "year", "ended", "December", "31,", "2009."], "wordsB": ["In", "addition,", "during", "the", "year", "ended", "December", "31,", "2011,", "we", "made", "$11.2", "million", "of", "prepayments", "to", "certain", "vendors", "in", "our", "BEACON", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p61_s0", "idA": "906709_12_item7_p36_s1", "sentA": "We paid $0.2 million in transaction costs related to the sale during the year ended December 31, 2008 and $4.4 million in transaction costs during the year ended December 31, 2009.", "sentB": "If we had determined a longer or shorter amortization period was appropriate, our annual upfront fee amortization for these agreements could be as low as $2.4 million or as high as $11.0 million as compared to the $3.2 million recognized in the year ended December 31, 2012.", "type": 2, "words": ["<tag1>", "We", "paid", "$0.2", "million", "in", "transaction", "costs", "related", "to", "the", "sale", "during", "the", "year", "ended", "December", "31,", "2008", "and", "$4.4", "million", "in", "transaction", "costs", "during", "the", "year", "ended", "December", "31,", "2009.", "<tag2>", "If", "we", "had", "determined", "a", "longer", "or", "shorter", "amortization", "period", "was", "appropriate,", "our", "annual", "upfront", "fee", "amortization", "for", "these", "agreements", "could", "be", "as", "low", "as", "$2.4", "million", "or", "as", "high", "as", "$11.0", "million", "as", "compared", "to", "the", "$3.2", "million", "recognized", "in", "the", "year", "ended", "December", "31,", "2012.", "<tag3>"], "wordsA": ["We", "paid", "$0.2", "million", "in", "transaction", "costs", "related", "to", "the", "sale", "during", "the", "year", "ended", "December", "31,", "2008", "and", "$4.4", "million", "in", "transaction", "costs", "during", "the", "year", "ended", "December", "31,", "2009."], "wordsB": ["If", "we", "had", "determined", "a", "longer", "or", "shorter", "amortization", "period", "was", "appropriate,", "our", "annual", "upfront", "fee", "amortization", "for", "these", "agreements", "could", "be", "as", "low", "as", "$2.4", "million", "or", "as", "high", "as", "$11.0", "million", "as", "compared", "to", "the", "$3.2", "million", "recognized", "in", "the", "year", "ended", "December", "31,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p48_s2", "idA": "906709_12_item7_p36_s4", "sentA": "We received proceeds from issuance of common stock related to our employee option and stock purchase plans of $4.5 million, $8.9 million, and $4.8 million in the years ended December 31, 2011, 2010, and 2009, respectively.", "sentB": "We received proceeds from issuance of common stock related to our employee option and stock purchase plans of $4.1 million, $4.5 million, and $8.9 million in the years ended December 31, 2012, 2011, and 2010, respectively.", "type": 2, "words": ["<tag1>", "We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$4.5", "million,", "$8.9", "million,", "and", "$4.8", "million", "in", "the", "years", "ended", "December", "31,", "2011,", "2010,", "and", "2009,", "respectively.", "<tag2>", "We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$4.1", "million,", "$4.5", "million,", "and", "$8.9", "million", "in", "the", "years", "ended", "December", "31,", "2012,", "2011,", "and", "2010,", "respectively.", "<tag3>"], "wordsA": ["We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$4.5", "million,", "$8.9", "million,", "and", "$4.8", "million", "in", "the", "years", "ended", "December", "31,", "2011,", "2010,", "and", "2009,", "respectively."], "wordsB": ["We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$4.1", "million,", "$4.5", "million,", "and", "$8.9", "million", "in", "the", "years", "ended", "December", "31,", "2012,", "2011,", "and", "2010,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p49_s0", "idA": "906709_12_item7_p37_s0", "sentA": "(1) The above table does not include certain commitments and contingencies which are discussed in Note 7 of Item 8.", "sentB": "(1) The above table does not include certain commitments and contingencies which are discussed in Note 8 of Item 8.", "type": 2, "words": ["<tag1>", "(1)", "The", "above", "table", "does", "not", "include", "certain", "commitments", "and", "contingencies", "which", "are", "discussed", "in", "Note", "7", "of", "Item", "8.", "<tag2>", "(1)", "The", "above", "table", "does", "not", "include", "certain", "commitments", "and", "contingencies", "which", "are", "discussed", "in", "Note", "8", "of", "Item", "8.", "<tag3>"], "wordsA": ["(1)", "The", "above", "table", "does", "not", "include", "certain", "commitments", "and", "contingencies", "which", "are", "discussed", "in", "Note", "7", "of", "Item", "8."], "wordsB": ["(1)", "The", "above", "table", "does", "not", "include", "certain", "commitments", "and", "contingencies", "which", "are", "discussed", "in", "Note", "8", "of", "Item", "8."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p52_s0", "idA": "906709_12_item7_p38_s0", "sentA": "(2) These amounts primarily result from capital lease obligations arising from our office space lease at 201 Industrial Road in San Carlos, California.", "sentB": "(3) These amounts primarily result from capital lease obligations arising from our office space lease at 201 Industrial Road in San Carlos, California.", "type": 2, "words": ["<tag1>", "(2)", "These", "amounts", "primarily", "result", "from", "capital", "lease", "obligations", "arising", "from", "our", "office", "space", "lease", "at", "201", "Industrial", "Road", "in", "San", "Carlos,", "California.", "<tag2>", "(3)", "These", "amounts", "primarily", "result", "from", "capital", "lease", "obligations", "arising", "from", "our", "office", "space", "lease", "at", "201", "Industrial", "Road", "in", "San", "Carlos,", "California.", "<tag3>"], "wordsA": ["(2)", "These", "amounts", "primarily", "result", "from", "capital", "lease", "obligations", "arising", "from", "our", "office", "space", "lease", "at", "201", "Industrial", "Road", "in", "San", "Carlos,", "California."], "wordsB": ["(3)", "These", "amounts", "primarily", "result", "from", "capital", "lease", "obligations", "arising", "from", "our", "office", "space", "lease", "at", "201", "Industrial", "Road", "in", "San", "Carlos,", "California."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p52_s1", "idA": "906709_12_item7_p39_s0", "sentA": "result of the relocation of all of our California functions, including our corporate headquarters and an R D center, to our Mission Bay Facility.", "sentB": "In November 2010, we ceased use of this space as a result of the relocation of all of our California functions to our Mission Bay Facility.", "type": 2, "words": ["<tag1>", "result", "of", "the", "relocation", "of", "all", "of", "our", "California", "functions,", "including", "our", "corporate", "headquarters", "and", "an", "R", "D", "center,", "to", "our", "Mission", "Bay", "Facility.", "<tag2>", "In", "November", "2010,", "we", "ceased", "use", "of", "this", "space", "as", "a", "result", "of", "the", "relocation", "of", "all", "of", "our", "California", "functions", "to", "our", "Mission", "Bay", "Facility.", "<tag3>"], "wordsA": ["result", "of", "the", "relocation", "of", "all", "of", "our", "California", "functions,", "including", "our", "corporate", "headquarters", "and", "an", "R", "D", "center,", "to", "our", "Mission", "Bay", "Facility."], "wordsB": ["In", "November", "2010,", "we", "ceased", "use", "of", "this", "space", "as", "a", "result", "of", "the", "relocation", "of", "all", "of", "our", "California", "functions", "to", "our", "Mission", "Bay", "Facility."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p51_s3", "idA": "906709_12_item7_p39_s2", "sentA": "This is further discussed in Note 6 of Item 8.", "sentB": "The sublease is discussed in Note 6 of Item 8.", "type": 2, "words": ["<tag1>", "This", "is", "further", "discussed", "in", "Note", "6", "of", "Item", "8.", "<tag2>", "The", "sublease", "is", "discussed", "in", "Note", "6", "of", "Item", "8.", "<tag3>"], "wordsA": ["This", "is", "further", "discussed", "in", "Note", "6", "of", "Item", "8."], "wordsB": ["The", "sublease", "is", "discussed", "in", "Note", "6", "of", "Item", "8."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p50_s0", "idA": "906709_12_item7_p40_s0", "sentA": "(3) In November 2010, we moved into our Mission Bay Facility, which includes our corporate headquarters and an R D center.", "sentB": "In November 2010, we moved into our Mission Bay Facility, which includes our corporate headquarters and a research and development center.", "type": 2, "words": ["<tag1>", "(3)", "In", "November", "2010,", "we", "moved", "into", "our", "Mission", "Bay", "Facility,", "which", "includes", "our", "corporate", "headquarters", "and", "an", "R", "D", "center.", "<tag2>", "In", "November", "2010,", "we", "moved", "into", "our", "Mission", "Bay", "Facility,", "which", "includes", "our", "corporate", "headquarters", "and", "a", "research", "and", "development", "center.", "<tag3>"], "wordsA": ["(3)", "In", "November", "2010,", "we", "moved", "into", "our", "Mission", "Bay", "Facility,", "which", "includes", "our", "corporate", "headquarters", "and", "an", "R", "D", "center."], "wordsB": ["In", "November", "2010,", "we", "moved", "into", "our", "Mission", "Bay", "Facility,", "which", "includes", "our", "corporate", "headquarters", "and", "a", "research", "and", "development", "center."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p51_s0", "idA": "906709_12_item7_p40_s1", "sentA": "Under the terms of the sublease we entered into with Pfizer Inc. on September 30, 2009 for the Mission Bay Facility, we will begin making non-cancelable lease payments in 2014.", "sentB": "September 30, 2009 for the Mission Bay Facility, we will begin making non-cancelable lease payments in 2014.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "of", "the", "sublease", "we", "entered", "into", "with", "Pfizer", "Inc.", "on", "September", "30,", "2009", "for", "the", "Mission", "Bay", "Facility,", "we", "will", "begin", "making", "non-cancelable", "lease", "payments", "in", "2014.", "<tag2>", "September", "30,", "2009", "for", "the", "Mission", "Bay", "Facility,", "we", "will", "begin", "making", "non-cancelable", "lease", "payments", "in", "2014.", "<tag3>"], "wordsA": ["Under", "the", "terms", "of", "the", "sublease", "we", "entered", "into", "with", "Pfizer", "Inc.", "on", "September", "30,", "2009", "for", "the", "Mission", "Bay", "Facility,", "we", "will", "begin", "making", "non-cancelable", "lease", "payments", "in", "2014."], "wordsB": ["September", "30,", "2009", "for", "the", "Mission", "Bay", "Facility,", "we", "will", "begin", "making", "non-cancelable", "lease", "payments", "in", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p51_s2", "idA": "906709_12_item7_p40_s3", "sentA": "Under the terms of the amendment, beginning January 1, 2012, we will begin making lease payments for this additional space of $40,000 per month until May 31, 2013.", "sentB": "Under the terms of the amendment, beginning January 1, 2012, we began making lease payments for this additional space of $40,000 per month until at least May 31, 2013.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "of", "the", "amendment,", "beginning", "January", "1,", "2012,", "we", "will", "begin", "making", "lease", "payments", "for", "this", "additional", "space", "of", "$40,000", "per", "month", "until", "May", "31,", "2013.", "<tag2>", "Under", "the", "terms", "of", "the", "amendment,", "beginning", "January", "1,", "2012,", "we", "began", "making", "lease", "payments", "for", "this", "additional", "space", "of", "$40,000", "per", "month", "until", "at", "least", "May", "31,", "2013.", "<tag3>"], "wordsA": ["Under", "the", "terms", "of", "the", "amendment,", "beginning", "January", "1,", "2012,", "we", "will", "begin", "making", "lease", "payments", "for", "this", "additional", "space", "of", "$40,000", "per", "month", "until", "May", "31,", "2013."], "wordsB": ["Under", "the", "terms", "of", "the", "amendment,", "beginning", "January", "1,", "2012,", "we", "began", "making", "lease", "payments", "for", "this", "additional", "space", "of", "$40,000", "per", "month", "until", "at", "least", "May", "31,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p53_s2", "idA": "906709_12_item7_p40_s3", "sentA": "Under the terms of the amendment, beginning January 1, 2012, we will begin making lease payments for this additional space of $40,000 per month until May 31, 2013.", "sentB": "Given our current cash requirements, we forecast that we will have sufficient cash to meet our net operating expense requirements and contractual obligations at least through December 31, 2013.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "of", "the", "amendment,", "beginning", "January", "1,", "2012,", "we", "will", "begin", "making", "lease", "payments", "for", "this", "additional", "space", "of", "$40,000", "per", "month", "until", "May", "31,", "2013.", "<tag2>", "Given", "our", "current", "cash", "requirements,", "we", "forecast", "that", "we", "will", "have", "sufficient", "cash", "to", "meet", "our", "net", "operating", "expense", "requirements", "and", "contractual", "obligations", "at", "least", "through", "December", "31,", "2013.", "<tag3>"], "wordsA": ["Under", "the", "terms", "of", "the", "amendment,", "beginning", "January", "1,", "2012,", "we", "will", "begin", "making", "lease", "payments", "for", "this", "additional", "space", "of", "$40,000", "per", "month", "until", "May", "31,", "2013."], "wordsB": ["Given", "our", "current", "cash", "requirements,", "we", "forecast", "that", "we", "will", "have", "sufficient", "cash", "to", "meet", "our", "net", "operating", "expense", "requirements", "and", "contractual", "obligations", "at", "least", "through", "December", "31,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p11_s1", "idA": "906709_12_item7_p4_s0", "sentA": "Our second most advanced drug candidate, NKTR-102, is a next-generation topoisomerase I inhibitor, currently being evaluated as a single-agent therapy in a Phase 3 open-label, randomized, multicenter clinical study in patients with metastatic breast cancer.", "sentB": "In February 2013, Baxter initiated a Phase 3 multi-center, open-label clinical study called PROLONG-ATE that will enroll more than 100 previously treated adult patients with severe hemophilia A to assess the efficacy, safety and pharmacokinetics of BAX 855 for prophylaxis and on-demand treatment of bleeding.", "type": 2, "words": ["<tag1>", "Our", "second", "most", "advanced", "drug", "candidate,", "NKTR-102,", "is", "a", "next-generation", "topoisomerase", "I", "inhibitor,", "currently", "being", "evaluated", "as", "a", "single-agent", "therapy", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "in", "patients", "with", "metastatic", "breast", "cancer.", "<tag2>", "In", "February", "2013,", "Baxter", "initiated", "a", "Phase", "3", "multi-center,", "open-label", "clinical", "study", "called", "PROLONG-ATE", "that", "will", "enroll", "more", "than", "100", "previously", "treated", "adult", "patients", "with", "severe", "hemophilia", "A", "to", "assess", "the", "efficacy,", "safety", "and", "pharmacokinetics", "of", "BAX", "855", "for", "prophylaxis", "and", "on-demand", "treatment", "of", "bleeding.", "<tag3>"], "wordsA": ["Our", "second", "most", "advanced", "drug", "candidate,", "NKTR-102,", "is", "a", "next-generation", "topoisomerase", "I", "inhibitor,", "currently", "being", "evaluated", "as", "a", "single-agent", "therapy", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "in", "patients", "with", "metastatic", "breast", "cancer."], "wordsB": ["In", "February", "2013,", "Baxter", "initiated", "a", "Phase", "3", "multi-center,", "open-label", "clinical", "study", "called", "PROLONG-ATE", "that", "will", "enroll", "more", "than", "100", "previously", "treated", "adult", "patients", "with", "severe", "hemophilia", "A", "to", "assess", "the", "efficacy,", "safety", "and", "pharmacokinetics", "of", "BAX", "855", "for", "prophylaxis", "and", "on-demand", "treatment", "of", "bleeding."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p7_s0", "idA": "906709_12_item7_p4_s0", "sentA": "Our second most advanced drug candidate, NKTR-102, is a next-generation topoisomerase I inhibitor, currently being evaluated as a single-agent therapy in a Phase 3 open-label, randomized, multicenter clinical study in patients with metastatic breast cancer.", "sentB": "Our second most advanced proprietary drug candidate, etirinotecan pegol (formerly known as NKTR-102), is a next-generation topoisomerase I inhibitor.", "type": 2, "words": ["<tag1>", "Our", "second", "most", "advanced", "drug", "candidate,", "NKTR-102,", "is", "a", "next-generation", "topoisomerase", "I", "inhibitor,", "currently", "being", "evaluated", "as", "a", "single-agent", "therapy", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "in", "patients", "with", "metastatic", "breast", "cancer.", "<tag2>", "Our", "second", "most", "advanced", "proprietary", "drug", "candidate,", "etirinotecan", "pegol", "(formerly", "known", "as", "NKTR-102),", "is", "a", "next-generation", "topoisomerase", "I", "inhibitor.", "<tag3>"], "wordsA": ["Our", "second", "most", "advanced", "drug", "candidate,", "NKTR-102,", "is", "a", "next-generation", "topoisomerase", "I", "inhibitor,", "currently", "being", "evaluated", "as", "a", "single-agent", "therapy", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "in", "patients", "with", "metastatic", "breast", "cancer."], "wordsB": ["Our", "second", "most", "advanced", "proprietary", "drug", "candidate,", "etirinotecan", "pegol", "(formerly", "known", "as", "NKTR-102),", "is", "a", "next-generation", "topoisomerase", "I", "inhibitor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p7_s1", "idA": "906709_12_item7_p4_s0", "sentA": "Our second most advanced drug candidate, NKTR-102, is a next-generation topoisomerase I inhibitor, currently being evaluated as a single-agent therapy in a Phase 3 open-label, randomized, multicenter clinical study in patients with metastatic breast cancer.", "sentB": "Etirinotecan pegol is currently being evaluated as a single-agent therapy in a Phase 3 open-label, randomized, multicenter clinical study in patients with metastatic breast cancer.", "type": 2, "words": ["<tag1>", "Our", "second", "most", "advanced", "drug", "candidate,", "NKTR-102,", "is", "a", "next-generation", "topoisomerase", "I", "inhibitor,", "currently", "being", "evaluated", "as", "a", "single-agent", "therapy", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "in", "patients", "with", "metastatic", "breast", "cancer.", "<tag2>", "Etirinotecan", "pegol", "is", "currently", "being", "evaluated", "as", "a", "single-agent", "therapy", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "in", "patients", "with", "metastatic", "breast", "cancer.", "<tag3>"], "wordsA": ["Our", "second", "most", "advanced", "drug", "candidate,", "NKTR-102,", "is", "a", "next-generation", "topoisomerase", "I", "inhibitor,", "currently", "being", "evaluated", "as", "a", "single-agent", "therapy", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "in", "patients", "with", "metastatic", "breast", "cancer."], "wordsB": ["Etirinotecan", "pegol", "is", "currently", "being", "evaluated", "as", "a", "single-agent", "therapy", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "in", "patients", "with", "metastatic", "breast", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p7_s2", "idA": "906709_12_item7_p4_s1", "sentA": "This Phase 3 clinical study, which we call the BEACON study (BrEAst Cancer Outcomes with NKTR-102), was initiated by us in December 2011.", "sentB": "This Phase 3 clinical study, which we call the BEACON study (BrEAst Cancer Outcomes with NKTR-102), is scheduled to enroll approximately 840 patients with metastatic breast cancer that have previously received treatment with an anthracycline, a taxane, and capecitabine.", "type": 2, "words": ["<tag1>", "This", "Phase", "3", "clinical", "study,", "which", "we", "call", "the", "BEACON", "study", "(BrEAst", "Cancer", "Outcomes", "with", "NKTR-102),", "was", "initiated", "by", "us", "in", "December", "2011.", "<tag2>", "This", "Phase", "3", "clinical", "study,", "which", "we", "call", "the", "BEACON", "study", "(BrEAst", "Cancer", "Outcomes", "with", "NKTR-102),", "is", "scheduled", "to", "enroll", "approximately", "840", "patients", "with", "metastatic", "breast", "cancer", "that", "have", "previously", "received", "treatment", "with", "an", "anthracycline,", "a", "taxane,", "and", "capecitabine.", "<tag3>"], "wordsA": ["This", "Phase", "3", "clinical", "study,", "which", "we", "call", "the", "BEACON", "study", "(BrEAst", "Cancer", "Outcomes", "with", "NKTR-102),", "was", "initiated", "by", "us", "in", "December", "2011."], "wordsB": ["This", "Phase", "3", "clinical", "study,", "which", "we", "call", "the", "BEACON", "study", "(BrEAst", "Cancer", "Outcomes", "with", "NKTR-102),", "is", "scheduled", "to", "enroll", "approximately", "840", "patients", "with", "metastatic", "breast", "cancer", "that", "have", "previously", "received", "treatment", "with", "an", "anthracycline,", "a", "taxane,", "and", "capecitabine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p8_s0", "idA": "906709_12_item7_p4_s2", "sentA": "The BEACON study is scheduled to enroll approximately 840 patients with metastatic breast cancer.", "sentB": "In November 2012, etirinotecan pegol was designated by the FDA as a Fast Track development program for the treatment of patients with locally recurrent or metastatic breast cancer progressing after treatment with an anthracycline, a taxane, and capecitabine.", "type": 2, "words": ["<tag1>", "The", "BEACON", "study", "is", "scheduled", "to", "enroll", "approximately", "840", "patients", "with", "metastatic", "breast", "cancer.", "<tag2>", "In", "November", "2012,", "etirinotecan", "pegol", "was", "designated", "by", "the", "FDA", "as", "a", "Fast", "Track", "development", "program", "for", "the", "treatment", "of", "patients", "with", "locally", "recurrent", "or", "metastatic", "breast", "cancer", "progressing", "after", "treatment", "with", "an", "anthracycline,", "a", "taxane,", "and", "capecitabine.", "<tag3>"], "wordsA": ["The", "BEACON", "study", "is", "scheduled", "to", "enroll", "approximately", "840", "patients", "with", "metastatic", "breast", "cancer."], "wordsB": ["In", "November", "2012,", "etirinotecan", "pegol", "was", "designated", "by", "the", "FDA", "as", "a", "Fast", "Track", "development", "program", "for", "the", "treatment", "of", "patients", "with", "locally", "recurrent", "or", "metastatic", "breast", "cancer", "progressing", "after", "treatment", "with", "an", "anthracycline,", "a", "taxane,", "and", "capecitabine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p7_s3", "idA": "906709_12_item7_p4_s3", "sentA": "The BEACON study will require a substantial investment over the next three years.", "sentB": "The BEACON study will require a substantial investment over the next two years.", "type": 2, "words": ["<tag1>", "The", "BEACON", "study", "will", "require", "a", "substantial", "investment", "over", "the", "next", "three", "years.", "<tag2>", "The", "BEACON", "study", "will", "require", "a", "substantial", "investment", "over", "the", "next", "two", "years.", "<tag3>"], "wordsA": ["The", "BEACON", "study", "will", "require", "a", "substantial", "investment", "over", "the", "next", "three", "years."], "wordsB": ["The", "BEACON", "study", "will", "require", "a", "substantial", "investment", "over", "the", "next", "two", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p32_s2", "idA": "906709_12_item7_p4_s4", "sentA": "In the first quarter of 2012, we are also completing an expanded Phase 2 clinical study for NKTR-102 in patients with platinum-resistant ovarian cancer.", "sentB": "We are also finishing data analysis from the expanded Phase 2 clinical study for etirinotecan pegol in patients with platinum resistant/refractory ovarian cancer in preparation for meetings with health authorities in 2013.", "type": 2, "words": ["<tag1>", "In", "the", "first", "quarter", "of", "2012,", "we", "are", "also", "completing", "an", "expanded", "Phase", "2", "clinical", "study", "for", "NKTR-102", "in", "patients", "with", "platinum-resistant", "ovarian", "cancer.", "<tag2>", "We", "are", "also", "finishing", "data", "analysis", "from", "the", "expanded", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "patients", "with", "platinum", "resistant/refractory", "ovarian", "cancer", "in", "preparation", "for", "meetings", "with", "health", "authorities", "in", "2013.", "<tag3>"], "wordsA": ["In", "the", "first", "quarter", "of", "2012,", "we", "are", "also", "completing", "an", "expanded", "Phase", "2", "clinical", "study", "for", "NKTR-102", "in", "patients", "with", "platinum-resistant", "ovarian", "cancer."], "wordsB": ["We", "are", "also", "finishing", "data", "analysis", "from", "the", "expanded", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "patients", "with", "platinum", "resistant/refractory", "ovarian", "cancer", "in", "preparation", "for", "meetings", "with", "health", "authorities", "in", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p5_s1", "idA": "906709_12_item7_p4_s4", "sentA": "In the first quarter of 2012, we are also completing an expanded Phase 2 clinical study for NKTR-102 in patients with platinum-resistant ovarian cancer.", "sentB": "On February 26, 2013, AstraZeneca announced positive top-line results from the long-term safety study (KODIAC-08) of naloxegol in patients with OIC.", "type": 2, "words": ["<tag1>", "In", "the", "first", "quarter", "of", "2012,", "we", "are", "also", "completing", "an", "expanded", "Phase", "2", "clinical", "study", "for", "NKTR-102", "in", "patients", "with", "platinum-resistant", "ovarian", "cancer.", "<tag2>", "On", "February", "26,", "2013,", "AstraZeneca", "announced", "positive", "top-line", "results", "from", "the", "long-term", "safety", "study", "(KODIAC-08)", "of", "naloxegol", "in", "patients", "with", "OIC.", "<tag3>"], "wordsA": ["In", "the", "first", "quarter", "of", "2012,", "we", "are", "also", "completing", "an", "expanded", "Phase", "2", "clinical", "study", "for", "NKTR-102", "in", "patients", "with", "platinum-resistant", "ovarian", "cancer."], "wordsB": ["On", "February", "26,", "2013,", "AstraZeneca", "announced", "positive", "top-line", "results", "from", "the", "long-term", "safety", "study", "(KODIAC-08)", "of", "naloxegol", "in", "patients", "with", "OIC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p8_s1", "idA": "906709_12_item7_p4_s4", "sentA": "In the first quarter of 2012, we are also completing an expanded Phase 2 clinical study for NKTR-102 in patients with platinum-resistant ovarian cancer.", "sentB": "We have completed an expanded Phase 2 clinical study for etirinotecan pegol in patients with platinum-resistant ovarian cancer.", "type": 2, "words": ["<tag1>", "In", "the", "first", "quarter", "of", "2012,", "we", "are", "also", "completing", "an", "expanded", "Phase", "2", "clinical", "study", "for", "NKTR-102", "in", "patients", "with", "platinum-resistant", "ovarian", "cancer.", "<tag2>", "We", "have", "completed", "an", "expanded", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "patients", "with", "platinum-resistant", "ovarian", "cancer.", "<tag3>"], "wordsA": ["In", "the", "first", "quarter", "of", "2012,", "we", "are", "also", "completing", "an", "expanded", "Phase", "2", "clinical", "study", "for", "NKTR-102", "in", "patients", "with", "platinum-resistant", "ovarian", "cancer."], "wordsB": ["We", "have", "completed", "an", "expanded", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "patients", "with", "platinum-resistant", "ovarian", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p8_s3", "idA": "906709_12_item7_p4_s4", "sentA": "In the first quarter of 2012, we are also completing an expanded Phase 2 clinical study for NKTR-102 in patients with platinum-resistant ovarian cancer.", "sentB": "In addition, a Phase 2 clinical study for etirinotecan pegol in patients with metastatic colorectal cancer is still open for enrollment.", "type": 2, "words": ["<tag1>", "In", "the", "first", "quarter", "of", "2012,", "we", "are", "also", "completing", "an", "expanded", "Phase", "2", "clinical", "study", "for", "NKTR-102", "in", "patients", "with", "platinum-resistant", "ovarian", "cancer.", "<tag2>", "In", "addition,", "a", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "patients", "with", "metastatic", "colorectal", "cancer", "is", "still", "open", "for", "enrollment.", "<tag3>"], "wordsA": ["In", "the", "first", "quarter", "of", "2012,", "we", "are", "also", "completing", "an", "expanded", "Phase", "2", "clinical", "study", "for", "NKTR-102", "in", "patients", "with", "platinum-resistant", "ovarian", "cancer."], "wordsB": ["In", "addition,", "a", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "patients", "with", "metastatic", "colorectal", "cancer", "is", "still", "open", "for", "enrollment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p8_s2", "idA": "906709_12_item7_p5_s4", "sentA": "Results from this study and communication with government health authorities in both the United States and EU, will guide our future development and regulatory strategy for NKTR-102 in ovarian cancer.", "sentB": "We are currently in the process of finalizing the data in furtherance of planned meetings with health authorities in 2013 which will guide our future development and regulatory strategy for etirinotecan pegol in ovarian cancer.", "type": 2, "words": ["<tag1>", "Results", "from", "this", "study", "and", "communication", "with", "government", "health", "authorities", "in", "both", "the", "United", "States", "and", "EU,", "will", "guide", "our", "future", "development", "and", "regulatory", "strategy", "for", "NKTR-102", "in", "ovarian", "cancer.", "<tag2>", "We", "are", "currently", "in", "the", "process", "of", "finalizing", "the", "data", "in", "furtherance", "of", "planned", "meetings", "with", "health", "authorities", "in", "2013", "which", "will", "guide", "our", "future", "development", "and", "regulatory", "strategy", "for", "etirinotecan", "pegol", "in", "ovarian", "cancer.", "<tag3>"], "wordsA": ["Results", "from", "this", "study", "and", "communication", "with", "government", "health", "authorities", "in", "both", "the", "United", "States", "and", "EU,", "will", "guide", "our", "future", "development", "and", "regulatory", "strategy", "for", "NKTR-102", "in", "ovarian", "cancer."], "wordsB": ["We", "are", "currently", "in", "the", "process", "of", "finalizing", "the", "data", "in", "furtherance", "of", "planned", "meetings", "with", "health", "authorities", "in", "2013", "which", "will", "guide", "our", "future", "development", "and", "regulatory", "strategy", "for", "etirinotecan", "pegol", "in", "ovarian", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p9_s0", "idA": "906709_12_item7_p5_s5", "sentA": "We also have a significant collaboration with Bayer Healthcare LLC (Bayer) for Amikacin Inhale, an inhaled solution of amikacin, an aminoglycoside antibiotic, that has completed Phase 2 development.", "sentB": "We have a significant collaboration with Bayer Healthcare LLC (Bayer) to develop BAY41-6551 (Amikacin Inhale, formerly known as NKTR-061), which is an inhaled solution of amikacin, an aminoglycoside antibiotic, that has completed Phase 2 clinical development.", "type": 2, "words": ["<tag1>", "We", "also", "have", "a", "significant", "collaboration", "with", "Bayer", "Healthcare", "LLC", "(Bayer)", "for", "Amikacin", "Inhale,", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic,", "that", "has", "completed", "Phase", "2", "development.", "<tag2>", "We", "have", "a", "significant", "collaboration", "with", "Bayer", "Healthcare", "LLC", "(Bayer)", "to", "develop", "BAY41-6551", "(Amikacin", "Inhale,", "formerly", "known", "as", "NKTR-061),", "which", "is", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic,", "that", "has", "completed", "Phase", "2", "clinical", "development.", "<tag3>"], "wordsA": ["We", "also", "have", "a", "significant", "collaboration", "with", "Bayer", "Healthcare", "LLC", "(Bayer)", "for", "Amikacin", "Inhale,", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic,", "that", "has", "completed", "Phase", "2", "development."], "wordsB": ["We", "have", "a", "significant", "collaboration", "with", "Bayer", "Healthcare", "LLC", "(Bayer)", "to", "develop", "BAY41-6551", "(Amikacin", "Inhale,", "formerly", "known", "as", "NKTR-061),", "which", "is", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic,", "that", "has", "completed", "Phase", "2", "clinical", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p9_s5", "idA": "906709_12_item7_p5_s5", "sentA": "We also have a significant collaboration with Bayer Healthcare LLC (Bayer) for Amikacin Inhale, an inhaled solution of amikacin, an aminoglycoside antibiotic, that has completed Phase 2 development.", "sentB": "We also have a significant collaboration with Baxter Healthcare to identify and develop PEGylated drug candidates with the objective of providing new long-acting therapies for hemophilia patients.", "type": 2, "words": ["<tag1>", "We", "also", "have", "a", "significant", "collaboration", "with", "Bayer", "Healthcare", "LLC", "(Bayer)", "for", "Amikacin", "Inhale,", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic,", "that", "has", "completed", "Phase", "2", "development.", "<tag2>", "We", "also", "have", "a", "significant", "collaboration", "with", "Baxter", "Healthcare", "to", "identify", "and", "develop", "PEGylated", "drug", "candidates", "with", "the", "objective", "of", "providing", "new", "long-acting", "therapies", "for", "hemophilia", "patients.", "<tag3>"], "wordsA": ["We", "also", "have", "a", "significant", "collaboration", "with", "Bayer", "Healthcare", "LLC", "(Bayer)", "for", "Amikacin", "Inhale,", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic,", "that", "has", "completed", "Phase", "2", "development."], "wordsB": ["We", "also", "have", "a", "significant", "collaboration", "with", "Baxter", "Healthcare", "to", "identify", "and", "develop", "PEGylated", "drug", "candidates", "with", "the", "objective", "of", "providing", "new", "long-acting", "therapies", "for", "hemophilia", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p9_s2", "idA": "906709_12_item7_p5_s8", "sentA": "We expect to continue to make significant investments over the next two years in establishing manufacturing capability for the nebulizer device necessary to support the Phase 3 clinical study of this drug candidate and, if such study is successful and the drug candidate is approved by government health authorities, the commercial supply of the nebulizer device.", "sentB": "The stability studies on the nebulizer device that needed to be completed prior to the start of the Phase 3 clinical study were successfully completed in February 2013.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "continue", "to", "make", "significant", "investments", "over", "the", "next", "two", "years", "in", "establishing", "manufacturing", "capability", "for", "the", "nebulizer", "device", "necessary", "to", "support", "the", "Phase", "3", "clinical", "study", "of", "this", "drug", "candidate", "and,", "if", "such", "study", "is", "successful", "and", "the", "drug", "candidate", "is", "approved", "by", "government", "health", "authorities,", "the", "commercial", "supply", "of", "the", "nebulizer", "device.", "<tag2>", "The", "stability", "studies", "on", "the", "nebulizer", "device", "that", "needed", "to", "be", "completed", "prior", "to", "the", "start", "of", "the", "Phase", "3", "clinical", "study", "were", "successfully", "completed", "in", "February", "2013.", "<tag3>"], "wordsA": ["We", "expect", "to", "continue", "to", "make", "significant", "investments", "over", "the", "next", "two", "years", "in", "establishing", "manufacturing", "capability", "for", "the", "nebulizer", "device", "necessary", "to", "support", "the", "Phase", "3", "clinical", "study", "of", "this", "drug", "candidate", "and,", "if", "such", "study", "is", "successful", "and", "the", "drug", "candidate", "is", "approved", "by", "government", "health", "authorities,", "the", "commercial", "supply", "of", "the", "nebulizer", "device."], "wordsB": ["The", "stability", "studies", "on", "the", "nebulizer", "device", "that", "needed", "to", "be", "completed", "prior", "to", "the", "start", "of", "the", "Phase", "3", "clinical", "study", "were", "successfully", "completed", "in", "February", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p9_s4", "idA": "906709_12_item7_p5_s8", "sentA": "We expect to continue to make significant investments over the next two years in establishing manufacturing capability for the nebulizer device necessary to support the Phase 3 clinical study of this drug candidate and, if such study is successful and the drug candidate is approved by government health authorities, the commercial supply of the nebulizer device.", "sentB": "In 2011, Bayer achieved agreement with the FDA on the design of the planned Phase 3 clinical studies of BAY41-6551 under the Special Protocol Assessment process that is intended to support the submission of a NDA if the planned Phase 3 clinical study is successful.", "type": 2, "words": ["<tag1>", "We", "expect", "to", "continue", "to", "make", "significant", "investments", "over", "the", "next", "two", "years", "in", "establishing", "manufacturing", "capability", "for", "the", "nebulizer", "device", "necessary", "to", "support", "the", "Phase", "3", "clinical", "study", "of", "this", "drug", "candidate", "and,", "if", "such", "study", "is", "successful", "and", "the", "drug", "candidate", "is", "approved", "by", "government", "health", "authorities,", "the", "commercial", "supply", "of", "the", "nebulizer", "device.", "<tag2>", "In", "2011,", "Bayer", "achieved", "agreement", "with", "the", "FDA", "on", "the", "design", "of", "the", "planned", "Phase", "3", "clinical", "studies", "of", "BAY41-6551", "under", "the", "Special", "Protocol", "Assessment", "process", "that", "is", "intended", "to", "support", "the", "submission", "of", "a", "NDA", "if", "the", "planned", "Phase", "3", "clinical", "study", "is", "successful.", "<tag3>"], "wordsA": ["We", "expect", "to", "continue", "to", "make", "significant", "investments", "over", "the", "next", "two", "years", "in", "establishing", "manufacturing", "capability", "for", "the", "nebulizer", "device", "necessary", "to", "support", "the", "Phase", "3", "clinical", "study", "of", "this", "drug", "candidate", "and,", "if", "such", "study", "is", "successful", "and", "the", "drug", "candidate", "is", "approved", "by", "government", "health", "authorities,", "the", "commercial", "supply", "of", "the", "nebulizer", "device."], "wordsB": ["In", "2011,", "Bayer", "achieved", "agreement", "with", "the", "FDA", "on", "the", "design", "of", "the", "planned", "Phase", "3", "clinical", "studies", "of", "BAY41-6551", "under", "the", "Special", "Protocol", "Assessment", "process", "that", "is", "intended", "to", "support", "the", "submission", "of", "a", "NDA", "if", "the", "planned", "Phase", "3", "clinical", "study", "is", "successful."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p53_s4", "idA": "906709_12_item7_p6_s0", "sentA": "While we believe that our substantial investment in research and development has the potential to create significant value if one or more of our drug candidates demonstrates positive clinical results and/or receives regulatory approval in one or more major markets, drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval and the timing and outcome of clinical trial results is extremely difficult to predict.", "sentB": "Our capital needs will depend on many factors, including continued progress in our research and development programs, progress with preclinical and clinical trials of our proprietary and partnered drug candidates, our ability to successfully enter into additional collaboration agreements for one or more of our proprietary drug candidates or intellectual property that we control, the time and costs involved in obtaining regulatory approvals, the costs of developing and scaling our clinical and commercial manufacturing operations, the costs involved in preparing, filing, prosecuting, maintaining and enforcing patent claims, the need to acquire licenses to new technologies and the status of competitive products.", "type": 2, "words": ["<tag1>", "While", "we", "believe", "that", "our", "substantial", "investment", "in", "research", "and", "development", "has", "the", "potential", "to", "create", "significant", "value", "if", "one", "or", "more", "of", "our", "drug", "candidates", "demonstrates", "positive", "clinical", "results", "and/or", "receives", "regulatory", "approval", "in", "one", "or", "more", "major", "markets,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "outcome", "of", "clinical", "trial", "results", "is", "extremely", "difficult", "to", "predict.", "<tag2>", "Our", "capital", "needs", "will", "depend", "on", "many", "factors,", "including", "continued", "progress", "in", "our", "research", "and", "development", "programs,", "progress", "with", "preclinical", "and", "clinical", "trials", "of", "our", "proprietary", "and", "partnered", "drug", "candidates,", "our", "ability", "to", "successfully", "enter", "into", "additional", "collaboration", "agreements", "for", "one", "or", "more", "of", "our", "proprietary", "drug", "candidates", "or", "intellectual", "property", "that", "we", "control,", "the", "time", "and", "costs", "involved", "in", "obtaining", "regulatory", "approvals,", "the", "costs", "of", "developing", "and", "scaling", "our", "clinical", "and", "commercial", "manufacturing", "operations,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining", "and", "enforcing", "patent", "claims,", "the", "need", "to", "acquire", "licenses", "to", "new", "technologies", "and", "the", "status", "of", "competitive", "products.", "<tag3>"], "wordsA": ["While", "we", "believe", "that", "our", "substantial", "investment", "in", "research", "and", "development", "has", "the", "potential", "to", "create", "significant", "value", "if", "one", "or", "more", "of", "our", "drug", "candidates", "demonstrates", "positive", "clinical", "results", "and/or", "receives", "regulatory", "approval", "in", "one", "or", "more", "major", "markets,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "outcome", "of", "clinical", "trial", "results", "is", "extremely", "difficult", "to", "predict."], "wordsB": ["Our", "capital", "needs", "will", "depend", "on", "many", "factors,", "including", "continued", "progress", "in", "our", "research", "and", "development", "programs,", "progress", "with", "preclinical", "and", "clinical", "trials", "of", "our", "proprietary", "and", "partnered", "drug", "candidates,", "our", "ability", "to", "successfully", "enter", "into", "additional", "collaboration", "agreements", "for", "one", "or", "more", "of", "our", "proprietary", "drug", "candidates", "or", "intellectual", "property", "that", "we", "control,", "the", "time", "and", "costs", "involved", "in", "obtaining", "regulatory", "approvals,", "the", "costs", "of", "developing", "and", "scaling", "our", "clinical", "and", "commercial", "manufacturing", "operations,", "the", "costs", "involved", "in", "preparing,", "filing,", "prosecuting,", "maintaining", "and", "enforcing", "patent", "claims,", "the", "need", "to", "acquire", "licenses", "to", "new", "technologies", "and", "the", "status", "of", "competitive", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p40_s8", "idA": "906709_12_item7_p7_s0", "sentA": "Historically, we have entered into a number of license and supply contracts under which we manufactured and supplied our proprietary PEGylation reagents on a cost-plus or fixed price basis.", "sentB": "There are a number of factors that could materially affect the estimated interest rate and we will assess this estimate on a periodic basis.", "type": 2, "words": ["<tag1>", "Historically,", "we", "have", "entered", "into", "a", "number", "of", "license", "and", "supply", "contracts", "under", "which", "we", "manufactured", "and", "supplied", "our", "proprietary", "PEGylation", "reagents", "on", "a", "cost-plus", "or", "fixed", "price", "basis.", "<tag2>", "There", "are", "a", "number", "of", "factors", "that", "could", "materially", "affect", "the", "estimated", "interest", "rate", "and", "we", "will", "assess", "this", "estimate", "on", "a", "periodic", "basis.", "<tag3>"], "wordsA": ["Historically,", "we", "have", "entered", "into", "a", "number", "of", "license", "and", "supply", "contracts", "under", "which", "we", "manufactured", "and", "supplied", "our", "proprietary", "PEGylation", "reagents", "on", "a", "cost-plus", "or", "fixed", "price", "basis."], "wordsB": ["There", "are", "a", "number", "of", "factors", "that", "could", "materially", "affect", "the", "estimated", "interest", "rate", "and", "we", "will", "assess", "this", "estimate", "on", "a", "periodic", "basis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p62_s3", "idA": "906709_12_item7_p7_s0", "sentA": "Historically, we have entered into a number of license and supply contracts under which we manufactured and supplied our proprietary PEGylation reagents on a cost-plus or fixed price basis.", "sentB": "The objective of ESP is to determine the price at which we would transact a sale if the product or service was sold on a stand-alone basis.", "type": 2, "words": ["<tag1>", "Historically,", "we", "have", "entered", "into", "a", "number", "of", "license", "and", "supply", "contracts", "under", "which", "we", "manufactured", "and", "supplied", "our", "proprietary", "PEGylation", "reagents", "on", "a", "cost-plus", "or", "fixed", "price", "basis.", "<tag2>", "The", "objective", "of", "ESP", "is", "to", "determine", "the", "price", "at", "which", "we", "would", "transact", "a", "sale", "if", "the", "product", "or", "service", "was", "sold", "on", "a", "stand-alone", "basis.", "<tag3>"], "wordsA": ["Historically,", "we", "have", "entered", "into", "a", "number", "of", "license", "and", "supply", "contracts", "under", "which", "we", "manufactured", "and", "supplied", "our", "proprietary", "PEGylation", "reagents", "on", "a", "cost-plus", "or", "fixed", "price", "basis."], "wordsB": ["The", "objective", "of", "ESP", "is", "to", "determine", "the", "price", "at", "which", "we", "would", "transact", "a", "sale", "if", "the", "product", "or", "service", "was", "sold", "on", "a", "stand-alone", "basis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p16_s0", "idA": "906709_12_item7_p8_s0", "sentA": "Key Developments and Trends in Liquidity and Capital Resources At December 31, 2011, we had approximately $414.9 million in cash, cash equivalents, and investments in marketable securities and $239.9 million in indebtedness.", "sentB": "Key Developments and Trends in Liquidity and Capital Resources At December 31, 2012, we had approximately $302.2 million in cash, cash equivalents, and investments in marketable securities and $149.0 million in indebtedness.", "type": 2, "words": ["<tag1>", "Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "At", "December", "31,", "2011,", "we", "had", "approximately", "$414.9", "million", "in", "cash,", "cash", "equivalents,", "and", "investments", "in", "marketable", "securities", "and", "$239.9", "million", "in", "indebtedness.", "<tag2>", "Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "At", "December", "31,", "2012,", "we", "had", "approximately", "$302.2", "million", "in", "cash,", "cash", "equivalents,", "and", "investments", "in", "marketable", "securities", "and", "$149.0", "million", "in", "indebtedness.", "<tag3>"], "wordsA": ["Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "At", "December", "31,", "2011,", "we", "had", "approximately", "$414.9", "million", "in", "cash,", "cash", "equivalents,", "and", "investments", "in", "marketable", "securities", "and", "$239.9", "million", "in", "indebtedness."], "wordsB": ["Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "At", "December", "31,", "2012,", "we", "had", "approximately", "$302.2", "million", "in", "cash,", "cash", "equivalents,", "and", "investments", "in", "marketable", "securities", "and", "$149.0", "million", "in", "indebtedness."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p17_s0", "idA": "906709_12_item7_p8_s1", "sentA": "We have $215.0 million in outstanding convertible subordinated notes due September 2012.", "sentB": "During the year-ended December 31, 2012, we retired $215.0 million in aggregate principal amount of our previously outstanding convertible subordinated notes.", "type": 2, "words": ["<tag1>", "We", "have", "$215.0", "million", "in", "outstanding", "convertible", "subordinated", "notes", "due", "September", "2012.", "<tag2>", "During", "the", "year-ended", "December", "31,", "2012,", "we", "retired", "$215.0", "million", "in", "aggregate", "principal", "amount", "of", "our", "previously", "outstanding", "convertible", "subordinated", "notes.", "<tag3>"], "wordsA": ["We", "have", "$215.0", "million", "in", "outstanding", "convertible", "subordinated", "notes", "due", "September", "2012."], "wordsB": ["During", "the", "year-ended", "December", "31,", "2012,", "we", "retired", "$215.0", "million", "in", "aggregate", "principal", "amount", "of", "our", "previously", "outstanding", "convertible", "subordinated", "notes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p40_s2", "idA": "906709_12_item7_p8_s1", "sentA": "We have $215.0 million in outstanding convertible subordinated notes due September 2012.", "sentB": "In connection with this transaction, we retired a principal amount of $42.5 million of our $215.0 million in aggregate principal amount of 3.25% convertible subordinated notes in exchange for $42.5 million in principal amount of 12% senior secured notes.", "type": 2, "words": ["<tag1>", "We", "have", "$215.0", "million", "in", "outstanding", "convertible", "subordinated", "notes", "due", "September", "2012.", "<tag2>", "In", "connection", "with", "this", "transaction,", "we", "retired", "a", "principal", "amount", "of", "$42.5", "million", "of", "our", "$215.0", "million", "in", "aggregate", "principal", "amount", "of", "3.25%", "convertible", "subordinated", "notes", "in", "exchange", "for", "$42.5", "million", "in", "principal", "amount", "of", "12%", "senior", "secured", "notes.", "<tag3>"], "wordsA": ["We", "have", "$215.0", "million", "in", "outstanding", "convertible", "subordinated", "notes", "due", "September", "2012."], "wordsB": ["In", "connection", "with", "this", "transaction,", "we", "retired", "a", "principal", "amount", "of", "$42.5", "million", "of", "our", "$215.0", "million", "in", "aggregate", "principal", "amount", "of", "3.25%", "convertible", "subordinated", "notes", "in", "exchange", "for", "$42.5", "million", "in", "principal", "amount", "of", "12%", "senior", "secured", "notes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p40_s3", "idA": "906709_12_item7_p8_s1", "sentA": "We have $215.0 million in outstanding convertible subordinated notes due September 2012.", "sentB": "We repaid the remaining $172.4 million in principal amount of convertible subordinated notes in full at maturity on September 28, 2012.", "type": 2, "words": ["<tag1>", "We", "have", "$215.0", "million", "in", "outstanding", "convertible", "subordinated", "notes", "due", "September", "2012.", "<tag2>", "We", "repaid", "the", "remaining", "$172.4", "million", "in", "principal", "amount", "of", "convertible", "subordinated", "notes", "in", "full", "at", "maturity", "on", "September", "28,", "2012.", "<tag3>"], "wordsA": ["We", "have", "$215.0", "million", "in", "outstanding", "convertible", "subordinated", "notes", "due", "September", "2012."], "wordsB": ["We", "repaid", "the", "remaining", "$172.4", "million", "in", "principal", "amount", "of", "convertible", "subordinated", "notes", "in", "full", "at", "maturity", "on", "September", "28,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p41_s4", "idA": "906709_12_item7_p8_s1", "sentA": "We have $215.0 million in outstanding convertible subordinated notes due September 2012.", "sentB": "The indebtedness includes $125.0 million in aggregate principal amount of 12.0% senior secured notes due July 15, 2017, but excludes our long-term liability relating to the sale of future royalties.", "type": 2, "words": ["<tag1>", "We", "have", "$215.0", "million", "in", "outstanding", "convertible", "subordinated", "notes", "due", "September", "2012.", "<tag2>", "The", "indebtedness", "includes", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "15,", "2017,", "but", "excludes", "our", "long-term", "liability", "relating", "to", "the", "sale", "of", "future", "royalties.", "<tag3>"], "wordsA": ["We", "have", "$215.0", "million", "in", "outstanding", "convertible", "subordinated", "notes", "due", "September", "2012."], "wordsB": ["The", "indebtedness", "includes", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "15,", "2017,", "but", "excludes", "our", "long-term", "liability", "relating", "to", "the", "sale", "of", "future", "royalties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p42_s0", "idA": "906709_12_item7_p8_s1", "sentA": "We have $215.0 million in outstanding convertible subordinated notes due September 2012.", "sentB": "On July 11, 2012, we issued $125.0 million in aggregate principal amount of senior secured notes.", "type": 2, "words": ["<tag1>", "We", "have", "$215.0", "million", "in", "outstanding", "convertible", "subordinated", "notes", "due", "September", "2012.", "<tag2>", "On", "July", "11,", "2012,", "we", "issued", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "senior", "secured", "notes.", "<tag3>"], "wordsA": ["We", "have", "$215.0", "million", "in", "outstanding", "convertible", "subordinated", "notes", "due", "September", "2012."], "wordsB": ["On", "July", "11,", "2012,", "we", "issued", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "senior", "secured", "notes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p42_s1", "idA": "906709_12_item7_p8_s1", "sentA": "We have $215.0 million in outstanding convertible subordinated notes due September 2012.", "sentB": "In connection with this transaction, we retired a principal amount of $42.5 million of our $215.0 million in aggregate principal amount of 3.25% convertible subordinated notes in exchange for $42.5 million in principal amount of senior secured notes.", "type": 2, "words": ["<tag1>", "We", "have", "$215.0", "million", "in", "outstanding", "convertible", "subordinated", "notes", "due", "September", "2012.", "<tag2>", "In", "connection", "with", "this", "transaction,", "we", "retired", "a", "principal", "amount", "of", "$42.5", "million", "of", "our", "$215.0", "million", "in", "aggregate", "principal", "amount", "of", "3.25%", "convertible", "subordinated", "notes", "in", "exchange", "for", "$42.5", "million", "in", "principal", "amount", "of", "senior", "secured", "notes.", "<tag3>"], "wordsA": ["We", "have", "$215.0", "million", "in", "outstanding", "convertible", "subordinated", "notes", "due", "September", "2012."], "wordsB": ["In", "connection", "with", "this", "transaction,", "we", "retired", "a", "principal", "amount", "of", "$42.5", "million", "of", "our", "$215.0", "million", "in", "aggregate", "principal", "amount", "of", "3.25%", "convertible", "subordinated", "notes", "in", "exchange", "for", "$42.5", "million", "in", "principal", "amount", "of", "senior", "secured", "notes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p42_s3", "idA": "906709_12_item7_p8_s1", "sentA": "We have $215.0 million in outstanding convertible subordinated notes due September 2012.", "sentB": "On September 28, 2012, we repaid the remaining $172.4 million in principal amount on the convertible subordinated notes.", "type": 2, "words": ["<tag1>", "We", "have", "$215.0", "million", "in", "outstanding", "convertible", "subordinated", "notes", "due", "September", "2012.", "<tag2>", "On", "September", "28,", "2012,", "we", "repaid", "the", "remaining", "$172.4", "million", "in", "principal", "amount", "on", "the", "convertible", "subordinated", "notes.", "<tag3>"], "wordsA": ["We", "have", "$215.0", "million", "in", "outstanding", "convertible", "subordinated", "notes", "due", "September", "2012."], "wordsB": ["On", "September", "28,", "2012,", "we", "repaid", "the", "remaining", "$172.4", "million", "in", "principal", "amount", "on", "the", "convertible", "subordinated", "notes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p46_s1", "idA": "906709_12_item7_p8_s1", "sentA": "We have $215.0 million in outstanding convertible subordinated notes due September 2012.", "sentB": "Net operating cash uses also include $6.7 million in interest payments on our convertible subordinated notes retired in full on September 28, 2012.", "type": 2, "words": ["<tag1>", "We", "have", "$215.0", "million", "in", "outstanding", "convertible", "subordinated", "notes", "due", "September", "2012.", "<tag2>", "Net", "operating", "cash", "uses", "also", "include", "$6.7", "million", "in", "interest", "payments", "on", "our", "convertible", "subordinated", "notes", "retired", "in", "full", "on", "September", "28,", "2012.", "<tag3>"], "wordsA": ["We", "have", "$215.0", "million", "in", "outstanding", "convertible", "subordinated", "notes", "due", "September", "2012."], "wordsB": ["Net", "operating", "cash", "uses", "also", "include", "$6.7", "million", "in", "interest", "payments", "on", "our", "convertible", "subordinated", "notes", "retired", "in", "full", "on", "September", "28,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p47_s10", "idA": "906709_12_item7_p8_s1", "sentA": "We have $215.0 million in outstanding convertible subordinated notes due September 2012.", "sentB": "On September 28, 2012, we repaid the remaining $172.4 million in principal amount of the convertible subordinated notes.", "type": 2, "words": ["<tag1>", "We", "have", "$215.0", "million", "in", "outstanding", "convertible", "subordinated", "notes", "due", "September", "2012.", "<tag2>", "On", "September", "28,", "2012,", "we", "repaid", "the", "remaining", "$172.4", "million", "in", "principal", "amount", "of", "the", "convertible", "subordinated", "notes.", "<tag3>"], "wordsA": ["We", "have", "$215.0", "million", "in", "outstanding", "convertible", "subordinated", "notes", "due", "September", "2012."], "wordsB": ["On", "September", "28,", "2012,", "we", "repaid", "the", "remaining", "$172.4", "million", "in", "principal", "amount", "of", "the", "convertible", "subordinated", "notes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p47_s8", "idA": "906709_12_item7_p8_s1", "sentA": "We have $215.0 million in outstanding convertible subordinated notes due September 2012.", "sentB": "In connection with this transaction, we retired the principal amount of $42.5 million of our $215.0 million in aggregate principal amount of convertible subordinated notes in exchange for $42.5 million in principal amount of the senior secured notes.", "type": 2, "words": ["<tag1>", "We", "have", "$215.0", "million", "in", "outstanding", "convertible", "subordinated", "notes", "due", "September", "2012.", "<tag2>", "In", "connection", "with", "this", "transaction,", "we", "retired", "the", "principal", "amount", "of", "$42.5", "million", "of", "our", "$215.0", "million", "in", "aggregate", "principal", "amount", "of", "convertible", "subordinated", "notes", "in", "exchange", "for", "$42.5", "million", "in", "principal", "amount", "of", "the", "senior", "secured", "notes.", "<tag3>"], "wordsA": ["We", "have", "$215.0", "million", "in", "outstanding", "convertible", "subordinated", "notes", "due", "September", "2012."], "wordsB": ["In", "connection", "with", "this", "transaction,", "we", "retired", "the", "principal", "amount", "of", "$42.5", "million", "of", "our", "$215.0", "million", "in", "aggregate", "principal", "amount", "of", "convertible", "subordinated", "notes", "in", "exchange", "for", "$42.5", "million", "in", "principal", "amount", "of", "the", "senior", "secured", "notes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p17_s2", "idA": "906709_12_item7_p8_s3", "sentA": "We expect the clinical development of our proprietary drug candidates including NKTR-102, NKTR-061, NKTR-181, and NKTR-192 will continue to require significant investments in order to advance through the clinic with the objective of entering into a collaboration partnership or obtaining regulatory approval.", "sentB": "We expect the clinical development of our proprietary drug candidates including etirinotecan pegol, Amikacin Inhale, NKTR-181, and NKTR-192 will require significant investment in order to continue to advance in clinical development with the objective of entering into a collaboration partnership or obtaining regulatory approval.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates", "including", "NKTR-102,", "NKTR-061,", "NKTR-181,", "and", "NKTR-192", "will", "continue", "to", "require", "significant", "investments", "in", "order", "to", "advance", "through", "the", "clinic", "with", "the", "objective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval.", "<tag2>", "We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates", "including", "etirinotecan", "pegol,", "Amikacin", "Inhale,", "NKTR-181,", "and", "NKTR-192", "will", "require", "significant", "investment", "in", "order", "to", "continue", "to", "advance", "in", "clinical", "development", "with", "the", "objective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval.", "<tag3>"], "wordsA": ["We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates", "including", "NKTR-102,", "NKTR-061,", "NKTR-181,", "and", "NKTR-192", "will", "continue", "to", "require", "significant", "investments", "in", "order", "to", "advance", "through", "the", "clinic", "with", "the", "objective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval."], "wordsB": ["We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates", "including", "etirinotecan", "pegol,", "Amikacin", "Inhale,", "NKTR-181,", "and", "NKTR-192", "will", "require", "significant", "investment", "in", "order", "to", "continue", "to", "advance", "in", "clinical", "development", "with", "the", "objective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p43_s2", "idA": "906709_12_item7_p8_s3", "sentA": "We expect the clinical development of our proprietary drug candidates including NKTR-102, NKTR-061, NKTR-181, and NKTR-192 will continue to require significant investments in order to advance through the clinic with the objective of entering into a collaboration partnership or obtaining regulatory approval.", "sentB": "We expect the clinical development of our proprietary drug candidates including etirinotecan pegol (NKTR-102), Amikacin Inhale, NKTR-181, and NKTR-192 will require significant investment in order to continue to advance in clinical development with the objective of entering into a collaboration partnership or obtaining regulatory approval.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates", "including", "NKTR-102,", "NKTR-061,", "NKTR-181,", "and", "NKTR-192", "will", "continue", "to", "require", "significant", "investments", "in", "order", "to", "advance", "through", "the", "clinic", "with", "the", "objective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval.", "<tag2>", "We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates", "including", "etirinotecan", "pegol", "(NKTR-102),", "Amikacin", "Inhale,", "NKTR-181,", "and", "NKTR-192", "will", "require", "significant", "investment", "in", "order", "to", "continue", "to", "advance", "in", "clinical", "development", "with", "the", "objective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval.", "<tag3>"], "wordsA": ["We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates", "including", "NKTR-102,", "NKTR-061,", "NKTR-181,", "and", "NKTR-192", "will", "continue", "to", "require", "significant", "investments", "in", "order", "to", "advance", "through", "the", "clinic", "with", "the", "objective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval."], "wordsB": ["We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates", "including", "etirinotecan", "pegol", "(NKTR-102),", "Amikacin", "Inhale,", "NKTR-181,", "and", "NKTR-192", "will", "require", "significant", "investment", "in", "order", "to", "continue", "to", "advance", "in", "clinical", "development", "with", "the", "objective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p17_s4", "idA": "906709_12_item7_p9_s1", "sentA": "While in the past we have received a number of significant payments from license and collaboration agreements and other significant transactions, we do not currently anticipate completing new transactions with substantial upfront payments in the near future.", "sentB": "In addition, while in the past we have received a number of significant payments from license and collaboration agreements and other significant transactions, we do not currently anticipate completing new transactions with substantial upfront payments in the near -term.", "type": 2, "words": ["<tag1>", "While", "in", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "license", "and", "collaboration", "agreements", "and", "other", "significant", "transactions,", "we", "do", "not", "currently", "anticipate", "completing", "new", "transactions", "with", "substantial", "upfront", "payments", "in", "the", "near", "future.", "<tag2>", "In", "addition,", "while", "in", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "license", "and", "collaboration", "agreements", "and", "other", "significant", "transactions,", "we", "do", "not", "currently", "anticipate", "completing", "new", "transactions", "with", "substantial", "upfront", "payments", "in", "the", "near", "-term.", "<tag3>"], "wordsA": ["While", "in", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "license", "and", "collaboration", "agreements", "and", "other", "significant", "transactions,", "we", "do", "not", "currently", "anticipate", "completing", "new", "transactions", "with", "substantial", "upfront", "payments", "in", "the", "near", "future."], "wordsB": ["In", "addition,", "while", "in", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "license", "and", "collaboration", "agreements", "and", "other", "significant", "transactions,", "we", "do", "not", "currently", "anticipate", "completing", "new", "transactions", "with", "substantial", "upfront", "payments", "in", "the", "near", "-term."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_13_item7_p44_s0", "idA": "906709_12_item7_p9_s1", "sentA": "While in the past we have received a number of significant payments from license and collaboration agreements and other significant transactions, we do not currently anticipate completing new transactions with substantial upfront payments in the near future.", "sentB": ", we do not currently anticipate completing new transactions with substantial upfront payments in the near -term.", "type": 2, "words": ["<tag1>", "While", "in", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "license", "and", "collaboration", "agreements", "and", "other", "significant", "transactions,", "we", "do", "not", "currently", "anticipate", "completing", "new", "transactions", "with", "substantial", "upfront", "payments", "in", "the", "near", "future.", "<tag2>", ",", "we", "do", "not", "currently", "anticipate", "completing", "new", "transactions", "with", "substantial", "upfront", "payments", "in", "the", "near", "-term.", "<tag3>"], "wordsA": ["While", "in", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "license", "and", "collaboration", "agreements", "and", "other", "significant", "transactions,", "we", "do", "not", "currently", "anticipate", "completing", "new", "transactions", "with", "substantial", "upfront", "payments", "in", "the", "near", "future."], "wordsB": [",", "we", "do", "not", "currently", "anticipate", "completing", "new", "transactions", "with", "substantial", "upfront", "payments", "in", "the", "near", "-term."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p10_s3", "idA": "906709_13_item7_p11_s1", "sentA": "In February 2013, Baxter initiated a Phase 3 multi-center, open-label clinical study called PROLONG-ATE that will enroll more than 100 previously treated adult patients with severe hemophilia A to assess the efficacy, safety and pharmacokinetics of BAX 855 for prophylaxis and on-demand treatment of bleeding.", "sentB": "The Phase 2 study utilized a double-blind, placebo-controlled, randomized withdrawal study design to assess the efficacy, safety and tolerability of NKTR-181.", "type": 2, "words": ["<tag1>", "In", "February", "2013,", "Baxter", "initiated", "a", "Phase", "3", "multi-center,", "open-label", "clinical", "study", "called", "PROLONG-ATE", "that", "will", "enroll", "more", "than", "100", "previously", "treated", "adult", "patients", "with", "severe", "hemophilia", "A", "to", "assess", "the", "efficacy,", "safety", "and", "pharmacokinetics", "of", "BAX", "855", "for", "prophylaxis", "and", "on-demand", "treatment", "of", "bleeding.", "<tag2>", "The", "Phase", "2", "study", "utilized", "a", "double-blind,", "placebo-controlled,", "randomized", "withdrawal", "study", "design", "to", "assess", "the", "efficacy,", "safety", "and", "tolerability", "of", "NKTR-181.", "<tag3>"], "wordsA": ["In", "February", "2013,", "Baxter", "initiated", "a", "Phase", "3", "multi-center,", "open-label", "clinical", "study", "called", "PROLONG-ATE", "that", "will", "enroll", "more", "than", "100", "previously", "treated", "adult", "patients", "with", "severe", "hemophilia", "A", "to", "assess", "the", "efficacy,", "safety", "and", "pharmacokinetics", "of", "BAX", "855", "for", "prophylaxis", "and", "on-demand", "treatment", "of", "bleeding."], "wordsB": ["The", "Phase", "2", "study", "utilized", "a", "double-blind,", "placebo-controlled,", "randomized", "withdrawal", "study", "design", "to", "assess", "the", "efficacy,", "safety", "and", "tolerability", "of", "NKTR-181."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p14_s1", "idA": "906709_13_item7_p11_s1", "sentA": "In February 2013, Baxter initiated a Phase 3 multi-center, open-label clinical study called PROLONG-ATE that will enroll more than 100 previously treated adult patients with severe hemophilia A to assess the efficacy, safety and pharmacokinetics of BAX 855 for prophylaxis and on-demand treatment of bleeding.", "sentB": "In February 2013, Baxter initiated a Phase 3 multi-center, open-label clinical study called PROLONG-ATE in previously treated adult patients with severe hemophilia A to assess the efficacy, safety and pharmacokinetics of BAX 855 for prophylaxis and on-demand treatment of bleeding.", "type": 2, "words": ["<tag1>", "In", "February", "2013,", "Baxter", "initiated", "a", "Phase", "3", "multi-center,", "open-label", "clinical", "study", "called", "PROLONG-ATE", "that", "will", "enroll", "more", "than", "100", "previously", "treated", "adult", "patients", "with", "severe", "hemophilia", "A", "to", "assess", "the", "efficacy,", "safety", "and", "pharmacokinetics", "of", "BAX", "855", "for", "prophylaxis", "and", "on-demand", "treatment", "of", "bleeding.", "<tag2>", "In", "February", "2013,", "Baxter", "initiated", "a", "Phase", "3", "multi-center,", "open-label", "clinical", "study", "called", "PROLONG-ATE", "in", "previously", "treated", "adult", "patients", "with", "severe", "hemophilia", "A", "to", "assess", "the", "efficacy,", "safety", "and", "pharmacokinetics", "of", "BAX", "855", "for", "prophylaxis", "and", "on-demand", "treatment", "of", "bleeding.", "<tag3>"], "wordsA": ["In", "February", "2013,", "Baxter", "initiated", "a", "Phase", "3", "multi-center,", "open-label", "clinical", "study", "called", "PROLONG-ATE", "that", "will", "enroll", "more", "than", "100", "previously", "treated", "adult", "patients", "with", "severe", "hemophilia", "A", "to", "assess", "the", "efficacy,", "safety", "and", "pharmacokinetics", "of", "BAX", "855", "for", "prophylaxis", "and", "on-demand", "treatment", "of", "bleeding."], "wordsB": ["In", "February", "2013,", "Baxter", "initiated", "a", "Phase", "3", "multi-center,", "open-label", "clinical", "study", "called", "PROLONG-ATE", "in", "previously", "treated", "adult", "patients", "with", "severe", "hemophilia", "A", "to", "assess", "the", "efficacy,", "safety", "and", "pharmacokinetics", "of", "BAX", "855", "for", "prophylaxis", "and", "on-demand", "treatment", "of", "bleeding."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p15_s0", "idA": "906709_13_item7_p12_s0", "sentA": "If BAX 855 is approved by health authorities and is successfully commercialized by Baxter, this would represent a substantial royalty revenue opportunity for us, subject to significant risks and uncertainties relating to regulatory approval with health authorities and subsequent commercial success.", "sentB": "If BAX 855 is approved by health authorities and is successfully commercialized by Baxter, this will represent a substantial royalty revenue opportunity for us, subject to significant risks and uncertainties relating to the outcome of the ongoing Phase 3 clinical study, the health authority regulatory review process, and if approved, subsequent commercial success.", "type": 2, "words": ["<tag1>", "If", "BAX", "855", "is", "approved", "by", "health", "authorities", "and", "is", "successfully", "commercialized", "by", "Baxter,", "this", "would", "represent", "a", "substantial", "royalty", "revenue", "opportunity", "for", "us,", "subject", "to", "significant", "risks", "and", "uncertainties", "relating", "to", "regulatory", "approval", "with", "health", "authorities", "and", "subsequent", "commercial", "success.", "<tag2>", "If", "BAX", "855", "is", "approved", "by", "health", "authorities", "and", "is", "successfully", "commercialized", "by", "Baxter,", "this", "will", "represent", "a", "substantial", "royalty", "revenue", "opportunity", "for", "us,", "subject", "to", "significant", "risks", "and", "uncertainties", "relating", "to", "the", "outcome", "of", "the", "ongoing", "Phase", "3", "clinical", "study,", "the", "health", "authority", "regulatory", "review", "process,", "and", "if", "approved,", "subsequent", "commercial", "success.", "<tag3>"], "wordsA": ["If", "BAX", "855", "is", "approved", "by", "health", "authorities", "and", "is", "successfully", "commercialized", "by", "Baxter,", "this", "would", "represent", "a", "substantial", "royalty", "revenue", "opportunity", "for", "us,", "subject", "to", "significant", "risks", "and", "uncertainties", "relating", "to", "regulatory", "approval", "with", "health", "authorities", "and", "subsequent", "commercial", "success."], "wordsB": ["If", "BAX", "855", "is", "approved", "by", "health", "authorities", "and", "is", "successfully", "commercialized", "by", "Baxter,", "this", "will", "represent", "a", "substantial", "royalty", "revenue", "opportunity", "for", "us,", "subject", "to", "significant", "risks", "and", "uncertainties", "relating", "to", "the", "outcome", "of", "the", "ongoing", "Phase", "3", "clinical", "study,", "the", "health", "authority", "regulatory", "review", "process,", "and", "if", "approved,", "subsequent", "commercial", "success."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p17_s0", "idA": "906709_13_item7_p13_s1", "sentA": "For example, in April 2012 we advanced NKTR-192, our short-acting opioid drug candidate, into Phase 1 clinical studies and in July 2012 we advanced NKTR-181 into a Phase 2 clinical study and plan to conduct a human abuse liability study for NKTR-181 in the first half of 2013.", "sentB": "In January 2014, we initiated a single-ascending dose Phase 1 clinical study of NKTR-171.", "type": 2, "words": ["<tag1>", "For", "example,", "in", "April", "2012", "we", "advanced", "NKTR-192,", "our", "short-acting", "opioid", "drug", "candidate,", "into", "Phase", "1", "clinical", "studies", "and", "in", "July", "2012", "we", "advanced", "NKTR-181", "into", "a", "Phase", "2", "clinical", "study", "and", "plan", "to", "conduct", "a", "human", "abuse", "liability", "study", "for", "NKTR-181", "in", "the", "first", "half", "of", "2013.", "<tag2>", "In", "January", "2014,", "we", "initiated", "a", "single-ascending", "dose", "Phase", "1", "clinical", "study", "of", "NKTR-171.", "<tag3>"], "wordsA": ["For", "example,", "in", "April", "2012", "we", "advanced", "NKTR-192,", "our", "short-acting", "opioid", "drug", "candidate,", "into", "Phase", "1", "clinical", "studies", "and", "in", "July", "2012", "we", "advanced", "NKTR-181", "into", "a", "Phase", "2", "clinical", "study", "and", "plan", "to", "conduct", "a", "human", "abuse", "liability", "study", "for", "NKTR-181", "in", "the", "first", "half", "of", "2013."], "wordsB": ["In", "January", "2014,", "we", "initiated", "a", "single-ascending", "dose", "Phase", "1", "clinical", "study", "of", "NKTR-171."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p39_s1", "idA": "906709_13_item7_p16_s0", "sentA": "Key Developments and Trends in Liquidity and Capital Resources At December 31, 2012, we had approximately $302.2 million in cash, cash equivalents, and investments in marketable securities and $149.0 million in indebtedness.", "sentB": "At December 31, 2013, we had approximately $262.0 million in cash and investments in marketable securities, of which $25.0 million was restricted in relation to our 12.0% senior secured notes, and $160.8 million in indebtedness.", "type": 2, "words": ["<tag1>", "Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "At", "December", "31,", "2012,", "we", "had", "approximately", "$302.2", "million", "in", "cash,", "cash", "equivalents,", "and", "investments", "in", "marketable", "securities", "and", "$149.0", "million", "in", "indebtedness.", "<tag2>", "At", "December", "31,", "2013,", "we", "had", "approximately", "$262.0", "million", "in", "cash", "and", "investments", "in", "marketable", "securities,", "of", "which", "$25.0", "million", "was", "restricted", "in", "relation", "to", "our", "12.0%", "senior", "secured", "notes,", "and", "$160.8", "million", "in", "indebtedness.", "<tag3>"], "wordsA": ["Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "At", "December", "31,", "2012,", "we", "had", "approximately", "$302.2", "million", "in", "cash,", "cash", "equivalents,", "and", "investments", "in", "marketable", "securities", "and", "$149.0", "million", "in", "indebtedness."], "wordsB": ["At", "December", "31,", "2013,", "we", "had", "approximately", "$262.0", "million", "in", "cash", "and", "investments", "in", "marketable", "securities,", "of", "which", "$25.0", "million", "was", "restricted", "in", "relation", "to", "our", "12.0%", "senior", "secured", "notes,", "and", "$160.8", "million", "in", "indebtedness."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p39_s6", "idA": "906709_13_item7_p17_s1", "sentA": "As of December 31, 2012, we had at least twelve months of working capital to fund our current business plans.", "sentB": "As of December 31, 2013, we estimated that we had at least twelve months of working capital to fund our current business plans.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2012,", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans.", "<tag2>", "As", "of", "December", "31,", "2013,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2012,", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans."], "wordsB": ["As", "of", "December", "31,", "2013,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p40_s6", "idA": "906709_13_item7_p17_s10", "sentA": "In the event we do not enter into any new collaboration partnerships with significant up-front payments or do not receive the naloxegol regulatory milestone payments in 2013, we would likely be required to pursue financing alternatives.", "sentB": "In the event we do not enter into any new collaboration partnerships with significant upfront payments or do not receive the naloxegol milestone payments as discussed above, we would likely be required to pursue financing alternatives.", "type": 2, "words": ["<tag1>", "In", "the", "event", "we", "do", "not", "enter", "into", "any", "new", "collaboration", "partnerships", "with", "significant", "up-front", "payments", "or", "do", "not", "receive", "the", "naloxegol", "regulatory", "milestone", "payments", "in", "2013,", "we", "would", "likely", "be", "required", "to", "pursue", "financing", "alternatives.", "<tag2>", "In", "the", "event", "we", "do", "not", "enter", "into", "any", "new", "collaboration", "partnerships", "with", "significant", "upfront", "payments", "or", "do", "not", "receive", "the", "naloxegol", "milestone", "payments", "as", "discussed", "above,", "we", "would", "likely", "be", "required", "to", "pursue", "financing", "alternatives.", "<tag3>"], "wordsA": ["In", "the", "event", "we", "do", "not", "enter", "into", "any", "new", "collaboration", "partnerships", "with", "significant", "up-front", "payments", "or", "do", "not", "receive", "the", "naloxegol", "regulatory", "milestone", "payments", "in", "2013,", "we", "would", "likely", "be", "required", "to", "pursue", "financing", "alternatives."], "wordsB": ["In", "the", "event", "we", "do", "not", "enter", "into", "any", "new", "collaboration", "partnerships", "with", "significant", "upfront", "payments", "or", "do", "not", "receive", "the", "naloxegol", "milestone", "payments", "as", "discussed", "above,", "we", "would", "likely", "be", "required", "to", "pursue", "financing", "alternatives."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p40_s9", "idA": "906709_13_item7_p17_s10", "sentA": "In the event we do not enter into any new collaboration partnerships with significant up-front payments or do not receive the naloxegol regulatory milestone payments in 2013, we would likely be required to pursue financing alternatives.", "sentB": "If we do not receive substantial milestone payments from our existing collaboration agreements, execute new high-value collaborations or other arrangements, or are unable to raise additional capital in one or more financing transactions, we would be unable to continue our current level of investment in research and development.", "type": 2, "words": ["<tag1>", "In", "the", "event", "we", "do", "not", "enter", "into", "any", "new", "collaboration", "partnerships", "with", "significant", "up-front", "payments", "or", "do", "not", "receive", "the", "naloxegol", "regulatory", "milestone", "payments", "in", "2013,", "we", "would", "likely", "be", "required", "to", "pursue", "financing", "alternatives.", "<tag2>", "If", "we", "do", "not", "receive", "substantial", "milestone", "payments", "from", "our", "existing", "collaboration", "agreements,", "execute", "new", "high-value", "collaborations", "or", "other", "arrangements,", "or", "are", "unable", "to", "raise", "additional", "capital", "in", "one", "or", "more", "financing", "transactions,", "we", "would", "be", "unable", "to", "continue", "our", "current", "level", "of", "investment", "in", "research", "and", "development.", "<tag3>"], "wordsA": ["In", "the", "event", "we", "do", "not", "enter", "into", "any", "new", "collaboration", "partnerships", "with", "significant", "up-front", "payments", "or", "do", "not", "receive", "the", "naloxegol", "regulatory", "milestone", "payments", "in", "2013,", "we", "would", "likely", "be", "required", "to", "pursue", "financing", "alternatives."], "wordsB": ["If", "we", "do", "not", "receive", "substantial", "milestone", "payments", "from", "our", "existing", "collaboration", "agreements,", "execute", "new", "high-value", "collaborations", "or", "other", "arrangements,", "or", "are", "unable", "to", "raise", "additional", "capital", "in", "one", "or", "more", "financing", "transactions,", "we", "would", "be", "unable", "to", "continue", "our", "current", "level", "of", "investment", "in", "research", "and", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p40_s0", "idA": "906709_13_item7_p17_s2", "sentA": "We expect the clinical development of our proprietary drug candidates including etirinotecan pegol, Amikacin Inhale, NKTR-181, and NKTR-192 will require significant investment in order to continue to advance in clinical development with the objective of entering into a collaboration partnership or obtaining regulatory approval.", "sentB": "a collaboration partnership or obtaining regulatory approval.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates", "including", "etirinotecan", "pegol,", "Amikacin", "Inhale,", "NKTR-181,", "and", "NKTR-192", "will", "require", "significant", "investment", "in", "order", "to", "continue", "to", "advance", "in", "clinical", "development", "with", "the", "objective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval.", "<tag2>", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval.", "<tag3>"], "wordsA": ["We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates", "including", "etirinotecan", "pegol,", "Amikacin", "Inhale,", "NKTR-181,", "and", "NKTR-192", "will", "require", "significant", "investment", "in", "order", "to", "continue", "to", "advance", "in", "clinical", "development", "with", "the", "objective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval."], "wordsB": ["a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p40_s4", "idA": "906709_13_item7_p17_s6", "sentA": "The availability and terms of various financing alternatives substantially depend on the success or failure of our drug development programs including naloxegol, etirinotecan pegol, BAX 855, Amikacin Inhale, NKTR-181, and NKTR-192.", "sentB": "The availability and terms of various financing alternatives substantially depend on the success or failure of our drug development programs, including naloxegol, etirinotecan pegol, BAX 855, Amikacin Inhale, NKTR-181, and NKTR-171.", "type": 2, "words": ["<tag1>", "The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "the", "success", "or", "failure", "of", "our", "drug", "development", "programs", "including", "naloxegol,", "etirinotecan", "pegol,", "BAX", "855,", "Amikacin", "Inhale,", "NKTR-181,", "and", "NKTR-192.", "<tag2>", "The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "the", "success", "or", "failure", "of", "our", "drug", "development", "programs,", "including", "naloxegol,", "etirinotecan", "pegol,", "BAX", "855,", "Amikacin", "Inhale,", "NKTR-181,", "and", "NKTR-171.", "<tag3>"], "wordsA": ["The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "the", "success", "or", "failure", "of", "our", "drug", "development", "programs", "including", "naloxegol,", "etirinotecan", "pegol,", "BAX", "855,", "Amikacin", "Inhale,", "NKTR-181,", "and", "NKTR-192."], "wordsB": ["The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "the", "success", "or", "failure", "of", "our", "drug", "development", "programs,", "including", "naloxegol,", "etirinotecan", "pegol,", "BAX", "855,", "Amikacin", "Inhale,", "NKTR-181,", "and", "NKTR-171."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p21_s0", "idA": "906709_13_item7_p20_s1", "sentA": "Product sales increased during the year ended December 31, 2012 compared to the year ended December 31, 2011 as a result of increased product demand from a number of our collaboration partners.", "sentB": "Product sales increased for the year ended December 31, 2013 compared to the year ended December 31, 2012 primarily as a result of an $9.0 million increase in product sales to one of our collaboration partners.", "type": 2, "words": ["<tag1>", "Product", "sales", "increased", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "as", "a", "result", "of", "increased", "product", "demand", "from", "a", "number", "of", "our", "collaboration", "partners.", "<tag2>", "Product", "sales", "increased", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "as", "a", "result", "of", "an", "$9.0", "million", "increase", "in", "product", "sales", "to", "one", "of", "our", "collaboration", "partners.", "<tag3>"], "wordsA": ["Product", "sales", "increased", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "as", "a", "result", "of", "increased", "product", "demand", "from", "a", "number", "of", "our", "collaboration", "partners."], "wordsB": ["Product", "sales", "increased", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "as", "a", "result", "of", "an", "$9.0", "million", "increase", "in", "product", "sales", "to", "one", "of", "our", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p22_s0", "idA": "906709_13_item7_p20_s4", "sentA": "We expect product sales to increase in 2013 as compared to 2012.", "sentB": "We currently expect product sales to decrease substantially in 2014 as compared to 2013 due to decreased product demand from our collaboration partners.", "type": 2, "words": ["<tag1>", "We", "expect", "product", "sales", "to", "increase", "in", "2013", "as", "compared", "to", "2012.", "<tag2>", "We", "currently", "expect", "product", "sales", "to", "decrease", "substantially", "in", "2014", "as", "compared", "to", "2013", "due", "to", "decreased", "product", "demand", "from", "our", "collaboration", "partners.", "<tag3>"], "wordsA": ["We", "expect", "product", "sales", "to", "increase", "in", "2013", "as", "compared", "to", "2012."], "wordsB": ["We", "currently", "expect", "product", "sales", "to", "decrease", "substantially", "in", "2014", "as", "compared", "to", "2013", "due", "to", "decreased", "product", "demand", "from", "our", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p22_s2", "idA": "906709_13_item7_p20_s6", "sentA": "Royalty revenues decreased during the year ended December 31, 2012 compared to the year ended December 31, 2011 primarily as a result of the sale of the royalties we receive from UCB s CIMZIA and Roche s MIRCERA product sales as is further described below.", "sentB": "Royalty revenue received in cash decreased during the year ended December 31, 2013 compared to the year ended December 31, 2012 and decreased during the year ended December 31, 2012 compared to the year ended December 31, 2011 primarily as a result of the sale of our rights to receive the royalties from product sales of UCB s CIMZIA and Roche s MIRCERA as is further described below.", "type": 2, "words": ["<tag1>", "Royalty", "revenues", "decreased", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "primarily", "as", "a", "result", "of", "the", "sale", "of", "the", "royalties", "we", "receive", "from", "UCB", "s", "CIMZIA", "and", "Roche", "s", "MIRCERA", "product", "sales", "as", "is", "further", "described", "below.", "<tag2>", "Royalty", "revenue", "received", "in", "cash", "decreased", "during", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "and", "decreased", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "primarily", "as", "a", "result", "of", "the", "sale", "of", "our", "rights", "to", "receive", "the", "royalties", "from", "product", "sales", "of", "UCB", "s", "CIMZIA", "and", "Roche", "s", "MIRCERA", "as", "is", "further", "described", "below.", "<tag3>"], "wordsA": ["Royalty", "revenues", "decreased", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "primarily", "as", "a", "result", "of", "the", "sale", "of", "the", "royalties", "we", "receive", "from", "UCB", "s", "CIMZIA", "and", "Roche", "s", "MIRCERA", "product", "sales", "as", "is", "further", "described", "below."], "wordsB": ["Royalty", "revenue", "received", "in", "cash", "decreased", "during", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "and", "decreased", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "primarily", "as", "a", "result", "of", "the", "sale", "of", "our", "rights", "to", "receive", "the", "royalties", "from", "product", "sales", "of", "UCB", "s", "CIMZIA", "and", "Roche", "s", "MIRCERA", "as", "is", "further", "described", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p42_s5", "idA": "906709_13_item7_p20_s7", "sentA": "Royalty revenues increased during the year ended December 31, 2011 as compared to the year ended December 31, 2010 primarily as a result of the increase in royalties received from net sales of CIMZIA and MIRCERA .", "sentB": "During the year ended December 31, 2013, we made a $3.0 million payment to the purchaser of these royalties because the minimum 2012 MIRCERA net sales threshold was not met.", "type": 2, "words": ["<tag1>", "Royalty", "revenues", "increased", "during", "the", "year", "ended", "December", "31,", "2011", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "primarily", "as", "a", "result", "of", "the", "increase", "in", "royalties", "received", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", ".", "<tag2>", "During", "the", "year", "ended", "December", "31,", "2013,", "we", "made", "a", "$3.0", "million", "payment", "to", "the", "purchaser", "of", "these", "royalties", "because", "the", "minimum", "2012", "MIRCERA", "net", "sales", "threshold", "was", "not", "met.", "<tag3>"], "wordsA": ["Royalty", "revenues", "increased", "during", "the", "year", "ended", "December", "31,", "2011", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "primarily", "as", "a", "result", "of", "the", "increase", "in", "royalties", "received", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "."], "wordsB": ["During", "the", "year", "ended", "December", "31,", "2013,", "we", "made", "a", "$3.0", "million", "payment", "to", "the", "purchaser", "of", "these", "royalties", "because", "the", "minimum", "2012", "MIRCERA", "net", "sales", "threshold", "was", "not", "met."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p7_s6", "idA": "906709_13_item7_p20_s7", "sentA": "Royalty revenues increased during the year ended December 31, 2011 as compared to the year ended December 31, 2010 primarily as a result of the increase in royalties received from net sales of CIMZIA and MIRCERA .", "sentB": "If the FDA requires a post-approval cardiovascular safety study as a condition to approval of the naloxegol NDA, then the royalty rate payable to us from net sales of naloxegol in the U.S. by AstraZeneca would be reduced by two percentage points until the aggregate accumulated amount of such royalty payment reduction is equal to a maximum of $35.0 million.", "type": 2, "words": ["<tag1>", "Royalty", "revenues", "increased", "during", "the", "year", "ended", "December", "31,", "2011", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "primarily", "as", "a", "result", "of", "the", "increase", "in", "royalties", "received", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", ".", "<tag2>", "If", "the", "FDA", "requires", "a", "post-approval", "cardiovascular", "safety", "study", "as", "a", "condition", "to", "approval", "of", "the", "naloxegol", "NDA,", "then", "the", "royalty", "rate", "payable", "to", "us", "from", "net", "sales", "of", "naloxegol", "in", "the", "U.S.", "by", "AstraZeneca", "would", "be", "reduced", "by", "two", "percentage", "points", "until", "the", "aggregate", "accumulated", "amount", "of", "such", "royalty", "payment", "reduction", "is", "equal", "to", "a", "maximum", "of", "$35.0", "million.", "<tag3>"], "wordsA": ["Royalty", "revenues", "increased", "during", "the", "year", "ended", "December", "31,", "2011", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "primarily", "as", "a", "result", "of", "the", "increase", "in", "royalties", "received", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "."], "wordsB": ["If", "the", "FDA", "requires", "a", "post-approval", "cardiovascular", "safety", "study", "as", "a", "condition", "to", "approval", "of", "the", "naloxegol", "NDA,", "then", "the", "royalty", "rate", "payable", "to", "us", "from", "net", "sales", "of", "naloxegol", "in", "the", "U.S.", "by", "AstraZeneca", "would", "be", "reduced", "by", "two", "percentage", "points", "until", "the", "aggregate", "accumulated", "amount", "of", "such", "royalty", "payment", "reduction", "is", "equal", "to", "a", "maximum", "of", "$35.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p22_s4", "idA": "906709_13_item7_p20_s8", "sentA": "We expect royalties to decrease in 2013 as compared to 2012.", "sentB": "We expect royalty revenue received in cash to decrease in 2014 as compared to 2013.", "type": 2, "words": ["<tag1>", "We", "expect", "royalties", "to", "decrease", "in", "2013", "as", "compared", "to", "2012.", "<tag2>", "We", "expect", "royalty", "revenue", "received", "in", "cash", "to", "decrease", "in", "2014", "as", "compared", "to", "2013.", "<tag3>"], "wordsA": ["We", "expect", "royalties", "to", "decrease", "in", "2013", "as", "compared", "to", "2012."], "wordsB": ["We", "expect", "royalty", "revenue", "received", "in", "cash", "to", "decrease", "in", "2014", "as", "compared", "to", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p27_s5", "idA": "906709_13_item7_p20_s8", "sentA": "We expect royalties to decrease in 2013 as compared to 2012.", "sentB": "We currently expect product gross margin to decrease in 2014 as compared to 2013 as a result of the anticipated reduction in product sales.", "type": 2, "words": ["<tag1>", "We", "expect", "royalties", "to", "decrease", "in", "2013", "as", "compared", "to", "2012.", "<tag2>", "We", "currently", "expect", "product", "gross", "margin", "to", "decrease", "in", "2014", "as", "compared", "to", "2013", "as", "a", "result", "of", "the", "anticipated", "reduction", "in", "product", "sales.", "<tag3>"], "wordsA": ["We", "expect", "royalties", "to", "decrease", "in", "2013", "as", "compared", "to", "2012."], "wordsB": ["We", "currently", "expect", "product", "gross", "margin", "to", "decrease", "in", "2014", "as", "compared", "to", "2013", "as", "a", "result", "of", "the", "anticipated", "reduction", "in", "product", "sales."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p23_s4", "idA": "906709_13_item7_p21_s10", "sentA": "We expect license, collaboration and other revenue in 2013 to increase as compared to 2012 primarily as a result of the recognition of milestones under existing collaboration agreements.", "sentB": "We expect license, collaboration and other revenue in 2014 will be significantly impacted by the outcome and timing of the naloxegol regulatory review events.", "type": 2, "words": ["<tag1>", "We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2013", "to", "increase", "as", "compared", "to", "2012", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "milestones", "under", "existing", "collaboration", "agreements.", "<tag2>", "We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2014", "will", "be", "significantly", "impacted", "by", "the", "outcome", "and", "timing", "of", "the", "naloxegol", "regulatory", "review", "events.", "<tag3>"], "wordsA": ["We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2013", "to", "increase", "as", "compared", "to", "2012", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "milestones", "under", "existing", "collaboration", "agreements."], "wordsB": ["We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2014", "will", "be", "significantly", "impacted", "by", "the", "outcome", "and", "timing", "of", "the", "naloxegol", "regulatory", "review", "events."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p42_s2", "idA": "906709_13_item7_p21_s10", "sentA": "We expect license, collaboration and other revenue in 2013 to increase as compared to 2012 primarily as a result of the recognition of milestones under existing collaboration agreements.", "sentB": "We expect our capital expenditures in 2014 to increase significantly as compared to 2013 primarily as a result of our plan to build commercial manufacturing capability for the devices for the Amikacin Inhale program.", "type": 2, "words": ["<tag1>", "We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2013", "to", "increase", "as", "compared", "to", "2012", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "milestones", "under", "existing", "collaboration", "agreements.", "<tag2>", "We", "expect", "our", "capital", "expenditures", "in", "2014", "to", "increase", "significantly", "as", "compared", "to", "2013", "primarily", "as", "a", "result", "of", "our", "plan", "to", "build", "commercial", "manufacturing", "capability", "for", "the", "devices", "for", "the", "Amikacin", "Inhale", "program.", "<tag3>"], "wordsA": ["We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2013", "to", "increase", "as", "compared", "to", "2012", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "milestones", "under", "existing", "collaboration", "agreements."], "wordsB": ["We", "expect", "our", "capital", "expenditures", "in", "2014", "to", "increase", "significantly", "as", "compared", "to", "2013", "primarily", "as", "a", "result", "of", "our", "plan", "to", "build", "commercial", "manufacturing", "capability", "for", "the", "devices", "for", "the", "Amikacin", "Inhale", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p23_s5", "idA": "906709_13_item7_p21_s11", "sentA": "In the event regulatory approval filings for naloxegol are submitted by AstraZeneca and accepted by the FDA and by the EMA, we would be entitled to $95.0 million in milestone payments.", "sentB": "In particular, in the event naloxegol is approved by the FDA, we would expect to recognize as revenue the $70.0 million payment received from AstraZeneca in November 2013 and we would be entitled to a $35.0 million milestone payment.", "type": 2, "words": ["<tag1>", "In", "the", "event", "regulatory", "approval", "filings", "for", "naloxegol", "are", "submitted", "by", "AstraZeneca", "and", "accepted", "by", "the", "FDA", "and", "by", "the", "EMA,", "we", "would", "be", "entitled", "to", "$95.0", "million", "in", "milestone", "payments.", "<tag2>", "In", "particular,", "in", "the", "event", "naloxegol", "is", "approved", "by", "the", "FDA,", "we", "would", "expect", "to", "recognize", "as", "revenue", "the", "$70.0", "million", "payment", "received", "from", "AstraZeneca", "in", "November", "2013", "and", "we", "would", "be", "entitled", "to", "a", "$35.0", "million", "milestone", "payment.", "<tag3>"], "wordsA": ["In", "the", "event", "regulatory", "approval", "filings", "for", "naloxegol", "are", "submitted", "by", "AstraZeneca", "and", "accepted", "by", "the", "FDA", "and", "by", "the", "EMA,", "we", "would", "be", "entitled", "to", "$95.0", "million", "in", "milestone", "payments."], "wordsB": ["In", "particular,", "in", "the", "event", "naloxegol", "is", "approved", "by", "the", "FDA,", "we", "would", "expect", "to", "recognize", "as", "revenue", "the", "$70.0", "million", "payment", "received", "from", "AstraZeneca", "in", "November", "2013", "and", "we", "would", "be", "entitled", "to", "a", "$35.0", "million", "milestone", "payment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p23_s6", "idA": "906709_13_item7_p21_s12", "sentA": "If these filings occur in 2013, our license, collaboration and other revenue in 2013 will increase significantly from 2012.", "sentB": "If these activities occur in 2014, our license, collaboration and other revenue in 2014 will increase significantly from 2013.", "type": 2, "words": ["<tag1>", "If", "these", "filings", "occur", "in", "2013,", "our", "license,", "collaboration", "and", "other", "revenue", "in", "2013", "will", "increase", "significantly", "from", "2012.", "<tag2>", "If", "these", "activities", "occur", "in", "2014,", "our", "license,", "collaboration", "and", "other", "revenue", "in", "2014", "will", "increase", "significantly", "from", "2013.", "<tag3>"], "wordsA": ["If", "these", "filings", "occur", "in", "2013,", "our", "license,", "collaboration", "and", "other", "revenue", "in", "2013", "will", "increase", "significantly", "from", "2012."], "wordsB": ["If", "these", "activities", "occur", "in", "2014,", "our", "license,", "collaboration", "and", "other", "revenue", "in", "2014", "will", "increase", "significantly", "from", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p22_s7", "idA": "906709_13_item7_p21_s3", "sentA": "As a result of this liability accounting, even though the royalties from UCB and Roche are remitted directly to the purchaser, we will continue to record revenue for these royalties.", "sentB": "As a result of this liability accounting, even though the royalties from UCB and Roche are remitted directly to the purchaser of these royalty interests, we will continue to record revenue for these royalties.", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "this", "liability", "accounting,", "even", "though", "the", "royalties", "from", "UCB", "and", "Roche", "are", "remitted", "directly", "to", "the", "purchaser,", "we", "will", "continue", "to", "record", "revenue", "for", "these", "royalties.", "<tag2>", "As", "a", "result", "of", "this", "liability", "accounting,", "even", "though", "the", "royalties", "from", "UCB", "and", "Roche", "are", "remitted", "directly", "to", "the", "purchaser", "of", "these", "royalty", "interests,", "we", "will", "continue", "to", "record", "revenue", "for", "these", "royalties.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "this", "liability", "accounting,", "even", "though", "the", "royalties", "from", "UCB", "and", "Roche", "are", "remitted", "directly", "to", "the", "purchaser,", "we", "will", "continue", "to", "record", "revenue", "for", "these", "royalties."], "wordsB": ["As", "a", "result", "of", "this", "liability", "accounting,", "even", "though", "the", "royalties", "from", "UCB", "and", "Roche", "are", "remitted", "directly", "to", "the", "purchaser", "of", "these", "royalty", "interests,", "we", "will", "continue", "to", "record", "revenue", "for", "these", "royalties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p22_s8", "idA": "906709_13_item7_p21_s4", "sentA": "During the year ended December 31, 2012, we recognized $13.5 million in aggregate royalties from net sales of CIMZIA and MIRCERA , of which the $2.7 million recognized in the three months ended March 31, 2012 was retained by us as these amounts resulted from product sales in the fourth quarter of 2011 and the $10.8 million recognized in the nine months ended December 31, 2012 was remitted directly to the purchaser as these amounts resulted from product sales in the first three quarters of 2012.", "sentB": "During the year ended December 31, 2013 and 2012, we recognized $22.1 million and $13.5 million, respectively, in aggregate royalties from net sales of CIMZIA and MIRCERA , of which the $2.7 million recognized in the three months ended March 31, 2012 was retained by us as these amounts resulted from product sales in the fourth quarter of 2011.", "type": 2, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2012,", "we", "recognized", "$13.5", "million", "in", "aggregate", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", ",", "of", "which", "the", "$2.7", "million", "recognized", "in", "the", "three", "months", "ended", "March", "31,", "2012", "was", "retained", "by", "us", "as", "these", "amounts", "resulted", "from", "product", "sales", "in", "the", "fourth", "quarter", "of", "2011", "and", "the", "$10.8", "million", "recognized", "in", "the", "nine", "months", "ended", "December", "31,", "2012", "was", "remitted", "directly", "to", "the", "purchaser", "as", "these", "amounts", "resulted", "from", "product", "sales", "in", "the", "first", "three", "quarters", "of", "2012.", "<tag2>", "During", "the", "year", "ended", "December", "31,", "2013", "and", "2012,", "we", "recognized", "$22.1", "million", "and", "$13.5", "million,", "respectively,", "in", "aggregate", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", ",", "of", "which", "the", "$2.7", "million", "recognized", "in", "the", "three", "months", "ended", "March", "31,", "2012", "was", "retained", "by", "us", "as", "these", "amounts", "resulted", "from", "product", "sales", "in", "the", "fourth", "quarter", "of", "2011.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2012,", "we", "recognized", "$13.5", "million", "in", "aggregate", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", ",", "of", "which", "the", "$2.7", "million", "recognized", "in", "the", "three", "months", "ended", "March", "31,", "2012", "was", "retained", "by", "us", "as", "these", "amounts", "resulted", "from", "product", "sales", "in", "the", "fourth", "quarter", "of", "2011", "and", "the", "$10.8", "million", "recognized", "in", "the", "nine", "months", "ended", "December", "31,", "2012", "was", "remitted", "directly", "to", "the", "purchaser", "as", "these", "amounts", "resulted", "from", "product", "sales", "in", "the", "first", "three", "quarters", "of", "2012."], "wordsB": ["During", "the", "year", "ended", "December", "31,", "2013", "and", "2012,", "we", "recognized", "$22.1", "million", "and", "$13.5", "million,", "respectively,", "in", "aggregate", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", ",", "of", "which", "the", "$2.7", "million", "recognized", "in", "the", "three", "months", "ended", "March", "31,", "2012", "was", "retained", "by", "us", "as", "these", "amounts", "resulted", "from", "product", "sales", "in", "the", "fourth", "quarter", "of", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p22_s9", "idA": "906709_13_item7_p21_s5", "sentA": "We expect non cash royalties from net sales of CIMZIA and MIRCERA to increase in 2013 as compared to 2012.", "sentB": "We expect non-cash royalties from net sales of CIMZIA and MIRCERA to decrease slightly in 2014 as compared to 2013.", "type": 2, "words": ["<tag1>", "We", "expect", "non", "cash", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "to", "increase", "in", "2013", "as", "compared", "to", "2012.", "<tag2>", "We", "expect", "non-cash", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "to", "decrease", "slightly", "in", "2014", "as", "compared", "to", "2013.", "<tag3>"], "wordsA": ["We", "expect", "non", "cash", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "to", "increase", "in", "2013", "as", "compared", "to", "2012."], "wordsB": ["We", "expect", "non-cash", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "to", "decrease", "slightly", "in", "2014", "as", "compared", "to", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p23_s0", "idA": "906709_13_item7_p21_s6", "sentA": "License, collaboration and other revenue License, collaboration and other revenue includes amortization of upfront payments and milestone payments received in connection with our license and collaboration agreements and reimbursed research and development expenses.", "sentB": "License, collaboration and other revenue License, collaboration and other revenue includes the recognition of upfront payments and milestone payments received in connection with our license and collaboration agreements and reimbursed research and development expenses.", "type": 2, "words": ["<tag1>", "License,", "collaboration", "and", "other", "revenue", "License,", "collaboration", "and", "other", "revenue", "includes", "amortization", "of", "upfront", "payments", "and", "milestone", "payments", "received", "in", "connection", "with", "our", "license", "and", "collaboration", "agreements", "and", "reimbursed", "research", "and", "development", "expenses.", "<tag2>", "License,", "collaboration", "and", "other", "revenue", "License,", "collaboration", "and", "other", "revenue", "includes", "the", "recognition", "of", "upfront", "payments", "and", "milestone", "payments", "received", "in", "connection", "with", "our", "license", "and", "collaboration", "agreements", "and", "reimbursed", "research", "and", "development", "expenses.", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "revenue", "License,", "collaboration", "and", "other", "revenue", "includes", "amortization", "of", "upfront", "payments", "and", "milestone", "payments", "received", "in", "connection", "with", "our", "license", "and", "collaboration", "agreements", "and", "reimbursed", "research", "and", "development", "expenses."], "wordsB": ["License,", "collaboration", "and", "other", "revenue", "License,", "collaboration", "and", "other", "revenue", "includes", "the", "recognition", "of", "upfront", "payments", "and", "milestone", "payments", "received", "in", "connection", "with", "our", "license", "and", "collaboration", "agreements", "and", "reimbursed", "research", "and", "development", "expenses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p23_s2", "idA": "906709_13_item7_p21_s8", "sentA": "License, collaboration and other revenue for the year ended December 31, 2012 decreased compared to the year ended December 31, 2011 primarily due to the recognition in 2011 of a $5.0 million license fee from an agreement signed in September 2011.", "sentB": "License, collaboration and other revenue increased for the year ended December 31, 2013 compared to the year ended December 31, 2012 primarily as a result of the recognition of a $25.0 million payment from AstraZeneca achieved in September 2013 on the acceptance for review by the EMA of the naloxegol regulatory approval application filed by AstraZeneca, the recognition of a $10.0 million milestone achieved upon the start of the Amikacin Inhale Phase 3 clinical trial by Bayer in April 2013, the recognition of $7.9 million related to the delivery of additional quantities of our proprietary PEGylation reagent to Roche in the fourth quarter of 2013, and the recognition of the remaining $6.7 million deferred revenue balance related to our agreement with Affymax as a result of the termination of that agreement.", "type": 2, "words": ["<tag1>", "License,", "collaboration", "and", "other", "revenue", "for", "the", "year", "ended", "December", "31,", "2012", "decreased", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "primarily", "due", "to", "the", "recognition", "in", "2011", "of", "a", "$5.0", "million", "license", "fee", "from", "an", "agreement", "signed", "in", "September", "2011.", "<tag2>", "License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "a", "$25.0", "million", "payment", "from", "AstraZeneca", "achieved", "in", "September", "2013", "on", "the", "acceptance", "for", "review", "by", "the", "EMA", "of", "the", "naloxegol", "regulatory", "approval", "application", "filed", "by", "AstraZeneca,", "the", "recognition", "of", "a", "$10.0", "million", "milestone", "achieved", "upon", "the", "start", "of", "the", "Amikacin", "Inhale", "Phase", "3", "clinical", "trial", "by", "Bayer", "in", "April", "2013,", "the", "recognition", "of", "$7.9", "million", "related", "to", "the", "delivery", "of", "additional", "quantities", "of", "our", "proprietary", "PEGylation", "reagent", "to", "Roche", "in", "the", "fourth", "quarter", "of", "2013,", "and", "the", "recognition", "of", "the", "remaining", "$6.7", "million", "deferred", "revenue", "balance", "related", "to", "our", "agreement", "with", "Affymax", "as", "a", "result", "of", "the", "termination", "of", "that", "agreement.", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "revenue", "for", "the", "year", "ended", "December", "31,", "2012", "decreased", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "primarily", "due", "to", "the", "recognition", "in", "2011", "of", "a", "$5.0", "million", "license", "fee", "from", "an", "agreement", "signed", "in", "September", "2011."], "wordsB": ["License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "a", "$25.0", "million", "payment", "from", "AstraZeneca", "achieved", "in", "September", "2013", "on", "the", "acceptance", "for", "review", "by", "the", "EMA", "of", "the", "naloxegol", "regulatory", "approval", "application", "filed", "by", "AstraZeneca,", "the", "recognition", "of", "a", "$10.0", "million", "milestone", "achieved", "upon", "the", "start", "of", "the", "Amikacin", "Inhale", "Phase", "3", "clinical", "trial", "by", "Bayer", "in", "April", "2013,", "the", "recognition", "of", "$7.9", "million", "related", "to", "the", "delivery", "of", "additional", "quantities", "of", "our", "proprietary", "PEGylation", "reagent", "to", "Roche", "in", "the", "fourth", "quarter", "of", "2013,", "and", "the", "recognition", "of", "the", "remaining", "$6.7", "million", "deferred", "revenue", "balance", "related", "to", "our", "agreement", "with", "Affymax", "as", "a", "result", "of", "the", "termination", "of", "that", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p25_s1", "idA": "906709_13_item7_p23_s1", "sentA": "The following table sets forth revenue by geographic area (in thousands): The increase in revenue attributable to European countries for the year ended December 31, 2012 compared to the year ended December 31, 2011 is primarily attributable to increased product sales and royalty revenues from our existing European collaboration partners.", "sentB": "The following table sets forth revenue by geographic area (in thousands):", "type": 2, "words": ["<tag1>", "The", "following", "table", "sets", "forth", "revenue", "by", "geographic", "area", "(in", "thousands):", "The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "attributable", "to", "increased", "product", "sales", "and", "royalty", "revenues", "from", "our", "existing", "European", "collaboration", "partners.", "<tag2>", "The", "following", "table", "sets", "forth", "revenue", "by", "geographic", "area", "(in", "thousands):", "<tag3>"], "wordsA": ["The", "following", "table", "sets", "forth", "revenue", "by", "geographic", "area", "(in", "thousands):", "The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "attributable", "to", "increased", "product", "sales", "and", "royalty", "revenues", "from", "our", "existing", "European", "collaboration", "partners."], "wordsB": ["The", "following", "table", "sets", "forth", "revenue", "by", "geographic", "area", "(in", "thousands):"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p26_s0", "idA": "906709_13_item7_p23_s1", "sentA": "The following table sets forth revenue by geographic area (in thousands): The increase in revenue attributable to European countries for the year ended December 31, 2012 compared to the year ended December 31, 2011 is primarily attributable to increased product sales and royalty revenues from our existing European collaboration partners.", "sentB": "The increase in revenue attributable to European countries for the year ended December 31, 2013 compared to the year ended December 31, 2012 is primarily attributable to increased milestone and royalty revenues from our existing European collaboration partners, including the $25.0 million milestone payment from AstraZeneca described above.", "type": 2, "words": ["<tag1>", "The", "following", "table", "sets", "forth", "revenue", "by", "geographic", "area", "(in", "thousands):", "The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "attributable", "to", "increased", "product", "sales", "and", "royalty", "revenues", "from", "our", "existing", "European", "collaboration", "partners.", "<tag2>", "The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "is", "primarily", "attributable", "to", "increased", "milestone", "and", "royalty", "revenues", "from", "our", "existing", "European", "collaboration", "partners,", "including", "the", "$25.0", "million", "milestone", "payment", "from", "AstraZeneca", "described", "above.", "<tag3>"], "wordsA": ["The", "following", "table", "sets", "forth", "revenue", "by", "geographic", "area", "(in", "thousands):", "The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "attributable", "to", "increased", "product", "sales", "and", "royalty", "revenues", "from", "our", "existing", "European", "collaboration", "partners."], "wordsB": ["The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "is", "primarily", "attributable", "to", "increased", "milestone", "and", "royalty", "revenues", "from", "our", "existing", "European", "collaboration", "partners,", "including", "the", "$25.0", "million", "milestone", "payment", "from", "AstraZeneca", "described", "above."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p26_s1", "idA": "906709_13_item7_p23_s1", "sentA": "The following table sets forth revenue by geographic area (in thousands): The increase in revenue attributable to European countries for the year ended December 31, 2012 compared to the year ended December 31, 2011 is primarily attributable to increased product sales and royalty revenues from our existing European collaboration partners.", "sentB": "The increase in revenue attributable to European countries for the year ended December 31, 2012 compared to the year ended December 31, 2011 is primarily attributable to increased product sales and royalty revenues from our existing European collaboration partners.", "type": 2, "words": ["<tag1>", "The", "following", "table", "sets", "forth", "revenue", "by", "geographic", "area", "(in", "thousands):", "The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "attributable", "to", "increased", "product", "sales", "and", "royalty", "revenues", "from", "our", "existing", "European", "collaboration", "partners.", "<tag2>", "The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "attributable", "to", "increased", "product", "sales", "and", "royalty", "revenues", "from", "our", "existing", "European", "collaboration", "partners.", "<tag3>"], "wordsA": ["The", "following", "table", "sets", "forth", "revenue", "by", "geographic", "area", "(in", "thousands):", "The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "attributable", "to", "increased", "product", "sales", "and", "royalty", "revenues", "from", "our", "existing", "European", "collaboration", "partners."], "wordsB": ["The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "attributable", "to", "increased", "product", "sales", "and", "royalty", "revenues", "from", "our", "existing", "European", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p27_s0", "idA": "906709_13_item7_p24_s0", "sentA": "Cost of goods sold increased during the year ended December 31, 2012 compared to the year ended December 31, 2011 primarily due to the $10.5 million increase in product sales in 2012.", "sentB": "Cost of goods sold and product gross profit increased during the year ended December 31, 2013 compared to the year ended December 31, 2012 primarily due to the $9.4 million increase in product sales in the year ended December 31, 2013 compared to the year ended December 31, 2012.", "type": 2, "words": ["<tag1>", "Cost", "of", "goods", "sold", "increased", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "primarily", "due", "to", "the", "$10.5", "million", "increase", "in", "product", "sales", "in", "2012.", "<tag2>", "Cost", "of", "goods", "sold", "and", "product", "gross", "profit", "increased", "during", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "due", "to", "the", "$9.4", "million", "increase", "in", "product", "sales", "in", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012.", "<tag3>"], "wordsA": ["Cost", "of", "goods", "sold", "increased", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "primarily", "due", "to", "the", "$10.5", "million", "increase", "in", "product", "sales", "in", "2012."], "wordsB": ["Cost", "of", "goods", "sold", "and", "product", "gross", "profit", "increased", "during", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "due", "to", "the", "$9.4", "million", "increase", "in", "product", "sales", "in", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p27_s3", "idA": "906709_13_item7_p24_s1", "sentA": "The increase in product gross margin during the year ended December 31, 2012 compared to the year ended December 31, 2011 is primarily due to the decreased cost per unit in 2012 resulting from increased manufacturing activity, resulting in improved overhead absorption.", "sentB": "The increase in product gross margin during the year ended December 31, 2012 compared to the year ended December 31, 2011 is primarily due to the decreased cost per unit in 2012 resulting from increased manufacturing activity and improved overhead absorption.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "product", "gross", "margin", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "due", "to", "the", "decreased", "cost", "per", "unit", "in", "2012", "resulting", "from", "increased", "manufacturing", "activity,", "resulting", "in", "improved", "overhead", "absorption.", "<tag2>", "The", "increase", "in", "product", "gross", "margin", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "due", "to", "the", "decreased", "cost", "per", "unit", "in", "2012", "resulting", "from", "increased", "manufacturing", "activity", "and", "improved", "overhead", "absorption.", "<tag3>"], "wordsA": ["The", "increase", "in", "product", "gross", "margin", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "due", "to", "the", "decreased", "cost", "per", "unit", "in", "2012", "resulting", "from", "increased", "manufacturing", "activity,", "resulting", "in", "improved", "overhead", "absorption."], "wordsB": ["The", "increase", "in", "product", "gross", "margin", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "due", "to", "the", "decreased", "cost", "per", "unit", "in", "2012", "resulting", "from", "increased", "manufacturing", "activity", "and", "improved", "overhead", "absorption."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p27_s4", "idA": "906709_13_item7_p24_s4", "sentA": "We expect product gross margin to fluctuate in future periods depending on the level and mix of manufacturing orders from our customers due to the fixed cost base associated with our manufacturing activities.", "sentB": "We expect product gross margin to fluctuate in future periods depending on the level and mix of manufacturing orders from our customers due to the predominantly fixed cost base associated with our manufacturing activities.", "type": 2, "words": ["<tag1>", "We", "expect", "product", "gross", "margin", "to", "fluctuate", "in", "future", "periods", "depending", "on", "the", "level", "and", "mix", "of", "manufacturing", "orders", "from", "our", "customers", "due", "to", "the", "fixed", "cost", "base", "associated", "with", "our", "manufacturing", "activities.", "<tag2>", "We", "expect", "product", "gross", "margin", "to", "fluctuate", "in", "future", "periods", "depending", "on", "the", "level", "and", "mix", "of", "manufacturing", "orders", "from", "our", "customers", "due", "to", "the", "predominantly", "fixed", "cost", "base", "associated", "with", "our", "manufacturing", "activities.", "<tag3>"], "wordsA": ["We", "expect", "product", "gross", "margin", "to", "fluctuate", "in", "future", "periods", "depending", "on", "the", "level", "and", "mix", "of", "manufacturing", "orders", "from", "our", "customers", "due", "to", "the", "fixed", "cost", "base", "associated", "with", "our", "manufacturing", "activities."], "wordsB": ["We", "expect", "product", "gross", "margin", "to", "fluctuate", "in", "future", "periods", "depending", "on", "the", "level", "and", "mix", "of", "manufacturing", "orders", "from", "our", "customers", "due", "to", "the", "predominantly", "fixed", "cost", "base", "associated", "with", "our", "manufacturing", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p28_s0", "idA": "906709_13_item7_p25_s0", "sentA": "Research and development expense consists primarily of personnel costs (including salaries, benefits, and stock-based compensation), clinical study costs, direct costs of outside research conducted by clinical research organizations, materials, supplies, licenses and fees.", "sentB": "Research and development expense consists primarily of clinical study costs, direct costs of outside research, materials, supplies, licenses and fees as well as personnel costs (including salaries, benefits, and stock-based compensation).", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expense", "consists", "primarily", "of", "personnel", "costs", "(including", "salaries,", "benefits,", "and", "stock-based", "compensation),", "clinical", "study", "costs,", "direct", "costs", "of", "outside", "research", "conducted", "by", "clinical", "research", "organizations,", "materials,", "supplies,", "licenses", "and", "fees.", "<tag2>", "Research", "and", "development", "expense", "consists", "primarily", "of", "clinical", "study", "costs,", "direct", "costs", "of", "outside", "research,", "materials,", "supplies,", "licenses", "and", "fees", "as", "well", "as", "personnel", "costs", "(including", "salaries,", "benefits,", "and", "stock-based", "compensation).", "<tag3>"], "wordsA": ["Research", "and", "development", "expense", "consists", "primarily", "of", "personnel", "costs", "(including", "salaries,", "benefits,", "and", "stock-based", "compensation),", "clinical", "study", "costs,", "direct", "costs", "of", "outside", "research", "conducted", "by", "clinical", "research", "organizations,", "materials,", "supplies,", "licenses", "and", "fees."], "wordsB": ["Research", "and", "development", "expense", "consists", "primarily", "of", "clinical", "study", "costs,", "direct", "costs", "of", "outside", "research,", "materials,", "supplies,", "licenses", "and", "fees", "as", "well", "as", "personnel", "costs", "(including", "salaries,", "benefits,", "and", "stock-based", "compensation)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p28_s1", "idA": "906709_13_item7_p25_s1", "sentA": "Research and development expense also includes certain overhead allocations consisting of various support and facilities related costs.", "sentB": "Research and development expense also includes certain overhead allocations consisting of support and facilities-related costs.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expense", "also", "includes", "certain", "overhead", "allocations", "consisting", "of", "various", "support", "and", "facilities", "related", "costs.", "<tag2>", "Research", "and", "development", "expense", "also", "includes", "certain", "overhead", "allocations", "consisting", "of", "support", "and", "facilities-related", "costs.", "<tag3>"], "wordsA": ["Research", "and", "development", "expense", "also", "includes", "certain", "overhead", "allocations", "consisting", "of", "various", "support", "and", "facilities", "related", "costs."], "wordsB": ["Research", "and", "development", "expense", "also", "includes", "certain", "overhead", "allocations", "consisting", "of", "support", "and", "facilities-related", "costs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p28_s2", "idA": "906709_13_item7_p25_s2", "sentA": "The increase in research and development expense for the year ended December 31, 2012 compared to the year ended December 31, 2011 is primarily attributable to the $15.2 million increase in direct research and development program costs, a substantial portion of which is attributable to the etirinotecan pegol (NKTR-102) Phase 3 BEACON clinical study initiated in December 2011 as well as the NKTR-181 Phase 2 clinical study initiated in July 2012.", "sentB": "Research and development expense increased during the year ended December 31, 2013 compared to the year ended December 31, 2012 primarily due to the etirinotecan pegol (NKTR-102) Phase 3 BEACON clinical study initiated in December 2011 as well as the NKTR-181 Phase 2 clinical study initiated in July 2012.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "research", "and", "development", "expense", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "attributable", "to", "the", "$15.2", "million", "increase", "in", "direct", "research", "and", "development", "program", "costs,", "a", "substantial", "portion", "of", "which", "is", "attributable", "to", "the", "etirinotecan", "pegol", "(NKTR-102)", "Phase", "3", "BEACON", "clinical", "study", "initiated", "in", "December", "2011", "as", "well", "as", "the", "NKTR-181", "Phase", "2", "clinical", "study", "initiated", "in", "July", "2012.", "<tag2>", "Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "due", "to", "the", "etirinotecan", "pegol", "(NKTR-102)", "Phase", "3", "BEACON", "clinical", "study", "initiated", "in", "December", "2011", "as", "well", "as", "the", "NKTR-181", "Phase", "2", "clinical", "study", "initiated", "in", "July", "2012.", "<tag3>"], "wordsA": ["The", "increase", "in", "research", "and", "development", "expense", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "attributable", "to", "the", "$15.2", "million", "increase", "in", "direct", "research", "and", "development", "program", "costs,", "a", "substantial", "portion", "of", "which", "is", "attributable", "to", "the", "etirinotecan", "pegol", "(NKTR-102)", "Phase", "3", "BEACON", "clinical", "study", "initiated", "in", "December", "2011", "as", "well", "as", "the", "NKTR-181", "Phase", "2", "clinical", "study", "initiated", "in", "July", "2012."], "wordsB": ["Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "due", "to", "the", "etirinotecan", "pegol", "(NKTR-102)", "Phase", "3", "BEACON", "clinical", "study", "initiated", "in", "December", "2011", "as", "well", "as", "the", "NKTR-181", "Phase", "2", "clinical", "study", "initiated", "in", "July", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p28_s4", "idA": "906709_13_item7_p25_s2", "sentA": "The increase in research and development expense for the year ended December 31, 2012 compared to the year ended December 31, 2011 is primarily attributable to the $15.2 million increase in direct research and development program costs, a substantial portion of which is attributable to the etirinotecan pegol (NKTR-102) Phase 3 BEACON clinical study initiated in December 2011 as well as the NKTR-181 Phase 2 clinical study initiated in July 2012.", "sentB": "The increase in research and development expense for the year ended December 31, 2012 compared to the year ended December 31, 2011 is primarily attributable to the $15.2 million increase in direct research and development program costs, a substantial portion of which is attributable to our etirinotecan pegol Phase 3 BEACON study as well as the NKTR-181 Phase 2 clinical study.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "research", "and", "development", "expense", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "attributable", "to", "the", "$15.2", "million", "increase", "in", "direct", "research", "and", "development", "program", "costs,", "a", "substantial", "portion", "of", "which", "is", "attributable", "to", "the", "etirinotecan", "pegol", "(NKTR-102)", "Phase", "3", "BEACON", "clinical", "study", "initiated", "in", "December", "2011", "as", "well", "as", "the", "NKTR-181", "Phase", "2", "clinical", "study", "initiated", "in", "July", "2012.", "<tag2>", "The", "increase", "in", "research", "and", "development", "expense", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "attributable", "to", "the", "$15.2", "million", "increase", "in", "direct", "research", "and", "development", "program", "costs,", "a", "substantial", "portion", "of", "which", "is", "attributable", "to", "our", "etirinotecan", "pegol", "Phase", "3", "BEACON", "study", "as", "well", "as", "the", "NKTR-181", "Phase", "2", "clinical", "study.", "<tag3>"], "wordsA": ["The", "increase", "in", "research", "and", "development", "expense", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "attributable", "to", "the", "$15.2", "million", "increase", "in", "direct", "research", "and", "development", "program", "costs,", "a", "substantial", "portion", "of", "which", "is", "attributable", "to", "the", "etirinotecan", "pegol", "(NKTR-102)", "Phase", "3", "BEACON", "clinical", "study", "initiated", "in", "December", "2011", "as", "well", "as", "the", "NKTR-181", "Phase", "2", "clinical", "study", "initiated", "in", "July", "2012."], "wordsB": ["The", "increase", "in", "research", "and", "development", "expense", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "attributable", "to", "the", "$15.2", "million", "increase", "in", "direct", "research", "and", "development", "program", "costs,", "a", "substantial", "portion", "of", "which", "is", "attributable", "to", "our", "etirinotecan", "pegol", "Phase", "3", "BEACON", "study", "as", "well", "as", "the", "NKTR-181", "Phase", "2", "clinical", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p28_s7", "idA": "906709_13_item7_p27_s0", "sentA": "The following table shows expenses incurred for preclinical study support, clinical supplies, clinical and regulatory services provided by third parties and direct materials costs for each of our drug candidates.", "sentB": "The following table shows expenses incurred for clinical and regulatory services, clinical supplies, and preclinical study support provided by third parties as well as direct materials costs for each of our drug candidates.", "type": 2, "words": ["<tag1>", "The", "following", "table", "shows", "expenses", "incurred", "for", "preclinical", "study", "support,", "clinical", "supplies,", "clinical", "and", "regulatory", "services", "provided", "by", "third", "parties", "and", "direct", "materials", "costs", "for", "each", "of", "our", "drug", "candidates.", "<tag2>", "The", "following", "table", "shows", "expenses", "incurred", "for", "clinical", "and", "regulatory", "services,", "clinical", "supplies,", "and", "preclinical", "study", "support", "provided", "by", "third", "parties", "as", "well", "as", "direct", "materials", "costs", "for", "each", "of", "our", "drug", "candidates.", "<tag3>"], "wordsA": ["The", "following", "table", "shows", "expenses", "incurred", "for", "preclinical", "study", "support,", "clinical", "supplies,", "clinical", "and", "regulatory", "services", "provided", "by", "third", "parties", "and", "direct", "materials", "costs", "for", "each", "of", "our", "drug", "candidates."], "wordsB": ["The", "following", "table", "shows", "expenses", "incurred", "for", "clinical", "and", "regulatory", "services,", "clinical", "supplies,", "and", "preclinical", "study", "support", "provided", "by", "third", "parties", "as", "well", "as", "direct", "materials", "costs", "for", "each", "of", "our", "drug", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p28_s3", "idA": "906709_13_item7_p29_s0", "sentA": "In addition, during the year ended December 31, 2011, we made $11.2 million of prepayments to certain vendors in our BEACON study.", "sentB": "In addition, during the year ended December 31, 2013, we recorded a charge of $11.3 million resulting from the settlement of a dispute with the Research Foundation of the State University of New York related to our collaboration with Bayer to develop inhaled amikacin (see Note 8 to our Consolidated Financial Statements).", "type": 2, "words": ["<tag1>", "In", "addition,", "during", "the", "year", "ended", "December", "31,", "2011,", "we", "made", "$11.2", "million", "of", "prepayments", "to", "certain", "vendors", "in", "our", "BEACON", "study.", "<tag2>", "In", "addition,", "during", "the", "year", "ended", "December", "31,", "2013,", "we", "recorded", "a", "charge", "of", "$11.3", "million", "resulting", "from", "the", "settlement", "of", "a", "dispute", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "related", "to", "our", "collaboration", "with", "Bayer", "to", "develop", "inhaled", "amikacin", "(see", "Note", "8", "to", "our", "Consolidated", "Financial", "Statements).", "<tag3>"], "wordsA": ["In", "addition,", "during", "the", "year", "ended", "December", "31,", "2011,", "we", "made", "$11.2", "million", "of", "prepayments", "to", "certain", "vendors", "in", "our", "BEACON", "study."], "wordsB": ["In", "addition,", "during", "the", "year", "ended", "December", "31,", "2013,", "we", "recorded", "a", "charge", "of", "$11.3", "million", "resulting", "from", "the", "settlement", "of", "a", "dispute", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "related", "to", "our", "collaboration", "with", "Bayer", "to", "develop", "inhaled", "amikacin", "(see", "Note", "8", "to", "our", "Consolidated", "Financial", "Statements)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p31_s2", "idA": "906709_13_item7_p32_s0", "sentA": "We expect research and development expense to increase in 2013 as compared to 2012 and to continue at or above the 2012 level for the next several years.", "sentB": "We expect research and development expense to decrease in 2014 as compared to 2013 and to continue at or above the 2012 level.", "type": 2, "words": ["<tag1>", "We", "expect", "research", "and", "development", "expense", "to", "increase", "in", "2013", "as", "compared", "to", "2012", "and", "to", "continue", "at", "or", "above", "the", "2012", "level", "for", "the", "next", "several", "years.", "<tag2>", "We", "expect", "research", "and", "development", "expense", "to", "decrease", "in", "2014", "as", "compared", "to", "2013", "and", "to", "continue", "at", "or", "above", "the", "2012", "level.", "<tag3>"], "wordsA": ["We", "expect", "research", "and", "development", "expense", "to", "increase", "in", "2013", "as", "compared", "to", "2012", "and", "to", "continue", "at", "or", "above", "the", "2012", "level", "for", "the", "next", "several", "years."], "wordsB": ["We", "expect", "research", "and", "development", "expense", "to", "decrease", "in", "2014", "as", "compared", "to", "2013", "and", "to", "continue", "at", "or", "above", "the", "2012", "level."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p31_s3", "idA": "906709_13_item7_p32_s1", "sentA": "We plan to continue to advance etirinotecan pegol in the Phase 3 BEACON study for metastatic breast cancer for which we expect patient enrollment to continue throughout 2013 and the clinical study to continue through 2014.", "sentB": "We plan to continue to advance etirinotecan pegol in the Phase 3 BEACON study for metastatic breast cancer for which we expect the clinical study to continue through early 2015.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "continue", "to", "advance", "etirinotecan", "pegol", "in", "the", "Phase", "3", "BEACON", "study", "for", "metastatic", "breast", "cancer", "for", "which", "we", "expect", "patient", "enrollment", "to", "continue", "throughout", "2013", "and", "the", "clinical", "study", "to", "continue", "through", "2014.", "<tag2>", "We", "plan", "to", "continue", "to", "advance", "etirinotecan", "pegol", "in", "the", "Phase", "3", "BEACON", "study", "for", "metastatic", "breast", "cancer", "for", "which", "we", "expect", "the", "clinical", "study", "to", "continue", "through", "early", "2015.", "<tag3>"], "wordsA": ["We", "plan", "to", "continue", "to", "advance", "etirinotecan", "pegol", "in", "the", "Phase", "3", "BEACON", "study", "for", "metastatic", "breast", "cancer", "for", "which", "we", "expect", "patient", "enrollment", "to", "continue", "throughout", "2013", "and", "the", "clinical", "study", "to", "continue", "through", "2014."], "wordsB": ["We", "plan", "to", "continue", "to", "advance", "etirinotecan", "pegol", "in", "the", "Phase", "3", "BEACON", "study", "for", "metastatic", "breast", "cancer", "for", "which", "we", "expect", "the", "clinical", "study", "to", "continue", "through", "early", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p8_s3", "idA": "906709_13_item7_p32_s1", "sentA": "We plan to continue to advance etirinotecan pegol in the Phase 3 BEACON study for metastatic breast cancer for which we expect patient enrollment to continue throughout 2013 and the clinical study to continue through 2014.", "sentB": "We completed enrollment in the BEACON study in late July 2013.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "continue", "to", "advance", "etirinotecan", "pegol", "in", "the", "Phase", "3", "BEACON", "study", "for", "metastatic", "breast", "cancer", "for", "which", "we", "expect", "patient", "enrollment", "to", "continue", "throughout", "2013", "and", "the", "clinical", "study", "to", "continue", "through", "2014.", "<tag2>", "We", "completed", "enrollment", "in", "the", "BEACON", "study", "in", "late", "July", "2013.", "<tag3>"], "wordsA": ["We", "plan", "to", "continue", "to", "advance", "etirinotecan", "pegol", "in", "the", "Phase", "3", "BEACON", "study", "for", "metastatic", "breast", "cancer", "for", "which", "we", "expect", "patient", "enrollment", "to", "continue", "throughout", "2013", "and", "the", "clinical", "study", "to", "continue", "through", "2014."], "wordsB": ["We", "completed", "enrollment", "in", "the", "BEACON", "study", "in", "late", "July", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p5_s0", "idA": "906709_13_item7_p32_s14", "sentA": "We do not expect to have any significant future research and development costs associated with naloxegol or the naloxegol fixed-dose combination products as AstraZeneca is responsible for all further development and commercialization costs for these drug candidates.", "sentB": "The naloxegol fixed-dose combination program is an early stage research and development program that is designed to combine various opioids with naloxegol AstraZeneca is responsible for all clinical, regulatory and commercialization costs for both the naloxegol drug candidate and all drug candidates within the naloxegol fixed-dose combination program.", "type": 2, "words": ["<tag1>", "We", "do", "not", "expect", "to", "have", "any", "significant", "future", "research", "and", "development", "costs", "associated", "with", "naloxegol", "or", "the", "naloxegol", "fixed-dose", "combination", "products", "as", "AstraZeneca", "is", "responsible", "for", "all", "further", "development", "and", "commercialization", "costs", "for", "these", "drug", "candidates.", "<tag2>", "The", "naloxegol", "fixed-dose", "combination", "program", "is", "an", "early", "stage", "research", "and", "development", "program", "that", "is", "designed", "to", "combine", "various", "opioids", "with", "naloxegol", "AstraZeneca", "is", "responsible", "for", "all", "clinical,", "regulatory", "and", "commercialization", "costs", "for", "both", "the", "naloxegol", "drug", "candidate", "and", "all", "drug", "candidates", "within", "the", "naloxegol", "fixed-dose", "combination", "program.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "to", "have", "any", "significant", "future", "research", "and", "development", "costs", "associated", "with", "naloxegol", "or", "the", "naloxegol", "fixed-dose", "combination", "products", "as", "AstraZeneca", "is", "responsible", "for", "all", "further", "development", "and", "commercialization", "costs", "for", "these", "drug", "candidates."], "wordsB": ["The", "naloxegol", "fixed-dose", "combination", "program", "is", "an", "early", "stage", "research", "and", "development", "program", "that", "is", "designed", "to", "combine", "various", "opioids", "with", "naloxegol", "AstraZeneca", "is", "responsible", "for", "all", "clinical,", "regulatory", "and", "commercialization", "costs", "for", "both", "the", "naloxegol", "drug", "candidate", "and", "all", "drug", "candidates", "within", "the", "naloxegol", "fixed-dose", "combination", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p17_s2", "idA": "906709_13_item7_p32_s15", "sentA": "In addition to our drug candidates that we plan to have in clinical development during 2013 and beyond, we believe it is vitally important to continue our substantial investment in a diverse pipeline of new drug candidates to continue to build the value of our drug candidate pipeline and our business.", "sentB": "While we believe that our substantial investment in research and development has the potential to create significant value if one or more of our drug candidates demonstrate positive clinical results and receive regulatory approval in one or more major markets, drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval and the timing and outcome of clinical trial results are extremely difficult to predict.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "our", "drug", "candidates", "that", "we", "plan", "to", "have", "in", "clinical", "development", "during", "2013", "and", "beyond,", "we", "believe", "it", "is", "vitally", "important", "to", "continue", "our", "substantial", "investment", "in", "a", "diverse", "pipeline", "of", "new", "drug", "candidates", "to", "continue", "to", "build", "the", "value", "of", "our", "drug", "candidate", "pipeline", "and", "our", "business.", "<tag2>", "While", "we", "believe", "that", "our", "substantial", "investment", "in", "research", "and", "development", "has", "the", "potential", "to", "create", "significant", "value", "if", "one", "or", "more", "of", "our", "drug", "candidates", "demonstrate", "positive", "clinical", "results", "and", "receive", "regulatory", "approval", "in", "one", "or", "more", "major", "markets,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "outcome", "of", "clinical", "trial", "results", "are", "extremely", "difficult", "to", "predict.", "<tag3>"], "wordsA": ["In", "addition", "to", "our", "drug", "candidates", "that", "we", "plan", "to", "have", "in", "clinical", "development", "during", "2013", "and", "beyond,", "we", "believe", "it", "is", "vitally", "important", "to", "continue", "our", "substantial", "investment", "in", "a", "diverse", "pipeline", "of", "new", "drug", "candidates", "to", "continue", "to", "build", "the", "value", "of", "our", "drug", "candidate", "pipeline", "and", "our", "business."], "wordsB": ["While", "we", "believe", "that", "our", "substantial", "investment", "in", "research", "and", "development", "has", "the", "potential", "to", "create", "significant", "value", "if", "one", "or", "more", "of", "our", "drug", "candidates", "demonstrate", "positive", "clinical", "results", "and", "receive", "regulatory", "approval", "in", "one", "or", "more", "major", "markets,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "outcome", "of", "clinical", "trial", "results", "are", "extremely", "difficult", "to", "predict."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p31_s12", "idA": "906709_13_item7_p32_s15", "sentA": "In addition to our drug candidates that we plan to have in clinical development during 2013 and beyond, we believe it is vitally important to continue our substantial investment in a diverse pipeline of new drug candidates to continue to build the value of our drug candidate pipeline and our business.", "sentB": "In addition to our drug candidates that we plan to have in clinical development during 2014 and beyond, we believe it is vitally important to continue our substantial investment in a diverse pipeline of new drug candidates to continue to build the value of our drug candidate pipeline and our business.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "our", "drug", "candidates", "that", "we", "plan", "to", "have", "in", "clinical", "development", "during", "2013", "and", "beyond,", "we", "believe", "it", "is", "vitally", "important", "to", "continue", "our", "substantial", "investment", "in", "a", "diverse", "pipeline", "of", "new", "drug", "candidates", "to", "continue", "to", "build", "the", "value", "of", "our", "drug", "candidate", "pipeline", "and", "our", "business.", "<tag2>", "In", "addition", "to", "our", "drug", "candidates", "that", "we", "plan", "to", "have", "in", "clinical", "development", "during", "2014", "and", "beyond,", "we", "believe", "it", "is", "vitally", "important", "to", "continue", "our", "substantial", "investment", "in", "a", "diverse", "pipeline", "of", "new", "drug", "candidates", "to", "continue", "to", "build", "the", "value", "of", "our", "drug", "candidate", "pipeline", "and", "our", "business.", "<tag3>"], "wordsA": ["In", "addition", "to", "our", "drug", "candidates", "that", "we", "plan", "to", "have", "in", "clinical", "development", "during", "2013", "and", "beyond,", "we", "believe", "it", "is", "vitally", "important", "to", "continue", "our", "substantial", "investment", "in", "a", "diverse", "pipeline", "of", "new", "drug", "candidates", "to", "continue", "to", "build", "the", "value", "of", "our", "drug", "candidate", "pipeline", "and", "our", "business."], "wordsB": ["In", "addition", "to", "our", "drug", "candidates", "that", "we", "plan", "to", "have", "in", "clinical", "development", "during", "2014", "and", "beyond,", "we", "believe", "it", "is", "vitally", "important", "to", "continue", "our", "substantial", "investment", "in", "a", "diverse", "pipeline", "of", "new", "drug", "candidates", "to", "continue", "to", "build", "the", "value", "of", "our", "drug", "candidate", "pipeline", "and", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p17_s1", "idA": "906709_13_item7_p32_s17", "sentA": "We plan to continue to advance our most promising early research drug candidates into preclinical development with the objective to advance these early stage research programs to human clinical studies over the next several years.", "sentB": "Further, we have several drug candidates in research that we are preparing to advance into the clinic in future years.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "continue", "to", "advance", "our", "most", "promising", "early", "research", "drug", "candidates", "into", "preclinical", "development", "with", "the", "objective", "to", "advance", "these", "early", "stage", "research", "programs", "to", "human", "clinical", "studies", "over", "the", "next", "several", "years.", "<tag2>", "Further,", "we", "have", "several", "drug", "candidates", "in", "research", "that", "we", "are", "preparing", "to", "advance", "into", "the", "clinic", "in", "future", "years.", "<tag3>"], "wordsA": ["We", "plan", "to", "continue", "to", "advance", "our", "most", "promising", "early", "research", "drug", "candidates", "into", "preclinical", "development", "with", "the", "objective", "to", "advance", "these", "early", "stage", "research", "programs", "to", "human", "clinical", "studies", "over", "the", "next", "several", "years."], "wordsB": ["Further,", "we", "have", "several", "drug", "candidates", "in", "research", "that", "we", "are", "preparing", "to", "advance", "into", "the", "clinic", "in", "future", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p31_s5", "idA": "906709_13_item7_p32_s6", "sentA": "We estimate that the total third party and direct material costs over the life of the BEACON study will range from approximately $110.0 million to $120.0 million, of which $26.0 million was incurred through the end of 2012.", "sentB": "We estimate that the total third party and direct material costs over the life of the BEACON study will be approximately $100.0 million, of which $64.7 million was incurred through the end of 2013.", "type": 2, "words": ["<tag1>", "We", "estimate", "that", "the", "total", "third", "party", "and", "direct", "material", "costs", "over", "the", "life", "of", "the", "BEACON", "study", "will", "range", "from", "approximately", "$110.0", "million", "to", "$120.0", "million,", "of", "which", "$26.0", "million", "was", "incurred", "through", "the", "end", "of", "2012.", "<tag2>", "We", "estimate", "that", "the", "total", "third", "party", "and", "direct", "material", "costs", "over", "the", "life", "of", "the", "BEACON", "study", "will", "be", "approximately", "$100.0", "million,", "of", "which", "$64.7", "million", "was", "incurred", "through", "the", "end", "of", "2013.", "<tag3>"], "wordsA": ["We", "estimate", "that", "the", "total", "third", "party", "and", "direct", "material", "costs", "over", "the", "life", "of", "the", "BEACON", "study", "will", "range", "from", "approximately", "$110.0", "million", "to", "$120.0", "million,", "of", "which", "$26.0", "million", "was", "incurred", "through", "the", "end", "of", "2012."], "wordsB": ["We", "estimate", "that", "the", "total", "third", "party", "and", "direct", "material", "costs", "over", "the", "life", "of", "the", "BEACON", "study", "will", "be", "approximately", "$100.0", "million,", "of", "which", "$64.7", "million", "was", "incurred", "through", "the", "end", "of", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p10_s1", "idA": "906709_13_item7_p32_s8", "sentA": "In addition to our etirinotecan pegol development activities, in 2013, we plan to continue to enroll the ongoing Phase 2 clinical study for NKTR-181 and also initiate and complete a human abuse liability study for NKTR-181.", "sentB": "On June 19, 2013, we announced positive data from a human abuse liability study of NKTR-181.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "our", "etirinotecan", "pegol", "development", "activities,", "in", "2013,", "we", "plan", "to", "continue", "to", "enroll", "the", "ongoing", "Phase", "2", "clinical", "study", "for", "NKTR-181", "and", "also", "initiate", "and", "complete", "a", "human", "abuse", "liability", "study", "for", "NKTR-181.", "<tag2>", "On", "June", "19,", "2013,", "we", "announced", "positive", "data", "from", "a", "human", "abuse", "liability", "study", "of", "NKTR-181.", "<tag3>"], "wordsA": ["In", "addition", "to", "our", "etirinotecan", "pegol", "development", "activities,", "in", "2013,", "we", "plan", "to", "continue", "to", "enroll", "the", "ongoing", "Phase", "2", "clinical", "study", "for", "NKTR-181", "and", "also", "initiate", "and", "complete", "a", "human", "abuse", "liability", "study", "for", "NKTR-181."], "wordsB": ["On", "June", "19,", "2013,", "we", "announced", "positive", "data", "from", "a", "human", "abuse", "liability", "study", "of", "NKTR-181."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p31_s8", "idA": "906709_13_item7_p32_s8", "sentA": "In addition to our etirinotecan pegol development activities, in 2013, we plan to continue to enroll the ongoing Phase 2 clinical study for NKTR-181 and also initiate and complete a human abuse liability study for NKTR-181.", "sentB": "In addition to our etirinotecan pegol development activities, in 2014, we plan to commence Phase 3 clinical studies for NKTR-181 and we also plan to continue to advance the development of NKTR-171.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "our", "etirinotecan", "pegol", "development", "activities,", "in", "2013,", "we", "plan", "to", "continue", "to", "enroll", "the", "ongoing", "Phase", "2", "clinical", "study", "for", "NKTR-181", "and", "also", "initiate", "and", "complete", "a", "human", "abuse", "liability", "study", "for", "NKTR-181.", "<tag2>", "In", "addition", "to", "our", "etirinotecan", "pegol", "development", "activities,", "in", "2014,", "we", "plan", "to", "commence", "Phase", "3", "clinical", "studies", "for", "NKTR-181", "and", "we", "also", "plan", "to", "continue", "to", "advance", "the", "development", "of", "NKTR-171.", "<tag3>"], "wordsA": ["In", "addition", "to", "our", "etirinotecan", "pegol", "development", "activities,", "in", "2013,", "we", "plan", "to", "continue", "to", "enroll", "the", "ongoing", "Phase", "2", "clinical", "study", "for", "NKTR-181", "and", "also", "initiate", "and", "complete", "a", "human", "abuse", "liability", "study", "for", "NKTR-181."], "wordsB": ["In", "addition", "to", "our", "etirinotecan", "pegol", "development", "activities,", "in", "2014,", "we", "plan", "to", "commence", "Phase", "3", "clinical", "studies", "for", "NKTR-181", "and", "we", "also", "plan", "to", "continue", "to", "advance", "the", "development", "of", "NKTR-171."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p11_s1", "idA": "906709_13_item7_p32_s9", "sentA": "Further, if the Phase 2 clinical results are successful, we plan to begin preparations for the commencement of Phase 3 clinical studies for NKTR-181.", "sentB": "In December 2013, we met with the FDA to discuss the results of the Phase 2 clinical study and certain preliminary considerations for the Phase 3 clinical study design.", "type": 2, "words": ["<tag1>", "Further,", "if", "the", "Phase", "2", "clinical", "results", "are", "successful,", "we", "plan", "to", "begin", "preparations", "for", "the", "commencement", "of", "Phase", "3", "clinical", "studies", "for", "NKTR-181.", "<tag2>", "In", "December", "2013,", "we", "met", "with", "the", "FDA", "to", "discuss", "the", "results", "of", "the", "Phase", "2", "clinical", "study", "and", "certain", "preliminary", "considerations", "for", "the", "Phase", "3", "clinical", "study", "design.", "<tag3>"], "wordsA": ["Further,", "if", "the", "Phase", "2", "clinical", "results", "are", "successful,", "we", "plan", "to", "begin", "preparations", "for", "the", "commencement", "of", "Phase", "3", "clinical", "studies", "for", "NKTR-181."], "wordsB": ["In", "December", "2013,", "we", "met", "with", "the", "FDA", "to", "discuss", "the", "results", "of", "the", "Phase", "2", "clinical", "study", "and", "certain", "preliminary", "considerations", "for", "the", "Phase", "3", "clinical", "study", "design."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p35_s0", "idA": "906709_13_item7_p36_s0", "sentA": "General and administrative expense includes the cost of administrative staffing, business development, marketing, finance, human resources and legal activities.", "sentB": "General and administrative expense includes the cost of administrative staffing, business development, marketing, finance, and legal activities.", "type": 2, "words": ["<tag1>", "General", "and", "administrative", "expense", "includes", "the", "cost", "of", "administrative", "staffing,", "business", "development,", "marketing,", "finance,", "human", "resources", "and", "legal", "activities.", "<tag2>", "General", "and", "administrative", "expense", "includes", "the", "cost", "of", "administrative", "staffing,", "business", "development,", "marketing,", "finance,", "and", "legal", "activities.", "<tag3>"], "wordsA": ["General", "and", "administrative", "expense", "includes", "the", "cost", "of", "administrative", "staffing,", "business", "development,", "marketing,", "finance,", "human", "resources", "and", "legal", "activities."], "wordsB": ["General", "and", "administrative", "expense", "includes", "the", "cost", "of", "administrative", "staffing,", "business", "development,", "marketing,", "finance,", "and", "legal", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p35_s3", "idA": "906709_13_item7_p36_s4", "sentA": "In 2013, we expect general and administrative expenses to increase modestly compared to 2012.", "sentB": "In 2014, we expect general and administrative expenses to be consistent with 2013.", "type": 2, "words": ["<tag1>", "In", "2013,", "we", "expect", "general", "and", "administrative", "expenses", "to", "increase", "modestly", "compared", "to", "2012.", "<tag2>", "In", "2014,", "we", "expect", "general", "and", "administrative", "expenses", "to", "be", "consistent", "with", "2013.", "<tag3>"], "wordsA": ["In", "2013,", "we", "expect", "general", "and", "administrative", "expenses", "to", "increase", "modestly", "compared", "to", "2012."], "wordsB": ["In", "2014,", "we", "expect", "general", "and", "administrative", "expenses", "to", "be", "consistent", "with", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p27_s1", "idA": "906709_13_item7_p39_s0", "sentA": "Interest income for the year ended December 31, 2012 was consistent with the year ended December 31, 2011.", "sentB": "Product gross margin in the year ended December 31, 2013 was consistent with the year ended December 31, 2012.", "type": 2, "words": ["<tag1>", "Interest", "income", "for", "the", "year", "ended", "December", "31,", "2012", "was", "consistent", "with", "the", "year", "ended", "December", "31,", "2011.", "<tag2>", "Product", "gross", "margin", "in", "the", "year", "ended", "December", "31,", "2013", "was", "consistent", "with", "the", "year", "ended", "December", "31,", "2012.", "<tag3>"], "wordsA": ["Interest", "income", "for", "the", "year", "ended", "December", "31,", "2012", "was", "consistent", "with", "the", "year", "ended", "December", "31,", "2011."], "wordsB": ["Product", "gross", "margin", "in", "the", "year", "ended", "December", "31,", "2013", "was", "consistent", "with", "the", "year", "ended", "December", "31,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p35_s1", "idA": "906709_13_item7_p39_s0", "sentA": "Interest income for the year ended December 31, 2012 was consistent with the year ended December 31, 2011.", "sentB": "General and administrative expense during the year ended December 31, 2013 was consistent with the year ended December 31, 2012.", "type": 2, "words": ["<tag1>", "Interest", "income", "for", "the", "year", "ended", "December", "31,", "2012", "was", "consistent", "with", "the", "year", "ended", "December", "31,", "2011.", "<tag2>", "General", "and", "administrative", "expense", "during", "the", "year", "ended", "December", "31,", "2013", "was", "consistent", "with", "the", "year", "ended", "December", "31,", "2012.", "<tag3>"], "wordsA": ["Interest", "income", "for", "the", "year", "ended", "December", "31,", "2012", "was", "consistent", "with", "the", "year", "ended", "December", "31,", "2011."], "wordsB": ["General", "and", "administrative", "expense", "during", "the", "year", "ended", "December", "31,", "2013", "was", "consistent", "with", "the", "year", "ended", "December", "31,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p36_s0", "idA": "906709_13_item7_p39_s1", "sentA": "The increase in interest income for the year ended December 31, 2011 compared to the year ended December 31, 2010 is a result of higher average cash and investment balances partially offset by the impact of lower interest rates earned on our cash, cash equivalents, and available-for-sale investments.", "sentB": "Interest income (in thousands except percentages) Interest income for the year ended December 31, 2013 decreased as compared to the year ended December 31, 2012 as a result of lower average cash and investment balances as well as the impact of lower interest rates earned on our investment balances.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "interest", "income", "for", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "a", "result", "of", "higher", "average", "cash", "and", "investment", "balances", "partially", "offset", "by", "the", "impact", "of", "lower", "interest", "rates", "earned", "on", "our", "cash,", "cash", "equivalents,", "and", "available-for-sale", "investments.", "<tag2>", "Interest", "income", "(in", "thousands", "except", "percentages)", "Interest", "income", "for", "the", "year", "ended", "December", "31,", "2013", "decreased", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "as", "a", "result", "of", "lower", "average", "cash", "and", "investment", "balances", "as", "well", "as", "the", "impact", "of", "lower", "interest", "rates", "earned", "on", "our", "investment", "balances.", "<tag3>"], "wordsA": ["The", "increase", "in", "interest", "income", "for", "the", "year", "ended", "December", "31,", "2011", "compared", "to", "the", "year", "ended", "December", "31,", "2010", "is", "a", "result", "of", "higher", "average", "cash", "and", "investment", "balances", "partially", "offset", "by", "the", "impact", "of", "lower", "interest", "rates", "earned", "on", "our", "cash,", "cash", "equivalents,", "and", "available-for-sale", "investments."], "wordsB": ["Interest", "income", "(in", "thousands", "except", "percentages)", "Interest", "income", "for", "the", "year", "ended", "December", "31,", "2013", "decreased", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "as", "a", "result", "of", "lower", "average", "cash", "and", "investment", "balances", "as", "well", "as", "the", "impact", "of", "lower", "interest", "rates", "earned", "on", "our", "investment", "balances."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p3_s0", "idA": "906709_13_item7_p3_s0", "sentA": "Our most advanced proprietary product candidate, naloxegol (formerly known as NKTR-118), is a peripheral opioid antagonist which has completed Phase 3 clinical studies for the treatment of opioid-induced constipation (OIC).", "sentB": "Our most advanced proprietary product candidate, naloxegol (formerly known as NKTR-118), is an oral peripheral opioid antagonist which has completed Phase 3 clinical studies and has been filed for regulatory approvals in the US, E.U. and Canada for the treatment of opioid-induced constipation (OIC) in patients with non-cancer pain.", "type": 2, "words": ["<tag1>", "Our", "most", "advanced", "proprietary", "product", "candidate,", "naloxegol", "(formerly", "known", "as", "NKTR-118),", "is", "a", "peripheral", "opioid", "antagonist", "which", "has", "completed", "Phase", "3", "clinical", "studies", "for", "the", "treatment", "of", "opioid-induced", "constipation", "(OIC).", "<tag2>", "Our", "most", "advanced", "proprietary", "product", "candidate,", "naloxegol", "(formerly", "known", "as", "NKTR-118),", "is", "an", "oral", "peripheral", "opioid", "antagonist", "which", "has", "completed", "Phase", "3", "clinical", "studies", "and", "has", "been", "filed", "for", "regulatory", "approvals", "in", "the", "US,", "E.U.", "and", "Canada", "for", "the", "treatment", "of", "opioid-induced", "constipation", "(OIC)", "in", "patients", "with", "non-cancer", "pain.", "<tag3>"], "wordsA": ["Our", "most", "advanced", "proprietary", "product", "candidate,", "naloxegol", "(formerly", "known", "as", "NKTR-118),", "is", "a", "peripheral", "opioid", "antagonist", "which", "has", "completed", "Phase", "3", "clinical", "studies", "for", "the", "treatment", "of", "opioid-induced", "constipation", "(OIC)."], "wordsB": ["Our", "most", "advanced", "proprietary", "product", "candidate,", "naloxegol", "(formerly", "known", "as", "NKTR-118),", "is", "an", "oral", "peripheral", "opioid", "antagonist", "which", "has", "completed", "Phase", "3", "clinical", "studies", "and", "has", "been", "filed", "for", "regulatory", "approvals", "in", "the", "US,", "E.U.", "and", "Canada", "for", "the", "treatment", "of", "opioid-induced", "constipation", "(OIC)", "in", "patients", "with", "non-cancer", "pain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p3_s1", "idA": "906709_13_item7_p3_s1", "sentA": "We are a party to an exclusive worldwide license agreement with AstraZeneca for the global development and commercialization of naloxegol and naloxegol fixed-dose combination products (formerly known as NKTR-119).", "sentB": "We are a party to an exclusive worldwide license agreement with AstraZeneca AB (AstraZeneca) for the global development and commercialization of naloxegol and naloxegol fixed-dose combination products (formerly known as NKTR-119).", "type": 2, "words": ["<tag1>", "We", "are", "a", "party", "to", "an", "exclusive", "worldwide", "license", "agreement", "with", "AstraZeneca", "for", "the", "global", "development", "and", "commercialization", "of", "naloxegol", "and", "naloxegol", "fixed-dose", "combination", "products", "(formerly", "known", "as", "NKTR-119).", "<tag2>", "We", "are", "a", "party", "to", "an", "exclusive", "worldwide", "license", "agreement", "with", "AstraZeneca", "AB", "(AstraZeneca)", "for", "the", "global", "development", "and", "commercialization", "of", "naloxegol", "and", "naloxegol", "fixed-dose", "combination", "products", "(formerly", "known", "as", "NKTR-119).", "<tag3>"], "wordsA": ["We", "are", "a", "party", "to", "an", "exclusive", "worldwide", "license", "agreement", "with", "AstraZeneca", "for", "the", "global", "development", "and", "commercialization", "of", "naloxegol", "and", "naloxegol", "fixed-dose", "combination", "products", "(formerly", "known", "as", "NKTR-119)."], "wordsB": ["We", "are", "a", "party", "to", "an", "exclusive", "worldwide", "license", "agreement", "with", "AstraZeneca", "AB", "(AstraZeneca)", "for", "the", "global", "development", "and", "commercialization", "of", "naloxegol", "and", "naloxegol", "fixed-dose", "combination", "products", "(formerly", "known", "as", "NKTR-119)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p37_s0", "idA": "906709_13_item7_p40_s0", "sentA": "The increase in interest expense for the year ended December 31, 2012 compared to the year ended December 31, 2011 is attributable to the interest expense recorded on the senior secured notes we issued in 2012.", "sentB": "The increase in interest expense for the year ended December 31, 2013 compared to the year ended December 31, 2012 and the year ended December 31, 2011 is attributable to the interest expense recorded on the senior secured notes we issued in 2012.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "interest", "expense", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "interest", "expense", "recorded", "on", "the", "senior", "secured", "notes", "we", "issued", "in", "2012.", "<tag2>", "The", "increase", "in", "interest", "expense", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "and", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "interest", "expense", "recorded", "on", "the", "senior", "secured", "notes", "we", "issued", "in", "2012.", "<tag3>"], "wordsA": ["The", "increase", "in", "interest", "expense", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "interest", "expense", "recorded", "on", "the", "senior", "secured", "notes", "we", "issued", "in", "2012."], "wordsB": ["The", "increase", "in", "interest", "expense", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "and", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "interest", "expense", "recorded", "on", "the", "senior", "secured", "notes", "we", "issued", "in", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p22_s3", "idA": "906709_13_item7_p40_s4", "sentA": "The increase in non-cash interest expense on liability related to sale of future royalties for the year ended December 31, 2012 compared to the year ended December 31, 2011 is attributable to the royalty sale transaction that we completed in 2012.", "sentB": "Royalties from CIMZIA and MIRCERA recognized after the royalty sale transaction took effect are presented on a separate revenue line item entitled Non-cash royalty revenue related to sale of future royalties.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "non-cash", "interest", "expense", "on", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "royalty", "sale", "transaction", "that", "we", "completed", "in", "2012.", "<tag2>", "Royalties", "from", "CIMZIA", "and", "MIRCERA", "recognized", "after", "the", "royalty", "sale", "transaction", "took", "effect", "are", "presented", "on", "a", "separate", "revenue", "line", "item", "entitled", "Non-cash", "royalty", "revenue", "related", "to", "sale", "of", "future", "royalties.", "<tag3>"], "wordsA": ["The", "increase", "in", "non-cash", "interest", "expense", "on", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "royalty", "sale", "transaction", "that", "we", "completed", "in", "2012."], "wordsB": ["Royalties", "from", "CIMZIA", "and", "MIRCERA", "recognized", "after", "the", "royalty", "sale", "transaction", "took", "effect", "are", "presented", "on", "a", "separate", "revenue", "line", "item", "entitled", "Non-cash", "royalty", "revenue", "related", "to", "sale", "of", "future", "royalties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p37_s4", "idA": "906709_13_item7_p40_s4", "sentA": "The increase in non-cash interest expense on liability related to sale of future royalties for the year ended December 31, 2012 compared to the year ended December 31, 2011 is attributable to the royalty sale transaction that we completed in 2012.", "sentB": "The increase in non-cash interest expense on liability related to sale of future royalties for the year ended December 31, 2013 compared to the year ended December 31, 2012 and the year ended December 31, 2011 is attributable to the royalty sale transaction that we completed in 2012.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "non-cash", "interest", "expense", "on", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "royalty", "sale", "transaction", "that", "we", "completed", "in", "2012.", "<tag2>", "The", "increase", "in", "non-cash", "interest", "expense", "on", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "and", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "royalty", "sale", "transaction", "that", "we", "completed", "in", "2012.", "<tag3>"], "wordsA": ["The", "increase", "in", "non-cash", "interest", "expense", "on", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "royalty", "sale", "transaction", "that", "we", "completed", "in", "2012."], "wordsB": ["The", "increase", "in", "non-cash", "interest", "expense", "on", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "and", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "royalty", "sale", "transaction", "that", "we", "completed", "in", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p22_s5", "idA": "906709_13_item7_p40_s5", "sentA": "On February 24, 2012, we sold all of our rights to receive future royalty payments on CIMZIA and MIRCERA in exchange for $124.0 million.", "sentB": "In February 2012, we sold all of our rights to receive future royalty payments on CIMZIA and MIRCERA .", "type": 2, "words": ["<tag1>", "On", "February", "24,", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "on", "CIMZIA", "and", "MIRCERA", "in", "exchange", "for", "$124.0", "million.", "<tag2>", "In", "February", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "on", "CIMZIA", "and", "MIRCERA", ".", "<tag3>"], "wordsA": ["On", "February", "24,", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "on", "CIMZIA", "and", "MIRCERA", "in", "exchange", "for", "$124.0", "million."], "wordsB": ["In", "February", "2012,", "we", "sold", "all", "of", "our", "rights", "to", "receive", "future", "royalty", "payments", "on", "CIMZIA", "and", "MIRCERA", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p57_s1", "idA": "906709_13_item7_p41_s0", "sentA": "As a result of the timing of the royalty sale transaction and the issuance of the senior secured notes in 2012, we expect interest expense and non-cash interest expense to increase in 2013 as compared to 2012.", "sentB": "In specific circumstances, such as for certain time-based costs, we recognize clinical trial expenses using a methodology that we consider to be more reflective of the timing of costs incurred.", "type": 2, "words": ["<tag1>", "As", "a", "result", "of", "the", "timing", "of", "the", "royalty", "sale", "transaction", "and", "the", "issuance", "of", "the", "senior", "secured", "notes", "in", "2012,", "we", "expect", "interest", "expense", "and", "non-cash", "interest", "expense", "to", "increase", "in", "2013", "as", "compared", "to", "2012.", "<tag2>", "In", "specific", "circumstances,", "such", "as", "for", "certain", "time-based", "costs,", "we", "recognize", "clinical", "trial", "expenses", "using", "a", "methodology", "that", "we", "consider", "to", "be", "more", "reflective", "of", "the", "timing", "of", "costs", "incurred.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "the", "timing", "of", "the", "royalty", "sale", "transaction", "and", "the", "issuance", "of", "the", "senior", "secured", "notes", "in", "2012,", "we", "expect", "interest", "expense", "and", "non-cash", "interest", "expense", "to", "increase", "in", "2013", "as", "compared", "to", "2012."], "wordsB": ["In", "specific", "circumstances,", "such", "as", "for", "certain", "time-based", "costs,", "we", "recognize", "clinical", "trial", "expenses", "using", "a", "methodology", "that", "we", "consider", "to", "be", "more", "reflective", "of", "the", "timing", "of", "costs", "incurred."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p39_s0", "idA": "906709_13_item7_p41_s2", "sentA": "Liquidity and Capital Resources We have financed our operations primarily through revenue from product sales, royalties and research and development contracts, as well as public and private placements of debt and equity.", "sentB": "Liquidity and Capital Resources We have financed our operations primarily through revenue from product sales, royalties and collaboration agreements, as well as public and private placements of debt and equity.", "type": 2, "words": ["<tag1>", "Liquidity", "and", "Capital", "Resources", "We", "have", "financed", "our", "operations", "primarily", "through", "revenue", "from", "product", "sales,", "royalties", "and", "research", "and", "development", "contracts,", "as", "well", "as", "public", "and", "private", "placements", "of", "debt", "and", "equity.", "<tag2>", "Liquidity", "and", "Capital", "Resources", "We", "have", "financed", "our", "operations", "primarily", "through", "revenue", "from", "product", "sales,", "royalties", "and", "collaboration", "agreements,", "as", "well", "as", "public", "and", "private", "placements", "of", "debt", "and", "equity.", "<tag3>"], "wordsA": ["Liquidity", "and", "Capital", "Resources", "We", "have", "financed", "our", "operations", "primarily", "through", "revenue", "from", "product", "sales,", "royalties", "and", "research", "and", "development", "contracts,", "as", "well", "as", "public", "and", "private", "placements", "of", "debt", "and", "equity."], "wordsB": ["Liquidity", "and", "Capital", "Resources", "We", "have", "financed", "our", "operations", "primarily", "through", "revenue", "from", "product", "sales,", "royalties", "and", "collaboration", "agreements,", "as", "well", "as", "public", "and", "private", "placements", "of", "debt", "and", "equity."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p19_s0", "idA": "906709_13_item7_p41_s4", "sentA": "The indebtedness includes $125.0 million in aggregate principal amount of 12.0% senior secured notes due July 15, 2017, but excludes our long-term liability relating to the sale of future royalties.", "sentB": "The indebtedness includes $125.0 million in aggregate principal amount of 12.0% senior secured notes due July 15, 2017, but excludes our long-term liability relating to the sale of future royalties under the Purchase and Sale Agreement with RPI Finance Trust.", "type": 2, "words": ["<tag1>", "The", "indebtedness", "includes", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "15,", "2017,", "but", "excludes", "our", "long-term", "liability", "relating", "to", "the", "sale", "of", "future", "royalties.", "<tag2>", "The", "indebtedness", "includes", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "15,", "2017,", "but", "excludes", "our", "long-term", "liability", "relating", "to", "the", "sale", "of", "future", "royalties", "under", "the", "Purchase", "and", "Sale", "Agreement", "with", "RPI", "Finance", "Trust.", "<tag3>"], "wordsA": ["The", "indebtedness", "includes", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "15,", "2017,", "but", "excludes", "our", "long-term", "liability", "relating", "to", "the", "sale", "of", "future", "royalties."], "wordsB": ["The", "indebtedness", "includes", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "15,", "2017,", "but", "excludes", "our", "long-term", "liability", "relating", "to", "the", "sale", "of", "future", "royalties", "under", "the", "Purchase", "and", "Sale", "Agreement", "with", "RPI", "Finance", "Trust."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p19_s1", "idA": "906709_13_item7_p41_s5", "sentA": "As is further described in Note 7 to our Consolidated Financial Statements, this royalty obligation liability will not be settled in cash, but we may be required to make a payment of up to $7.0 million in 2014 if the worldwide net sales thresholds of MIRCERA in 2013 are not met.", "sentB": "As is further described in Note 7 to our Consolidated Financial Statements, this royalty obligation liability will generally not be settled in cash, but we expect to make a cash payment of $7.0 million in 2014 as a specified worldwide 2013 net sales threshold of MIRCERA is not expected to be met.", "type": 2, "words": ["<tag1>", "As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash,", "but", "we", "may", "be", "required", "to", "make", "a", "payment", "of", "up", "to", "$7.0", "million", "in", "2014", "if", "the", "worldwide", "net", "sales", "thresholds", "of", "MIRCERA", "in", "2013", "are", "not", "met.", "<tag2>", "As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "generally", "not", "be", "settled", "in", "cash,", "but", "we", "expect", "to", "make", "a", "cash", "payment", "of", "$7.0", "million", "in", "2014", "as", "a", "specified", "worldwide", "2013", "net", "sales", "threshold", "of", "MIRCERA", "is", "not", "expected", "to", "be", "met.", "<tag3>"], "wordsA": ["As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash,", "but", "we", "may", "be", "required", "to", "make", "a", "payment", "of", "up", "to", "$7.0", "million", "in", "2014", "if", "the", "worldwide", "net", "sales", "thresholds", "of", "MIRCERA", "in", "2013", "are", "not", "met."], "wordsB": ["As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "generally", "not", "be", "settled", "in", "cash,", "but", "we", "expect", "to", "make", "a", "cash", "payment", "of", "$7.0", "million", "in", "2014", "as", "a", "specified", "worldwide", "2013", "net", "sales", "threshold", "of", "MIRCERA", "is", "not", "expected", "to", "be", "met."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p39_s3", "idA": "906709_13_item7_p41_s5", "sentA": "As is further described in Note 7 to our Consolidated Financial Statements, this royalty obligation liability will not be settled in cash, but we may be required to make a payment of up to $7.0 million in 2014 if the worldwide net sales thresholds of MIRCERA in 2013 are not met.", "sentB": "As is further described in Note 7 to our Consolidated Financial Statements, this royalty obligation liability will not generally be settled in cash, but we expect to make a payment of $7.0 million in 2014 as a specified worldwide 2013 net sales threshold of MIRCERA is not expected to be met.", "type": 2, "words": ["<tag1>", "As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash,", "but", "we", "may", "be", "required", "to", "make", "a", "payment", "of", "up", "to", "$7.0", "million", "in", "2014", "if", "the", "worldwide", "net", "sales", "thresholds", "of", "MIRCERA", "in", "2013", "are", "not", "met.", "<tag2>", "As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "not", "generally", "be", "settled", "in", "cash,", "but", "we", "expect", "to", "make", "a", "payment", "of", "$7.0", "million", "in", "2014", "as", "a", "specified", "worldwide", "2013", "net", "sales", "threshold", "of", "MIRCERA", "is", "not", "expected", "to", "be", "met.", "<tag3>"], "wordsA": ["As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash,", "but", "we", "may", "be", "required", "to", "make", "a", "payment", "of", "up", "to", "$7.0", "million", "in", "2014", "if", "the", "worldwide", "net", "sales", "thresholds", "of", "MIRCERA", "in", "2013", "are", "not", "met."], "wordsB": ["As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "not", "generally", "be", "settled", "in", "cash,", "but", "we", "expect", "to", "make", "a", "payment", "of", "$7.0", "million", "in", "2014", "as", "a", "specified", "worldwide", "2013", "net", "sales", "threshold", "of", "MIRCERA", "is", "not", "expected", "to", "be", "met."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p18_s2", "idA": "906709_13_item7_p43_s1", "sentA": "As of December 31, 2012, we had at least twelve months of working capital to fund our current business plans.", "sentB": "Key Developments and Trends in Liquidity and Capital Resources As of December 31, 2013, we estimated that we had at least twelve months of working capital to fund our current business plans.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2012,", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans.", "<tag2>", "Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "As", "of", "December", "31,", "2013,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2012,", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans."], "wordsB": ["Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "As", "of", "December", "31,", "2013,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p40_s7", "idA": "906709_13_item7_p44_s7", "sentA": "In the event we determine to explore financing alternatives, our objective would be to first pursue financing alternatives that are not dilutive to the ownership of our common stock security holders.", "sentB": "In the event we determine to pursue financing alternatives, our objective would be to first explore financing alternatives that are not dilutive to the ownership of our common stock security holders.", "type": 2, "words": ["<tag1>", "In", "the", "event", "we", "determine", "to", "explore", "financing", "alternatives,", "our", "objective", "would", "be", "to", "first", "pursue", "financing", "alternatives", "that", "are", "not", "dilutive", "to", "the", "ownership", "of", "our", "common", "stock", "security", "holders.", "<tag2>", "In", "the", "event", "we", "determine", "to", "pursue", "financing", "alternatives,", "our", "objective", "would", "be", "to", "first", "explore", "financing", "alternatives", "that", "are", "not", "dilutive", "to", "the", "ownership", "of", "our", "common", "stock", "security", "holders.", "<tag3>"], "wordsA": ["In", "the", "event", "we", "determine", "to", "explore", "financing", "alternatives,", "our", "objective", "would", "be", "to", "first", "pursue", "financing", "alternatives", "that", "are", "not", "dilutive", "to", "the", "ownership", "of", "our", "common", "stock", "security", "holders."], "wordsB": ["In", "the", "event", "we", "determine", "to", "pursue", "financing", "alternatives,", "our", "objective", "would", "be", "to", "first", "explore", "financing", "alternatives", "that", "are", "not", "dilutive", "to", "the", "ownership", "of", "our", "common", "stock", "security", "holders."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p40_s10", "idA": "906709_13_item7_p45_s0", "sentA": "Due to the potential for continued uncertainty in the credit markets in 2013 and thereafter, we may experience reduced liquidity with respect to some of our investments in marketable securities.", "sentB": "Due to the potential for continued uncertainty in the credit markets in 2014 and thereafter, we may experience reduced liquidity with respect to some of our investments in marketable securities.", "type": 2, "words": ["<tag1>", "Due", "to", "the", "potential", "for", "continued", "uncertainty", "in", "the", "credit", "markets", "in", "2013", "and", "thereafter,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities.", "<tag2>", "Due", "to", "the", "potential", "for", "continued", "uncertainty", "in", "the", "credit", "markets", "in", "2014", "and", "thereafter,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities.", "<tag3>"], "wordsA": ["Due", "to", "the", "potential", "for", "continued", "uncertainty", "in", "the", "credit", "markets", "in", "2013", "and", "thereafter,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities."], "wordsB": ["Due", "to", "the", "potential", "for", "continued", "uncertainty", "in", "the", "credit", "markets", "in", "2014", "and", "thereafter,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p7_s3", "idA": "906709_13_item7_p45_s0", "sentA": "Due to the potential for continued uncertainty in the credit markets in 2013 and thereafter, we may experience reduced liquidity with respect to some of our investments in marketable securities.", "sentB": "If the FDA does require a CV Safety Study, AstraZeneca may terminate the license agreement with us in its entirety or only with respect to its rights in the United States.", "type": 2, "words": ["<tag1>", "Due", "to", "the", "potential", "for", "continued", "uncertainty", "in", "the", "credit", "markets", "in", "2013", "and", "thereafter,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities.", "<tag2>", "If", "the", "FDA", "does", "require", "a", "CV", "Safety", "Study,", "AstraZeneca", "may", "terminate", "the", "license", "agreement", "with", "us", "in", "its", "entirety", "or", "only", "with", "respect", "to", "its", "rights", "in", "the", "United", "States.", "<tag3>"], "wordsA": ["Due", "to", "the", "potential", "for", "continued", "uncertainty", "in", "the", "credit", "markets", "in", "2013", "and", "thereafter,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities."], "wordsB": ["If", "the", "FDA", "does", "require", "a", "CV", "Safety", "Study,", "AstraZeneca", "may", "terminate", "the", "license", "agreement", "with", "us", "in", "its", "entirety", "or", "only", "with", "respect", "to", "its", "rights", "in", "the", "United", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p40_s11", "idA": "906709_13_item7_p45_s1", "sentA": "These investments are generally held to maturity, which is less than two years.", "sentB": "These investments are generally held to maturity, which, in accordance with our investment policy, is less than two years.", "type": 2, "words": ["<tag1>", "These", "investments", "are", "generally", "held", "to", "maturity,", "which", "is", "less", "than", "two", "years.", "<tag2>", "These", "investments", "are", "generally", "held", "to", "maturity,", "which,", "in", "accordance", "with", "our", "investment", "policy,", "is", "less", "than", "two", "years.", "<tag3>"], "wordsA": ["These", "investments", "are", "generally", "held", "to", "maturity,", "which", "is", "less", "than", "two", "years."], "wordsB": ["These", "investments", "are", "generally", "held", "to", "maturity,", "which,", "in", "accordance", "with", "our", "investment", "policy,", "is", "less", "than", "two", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p40_s13", "idA": "906709_13_item7_p45_s3", "sentA": "At December 31, 2012, the average time to maturity of the investments held in our portfolio was approximately four months and the maturity of any single investment did not exceed two years.", "sentB": "At December 31, 2013, the average time to maturity of the investments held in our portfolio was approximately five months and the maturity of any single investment did not exceed one year.", "type": 2, "words": ["<tag1>", "At", "December", "31,", "2012,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "four", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "two", "years.", "<tag2>", "At", "December", "31,", "2013,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "five", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "one", "year.", "<tag3>"], "wordsA": ["At", "December", "31,", "2012,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "four", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "two", "years."], "wordsB": ["At", "December", "31,", "2013,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "five", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "one", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p40_s15", "idA": "906709_13_item7_p45_s5", "sentA": "We believe that, even allowing for potential liquidity issues with respect to these securities, our remaining cash, cash equivalents, and investments will be sufficient to meet our anticipated cash needs for at least the next twelve months.", "sentB": "We believe that, even allowing for potential liquidity issues with respect to these securities, our remaining cash and investments in marketable securities will be sufficient to meet our anticipated cash needs for at least the next twelve months.", "type": 2, "words": ["<tag1>", "We", "believe", "that,", "even", "allowing", "for", "potential", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "our", "remaining", "cash,", "cash", "equivalents,", "and", "investments", "will", "be", "sufficient", "to", "meet", "our", "anticipated", "cash", "needs", "for", "at", "least", "the", "next", "twelve", "months.", "<tag2>", "We", "believe", "that,", "even", "allowing", "for", "potential", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "our", "remaining", "cash", "and", "investments", "in", "marketable", "securities", "will", "be", "sufficient", "to", "meet", "our", "anticipated", "cash", "needs", "for", "at", "least", "the", "next", "twelve", "months.", "<tag3>"], "wordsA": ["We", "believe", "that,", "even", "allowing", "for", "potential", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "our", "remaining", "cash,", "cash", "equivalents,", "and", "investments", "will", "be", "sufficient", "to", "meet", "our", "anticipated", "cash", "needs", "for", "at", "least", "the", "next", "twelve", "months."], "wordsB": ["We", "believe", "that,", "even", "allowing", "for", "potential", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "our", "remaining", "cash", "and", "investments", "in", "marketable", "securities", "will", "be", "sufficient", "to", "meet", "our", "anticipated", "cash", "needs", "for", "at", "least", "the", "next", "twelve", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p41_s0", "idA": "906709_13_item7_p46_s0", "sentA": "Cash flows from operating activities Cash flows used in operating activities for the year ended December 31, 2012 totaled $129.8 million, which includes $148.3 million of net operating cash uses, partially offset by the receipt of $18.5 million from collaboration agreements.", "sentB": "Cash flows from operating activities Cash flows used in operating activities for the year ended December 31, 2013 totaled $38.5 million, which includes $158.3 million of net operating cash uses as well as $15.2 million for interest payments on our senior secured notes, partially offset by the receipt of $135.0 million for milestones from collaboration agreements.", "type": 2, "words": ["<tag1>", "Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2012", "totaled", "$129.8", "million,", "which", "includes", "$148.3", "million", "of", "net", "operating", "cash", "uses,", "partially", "offset", "by", "the", "receipt", "of", "$18.5", "million", "from", "collaboration", "agreements.", "<tag2>", "Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2013", "totaled", "$38.5", "million,", "which", "includes", "$158.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$15.2", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$135.0", "million", "for", "milestones", "from", "collaboration", "agreements.", "<tag3>"], "wordsA": ["Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2012", "totaled", "$129.8", "million,", "which", "includes", "$148.3", "million", "of", "net", "operating", "cash", "uses,", "partially", "offset", "by", "the", "receipt", "of", "$18.5", "million", "from", "collaboration", "agreements."], "wordsB": ["Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2013", "totaled", "$38.5", "million,", "which", "includes", "$158.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$15.2", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$135.0", "million", "for", "milestones", "from", "collaboration", "agreements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p41_s2", "idA": "906709_13_item7_p46_s0", "sentA": "Cash flows from operating activities Cash flows used in operating activities for the year ended December 31, 2012 totaled $129.8 million, which includes $148.3 million of net operating cash uses, partially offset by the receipt of $18.5 million from collaboration agreements.", "sentB": "Cash flows used in operating activities for the year ended December 31, 2012 totaled $129.8 million, which includes $148.3 million of net operating cash uses, partially offset by the receipt of $18.5 million from collaboration agreements.", "type": 2, "words": ["<tag1>", "Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2012", "totaled", "$129.8", "million,", "which", "includes", "$148.3", "million", "of", "net", "operating", "cash", "uses,", "partially", "offset", "by", "the", "receipt", "of", "$18.5", "million", "from", "collaboration", "agreements.", "<tag2>", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2012", "totaled", "$129.8", "million,", "which", "includes", "$148.3", "million", "of", "net", "operating", "cash", "uses,", "partially", "offset", "by", "the", "receipt", "of", "$18.5", "million", "from", "collaboration", "agreements.", "<tag3>"], "wordsA": ["Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2012", "totaled", "$129.8", "million,", "which", "includes", "$148.3", "million", "of", "net", "operating", "cash", "uses,", "partially", "offset", "by", "the", "receipt", "of", "$18.5", "million", "from", "collaboration", "agreements."], "wordsB": ["Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2012", "totaled", "$129.8", "million,", "which", "includes", "$148.3", "million", "of", "net", "operating", "cash", "uses,", "partially", "offset", "by", "the", "receipt", "of", "$18.5", "million", "from", "collaboration", "agreements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p41_s1", "idA": "906709_13_item7_p46_s2", "sentA": "We expect that cash flows used in operating activities, excluding upfront and milestone payments received, if any, will increase in 2013 as a result of increased spending on our proprietary research and development programs, in particular, our BEACON study.", "sentB": "We expect that cash flows used in operating activities, excluding upfront and milestone payments received, if any, will increase in 2014 as a result of increased spending on our proprietary research and development programs.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront", "and", "milestone", "payments", "received,", "if", "any,", "will", "increase", "in", "2013", "as", "a", "result", "of", "increased", "spending", "on", "our", "proprietary", "research", "and", "development", "programs,", "in", "particular,", "our", "BEACON", "study.", "<tag2>", "We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront", "and", "milestone", "payments", "received,", "if", "any,", "will", "increase", "in", "2014", "as", "a", "result", "of", "increased", "spending", "on", "our", "proprietary", "research", "and", "development", "programs.", "<tag3>"], "wordsA": ["We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront", "and", "milestone", "payments", "received,", "if", "any,", "will", "increase", "in", "2013", "as", "a", "result", "of", "increased", "spending", "on", "our", "proprietary", "research", "and", "development", "programs,", "in", "particular,", "our", "BEACON", "study."], "wordsB": ["We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront", "and", "milestone", "payments", "received,", "if", "any,", "will", "increase", "in", "2014", "as", "a", "result", "of", "increased", "spending", "on", "our", "proprietary", "research", "and", "development", "programs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p42_s0", "idA": "906709_13_item7_p46_s3", "sentA": "Cash flows used in operating activities for the year ended December 31, 2011 totaled $113.7 million, which includes $7.0 million for semi-annual interest payments on our convertible subordinated notes, $11.2 million of prepayments to certain vendors in our BEACON study, and $125.0 million of other net operating cash uses, partially offset by the receipt of $29.5 million from collaboration agreements, of which $16.5 million was included in accounts receivable at December 31, 2010 resulting from an upfront payment obligation arising from an amendment to one of our manufacturing and supply agreements.", "sentB": "partially offset by the receipt of $29.5 million from collaboration agreements, of which $16.5 million was included in accounts receivable at December 31, 2010 resulting from an upfront payment obligation arising from an amendment to one of our manufacturing and supply agreements.", "type": 2, "words": ["<tag1>", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2011", "totaled", "$113.7", "million,", "which", "includes", "$7.0", "million", "for", "semi-annual", "interest", "payments", "on", "our", "convertible", "subordinated", "notes,", "$11.2", "million", "of", "prepayments", "to", "certain", "vendors", "in", "our", "BEACON", "study,", "and", "$125.0", "million", "of", "other", "net", "operating", "cash", "uses,", "partially", "offset", "by", "the", "receipt", "of", "$29.5", "million", "from", "collaboration", "agreements,", "of", "which", "$16.5", "million", "was", "included", "in", "accounts", "receivable", "at", "December", "31,", "2010", "resulting", "from", "an", "upfront", "payment", "obligation", "arising", "from", "an", "amendment", "to", "one", "of", "our", "manufacturing", "and", "supply", "agreements.", "<tag2>", "partially", "offset", "by", "the", "receipt", "of", "$29.5", "million", "from", "collaboration", "agreements,", "of", "which", "$16.5", "million", "was", "included", "in", "accounts", "receivable", "at", "December", "31,", "2010", "resulting", "from", "an", "upfront", "payment", "obligation", "arising", "from", "an", "amendment", "to", "one", "of", "our", "manufacturing", "and", "supply", "agreements.", "<tag3>"], "wordsA": ["Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2011", "totaled", "$113.7", "million,", "which", "includes", "$7.0", "million", "for", "semi-annual", "interest", "payments", "on", "our", "convertible", "subordinated", "notes,", "$11.2", "million", "of", "prepayments", "to", "certain", "vendors", "in", "our", "BEACON", "study,", "and", "$125.0", "million", "of", "other", "net", "operating", "cash", "uses,", "partially", "offset", "by", "the", "receipt", "of", "$29.5", "million", "from", "collaboration", "agreements,", "of", "which", "$16.5", "million", "was", "included", "in", "accounts", "receivable", "at", "December", "31,", "2010", "resulting", "from", "an", "upfront", "payment", "obligation", "arising", "from", "an", "amendment", "to", "one", "of", "our", "manufacturing", "and", "supply", "agreements."], "wordsB": ["partially", "offset", "by", "the", "receipt", "of", "$29.5", "million", "from", "collaboration", "agreements,", "of", "which", "$16.5", "million", "was", "included", "in", "accounts", "receivable", "at", "December", "31,", "2010", "resulting", "from", "an", "upfront", "payment", "obligation", "arising", "from", "an", "amendment", "to", "one", "of", "our", "manufacturing", "and", "supply", "agreements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p42_s1", "idA": "906709_13_item7_p47_s1", "sentA": "Cash flows from investing activities We purchased $10.6 million, $9.7 million, and $31.5 million of property and equipment in the years ended December 31, 2012, 2011, and 2010, respectively.", "sentB": "Cash flows from investing activities We paid $4.1 million, $10.6 million, and $9.7 million to purchase property and equipment in the years ended December 31, 2013, 2012, and 2011, respectively.", "type": 2, "words": ["<tag1>", "Cash", "flows", "from", "investing", "activities", "We", "purchased", "$10.6", "million,", "$9.7", "million,", "and", "$31.5", "million", "of", "property", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2012,", "2011,", "and", "2010,", "respectively.", "<tag2>", "Cash", "flows", "from", "investing", "activities", "We", "paid", "$4.1", "million,", "$10.6", "million,", "and", "$9.7", "million", "to", "purchase", "property", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2013,", "2012,", "and", "2011,", "respectively.", "<tag3>"], "wordsA": ["Cash", "flows", "from", "investing", "activities", "We", "purchased", "$10.6", "million,", "$9.7", "million,", "and", "$31.5", "million", "of", "property", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2012,", "2011,", "and", "2010,", "respectively."], "wordsB": ["Cash", "flows", "from", "investing", "activities", "We", "paid", "$4.1", "million,", "$10.6", "million,", "and", "$9.7", "million", "to", "purchase", "property", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2013,", "2012,", "and", "2011,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p38_s0", "idA": "906709_13_item7_p47_s3", "sentA": "We expect our capital expenditures in 2013 to be consistent with 2012.", "sentB": "We expect interest expense and non-cash interest expense in 2014 to be consistent with 2013.", "type": 2, "words": ["<tag1>", "We", "expect", "our", "capital", "expenditures", "in", "2013", "to", "be", "consistent", "with", "2012.", "<tag2>", "We", "expect", "interest", "expense", "and", "non-cash", "interest", "expense", "in", "2014", "to", "be", "consistent", "with", "2013.", "<tag3>"], "wordsA": ["We", "expect", "our", "capital", "expenditures", "in", "2013", "to", "be", "consistent", "with", "2012."], "wordsB": ["We", "expect", "interest", "expense", "and", "non-cash", "interest", "expense", "in", "2014", "to", "be", "consistent", "with", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p7_s0", "idA": "906709_13_item7_p47_s9", "sentA": "In addition, $25.0 million of the proceeds from the senior secured notes issuance is required to be maintained in a restricted account until July 1, 2015.", "sentB": "entitled to a $25.0 million payment from AstraZeneca, which was received on September 30, 2013.", "type": 2, "words": ["<tag1>", "In", "addition,", "$25.0", "million", "of", "the", "proceeds", "from", "the", "senior", "secured", "notes", "issuance", "is", "required", "to", "be", "maintained", "in", "a", "restricted", "account", "until", "July", "1,", "2015.", "<tag2>", "entitled", "to", "a", "$25.0", "million", "payment", "from", "AstraZeneca,", "which", "was", "received", "on", "September", "30,", "2013.", "<tag3>"], "wordsA": ["In", "addition,", "$25.0", "million", "of", "the", "proceeds", "from", "the", "senior", "secured", "notes", "issuance", "is", "required", "to", "be", "maintained", "in", "a", "restricted", "account", "until", "July", "1,", "2015."], "wordsB": ["entitled", "to", "a", "$25.0", "million", "payment", "from", "AstraZeneca,", "which", "was", "received", "on", "September", "30,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p19_s2", "idA": "906709_13_item7_p48_s0", "sentA": "On January 24, 2011, we completed a public offering of our common stock with gross proceeds of approximately $220.4 million.", "sentB": "On January 28, 2014, we completed the issuance and sale of 9,775,000 shares of our common stock with gross proceeds of approximately $117.2 million.", "type": 2, "words": ["<tag1>", "On", "January", "24,", "2011,", "we", "completed", "a", "public", "offering", "of", "our", "common", "stock", "with", "gross", "proceeds", "of", "approximately", "$220.4", "million.", "<tag2>", "On", "January", "28,", "2014,", "we", "completed", "the", "issuance", "and", "sale", "of", "9,775,000", "shares", "of", "our", "common", "stock", "with", "gross", "proceeds", "of", "approximately", "$117.2", "million.", "<tag3>"], "wordsA": ["On", "January", "24,", "2011,", "we", "completed", "a", "public", "offering", "of", "our", "common", "stock", "with", "gross", "proceeds", "of", "approximately", "$220.4", "million."], "wordsB": ["On", "January", "28,", "2014,", "we", "completed", "the", "issuance", "and", "sale", "of", "9,775,000", "shares", "of", "our", "common", "stock", "with", "gross", "proceeds", "of", "approximately", "$117.2", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p39_s4", "idA": "906709_13_item7_p48_s0", "sentA": "On January 24, 2011, we completed a public offering of our common stock with gross proceeds of approximately $220.4 million.", "sentB": "On January 28, 2014, we completed the issuance and sale of 9,775,000 shares of our common stock for gross proceeds to the Company of approximately $117.2 million.", "type": 2, "words": ["<tag1>", "On", "January", "24,", "2011,", "we", "completed", "a", "public", "offering", "of", "our", "common", "stock", "with", "gross", "proceeds", "of", "approximately", "$220.4", "million.", "<tag2>", "On", "January", "28,", "2014,", "we", "completed", "the", "issuance", "and", "sale", "of", "9,775,000", "shares", "of", "our", "common", "stock", "for", "gross", "proceeds", "to", "the", "Company", "of", "approximately", "$117.2", "million.", "<tag3>"], "wordsA": ["On", "January", "24,", "2011,", "we", "completed", "a", "public", "offering", "of", "our", "common", "stock", "with", "gross", "proceeds", "of", "approximately", "$220.4", "million."], "wordsB": ["On", "January", "28,", "2014,", "we", "completed", "the", "issuance", "and", "sale", "of", "9,775,000", "shares", "of", "our", "common", "stock", "for", "gross", "proceeds", "to", "the", "Company", "of", "approximately", "$117.2", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p43_s3", "idA": "906709_13_item7_p48_s0", "sentA": "On January 24, 2011, we completed a public offering of our common stock with gross proceeds of approximately $220.4 million.", "sentB": "On January 28, 2014, we completed the issuance and sale of 9,775,000 shares of our common stock for gross proceeds to the Company of approximately $117.2 million.", "type": 2, "words": ["<tag1>", "On", "January", "24,", "2011,", "we", "completed", "a", "public", "offering", "of", "our", "common", "stock", "with", "gross", "proceeds", "of", "approximately", "$220.4", "million.", "<tag2>", "On", "January", "28,", "2014,", "we", "completed", "the", "issuance", "and", "sale", "of", "9,775,000", "shares", "of", "our", "common", "stock", "for", "gross", "proceeds", "to", "the", "Company", "of", "approximately", "$117.2", "million.", "<tag3>"], "wordsA": ["On", "January", "24,", "2011,", "we", "completed", "a", "public", "offering", "of", "our", "common", "stock", "with", "gross", "proceeds", "of", "approximately", "$220.4", "million."], "wordsB": ["On", "January", "28,", "2014,", "we", "completed", "the", "issuance", "and", "sale", "of", "9,775,000", "shares", "of", "our", "common", "stock", "for", "gross", "proceeds", "to", "the", "Company", "of", "approximately", "$117.2", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p19_s3", "idA": "906709_13_item7_p48_s1", "sentA": "As part of the public offering, we incurred approximately $0.6 million in legal and accounting fees, filing fees, and other offering expenses.", "sentB": "Additionally, we incurred approximately $0.6 million in legal and accounting fees, filing fees, and other offering expenses.", "type": 2, "words": ["<tag1>", "As", "part", "of", "the", "public", "offering,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses.", "<tag2>", "Additionally,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses.", "<tag3>"], "wordsA": ["As", "part", "of", "the", "public", "offering,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses."], "wordsB": ["Additionally,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p39_s5", "idA": "906709_13_item7_p48_s1", "sentA": "As part of the public offering, we incurred approximately $0.6 million in legal and accounting fees, filing fees, and other offering expenses.", "sentB": "Additionally, we incurred approximately $0.6 million in legal and accounting fees, filing fees, and other offering expenses.", "type": 2, "words": ["<tag1>", "As", "part", "of", "the", "public", "offering,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses.", "<tag2>", "Additionally,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses.", "<tag3>"], "wordsA": ["As", "part", "of", "the", "public", "offering,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses."], "wordsB": ["Additionally,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p43_s4", "idA": "906709_13_item7_p48_s1", "sentA": "As part of the public offering, we incurred approximately $0.6 million in legal and accounting fees, filing fees, and other offering expenses.", "sentB": "Additionally, we incurred approximately $0.6 million in legal and accounting fees, filing fees, and other offering expenses.", "type": 2, "words": ["<tag1>", "As", "part", "of", "the", "public", "offering,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses.", "<tag2>", "Additionally,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses.", "<tag3>"], "wordsA": ["As", "part", "of", "the", "public", "offering,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses."], "wordsB": ["Additionally,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p43_s2", "idA": "906709_13_item7_p48_s2", "sentA": "We received proceeds from issuance of common stock related to our employee option and stock purchase plans of $4.1 million, $4.5 million, and $8.9 million in the years ended December 31, 2012, 2011, and 2010, respectively.", "sentB": "We received proceeds from issuance of common stock related to our employee option and stock purchase plans of $8.2 million, $4.1 million, and $4.5 million in the years ended December 31, 2013, 2012, and 2011, respectively.", "type": 2, "words": ["<tag1>", "We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$4.1", "million,", "$4.5", "million,", "and", "$8.9", "million", "in", "the", "years", "ended", "December", "31,", "2012,", "2011,", "and", "2010,", "respectively.", "<tag2>", "We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$8.2", "million,", "$4.1", "million,", "and", "$4.5", "million", "in", "the", "years", "ended", "December", "31,", "2013,", "2012,", "and", "2011,", "respectively.", "<tag3>"], "wordsA": ["We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$4.1", "million,", "$4.5", "million,", "and", "$8.9", "million", "in", "the", "years", "ended", "December", "31,", "2012,", "2011,", "and", "2010,", "respectively."], "wordsB": ["We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$8.2", "million,", "$4.1", "million,", "and", "$4.5", "million", "in", "the", "years", "ended", "December", "31,", "2013,", "2012,", "and", "2011,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p4_s1", "idA": "906709_13_item7_p4_s1", "sentA": "The outcome and timing of the naloxegol development program will have a substantial impact on our financial condition as we are entitled to up to $95 million in regulatory filing milestones and $140 million in commercial launch milestones.", "sentB": "The outcome and timing of the naloxegol regulatory review events will have a substantial impact on our financial condition as we are entitled to up to $35.0 million in regulatory milestones and $140.0 million in commercial launch milestones, as well as up to $75 million of payments related to the naloxegol fixed-dose combination program.", "type": 2, "words": ["<tag1>", "The", "outcome", "and", "timing", "of", "the", "naloxegol", "development", "program", "will", "have", "a", "substantial", "impact", "on", "our", "financial", "condition", "as", "we", "are", "entitled", "to", "up", "to", "$95", "million", "in", "regulatory", "filing", "milestones", "and", "$140", "million", "in", "commercial", "launch", "milestones.", "<tag2>", "The", "outcome", "and", "timing", "of", "the", "naloxegol", "regulatory", "review", "events", "will", "have", "a", "substantial", "impact", "on", "our", "financial", "condition", "as", "we", "are", "entitled", "to", "up", "to", "$35.0", "million", "in", "regulatory", "milestones", "and", "$140.0", "million", "in", "commercial", "launch", "milestones,", "as", "well", "as", "up", "to", "$75", "million", "of", "payments", "related", "to", "the", "naloxegol", "fixed-dose", "combination", "program.", "<tag3>"], "wordsA": ["The", "outcome", "and", "timing", "of", "the", "naloxegol", "development", "program", "will", "have", "a", "substantial", "impact", "on", "our", "financial", "condition", "as", "we", "are", "entitled", "to", "up", "to", "$95", "million", "in", "regulatory", "filing", "milestones", "and", "$140", "million", "in", "commercial", "launch", "milestones."], "wordsB": ["The", "outcome", "and", "timing", "of", "the", "naloxegol", "regulatory", "review", "events", "will", "have", "a", "substantial", "impact", "on", "our", "financial", "condition", "as", "we", "are", "entitled", "to", "up", "to", "$35.0", "million", "in", "regulatory", "milestones", "and", "$140.0", "million", "in", "commercial", "launch", "milestones,", "as", "well", "as", "up", "to", "$75", "million", "of", "payments", "related", "to", "the", "naloxegol", "fixed-dose", "combination", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p64_s2", "idA": "906709_13_item7_p4_s1", "sentA": "The outcome and timing of the naloxegol development program will have a substantial impact on our financial condition as we are entitled to up to $95 million in regulatory filing milestones and $140 million in commercial launch milestones.", "sentB": "We do not believe the adoption of this guidance will have a material impact on our consolidated financial statements.", "type": 2, "words": ["<tag1>", "The", "outcome", "and", "timing", "of", "the", "naloxegol", "development", "program", "will", "have", "a", "substantial", "impact", "on", "our", "financial", "condition", "as", "we", "are", "entitled", "to", "up", "to", "$95", "million", "in", "regulatory", "filing", "milestones", "and", "$140", "million", "in", "commercial", "launch", "milestones.", "<tag2>", "We", "do", "not", "believe", "the", "adoption", "of", "this", "guidance", "will", "have", "a", "material", "impact", "on", "our", "consolidated", "financial", "statements.", "<tag3>"], "wordsA": ["The", "outcome", "and", "timing", "of", "the", "naloxegol", "development", "program", "will", "have", "a", "substantial", "impact", "on", "our", "financial", "condition", "as", "we", "are", "entitled", "to", "up", "to", "$95", "million", "in", "regulatory", "filing", "milestones", "and", "$140", "million", "in", "commercial", "launch", "milestones."], "wordsB": ["We", "do", "not", "believe", "the", "adoption", "of", "this", "guidance", "will", "have", "a", "material", "impact", "on", "our", "consolidated", "financial", "statements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p45_s1", "idA": "906709_13_item7_p51_s0", "sentA": "September 30, 2009 for the Mission Bay Facility, we will begin making non-cancelable lease payments in 2014.", "sentB": "Under the terms of the sublease we entered into with Pfizer Inc. on September 30, 2009 for the Mission Bay Facility, we will begin making non-cancelable lease payments in 2014.", "type": 2, "words": ["<tag1>", "September", "30,", "2009", "for", "the", "Mission", "Bay", "Facility,", "we", "will", "begin", "making", "non-cancelable", "lease", "payments", "in", "2014.", "<tag2>", "Under", "the", "terms", "of", "the", "sublease", "we", "entered", "into", "with", "Pfizer", "Inc.", "on", "September", "30,", "2009", "for", "the", "Mission", "Bay", "Facility,", "we", "will", "begin", "making", "non-cancelable", "lease", "payments", "in", "2014.", "<tag3>"], "wordsA": ["September", "30,", "2009", "for", "the", "Mission", "Bay", "Facility,", "we", "will", "begin", "making", "non-cancelable", "lease", "payments", "in", "2014."], "wordsB": ["Under", "the", "terms", "of", "the", "sublease", "we", "entered", "into", "with", "Pfizer", "Inc.", "on", "September", "30,", "2009", "for", "the", "Mission", "Bay", "Facility,", "we", "will", "begin", "making", "non-cancelable", "lease", "payments", "in", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p45_s2", "idA": "906709_13_item7_p51_s1", "sentA": "On December 28, 2011, we amended the sublease of the Mission Bay Facility to include an additional 24,002 square feet of space.", "sentB": "On December 28, 2011, we amended the lease of the Mission Bay Facility to include an additional 24,002 square feet of space.", "type": 2, "words": ["<tag1>", "On", "December", "28,", "2011,", "we", "amended", "the", "sublease", "of", "the", "Mission", "Bay", "Facility", "to", "include", "an", "additional", "24,002", "square", "feet", "of", "space.", "<tag2>", "On", "December", "28,", "2011,", "we", "amended", "the", "lease", "of", "the", "Mission", "Bay", "Facility", "to", "include", "an", "additional", "24,002", "square", "feet", "of", "space.", "<tag3>"], "wordsA": ["On", "December", "28,", "2011,", "we", "amended", "the", "sublease", "of", "the", "Mission", "Bay", "Facility", "to", "include", "an", "additional", "24,002", "square", "feet", "of", "space."], "wordsB": ["On", "December", "28,", "2011,", "we", "amended", "the", "lease", "of", "the", "Mission", "Bay", "Facility", "to", "include", "an", "additional", "24,002", "square", "feet", "of", "space."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p45_s3", "idA": "906709_13_item7_p51_s2", "sentA": "Under the terms of the amendment, beginning January 1, 2012, we began making lease payments for this additional space of $40,000 per month until at least May 31, 2013.", "sentB": "Under the terms of the amendment, beginning January 1, 2012, we began making lease payments for this additional space.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "of", "the", "amendment,", "beginning", "January", "1,", "2012,", "we", "began", "making", "lease", "payments", "for", "this", "additional", "space", "of", "$40,000", "per", "month", "until", "at", "least", "May", "31,", "2013.", "<tag2>", "Under", "the", "terms", "of", "the", "amendment,", "beginning", "January", "1,", "2012,", "we", "began", "making", "lease", "payments", "for", "this", "additional", "space.", "<tag3>"], "wordsA": ["Under", "the", "terms", "of", "the", "amendment,", "beginning", "January", "1,", "2012,", "we", "began", "making", "lease", "payments", "for", "this", "additional", "space", "of", "$40,000", "per", "month", "until", "at", "least", "May", "31,", "2013."], "wordsB": ["Under", "the", "terms", "of", "the", "amendment,", "beginning", "January", "1,", "2012,", "we", "began", "making", "lease", "payments", "for", "this", "additional", "space."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p64_s1", "idA": "906709_13_item7_p51_s2", "sentA": "Under the terms of the amendment, beginning January 1, 2012, we began making lease payments for this additional space of $40,000 per month until at least May 31, 2013.", "sentB": "This guidance is effective for our interim and annual periods beginning January 1, 2014.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "of", "the", "amendment,", "beginning", "January", "1,", "2012,", "we", "began", "making", "lease", "payments", "for", "this", "additional", "space", "of", "$40,000", "per", "month", "until", "at", "least", "May", "31,", "2013.", "<tag2>", "This", "guidance", "is", "effective", "for", "our", "interim", "and", "annual", "periods", "beginning", "January", "1,", "2014.", "<tag3>"], "wordsA": ["Under", "the", "terms", "of", "the", "amendment,", "beginning", "January", "1,", "2012,", "we", "began", "making", "lease", "payments", "for", "this", "additional", "space", "of", "$40,000", "per", "month", "until", "at", "least", "May", "31,", "2013."], "wordsB": ["This", "guidance", "is", "effective", "for", "our", "interim", "and", "annual", "periods", "beginning", "January", "1,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p46_s2", "idA": "906709_13_item7_p52_s2", "sentA": "We have subleased a portion of the San Carlos Facility and are currently seeking one or more subtenants for the remaining space.", "sentB": "We have subleased all of the San Carlos Facility.", "type": 2, "words": ["<tag1>", "We", "have", "subleased", "a", "portion", "of", "the", "San", "Carlos", "Facility", "and", "are", "currently", "seeking", "one", "or", "more", "subtenants", "for", "the", "remaining", "space.", "<tag2>", "We", "have", "subleased", "all", "of", "the", "San", "Carlos", "Facility.", "<tag3>"], "wordsA": ["We", "have", "subleased", "a", "portion", "of", "the", "San", "Carlos", "Facility", "and", "are", "currently", "seeking", "one", "or", "more", "subtenants", "for", "the", "remaining", "space."], "wordsB": ["We", "have", "subleased", "all", "of", "the", "San", "Carlos", "Facility."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p47_s0", "idA": "906709_13_item7_p53_s0", "sentA": "(4) Substantially all of this amount was subject to open purchase orders as of December 31, 2012 that were issued under existing contracts.", "sentB": "(4) Substantially all of this amount was subject to open purchase orders as of December 31, 2013 that were issued under existing contracts.", "type": 2, "words": ["<tag1>", "(4)", "Substantially", "all", "of", "this", "amount", "was", "subject", "to", "open", "purchase", "orders", "as", "of", "December", "31,", "2012", "that", "were", "issued", "under", "existing", "contracts.", "<tag2>", "(4)", "Substantially", "all", "of", "this", "amount", "was", "subject", "to", "open", "purchase", "orders", "as", "of", "December", "31,", "2013", "that", "were", "issued", "under", "existing", "contracts.", "<tag3>"], "wordsA": ["(4)", "Substantially", "all", "of", "this", "amount", "was", "subject", "to", "open", "purchase", "orders", "as", "of", "December", "31,", "2012", "that", "were", "issued", "under", "existing", "contracts."], "wordsB": ["(4)", "Substantially", "all", "of", "this", "amount", "was", "subject", "to", "open", "purchase", "orders", "as", "of", "December", "31,", "2013", "that", "were", "issued", "under", "existing", "contracts."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p49_s0", "idA": "906709_13_item7_p54_s0", "sentA": "The preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.", "sentB": "The preparation and presentation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (GAAP) requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.", "type": 2, "words": ["<tag1>", "The", "preparation", "of", "financial", "statements", "in", "conformity", "with", "U.S.", "Generally", "Accepted", "Accounting", "Principles", "(GAAP)", "requires", "management", "to", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period.", "<tag2>", "The", "preparation", "and", "presentation", "of", "financial", "statements", "in", "conformity", "with", "U.S.", "Generally", "Accepted", "Accounting", "Principles", "(GAAP)", "requires", "management", "to", "make", "judgments,", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period.", "<tag3>"], "wordsA": ["The", "preparation", "of", "financial", "statements", "in", "conformity", "with", "U.S.", "Generally", "Accepted", "Accounting", "Principles", "(GAAP)", "requires", "management", "to", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period."], "wordsB": ["The", "preparation", "and", "presentation", "of", "financial", "statements", "in", "conformity", "with", "U.S.", "Generally", "Accepted", "Accounting", "Principles", "(GAAP)", "requires", "management", "to", "make", "judgments,", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p49_s2", "idA": "906709_13_item7_p54_s2", "sentA": "Actual results may differ from those estimates under different assumptions or conditions.", "sentB": "Actual results may differ materially from those estimates under different assumptions or conditions.", "type": 2, "words": ["<tag1>", "Actual", "results", "may", "differ", "from", "those", "estimates", "under", "different", "assumptions", "or", "conditions.", "<tag2>", "Actual", "results", "may", "differ", "materially", "from", "those", "estimates", "under", "different", "assumptions", "or", "conditions.", "<tag3>"], "wordsA": ["Actual", "results", "may", "differ", "from", "those", "estimates", "under", "different", "assumptions", "or", "conditions."], "wordsB": ["Actual", "results", "may", "differ", "materially", "from", "those", "estimates", "under", "different", "assumptions", "or", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p49_s3", "idA": "906709_13_item7_p54_s3", "sentA": "We have determined that for the periods reported in this report, the following accounting policies and estimates are critical in understanding our financial condition and results of our operations.", "sentB": "We have determined that for the periods in this report, the following accounting policies and estimates are critical in understanding our financial condition and results of our operations.", "type": 2, "words": ["<tag1>", "We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations.", "<tag2>", "We", "have", "determined", "that", "for", "the", "periods", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations.", "<tag3>"], "wordsA": ["We", "have", "determined", "that", "for", "the", "periods", "reported", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations."], "wordsB": ["We", "have", "determined", "that", "for", "the", "periods", "in", "this", "report,", "the", "following", "accounting", "policies", "and", "estimates", "are", "critical", "in", "understanding", "our", "financial", "condition", "and", "results", "of", "our", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p6_s0", "idA": "906709_13_item7_p5_s0", "sentA": "On November 12, 2012, AstraZeneca announced positive top-line results from two Phase 3 efficacy and safety clinical trials and from a safety extension trial (KODIAC-04, -05, and -07).", "sentB": "On November 12, 2012, AstraZeneca announced positive top-line results for naloxegol from two Phase 3 efficacy and safety clinical trials and from a safety extension trial (KODIAC-04, -05, and -07).", "type": 2, "words": ["<tag1>", "On", "November", "12,", "2012,", "AstraZeneca", "announced", "positive", "top-line", "results", "from", "two", "Phase", "3", "efficacy", "and", "safety", "clinical", "trials", "and", "from", "a", "safety", "extension", "trial", "(KODIAC-04,", "-05,", "and", "-07).", "<tag2>", "On", "November", "12,", "2012,", "AstraZeneca", "announced", "positive", "top-line", "results", "for", "naloxegol", "from", "two", "Phase", "3", "efficacy", "and", "safety", "clinical", "trials", "and", "from", "a", "safety", "extension", "trial", "(KODIAC-04,", "-05,", "and", "-07).", "<tag3>"], "wordsA": ["On", "November", "12,", "2012,", "AstraZeneca", "announced", "positive", "top-line", "results", "from", "two", "Phase", "3", "efficacy", "and", "safety", "clinical", "trials", "and", "from", "a", "safety", "extension", "trial", "(KODIAC-04,", "-05,", "and", "-07)."], "wordsB": ["On", "November", "12,", "2012,", "AstraZeneca", "announced", "positive", "top-line", "results", "for", "naloxegol", "from", "two", "Phase", "3", "efficacy", "and", "safety", "clinical", "trials", "and", "from", "a", "safety", "extension", "trial", "(KODIAC-04,", "-05,", "and", "-07)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p55_s0", "idA": "906709_13_item7_p60_s0", "sentA": "Given the statistical probability of drug development success in the bio-pharmaceutical industry, drug development programs have only a 5% to 10% probability of reaching commercial success.", "sentB": "only a 5% to 10% probability of reaching commercial success.", "type": 2, "words": ["<tag1>", "Given", "the", "statistical", "probability", "of", "drug", "development", "success", "in", "the", "bio-pharmaceutical", "industry,", "drug", "development", "programs", "have", "only", "a", "5%", "to", "10%", "probability", "of", "reaching", "commercial", "success.", "<tag2>", "only", "a", "5%", "to", "10%", "probability", "of", "reaching", "commercial", "success.", "<tag3>"], "wordsA": ["Given", "the", "statistical", "probability", "of", "drug", "development", "success", "in", "the", "bio-pharmaceutical", "industry,", "drug", "development", "programs", "have", "only", "a", "5%", "to", "10%", "probability", "of", "reaching", "commercial", "success."], "wordsB": ["only", "a", "5%", "to", "10%", "probability", "of", "reaching", "commercial", "success."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p55_s1", "idA": "906709_13_item7_p61_s0", "sentA": "If we had determined a longer or shorter amortization period was appropriate, our annual upfront fee amortization for these agreements could be as low as $2.4 million or as high as $11.0 million as compared to the $3.2 million recognized in the year ended December 31, 2012.", "sentB": "If we had determined a longer or shorter amortization period was appropriate, our annual upfront fee amortization for these agreements could be as low as $2.2 million or as high as $11.0 million as compared to the $2.4 million recognized in the year ended December 31, 2013.", "type": 2, "words": ["<tag1>", "If", "we", "had", "determined", "a", "longer", "or", "shorter", "amortization", "period", "was", "appropriate,", "our", "annual", "upfront", "fee", "amortization", "for", "these", "agreements", "could", "be", "as", "low", "as", "$2.4", "million", "or", "as", "high", "as", "$11.0", "million", "as", "compared", "to", "the", "$3.2", "million", "recognized", "in", "the", "year", "ended", "December", "31,", "2012.", "<tag2>", "If", "we", "had", "determined", "a", "longer", "or", "shorter", "amortization", "period", "was", "appropriate,", "our", "annual", "upfront", "fee", "amortization", "for", "these", "agreements", "could", "be", "as", "low", "as", "$2.2", "million", "or", "as", "high", "as", "$11.0", "million", "as", "compared", "to", "the", "$2.4", "million", "recognized", "in", "the", "year", "ended", "December", "31,", "2013.", "<tag3>"], "wordsA": ["If", "we", "had", "determined", "a", "longer", "or", "shorter", "amortization", "period", "was", "appropriate,", "our", "annual", "upfront", "fee", "amortization", "for", "these", "agreements", "could", "be", "as", "low", "as", "$2.4", "million", "or", "as", "high", "as", "$11.0", "million", "as", "compared", "to", "the", "$3.2", "million", "recognized", "in", "the", "year", "ended", "December", "31,", "2012."], "wordsB": ["If", "we", "had", "determined", "a", "longer", "or", "shorter", "amortization", "period", "was", "appropriate,", "our", "annual", "upfront", "fee", "amortization", "for", "these", "agreements", "could", "be", "as", "low", "as", "$2.2", "million", "or", "as", "high", "as", "$11.0", "million", "as", "compared", "to", "the", "$2.4", "million", "recognized", "in", "the", "year", "ended", "December", "31,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p55_s2", "idA": "906709_13_item7_p61_s1", "sentA": "As of December 31, 2012, we also had $90.4 million of deferred upfront fees related to seven license, manufacturing and supply agreements that are being amortized over periods from 5 to 10 years.", "sentB": "As of December 31, 2013, we also had $80.7 million of deferred upfront fees related to seven license, manufacturing and supply agreements that are being amortized over periods from 3 to 10 years.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2012,", "we", "also", "had", "$90.4", "million", "of", "deferred", "upfront", "fees", "related", "to", "seven", "license,", "manufacturing", "and", "supply", "agreements", "that", "are", "being", "amortized", "over", "periods", "from", "5", "to", "10", "years.", "<tag2>", "As", "of", "December", "31,", "2013,", "we", "also", "had", "$80.7", "million", "of", "deferred", "upfront", "fees", "related", "to", "seven", "license,", "manufacturing", "and", "supply", "agreements", "that", "are", "being", "amortized", "over", "periods", "from", "3", "to", "10", "years.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2012,", "we", "also", "had", "$90.4", "million", "of", "deferred", "upfront", "fees", "related", "to", "seven", "license,", "manufacturing", "and", "supply", "agreements", "that", "are", "being", "amortized", "over", "periods", "from", "5", "to", "10", "years."], "wordsB": ["As", "of", "December", "31,", "2013,", "we", "also", "had", "$80.7", "million", "of", "deferred", "upfront", "fees", "related", "to", "seven", "license,", "manufacturing", "and", "supply", "agreements", "that", "are", "being", "amortized", "over", "periods", "from", "3", "to", "10", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p55_s6", "idA": "906709_13_item7_p62_s2", "sentA": "Under this guidance, at the inception of each new multiple-element arrangement or the material modification of an existing multiple-element arrangement, we allocate arrangement consideration to all units of accounting based on the relative selling price method, generally based on our best estimate of selling price (ESP).", "sentB": "In addition, at the inception of each new multiple-element arrangement or the material modification of an existing multiple-element arrangement, we allocate arrangement consideration to all units of accounting based on the relative selling price method, generally based on our best estimate of selling price (ESP).", "type": 2, "words": ["<tag1>", "Under", "this", "guidance,", "at", "the", "inception", "of", "each", "new", "multiple-element", "arrangement", "or", "the", "material", "modification", "of", "an", "existing", "multiple-element", "arrangement,", "we", "allocate", "arrangement", "consideration", "to", "all", "units", "of", "accounting", "based", "on", "the", "relative", "selling", "price", "method,", "generally", "based", "on", "our", "best", "estimate", "of", "selling", "price", "(ESP).", "<tag2>", "In", "addition,", "at", "the", "inception", "of", "each", "new", "multiple-element", "arrangement", "or", "the", "material", "modification", "of", "an", "existing", "multiple-element", "arrangement,", "we", "allocate", "arrangement", "consideration", "to", "all", "units", "of", "accounting", "based", "on", "the", "relative", "selling", "price", "method,", "generally", "based", "on", "our", "best", "estimate", "of", "selling", "price", "(ESP).", "<tag3>"], "wordsA": ["Under", "this", "guidance,", "at", "the", "inception", "of", "each", "new", "multiple-element", "arrangement", "or", "the", "material", "modification", "of", "an", "existing", "multiple-element", "arrangement,", "we", "allocate", "arrangement", "consideration", "to", "all", "units", "of", "accounting", "based", "on", "the", "relative", "selling", "price", "method,", "generally", "based", "on", "our", "best", "estimate", "of", "selling", "price", "(ESP)."], "wordsB": ["In", "addition,", "at", "the", "inception", "of", "each", "new", "multiple-element", "arrangement", "or", "the", "material", "modification", "of", "an", "existing", "multiple-element", "arrangement,", "we", "allocate", "arrangement", "consideration", "to", "all", "units", "of", "accounting", "based", "on", "the", "relative", "selling", "price", "method,", "generally", "based", "on", "our", "best", "estimate", "of", "selling", "price", "(ESP)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p56_s1", "idA": "906709_13_item7_p64_s0", "sentA": "estimated duration of the start-up and reporting phases.", "sentB": "We generally accrue costs associated with the start-up and reporting phases of the clinical studies ratably over the estimated duration of the start-up and reporting phases.", "type": 2, "words": ["<tag1>", "estimated", "duration", "of", "the", "start-up", "and", "reporting", "phases.", "<tag2>", "We", "generally", "accrue", "costs", "associated", "with", "the", "start-up", "and", "reporting", "phases", "of", "the", "clinical", "studies", "ratably", "over", "the", "estimated", "duration", "of", "the", "start-up", "and", "reporting", "phases.", "<tag3>"], "wordsA": ["estimated", "duration", "of", "the", "start-up", "and", "reporting", "phases."], "wordsB": ["We", "generally", "accrue", "costs", "associated", "with", "the", "start-up", "and", "reporting", "phases", "of", "the", "clinical", "studies", "ratably", "over", "the", "estimated", "duration", "of", "the", "start-up", "and", "reporting", "phases."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p59_s0", "idA": "906709_13_item7_p66_s0", "sentA": "Stock-Based Compensation We use the Black-Scholes option valuation model for each respective grant to determine the estimated fair value of stock options on the date of grant (grant date fair value) and common stock purchased under the ESPP.", "sentB": "Stock-Based Compensation We use the Black-Scholes option valuation model for each respective grant to determine the estimated fair value of stock options on the date of grant (grant date fair value) and common stock purchased under our Employee Stock Purchase Plan (ESPP).", "type": 2, "words": ["<tag1>", "Stock-Based", "Compensation", "We", "use", "the", "Black-Scholes", "option", "valuation", "model", "for", "each", "respective", "grant", "to", "determine", "the", "estimated", "fair", "value", "of", "stock", "options", "on", "the", "date", "of", "grant", "(grant", "date", "fair", "value)", "and", "common", "stock", "purchased", "under", "the", "ESPP.", "<tag2>", "Stock-Based", "Compensation", "We", "use", "the", "Black-Scholes", "option", "valuation", "model", "for", "each", "respective", "grant", "to", "determine", "the", "estimated", "fair", "value", "of", "stock", "options", "on", "the", "date", "of", "grant", "(grant", "date", "fair", "value)", "and", "common", "stock", "purchased", "under", "our", "Employee", "Stock", "Purchase", "Plan", "(ESPP).", "<tag3>"], "wordsA": ["Stock-Based", "Compensation", "We", "use", "the", "Black-Scholes", "option", "valuation", "model", "for", "each", "respective", "grant", "to", "determine", "the", "estimated", "fair", "value", "of", "stock", "options", "on", "the", "date", "of", "grant", "(grant", "date", "fair", "value)", "and", "common", "stock", "purchased", "under", "the", "ESPP."], "wordsB": ["Stock-Based", "Compensation", "We", "use", "the", "Black-Scholes", "option", "valuation", "model", "for", "each", "respective", "grant", "to", "determine", "the", "estimated", "fair", "value", "of", "stock", "options", "on", "the", "date", "of", "grant", "(grant", "date", "fair", "value)", "and", "common", "stock", "purchased", "under", "our", "Employee", "Stock", "Purchase", "Plan", "(ESPP)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p60_s1", "idA": "906709_13_item7_p67_s1", "sentA": "Because our employee stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect fair value estimates, in management s opinion, the existing models may not provide a reliable single measure of the fair value of our employee stock options or common stock purchased under our employee stock purchase plan.", "sentB": "Because our employee stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect fair value estimates, in management s opinion, the existing models may not provide a reliable single measure of the fair value of our employee stock options or common stock purchased under our ESPP.", "type": 2, "words": ["<tag1>", "Because", "our", "employee", "stock", "options", "have", "characteristics", "significantly", "different", "from", "those", "of", "traded", "options,", "and", "because", "changes", "in", "the", "subjective", "input", "assumptions", "can", "materially", "affect", "fair", "value", "estimates,", "in", "management", "s", "opinion,", "the", "existing", "models", "may", "not", "provide", "a", "reliable", "single", "measure", "of", "the", "fair", "value", "of", "our", "employee", "stock", "options", "or", "common", "stock", "purchased", "under", "our", "employee", "stock", "purchase", "plan.", "<tag2>", "Because", "our", "employee", "stock", "options", "have", "characteristics", "significantly", "different", "from", "those", "of", "traded", "options,", "and", "because", "changes", "in", "the", "subjective", "input", "assumptions", "can", "materially", "affect", "fair", "value", "estimates,", "in", "management", "s", "opinion,", "the", "existing", "models", "may", "not", "provide", "a", "reliable", "single", "measure", "of", "the", "fair", "value", "of", "our", "employee", "stock", "options", "or", "common", "stock", "purchased", "under", "our", "ESPP.", "<tag3>"], "wordsA": ["Because", "our", "employee", "stock", "options", "have", "characteristics", "significantly", "different", "from", "those", "of", "traded", "options,", "and", "because", "changes", "in", "the", "subjective", "input", "assumptions", "can", "materially", "affect", "fair", "value", "estimates,", "in", "management", "s", "opinion,", "the", "existing", "models", "may", "not", "provide", "a", "reliable", "single", "measure", "of", "the", "fair", "value", "of", "our", "employee", "stock", "options", "or", "common", "stock", "purchased", "under", "our", "employee", "stock", "purchase", "plan."], "wordsB": ["Because", "our", "employee", "stock", "options", "have", "characteristics", "significantly", "different", "from", "those", "of", "traded", "options,", "and", "because", "changes", "in", "the", "subjective", "input", "assumptions", "can", "materially", "affect", "fair", "value", "estimates,", "in", "management", "s", "opinion,", "the", "existing", "models", "may", "not", "provide", "a", "reliable", "single", "measure", "of", "the", "fair", "value", "of", "our", "employee", "stock", "options", "or", "common", "stock", "purchased", "under", "our", "ESPP."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p7_s4", "idA": "906709_13_item7_p69_s1", "sentA": "Although we are required to make payments to the purchaser only in certain situations, including the event of our breach of a representation, warranty or covenant in the Purchase and Sale Agreement that gives rise to a liability in accordance with the terms and conditions of such agreement, this royalty sale transaction was recorded as a liability (Royalty Obligation) that we will amortize using the interest method over the estimated life of the Purchase and Sale Agreement.", "sentB": "If AstraZeneca elects to terminate the license agreement in its entirety due to a CV Safety Study, we will be required to repay them the $70.0 million we received plus accrued interest at 4.5% compounded annually in four installments in accordance with the following payment schedule: $10.0 million plus accrued interest on January 15, 2015, $10.0 million plus accrued interest on January 15, 2016, $20.0 million plus accrued interest on January 15, 2017 and $30.0 million plus accrued interest on January 15, 2018.", "type": 2, "words": ["<tag1>", "Although", "we", "are", "required", "to", "make", "payments", "to", "the", "purchaser", "only", "in", "certain", "situations,", "including", "the", "event", "of", "our", "breach", "of", "a", "representation,", "warranty", "or", "covenant", "in", "the", "Purchase", "and", "Sale", "Agreement", "that", "gives", "rise", "to", "a", "liability", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "such", "agreement,", "this", "royalty", "sale", "transaction", "was", "recorded", "as", "a", "liability", "(Royalty", "Obligation)", "that", "we", "will", "amortize", "using", "the", "interest", "method", "over", "the", "estimated", "life", "of", "the", "Purchase", "and", "Sale", "Agreement.", "<tag2>", "If", "AstraZeneca", "elects", "to", "terminate", "the", "license", "agreement", "in", "its", "entirety", "due", "to", "a", "CV", "Safety", "Study,", "we", "will", "be", "required", "to", "repay", "them", "the", "$70.0", "million", "we", "received", "plus", "accrued", "interest", "at", "4.5%", "compounded", "annually", "in", "four", "installments", "in", "accordance", "with", "the", "following", "payment", "schedule:", "$10.0", "million", "plus", "accrued", "interest", "on", "January", "15,", "2015,", "$10.0", "million", "plus", "accrued", "interest", "on", "January", "15,", "2016,", "$20.0", "million", "plus", "accrued", "interest", "on", "January", "15,", "2017", "and", "$30.0", "million", "plus", "accrued", "interest", "on", "January", "15,", "2018.", "<tag3>"], "wordsA": ["Although", "we", "are", "required", "to", "make", "payments", "to", "the", "purchaser", "only", "in", "certain", "situations,", "including", "the", "event", "of", "our", "breach", "of", "a", "representation,", "warranty", "or", "covenant", "in", "the", "Purchase", "and", "Sale", "Agreement", "that", "gives", "rise", "to", "a", "liability", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "such", "agreement,", "this", "royalty", "sale", "transaction", "was", "recorded", "as", "a", "liability", "(Royalty", "Obligation)", "that", "we", "will", "amortize", "using", "the", "interest", "method", "over", "the", "estimated", "life", "of", "the", "Purchase", "and", "Sale", "Agreement."], "wordsB": ["If", "AstraZeneca", "elects", "to", "terminate", "the", "license", "agreement", "in", "its", "entirety", "due", "to", "a", "CV", "Safety", "Study,", "we", "will", "be", "required", "to", "repay", "them", "the", "$70.0", "million", "we", "received", "plus", "accrued", "interest", "at", "4.5%", "compounded", "annually", "in", "four", "installments", "in", "accordance", "with", "the", "following", "payment", "schedule:", "$10.0", "million", "plus", "accrued", "interest", "on", "January", "15,", "2015,", "$10.0", "million", "plus", "accrued", "interest", "on", "January", "15,", "2016,", "$20.0", "million", "plus", "accrued", "interest", "on", "January", "15,", "2017", "and", "$30.0", "million", "plus", "accrued", "interest", "on", "January", "15,", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p62_s3", "idA": "906709_13_item7_p69_s3", "sentA": "Our estimate of the interest rate under the agreement is based on the amount of royalty payments to be received by RPI over the life of the arrangement and payments we may be required to make to RPI under the agreement, if any.", "sentB": "Our estimate of the interest rate under the agreement is based on the amount of royalty payments to be received by RPI over the life of the arrangement and payments we may be required to make to RPI under the agreement.", "type": 2, "words": ["<tag1>", "Our", "estimate", "of", "the", "interest", "rate", "under", "the", "agreement", "is", "based", "on", "the", "amount", "of", "royalty", "payments", "to", "be", "received", "by", "RPI", "over", "the", "life", "of", "the", "arrangement", "and", "payments", "we", "may", "be", "required", "to", "make", "to", "RPI", "under", "the", "agreement,", "if", "any.", "<tag2>", "Our", "estimate", "of", "the", "interest", "rate", "under", "the", "agreement", "is", "based", "on", "the", "amount", "of", "royalty", "payments", "to", "be", "received", "by", "RPI", "over", "the", "life", "of", "the", "arrangement", "and", "payments", "we", "may", "be", "required", "to", "make", "to", "RPI", "under", "the", "agreement.", "<tag3>"], "wordsA": ["Our", "estimate", "of", "the", "interest", "rate", "under", "the", "agreement", "is", "based", "on", "the", "amount", "of", "royalty", "payments", "to", "be", "received", "by", "RPI", "over", "the", "life", "of", "the", "arrangement", "and", "payments", "we", "may", "be", "required", "to", "make", "to", "RPI", "under", "the", "agreement,", "if", "any."], "wordsB": ["Our", "estimate", "of", "the", "interest", "rate", "under", "the", "agreement", "is", "based", "on", "the", "amount", "of", "royalty", "payments", "to", "be", "received", "by", "RPI", "over", "the", "life", "of", "the", "arrangement", "and", "payments", "we", "may", "be", "required", "to", "make", "to", "RPI", "under", "the", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p7_s7", "idA": "906709_13_item7_p6_s0", "sentA": "result, the outcome of AstraZeneca s determination to make regulatory filings for naloxegol with the FDA and EMA is critical to our financial position in 2013 as well as our future business prospects as a result of the significant economic stake that we have in success of the potential commercialization of naloxegol.", "sentB": "We will be entitled to $140.0 million in commercial launch milestone payments if naloxegol is approved by the FDA and EMA and commercial launch is achieved in the U.S. and one major country in the E.U. As a result, the FDA s determination as to whether to require a CV Safety Study prior to an approval determination and the decisions of both the FDA and E.U. with regard to the marketing applications currently filed for naloxegol is critical to our financial position as well as our future business prospects.", "type": 2, "words": ["<tag1>", "result,", "the", "outcome", "of", "AstraZeneca", "s", "determination", "to", "make", "regulatory", "filings", "for", "naloxegol", "with", "the", "FDA", "and", "EMA", "is", "critical", "to", "our", "financial", "position", "in", "2013", "as", "well", "as", "our", "future", "business", "prospects", "as", "a", "result", "of", "the", "significant", "economic", "stake", "that", "we", "have", "in", "success", "of", "the", "potential", "commercialization", "of", "naloxegol.", "<tag2>", "We", "will", "be", "entitled", "to", "$140.0", "million", "in", "commercial", "launch", "milestone", "payments", "if", "naloxegol", "is", "approved", "by", "the", "FDA", "and", "EMA", "and", "commercial", "launch", "is", "achieved", "in", "the", "U.S.", "and", "one", "major", "country", "in", "the", "E.U.", "As", "a", "result,", "the", "FDA", "s", "determination", "as", "to", "whether", "to", "require", "a", "CV", "Safety", "Study", "prior", "to", "an", "approval", "determination", "and", "the", "decisions", "of", "both", "the", "FDA", "and", "E.U.", "with", "regard", "to", "the", "marketing", "applications", "currently", "filed", "for", "naloxegol", "is", "critical", "to", "our", "financial", "position", "as", "well", "as", "our", "future", "business", "prospects.", "<tag3>"], "wordsA": ["result,", "the", "outcome", "of", "AstraZeneca", "s", "determination", "to", "make", "regulatory", "filings", "for", "naloxegol", "with", "the", "FDA", "and", "EMA", "is", "critical", "to", "our", "financial", "position", "in", "2013", "as", "well", "as", "our", "future", "business", "prospects", "as", "a", "result", "of", "the", "significant", "economic", "stake", "that", "we", "have", "in", "success", "of", "the", "potential", "commercialization", "of", "naloxegol."], "wordsB": ["We", "will", "be", "entitled", "to", "$140.0", "million", "in", "commercial", "launch", "milestone", "payments", "if", "naloxegol", "is", "approved", "by", "the", "FDA", "and", "EMA", "and", "commercial", "launch", "is", "achieved", "in", "the", "U.S.", "and", "one", "major", "country", "in", "the", "E.U.", "As", "a", "result,", "the", "FDA", "s", "determination", "as", "to", "whether", "to", "require", "a", "CV", "Safety", "Study", "prior", "to", "an", "approval", "determination", "and", "the", "decisions", "of", "both", "the", "FDA", "and", "E.U.", "with", "regard", "to", "the", "marketing", "applications", "currently", "filed", "for", "naloxegol", "is", "critical", "to", "our", "financial", "position", "as", "well", "as", "our", "future", "business", "prospects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p10_s5", "idA": "906709_13_item7_p70_s0", "sentA": "There are a number of factors that could materially affect the amount and timing of royalty payments from CIMZIA and MIRCERA , most of which are not within our control.", "sentB": "During the titration period, 53 (18%) patients discontinued treatment because of adverse events, most of which are those commonly associated with opioids.", "type": 2, "words": ["<tag1>", "There", "are", "a", "number", "of", "factors", "that", "could", "materially", "affect", "the", "amount", "and", "timing", "of", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "most", "of", "which", "are", "not", "within", "our", "control.", "<tag2>", "During", "the", "titration", "period,", "53", "(18%)", "patients", "discontinued", "treatment", "because", "of", "adverse", "events,", "most", "of", "which", "are", "those", "commonly", "associated", "with", "opioids.", "<tag3>"], "wordsA": ["There", "are", "a", "number", "of", "factors", "that", "could", "materially", "affect", "the", "amount", "and", "timing", "of", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "most", "of", "which", "are", "not", "within", "our", "control."], "wordsB": ["During", "the", "titration", "period,", "53", "(18%)", "patients", "discontinued", "treatment", "because", "of", "adverse", "events,", "most", "of", "which", "are", "those", "commonly", "associated", "with", "opioids."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p63_s2", "idA": "906709_13_item7_p70_s2", "sentA": "Conversely, if sales of CIMZIA and MIRCERA are higher than expected, non-cash royalty revenues and non-cash interest expense would also be greater over the term of the Royalty Obligation.", "sentB": "Conversely, if sales of CIMZIA and MIRCERA are higher than expected, non-cash royalty revenue and non-cash interest expense would also be greater over the term of the Royalty Obligation.", "type": 2, "words": ["<tag1>", "Conversely,", "if", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "higher", "than", "expected,", "non-cash", "royalty", "revenues", "and", "non-cash", "interest", "expense", "would", "also", "be", "greater", "over", "the", "term", "of", "the", "Royalty", "Obligation.", "<tag2>", "Conversely,", "if", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "higher", "than", "expected,", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "would", "also", "be", "greater", "over", "the", "term", "of", "the", "Royalty", "Obligation.", "<tag3>"], "wordsA": ["Conversely,", "if", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "higher", "than", "expected,", "non-cash", "royalty", "revenues", "and", "non-cash", "interest", "expense", "would", "also", "be", "greater", "over", "the", "term", "of", "the", "Royalty", "Obligation."], "wordsB": ["Conversely,", "if", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "higher", "than", "expected,", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "would", "also", "be", "greater", "over", "the", "term", "of", "the", "Royalty", "Obligation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p63_s3", "idA": "906709_13_item7_p71_s0", "sentA": "current estimate of 17%, the non-cash interest expense recognized in the year ended December 31, 2012 would have increased by $1.2 million.", "sentB": "If we had determined that the interest rate used in 2013 should have been one percentage point higher than our current estimate of 17%, the non-cash interest expense recognized in the year ended December 31, 2013 would have increased by $1.5 million.", "type": 2, "words": ["<tag1>", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2012", "would", "have", "increased", "by", "$1.2", "million.", "<tag2>", "If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2013", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2013", "would", "have", "increased", "by", "$1.5", "million.", "<tag3>"], "wordsA": ["current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2012", "would", "have", "increased", "by", "$1.2", "million."], "wordsB": ["If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2013", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2013", "would", "have", "increased", "by", "$1.5", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p9_s0", "idA": "906709_13_item7_p7_s0", "sentA": "Our second most advanced proprietary drug candidate, etirinotecan pegol (formerly known as NKTR-102), is a next-generation topoisomerase I inhibitor.", "sentB": "Our third most advanced proprietary drug candidate, NKTR-181, is a novel mu-opioid analgesic drug candidate for chronic pain conditions.", "type": 2, "words": ["<tag1>", "Our", "second", "most", "advanced", "proprietary", "drug", "candidate,", "etirinotecan", "pegol", "(formerly", "known", "as", "NKTR-102),", "is", "a", "next-generation", "topoisomerase", "I", "inhibitor.", "<tag2>", "Our", "third", "most", "advanced", "proprietary", "drug", "candidate,", "NKTR-181,", "is", "a", "novel", "mu-opioid", "analgesic", "drug", "candidate", "for", "chronic", "pain", "conditions.", "<tag3>"], "wordsA": ["Our", "second", "most", "advanced", "proprietary", "drug", "candidate,", "etirinotecan", "pegol", "(formerly", "known", "as", "NKTR-102),", "is", "a", "next-generation", "topoisomerase", "I", "inhibitor."], "wordsB": ["Our", "third", "most", "advanced", "proprietary", "drug", "candidate,", "NKTR-181,", "is", "a", "novel", "mu-opioid", "analgesic", "drug", "candidate", "for", "chronic", "pain", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p11_s2", "idA": "906709_13_item7_p7_s1", "sentA": "Etirinotecan pegol is currently being evaluated as a single-agent therapy in a Phase 3 open-label, randomized, multicenter clinical study in patients with metastatic breast cancer.", "sentB": "We are currently evaluating the appropriate Phase 3 clinical study design for NKTR-181 and expect to start a Phase 3 clinical study in mid-2014.", "type": 2, "words": ["<tag1>", "Etirinotecan", "pegol", "is", "currently", "being", "evaluated", "as", "a", "single-agent", "therapy", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "in", "patients", "with", "metastatic", "breast", "cancer.", "<tag2>", "We", "are", "currently", "evaluating", "the", "appropriate", "Phase", "3", "clinical", "study", "design", "for", "NKTR-181", "and", "expect", "to", "start", "a", "Phase", "3", "clinical", "study", "in", "mid-2014.", "<tag3>"], "wordsA": ["Etirinotecan", "pegol", "is", "currently", "being", "evaluated", "as", "a", "single-agent", "therapy", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "in", "patients", "with", "metastatic", "breast", "cancer."], "wordsB": ["We", "are", "currently", "evaluating", "the", "appropriate", "Phase", "3", "clinical", "study", "design", "for", "NKTR-181", "and", "expect", "to", "start", "a", "Phase", "3", "clinical", "study", "in", "mid-2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p8_s2", "idA": "906709_13_item7_p7_s2", "sentA": "This Phase 3 clinical study, which we call the BEACON study (BrEAst Cancer Outcomes with NKTR-102), is scheduled to enroll approximately 840 patients with metastatic breast cancer that have previously received treatment with an anthracycline, a taxane, and capecitabine.", "sentB": "This Phase 3 clinical study, which we call the BEACON study (BrEAst Cancer Outcomes with NKTR-102), enrolled approximately 850 patients with metastatic breast cancer that have previously received treatment with an anthracycline, a taxane, and capecitabine.", "type": 2, "words": ["<tag1>", "This", "Phase", "3", "clinical", "study,", "which", "we", "call", "the", "BEACON", "study", "(BrEAst", "Cancer", "Outcomes", "with", "NKTR-102),", "is", "scheduled", "to", "enroll", "approximately", "840", "patients", "with", "metastatic", "breast", "cancer", "that", "have", "previously", "received", "treatment", "with", "an", "anthracycline,", "a", "taxane,", "and", "capecitabine.", "<tag2>", "This", "Phase", "3", "clinical", "study,", "which", "we", "call", "the", "BEACON", "study", "(BrEAst", "Cancer", "Outcomes", "with", "NKTR-102),", "enrolled", "approximately", "850", "patients", "with", "metastatic", "breast", "cancer", "that", "have", "previously", "received", "treatment", "with", "an", "anthracycline,", "a", "taxane,", "and", "capecitabine.", "<tag3>"], "wordsA": ["This", "Phase", "3", "clinical", "study,", "which", "we", "call", "the", "BEACON", "study", "(BrEAst", "Cancer", "Outcomes", "with", "NKTR-102),", "is", "scheduled", "to", "enroll", "approximately", "840", "patients", "with", "metastatic", "breast", "cancer", "that", "have", "previously", "received", "treatment", "with", "an", "anthracycline,", "a", "taxane,", "and", "capecitabine."], "wordsB": ["This", "Phase", "3", "clinical", "study,", "which", "we", "call", "the", "BEACON", "study", "(BrEAst", "Cancer", "Outcomes", "with", "NKTR-102),", "enrolled", "approximately", "850", "patients", "with", "metastatic", "breast", "cancer", "that", "have", "previously", "received", "treatment", "with", "an", "anthracycline,", "a", "taxane,", "and", "capecitabine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p10_s0", "idA": "906709_13_item7_p8_s0", "sentA": "In November 2012, etirinotecan pegol was designated by the FDA as a Fast Track development program for the treatment of patients with locally recurrent or metastatic breast cancer progressing after treatment with an anthracycline, a taxane, and capecitabine.", "sentB": "In May 2012, the development program for NKTR-181 for the treatment of moderate to severe chronic pain was granted Fast Track designation by the FDA.", "type": 2, "words": ["<tag1>", "In", "November", "2012,", "etirinotecan", "pegol", "was", "designated", "by", "the", "FDA", "as", "a", "Fast", "Track", "development", "program", "for", "the", "treatment", "of", "patients", "with", "locally", "recurrent", "or", "metastatic", "breast", "cancer", "progressing", "after", "treatment", "with", "an", "anthracycline,", "a", "taxane,", "and", "capecitabine.", "<tag2>", "In", "May", "2012,", "the", "development", "program", "for", "NKTR-181", "for", "the", "treatment", "of", "moderate", "to", "severe", "chronic", "pain", "was", "granted", "Fast", "Track", "designation", "by", "the", "FDA.", "<tag3>"], "wordsA": ["In", "November", "2012,", "etirinotecan", "pegol", "was", "designated", "by", "the", "FDA", "as", "a", "Fast", "Track", "development", "program", "for", "the", "treatment", "of", "patients", "with", "locally", "recurrent", "or", "metastatic", "breast", "cancer", "progressing", "after", "treatment", "with", "an", "anthracycline,", "a", "taxane,", "and", "capecitabine."], "wordsB": ["In", "May", "2012,", "the", "development", "program", "for", "NKTR-181", "for", "the", "treatment", "of", "moderate", "to", "severe", "chronic", "pain", "was", "granted", "Fast", "Track", "designation", "by", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p31_s6", "idA": "906709_13_item7_p8_s1", "sentA": "We have completed an expanded Phase 2 clinical study for etirinotecan pegol in patients with platinum-resistant ovarian cancer.", "sentB": "We have also studied or have ongoing studies being conducted for etirinotecan pegol, including investigator-initiated clinical studies, in bevacizumab (Avastin)-resistant high-grade glioma, colorectal cancer, metastatic and recurrent non-small cell lung cancer, and ovarian cancer.", "type": 2, "words": ["<tag1>", "We", "have", "completed", "an", "expanded", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "patients", "with", "platinum-resistant", "ovarian", "cancer.", "<tag2>", "We", "have", "also", "studied", "or", "have", "ongoing", "studies", "being", "conducted", "for", "etirinotecan", "pegol,", "including", "investigator-initiated", "clinical", "studies,", "in", "bevacizumab", "(Avastin)-resistant", "high-grade", "glioma,", "colorectal", "cancer,", "metastatic", "and", "recurrent", "non-small", "cell", "lung", "cancer,", "and", "ovarian", "cancer.", "<tag3>"], "wordsA": ["We", "have", "completed", "an", "expanded", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "patients", "with", "platinum-resistant", "ovarian", "cancer."], "wordsB": ["We", "have", "also", "studied", "or", "have", "ongoing", "studies", "being", "conducted", "for", "etirinotecan", "pegol,", "including", "investigator-initiated", "clinical", "studies,", "in", "bevacizumab", "(Avastin)-resistant", "high-grade", "glioma,", "colorectal", "cancer,", "metastatic", "and", "recurrent", "non-small", "cell", "lung", "cancer,", "and", "ovarian", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p10_s2", "idA": "906709_13_item7_p8_s3", "sentA": "In addition, a Phase 2 clinical study for etirinotecan pegol in patients with metastatic colorectal cancer is still open for enrollment.", "sentB": "On September 26, 2013, we announced preliminary topline results from a Phase 2 clinical study of NKTR-181 in patients with moderate to severe chronic pain from osteoarthritis of the knee.", "type": 2, "words": ["<tag1>", "In", "addition,", "a", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "patients", "with", "metastatic", "colorectal", "cancer", "is", "still", "open", "for", "enrollment.", "<tag2>", "On", "September", "26,", "2013,", "we", "announced", "preliminary", "topline", "results", "from", "a", "Phase", "2", "clinical", "study", "of", "NKTR-181", "in", "patients", "with", "moderate", "to", "severe", "chronic", "pain", "from", "osteoarthritis", "of", "the", "knee.", "<tag3>"], "wordsA": ["In", "addition,", "a", "Phase", "2", "clinical", "study", "for", "etirinotecan", "pegol", "in", "patients", "with", "metastatic", "colorectal", "cancer", "is", "still", "open", "for", "enrollment."], "wordsB": ["On", "September", "26,", "2013,", "we", "announced", "preliminary", "topline", "results", "from", "a", "Phase", "2", "clinical", "study", "of", "NKTR-181", "in", "patients", "with", "moderate", "to", "severe", "chronic", "pain", "from", "osteoarthritis", "of", "the", "knee."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p12_s0", "idA": "906709_13_item7_p9_s0", "sentA": "We have a significant collaboration with Bayer Healthcare LLC (Bayer) to develop BAY41-6551 (Amikacin Inhale, formerly known as NKTR-061), which is an inhaled solution of amikacin, an aminoglycoside antibiotic, that has completed Phase 2 clinical development.", "sentB": "We have a significant collaboration with Bayer Healthcare LLC (Bayer) to develop BAY41-6551 (Amikacin Inhale, formerly known as NKTR-061), which is an inhaled solution of amikacin, an aminoglycoside antibiotic.", "type": 2, "words": ["<tag1>", "We", "have", "a", "significant", "collaboration", "with", "Bayer", "Healthcare", "LLC", "(Bayer)", "to", "develop", "BAY41-6551", "(Amikacin", "Inhale,", "formerly", "known", "as", "NKTR-061),", "which", "is", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic,", "that", "has", "completed", "Phase", "2", "clinical", "development.", "<tag2>", "We", "have", "a", "significant", "collaboration", "with", "Bayer", "Healthcare", "LLC", "(Bayer)", "to", "develop", "BAY41-6551", "(Amikacin", "Inhale,", "formerly", "known", "as", "NKTR-061),", "which", "is", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic.", "<tag3>"], "wordsA": ["We", "have", "a", "significant", "collaboration", "with", "Bayer", "Healthcare", "LLC", "(Bayer)", "to", "develop", "BAY41-6551", "(Amikacin", "Inhale,", "formerly", "known", "as", "NKTR-061),", "which", "is", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic,", "that", "has", "completed", "Phase", "2", "clinical", "development."], "wordsB": ["We", "have", "a", "significant", "collaboration", "with", "Bayer", "Healthcare", "LLC", "(Bayer)", "to", "develop", "BAY41-6551", "(Amikacin", "Inhale,", "formerly", "known", "as", "NKTR-061),", "which", "is", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p11_s0", "idA": "906709_13_item7_p9_s2", "sentA": "The stability studies on the nebulizer device that needed to be completed prior to the start of the Phase 3 clinical study were successfully completed in February 2013.", "sentB": "lack of a placebo rebound caused the Phase 2 study to miss the primary endpoint, which was the average change in a patient s pain score from baseline to the end of the double-blind, randomized treatment period.", "type": 2, "words": ["<tag1>", "The", "stability", "studies", "on", "the", "nebulizer", "device", "that", "needed", "to", "be", "completed", "prior", "to", "the", "start", "of", "the", "Phase", "3", "clinical", "study", "were", "successfully", "completed", "in", "February", "2013.", "<tag2>", "lack", "of", "a", "placebo", "rebound", "caused", "the", "Phase", "2", "study", "to", "miss", "the", "primary", "endpoint,", "which", "was", "the", "average", "change", "in", "a", "patient", "s", "pain", "score", "from", "baseline", "to", "the", "end", "of", "the", "double-blind,", "randomized", "treatment", "period.", "<tag3>"], "wordsA": ["The", "stability", "studies", "on", "the", "nebulizer", "device", "that", "needed", "to", "be", "completed", "prior", "to", "the", "start", "of", "the", "Phase", "3", "clinical", "study", "were", "successfully", "completed", "in", "February", "2013."], "wordsB": ["lack", "of", "a", "placebo", "rebound", "caused", "the", "Phase", "2", "study", "to", "miss", "the", "primary", "endpoint,", "which", "was", "the", "average", "change", "in", "a", "patient", "s", "pain", "score", "from", "baseline", "to", "the", "end", "of", "the", "double-blind,", "randomized", "treatment", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p8_s4", "idA": "906709_13_item7_p9_s2", "sentA": "The stability studies on the nebulizer device that needed to be completed prior to the start of the Phase 3 clinical study were successfully completed in February 2013.", "sentB": "On January 14, 2014, we announced that the Independent Data Monitoring Committee, or the DMC, created to provide safety oversight for the BEACON study recommended continuation of the Phase 3 BEACON study following an interim data analysis which was performed after reaching 50% of the events needed to achieve the primary endpoint of overall survival.", "type": 2, "words": ["<tag1>", "The", "stability", "studies", "on", "the", "nebulizer", "device", "that", "needed", "to", "be", "completed", "prior", "to", "the", "start", "of", "the", "Phase", "3", "clinical", "study", "were", "successfully", "completed", "in", "February", "2013.", "<tag2>", "On", "January", "14,", "2014,", "we", "announced", "that", "the", "Independent", "Data", "Monitoring", "Committee,", "or", "the", "DMC,", "created", "to", "provide", "safety", "oversight", "for", "the", "BEACON", "study", "recommended", "continuation", "of", "the", "Phase", "3", "BEACON", "study", "following", "an", "interim", "data", "analysis", "which", "was", "performed", "after", "reaching", "50%", "of", "the", "events", "needed", "to", "achieve", "the", "primary", "endpoint", "of", "overall", "survival.", "<tag3>"], "wordsA": ["The", "stability", "studies", "on", "the", "nebulizer", "device", "that", "needed", "to", "be", "completed", "prior", "to", "the", "start", "of", "the", "Phase", "3", "clinical", "study", "were", "successfully", "completed", "in", "February", "2013."], "wordsB": ["On", "January", "14,", "2014,", "we", "announced", "that", "the", "Independent", "Data", "Monitoring", "Committee,", "or", "the", "DMC,", "created", "to", "provide", "safety", "oversight", "for", "the", "BEACON", "study", "recommended", "continuation", "of", "the", "Phase", "3", "BEACON", "study", "following", "an", "interim", "data", "analysis", "which", "was", "performed", "after", "reaching", "50%", "of", "the", "events", "needed", "to", "achieve", "the", "primary", "endpoint", "of", "overall", "survival."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p12_s1", "idA": "906709_13_item7_p9_s3", "sentA": "The Phase 3 clinical program is expected to be initiated by Bayer in March 2013.", "sentB": "Bayer has initiated a Phase 3 clinical development of BAY41-6551 with the first patient enrolled in April 2013.", "type": 2, "words": ["<tag1>", "The", "Phase", "3", "clinical", "program", "is", "expected", "to", "be", "initiated", "by", "Bayer", "in", "March", "2013.", "<tag2>", "Bayer", "has", "initiated", "a", "Phase", "3", "clinical", "development", "of", "BAY41-6551", "with", "the", "first", "patient", "enrolled", "in", "April", "2013.", "<tag3>"], "wordsA": ["The", "Phase", "3", "clinical", "program", "is", "expected", "to", "be", "initiated", "by", "Bayer", "in", "March", "2013."], "wordsB": ["Bayer", "has", "initiated", "a", "Phase", "3", "clinical", "development", "of", "BAY41-6551", "with", "the", "first", "patient", "enrolled", "in", "April", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_14_item7_p12_s5", "idA": "906709_13_item7_p9_s6", "sentA": "Under the terms of this collaboration, we are providing a license to our intellectual property and our PEGylation technology and expertise.", "sentB": "Under the terms of this collaboration, we are providing a license to our PEGylation intellectual property, technology and expertise.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "of", "this", "collaboration,", "we", "are", "providing", "a", "license", "to", "our", "intellectual", "property", "and", "our", "PEGylation", "technology", "and", "expertise.", "<tag2>", "Under", "the", "terms", "of", "this", "collaboration,", "we", "are", "providing", "a", "license", "to", "our", "PEGylation", "intellectual", "property,", "technology", "and", "expertise.", "<tag3>"], "wordsA": ["Under", "the", "terms", "of", "this", "collaboration,", "we", "are", "providing", "a", "license", "to", "our", "intellectual", "property", "and", "our", "PEGylation", "technology", "and", "expertise."], "wordsB": ["Under", "the", "terms", "of", "this", "collaboration,", "we", "are", "providing", "a", "license", "to", "our", "PEGylation", "intellectual", "property,", "technology", "and", "expertise."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p0_s0", "idA": "906709_14_item7_p0_s0", "sentA": "We are a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize our PEGylation and advanced polymer conjugate technology platforms, which are designed to enable the development of new molecular entities that target known mechanisms of action.", "sentB": "We are a biopharmaceutical company developing a pipeline of drug candidates that utilize our PEGylation and advanced polymer conjugate technology platforms, which are designed to enable the development of new molecular entities that target known mechanisms of action.", "type": 2, "words": ["<tag1>", "We", "are", "a", "clinical-stage", "biopharmaceutical", "company", "developing", "a", "pipeline", "of", "drug", "candidates", "that", "utilize", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "technology", "platforms,", "which", "are", "designed", "to", "enable", "the", "development", "of", "new", "molecular", "entities", "that", "target", "known", "mechanisms", "of", "action.", "<tag2>", "We", "are", "a", "biopharmaceutical", "company", "developing", "a", "pipeline", "of", "drug", "candidates", "that", "utilize", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "technology", "platforms,", "which", "are", "designed", "to", "enable", "the", "development", "of", "new", "molecular", "entities", "that", "target", "known", "mechanisms", "of", "action.", "<tag3>"], "wordsA": ["We", "are", "a", "clinical-stage", "biopharmaceutical", "company", "developing", "a", "pipeline", "of", "drug", "candidates", "that", "utilize", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "technology", "platforms,", "which", "are", "designed", "to", "enable", "the", "development", "of", "new", "molecular", "entities", "that", "target", "known", "mechanisms", "of", "action."], "wordsB": ["We", "are", "a", "biopharmaceutical", "company", "developing", "a", "pipeline", "of", "drug", "candidates", "that", "utilize", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "technology", "platforms,", "which", "are", "designed", "to", "enable", "the", "development", "of", "new", "molecular", "entities", "that", "target", "known", "mechanisms", "of", "action."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p11_s10", "idA": "906709_14_item7_p0_s2", "sentA": "Our research and development activities involve small molecule drugs, peptides and other biologic drug candidates.", "sentB": "We also have additional proprietary preclinical and clinical drug candidates in research and development.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "other", "biologic", "drug", "candidates.", "<tag2>", "We", "also", "have", "additional", "proprietary", "preclinical", "and", "clinical", "drug", "candidates", "in", "research", "and", "development.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "other", "biologic", "drug", "candidates."], "wordsB": ["We", "also", "have", "additional", "proprietary", "preclinical", "and", "clinical", "drug", "candidates", "in", "research", "and", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p11_s14", "idA": "906709_14_item7_p0_s2", "sentA": "Our research and development activities involve small molecule drugs, peptides and other biologic drug candidates.", "sentB": "We are also advancing numerous other drug candidates in preclinical development in the areas of cancer immunotherapy, pain and other therapeutic indications.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "other", "biologic", "drug", "candidates.", "<tag2>", "We", "are", "also", "advancing", "numerous", "other", "drug", "candidates", "in", "preclinical", "development", "in", "the", "areas", "of", "cancer", "immunotherapy,", "pain", "and", "other", "therapeutic", "indications.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "other", "biologic", "drug", "candidates."], "wordsB": ["We", "are", "also", "advancing", "numerous", "other", "drug", "candidates", "in", "preclinical", "development", "in", "the", "areas", "of", "cancer", "immunotherapy,", "pain", "and", "other", "therapeutic", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p62_s1", "idA": "906709_14_item7_p0_s2", "sentA": "Our research and development activities involve small molecule drugs, peptides and other biologic drug candidates.", "sentB": "However, since a portion of our operations consists of research and development activities outside the United States, we have entered into transactions in other currencies, primarily the Indian Rupee, and we therefore are subject to foreign exchange risk.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "other", "biologic", "drug", "candidates.", "<tag2>", "However,", "since", "a", "portion", "of", "our", "operations", "consists", "of", "research", "and", "development", "activities", "outside", "the", "United", "States,", "we", "have", "entered", "into", "transactions", "in", "other", "currencies,", "primarily", "the", "Indian", "Rupee,", "and", "we", "therefore", "are", "subject", "to", "foreign", "exchange", "risk.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "other", "biologic", "drug", "candidates."], "wordsB": ["However,", "since", "a", "portion", "of", "our", "operations", "consists", "of", "research", "and", "development", "activities", "outside", "the", "United", "States,", "we", "have", "entered", "into", "transactions", "in", "other", "currencies,", "primarily", "the", "Indian", "Rupee,", "and", "we", "therefore", "are", "subject", "to", "foreign", "exchange", "risk."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p8_s0", "idA": "906709_14_item7_p10_s0", "sentA": "In May 2012, the development program for NKTR-181 for the treatment of moderate to severe chronic pain was granted Fast Track designation by the FDA.", "sentB": "In May 2012, the FDA designated NKTR-181 as a Fast Track development program for the treatment of moderate to severe chronic pain.", "type": 2, "words": ["<tag1>", "In", "May", "2012,", "the", "development", "program", "for", "NKTR-181", "for", "the", "treatment", "of", "moderate", "to", "severe", "chronic", "pain", "was", "granted", "Fast", "Track", "designation", "by", "the", "FDA.", "<tag2>", "In", "May", "2012,", "the", "FDA", "designated", "NKTR-181", "as", "a", "Fast", "Track", "development", "program", "for", "the", "treatment", "of", "moderate", "to", "severe", "chronic", "pain.", "<tag3>"], "wordsA": ["In", "May", "2012,", "the", "development", "program", "for", "NKTR-181", "for", "the", "treatment", "of", "moderate", "to", "severe", "chronic", "pain", "was", "granted", "Fast", "Track", "designation", "by", "the", "FDA."], "wordsB": ["In", "May", "2012,", "the", "FDA", "designated", "NKTR-181", "as", "a", "Fast", "Track", "development", "program", "for", "the", "treatment", "of", "moderate", "to", "severe", "chronic", "pain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p8_s1", "idA": "906709_14_item7_p10_s1", "sentA": "On June 19, 2013, we announced positive data from a human abuse liability study of NKTR-181.", "sentB": "In June 2013, we announced results from a human abuse liability study that demonstrated that NKTR-181 had highly statistically significant lower drug liking scores and reduced feeling high scores as compared to oxycodone at all doses tested (p 0.0001).", "type": 2, "words": ["<tag1>", "On", "June", "19,", "2013,", "we", "announced", "positive", "data", "from", "a", "human", "abuse", "liability", "study", "of", "NKTR-181.", "<tag2>", "In", "June", "2013,", "we", "announced", "results", "from", "a", "human", "abuse", "liability", "study", "that", "demonstrated", "that", "NKTR-181", "had", "highly", "statistically", "significant", "lower", "drug", "liking", "scores", "and", "reduced", "feeling", "high", "scores", "as", "compared", "to", "oxycodone", "at", "all", "doses", "tested", "(p", "0.0001).", "<tag3>"], "wordsA": ["On", "June", "19,", "2013,", "we", "announced", "positive", "data", "from", "a", "human", "abuse", "liability", "study", "of", "NKTR-181."], "wordsB": ["In", "June", "2013,", "we", "announced", "results", "from", "a", "human", "abuse", "liability", "study", "that", "demonstrated", "that", "NKTR-181", "had", "highly", "statistically", "significant", "lower", "drug", "liking", "scores", "and", "reduced", "feeling", "high", "scores", "as", "compared", "to", "oxycodone", "at", "all", "doses", "tested", "(p", "0.0001)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p8_s7", "idA": "906709_14_item7_p10_s1", "sentA": "On June 19, 2013, we announced positive data from a human abuse liability study of NKTR-181.", "sentB": "In this Phase 3 program for NKTR-181 we plan to include two separate efficacy studies in patients with chronic lower back pain, a long-term safety study, and a human abuse liability study.", "type": 2, "words": ["<tag1>", "On", "June", "19,", "2013,", "we", "announced", "positive", "data", "from", "a", "human", "abuse", "liability", "study", "of", "NKTR-181.", "<tag2>", "In", "this", "Phase", "3", "program", "for", "NKTR-181", "we", "plan", "to", "include", "two", "separate", "efficacy", "studies", "in", "patients", "with", "chronic", "lower", "back", "pain,", "a", "long-term", "safety", "study,", "and", "a", "human", "abuse", "liability", "study.", "<tag3>"], "wordsA": ["On", "June", "19,", "2013,", "we", "announced", "positive", "data", "from", "a", "human", "abuse", "liability", "study", "of", "NKTR-181."], "wordsB": ["In", "this", "Phase", "3", "program", "for", "NKTR-181", "we", "plan", "to", "include", "two", "separate", "efficacy", "studies", "in", "patients", "with", "chronic", "lower", "back", "pain,", "a", "long-term", "safety", "study,", "and", "a", "human", "abuse", "liability", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p8_s2", "idA": "906709_14_item7_p10_s2", "sentA": "On September 26, 2013, we announced preliminary topline results from a Phase 2 clinical study of NKTR-181 in patients with moderate to severe chronic pain from osteoarthritis of the knee.", "sentB": "In September 2013, we announced topline results from a Phase 2 clinical study of NKTR-181 in patients with moderate to severe chronic pain from osteoarthritis of the knee.", "type": 2, "words": ["<tag1>", "On", "September", "26,", "2013,", "we", "announced", "preliminary", "topline", "results", "from", "a", "Phase", "2", "clinical", "study", "of", "NKTR-181", "in", "patients", "with", "moderate", "to", "severe", "chronic", "pain", "from", "osteoarthritis", "of", "the", "knee.", "<tag2>", "In", "September", "2013,", "we", "announced", "topline", "results", "from", "a", "Phase", "2", "clinical", "study", "of", "NKTR-181", "in", "patients", "with", "moderate", "to", "severe", "chronic", "pain", "from", "osteoarthritis", "of", "the", "knee.", "<tag3>"], "wordsA": ["On", "September", "26,", "2013,", "we", "announced", "preliminary", "topline", "results", "from", "a", "Phase", "2", "clinical", "study", "of", "NKTR-181", "in", "patients", "with", "moderate", "to", "severe", "chronic", "pain", "from", "osteoarthritis", "of", "the", "knee."], "wordsB": ["In", "September", "2013,", "we", "announced", "topline", "results", "from", "a", "Phase", "2", "clinical", "study", "of", "NKTR-181", "in", "patients", "with", "moderate", "to", "severe", "chronic", "pain", "from", "osteoarthritis", "of", "the", "knee."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p8_s4", "idA": "906709_14_item7_p10_s8", "sentA": "However, patients who were randomized to the placebo arm did not show the expected increase in pain scores observed in similar enriched enrollment, randomized withdrawal studies.", "sentB": "However, patients who were randomized to the placebo arm following a drug titration phase did not show the expected increase in pain scores observed in similar enriched enrollment, randomized withdrawal studies.", "type": 2, "words": ["<tag1>", "However,", "patients", "who", "were", "randomized", "to", "the", "placebo", "arm", "did", "not", "show", "the", "expected", "increase", "in", "pain", "scores", "observed", "in", "similar", "enriched", "enrollment,", "randomized", "withdrawal", "studies.", "<tag2>", "However,", "patients", "who", "were", "randomized", "to", "the", "placebo", "arm", "following", "a", "drug", "titration", "phase", "did", "not", "show", "the", "expected", "increase", "in", "pain", "scores", "observed", "in", "similar", "enriched", "enrollment,", "randomized", "withdrawal", "studies.", "<tag3>"], "wordsA": ["However,", "patients", "who", "were", "randomized", "to", "the", "placebo", "arm", "did", "not", "show", "the", "expected", "increase", "in", "pain", "scores", "observed", "in", "similar", "enriched", "enrollment,", "randomized", "withdrawal", "studies."], "wordsB": ["However,", "patients", "who", "were", "randomized", "to", "the", "placebo", "arm", "following", "a", "drug", "titration", "phase", "did", "not", "show", "the", "expected", "increase", "in", "pain", "scores", "observed", "in", "similar", "enriched", "enrollment,", "randomized", "withdrawal", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p8_s5", "idA": "906709_14_item7_p11_s0", "sentA": "lack of a placebo rebound caused the Phase 2 study to miss the primary endpoint, which was the average change in a patient s pain score from baseline to the end of the double-blind, randomized treatment period.", "sentB": "This lack of a placebo rebound in the maintenance phase of the trial caused the Phase 2 study to miss the primary endpoint.", "type": 2, "words": ["<tag1>", "lack", "of", "a", "placebo", "rebound", "caused", "the", "Phase", "2", "study", "to", "miss", "the", "primary", "endpoint,", "which", "was", "the", "average", "change", "in", "a", "patient", "s", "pain", "score", "from", "baseline", "to", "the", "end", "of", "the", "double-blind,", "randomized", "treatment", "period.", "<tag2>", "This", "lack", "of", "a", "placebo", "rebound", "in", "the", "maintenance", "phase", "of", "the", "trial", "caused", "the", "Phase", "2", "study", "to", "miss", "the", "primary", "endpoint.", "<tag3>"], "wordsA": ["lack", "of", "a", "placebo", "rebound", "caused", "the", "Phase", "2", "study", "to", "miss", "the", "primary", "endpoint,", "which", "was", "the", "average", "change", "in", "a", "patient", "s", "pain", "score", "from", "baseline", "to", "the", "end", "of", "the", "double-blind,", "randomized", "treatment", "period."], "wordsB": ["This", "lack", "of", "a", "placebo", "rebound", "in", "the", "maintenance", "phase", "of", "the", "trial", "caused", "the", "Phase", "2", "study", "to", "miss", "the", "primary", "endpoint."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p8_s12", "idA": "906709_14_item7_p11_s1", "sentA": "In December 2013, we met with the FDA to discuss the results of the Phase 2 clinical study and certain preliminary considerations for the Phase 3 clinical study design.", "sentB": "We plan to have further interactions with the FDA to finalize the study design for the other clinical studies planned for the Phase 3 program.", "type": 2, "words": ["<tag1>", "In", "December", "2013,", "we", "met", "with", "the", "FDA", "to", "discuss", "the", "results", "of", "the", "Phase", "2", "clinical", "study", "and", "certain", "preliminary", "considerations", "for", "the", "Phase", "3", "clinical", "study", "design.", "<tag2>", "We", "plan", "to", "have", "further", "interactions", "with", "the", "FDA", "to", "finalize", "the", "study", "design", "for", "the", "other", "clinical", "studies", "planned", "for", "the", "Phase", "3", "program.", "<tag3>"], "wordsA": ["In", "December", "2013,", "we", "met", "with", "the", "FDA", "to", "discuss", "the", "results", "of", "the", "Phase", "2", "clinical", "study", "and", "certain", "preliminary", "considerations", "for", "the", "Phase", "3", "clinical", "study", "design."], "wordsB": ["We", "plan", "to", "have", "further", "interactions", "with", "the", "FDA", "to", "finalize", "the", "study", "design", "for", "the", "other", "clinical", "studies", "planned", "for", "the", "Phase", "3", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p8_s6", "idA": "906709_14_item7_p11_s1", "sentA": "In December 2013, we met with the FDA to discuss the results of the Phase 2 clinical study and certain preliminary considerations for the Phase 3 clinical study design.", "sentB": "In October 2014, we had an end-of-Phase 2 meeting for NKTR-181 with the FDA, which included discussions of certain considerations for the Phase 3 clinical study program.", "type": 2, "words": ["<tag1>", "In", "December", "2013,", "we", "met", "with", "the", "FDA", "to", "discuss", "the", "results", "of", "the", "Phase", "2", "clinical", "study", "and", "certain", "preliminary", "considerations", "for", "the", "Phase", "3", "clinical", "study", "design.", "<tag2>", "In", "October", "2014,", "we", "had", "an", "end-of-Phase", "2", "meeting", "for", "NKTR-181", "with", "the", "FDA,", "which", "included", "discussions", "of", "certain", "considerations", "for", "the", "Phase", "3", "clinical", "study", "program.", "<tag3>"], "wordsA": ["In", "December", "2013,", "we", "met", "with", "the", "FDA", "to", "discuss", "the", "results", "of", "the", "Phase", "2", "clinical", "study", "and", "certain", "preliminary", "considerations", "for", "the", "Phase", "3", "clinical", "study", "design."], "wordsB": ["In", "October", "2014,", "we", "had", "an", "end-of-Phase", "2", "meeting", "for", "NKTR-181", "with", "the", "FDA,", "which", "included", "discussions", "of", "certain", "considerations", "for", "the", "Phase", "3", "clinical", "study", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p58_s1", "idA": "906709_14_item7_p11_s2", "sentA": "We are currently evaluating the appropriate Phase 3 clinical study design for NKTR-181 and expect to start a Phase 3 clinical study in mid-2014.", "sentB": "We are currently evaluating the impact of the provisions of ASC 606.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "evaluating", "the", "appropriate", "Phase", "3", "clinical", "study", "design", "for", "NKTR-181", "and", "expect", "to", "start", "a", "Phase", "3", "clinical", "study", "in", "mid-2014.", "<tag2>", "We", "are", "currently", "evaluating", "the", "impact", "of", "the", "provisions", "of", "ASC", "606.", "<tag3>"], "wordsA": ["We", "are", "currently", "evaluating", "the", "appropriate", "Phase", "3", "clinical", "study", "design", "for", "NKTR-181", "and", "expect", "to", "start", "a", "Phase", "3", "clinical", "study", "in", "mid-2014."], "wordsB": ["We", "are", "currently", "evaluating", "the", "impact", "of", "the", "provisions", "of", "ASC", "606."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p11_s1", "idA": "906709_14_item7_p12_s0", "sentA": "We have a significant collaboration with Bayer Healthcare LLC (Bayer) to develop BAY41-6551 (Amikacin Inhale, formerly known as NKTR-061), which is an inhaled solution of amikacin, an aminoglycoside antibiotic.", "sentB": "This first is a collaboration to develop BAY41-6551 (Amikacin Inhale, formerly known as NKTR-061), which is an inhaled solution of amikacin, an aminoglycoside antibiotic.", "type": 2, "words": ["<tag1>", "We", "have", "a", "significant", "collaboration", "with", "Bayer", "Healthcare", "LLC", "(Bayer)", "to", "develop", "BAY41-6551", "(Amikacin", "Inhale,", "formerly", "known", "as", "NKTR-061),", "which", "is", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic.", "<tag2>", "This", "first", "is", "a", "collaboration", "to", "develop", "BAY41-6551", "(Amikacin", "Inhale,", "formerly", "known", "as", "NKTR-061),", "which", "is", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic.", "<tag3>"], "wordsA": ["We", "have", "a", "significant", "collaboration", "with", "Bayer", "Healthcare", "LLC", "(Bayer)", "to", "develop", "BAY41-6551", "(Amikacin", "Inhale,", "formerly", "known", "as", "NKTR-061),", "which", "is", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic."], "wordsB": ["This", "first", "is", "a", "collaboration", "to", "develop", "BAY41-6551", "(Amikacin", "Inhale,", "formerly", "known", "as", "NKTR-061),", "which", "is", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p8_s8", "idA": "906709_14_item7_p12_s1", "sentA": "Bayer has initiated a Phase 3 clinical development of BAY41-6551 with the first patient enrolled in April 2013.", "sentB": "We enrolled the first patient in this first Phase 3 study on February 24, 2015.", "type": 2, "words": ["<tag1>", "Bayer", "has", "initiated", "a", "Phase", "3", "clinical", "development", "of", "BAY41-6551", "with", "the", "first", "patient", "enrolled", "in", "April", "2013.", "<tag2>", "We", "enrolled", "the", "first", "patient", "in", "this", "first", "Phase", "3", "study", "on", "February", "24,", "2015.", "<tag3>"], "wordsA": ["Bayer", "has", "initiated", "a", "Phase", "3", "clinical", "development", "of", "BAY41-6551", "with", "the", "first", "patient", "enrolled", "in", "April", "2013."], "wordsB": ["We", "enrolled", "the", "first", "patient", "in", "this", "first", "Phase", "3", "study", "on", "February", "24,", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p11_s2", "idA": "906709_14_item7_p12_s2", "sentA": "We originally developed the liquid aerosol inhalation platform and Amikacin Inhale and entered into a collaboration agreement with Bayer in August 2007 to further advance the drug candidate s development and potential commercialization.", "sentB": "We originally developed the liquid aerosol inhalation platform and the NKTR-061 drug candidate and entered into a collaboration agreement with Bayer to further advance the drug candidate s development and potential commercialization.", "type": 2, "words": ["<tag1>", "We", "originally", "developed", "the", "liquid", "aerosol", "inhalation", "platform", "and", "Amikacin", "Inhale", "and", "entered", "into", "a", "collaboration", "agreement", "with", "Bayer", "in", "August", "2007", "to", "further", "advance", "the", "drug", "candidate", "s", "development", "and", "potential", "commercialization.", "<tag2>", "We", "originally", "developed", "the", "liquid", "aerosol", "inhalation", "platform", "and", "the", "NKTR-061", "drug", "candidate", "and", "entered", "into", "a", "collaboration", "agreement", "with", "Bayer", "to", "further", "advance", "the", "drug", "candidate", "s", "development", "and", "potential", "commercialization.", "<tag3>"], "wordsA": ["We", "originally", "developed", "the", "liquid", "aerosol", "inhalation", "platform", "and", "Amikacin", "Inhale", "and", "entered", "into", "a", "collaboration", "agreement", "with", "Bayer", "in", "August", "2007", "to", "further", "advance", "the", "drug", "candidate", "s", "development", "and", "potential", "commercialization."], "wordsB": ["We", "originally", "developed", "the", "liquid", "aerosol", "inhalation", "platform", "and", "the", "NKTR-061", "drug", "candidate", "and", "entered", "into", "a", "collaboration", "agreement", "with", "Bayer", "to", "further", "advance", "the", "drug", "candidate", "s", "development", "and", "potential", "commercialization."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p11_s4", "idA": "906709_14_item7_p12_s3", "sentA": "In 2011, Bayer achieved agreement with the FDA on the design of the planned Phase 3 clinical studies of BAY41-6551 under the Special Protocol Assessment process that is intended to support the submission of an NDA if the ongoing Phase 3 clinical study is successful.", "sentB": "Bayer is conducting this study under a Special Protocol Assessment process agreed to with the FDA.", "type": 2, "words": ["<tag1>", "In", "2011,", "Bayer", "achieved", "agreement", "with", "the", "FDA", "on", "the", "design", "of", "the", "planned", "Phase", "3", "clinical", "studies", "of", "BAY41-6551", "under", "the", "Special", "Protocol", "Assessment", "process", "that", "is", "intended", "to", "support", "the", "submission", "of", "an", "NDA", "if", "the", "ongoing", "Phase", "3", "clinical", "study", "is", "successful.", "<tag2>", "Bayer", "is", "conducting", "this", "study", "under", "a", "Special", "Protocol", "Assessment", "process", "agreed", "to", "with", "the", "FDA.", "<tag3>"], "wordsA": ["In", "2011,", "Bayer", "achieved", "agreement", "with", "the", "FDA", "on", "the", "design", "of", "the", "planned", "Phase", "3", "clinical", "studies", "of", "BAY41-6551", "under", "the", "Special", "Protocol", "Assessment", "process", "that", "is", "intended", "to", "support", "the", "submission", "of", "an", "NDA", "if", "the", "ongoing", "Phase", "3", "clinical", "study", "is", "successful."], "wordsB": ["Bayer", "is", "conducting", "this", "study", "under", "a", "Special", "Protocol", "Assessment", "process", "agreed", "to", "with", "the", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p9_s1", "idA": "906709_14_item7_p12_s4", "sentA": "We also have a significant collaboration with Baxter Healthcare to identify and develop PEGylated drug candidates with the objective of providing new long-acting therapies for hemophilia patients.", "sentB": "We have a collaboration with Baxter Healthcare (Baxter), to identify and develop PEGylated drug candidates with the objective of providing new long-acting therapies for hemophilia patients.", "type": 2, "words": ["<tag1>", "We", "also", "have", "a", "significant", "collaboration", "with", "Baxter", "Healthcare", "to", "identify", "and", "develop", "PEGylated", "drug", "candidates", "with", "the", "objective", "of", "providing", "new", "long-acting", "therapies", "for", "hemophilia", "patients.", "<tag2>", "We", "have", "a", "collaboration", "with", "Baxter", "Healthcare", "(Baxter),", "to", "identify", "and", "develop", "PEGylated", "drug", "candidates", "with", "the", "objective", "of", "providing", "new", "long-acting", "therapies", "for", "hemophilia", "patients.", "<tag3>"], "wordsA": ["We", "also", "have", "a", "significant", "collaboration", "with", "Baxter", "Healthcare", "to", "identify", "and", "develop", "PEGylated", "drug", "candidates", "with", "the", "objective", "of", "providing", "new", "long-acting", "therapies", "for", "hemophilia", "patients."], "wordsB": ["We", "have", "a", "collaboration", "with", "Baxter", "Healthcare", "(Baxter),", "to", "identify", "and", "develop", "PEGylated", "drug", "candidates", "with", "the", "objective", "of", "providing", "new", "long-acting", "therapies", "for", "hemophilia", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p50_s1", "idA": "906709_14_item7_p12_s5", "sentA": "Under the terms of this collaboration, we are providing a license to our PEGylation intellectual property, technology and expertise.", "sentB": "The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result in uneven payment flows to our vendors.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "of", "this", "collaboration,", "we", "are", "providing", "a", "license", "to", "our", "PEGylation", "intellectual", "property,", "technology", "and", "expertise.", "<tag2>", "The", "financial", "terms", "of", "these", "agreements", "are", "subject", "to", "negotiation,", "vary", "from", "contract", "to", "contract", "and", "may", "result", "in", "uneven", "payment", "flows", "to", "our", "vendors.", "<tag3>"], "wordsA": ["Under", "the", "terms", "of", "this", "collaboration,", "we", "are", "providing", "a", "license", "to", "our", "PEGylation", "intellectual", "property,", "technology", "and", "expertise."], "wordsB": ["The", "financial", "terms", "of", "these", "agreements", "are", "subject", "to", "negotiation,", "vary", "from", "contract", "to", "contract", "and", "may", "result", "in", "uneven", "payment", "flows", "to", "our", "vendors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p10_s0", "idA": "906709_14_item7_p14_s0", "sentA": "The first drug candidate in this collaboration, BAX 855, is a longer-acting (PEGylated) form of a full-length recombinant factor VIII (rFVIII) protein which has completed Phase 1 clinical development in patients with Hemophilia A.", "sentB": "The first drug candidate in this collaboration is BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)].", "type": 2, "words": ["<tag1>", "The", "first", "drug", "candidate", "in", "this", "collaboration,", "BAX", "855,", "is", "a", "longer-acting", "(PEGylated)", "form", "of", "a", "full-length", "recombinant", "factor", "VIII", "(rFVIII)", "protein", "which", "has", "completed", "Phase", "1", "clinical", "development", "in", "patients", "with", "Hemophilia", "A.", "<tag2>", "The", "first", "drug", "candidate", "in", "this", "collaboration", "is", "BAX", "855,", "an", "investigational,", "extended", "half-life", "recombinant", "factor", "VIII", "(rFVIII)", "treatment", "for", "hemophilia", "A", "based", "on", "ADVATE", "[Antihemophilic", "Factor", "(Recombinant)].", "<tag3>"], "wordsA": ["The", "first", "drug", "candidate", "in", "this", "collaboration,", "BAX", "855,", "is", "a", "longer-acting", "(PEGylated)", "form", "of", "a", "full-length", "recombinant", "factor", "VIII", "(rFVIII)", "protein", "which", "has", "completed", "Phase", "1", "clinical", "development", "in", "patients", "with", "Hemophilia", "A."], "wordsB": ["The", "first", "drug", "candidate", "in", "this", "collaboration", "is", "BAX", "855,", "an", "investigational,", "extended", "half-life", "recombinant", "factor", "VIII", "(rFVIII)", "treatment", "for", "hemophilia", "A", "based", "on", "ADVATE", "[Antihemophilic", "Factor", "(Recombinant)]."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p10_s2", "idA": "906709_14_item7_p14_s1", "sentA": "In February 2013, Baxter initiated a Phase 3 multi-center, open-label clinical study called PROLONG-ATE in previously treated adult patients with severe hemophilia A to assess the efficacy, safety and pharmacokinetics of BAX 855 for prophylaxis and on-demand treatment of bleeding.", "sentB": "This regulatory submission was based on positive results from a prospective, global, multi-center, open-label, two-arm Phase 3 study of BAX 855 in 137 previously treated patients.", "type": 2, "words": ["<tag1>", "In", "February", "2013,", "Baxter", "initiated", "a", "Phase", "3", "multi-center,", "open-label", "clinical", "study", "called", "PROLONG-ATE", "in", "previously", "treated", "adult", "patients", "with", "severe", "hemophilia", "A", "to", "assess", "the", "efficacy,", "safety", "and", "pharmacokinetics", "of", "BAX", "855", "for", "prophylaxis", "and", "on-demand", "treatment", "of", "bleeding.", "<tag2>", "This", "regulatory", "submission", "was", "based", "on", "positive", "results", "from", "a", "prospective,", "global,", "multi-center,", "open-label,", "two-arm", "Phase", "3", "study", "of", "BAX", "855", "in", "137", "previously", "treated", "patients.", "<tag3>"], "wordsA": ["In", "February", "2013,", "Baxter", "initiated", "a", "Phase", "3", "multi-center,", "open-label", "clinical", "study", "called", "PROLONG-ATE", "in", "previously", "treated", "adult", "patients", "with", "severe", "hemophilia", "A", "to", "assess", "the", "efficacy,", "safety", "and", "pharmacokinetics", "of", "BAX", "855", "for", "prophylaxis", "and", "on-demand", "treatment", "of", "bleeding."], "wordsB": ["This", "regulatory", "submission", "was", "based", "on", "positive", "results", "from", "a", "prospective,", "global,", "multi-center,", "open-label,", "two-arm", "Phase", "3", "study", "of", "BAX", "855", "in", "137", "previously", "treated", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p10_s1", "idA": "906709_14_item7_p14_s2", "sentA": "On November 13, 2013, Baxter announced that it had completed enrollment of 146 patients in the PROLONG-ATE clinical study.", "sentB": "In December 2014, Baxter announced that it filed a biologic license application with the FDA for BAX 855.", "type": 2, "words": ["<tag1>", "On", "November", "13,", "2013,", "Baxter", "announced", "that", "it", "had", "completed", "enrollment", "of", "146", "patients", "in", "the", "PROLONG-ATE", "clinical", "study.", "<tag2>", "In", "December", "2014,", "Baxter", "announced", "that", "it", "filed", "a", "biologic", "license", "application", "with", "the", "FDA", "for", "BAX", "855.", "<tag3>"], "wordsA": ["On", "November", "13,", "2013,", "Baxter", "announced", "that", "it", "had", "completed", "enrollment", "of", "146", "patients", "in", "the", "PROLONG-ATE", "clinical", "study."], "wordsB": ["In", "December", "2014,", "Baxter", "announced", "that", "it", "filed", "a", "biologic", "license", "application", "with", "the", "FDA", "for", "BAX", "855."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p11_s8", "idA": "906709_14_item7_p16_s0", "sentA": "While the late stage clinical development programs described above are key elements of the future success of our company, we believe it is critically important that we continue to make substantial investments in our earlier-stage drug candidate pipeline.", "sentB": "While the approved drugs and clinical development programs described above are key elements of the future success of our company, we believe it is critically important that we continue to make substantial investments in our earlier-stage drug candidate pipeline.", "type": 2, "words": ["<tag1>", "While", "the", "late", "stage", "clinical", "development", "programs", "described", "above", "are", "key", "elements", "of", "the", "future", "success", "of", "our", "company,", "we", "believe", "it", "is", "critically", "important", "that", "we", "continue", "to", "make", "substantial", "investments", "in", "our", "earlier-stage", "drug", "candidate", "pipeline.", "<tag2>", "While", "the", "approved", "drugs", "and", "clinical", "development", "programs", "described", "above", "are", "key", "elements", "of", "the", "future", "success", "of", "our", "company,", "we", "believe", "it", "is", "critically", "important", "that", "we", "continue", "to", "make", "substantial", "investments", "in", "our", "earlier-stage", "drug", "candidate", "pipeline.", "<tag3>"], "wordsA": ["While", "the", "late", "stage", "clinical", "development", "programs", "described", "above", "are", "key", "elements", "of", "the", "future", "success", "of", "our", "company,", "we", "believe", "it", "is", "critically", "important", "that", "we", "continue", "to", "make", "substantial", "investments", "in", "our", "earlier-stage", "drug", "candidate", "pipeline."], "wordsB": ["While", "the", "approved", "drugs", "and", "clinical", "development", "programs", "described", "above", "are", "key", "elements", "of", "the", "future", "success", "of", "our", "company,", "we", "believe", "it", "is", "critically", "important", "that", "we", "continue", "to", "make", "substantial", "investments", "in", "our", "earlier-stage", "drug", "candidate", "pipeline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p33_s8", "idA": "906709_14_item7_p16_s0", "sentA": "While the late stage clinical development programs described above are key elements of the future success of our company, we believe it is critically important that we continue to make substantial investments in our earlier-stage drug candidate pipeline.", "sentB": "In the future we expect to receive royalties from commercial sales of products such as MOVANTIK and BAX 855 (if approved) and substantial payments from future collaboration transactions if our later stage clinical development programs such as etirinotecan pegol and NKTR-181 have positive clinical outcomes.", "type": 2, "words": ["<tag1>", "While", "the", "late", "stage", "clinical", "development", "programs", "described", "above", "are", "key", "elements", "of", "the", "future", "success", "of", "our", "company,", "we", "believe", "it", "is", "critically", "important", "that", "we", "continue", "to", "make", "substantial", "investments", "in", "our", "earlier-stage", "drug", "candidate", "pipeline.", "<tag2>", "In", "the", "future", "we", "expect", "to", "receive", "royalties", "from", "commercial", "sales", "of", "products", "such", "as", "MOVANTIK", "and", "BAX", "855", "(if", "approved)", "and", "substantial", "payments", "from", "future", "collaboration", "transactions", "if", "our", "later", "stage", "clinical", "development", "programs", "such", "as", "etirinotecan", "pegol", "and", "NKTR-181", "have", "positive", "clinical", "outcomes.", "<tag3>"], "wordsA": ["While", "the", "late", "stage", "clinical", "development", "programs", "described", "above", "are", "key", "elements", "of", "the", "future", "success", "of", "our", "company,", "we", "believe", "it", "is", "critically", "important", "that", "we", "continue", "to", "make", "substantial", "investments", "in", "our", "earlier-stage", "drug", "candidate", "pipeline."], "wordsB": ["In", "the", "future", "we", "expect", "to", "receive", "royalties", "from", "commercial", "sales", "of", "products", "such", "as", "MOVANTIK", "and", "BAX", "855", "(if", "approved)", "and", "substantial", "payments", "from", "future", "collaboration", "transactions", "if", "our", "later", "stage", "clinical", "development", "programs", "such", "as", "etirinotecan", "pegol", "and", "NKTR-181", "have", "positive", "clinical", "outcomes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p11_s12", "idA": "906709_14_item7_p17_s0", "sentA": "In January 2014, we initiated a single-ascending dose Phase 1 clinical study of NKTR-171.", "sentB": "This year we plan to advance NKTR-214, an engineered immunostimulatory cytokine being developed for the treatment of solid tumors, into a Phase 1 clinical study.", "type": 2, "words": ["<tag1>", "In", "January", "2014,", "we", "initiated", "a", "single-ascending", "dose", "Phase", "1", "clinical", "study", "of", "NKTR-171.", "<tag2>", "This", "year", "we", "plan", "to", "advance", "NKTR-214,", "an", "engineered", "immunostimulatory", "cytokine", "being", "developed", "for", "the", "treatment", "of", "solid", "tumors,", "into", "a", "Phase", "1", "clinical", "study.", "<tag3>"], "wordsA": ["In", "January", "2014,", "we", "initiated", "a", "single-ascending", "dose", "Phase", "1", "clinical", "study", "of", "NKTR-171."], "wordsB": ["This", "year", "we", "plan", "to", "advance", "NKTR-214,", "an", "engineered", "immunostimulatory", "cytokine", "being", "developed", "for", "the", "treatment", "of", "solid", "tumors,", "into", "a", "Phase", "1", "clinical", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p11_s9", "idA": "906709_14_item7_p17_s1", "sentA": "Further, we have several drug candidates in research that we are preparing to advance into the clinic in future years.", "sentB": "We have several drug candidates in earlier stage clinical development or being explored in research that we are preparing to advance into the clinic in future years.", "type": 2, "words": ["<tag1>", "Further,", "we", "have", "several", "drug", "candidates", "in", "research", "that", "we", "are", "preparing", "to", "advance", "into", "the", "clinic", "in", "future", "years.", "<tag2>", "We", "have", "several", "drug", "candidates", "in", "earlier", "stage", "clinical", "development", "or", "being", "explored", "in", "research", "that", "we", "are", "preparing", "to", "advance", "into", "the", "clinic", "in", "future", "years.", "<tag3>"], "wordsA": ["Further,", "we", "have", "several", "drug", "candidates", "in", "research", "that", "we", "are", "preparing", "to", "advance", "into", "the", "clinic", "in", "future", "years."], "wordsB": ["We", "have", "several", "drug", "candidates", "in", "earlier", "stage", "clinical", "development", "or", "being", "explored", "in", "research", "that", "we", "are", "preparing", "to", "advance", "into", "the", "clinic", "in", "future", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p30_s4", "idA": "906709_14_item7_p17_s1", "sentA": "Further, we have several drug candidates in research that we are preparing to advance into the clinic in future years.", "sentB": "We would expect to incur significant costs related to these activities in 2015 and future years.", "type": 2, "words": ["<tag1>", "Further,", "we", "have", "several", "drug", "candidates", "in", "research", "that", "we", "are", "preparing", "to", "advance", "into", "the", "clinic", "in", "future", "years.", "<tag2>", "We", "would", "expect", "to", "incur", "significant", "costs", "related", "to", "these", "activities", "in", "2015", "and", "future", "years.", "<tag3>"], "wordsA": ["Further,", "we", "have", "several", "drug", "candidates", "in", "research", "that", "we", "are", "preparing", "to", "advance", "into", "the", "clinic", "in", "future", "years."], "wordsB": ["We", "would", "expect", "to", "incur", "significant", "costs", "related", "to", "these", "activities", "in", "2015", "and", "future", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p11_s15", "idA": "906709_14_item7_p17_s2", "sentA": "While we believe that our substantial investment in research and development has the potential to create significant value if one or more of our drug candidates demonstrate positive clinical results and receive regulatory approval in one or more major markets, drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval and the timing and outcome of clinical trial results are extremely difficult to predict.", "sentB": "While we believe that our substantial investment in research and development has the potential to create significant value if one or more of our drug candidates demonstrate positive clinical results, receive regulatory approval in one or more major markets and achieve commercialization success, drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval and the timing and outcome of clinical trial results are extremely difficult to predict.", "type": 2, "words": ["<tag1>", "While", "we", "believe", "that", "our", "substantial", "investment", "in", "research", "and", "development", "has", "the", "potential", "to", "create", "significant", "value", "if", "one", "or", "more", "of", "our", "drug", "candidates", "demonstrate", "positive", "clinical", "results", "and", "receive", "regulatory", "approval", "in", "one", "or", "more", "major", "markets,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "outcome", "of", "clinical", "trial", "results", "are", "extremely", "difficult", "to", "predict.", "<tag2>", "While", "we", "believe", "that", "our", "substantial", "investment", "in", "research", "and", "development", "has", "the", "potential", "to", "create", "significant", "value", "if", "one", "or", "more", "of", "our", "drug", "candidates", "demonstrate", "positive", "clinical", "results,", "receive", "regulatory", "approval", "in", "one", "or", "more", "major", "markets", "and", "achieve", "commercialization", "success,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "outcome", "of", "clinical", "trial", "results", "are", "extremely", "difficult", "to", "predict.", "<tag3>"], "wordsA": ["While", "we", "believe", "that", "our", "substantial", "investment", "in", "research", "and", "development", "has", "the", "potential", "to", "create", "significant", "value", "if", "one", "or", "more", "of", "our", "drug", "candidates", "demonstrate", "positive", "clinical", "results", "and", "receive", "regulatory", "approval", "in", "one", "or", "more", "major", "markets,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "outcome", "of", "clinical", "trial", "results", "are", "extremely", "difficult", "to", "predict."], "wordsB": ["While", "we", "believe", "that", "our", "substantial", "investment", "in", "research", "and", "development", "has", "the", "potential", "to", "create", "significant", "value", "if", "one", "or", "more", "of", "our", "drug", "candidates", "demonstrate", "positive", "clinical", "results,", "receive", "regulatory", "approval", "in", "one", "or", "more", "major", "markets", "and", "achieve", "commercialization", "success,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "outcome", "of", "clinical", "trial", "results", "are", "extremely", "difficult", "to", "predict."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p11_s16", "idA": "906709_14_item7_p17_s3", "sentA": "Clinical development successes and failures can have a disproportionate positive or negative impact on our scientific and medical prospects, financial prospects, financial condition, and market value.", "sentB": "Clinical development successes and failures can have a disproportionate positive or negative impact on our scientific and medical prospects, financial condition and prospects, results of operation and market value.", "type": 2, "words": ["<tag1>", "Clinical", "development", "successes", "and", "failures", "can", "have", "a", "disproportionate", "positive", "or", "negative", "impact", "on", "our", "scientific", "and", "medical", "prospects,", "financial", "prospects,", "financial", "condition,", "and", "market", "value.", "<tag2>", "Clinical", "development", "successes", "and", "failures", "can", "have", "a", "disproportionate", "positive", "or", "negative", "impact", "on", "our", "scientific", "and", "medical", "prospects,", "financial", "condition", "and", "prospects,", "results", "of", "operation", "and", "market", "value.", "<tag3>"], "wordsA": ["Clinical", "development", "successes", "and", "failures", "can", "have", "a", "disproportionate", "positive", "or", "negative", "impact", "on", "our", "scientific", "and", "medical", "prospects,", "financial", "prospects,", "financial", "condition,", "and", "market", "value."], "wordsB": ["Clinical", "development", "successes", "and", "failures", "can", "have", "a", "disproportionate", "positive", "or", "negative", "impact", "on", "our", "scientific", "and", "medical", "prospects,", "financial", "condition", "and", "prospects,", "results", "of", "operation", "and", "market", "value."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p12_s2", "idA": "906709_14_item7_p18_s2", "sentA": "Key Developments and Trends in Liquidity and Capital Resources As of December 31, 2013, we estimated that we had at least twelve months of working capital to fund our current business plans.", "sentB": "Key Developments and Trends in Liquidity and Capital Resources As of December 31, 2014, we estimated that we had at least twelve months of working capital to fund our current business plans.", "type": 2, "words": ["<tag1>", "Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "As", "of", "December", "31,", "2013,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans.", "<tag2>", "Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "As", "of", "December", "31,", "2014,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans.", "<tag3>"], "wordsA": ["Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "As", "of", "December", "31,", "2013,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans."], "wordsB": ["Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "As", "of", "December", "31,", "2014,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p13_s0", "idA": "906709_14_item7_p19_s0", "sentA": "The indebtedness includes $125.0 million in aggregate principal amount of 12.0% senior secured notes due July 15, 2017, but excludes our long-term liability relating to the sale of future royalties under the Purchase and Sale Agreement with RPI Finance Trust.", "sentB": "12.0% senior secured notes due July 15, 2017, but excludes our long-term liability relating to the sale of future royalties under the Purchase and Sale Agreement with RPI Finance Trust.", "type": 2, "words": ["<tag1>", "The", "indebtedness", "includes", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "15,", "2017,", "but", "excludes", "our", "long-term", "liability", "relating", "to", "the", "sale", "of", "future", "royalties", "under", "the", "Purchase", "and", "Sale", "Agreement", "with", "RPI", "Finance", "Trust.", "<tag2>", "12.0%", "senior", "secured", "notes", "due", "July", "15,", "2017,", "but", "excludes", "our", "long-term", "liability", "relating", "to", "the", "sale", "of", "future", "royalties", "under", "the", "Purchase", "and", "Sale", "Agreement", "with", "RPI", "Finance", "Trust.", "<tag3>"], "wordsA": ["The", "indebtedness", "includes", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "15,", "2017,", "but", "excludes", "our", "long-term", "liability", "relating", "to", "the", "sale", "of", "future", "royalties", "under", "the", "Purchase", "and", "Sale", "Agreement", "with", "RPI", "Finance", "Trust."], "wordsB": ["12.0%", "senior", "secured", "notes", "due", "July", "15,", "2017,", "but", "excludes", "our", "long-term", "liability", "relating", "to", "the", "sale", "of", "future", "royalties", "under", "the", "Purchase", "and", "Sale", "Agreement", "with", "RPI", "Finance", "Trust."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p35_s8", "idA": "906709_14_item7_p19_s2", "sentA": "On January 28, 2014, we completed the issuance and sale of 9,775,000 shares of our common stock with gross proceeds of approximately $117.2 million.", "sentB": "On January 28, 2014, we completed the issuance and sale of 9,775,000 shares of our common stock in a public offering with total proceeds of approximately $117.2 million after deducting the underwriting commissions and discounts of approximately $7.5 million.", "type": 2, "words": ["<tag1>", "On", "January", "28,", "2014,", "we", "completed", "the", "issuance", "and", "sale", "of", "9,775,000", "shares", "of", "our", "common", "stock", "with", "gross", "proceeds", "of", "approximately", "$117.2", "million.", "<tag2>", "On", "January", "28,", "2014,", "we", "completed", "the", "issuance", "and", "sale", "of", "9,775,000", "shares", "of", "our", "common", "stock", "in", "a", "public", "offering", "with", "total", "proceeds", "of", "approximately", "$117.2", "million", "after", "deducting", "the", "underwriting", "commissions", "and", "discounts", "of", "approximately", "$7.5", "million.", "<tag3>"], "wordsA": ["On", "January", "28,", "2014,", "we", "completed", "the", "issuance", "and", "sale", "of", "9,775,000", "shares", "of", "our", "common", "stock", "with", "gross", "proceeds", "of", "approximately", "$117.2", "million."], "wordsB": ["On", "January", "28,", "2014,", "we", "completed", "the", "issuance", "and", "sale", "of", "9,775,000", "shares", "of", "our", "common", "stock", "in", "a", "public", "offering", "with", "total", "proceeds", "of", "approximately", "$117.2", "million", "after", "deducting", "the", "underwriting", "commissions", "and", "discounts", "of", "approximately", "$7.5", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p44_s1", "idA": "906709_14_item7_p19_s6", "sentA": "The amount of upfront fees received under our license and collaboration agreements allocated to continuing obligations, such as manufacturing and supply commitments, are recognized ratably over our expected performance period under the arrangement.", "sentB": "The amount of upfront fees and other payments received under our license and collaboration agreements that are allocated to our continuing obligations are recognized ratably over our expected performance period under each arrangement.", "type": 2, "words": ["<tag1>", "The", "amount", "of", "upfront", "fees", "received", "under", "our", "license", "and", "collaboration", "agreements", "allocated", "to", "continuing", "obligations,", "such", "as", "manufacturing", "and", "supply", "commitments,", "are", "recognized", "ratably", "over", "our", "expected", "performance", "period", "under", "the", "arrangement.", "<tag2>", "The", "amount", "of", "upfront", "fees", "and", "other", "payments", "received", "under", "our", "license", "and", "collaboration", "agreements", "that", "are", "allocated", "to", "our", "continuing", "obligations", "are", "recognized", "ratably", "over", "our", "expected", "performance", "period", "under", "each", "arrangement.", "<tag3>"], "wordsA": ["The", "amount", "of", "upfront", "fees", "received", "under", "our", "license", "and", "collaboration", "agreements", "allocated", "to", "continuing", "obligations,", "such", "as", "manufacturing", "and", "supply", "commitments,", "are", "recognized", "ratably", "over", "our", "expected", "performance", "period", "under", "the", "arrangement."], "wordsB": ["The", "amount", "of", "upfront", "fees", "and", "other", "payments", "received", "under", "our", "license", "and", "collaboration", "agreements", "that", "are", "allocated", "to", "our", "continuing", "obligations", "are", "recognized", "ratably", "over", "our", "expected", "performance", "period", "under", "each", "arrangement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p52_s1", "idA": "906709_14_item7_p19_s9", "sentA": "Given the uncertainties in research and development collaborations, significant judgment is required by us to determine the performance periods.", "sentB": "However, additional information may become available to us which may allow us to make a more accurate estimate in future periods.", "type": 2, "words": ["<tag1>", "Given", "the", "uncertainties", "in", "research", "and", "development", "collaborations,", "significant", "judgment", "is", "required", "by", "us", "to", "determine", "the", "performance", "periods.", "<tag2>", "However,", "additional", "information", "may", "become", "available", "to", "us", "which", "may", "allow", "us", "to", "make", "a", "more", "accurate", "estimate", "in", "future", "periods.", "<tag3>"], "wordsA": ["Given", "the", "uncertainties", "in", "research", "and", "development", "collaborations,", "significant", "judgment", "is", "required", "by", "us", "to", "determine", "the", "performance", "periods."], "wordsB": ["However,", "additional", "information", "may", "become", "available", "to", "us", "which", "may", "allow", "us", "to", "make", "a", "more", "accurate", "estimate", "in", "future", "periods."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p52_s3", "idA": "906709_14_item7_p19_s9", "sentA": "Given the uncertainties in research and development collaborations, significant judgment is required by us to determine the performance periods.", "sentB": "Such increases or decreases in cost are generally considered to be changes in estimates and will be reflected in research and development expenses in the period first identified.", "type": 2, "words": ["<tag1>", "Given", "the", "uncertainties", "in", "research", "and", "development", "collaborations,", "significant", "judgment", "is", "required", "by", "us", "to", "determine", "the", "performance", "periods.", "<tag2>", "Such", "increases", "or", "decreases", "in", "cost", "are", "generally", "considered", "to", "be", "changes", "in", "estimates", "and", "will", "be", "reflected", "in", "research", "and", "development", "expenses", "in", "the", "period", "first", "identified.", "<tag3>"], "wordsA": ["Given", "the", "uncertainties", "in", "research", "and", "development", "collaborations,", "significant", "judgment", "is", "required", "by", "us", "to", "determine", "the", "performance", "periods."], "wordsB": ["Such", "increases", "or", "decreases", "in", "cost", "are", "generally", "considered", "to", "be", "changes", "in", "estimates", "and", "will", "be", "reflected", "in", "research", "and", "development", "expenses", "in", "the", "period", "first", "identified."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p1_s0", "idA": "906709_14_item7_p1_s0", "sentA": "Polymer chemistry is a science focused on the synthesis or bonding of polymer architectures with drug molecules to alter the properties of a molecule when it is bonded with polymers.", "sentB": "Polymer chemistry is a science focused on the synthesis or bonding of polymer architectures with drug molecules to alter the properties of a molecule.", "type": 2, "words": ["<tag1>", "Polymer", "chemistry", "is", "a", "science", "focused", "on", "the", "synthesis", "or", "bonding", "of", "polymer", "architectures", "with", "drug", "molecules", "to", "alter", "the", "properties", "of", "a", "molecule", "when", "it", "is", "bonded", "with", "polymers.", "<tag2>", "Polymer", "chemistry", "is", "a", "science", "focused", "on", "the", "synthesis", "or", "bonding", "of", "polymer", "architectures", "with", "drug", "molecules", "to", "alter", "the", "properties", "of", "a", "molecule.", "<tag3>"], "wordsA": ["Polymer", "chemistry", "is", "a", "science", "focused", "on", "the", "synthesis", "or", "bonding", "of", "polymer", "architectures", "with", "drug", "molecules", "to", "alter", "the", "properties", "of", "a", "molecule", "when", "it", "is", "bonded", "with", "polymers."], "wordsB": ["Polymer", "chemistry", "is", "a", "science", "focused", "on", "the", "synthesis", "or", "bonding", "of", "polymer", "architectures", "with", "drug", "molecules", "to", "alter", "the", "properties", "of", "a", "molecule."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p14_s0", "idA": "906709_14_item7_p20_s0", "sentA": "Product sales Product sales include fixed price and cost-plus manufacturing and supply agreements with our collaboration partners.", "sentB": "Product sales Product sales include fixed price and cost-plus manufacturing and supply agreements with our collaboration partners and result from the receipt of firm purchase orders from those partners.", "type": 2, "words": ["<tag1>", "Product", "sales", "Product", "sales", "include", "fixed", "price", "and", "cost-plus", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners.", "<tag2>", "Product", "sales", "Product", "sales", "include", "fixed", "price", "and", "cost-plus", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners", "and", "result", "from", "the", "receipt", "of", "firm", "purchase", "orders", "from", "those", "partners.", "<tag3>"], "wordsA": ["Product", "sales", "Product", "sales", "include", "fixed", "price", "and", "cost-plus", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners."], "wordsB": ["Product", "sales", "Product", "sales", "include", "fixed", "price", "and", "cost-plus", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners", "and", "result", "from", "the", "receipt", "of", "firm", "purchase", "orders", "from", "those", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p20_s4", "idA": "906709_14_item7_p21_s0", "sentA": "Product sales increased for the year ended December 31, 2013 compared to the year ended December 31, 2012 primarily as a result of an $9.0 million increase in product sales to one of our collaboration partners.", "sentB": "The manufacturing arrangement with one of our collaboration partners includes a fixed price for proprietary pegylation reagent sales, which is less than the fully burdened manufacturing cost for the reagent in 2014 and this situation is expected to continue in future years.", "type": 2, "words": ["<tag1>", "Product", "sales", "increased", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "as", "a", "result", "of", "an", "$9.0", "million", "increase", "in", "product", "sales", "to", "one", "of", "our", "collaboration", "partners.", "<tag2>", "The", "manufacturing", "arrangement", "with", "one", "of", "our", "collaboration", "partners", "includes", "a", "fixed", "price", "for", "proprietary", "pegylation", "reagent", "sales,", "which", "is", "less", "than", "the", "fully", "burdened", "manufacturing", "cost", "for", "the", "reagent", "in", "2014", "and", "this", "situation", "is", "expected", "to", "continue", "in", "future", "years.", "<tag3>"], "wordsA": ["Product", "sales", "increased", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "as", "a", "result", "of", "an", "$9.0", "million", "increase", "in", "product", "sales", "to", "one", "of", "our", "collaboration", "partners."], "wordsB": ["The", "manufacturing", "arrangement", "with", "one", "of", "our", "collaboration", "partners", "includes", "a", "fixed", "price", "for", "proprietary", "pegylation", "reagent", "sales,", "which", "is", "less", "than", "the", "fully", "burdened", "manufacturing", "cost", "for", "the", "reagent", "in", "2014", "and", "this", "situation", "is", "expected", "to", "continue", "in", "future", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p15_s0", "idA": "906709_14_item7_p21_s1", "sentA": "Product sales increased during the year ended December 31, 2012 compared to the year ended December 31, 2011 as a result of increased product demand from a number of our collaboration partners.", "sentB": "Product sales decreased for the year ended December 31, 2014 compared to the year ended December 31, 2013 primarily as a result of decreased product demand from a number of our collaboration partners.", "type": 2, "words": ["<tag1>", "Product", "sales", "increased", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "as", "a", "result", "of", "increased", "product", "demand", "from", "a", "number", "of", "our", "collaboration", "partners.", "<tag2>", "Product", "sales", "decreased", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "as", "a", "result", "of", "decreased", "product", "demand", "from", "a", "number", "of", "our", "collaboration", "partners.", "<tag3>"], "wordsA": ["Product", "sales", "increased", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "as", "a", "result", "of", "increased", "product", "demand", "from", "a", "number", "of", "our", "collaboration", "partners."], "wordsB": ["Product", "sales", "decreased", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "as", "a", "result", "of", "decreased", "product", "demand", "from", "a", "number", "of", "our", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p15_s2", "idA": "906709_14_item7_p22_s0", "sentA": "We currently expect product sales to decrease substantially in 2014 as compared to 2013 due to decreased product demand from our collaboration partners.", "sentB": "We currently expect product sales to increase in 2015 as compared to 2014 due to increased product demand from a number of our collaboration partners.", "type": 2, "words": ["<tag1>", "We", "currently", "expect", "product", "sales", "to", "decrease", "substantially", "in", "2014", "as", "compared", "to", "2013", "due", "to", "decreased", "product", "demand", "from", "our", "collaboration", "partners.", "<tag2>", "We", "currently", "expect", "product", "sales", "to", "increase", "in", "2015", "as", "compared", "to", "2014", "due", "to", "increased", "product", "demand", "from", "a", "number", "of", "our", "collaboration", "partners.", "<tag3>"], "wordsA": ["We", "currently", "expect", "product", "sales", "to", "decrease", "substantially", "in", "2014", "as", "compared", "to", "2013", "due", "to", "decreased", "product", "demand", "from", "our", "collaboration", "partners."], "wordsB": ["We", "currently", "expect", "product", "sales", "to", "increase", "in", "2015", "as", "compared", "to", "2014", "due", "to", "increased", "product", "demand", "from", "a", "number", "of", "our", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p21_s1", "idA": "906709_14_item7_p22_s1", "sentA": "We receive royalty revenue from certain of our collaboration partners based on their net sales of commercial products.", "sentB": "In 2014, the royalty revenue from the collaboration exceeded the related negative gross profit.", "type": 2, "words": ["<tag1>", "We", "receive", "royalty", "revenue", "from", "certain", "of", "our", "collaboration", "partners", "based", "on", "their", "net", "sales", "of", "commercial", "products.", "<tag2>", "In", "2014,", "the", "royalty", "revenue", "from", "the", "collaboration", "exceeded", "the", "related", "negative", "gross", "profit.", "<tag3>"], "wordsA": ["We", "receive", "royalty", "revenue", "from", "certain", "of", "our", "collaboration", "partners", "based", "on", "their", "net", "sales", "of", "commercial", "products."], "wordsB": ["In", "2014,", "the", "royalty", "revenue", "from", "the", "collaboration", "exceeded", "the", "related", "negative", "gross", "profit."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p16_s1", "idA": "906709_14_item7_p22_s2", "sentA": "Royalty revenue received in cash decreased during the year ended December 31, 2013 compared to the year ended December 31, 2012 and decreased during the year ended December 31, 2012 compared to the year ended December 31, 2011 primarily as a result of the sale of our rights to receive the royalties from product sales of UCB s CIMZIA and Roche s MIRCERA as is further described below.", "sentB": "Royalty revenue decreased during the year ended December 31, 2013 compared to the year ended December 31, 2012 primarily as a result of the sale of our rights to receive the royalties from product sales of UCB s CIMZIA and Roche s MIRCERA as is further described below.", "type": 2, "words": ["<tag1>", "Royalty", "revenue", "received", "in", "cash", "decreased", "during", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "and", "decreased", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "primarily", "as", "a", "result", "of", "the", "sale", "of", "our", "rights", "to", "receive", "the", "royalties", "from", "product", "sales", "of", "UCB", "s", "CIMZIA", "and", "Roche", "s", "MIRCERA", "as", "is", "further", "described", "below.", "<tag2>", "Royalty", "revenue", "decreased", "during", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "as", "a", "result", "of", "the", "sale", "of", "our", "rights", "to", "receive", "the", "royalties", "from", "product", "sales", "of", "UCB", "s", "CIMZIA", "and", "Roche", "s", "MIRCERA", "as", "is", "further", "described", "below.", "<tag3>"], "wordsA": ["Royalty", "revenue", "received", "in", "cash", "decreased", "during", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "and", "decreased", "during", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "primarily", "as", "a", "result", "of", "the", "sale", "of", "our", "rights", "to", "receive", "the", "royalties", "from", "product", "sales", "of", "UCB", "s", "CIMZIA", "and", "Roche", "s", "MIRCERA", "as", "is", "further", "described", "below."], "wordsB": ["Royalty", "revenue", "decreased", "during", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "as", "a", "result", "of", "the", "sale", "of", "our", "rights", "to", "receive", "the", "royalties", "from", "product", "sales", "of", "UCB", "s", "CIMZIA", "and", "Roche", "s", "MIRCERA", "as", "is", "further", "described", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p17_s1", "idA": "906709_14_item7_p22_s4", "sentA": "We expect royalty revenue received in cash to decrease in 2014 as compared to 2013.", "sentB": "If sales of MOVANTIK (and/or MOVENTIG ) are initiated during 2015, we expect royalty revenue received in cash will increase in 2015 as compared to 2014 due to royalties we expect to receive from net sales of MOVANTIK .", "type": 2, "words": ["<tag1>", "We", "expect", "royalty", "revenue", "received", "in", "cash", "to", "decrease", "in", "2014", "as", "compared", "to", "2013.", "<tag2>", "If", "sales", "of", "MOVANTIK", "(and/or", "MOVENTIG", ")", "are", "initiated", "during", "2015,", "we", "expect", "royalty", "revenue", "received", "in", "cash", "will", "increase", "in", "2015", "as", "compared", "to", "2014", "due", "to", "royalties", "we", "expect", "to", "receive", "from", "net", "sales", "of", "MOVANTIK", ".", "<tag3>"], "wordsA": ["We", "expect", "royalty", "revenue", "received", "in", "cash", "to", "decrease", "in", "2014", "as", "compared", "to", "2013."], "wordsB": ["If", "sales", "of", "MOVANTIK", "(and/or", "MOVENTIG", ")", "are", "initiated", "during", "2015,", "we", "expect", "royalty", "revenue", "received", "in", "cash", "will", "increase", "in", "2015", "as", "compared", "to", "2014", "due", "to", "royalties", "we", "expect", "to", "receive", "from", "net", "sales", "of", "MOVANTIK", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p17_s5", "idA": "906709_14_item7_p22_s9", "sentA": "We expect non-cash royalties from net sales of CIMZIA and MIRCERA to decrease slightly in 2014 as compared to 2013.", "sentB": "We expect non-cash royalties from net sales of CIMZIA and MIRCERA in 2015 to be consistent with 2014.", "type": 2, "words": ["<tag1>", "We", "expect", "non-cash", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "to", "decrease", "slightly", "in", "2014", "as", "compared", "to", "2013.", "<tag2>", "We", "expect", "non-cash", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "in", "2015", "to", "be", "consistent", "with", "2014.", "<tag3>"], "wordsA": ["We", "expect", "non-cash", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "to", "decrease", "slightly", "in", "2014", "as", "compared", "to", "2013."], "wordsB": ["We", "expect", "non-cash", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "in", "2015", "to", "be", "consistent", "with", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p17_s10", "idA": "906709_14_item7_p23_s2", "sentA": "License, collaboration and other revenue increased for the year ended December 31, 2013 compared to the year ended December 31, 2012 primarily as a result of the recognition of a $25.0 million payment from AstraZeneca achieved in September 2013 on the acceptance for review by the EMA of the naloxegol regulatory approval application filed by AstraZeneca, the recognition of a $10.0 million milestone achieved upon the start of the Amikacin Inhale Phase 3 clinical trial by Bayer in April 2013, the recognition of $7.9 million related to the delivery of additional quantities of our proprietary PEGylation reagent to Roche in the fourth quarter of 2013, and the recognition of the remaining $6.7 million deferred revenue balance related to our agreement with Affymax as a result of the termination of that agreement.", "sentB": "These increases in 2014 as compared to 2013 were partially offset by the recognition in 2013 of a $25.0 million payment from AstraZeneca achieved in September 2013 on the acceptance for review by the EMA of the MOVANTIK regulatory approval application filed by AstraZeneca as well as the recognition in July 2013 of the remaining $6.7 million deferred revenue balance related to our agreement with Affymax as a result of the termination of that agreement.", "type": 2, "words": ["<tag1>", "License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "a", "$25.0", "million", "payment", "from", "AstraZeneca", "achieved", "in", "September", "2013", "on", "the", "acceptance", "for", "review", "by", "the", "EMA", "of", "the", "naloxegol", "regulatory", "approval", "application", "filed", "by", "AstraZeneca,", "the", "recognition", "of", "a", "$10.0", "million", "milestone", "achieved", "upon", "the", "start", "of", "the", "Amikacin", "Inhale", "Phase", "3", "clinical", "trial", "by", "Bayer", "in", "April", "2013,", "the", "recognition", "of", "$7.9", "million", "related", "to", "the", "delivery", "of", "additional", "quantities", "of", "our", "proprietary", "PEGylation", "reagent", "to", "Roche", "in", "the", "fourth", "quarter", "of", "2013,", "and", "the", "recognition", "of", "the", "remaining", "$6.7", "million", "deferred", "revenue", "balance", "related", "to", "our", "agreement", "with", "Affymax", "as", "a", "result", "of", "the", "termination", "of", "that", "agreement.", "<tag2>", "These", "increases", "in", "2014", "as", "compared", "to", "2013", "were", "partially", "offset", "by", "the", "recognition", "in", "2013", "of", "a", "$25.0", "million", "payment", "from", "AstraZeneca", "achieved", "in", "September", "2013", "on", "the", "acceptance", "for", "review", "by", "the", "EMA", "of", "the", "MOVANTIK", "regulatory", "approval", "application", "filed", "by", "AstraZeneca", "as", "well", "as", "the", "recognition", "in", "July", "2013", "of", "the", "remaining", "$6.7", "million", "deferred", "revenue", "balance", "related", "to", "our", "agreement", "with", "Affymax", "as", "a", "result", "of", "the", "termination", "of", "that", "agreement.", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "a", "$25.0", "million", "payment", "from", "AstraZeneca", "achieved", "in", "September", "2013", "on", "the", "acceptance", "for", "review", "by", "the", "EMA", "of", "the", "naloxegol", "regulatory", "approval", "application", "filed", "by", "AstraZeneca,", "the", "recognition", "of", "a", "$10.0", "million", "milestone", "achieved", "upon", "the", "start", "of", "the", "Amikacin", "Inhale", "Phase", "3", "clinical", "trial", "by", "Bayer", "in", "April", "2013,", "the", "recognition", "of", "$7.9", "million", "related", "to", "the", "delivery", "of", "additional", "quantities", "of", "our", "proprietary", "PEGylation", "reagent", "to", "Roche", "in", "the", "fourth", "quarter", "of", "2013,", "and", "the", "recognition", "of", "the", "remaining", "$6.7", "million", "deferred", "revenue", "balance", "related", "to", "our", "agreement", "with", "Affymax", "as", "a", "result", "of", "the", "termination", "of", "that", "agreement."], "wordsB": ["These", "increases", "in", "2014", "as", "compared", "to", "2013", "were", "partially", "offset", "by", "the", "recognition", "in", "2013", "of", "a", "$25.0", "million", "payment", "from", "AstraZeneca", "achieved", "in", "September", "2013", "on", "the", "acceptance", "for", "review", "by", "the", "EMA", "of", "the", "MOVANTIK", "regulatory", "approval", "application", "filed", "by", "AstraZeneca", "as", "well", "as", "the", "recognition", "in", "July", "2013", "of", "the", "remaining", "$6.7", "million", "deferred", "revenue", "balance", "related", "to", "our", "agreement", "with", "Affymax", "as", "a", "result", "of", "the", "termination", "of", "that", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p17_s11", "idA": "906709_14_item7_p23_s2", "sentA": "License, collaboration and other revenue increased for the year ended December 31, 2013 compared to the year ended December 31, 2012 primarily as a result of the recognition of a $25.0 million payment from AstraZeneca achieved in September 2013 on the acceptance for review by the EMA of the naloxegol regulatory approval application filed by AstraZeneca, the recognition of a $10.0 million milestone achieved upon the start of the Amikacin Inhale Phase 3 clinical trial by Bayer in April 2013, the recognition of $7.9 million related to the delivery of additional quantities of our proprietary PEGylation reagent to Roche in the fourth quarter of 2013, and the recognition of the remaining $6.7 million deferred revenue balance related to our agreement with Affymax as a result of the termination of that agreement.", "sentB": "In addition, in April 2013, we recognized a $10.0 million milestone achieved upon the start of the Amikacin Inhale Phase 3 clinical trial by Bayer.", "type": 2, "words": ["<tag1>", "License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "a", "$25.0", "million", "payment", "from", "AstraZeneca", "achieved", "in", "September", "2013", "on", "the", "acceptance", "for", "review", "by", "the", "EMA", "of", "the", "naloxegol", "regulatory", "approval", "application", "filed", "by", "AstraZeneca,", "the", "recognition", "of", "a", "$10.0", "million", "milestone", "achieved", "upon", "the", "start", "of", "the", "Amikacin", "Inhale", "Phase", "3", "clinical", "trial", "by", "Bayer", "in", "April", "2013,", "the", "recognition", "of", "$7.9", "million", "related", "to", "the", "delivery", "of", "additional", "quantities", "of", "our", "proprietary", "PEGylation", "reagent", "to", "Roche", "in", "the", "fourth", "quarter", "of", "2013,", "and", "the", "recognition", "of", "the", "remaining", "$6.7", "million", "deferred", "revenue", "balance", "related", "to", "our", "agreement", "with", "Affymax", "as", "a", "result", "of", "the", "termination", "of", "that", "agreement.", "<tag2>", "In", "addition,", "in", "April", "2013,", "we", "recognized", "a", "$10.0", "million", "milestone", "achieved", "upon", "the", "start", "of", "the", "Amikacin", "Inhale", "Phase", "3", "clinical", "trial", "by", "Bayer.", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "a", "$25.0", "million", "payment", "from", "AstraZeneca", "achieved", "in", "September", "2013", "on", "the", "acceptance", "for", "review", "by", "the", "EMA", "of", "the", "naloxegol", "regulatory", "approval", "application", "filed", "by", "AstraZeneca,", "the", "recognition", "of", "a", "$10.0", "million", "milestone", "achieved", "upon", "the", "start", "of", "the", "Amikacin", "Inhale", "Phase", "3", "clinical", "trial", "by", "Bayer", "in", "April", "2013,", "the", "recognition", "of", "$7.9", "million", "related", "to", "the", "delivery", "of", "additional", "quantities", "of", "our", "proprietary", "PEGylation", "reagent", "to", "Roche", "in", "the", "fourth", "quarter", "of", "2013,", "and", "the", "recognition", "of", "the", "remaining", "$6.7", "million", "deferred", "revenue", "balance", "related", "to", "our", "agreement", "with", "Affymax", "as", "a", "result", "of", "the", "termination", "of", "that", "agreement."], "wordsB": ["In", "addition,", "in", "April", "2013,", "we", "recognized", "a", "$10.0", "million", "milestone", "achieved", "upon", "the", "start", "of", "the", "Amikacin", "Inhale", "Phase", "3", "clinical", "trial", "by", "Bayer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p17_s12", "idA": "906709_14_item7_p23_s2", "sentA": "License, collaboration and other revenue increased for the year ended December 31, 2013 compared to the year ended December 31, 2012 primarily as a result of the recognition of a $25.0 million payment from AstraZeneca achieved in September 2013 on the acceptance for review by the EMA of the naloxegol regulatory approval application filed by AstraZeneca, the recognition of a $10.0 million milestone achieved upon the start of the Amikacin Inhale Phase 3 clinical trial by Bayer in April 2013, the recognition of $7.9 million related to the delivery of additional quantities of our proprietary PEGylation reagent to Roche in the fourth quarter of 2013, and the recognition of the remaining $6.7 million deferred revenue balance related to our agreement with Affymax as a result of the termination of that agreement.", "sentB": "License, collaboration and other revenue increased for the year ended December 31, 2013 compared to the year ended December 31, 2012 primarily as a result of the recognition of a $25.0 million payment from AstraZeneca achieved in September 2013, the recognition of the $10.0 million milestone achieved upon the start of the Amikacin Inhale Phase 3 clinical trial by Bayer in April 2013, and the recognition of the remaining $6.7 million deferred revenue balance related to our agreement with Affymax as noted above.", "type": 2, "words": ["<tag1>", "License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "a", "$25.0", "million", "payment", "from", "AstraZeneca", "achieved", "in", "September", "2013", "on", "the", "acceptance", "for", "review", "by", "the", "EMA", "of", "the", "naloxegol", "regulatory", "approval", "application", "filed", "by", "AstraZeneca,", "the", "recognition", "of", "a", "$10.0", "million", "milestone", "achieved", "upon", "the", "start", "of", "the", "Amikacin", "Inhale", "Phase", "3", "clinical", "trial", "by", "Bayer", "in", "April", "2013,", "the", "recognition", "of", "$7.9", "million", "related", "to", "the", "delivery", "of", "additional", "quantities", "of", "our", "proprietary", "PEGylation", "reagent", "to", "Roche", "in", "the", "fourth", "quarter", "of", "2013,", "and", "the", "recognition", "of", "the", "remaining", "$6.7", "million", "deferred", "revenue", "balance", "related", "to", "our", "agreement", "with", "Affymax", "as", "a", "result", "of", "the", "termination", "of", "that", "agreement.", "<tag2>", "License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "a", "$25.0", "million", "payment", "from", "AstraZeneca", "achieved", "in", "September", "2013,", "the", "recognition", "of", "the", "$10.0", "million", "milestone", "achieved", "upon", "the", "start", "of", "the", "Amikacin", "Inhale", "Phase", "3", "clinical", "trial", "by", "Bayer", "in", "April", "2013,", "and", "the", "recognition", "of", "the", "remaining", "$6.7", "million", "deferred", "revenue", "balance", "related", "to", "our", "agreement", "with", "Affymax", "as", "noted", "above.", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "a", "$25.0", "million", "payment", "from", "AstraZeneca", "achieved", "in", "September", "2013", "on", "the", "acceptance", "for", "review", "by", "the", "EMA", "of", "the", "naloxegol", "regulatory", "approval", "application", "filed", "by", "AstraZeneca,", "the", "recognition", "of", "a", "$10.0", "million", "milestone", "achieved", "upon", "the", "start", "of", "the", "Amikacin", "Inhale", "Phase", "3", "clinical", "trial", "by", "Bayer", "in", "April", "2013,", "the", "recognition", "of", "$7.9", "million", "related", "to", "the", "delivery", "of", "additional", "quantities", "of", "our", "proprietary", "PEGylation", "reagent", "to", "Roche", "in", "the", "fourth", "quarter", "of", "2013,", "and", "the", "recognition", "of", "the", "remaining", "$6.7", "million", "deferred", "revenue", "balance", "related", "to", "our", "agreement", "with", "Affymax", "as", "a", "result", "of", "the", "termination", "of", "that", "agreement."], "wordsB": ["License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "a", "$25.0", "million", "payment", "from", "AstraZeneca", "achieved", "in", "September", "2013,", "the", "recognition", "of", "the", "$10.0", "million", "milestone", "achieved", "upon", "the", "start", "of", "the", "Amikacin", "Inhale", "Phase", "3", "clinical", "trial", "by", "Bayer", "in", "April", "2013,", "and", "the", "recognition", "of", "the", "remaining", "$6.7", "million", "deferred", "revenue", "balance", "related", "to", "our", "agreement", "with", "Affymax", "as", "noted", "above."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p17_s13", "idA": "906709_14_item7_p23_s2", "sentA": "License, collaboration and other revenue increased for the year ended December 31, 2013 compared to the year ended December 31, 2012 primarily as a result of the recognition of a $25.0 million payment from AstraZeneca achieved in September 2013 on the acceptance for review by the EMA of the naloxegol regulatory approval application filed by AstraZeneca, the recognition of a $10.0 million milestone achieved upon the start of the Amikacin Inhale Phase 3 clinical trial by Bayer in April 2013, the recognition of $7.9 million related to the delivery of additional quantities of our proprietary PEGylation reagent to Roche in the fourth quarter of 2013, and the recognition of the remaining $6.7 million deferred revenue balance related to our agreement with Affymax as a result of the termination of that agreement.", "sentB": "In addition, we recognized $7.9 million related to the delivery of additional quantities of our proprietary PEGylation reagent to Roche in the fourth quarter of 2013.", "type": 2, "words": ["<tag1>", "License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "a", "$25.0", "million", "payment", "from", "AstraZeneca", "achieved", "in", "September", "2013", "on", "the", "acceptance", "for", "review", "by", "the", "EMA", "of", "the", "naloxegol", "regulatory", "approval", "application", "filed", "by", "AstraZeneca,", "the", "recognition", "of", "a", "$10.0", "million", "milestone", "achieved", "upon", "the", "start", "of", "the", "Amikacin", "Inhale", "Phase", "3", "clinical", "trial", "by", "Bayer", "in", "April", "2013,", "the", "recognition", "of", "$7.9", "million", "related", "to", "the", "delivery", "of", "additional", "quantities", "of", "our", "proprietary", "PEGylation", "reagent", "to", "Roche", "in", "the", "fourth", "quarter", "of", "2013,", "and", "the", "recognition", "of", "the", "remaining", "$6.7", "million", "deferred", "revenue", "balance", "related", "to", "our", "agreement", "with", "Affymax", "as", "a", "result", "of", "the", "termination", "of", "that", "agreement.", "<tag2>", "In", "addition,", "we", "recognized", "$7.9", "million", "related", "to", "the", "delivery", "of", "additional", "quantities", "of", "our", "proprietary", "PEGylation", "reagent", "to", "Roche", "in", "the", "fourth", "quarter", "of", "2013.", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "a", "$25.0", "million", "payment", "from", "AstraZeneca", "achieved", "in", "September", "2013", "on", "the", "acceptance", "for", "review", "by", "the", "EMA", "of", "the", "naloxegol", "regulatory", "approval", "application", "filed", "by", "AstraZeneca,", "the", "recognition", "of", "a", "$10.0", "million", "milestone", "achieved", "upon", "the", "start", "of", "the", "Amikacin", "Inhale", "Phase", "3", "clinical", "trial", "by", "Bayer", "in", "April", "2013,", "the", "recognition", "of", "$7.9", "million", "related", "to", "the", "delivery", "of", "additional", "quantities", "of", "our", "proprietary", "PEGylation", "reagent", "to", "Roche", "in", "the", "fourth", "quarter", "of", "2013,", "and", "the", "recognition", "of", "the", "remaining", "$6.7", "million", "deferred", "revenue", "balance", "related", "to", "our", "agreement", "with", "Affymax", "as", "a", "result", "of", "the", "termination", "of", "that", "agreement."], "wordsB": ["In", "addition,", "we", "recognized", "$7.9", "million", "related", "to", "the", "delivery", "of", "additional", "quantities", "of", "our", "proprietary", "PEGylation", "reagent", "to", "Roche", "in", "the", "fourth", "quarter", "of", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p17_s8", "idA": "906709_14_item7_p23_s3", "sentA": "License, collaboration and other revenue for the year ended December 31, 2012 decreased compared to the year ended December 31, 2011 primarily due to the recognition in 2011 of a $5.0 million license fee from an agreement signed in September 2011.", "sentB": "License, collaboration and other revenue increased for the year ended December 31, 2014 compared to the year ended December 31, 2013 primarily as a result of the recognition in 2014 of the $35.0 million and $70.0 million milestone payments received in October 2014 and November 2013, respectively, from AstraZeneca as a result of the FDA s approval of MOVANTIK in September 2014.", "type": 2, "words": ["<tag1>", "License,", "collaboration", "and", "other", "revenue", "for", "the", "year", "ended", "December", "31,", "2012", "decreased", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "primarily", "due", "to", "the", "recognition", "in", "2011", "of", "a", "$5.0", "million", "license", "fee", "from", "an", "agreement", "signed", "in", "September", "2011.", "<tag2>", "License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "as", "a", "result", "of", "the", "recognition", "in", "2014", "of", "the", "$35.0", "million", "and", "$70.0", "million", "milestone", "payments", "received", "in", "October", "2014", "and", "November", "2013,", "respectively,", "from", "AstraZeneca", "as", "a", "result", "of", "the", "FDA", "s", "approval", "of", "MOVANTIK", "in", "September", "2014.", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "revenue", "for", "the", "year", "ended", "December", "31,", "2012", "decreased", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "primarily", "due", "to", "the", "recognition", "in", "2011", "of", "a", "$5.0", "million", "license", "fee", "from", "an", "agreement", "signed", "in", "September", "2011."], "wordsB": ["License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "as", "a", "result", "of", "the", "recognition", "in", "2014", "of", "the", "$35.0", "million", "and", "$70.0", "million", "milestone", "payments", "received", "in", "October", "2014", "and", "November", "2013,", "respectively,", "from", "AstraZeneca", "as", "a", "result", "of", "the", "FDA", "s", "approval", "of", "MOVANTIK", "in", "September", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p17_s14", "idA": "906709_14_item7_p23_s4", "sentA": "We expect license, collaboration and other revenue in 2014 will be significantly impacted by the outcome and timing of the naloxegol regulatory review events.", "sentB": "We expect license, collaboration and other revenue in 2015 will be significantly impacted by the outcome and timing of AstraZeneca s launch of MOVANTIK as we are entitled to $140.0 million of development milestone payments due upon the commercial launches of MOVANTIK in the U.S. ($100.0 million) and in the E.U. ($40.0 million).", "type": 2, "words": ["<tag1>", "We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2014", "will", "be", "significantly", "impacted", "by", "the", "outcome", "and", "timing", "of", "the", "naloxegol", "regulatory", "review", "events.", "<tag2>", "We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2015", "will", "be", "significantly", "impacted", "by", "the", "outcome", "and", "timing", "of", "AstraZeneca", "s", "launch", "of", "MOVANTIK", "as", "we", "are", "entitled", "to", "$140.0", "million", "of", "development", "milestone", "payments", "due", "upon", "the", "commercial", "launches", "of", "MOVANTIK", "in", "the", "U.S.", "($100.0", "million)", "and", "in", "the", "E.U.", "($40.0", "million).", "<tag3>"], "wordsA": ["We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2014", "will", "be", "significantly", "impacted", "by", "the", "outcome", "and", "timing", "of", "the", "naloxegol", "regulatory", "review", "events."], "wordsB": ["We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2015", "will", "be", "significantly", "impacted", "by", "the", "outcome", "and", "timing", "of", "AstraZeneca", "s", "launch", "of", "MOVANTIK", "as", "we", "are", "entitled", "to", "$140.0", "million", "of", "development", "milestone", "payments", "due", "upon", "the", "commercial", "launches", "of", "MOVANTIK", "in", "the", "U.S.", "($100.0", "million)", "and", "in", "the", "E.U.", "($40.0", "million)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p30_s3", "idA": "906709_14_item7_p23_s5", "sentA": "In particular, in the event naloxegol is approved by the FDA, we would expect to recognize as revenue the $70.0 million payment received from AstraZeneca in November 2013 and we would be entitled to a $35.0 million milestone payment.", "sentB": "In particular, if the BEACON study is successful and etirinotecan pegol is ultimately approved by the FDA, our current plan would be to market and sell etirinotecan pegol in the United States.", "type": 2, "words": ["<tag1>", "In", "particular,", "in", "the", "event", "naloxegol", "is", "approved", "by", "the", "FDA,", "we", "would", "expect", "to", "recognize", "as", "revenue", "the", "$70.0", "million", "payment", "received", "from", "AstraZeneca", "in", "November", "2013", "and", "we", "would", "be", "entitled", "to", "a", "$35.0", "million", "milestone", "payment.", "<tag2>", "In", "particular,", "if", "the", "BEACON", "study", "is", "successful", "and", "etirinotecan", "pegol", "is", "ultimately", "approved", "by", "the", "FDA,", "our", "current", "plan", "would", "be", "to", "market", "and", "sell", "etirinotecan", "pegol", "in", "the", "United", "States.", "<tag3>"], "wordsA": ["In", "particular,", "in", "the", "event", "naloxegol", "is", "approved", "by", "the", "FDA,", "we", "would", "expect", "to", "recognize", "as", "revenue", "the", "$70.0", "million", "payment", "received", "from", "AstraZeneca", "in", "November", "2013", "and", "we", "would", "be", "entitled", "to", "a", "$35.0", "million", "milestone", "payment."], "wordsB": ["In", "particular,", "if", "the", "BEACON", "study", "is", "successful", "and", "etirinotecan", "pegol", "is", "ultimately", "approved", "by", "the", "FDA,", "our", "current", "plan", "would", "be", "to", "market", "and", "sell", "etirinotecan", "pegol", "in", "the", "United", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p17_s15", "idA": "906709_14_item7_p23_s6", "sentA": "If these activities occur in 2014, our license, collaboration and other revenue in 2014 will increase significantly from 2013.", "sentB": "If these activities occur in 2015, our license, collaboration and other revenue in 2015 will increase from 2014.", "type": 2, "words": ["<tag1>", "If", "these", "activities", "occur", "in", "2014,", "our", "license,", "collaboration", "and", "other", "revenue", "in", "2014", "will", "increase", "significantly", "from", "2013.", "<tag2>", "If", "these", "activities", "occur", "in", "2015,", "our", "license,", "collaboration", "and", "other", "revenue", "in", "2015", "will", "increase", "from", "2014.", "<tag3>"], "wordsA": ["If", "these", "activities", "occur", "in", "2014,", "our", "license,", "collaboration", "and", "other", "revenue", "in", "2014", "will", "increase", "significantly", "from", "2013."], "wordsB": ["If", "these", "activities", "occur", "in", "2015,", "our", "license,", "collaboration", "and", "other", "revenue", "in", "2015", "will", "increase", "from", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p11_s0", "idA": "906709_14_item7_p24_s0", "sentA": "The timing and future success of our drug development programs and those of our collaboration partners are subject to a number of risks and uncertainties.", "sentB": "We also have two significant drug development programs with Bayer.", "type": 2, "words": ["<tag1>", "The", "timing", "and", "future", "success", "of", "our", "drug", "development", "programs", "and", "those", "of", "our", "collaboration", "partners", "are", "subject", "to", "a", "number", "of", "risks", "and", "uncertainties.", "<tag2>", "We", "also", "have", "two", "significant", "drug", "development", "programs", "with", "Bayer.", "<tag3>"], "wordsA": ["The", "timing", "and", "future", "success", "of", "our", "drug", "development", "programs", "and", "those", "of", "our", "collaboration", "partners", "are", "subject", "to", "a", "number", "of", "risks", "and", "uncertainties."], "wordsB": ["We", "also", "have", "two", "significant", "drug", "development", "programs", "with", "Bayer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p61_s2", "idA": "906709_14_item7_p25_s0", "sentA": "Revenue by geography Revenue by geographic area is based on locations of our partners.", "sentB": "This potential change is based on sensitivity analyses performed on our investment securities at December 31, 2014.", "type": 2, "words": ["<tag1>", "Revenue", "by", "geography", "Revenue", "by", "geographic", "area", "is", "based", "on", "locations", "of", "our", "partners.", "<tag2>", "This", "potential", "change", "is", "based", "on", "sensitivity", "analyses", "performed", "on", "our", "investment", "securities", "at", "December", "31,", "2014.", "<tag3>"], "wordsA": ["Revenue", "by", "geography", "Revenue", "by", "geographic", "area", "is", "based", "on", "locations", "of", "our", "partners."], "wordsB": ["This", "potential", "change", "is", "based", "on", "sensitivity", "analyses", "performed", "on", "our", "investment", "securities", "at", "December", "31,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p20_s0", "idA": "906709_14_item7_p26_s0", "sentA": "The increase in revenue attributable to European countries for the year ended December 31, 2013 compared to the year ended December 31, 2012 is primarily attributable to increased milestone and royalty revenues from our existing European collaboration partners, including the $25.0 million milestone payment from AstraZeneca described above.", "sentB": "The increase in revenue attributable to European countries for the year ended December 31, 2014 compared to the year ended December 31, 2013 is primarily attributable to increased milestone and royalty revenues from our existing European based collaboration partners, including the recognition of the $105.0 million milestone payments from AstraZeneca described above.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "is", "primarily", "attributable", "to", "increased", "milestone", "and", "royalty", "revenues", "from", "our", "existing", "European", "collaboration", "partners,", "including", "the", "$25.0", "million", "milestone", "payment", "from", "AstraZeneca", "described", "above.", "<tag2>", "The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "is", "primarily", "attributable", "to", "increased", "milestone", "and", "royalty", "revenues", "from", "our", "existing", "European", "based", "collaboration", "partners,", "including", "the", "recognition", "of", "the", "$105.0", "million", "milestone", "payments", "from", "AstraZeneca", "described", "above.", "<tag3>"], "wordsA": ["The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "is", "primarily", "attributable", "to", "increased", "milestone", "and", "royalty", "revenues", "from", "our", "existing", "European", "collaboration", "partners,", "including", "the", "$25.0", "million", "milestone", "payment", "from", "AstraZeneca", "described", "above."], "wordsB": ["The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "is", "primarily", "attributable", "to", "increased", "milestone", "and", "royalty", "revenues", "from", "our", "existing", "European", "based", "collaboration", "partners,", "including", "the", "recognition", "of", "the", "$105.0", "million", "milestone", "payments", "from", "AstraZeneca", "described", "above."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p20_s2", "idA": "906709_14_item7_p27_s0", "sentA": "Cost of goods sold and product gross profit increased during the year ended December 31, 2013 compared to the year ended December 31, 2012 primarily due to the $9.4 million increase in product sales in the year ended December 31, 2013 compared to the year ended December 31, 2012.", "sentB": "Cost of goods sold decreased during the year ended December 31, 2014 compared to the year ended December 31, 2013 primarily due to the decrease in product sales of $19.7 million in the year ended December 31, 2014 compared to the year ended December 31, 2013.", "type": 2, "words": ["<tag1>", "Cost", "of", "goods", "sold", "and", "product", "gross", "profit", "increased", "during", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "due", "to", "the", "$9.4", "million", "increase", "in", "product", "sales", "in", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012.", "<tag2>", "Cost", "of", "goods", "sold", "decreased", "during", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "due", "to", "the", "decrease", "in", "product", "sales", "of", "$19.7", "million", "in", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013.", "<tag3>"], "wordsA": ["Cost", "of", "goods", "sold", "and", "product", "gross", "profit", "increased", "during", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "due", "to", "the", "$9.4", "million", "increase", "in", "product", "sales", "in", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012."], "wordsB": ["Cost", "of", "goods", "sold", "decreased", "during", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "due", "to", "the", "decrease", "in", "product", "sales", "of", "$19.7", "million", "in", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p21_s4", "idA": "906709_14_item7_p27_s4", "sentA": "We expect product gross margin to fluctuate in future periods depending on the level and mix of manufacturing orders from our customers due to the predominantly fixed cost base associated with our manufacturing activities.", "sentB": "We expect product gross margin to continue to fluctuate in future periods depending on the level and mix of manufacturing orders from our customers due to the predominantly fixed cost base associated with our manufacturing activities.", "type": 2, "words": ["<tag1>", "We", "expect", "product", "gross", "margin", "to", "fluctuate", "in", "future", "periods", "depending", "on", "the", "level", "and", "mix", "of", "manufacturing", "orders", "from", "our", "customers", "due", "to", "the", "predominantly", "fixed", "cost", "base", "associated", "with", "our", "manufacturing", "activities.", "<tag2>", "We", "expect", "product", "gross", "margin", "to", "continue", "to", "fluctuate", "in", "future", "periods", "depending", "on", "the", "level", "and", "mix", "of", "manufacturing", "orders", "from", "our", "customers", "due", "to", "the", "predominantly", "fixed", "cost", "base", "associated", "with", "our", "manufacturing", "activities.", "<tag3>"], "wordsA": ["We", "expect", "product", "gross", "margin", "to", "fluctuate", "in", "future", "periods", "depending", "on", "the", "level", "and", "mix", "of", "manufacturing", "orders", "from", "our", "customers", "due", "to", "the", "predominantly", "fixed", "cost", "base", "associated", "with", "our", "manufacturing", "activities."], "wordsB": ["We", "expect", "product", "gross", "margin", "to", "continue", "to", "fluctuate", "in", "future", "periods", "depending", "on", "the", "level", "and", "mix", "of", "manufacturing", "orders", "from", "our", "customers", "due", "to", "the", "predominantly", "fixed", "cost", "base", "associated", "with", "our", "manufacturing", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p20_s5", "idA": "906709_14_item7_p27_s5", "sentA": "We currently expect product gross margin to decrease in 2014 as compared to 2013 as a result of the anticipated reduction in product sales.", "sentB": "As a result of decreased overall manufacturing volume in 2014 as compared to 2013 and given the increase in the percentage of overall sales attributable to this partner, gross profit for the year was negative.", "type": 2, "words": ["<tag1>", "We", "currently", "expect", "product", "gross", "margin", "to", "decrease", "in", "2014", "as", "compared", "to", "2013", "as", "a", "result", "of", "the", "anticipated", "reduction", "in", "product", "sales.", "<tag2>", "As", "a", "result", "of", "decreased", "overall", "manufacturing", "volume", "in", "2014", "as", "compared", "to", "2013", "and", "given", "the", "increase", "in", "the", "percentage", "of", "overall", "sales", "attributable", "to", "this", "partner,", "gross", "profit", "for", "the", "year", "was", "negative.", "<tag3>"], "wordsA": ["We", "currently", "expect", "product", "gross", "margin", "to", "decrease", "in", "2014", "as", "compared", "to", "2013", "as", "a", "result", "of", "the", "anticipated", "reduction", "in", "product", "sales."], "wordsB": ["As", "a", "result", "of", "decreased", "overall", "manufacturing", "volume", "in", "2014", "as", "compared", "to", "2013", "and", "given", "the", "increase", "in", "the", "percentage", "of", "overall", "sales", "attributable", "to", "this", "partner,", "gross", "profit", "for", "the", "year", "was", "negative."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p21_s5", "idA": "906709_14_item7_p27_s5", "sentA": "We currently expect product gross margin to decrease in 2014 as compared to 2013 as a result of the anticipated reduction in product sales.", "sentB": "We currently expect product gross margin to increase in 2015 as compared to 2014 as a result of the anticipated increase in product sales, as well as based on the anticipated product mix.", "type": 2, "words": ["<tag1>", "We", "currently", "expect", "product", "gross", "margin", "to", "decrease", "in", "2014", "as", "compared", "to", "2013", "as", "a", "result", "of", "the", "anticipated", "reduction", "in", "product", "sales.", "<tag2>", "We", "currently", "expect", "product", "gross", "margin", "to", "increase", "in", "2015", "as", "compared", "to", "2014", "as", "a", "result", "of", "the", "anticipated", "increase", "in", "product", "sales,", "as", "well", "as", "based", "on", "the", "anticipated", "product", "mix.", "<tag3>"], "wordsA": ["We", "currently", "expect", "product", "gross", "margin", "to", "decrease", "in", "2014", "as", "compared", "to", "2013", "as", "a", "result", "of", "the", "anticipated", "reduction", "in", "product", "sales."], "wordsB": ["We", "currently", "expect", "product", "gross", "margin", "to", "increase", "in", "2015", "as", "compared", "to", "2014", "as", "a", "result", "of", "the", "anticipated", "increase", "in", "product", "sales,", "as", "well", "as", "based", "on", "the", "anticipated", "product", "mix."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p16_s0", "idA": "906709_14_item7_p28_s2", "sentA": "Research and development expense increased during the year ended December 31, 2013 compared to the year ended December 31, 2012 primarily due to the etirinotecan pegol (NKTR-102) Phase 3 BEACON clinical study initiated in December 2011 as well as the NKTR-181 Phase 2 clinical study initiated in July 2012.", "sentB": "as well as the completion of the royalty term for one product.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "due", "to", "the", "etirinotecan", "pegol", "(NKTR-102)", "Phase", "3", "BEACON", "clinical", "study", "initiated", "in", "December", "2011", "as", "well", "as", "the", "NKTR-181", "Phase", "2", "clinical", "study", "initiated", "in", "July", "2012.", "<tag2>", "as", "well", "as", "the", "completion", "of", "the", "royalty", "term", "for", "one", "product.", "<tag3>"], "wordsA": ["Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "due", "to", "the", "etirinotecan", "pegol", "(NKTR-102)", "Phase", "3", "BEACON", "clinical", "study", "initiated", "in", "December", "2011", "as", "well", "as", "the", "NKTR-181", "Phase", "2", "clinical", "study", "initiated", "in", "July", "2012."], "wordsB": ["as", "well", "as", "the", "completion", "of", "the", "royalty", "term", "for", "one", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p22_s2", "idA": "906709_14_item7_p28_s2", "sentA": "Research and development expense increased during the year ended December 31, 2013 compared to the year ended December 31, 2012 primarily due to the etirinotecan pegol (NKTR-102) Phase 3 BEACON clinical study initiated in December 2011 as well as the NKTR-181 Phase 2 clinical study initiated in July 2012.", "sentB": "Research and development expense decreased during the year ended December 31, 2014 compared to the year ended December 31, 2013 primarily due to reduced activities on our ongoing Phase 3 BEACON study for etirinotecan pegol as the study progresses toward completion as well as the completion of our Phase 2 clinical study for NKTR-181 in the third quarter of 2013.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "due", "to", "the", "etirinotecan", "pegol", "(NKTR-102)", "Phase", "3", "BEACON", "clinical", "study", "initiated", "in", "December", "2011", "as", "well", "as", "the", "NKTR-181", "Phase", "2", "clinical", "study", "initiated", "in", "July", "2012.", "<tag2>", "Research", "and", "development", "expense", "decreased", "during", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "due", "to", "reduced", "activities", "on", "our", "ongoing", "Phase", "3", "BEACON", "study", "for", "etirinotecan", "pegol", "as", "the", "study", "progresses", "toward", "completion", "as", "well", "as", "the", "completion", "of", "our", "Phase", "2", "clinical", "study", "for", "NKTR-181", "in", "the", "third", "quarter", "of", "2013.", "<tag3>"], "wordsA": ["Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "due", "to", "the", "etirinotecan", "pegol", "(NKTR-102)", "Phase", "3", "BEACON", "clinical", "study", "initiated", "in", "December", "2011", "as", "well", "as", "the", "NKTR-181", "Phase", "2", "clinical", "study", "initiated", "in", "July", "2012."], "wordsB": ["Research", "and", "development", "expense", "decreased", "during", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "due", "to", "reduced", "activities", "on", "our", "ongoing", "Phase", "3", "BEACON", "study", "for", "etirinotecan", "pegol", "as", "the", "study", "progresses", "toward", "completion", "as", "well", "as", "the", "completion", "of", "our", "Phase", "2", "clinical", "study", "for", "NKTR-181", "in", "the", "third", "quarter", "of", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p22_s4", "idA": "906709_14_item7_p28_s2", "sentA": "Research and development expense increased during the year ended December 31, 2013 compared to the year ended December 31, 2012 primarily due to the etirinotecan pegol (NKTR-102) Phase 3 BEACON clinical study initiated in December 2011 as well as the NKTR-181 Phase 2 clinical study initiated in July 2012.", "sentB": "Research and development expense increased during the year ended December 31, 2013 compared to the year ended December 31, 2012 primarily due to the Phase 3 BEACON clinical study initiated in December 2011, the NKTR-181 Phase 2 clinical study initiated in July 2012 and the $11.3 million settlement charge recorded in 2013 noted above.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "due", "to", "the", "etirinotecan", "pegol", "(NKTR-102)", "Phase", "3", "BEACON", "clinical", "study", "initiated", "in", "December", "2011", "as", "well", "as", "the", "NKTR-181", "Phase", "2", "clinical", "study", "initiated", "in", "July", "2012.", "<tag2>", "Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "due", "to", "the", "Phase", "3", "BEACON", "clinical", "study", "initiated", "in", "December", "2011,", "the", "NKTR-181", "Phase", "2", "clinical", "study", "initiated", "in", "July", "2012", "and", "the", "$11.3", "million", "settlement", "charge", "recorded", "in", "2013", "noted", "above.", "<tag3>"], "wordsA": ["Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "due", "to", "the", "etirinotecan", "pegol", "(NKTR-102)", "Phase", "3", "BEACON", "clinical", "study", "initiated", "in", "December", "2011", "as", "well", "as", "the", "NKTR-181", "Phase", "2", "clinical", "study", "initiated", "in", "July", "2012."], "wordsB": ["Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "due", "to", "the", "Phase", "3", "BEACON", "clinical", "study", "initiated", "in", "December", "2011,", "the", "NKTR-181", "Phase", "2", "clinical", "study", "initiated", "in", "July", "2012", "and", "the", "$11.3", "million", "settlement", "charge", "recorded", "in", "2013", "noted", "above."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p22_s3", "idA": "906709_14_item7_p28_s3", "sentA": "In addition, during the year ended December 31, 2013, we recorded a charge of $11.3 million resulting from the settlement of a dispute with the Research Foundation of the State University of New York related to our collaboration with Bayer to develop inhaled amikacin (see Note 8 to our Consolidated Financial Statements).", "sentB": "In addition, during the year ended December 31, 2013, we recorded a charge of $11.3 million resulting from the settlement of a dispute with the Research Foundation of the State University of New York related to our collaboration with Bayer to develop inhaled amikacin.", "type": 2, "words": ["<tag1>", "In", "addition,", "during", "the", "year", "ended", "December", "31,", "2013,", "we", "recorded", "a", "charge", "of", "$11.3", "million", "resulting", "from", "the", "settlement", "of", "a", "dispute", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "related", "to", "our", "collaboration", "with", "Bayer", "to", "develop", "inhaled", "amikacin", "(see", "Note", "8", "to", "our", "Consolidated", "Financial", "Statements).", "<tag2>", "In", "addition,", "during", "the", "year", "ended", "December", "31,", "2013,", "we", "recorded", "a", "charge", "of", "$11.3", "million", "resulting", "from", "the", "settlement", "of", "a", "dispute", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "related", "to", "our", "collaboration", "with", "Bayer", "to", "develop", "inhaled", "amikacin.", "<tag3>"], "wordsA": ["In", "addition,", "during", "the", "year", "ended", "December", "31,", "2013,", "we", "recorded", "a", "charge", "of", "$11.3", "million", "resulting", "from", "the", "settlement", "of", "a", "dispute", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "related", "to", "our", "collaboration", "with", "Bayer", "to", "develop", "inhaled", "amikacin", "(see", "Note", "8", "to", "our", "Consolidated", "Financial", "Statements)."], "wordsB": ["In", "addition,", "during", "the", "year", "ended", "December", "31,", "2013,", "we", "recorded", "a", "charge", "of", "$11.3", "million", "resulting", "from", "the", "settlement", "of", "a", "dispute", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "related", "to", "our", "collaboration", "with", "Bayer", "to", "develop", "inhaled", "amikacin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p52_s4", "idA": "906709_14_item7_p28_s4", "sentA": "The increase in research and development expense for the year ended December 31, 2012 compared to the year ended December 31, 2011 is primarily attributable to the $15.2 million increase in direct research and development program costs, a substantial portion of which is attributable to our etirinotecan pegol Phase 3 BEACON study as well as the NKTR-181 Phase 2 clinical study.", "sentB": "During the year ended December 31, 2014, we recorded a reduction related to prior periods of approximately $4.7 million to our research and development expenses primarily related to our Beacon Phase 3 clinical trial for etirinotecan pegol.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "research", "and", "development", "expense", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "attributable", "to", "the", "$15.2", "million", "increase", "in", "direct", "research", "and", "development", "program", "costs,", "a", "substantial", "portion", "of", "which", "is", "attributable", "to", "our", "etirinotecan", "pegol", "Phase", "3", "BEACON", "study", "as", "well", "as", "the", "NKTR-181", "Phase", "2", "clinical", "study.", "<tag2>", "During", "the", "year", "ended", "December", "31,", "2014,", "we", "recorded", "a", "reduction", "related", "to", "prior", "periods", "of", "approximately", "$4.7", "million", "to", "our", "research", "and", "development", "expenses", "primarily", "related", "to", "our", "Beacon", "Phase", "3", "clinical", "trial", "for", "etirinotecan", "pegol.", "<tag3>"], "wordsA": ["The", "increase", "in", "research", "and", "development", "expense", "for", "the", "year", "ended", "December", "31,", "2012", "compared", "to", "the", "year", "ended", "December", "31,", "2011", "is", "primarily", "attributable", "to", "the", "$15.2", "million", "increase", "in", "direct", "research", "and", "development", "program", "costs,", "a", "substantial", "portion", "of", "which", "is", "attributable", "to", "our", "etirinotecan", "pegol", "Phase", "3", "BEACON", "study", "as", "well", "as", "the", "NKTR-181", "Phase", "2", "clinical", "study."], "wordsB": ["During", "the", "year", "ended", "December", "31,", "2014,", "we", "recorded", "a", "reduction", "related", "to", "prior", "periods", "of", "approximately", "$4.7", "million", "to", "our", "research", "and", "development", "expenses", "primarily", "related", "to", "our", "Beacon", "Phase", "3", "clinical", "trial", "for", "etirinotecan", "pegol."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p17_s9", "idA": "906709_14_item7_p30_s0", "sentA": "In addition, during the year ended December 31, 2011, we made $11.2 million of prepayments to certain vendors in our BEACON study.", "sentB": "In addition, we recognized $8.0 million of milestones received in December 2014 related to positive results from Baxter s BAX 855 Phase 3 study.", "type": 2, "words": ["<tag1>", "In", "addition,", "during", "the", "year", "ended", "December", "31,", "2011,", "we", "made", "$11.2", "million", "of", "prepayments", "to", "certain", "vendors", "in", "our", "BEACON", "study.", "<tag2>", "In", "addition,", "we", "recognized", "$8.0", "million", "of", "milestones", "received", "in", "December", "2014", "related", "to", "positive", "results", "from", "Baxter", "s", "BAX", "855", "Phase", "3", "study.", "<tag3>"], "wordsA": ["In", "addition,", "during", "the", "year", "ended", "December", "31,", "2011,", "we", "made", "$11.2", "million", "of", "prepayments", "to", "certain", "vendors", "in", "our", "BEACON", "study."], "wordsB": ["In", "addition,", "we", "recognized", "$8.0", "million", "of", "milestones", "received", "in", "December", "2014", "related", "to", "positive", "results", "from", "Baxter", "s", "BAX", "855", "Phase", "3", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p25_s0", "idA": "906709_14_item7_p31_s0", "sentA": "(3) We partnered this program with Bayer Healthcare LLC in August 2007.", "sentB": "(2) We partnered this program with Bayer Healthcare LLC in August 2007.", "type": 2, "words": ["<tag1>", "(3)", "We", "partnered", "this", "program", "with", "Bayer", "Healthcare", "LLC", "in", "August", "2007.", "<tag2>", "(2)", "We", "partnered", "this", "program", "with", "Bayer", "Healthcare", "LLC", "in", "August", "2007.", "<tag3>"], "wordsA": ["(3)", "We", "partnered", "this", "program", "with", "Bayer", "Healthcare", "LLC", "in", "August", "2007."], "wordsB": ["(2)", "We", "partnered", "this", "program", "with", "Bayer", "Healthcare", "LLC", "in", "August", "2007."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p26_s11", "idA": "906709_14_item7_p31_s11", "sentA": "We do not expect to have any significant future research and development costs associated with naloxegol or the naloxegol fixed-dose combination products as AstraZeneca is responsible for all further development and commercialization costs for these drug candidates.", "sentB": "We do not expect to have any significant future research and development costs associated with MOVANTIK or the MOVANTIK fixed-dose combination products as AstraZeneca is responsible for all further development and commercialization costs for these drug candidates.", "type": 2, "words": ["<tag1>", "We", "do", "not", "expect", "to", "have", "any", "significant", "future", "research", "and", "development", "costs", "associated", "with", "naloxegol", "or", "the", "naloxegol", "fixed-dose", "combination", "products", "as", "AstraZeneca", "is", "responsible", "for", "all", "further", "development", "and", "commercialization", "costs", "for", "these", "drug", "candidates.", "<tag2>", "We", "do", "not", "expect", "to", "have", "any", "significant", "future", "research", "and", "development", "costs", "associated", "with", "MOVANTIK", "or", "the", "MOVANTIK", "fixed-dose", "combination", "products", "as", "AstraZeneca", "is", "responsible", "for", "all", "further", "development", "and", "commercialization", "costs", "for", "these", "drug", "candidates.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "to", "have", "any", "significant", "future", "research", "and", "development", "costs", "associated", "with", "naloxegol", "or", "the", "naloxegol", "fixed-dose", "combination", "products", "as", "AstraZeneca", "is", "responsible", "for", "all", "further", "development", "and", "commercialization", "costs", "for", "these", "drug", "candidates."], "wordsB": ["We", "do", "not", "expect", "to", "have", "any", "significant", "future", "research", "and", "development", "costs", "associated", "with", "MOVANTIK", "or", "the", "MOVANTIK", "fixed-dose", "combination", "products", "as", "AstraZeneca", "is", "responsible", "for", "all", "further", "development", "and", "commercialization", "costs", "for", "these", "drug", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p26_s12", "idA": "906709_14_item7_p31_s12", "sentA": "In addition to our drug candidates that we plan to have in clinical development during 2014 and beyond, we believe it is vitally important to continue our substantial investment in a diverse pipeline of new drug candidates to continue to build the value of our drug candidate pipeline and our business.", "sentB": "In addition to our drug candidates that we plan to have in clinical development during 2015 and beyond, we believe it is vitally important to continue our substantial investment in a diverse pipeline of new drug candidates to continue to build the value of our drug candidate pipeline and our business.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "our", "drug", "candidates", "that", "we", "plan", "to", "have", "in", "clinical", "development", "during", "2014", "and", "beyond,", "we", "believe", "it", "is", "vitally", "important", "to", "continue", "our", "substantial", "investment", "in", "a", "diverse", "pipeline", "of", "new", "drug", "candidates", "to", "continue", "to", "build", "the", "value", "of", "our", "drug", "candidate", "pipeline", "and", "our", "business.", "<tag2>", "In", "addition", "to", "our", "drug", "candidates", "that", "we", "plan", "to", "have", "in", "clinical", "development", "during", "2015", "and", "beyond,", "we", "believe", "it", "is", "vitally", "important", "to", "continue", "our", "substantial", "investment", "in", "a", "diverse", "pipeline", "of", "new", "drug", "candidates", "to", "continue", "to", "build", "the", "value", "of", "our", "drug", "candidate", "pipeline", "and", "our", "business.", "<tag3>"], "wordsA": ["In", "addition", "to", "our", "drug", "candidates", "that", "we", "plan", "to", "have", "in", "clinical", "development", "during", "2014", "and", "beyond,", "we", "believe", "it", "is", "vitally", "important", "to", "continue", "our", "substantial", "investment", "in", "a", "diverse", "pipeline", "of", "new", "drug", "candidates", "to", "continue", "to", "build", "the", "value", "of", "our", "drug", "candidate", "pipeline", "and", "our", "business."], "wordsB": ["In", "addition", "to", "our", "drug", "candidates", "that", "we", "plan", "to", "have", "in", "clinical", "development", "during", "2015", "and", "beyond,", "we", "believe", "it", "is", "vitally", "important", "to", "continue", "our", "substantial", "investment", "in", "a", "diverse", "pipeline", "of", "new", "drug", "candidates", "to", "continue", "to", "build", "the", "value", "of", "our", "drug", "candidate", "pipeline", "and", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p60_s2", "idA": "906709_14_item7_p31_s15", "sentA": "Our expenditures on current and future preclinical and clinical development programs are subject to numerous uncertainties in timing and cost to completion.", "sentB": "Our investments in debt securities are subject to interest rate risk.", "type": 2, "words": ["<tag1>", "Our", "expenditures", "on", "current", "and", "future", "preclinical", "and", "clinical", "development", "programs", "are", "subject", "to", "numerous", "uncertainties", "in", "timing", "and", "cost", "to", "completion.", "<tag2>", "Our", "investments", "in", "debt", "securities", "are", "subject", "to", "interest", "rate", "risk.", "<tag3>"], "wordsA": ["Our", "expenditures", "on", "current", "and", "future", "preclinical", "and", "clinical", "development", "programs", "are", "subject", "to", "numerous", "uncertainties", "in", "timing", "and", "cost", "to", "completion."], "wordsB": ["Our", "investments", "in", "debt", "securities", "are", "subject", "to", "interest", "rate", "risk."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p26_s0", "idA": "906709_14_item7_p31_s2", "sentA": "We expect research and development expense to decrease in 2014 as compared to 2013 and to continue at or above the 2012 level.", "sentB": "We expect research and development expense to increase in 2015 as compared to 2014.", "type": 2, "words": ["<tag1>", "We", "expect", "research", "and", "development", "expense", "to", "decrease", "in", "2014", "as", "compared", "to", "2013", "and", "to", "continue", "at", "or", "above", "the", "2012", "level.", "<tag2>", "We", "expect", "research", "and", "development", "expense", "to", "increase", "in", "2015", "as", "compared", "to", "2014.", "<tag3>"], "wordsA": ["We", "expect", "research", "and", "development", "expense", "to", "decrease", "in", "2014", "as", "compared", "to", "2013", "and", "to", "continue", "at", "or", "above", "the", "2012", "level."], "wordsB": ["We", "expect", "research", "and", "development", "expense", "to", "increase", "in", "2015", "as", "compared", "to", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p34_s1", "idA": "906709_14_item7_p31_s2", "sentA": "We expect research and development expense to decrease in 2014 as compared to 2013 and to continue at or above the 2012 level.", "sentB": "We will pursue various financing alternatives, including equity and debt, as needed to continue to fund our research and development activities and to fund the expansion of our business as appropriate.", "type": 2, "words": ["<tag1>", "We", "expect", "research", "and", "development", "expense", "to", "decrease", "in", "2014", "as", "compared", "to", "2013", "and", "to", "continue", "at", "or", "above", "the", "2012", "level.", "<tag2>", "We", "will", "pursue", "various", "financing", "alternatives,", "including", "equity", "and", "debt,", "as", "needed", "to", "continue", "to", "fund", "our", "research", "and", "development", "activities", "and", "to", "fund", "the", "expansion", "of", "our", "business", "as", "appropriate.", "<tag3>"], "wordsA": ["We", "expect", "research", "and", "development", "expense", "to", "decrease", "in", "2014", "as", "compared", "to", "2013", "and", "to", "continue", "at", "or", "above", "the", "2012", "level."], "wordsB": ["We", "will", "pursue", "various", "financing", "alternatives,", "including", "equity", "and", "debt,", "as", "needed", "to", "continue", "to", "fund", "our", "research", "and", "development", "activities", "and", "to", "fund", "the", "expansion", "of", "our", "business", "as", "appropriate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p26_s3", "idA": "906709_14_item7_p31_s3", "sentA": "We plan to continue to advance etirinotecan pegol in the Phase 3 BEACON study for metastatic breast cancer for which we expect the clinical study to continue through early 2015.", "sentB": "In addition, we plan to continue to advance etirinotecan pegol in the Phase 3 BEACON study for metastatic breast cancer for which we expect the clinical study to continue through 2015.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "continue", "to", "advance", "etirinotecan", "pegol", "in", "the", "Phase", "3", "BEACON", "study", "for", "metastatic", "breast", "cancer", "for", "which", "we", "expect", "the", "clinical", "study", "to", "continue", "through", "early", "2015.", "<tag2>", "In", "addition,", "we", "plan", "to", "continue", "to", "advance", "etirinotecan", "pegol", "in", "the", "Phase", "3", "BEACON", "study", "for", "metastatic", "breast", "cancer", "for", "which", "we", "expect", "the", "clinical", "study", "to", "continue", "through", "2015.", "<tag3>"], "wordsA": ["We", "plan", "to", "continue", "to", "advance", "etirinotecan", "pegol", "in", "the", "Phase", "3", "BEACON", "study", "for", "metastatic", "breast", "cancer", "for", "which", "we", "expect", "the", "clinical", "study", "to", "continue", "through", "early", "2015."], "wordsB": ["In", "addition,", "we", "plan", "to", "continue", "to", "advance", "etirinotecan", "pegol", "in", "the", "Phase", "3", "BEACON", "study", "for", "metastatic", "breast", "cancer", "for", "which", "we", "expect", "the", "clinical", "study", "to", "continue", "through", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p6_s6", "idA": "906709_14_item7_p31_s3", "sentA": "We plan to continue to advance etirinotecan pegol in the Phase 3 BEACON study for metastatic breast cancer for which we expect the clinical study to continue through early 2015.", "sentB": "If the BEACON study is successful and etirinotecan pegol is ultimately approved by the FDA, our current plan would be to market and sell etirinotecan pegol in the United States ourselves for the FDA approved metastatic breast cancer indication and license the commercial rights outside of the U.S. to one or more collaboration partners.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "continue", "to", "advance", "etirinotecan", "pegol", "in", "the", "Phase", "3", "BEACON", "study", "for", "metastatic", "breast", "cancer", "for", "which", "we", "expect", "the", "clinical", "study", "to", "continue", "through", "early", "2015.", "<tag2>", "If", "the", "BEACON", "study", "is", "successful", "and", "etirinotecan", "pegol", "is", "ultimately", "approved", "by", "the", "FDA,", "our", "current", "plan", "would", "be", "to", "market", "and", "sell", "etirinotecan", "pegol", "in", "the", "United", "States", "ourselves", "for", "the", "FDA", "approved", "metastatic", "breast", "cancer", "indication", "and", "license", "the", "commercial", "rights", "outside", "of", "the", "U.S.", "to", "one", "or", "more", "collaboration", "partners.", "<tag3>"], "wordsA": ["We", "plan", "to", "continue", "to", "advance", "etirinotecan", "pegol", "in", "the", "Phase", "3", "BEACON", "study", "for", "metastatic", "breast", "cancer", "for", "which", "we", "expect", "the", "clinical", "study", "to", "continue", "through", "early", "2015."], "wordsB": ["If", "the", "BEACON", "study", "is", "successful", "and", "etirinotecan", "pegol", "is", "ultimately", "approved", "by", "the", "FDA,", "our", "current", "plan", "would", "be", "to", "market", "and", "sell", "etirinotecan", "pegol", "in", "the", "United", "States", "ourselves", "for", "the", "FDA", "approved", "metastatic", "breast", "cancer", "indication", "and", "license", "the", "commercial", "rights", "outside", "of", "the", "U.S.", "to", "one", "or", "more", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p26_s5", "idA": "906709_14_item7_p31_s5", "sentA": "We estimate that the total third party and direct material costs over the life of the BEACON study will be approximately $100.0 million, of which $64.7 million was incurred through the end of 2013.", "sentB": "We estimate that the total third party and direct material costs over the life of the BEACON study will be approximately $85.0 million, of which $72.7 million was incurred through the end of 2014.", "type": 2, "words": ["<tag1>", "We", "estimate", "that", "the", "total", "third", "party", "and", "direct", "material", "costs", "over", "the", "life", "of", "the", "BEACON", "study", "will", "be", "approximately", "$100.0", "million,", "of", "which", "$64.7", "million", "was", "incurred", "through", "the", "end", "of", "2013.", "<tag2>", "We", "estimate", "that", "the", "total", "third", "party", "and", "direct", "material", "costs", "over", "the", "life", "of", "the", "BEACON", "study", "will", "be", "approximately", "$85.0", "million,", "of", "which", "$72.7", "million", "was", "incurred", "through", "the", "end", "of", "2014.", "<tag3>"], "wordsA": ["We", "estimate", "that", "the", "total", "third", "party", "and", "direct", "material", "costs", "over", "the", "life", "of", "the", "BEACON", "study", "will", "be", "approximately", "$100.0", "million,", "of", "which", "$64.7", "million", "was", "incurred", "through", "the", "end", "of", "2013."], "wordsB": ["We", "estimate", "that", "the", "total", "third", "party", "and", "direct", "material", "costs", "over", "the", "life", "of", "the", "BEACON", "study", "will", "be", "approximately", "$85.0", "million,", "of", "which", "$72.7", "million", "was", "incurred", "through", "the", "end", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p26_s6", "idA": "906709_14_item7_p31_s6", "sentA": "We have also studied or have ongoing studies being conducted for etirinotecan pegol, including investigator-initiated clinical studies, in bevacizumab (Avastin)-resistant high-grade glioma, colorectal cancer, metastatic and recurrent non-small cell lung cancer, and ovarian cancer.", "sentB": "We have also studied or have ongoing studies being conducted for etirinotecan pegol, including investigator-initiated clinical studies, in bevacizumab (Avastin)-resistant high-grade glioma, colorectal cancer, relapsed or refractory small-cell lung cancer, metastatic and recurrent non-small cell lung cancer, and ovarian cancer.", "type": 2, "words": ["<tag1>", "We", "have", "also", "studied", "or", "have", "ongoing", "studies", "being", "conducted", "for", "etirinotecan", "pegol,", "including", "investigator-initiated", "clinical", "studies,", "in", "bevacizumab", "(Avastin)-resistant", "high-grade", "glioma,", "colorectal", "cancer,", "metastatic", "and", "recurrent", "non-small", "cell", "lung", "cancer,", "and", "ovarian", "cancer.", "<tag2>", "We", "have", "also", "studied", "or", "have", "ongoing", "studies", "being", "conducted", "for", "etirinotecan", "pegol,", "including", "investigator-initiated", "clinical", "studies,", "in", "bevacizumab", "(Avastin)-resistant", "high-grade", "glioma,", "colorectal", "cancer,", "relapsed", "or", "refractory", "small-cell", "lung", "cancer,", "metastatic", "and", "recurrent", "non-small", "cell", "lung", "cancer,", "and", "ovarian", "cancer.", "<tag3>"], "wordsA": ["We", "have", "also", "studied", "or", "have", "ongoing", "studies", "being", "conducted", "for", "etirinotecan", "pegol,", "including", "investigator-initiated", "clinical", "studies,", "in", "bevacizumab", "(Avastin)-resistant", "high-grade", "glioma,", "colorectal", "cancer,", "metastatic", "and", "recurrent", "non-small", "cell", "lung", "cancer,", "and", "ovarian", "cancer."], "wordsB": ["We", "have", "also", "studied", "or", "have", "ongoing", "studies", "being", "conducted", "for", "etirinotecan", "pegol,", "including", "investigator-initiated", "clinical", "studies,", "in", "bevacizumab", "(Avastin)-resistant", "high-grade", "glioma,", "colorectal", "cancer,", "relapsed", "or", "refractory", "small-cell", "lung", "cancer,", "metastatic", "and", "recurrent", "non-small", "cell", "lung", "cancer,", "and", "ovarian", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p21_s0", "idA": "906709_14_item7_p31_s8", "sentA": "In addition to our etirinotecan pegol development activities, in 2014, we plan to commence Phase 3 clinical studies for NKTR-181 and we also plan to continue to advance the development of NKTR-171.", "sentB": "In addition to product sales from the reagent, we also receive royalty revenues from this collaboration.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "our", "etirinotecan", "pegol", "development", "activities,", "in", "2014,", "we", "plan", "to", "commence", "Phase", "3", "clinical", "studies", "for", "NKTR-181", "and", "we", "also", "plan", "to", "continue", "to", "advance", "the", "development", "of", "NKTR-171.", "<tag2>", "In", "addition", "to", "product", "sales", "from", "the", "reagent,", "we", "also", "receive", "royalty", "revenues", "from", "this", "collaboration.", "<tag3>"], "wordsA": ["In", "addition", "to", "our", "etirinotecan", "pegol", "development", "activities,", "in", "2014,", "we", "plan", "to", "commence", "Phase", "3", "clinical", "studies", "for", "NKTR-181", "and", "we", "also", "plan", "to", "continue", "to", "advance", "the", "development", "of", "NKTR-171."], "wordsB": ["In", "addition", "to", "product", "sales", "from", "the", "reagent,", "we", "also", "receive", "royalty", "revenues", "from", "this", "collaboration."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p26_s1", "idA": "906709_14_item7_p31_s8", "sentA": "In addition to our etirinotecan pegol development activities, in 2014, we plan to commence Phase 3 clinical studies for NKTR-181 and we also plan to continue to advance the development of NKTR-171.", "sentB": "In particular, in 2015, we are commencing Phase 3 clinical studies for NKTR-181.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "our", "etirinotecan", "pegol", "development", "activities,", "in", "2014,", "we", "plan", "to", "commence", "Phase", "3", "clinical", "studies", "for", "NKTR-181", "and", "we", "also", "plan", "to", "continue", "to", "advance", "the", "development", "of", "NKTR-171.", "<tag2>", "In", "particular,", "in", "2015,", "we", "are", "commencing", "Phase", "3", "clinical", "studies", "for", "NKTR-181.", "<tag3>"], "wordsA": ["In", "addition", "to", "our", "etirinotecan", "pegol", "development", "activities,", "in", "2014,", "we", "plan", "to", "commence", "Phase", "3", "clinical", "studies", "for", "NKTR-181", "and", "we", "also", "plan", "to", "continue", "to", "advance", "the", "development", "of", "NKTR-171."], "wordsB": ["In", "particular,", "in", "2015,", "we", "are", "commencing", "Phase", "3", "clinical", "studies", "for", "NKTR-181."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p26_s8", "idA": "906709_14_item7_p31_s8", "sentA": "In addition to our etirinotecan pegol development activities, in 2014, we plan to commence Phase 3 clinical studies for NKTR-181 and we also plan to continue to advance the development of NKTR-171.", "sentB": "In addition to our NKTR-181 and etirinotecan pegol development activities, in 2015, we plan to continue to advance the development of NKTR-171 and NKTR-214.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "our", "etirinotecan", "pegol", "development", "activities,", "in", "2014,", "we", "plan", "to", "commence", "Phase", "3", "clinical", "studies", "for", "NKTR-181", "and", "we", "also", "plan", "to", "continue", "to", "advance", "the", "development", "of", "NKTR-171.", "<tag2>", "In", "addition", "to", "our", "NKTR-181", "and", "etirinotecan", "pegol", "development", "activities,", "in", "2015,", "we", "plan", "to", "continue", "to", "advance", "the", "development", "of", "NKTR-171", "and", "NKTR-214.", "<tag3>"], "wordsA": ["In", "addition", "to", "our", "etirinotecan", "pegol", "development", "activities,", "in", "2014,", "we", "plan", "to", "commence", "Phase", "3", "clinical", "studies", "for", "NKTR-181", "and", "we", "also", "plan", "to", "continue", "to", "advance", "the", "development", "of", "NKTR-171."], "wordsB": ["In", "addition", "to", "our", "NKTR-181", "and", "etirinotecan", "pegol", "development", "activities,", "in", "2015,", "we", "plan", "to", "continue", "to", "advance", "the", "development", "of", "NKTR-171", "and", "NKTR-214."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p28_s1", "idA": "906709_14_item7_p33_s1", "sentA": "Furthermore, our strategy includes the potential of entering into collaborations with third parties to participate in the development and commercialization of some of our drug candidates such as those collaborations that we have already completed for naloxegol and Amikacin Inhale.", "sentB": "Furthermore, our strategy includes the potential of entering into collaborations with third parties to participate in the development and commercialization of some of our drug candidates such as those collaborations that we have already completed for MOVANTIK TM and Amikacin Inhale.", "type": 2, "words": ["<tag1>", "Furthermore,", "our", "strategy", "includes", "the", "potential", "of", "entering", "into", "collaborations", "with", "third", "parties", "to", "participate", "in", "the", "development", "and", "commercialization", "of", "some", "of", "our", "drug", "candidates", "such", "as", "those", "collaborations", "that", "we", "have", "already", "completed", "for", "naloxegol", "and", "Amikacin", "Inhale.", "<tag2>", "Furthermore,", "our", "strategy", "includes", "the", "potential", "of", "entering", "into", "collaborations", "with", "third", "parties", "to", "participate", "in", "the", "development", "and", "commercialization", "of", "some", "of", "our", "drug", "candidates", "such", "as", "those", "collaborations", "that", "we", "have", "already", "completed", "for", "MOVANTIK", "TM", "and", "Amikacin", "Inhale.", "<tag3>"], "wordsA": ["Furthermore,", "our", "strategy", "includes", "the", "potential", "of", "entering", "into", "collaborations", "with", "third", "parties", "to", "participate", "in", "the", "development", "and", "commercialization", "of", "some", "of", "our", "drug", "candidates", "such", "as", "those", "collaborations", "that", "we", "have", "already", "completed", "for", "naloxegol", "and", "Amikacin", "Inhale."], "wordsB": ["Furthermore,", "our", "strategy", "includes", "the", "potential", "of", "entering", "into", "collaborations", "with", "third", "parties", "to", "participate", "in", "the", "development", "and", "commercialization", "of", "some", "of", "our", "drug", "candidates", "such", "as", "those", "collaborations", "that", "we", "have", "already", "completed", "for", "MOVANTIK", "TM", "and", "Amikacin", "Inhale."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p30_s1", "idA": "906709_14_item7_p35_s1", "sentA": "General and administrative expense during the year ended December 31, 2013 was consistent with the year ended December 31, 2012.", "sentB": "General and administrative expense was consistent during the years ended December 31, 2014, 2013 and 2012.", "type": 2, "words": ["<tag1>", "General", "and", "administrative", "expense", "during", "the", "year", "ended", "December", "31,", "2013", "was", "consistent", "with", "the", "year", "ended", "December", "31,", "2012.", "<tag2>", "General", "and", "administrative", "expense", "was", "consistent", "during", "the", "years", "ended", "December", "31,", "2014,", "2013", "and", "2012.", "<tag3>"], "wordsA": ["General", "and", "administrative", "expense", "during", "the", "year", "ended", "December", "31,", "2013", "was", "consistent", "with", "the", "year", "ended", "December", "31,", "2012."], "wordsB": ["General", "and", "administrative", "expense", "was", "consistent", "during", "the", "years", "ended", "December", "31,", "2014,", "2013", "and", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p30_s2", "idA": "906709_14_item7_p35_s3", "sentA": "In 2014, we expect general and administrative expenses to be consistent with 2013.", "sentB": "In 2015, we expect general and administrative expenses to increase compared with 2014.", "type": 2, "words": ["<tag1>", "In", "2014,", "we", "expect", "general", "and", "administrative", "expenses", "to", "be", "consistent", "with", "2013.", "<tag2>", "In", "2015,", "we", "expect", "general", "and", "administrative", "expenses", "to", "increase", "compared", "with", "2014.", "<tag3>"], "wordsA": ["In", "2014,", "we", "expect", "general", "and", "administrative", "expenses", "to", "be", "consistent", "with", "2013."], "wordsB": ["In", "2015,", "we", "expect", "general", "and", "administrative", "expenses", "to", "increase", "compared", "with", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p20_s3", "idA": "906709_14_item7_p36_s1", "sentA": "Interest income for the year ended December 31, 2012 was consistent with the year ended December 31, 2011.", "sentB": "During the year ended December 31, 2014, our gross profit was negative.", "type": 2, "words": ["<tag1>", "Interest", "income", "for", "the", "year", "ended", "December", "31,", "2012", "was", "consistent", "with", "the", "year", "ended", "December", "31,", "2011.", "<tag2>", "During", "the", "year", "ended", "December", "31,", "2014,", "our", "gross", "profit", "was", "negative.", "<tag3>"], "wordsA": ["Interest", "income", "for", "the", "year", "ended", "December", "31,", "2012", "was", "consistent", "with", "the", "year", "ended", "December", "31,", "2011."], "wordsB": ["During", "the", "year", "ended", "December", "31,", "2014,", "our", "gross", "profit", "was", "negative."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p31_s0", "idA": "906709_14_item7_p37_s0", "sentA": "The increase in interest expense for the year ended December 31, 2013 compared to the year ended December 31, 2012 and the year ended December 31, 2011 is attributable to the interest expense recorded on the senior secured notes we issued in 2012.", "sentB": "Interest expense for the year ended December 31, 2014 decreased marginally as compared to the year ended December 31, 2013.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "interest", "expense", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "and", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "interest", "expense", "recorded", "on", "the", "senior", "secured", "notes", "we", "issued", "in", "2012.", "<tag2>", "Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2014", "decreased", "marginally", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2013.", "<tag3>"], "wordsA": ["The", "increase", "in", "interest", "expense", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "and", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "interest", "expense", "recorded", "on", "the", "senior", "secured", "notes", "we", "issued", "in", "2012."], "wordsB": ["Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2014", "decreased", "marginally", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p31_s1", "idA": "906709_14_item7_p37_s0", "sentA": "The increase in interest expense for the year ended December 31, 2013 compared to the year ended December 31, 2012 and the year ended December 31, 2011 is attributable to the interest expense recorded on the senior secured notes we issued in 2012.", "sentB": "The increase in interest expense for the year ended December 31, 2013 compared to the year ended December 31, 2012 is attributable to the interest expense recorded on the senior secured notes we issued in 2012.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "interest", "expense", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "and", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "interest", "expense", "recorded", "on", "the", "senior", "secured", "notes", "we", "issued", "in", "2012.", "<tag2>", "The", "increase", "in", "interest", "expense", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "is", "attributable", "to", "the", "interest", "expense", "recorded", "on", "the", "senior", "secured", "notes", "we", "issued", "in", "2012.", "<tag3>"], "wordsA": ["The", "increase", "in", "interest", "expense", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "and", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "interest", "expense", "recorded", "on", "the", "senior", "secured", "notes", "we", "issued", "in", "2012."], "wordsB": ["The", "increase", "in", "interest", "expense", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "is", "attributable", "to", "the", "interest", "expense", "recorded", "on", "the", "senior", "secured", "notes", "we", "issued", "in", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p32_s0", "idA": "906709_14_item7_p37_s2", "sentA": "In connection with this transaction, we retired a principal amount of $42.5 million of our $215.0 million in aggregate principal amount of 3.25% convertible subordinated notes in exchange for $42.5 million in principal amount of 12% senior secured notes.", "sentB": "of our $215.0 million in aggregate principal amount of 3.25% convertible subordinated notes in exchange for $42.5 million in principal amount of 12% senior secured notes.", "type": 2, "words": ["<tag1>", "In", "connection", "with", "this", "transaction,", "we", "retired", "a", "principal", "amount", "of", "$42.5", "million", "of", "our", "$215.0", "million", "in", "aggregate", "principal", "amount", "of", "3.25%", "convertible", "subordinated", "notes", "in", "exchange", "for", "$42.5", "million", "in", "principal", "amount", "of", "12%", "senior", "secured", "notes.", "<tag2>", "of", "our", "$215.0", "million", "in", "aggregate", "principal", "amount", "of", "3.25%", "convertible", "subordinated", "notes", "in", "exchange", "for", "$42.5", "million", "in", "principal", "amount", "of", "12%", "senior", "secured", "notes.", "<tag3>"], "wordsA": ["In", "connection", "with", "this", "transaction,", "we", "retired", "a", "principal", "amount", "of", "$42.5", "million", "of", "our", "$215.0", "million", "in", "aggregate", "principal", "amount", "of", "3.25%", "convertible", "subordinated", "notes", "in", "exchange", "for", "$42.5", "million", "in", "principal", "amount", "of", "12%", "senior", "secured", "notes."], "wordsB": ["of", "our", "$215.0", "million", "in", "aggregate", "principal", "amount", "of", "3.25%", "convertible", "subordinated", "notes", "in", "exchange", "for", "$42.5", "million", "in", "principal", "amount", "of", "12%", "senior", "secured", "notes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p32_s10", "idA": "906709_14_item7_p37_s4", "sentA": "The increase in non-cash interest expense on liability related to sale of future royalties for the year ended December 31, 2013 compared to the year ended December 31, 2012 and the year ended December 31, 2011 is attributable to the royalty sale transaction that we completed in 2012.", "sentB": "Unless we adjust our estimated interest rate, we expect non-cash interest expense on the liability related to sale of future royalties during the full year of 2015 to be consistent with 2014.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "non-cash", "interest", "expense", "on", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "and", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "royalty", "sale", "transaction", "that", "we", "completed", "in", "2012.", "<tag2>", "Unless", "we", "adjust", "our", "estimated", "interest", "rate,", "we", "expect", "non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "during", "the", "full", "year", "of", "2015", "to", "be", "consistent", "with", "2014.", "<tag3>"], "wordsA": ["The", "increase", "in", "non-cash", "interest", "expense", "on", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "and", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "royalty", "sale", "transaction", "that", "we", "completed", "in", "2012."], "wordsB": ["Unless", "we", "adjust", "our", "estimated", "interest", "rate,", "we", "expect", "non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "during", "the", "full", "year", "of", "2015", "to", "be", "consistent", "with", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p32_s3", "idA": "906709_14_item7_p37_s4", "sentA": "The increase in non-cash interest expense on liability related to sale of future royalties for the year ended December 31, 2013 compared to the year ended December 31, 2012 and the year ended December 31, 2011 is attributable to the royalty sale transaction that we completed in 2012.", "sentB": "Non-cash interest expense on the liability related to sale of future royalties for the year ended December 31, 2014 decreased marginally as compared to the year ended December 31, 2013 due to the decrease in 2014 of the average balance of the related liability.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "non-cash", "interest", "expense", "on", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "and", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "royalty", "sale", "transaction", "that", "we", "completed", "in", "2012.", "<tag2>", "Non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2014", "decreased", "marginally", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "due", "to", "the", "decrease", "in", "2014", "of", "the", "average", "balance", "of", "the", "related", "liability.", "<tag3>"], "wordsA": ["The", "increase", "in", "non-cash", "interest", "expense", "on", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "and", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "royalty", "sale", "transaction", "that", "we", "completed", "in", "2012."], "wordsB": ["Non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2014", "decreased", "marginally", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "due", "to", "the", "decrease", "in", "2014", "of", "the", "average", "balance", "of", "the", "related", "liability."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p32_s4", "idA": "906709_14_item7_p37_s4", "sentA": "The increase in non-cash interest expense on liability related to sale of future royalties for the year ended December 31, 2013 compared to the year ended December 31, 2012 and the year ended December 31, 2011 is attributable to the royalty sale transaction that we completed in 2012.", "sentB": "The increase in non-cash interest expense on liability related to sale of future royalties for the year ended December 31, 2013 compared to the year ended December 31, 2012 is attributable to the timing of the royalty sale transaction that we completed in 2012.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "non-cash", "interest", "expense", "on", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "and", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "royalty", "sale", "transaction", "that", "we", "completed", "in", "2012.", "<tag2>", "The", "increase", "in", "non-cash", "interest", "expense", "on", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "is", "attributable", "to", "the", "timing", "of", "the", "royalty", "sale", "transaction", "that", "we", "completed", "in", "2012.", "<tag3>"], "wordsA": ["The", "increase", "in", "non-cash", "interest", "expense", "on", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "and", "the", "year", "ended", "December", "31,", "2011", "is", "attributable", "to", "the", "royalty", "sale", "transaction", "that", "we", "completed", "in", "2012."], "wordsB": ["The", "increase", "in", "non-cash", "interest", "expense", "on", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "is", "attributable", "to", "the", "timing", "of", "the", "royalty", "sale", "transaction", "that", "we", "completed", "in", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p32_s8", "idA": "906709_14_item7_p37_s8", "sentA": "There are a number of factors that could materially affect the estimated interest rate and we will assess this estimate on a periodic basis.", "sentB": "There are a number of factors that could materially affect the estimated interest rate, in particular, the amount and timing of royalty payments from future net sales of CIMZIA and MIRCERA , and we will assess this estimate on a periodic basis.", "type": 2, "words": ["<tag1>", "There", "are", "a", "number", "of", "factors", "that", "could", "materially", "affect", "the", "estimated", "interest", "rate", "and", "we", "will", "assess", "this", "estimate", "on", "a", "periodic", "basis.", "<tag2>", "There", "are", "a", "number", "of", "factors", "that", "could", "materially", "affect", "the", "estimated", "interest", "rate,", "in", "particular,", "the", "amount", "and", "timing", "of", "royalty", "payments", "from", "future", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", ",", "and", "we", "will", "assess", "this", "estimate", "on", "a", "periodic", "basis.", "<tag3>"], "wordsA": ["There", "are", "a", "number", "of", "factors", "that", "could", "materially", "affect", "the", "estimated", "interest", "rate", "and", "we", "will", "assess", "this", "estimate", "on", "a", "periodic", "basis."], "wordsB": ["There", "are", "a", "number", "of", "factors", "that", "could", "materially", "affect", "the", "estimated", "interest", "rate,", "in", "particular,", "the", "amount", "and", "timing", "of", "royalty", "payments", "from", "future", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", ",", "and", "we", "will", "assess", "this", "estimate", "on", "a", "periodic", "basis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p32_s2", "idA": "906709_14_item7_p38_s0", "sentA": "We expect interest expense and non-cash interest expense in 2014 to be consistent with 2013.", "sentB": "We expect interest expense to increase slightly in 2015 compared to 2014.", "type": 2, "words": ["<tag1>", "We", "expect", "interest", "expense", "and", "non-cash", "interest", "expense", "in", "2014", "to", "be", "consistent", "with", "2013.", "<tag2>", "We", "expect", "interest", "expense", "to", "increase", "slightly", "in", "2015", "compared", "to", "2014.", "<tag3>"], "wordsA": ["We", "expect", "interest", "expense", "and", "non-cash", "interest", "expense", "in", "2014", "to", "be", "consistent", "with", "2013."], "wordsB": ["We", "expect", "interest", "expense", "to", "increase", "slightly", "in", "2015", "compared", "to", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p33_s0", "idA": "906709_14_item7_p39_s0", "sentA": "Liquidity and Capital Resources We have financed our operations primarily through revenue from product sales, royalties and collaboration agreements, as well as public and private placements of debt and equity.", "sentB": "Liquidity and Capital Resources We have financed our operations primarily through revenue from product sales, royalties and research and development contracts, as well as public offering and private placements of debt and equity securities.", "type": 2, "words": ["<tag1>", "Liquidity", "and", "Capital", "Resources", "We", "have", "financed", "our", "operations", "primarily", "through", "revenue", "from", "product", "sales,", "royalties", "and", "collaboration", "agreements,", "as", "well", "as", "public", "and", "private", "placements", "of", "debt", "and", "equity.", "<tag2>", "Liquidity", "and", "Capital", "Resources", "We", "have", "financed", "our", "operations", "primarily", "through", "revenue", "from", "product", "sales,", "royalties", "and", "research", "and", "development", "contracts,", "as", "well", "as", "public", "offering", "and", "private", "placements", "of", "debt", "and", "equity", "securities.", "<tag3>"], "wordsA": ["Liquidity", "and", "Capital", "Resources", "We", "have", "financed", "our", "operations", "primarily", "through", "revenue", "from", "product", "sales,", "royalties", "and", "collaboration", "agreements,", "as", "well", "as", "public", "and", "private", "placements", "of", "debt", "and", "equity."], "wordsB": ["Liquidity", "and", "Capital", "Resources", "We", "have", "financed", "our", "operations", "primarily", "through", "revenue", "from", "product", "sales,", "royalties", "and", "research", "and", "development", "contracts,", "as", "well", "as", "public", "offering", "and", "private", "placements", "of", "debt", "and", "equity", "securities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p12_s3", "idA": "906709_14_item7_p39_s1", "sentA": "At December 31, 2013, we had approximately $262.0 million in cash and investments in marketable securities, of which $25.0 million was restricted in relation to our 12.0% senior secured notes, and $160.8 million in indebtedness.", "sentB": "At December 31, 2014, we had approximately $262.8 million in cash and investments in marketable securities, of which $25.0 million was restricted in relation to our 12.0% senior secured notes, and $151.8 million in indebtedness.", "type": 2, "words": ["<tag1>", "At", "December", "31,", "2013,", "we", "had", "approximately", "$262.0", "million", "in", "cash", "and", "investments", "in", "marketable", "securities,", "of", "which", "$25.0", "million", "was", "restricted", "in", "relation", "to", "our", "12.0%", "senior", "secured", "notes,", "and", "$160.8", "million", "in", "indebtedness.", "<tag2>", "At", "December", "31,", "2014,", "we", "had", "approximately", "$262.8", "million", "in", "cash", "and", "investments", "in", "marketable", "securities,", "of", "which", "$25.0", "million", "was", "restricted", "in", "relation", "to", "our", "12.0%", "senior", "secured", "notes,", "and", "$151.8", "million", "in", "indebtedness.", "<tag3>"], "wordsA": ["At", "December", "31,", "2013,", "we", "had", "approximately", "$262.0", "million", "in", "cash", "and", "investments", "in", "marketable", "securities,", "of", "which", "$25.0", "million", "was", "restricted", "in", "relation", "to", "our", "12.0%", "senior", "secured", "notes,", "and", "$160.8", "million", "in", "indebtedness."], "wordsB": ["At", "December", "31,", "2014,", "we", "had", "approximately", "$262.8", "million", "in", "cash", "and", "investments", "in", "marketable", "securities,", "of", "which", "$25.0", "million", "was", "restricted", "in", "relation", "to", "our", "12.0%", "senior", "secured", "notes,", "and", "$151.8", "million", "in", "indebtedness."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p33_s1", "idA": "906709_14_item7_p39_s1", "sentA": "At December 31, 2013, we had approximately $262.0 million in cash and investments in marketable securities, of which $25.0 million was restricted in relation to our 12.0% senior secured notes, and $160.8 million in indebtedness.", "sentB": "At December 31, 2014, we had approximately $262.8 million in cash and investments in marketable securities, of which $25.0 million was restricted as required by our 12% senior secured notes, and $151.8 million in indebtedness.", "type": 2, "words": ["<tag1>", "At", "December", "31,", "2013,", "we", "had", "approximately", "$262.0", "million", "in", "cash", "and", "investments", "in", "marketable", "securities,", "of", "which", "$25.0", "million", "was", "restricted", "in", "relation", "to", "our", "12.0%", "senior", "secured", "notes,", "and", "$160.8", "million", "in", "indebtedness.", "<tag2>", "At", "December", "31,", "2014,", "we", "had", "approximately", "$262.8", "million", "in", "cash", "and", "investments", "in", "marketable", "securities,", "of", "which", "$25.0", "million", "was", "restricted", "as", "required", "by", "our", "12%", "senior", "secured", "notes,", "and", "$151.8", "million", "in", "indebtedness.", "<tag3>"], "wordsA": ["At", "December", "31,", "2013,", "we", "had", "approximately", "$262.0", "million", "in", "cash", "and", "investments", "in", "marketable", "securities,", "of", "which", "$25.0", "million", "was", "restricted", "in", "relation", "to", "our", "12.0%", "senior", "secured", "notes,", "and", "$160.8", "million", "in", "indebtedness."], "wordsB": ["At", "December", "31,", "2014,", "we", "had", "approximately", "$262.8", "million", "in", "cash", "and", "investments", "in", "marketable", "securities,", "of", "which", "$25.0", "million", "was", "restricted", "as", "required", "by", "our", "12%", "senior", "secured", "notes,", "and", "$151.8", "million", "in", "indebtedness."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p13_s1", "idA": "906709_14_item7_p39_s3", "sentA": "As is further described in Note 7 to our Consolidated Financial Statements, this royalty obligation liability will not generally be settled in cash, but we expect to make a payment of $7.0 million in 2014 as a specified worldwide 2013 net sales threshold of MIRCERA is not expected to be met.", "sentB": "As is further described in Note 7 to our Consolidated Financial Statements, this royalty obligation liability will not be settled in cash.", "type": 2, "words": ["<tag1>", "As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "not", "generally", "be", "settled", "in", "cash,", "but", "we", "expect", "to", "make", "a", "payment", "of", "$7.0", "million", "in", "2014", "as", "a", "specified", "worldwide", "2013", "net", "sales", "threshold", "of", "MIRCERA", "is", "not", "expected", "to", "be", "met.", "<tag2>", "As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash.", "<tag3>"], "wordsA": ["As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "not", "generally", "be", "settled", "in", "cash,", "but", "we", "expect", "to", "make", "a", "payment", "of", "$7.0", "million", "in", "2014", "as", "a", "specified", "worldwide", "2013", "net", "sales", "threshold", "of", "MIRCERA", "is", "not", "expected", "to", "be", "met."], "wordsB": ["As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p33_s3", "idA": "906709_14_item7_p39_s3", "sentA": "As is further described in Note 7 to our Consolidated Financial Statements, this royalty obligation liability will not generally be settled in cash, but we expect to make a payment of $7.0 million in 2014 as a specified worldwide 2013 net sales threshold of MIRCERA is not expected to be met.", "sentB": "As is further described in Note 7 to our Consolidated Financial Statements, this royalty obligation liability will not be settled in cash.", "type": 2, "words": ["<tag1>", "As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "not", "generally", "be", "settled", "in", "cash,", "but", "we", "expect", "to", "make", "a", "payment", "of", "$7.0", "million", "in", "2014", "as", "a", "specified", "worldwide", "2013", "net", "sales", "threshold", "of", "MIRCERA", "is", "not", "expected", "to", "be", "met.", "<tag2>", "As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash.", "<tag3>"], "wordsA": ["As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "not", "generally", "be", "settled", "in", "cash,", "but", "we", "expect", "to", "make", "a", "payment", "of", "$7.0", "million", "in", "2014", "as", "a", "specified", "worldwide", "2013", "net", "sales", "threshold", "of", "MIRCERA", "is", "not", "expected", "to", "be", "met."], "wordsB": ["As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p36_s3", "idA": "906709_14_item7_p39_s3", "sentA": "As is further described in Note 7 to our Consolidated Financial Statements, this royalty obligation liability will not generally be settled in cash, but we expect to make a payment of $7.0 million in 2014 as a specified worldwide 2013 net sales threshold of MIRCERA is not expected to be met.", "sentB": "The remaining $120.5 million royalty obligation liability at December 31, 2014 will not be settled in cash.", "type": 2, "words": ["<tag1>", "As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "not", "generally", "be", "settled", "in", "cash,", "but", "we", "expect", "to", "make", "a", "payment", "of", "$7.0", "million", "in", "2014", "as", "a", "specified", "worldwide", "2013", "net", "sales", "threshold", "of", "MIRCERA", "is", "not", "expected", "to", "be", "met.", "<tag2>", "The", "remaining", "$120.5", "million", "royalty", "obligation", "liability", "at", "December", "31,", "2014", "will", "not", "be", "settled", "in", "cash.", "<tag3>"], "wordsA": ["As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "not", "generally", "be", "settled", "in", "cash,", "but", "we", "expect", "to", "make", "a", "payment", "of", "$7.0", "million", "in", "2014", "as", "a", "specified", "worldwide", "2013", "net", "sales", "threshold", "of", "MIRCERA", "is", "not", "expected", "to", "be", "met."], "wordsB": ["The", "remaining", "$120.5", "million", "royalty", "obligation", "liability", "at", "December", "31,", "2014", "will", "not", "be", "settled", "in", "cash."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p33_s4", "idA": "906709_14_item7_p39_s6", "sentA": "As of December 31, 2013, we estimated that we had at least twelve months of working capital to fund our current business plans.", "sentB": "As of December 31, 2014, we estimated that we had at least twelve months of working capital to fund our current business plans.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2013,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans.", "<tag2>", "As", "of", "December", "31,", "2014,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2013,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans."], "wordsB": ["As", "of", "December", "31,", "2014,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p2_s3", "idA": "906709_14_item7_p3_s0", "sentA": "Our most advanced proprietary product candidate, naloxegol (formerly known as NKTR-118), is an oral peripheral opioid antagonist which has completed Phase 3 clinical studies and has been filed for regulatory approvals in the US, E.U. and Canada for the treatment of opioid-induced constipation (OIC) in patients with non-cancer pain.", "sentB": "MOVANTIK is an oral peripherally-acting opioid antagonist, for the treatment of opioid-induced constipation, or OIC, a side effect caused by chronic administration of prescription opioid pain medicines.", "type": 2, "words": ["<tag1>", "Our", "most", "advanced", "proprietary", "product", "candidate,", "naloxegol", "(formerly", "known", "as", "NKTR-118),", "is", "an", "oral", "peripheral", "opioid", "antagonist", "which", "has", "completed", "Phase", "3", "clinical", "studies", "and", "has", "been", "filed", "for", "regulatory", "approvals", "in", "the", "US,", "E.U.", "and", "Canada", "for", "the", "treatment", "of", "opioid-induced", "constipation", "(OIC)", "in", "patients", "with", "non-cancer", "pain.", "<tag2>", "MOVANTIK", "is", "an", "oral", "peripherally-acting", "opioid", "antagonist,", "for", "the", "treatment", "of", "opioid-induced", "constipation,", "or", "OIC,", "a", "side", "effect", "caused", "by", "chronic", "administration", "of", "prescription", "opioid", "pain", "medicines.", "<tag3>"], "wordsA": ["Our", "most", "advanced", "proprietary", "product", "candidate,", "naloxegol", "(formerly", "known", "as", "NKTR-118),", "is", "an", "oral", "peripheral", "opioid", "antagonist", "which", "has", "completed", "Phase", "3", "clinical", "studies", "and", "has", "been", "filed", "for", "regulatory", "approvals", "in", "the", "US,", "E.U.", "and", "Canada", "for", "the", "treatment", "of", "opioid-induced", "constipation", "(OIC)", "in", "patients", "with", "non-cancer", "pain."], "wordsB": ["MOVANTIK", "is", "an", "oral", "peripherally-acting", "opioid", "antagonist,", "for", "the", "treatment", "of", "opioid-induced", "constipation,", "or", "OIC,", "a", "side", "effect", "caused", "by", "chronic", "administration", "of", "prescription", "opioid", "pain", "medicines."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p3_s0", "idA": "906709_14_item7_p3_s0", "sentA": "Our most advanced proprietary product candidate, naloxegol (formerly known as NKTR-118), is an oral peripheral opioid antagonist which has completed Phase 3 clinical studies and has been filed for regulatory approvals in the US, E.U. and Canada for the treatment of opioid-induced constipation (OIC) in patients with non-cancer pain.", "sentB": "On September 16, 2014, the United States Food and Drug Administration, or FDA, approved MOVANTIK as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain.", "type": 2, "words": ["<tag1>", "Our", "most", "advanced", "proprietary", "product", "candidate,", "naloxegol", "(formerly", "known", "as", "NKTR-118),", "is", "an", "oral", "peripheral", "opioid", "antagonist", "which", "has", "completed", "Phase", "3", "clinical", "studies", "and", "has", "been", "filed", "for", "regulatory", "approvals", "in", "the", "US,", "E.U.", "and", "Canada", "for", "the", "treatment", "of", "opioid-induced", "constipation", "(OIC)", "in", "patients", "with", "non-cancer", "pain.", "<tag2>", "On", "September", "16,", "2014,", "the", "United", "States", "Food", "and", "Drug", "Administration,", "or", "FDA,", "approved", "MOVANTIK", "as", "the", "first", "once-daily", "oral", "peripherally-acting", "mu-opioid", "receptor", "antagonist", "(PAMORA)", "medication", "for", "the", "treatment", "of", "opioid-induced", "constipation", "(OIC),", "in", "adult", "patients", "with", "chronic,", "non-cancer", "pain.", "<tag3>"], "wordsA": ["Our", "most", "advanced", "proprietary", "product", "candidate,", "naloxegol", "(formerly", "known", "as", "NKTR-118),", "is", "an", "oral", "peripheral", "opioid", "antagonist", "which", "has", "completed", "Phase", "3", "clinical", "studies", "and", "has", "been", "filed", "for", "regulatory", "approvals", "in", "the", "US,", "E.U.", "and", "Canada", "for", "the", "treatment", "of", "opioid-induced", "constipation", "(OIC)", "in", "patients", "with", "non-cancer", "pain."], "wordsB": ["On", "September", "16,", "2014,", "the", "United", "States", "Food", "and", "Drug", "Administration,", "or", "FDA,", "approved", "MOVANTIK", "as", "the", "first", "once-daily", "oral", "peripherally-acting", "mu-opioid", "receptor", "antagonist", "(PAMORA)", "medication", "for", "the", "treatment", "of", "opioid-induced", "constipation", "(OIC),", "in", "adult", "patients", "with", "chronic,", "non-cancer", "pain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p2_s2", "idA": "906709_14_item7_p3_s1", "sentA": "We are a party to an exclusive worldwide license agreement with AstraZeneca AB (AstraZeneca) for the global development and commercialization of naloxegol and naloxegol fixed-dose combination products (formerly known as NKTR-119).", "sentB": "In 2014, we achieved the first approval of one of our proprietary drug candidates, MOVANTIK (previously referred to as naloxegol and NKTR-118), under a global license agreement with AstraZeneca.", "type": 2, "words": ["<tag1>", "We", "are", "a", "party", "to", "an", "exclusive", "worldwide", "license", "agreement", "with", "AstraZeneca", "AB", "(AstraZeneca)", "for", "the", "global", "development", "and", "commercialization", "of", "naloxegol", "and", "naloxegol", "fixed-dose", "combination", "products", "(formerly", "known", "as", "NKTR-119).", "<tag2>", "In", "2014,", "we", "achieved", "the", "first", "approval", "of", "one", "of", "our", "proprietary", "drug", "candidates,", "MOVANTIK", "(previously", "referred", "to", "as", "naloxegol", "and", "NKTR-118),", "under", "a", "global", "license", "agreement", "with", "AstraZeneca.", "<tag3>"], "wordsA": ["We", "are", "a", "party", "to", "an", "exclusive", "worldwide", "license", "agreement", "with", "AstraZeneca", "AB", "(AstraZeneca)", "for", "the", "global", "development", "and", "commercialization", "of", "naloxegol", "and", "naloxegol", "fixed-dose", "combination", "products", "(formerly", "known", "as", "NKTR-119)."], "wordsB": ["In", "2014,", "we", "achieved", "the", "first", "approval", "of", "one", "of", "our", "proprietary", "drug", "candidates,", "MOVANTIK", "(previously", "referred", "to", "as", "naloxegol", "and", "NKTR-118),", "under", "a", "global", "license", "agreement", "with", "AstraZeneca."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p33_s5", "idA": "906709_14_item7_p40_s0", "sentA": "a collaboration partnership or obtaining regulatory approval.", "sentB": "We expect the clinical development of our proprietary drug candidates, including etirinotecan pegol, Amikacin Inhale, NKTR-181, and NKTR-171, will require significant investment in order to continue to advance in clinical development with the objective of entering into a collaboration partnership or obtaining regulatory approval.", "type": 2, "words": ["<tag1>", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval.", "<tag2>", "We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates,", "including", "etirinotecan", "pegol,", "Amikacin", "Inhale,", "NKTR-181,", "and", "NKTR-171,", "will", "require", "significant", "investment", "in", "order", "to", "continue", "to", "advance", "in", "clinical", "development", "with", "the", "objective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval.", "<tag3>"], "wordsA": ["a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval."], "wordsB": ["We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates,", "including", "etirinotecan", "pegol,", "Amikacin", "Inhale,", "NKTR-181,", "and", "NKTR-171,", "will", "require", "significant", "investment", "in", "order", "to", "continue", "to", "advance", "in", "clinical", "development", "with", "the", "objective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p34_s2", "idA": "906709_14_item7_p40_s10", "sentA": "Due to the potential for continued uncertainty in the credit markets in 2014 and thereafter, we may experience reduced liquidity with respect to some of our investments in marketable securities.", "sentB": "Due to the potential for adverse developments in the credit markets in 2015 and thereafter, we may experience reduced liquidity with respect to some of our investments in marketable securities.", "type": 2, "words": ["<tag1>", "Due", "to", "the", "potential", "for", "continued", "uncertainty", "in", "the", "credit", "markets", "in", "2014", "and", "thereafter,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities.", "<tag2>", "Due", "to", "the", "potential", "for", "adverse", "developments", "in", "the", "credit", "markets", "in", "2015", "and", "thereafter,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities.", "<tag3>"], "wordsA": ["Due", "to", "the", "potential", "for", "continued", "uncertainty", "in", "the", "credit", "markets", "in", "2014", "and", "thereafter,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities."], "wordsB": ["Due", "to", "the", "potential", "for", "adverse", "developments", "in", "the", "credit", "markets", "in", "2015", "and", "thereafter,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p34_s5", "idA": "906709_14_item7_p40_s13", "sentA": "At December 31, 2013, the average time to maturity of the investments held in our portfolio was approximately five months and the maturity of any single investment did not exceed one year.", "sentB": "At December 31, 2014, the average time to maturity of the investments held in our portfolio was approximately five months and the maturity of any single investment did not exceed one year.", "type": 2, "words": ["<tag1>", "At", "December", "31,", "2013,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "five", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "one", "year.", "<tag2>", "At", "December", "31,", "2014,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "five", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "one", "year.", "<tag3>"], "wordsA": ["At", "December", "31,", "2013,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "five", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "one", "year."], "wordsB": ["At", "December", "31,", "2014,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "five", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "one", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p61_s4", "idA": "906709_14_item7_p40_s13", "sentA": "At December 31, 2013, the average time to maturity of the investments held in our portfolio was approximately five months and the maturity of any single investment did not exceed one year.", "sentB": "As of December 31, 2014, we held $225.5 million of available-for-sale investments, excluding money market funds, with an average time to maturity of five months.", "type": 2, "words": ["<tag1>", "At", "December", "31,", "2013,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "five", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "one", "year.", "<tag2>", "As", "of", "December", "31,", "2014,", "we", "held", "$225.5", "million", "of", "available-for-sale", "investments,", "excluding", "money", "market", "funds,", "with", "an", "average", "time", "to", "maturity", "of", "five", "months.", "<tag3>"], "wordsA": ["At", "December", "31,", "2013,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "five", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "one", "year."], "wordsB": ["As", "of", "December", "31,", "2014,", "we", "held", "$225.5", "million", "of", "available-for-sale", "investments,", "excluding", "money", "market", "funds,", "with", "an", "average", "time", "to", "maturity", "of", "five", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p52_s2", "idA": "906709_14_item7_p40_s14", "sentA": "To date we have not experienced any liquidity issues with respect to these securities, but if such issues arise, we may be required to hold some, or all, of these securities until maturity.", "sentB": "In this event, we may be required to record adjustments to research and development expenses in future periods when the actual level of activity becomes more certain.", "type": 2, "words": ["<tag1>", "To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "if", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity.", "<tag2>", "In", "this", "event,", "we", "may", "be", "required", "to", "record", "adjustments", "to", "research", "and", "development", "expenses", "in", "future", "periods", "when", "the", "actual", "level", "of", "activity", "becomes", "more", "certain.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "if", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity."], "wordsB": ["In", "this", "event,", "we", "may", "be", "required", "to", "record", "adjustments", "to", "research", "and", "development", "expenses", "in", "future", "periods", "when", "the", "actual", "level", "of", "activity", "becomes", "more", "certain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p61_s5", "idA": "906709_14_item7_p40_s14", "sentA": "To date we have not experienced any liquidity issues with respect to these securities, but if such issues arise, we may be required to hold some, or all, of these securities until maturity.", "sentB": "To date we have not experienced any liquidity issues with respect to these securities, but should such issues arise, we may be required to hold some, or all, of these securities until maturity.", "type": 2, "words": ["<tag1>", "To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "if", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity.", "<tag2>", "To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "should", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "if", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity."], "wordsB": ["To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "should", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p61_s6", "idA": "906709_14_item7_p40_s15", "sentA": "We believe that, even allowing for potential liquidity issues with respect to these securities, our remaining cash and investments in marketable securities will be sufficient to meet our anticipated cash needs for at least the next twelve months.", "sentB": "We believe that, even allowing for potential liquidity issues with respect to these securities, our remaining cash, cash equivalents, and investments will be sufficient to meet our anticipated cash needs for at least the next twelve months.", "type": 2, "words": ["<tag1>", "We", "believe", "that,", "even", "allowing", "for", "potential", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "our", "remaining", "cash", "and", "investments", "in", "marketable", "securities", "will", "be", "sufficient", "to", "meet", "our", "anticipated", "cash", "needs", "for", "at", "least", "the", "next", "twelve", "months.", "<tag2>", "We", "believe", "that,", "even", "allowing", "for", "potential", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "our", "remaining", "cash,", "cash", "equivalents,", "and", "investments", "will", "be", "sufficient", "to", "meet", "our", "anticipated", "cash", "needs", "for", "at", "least", "the", "next", "twelve", "months.", "<tag3>"], "wordsA": ["We", "believe", "that,", "even", "allowing", "for", "potential", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "our", "remaining", "cash", "and", "investments", "in", "marketable", "securities", "will", "be", "sufficient", "to", "meet", "our", "anticipated", "cash", "needs", "for", "at", "least", "the", "next", "twelve", "months."], "wordsB": ["We", "believe", "that,", "even", "allowing", "for", "potential", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "our", "remaining", "cash,", "cash", "equivalents,", "and", "investments", "will", "be", "sufficient", "to", "meet", "our", "anticipated", "cash", "needs", "for", "at", "least", "the", "next", "twelve", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p33_s7", "idA": "906709_14_item7_p40_s2", "sentA": "In addition, while in the past we have received a number of significant payments from license and collaboration agreements and other significant transactions, we do not currently anticipate completing new transactions with substantial upfront payments in the near-term.", "sentB": "In the past we have received a number of significant payments from collaboration agreements and other significant transactions.", "type": 2, "words": ["<tag1>", "In", "addition,", "while", "in", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "license", "and", "collaboration", "agreements", "and", "other", "significant", "transactions,", "we", "do", "not", "currently", "anticipate", "completing", "new", "transactions", "with", "substantial", "upfront", "payments", "in", "the", "near-term.", "<tag2>", "In", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "collaboration", "agreements", "and", "other", "significant", "transactions.", "<tag3>"], "wordsA": ["In", "addition,", "while", "in", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "license", "and", "collaboration", "agreements", "and", "other", "significant", "transactions,", "we", "do", "not", "currently", "anticipate", "completing", "new", "transactions", "with", "substantial", "upfront", "payments", "in", "the", "near-term."], "wordsB": ["In", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "collaboration", "agreements", "and", "other", "significant", "transactions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p33_s9", "idA": "906709_14_item7_p40_s3", "sentA": "Our current business plan is also subject to significant uncertainties and risks as a result of, among other factors, expenses being higher than anticipated, unplanned expenses, cash receipts being lower than anticipated, and the need to satisfy contingent liabilities, including litigation matters and indemnification obligations.", "sentB": "Our current business plan is also subject to significant uncertainties and risks as a result of, among other factors, the sales levels of products for which we are entitled to royalties such as MOVANTIK , clinical program outcomes, whether, when and on what terms we are able to enter into new collaboration transactions, expenses being higher than anticipated, unplanned expenses, cash receipts being lower than anticipated, and the need to satisfy contingent liabilities, including litigation matters and indemnification obligations.", "type": 2, "words": ["<tag1>", "Our", "current", "business", "plan", "is", "also", "subject", "to", "significant", "uncertainties", "and", "risks", "as", "a", "result", "of,", "among", "other", "factors,", "expenses", "being", "higher", "than", "anticipated,", "unplanned", "expenses,", "cash", "receipts", "being", "lower", "than", "anticipated,", "and", "the", "need", "to", "satisfy", "contingent", "liabilities,", "including", "litigation", "matters", "and", "indemnification", "obligations.", "<tag2>", "Our", "current", "business", "plan", "is", "also", "subject", "to", "significant", "uncertainties", "and", "risks", "as", "a", "result", "of,", "among", "other", "factors,", "the", "sales", "levels", "of", "products", "for", "which", "we", "are", "entitled", "to", "royalties", "such", "as", "MOVANTIK", ",", "clinical", "program", "outcomes,", "whether,", "when", "and", "on", "what", "terms", "we", "are", "able", "to", "enter", "into", "new", "collaboration", "transactions,", "expenses", "being", "higher", "than", "anticipated,", "unplanned", "expenses,", "cash", "receipts", "being", "lower", "than", "anticipated,", "and", "the", "need", "to", "satisfy", "contingent", "liabilities,", "including", "litigation", "matters", "and", "indemnification", "obligations.", "<tag3>"], "wordsA": ["Our", "current", "business", "plan", "is", "also", "subject", "to", "significant", "uncertainties", "and", "risks", "as", "a", "result", "of,", "among", "other", "factors,", "expenses", "being", "higher", "than", "anticipated,", "unplanned", "expenses,", "cash", "receipts", "being", "lower", "than", "anticipated,", "and", "the", "need", "to", "satisfy", "contingent", "liabilities,", "including", "litigation", "matters", "and", "indemnification", "obligations."], "wordsB": ["Our", "current", "business", "plan", "is", "also", "subject", "to", "significant", "uncertainties", "and", "risks", "as", "a", "result", "of,", "among", "other", "factors,", "the", "sales", "levels", "of", "products", "for", "which", "we", "are", "entitled", "to", "royalties", "such", "as", "MOVANTIK", ",", "clinical", "program", "outcomes,", "whether,", "when", "and", "on", "what", "terms", "we", "are", "able", "to", "enter", "into", "new", "collaboration", "transactions,", "expenses", "being", "higher", "than", "anticipated,", "unplanned", "expenses,", "cash", "receipts", "being", "lower", "than", "anticipated,", "and", "the", "need", "to", "satisfy", "contingent", "liabilities,", "including", "litigation", "matters", "and", "indemnification", "obligations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p33_s10", "idA": "906709_14_item7_p40_s4", "sentA": "The availability and terms of various financing alternatives substantially depend on the success or failure of our drug development programs, including naloxegol, etirinotecan pegol, BAX 855, Amikacin Inhale, NKTR-181, and NKTR-171.", "sentB": "The availability and terms of various financing alternatives substantially depend on many factors including the success or failure of drug development programs in our pipeline, including etirinotecan pegol, BAX 855, Amikacin Inhale, NKTR-181, NKTR-171, NKTR-214, as well as other early stage development programs.", "type": 2, "words": ["<tag1>", "The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "the", "success", "or", "failure", "of", "our", "drug", "development", "programs,", "including", "naloxegol,", "etirinotecan", "pegol,", "BAX", "855,", "Amikacin", "Inhale,", "NKTR-181,", "and", "NKTR-171.", "<tag2>", "The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "many", "factors", "including", "the", "success", "or", "failure", "of", "drug", "development", "programs", "in", "our", "pipeline,", "including", "etirinotecan", "pegol,", "BAX", "855,", "Amikacin", "Inhale,", "NKTR-181,", "NKTR-171,", "NKTR-214,", "as", "well", "as", "other", "early", "stage", "development", "programs.", "<tag3>"], "wordsA": ["The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "the", "success", "or", "failure", "of", "our", "drug", "development", "programs,", "including", "naloxegol,", "etirinotecan", "pegol,", "BAX", "855,", "Amikacin", "Inhale,", "NKTR-181,", "and", "NKTR-171."], "wordsB": ["The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "many", "factors", "including", "the", "success", "or", "failure", "of", "drug", "development", "programs", "in", "our", "pipeline,", "including", "etirinotecan", "pegol,", "BAX", "855,", "Amikacin", "Inhale,", "NKTR-181,", "NKTR-171,", "NKTR-214,", "as", "well", "as", "other", "early", "stage", "development", "programs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p34_s0", "idA": "906709_14_item7_p40_s5", "sentA": "The availability and terms of financing alternatives and any future significant payments from existing or new collaborations all depend on the positive outcome of ongoing or planned clinical studies, whether we or our partners are successful in obtaining health authority approvals in major markets, and if approved, the commercial success of these drugs.", "sentB": "are successful in obtaining health authority approvals in major markets, and if approved, the commercial success of these drugs, as well as general capital market conditions.", "type": 2, "words": ["<tag1>", "The", "availability", "and", "terms", "of", "financing", "alternatives", "and", "any", "future", "significant", "payments", "from", "existing", "or", "new", "collaborations", "all", "depend", "on", "the", "positive", "outcome", "of", "ongoing", "or", "planned", "clinical", "studies,", "whether", "we", "or", "our", "partners", "are", "successful", "in", "obtaining", "health", "authority", "approvals", "in", "major", "markets,", "and", "if", "approved,", "the", "commercial", "success", "of", "these", "drugs.", "<tag2>", "are", "successful", "in", "obtaining", "health", "authority", "approvals", "in", "major", "markets,", "and", "if", "approved,", "the", "commercial", "success", "of", "these", "drugs,", "as", "well", "as", "general", "capital", "market", "conditions.", "<tag3>"], "wordsA": ["The", "availability", "and", "terms", "of", "financing", "alternatives", "and", "any", "future", "significant", "payments", "from", "existing", "or", "new", "collaborations", "all", "depend", "on", "the", "positive", "outcome", "of", "ongoing", "or", "planned", "clinical", "studies,", "whether", "we", "or", "our", "partners", "are", "successful", "in", "obtaining", "health", "authority", "approvals", "in", "major", "markets,", "and", "if", "approved,", "the", "commercial", "success", "of", "these", "drugs."], "wordsB": ["are", "successful", "in", "obtaining", "health", "authority", "approvals", "in", "major", "markets,", "and", "if", "approved,", "the", "commercial", "success", "of", "these", "drugs,", "as", "well", "as", "general", "capital", "market", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p35_s0", "idA": "906709_14_item7_p41_s0", "sentA": "Cash flows from operating activities Cash flows used in operating activities for the year ended December 31, 2013 totaled $38.5 million, which includes $158.3 million of net operating cash uses as well as $15.2 million for interest payments on our senior secured notes, partially offset by the receipt of $135.0 million for milestones from collaboration agreements.", "sentB": "Cash flows from operating activities Cash flows used in operating activities for the year ended December 31, 2014 totaled $142.0 million, which includes $199.0 million of net operating cash uses as well as $15.0 million for interest payments on our senior secured notes, partially offset by the receipt of $72.0 million of milestones from collaboration agreements.", "type": 2, "words": ["<tag1>", "Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2013", "totaled", "$38.5", "million,", "which", "includes", "$158.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$15.2", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$135.0", "million", "for", "milestones", "from", "collaboration", "agreements.", "<tag2>", "Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2014", "totaled", "$142.0", "million,", "which", "includes", "$199.0", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$15.0", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$72.0", "million", "of", "milestones", "from", "collaboration", "agreements.", "<tag3>"], "wordsA": ["Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2013", "totaled", "$38.5", "million,", "which", "includes", "$158.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$15.2", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$135.0", "million", "for", "milestones", "from", "collaboration", "agreements."], "wordsB": ["Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2014", "totaled", "$142.0", "million,", "which", "includes", "$199.0", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$15.0", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$72.0", "million", "of", "milestones", "from", "collaboration", "agreements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p35_s3", "idA": "906709_14_item7_p41_s0", "sentA": "Cash flows from operating activities Cash flows used in operating activities for the year ended December 31, 2013 totaled $38.5 million, which includes $158.3 million of net operating cash uses as well as $15.2 million for interest payments on our senior secured notes, partially offset by the receipt of $135.0 million for milestones from collaboration agreements.", "sentB": "Cash flows used in operating activities for the year ended December 31, 2013 totaled $38.5 million, which includes $158.3 million of net operating cash uses as well as $15.2 million for interest payments on our senior secured notes, partially offset by the receipt of $135.0 million for milestones from collaboration agreements.", "type": 2, "words": ["<tag1>", "Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2013", "totaled", "$38.5", "million,", "which", "includes", "$158.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$15.2", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$135.0", "million", "for", "milestones", "from", "collaboration", "agreements.", "<tag2>", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2013", "totaled", "$38.5", "million,", "which", "includes", "$158.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$15.2", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$135.0", "million", "for", "milestones", "from", "collaboration", "agreements.", "<tag3>"], "wordsA": ["Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2013", "totaled", "$38.5", "million,", "which", "includes", "$158.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$15.2", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$135.0", "million", "for", "milestones", "from", "collaboration", "agreements."], "wordsB": ["Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2013", "totaled", "$38.5", "million,", "which", "includes", "$158.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$15.2", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$135.0", "million", "for", "milestones", "from", "collaboration", "agreements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p35_s2", "idA": "906709_14_item7_p41_s1", "sentA": "We expect that cash flows used in operating activities, excluding upfront and milestone payments received, if any, will increase in 2014 as a result of increased spending on our proprietary research and development programs.", "sentB": "We expect that cash flows used in operating activities, excluding upfront and milestone payments received, if any, will increase in 2015 as a result of increased spending on our proprietary research and development programs, including the initiation of the Phase 3 clinical program for NKTR-181.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront", "and", "milestone", "payments", "received,", "if", "any,", "will", "increase", "in", "2014", "as", "a", "result", "of", "increased", "spending", "on", "our", "proprietary", "research", "and", "development", "programs.", "<tag2>", "We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront", "and", "milestone", "payments", "received,", "if", "any,", "will", "increase", "in", "2015", "as", "a", "result", "of", "increased", "spending", "on", "our", "proprietary", "research", "and", "development", "programs,", "including", "the", "initiation", "of", "the", "Phase", "3", "clinical", "program", "for", "NKTR-181.", "<tag3>"], "wordsA": ["We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront", "and", "milestone", "payments", "received,", "if", "any,", "will", "increase", "in", "2014", "as", "a", "result", "of", "increased", "spending", "on", "our", "proprietary", "research", "and", "development", "programs."], "wordsB": ["We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront", "and", "milestone", "payments", "received,", "if", "any,", "will", "increase", "in", "2015", "as", "a", "result", "of", "increased", "spending", "on", "our", "proprietary", "research", "and", "development", "programs,", "including", "the", "initiation", "of", "the", "Phase", "3", "clinical", "program", "for", "NKTR-181."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p35_s6", "idA": "906709_14_item7_p42_s1", "sentA": "Cash flows from investing activities We paid $4.1 million, $10.6 million, and $9.7 million to purchase property and equipment in the years ended December 31, 2013, 2012, and 2011, respectively.", "sentB": "Cash flows from investing activities We paid $10.0 million, $4.1 million, and $10.6 million to purchase property and equipment in the years ended December 31, 2014, 2013, and 2012, respectively.", "type": 2, "words": ["<tag1>", "Cash", "flows", "from", "investing", "activities", "We", "paid", "$4.1", "million,", "$10.6", "million,", "and", "$9.7", "million", "to", "purchase", "property", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2013,", "2012,", "and", "2011,", "respectively.", "<tag2>", "Cash", "flows", "from", "investing", "activities", "We", "paid", "$10.0", "million,", "$4.1", "million,", "and", "$10.6", "million", "to", "purchase", "property", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2014,", "2013,", "and", "2012,", "respectively.", "<tag3>"], "wordsA": ["Cash", "flows", "from", "investing", "activities", "We", "paid", "$4.1", "million,", "$10.6", "million,", "and", "$9.7", "million", "to", "purchase", "property", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2013,", "2012,", "and", "2011,", "respectively."], "wordsB": ["Cash", "flows", "from", "investing", "activities", "We", "paid", "$10.0", "million,", "$4.1", "million,", "and", "$10.6", "million", "to", "purchase", "property", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2014,", "2013,", "and", "2012,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p35_s7", "idA": "906709_14_item7_p42_s2", "sentA": "We expect our capital expenditures in 2014 to increase significantly as compared to 2013 primarily as a result of our plan to build commercial manufacturing capability for the devices for the Amikacin Inhale program.", "sentB": "We expect our capital expenditures in 2015 to increase as compared to 2014 primarily as a result of our plan to continue to build commercial manufacturing capacity for Amikacin Inhale devices.", "type": 2, "words": ["<tag1>", "We", "expect", "our", "capital", "expenditures", "in", "2014", "to", "increase", "significantly", "as", "compared", "to", "2013", "primarily", "as", "a", "result", "of", "our", "plan", "to", "build", "commercial", "manufacturing", "capability", "for", "the", "devices", "for", "the", "Amikacin", "Inhale", "program.", "<tag2>", "We", "expect", "our", "capital", "expenditures", "in", "2015", "to", "increase", "as", "compared", "to", "2014", "primarily", "as", "a", "result", "of", "our", "plan", "to", "continue", "to", "build", "commercial", "manufacturing", "capacity", "for", "Amikacin", "Inhale", "devices.", "<tag3>"], "wordsA": ["We", "expect", "our", "capital", "expenditures", "in", "2014", "to", "increase", "significantly", "as", "compared", "to", "2013", "primarily", "as", "a", "result", "of", "our", "plan", "to", "build", "commercial", "manufacturing", "capability", "for", "the", "devices", "for", "the", "Amikacin", "Inhale", "program."], "wordsB": ["We", "expect", "our", "capital", "expenditures", "in", "2015", "to", "increase", "as", "compared", "to", "2014", "primarily", "as", "a", "result", "of", "our", "plan", "to", "continue", "to", "build", "commercial", "manufacturing", "capacity", "for", "Amikacin", "Inhale", "devices."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p36_s2", "idA": "906709_14_item7_p42_s5", "sentA": "During the year ended December 31, 2013, we made a $3.0 million payment to the purchaser of these royalties because the minimum 2012 MIRCERA net sales threshold was not met.", "sentB": "During the years ended December 31, 2014 and 2013, we made payments of $7.0 million and $3.0 million, respectively, to the purchaser of these royalties because certain minimum MIRCERA net sales thresholds were not met.", "type": 2, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2013,", "we", "made", "a", "$3.0", "million", "payment", "to", "the", "purchaser", "of", "these", "royalties", "because", "the", "minimum", "2012", "MIRCERA", "net", "sales", "threshold", "was", "not", "met.", "<tag2>", "During", "the", "years", "ended", "December", "31,", "2014", "and", "2013,", "we", "made", "payments", "of", "$7.0", "million", "and", "$3.0", "million,", "respectively,", "to", "the", "purchaser", "of", "these", "royalties", "because", "certain", "minimum", "MIRCERA", "net", "sales", "thresholds", "were", "not", "met.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2013,", "we", "made", "a", "$3.0", "million", "payment", "to", "the", "purchaser", "of", "these", "royalties", "because", "the", "minimum", "2012", "MIRCERA", "net", "sales", "threshold", "was", "not", "met."], "wordsB": ["During", "the", "years", "ended", "December", "31,", "2014", "and", "2013,", "we", "made", "payments", "of", "$7.0", "million", "and", "$3.0", "million,", "respectively,", "to", "the", "purchaser", "of", "these", "royalties", "because", "certain", "minimum", "MIRCERA", "net", "sales", "thresholds", "were", "not", "met."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p36_s9", "idA": "906709_14_item7_p43_s2", "sentA": "We received proceeds from issuance of common stock related to our employee option and stock purchase plans of $8.2 million, $4.1 million, and $4.5 million in the years ended December 31, 2013, 2012, and 2011, respectively.", "sentB": "We received proceeds from issuance of common stock related to our employee option and stock purchase plans of $47.0 million, $8.2 million, and $4.1 million in the years ended December 31, 2014, 2013, and 2012, respectively.", "type": 2, "words": ["<tag1>", "We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$8.2", "million,", "$4.1", "million,", "and", "$4.5", "million", "in", "the", "years", "ended", "December", "31,", "2013,", "2012,", "and", "2011,", "respectively.", "<tag2>", "We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$47.0", "million,", "$8.2", "million,", "and", "$4.1", "million", "in", "the", "years", "ended", "December", "31,", "2014,", "2013,", "and", "2012,", "respectively.", "<tag3>"], "wordsA": ["We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$8.2", "million,", "$4.1", "million,", "and", "$4.5", "million", "in", "the", "years", "ended", "December", "31,", "2013,", "2012,", "and", "2011,", "respectively."], "wordsB": ["We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$47.0", "million,", "$8.2", "million,", "and", "$4.1", "million", "in", "the", "years", "ended", "December", "31,", "2014,", "2013,", "and", "2012,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p35_s9", "idA": "906709_14_item7_p43_s4", "sentA": "Additionally, we incurred approximately $0.6 million in legal and accounting fees, filing fees, and other offering expenses.", "sentB": "In addition, we incurred approximately $0.6 million in legal and accounting fees, filing fees, and other costs in connection with this offering.", "type": 2, "words": ["<tag1>", "Additionally,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses.", "<tag2>", "In", "addition,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "costs", "in", "connection", "with", "this", "offering.", "<tag3>"], "wordsA": ["Additionally,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "offering", "expenses."], "wordsB": ["In", "addition,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "costs", "in", "connection", "with", "this", "offering."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p38_s1", "idA": "906709_14_item7_p45_s1", "sentA": "Under the terms of the sublease we entered into with Pfizer Inc. on September 30, 2009 for the Mission Bay Facility, we will begin making non-cancelable lease payments in 2014.", "sentB": "Under the terms of the sublease we entered into with Pfizer Inc. on September 30, 2009 for the Mission Bay Facility, we began making non-cancelable lease payments in 2014.", "type": 2, "words": ["<tag1>", "Under", "the", "terms", "of", "the", "sublease", "we", "entered", "into", "with", "Pfizer", "Inc.", "on", "September", "30,", "2009", "for", "the", "Mission", "Bay", "Facility,", "we", "will", "begin", "making", "non-cancelable", "lease", "payments", "in", "2014.", "<tag2>", "Under", "the", "terms", "of", "the", "sublease", "we", "entered", "into", "with", "Pfizer", "Inc.", "on", "September", "30,", "2009", "for", "the", "Mission", "Bay", "Facility,", "we", "began", "making", "non-cancelable", "lease", "payments", "in", "2014.", "<tag3>"], "wordsA": ["Under", "the", "terms", "of", "the", "sublease", "we", "entered", "into", "with", "Pfizer", "Inc.", "on", "September", "30,", "2009", "for", "the", "Mission", "Bay", "Facility,", "we", "will", "begin", "making", "non-cancelable", "lease", "payments", "in", "2014."], "wordsB": ["Under", "the", "terms", "of", "the", "sublease", "we", "entered", "into", "with", "Pfizer", "Inc.", "on", "September", "30,", "2009", "for", "the", "Mission", "Bay", "Facility,", "we", "began", "making", "non-cancelable", "lease", "payments", "in", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p39_s4", "idA": "906709_14_item7_p46_s3", "sentA": "This is further discussed in Note 6 of Item 8.", "sentB": "In addition, these amounts include our obligation to purchase manufacturing equipment supporting our Amikacin Inhale program, which is further discussed in Note 4 of Item 8.", "type": 2, "words": ["<tag1>", "This", "is", "further", "discussed", "in", "Note", "6", "of", "Item", "8.", "<tag2>", "In", "addition,", "these", "amounts", "include", "our", "obligation", "to", "purchase", "manufacturing", "equipment", "supporting", "our", "Amikacin", "Inhale", "program,", "which", "is", "further", "discussed", "in", "Note", "4", "of", "Item", "8.", "<tag3>"], "wordsA": ["This", "is", "further", "discussed", "in", "Note", "6", "of", "Item", "8."], "wordsB": ["In", "addition,", "these", "amounts", "include", "our", "obligation", "to", "purchase", "manufacturing", "equipment", "supporting", "our", "Amikacin", "Inhale", "program,", "which", "is", "further", "discussed", "in", "Note", "4", "of", "Item", "8."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p40_s0", "idA": "906709_14_item7_p47_s0", "sentA": "(4) Substantially all of this amount was subject to open purchase orders as of December 31, 2013 that were issued under existing contracts.", "sentB": "(4) Substantially all of this amount was subject to open purchase orders as of December 31, 2014 that were issued under existing contracts.", "type": 2, "words": ["<tag1>", "(4)", "Substantially", "all", "of", "this", "amount", "was", "subject", "to", "open", "purchase", "orders", "as", "of", "December", "31,", "2013", "that", "were", "issued", "under", "existing", "contracts.", "<tag2>", "(4)", "Substantially", "all", "of", "this", "amount", "was", "subject", "to", "open", "purchase", "orders", "as", "of", "December", "31,", "2014", "that", "were", "issued", "under", "existing", "contracts.", "<tag3>"], "wordsA": ["(4)", "Substantially", "all", "of", "this", "amount", "was", "subject", "to", "open", "purchase", "orders", "as", "of", "December", "31,", "2013", "that", "were", "issued", "under", "existing", "contracts."], "wordsB": ["(4)", "Substantially", "all", "of", "this", "amount", "was", "subject", "to", "open", "purchase", "orders", "as", "of", "December", "31,", "2014", "that", "were", "issued", "under", "existing", "contracts."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p62_s3", "idA": "906709_14_item7_p48_s0", "sentA": "We do not utilize off-balance sheet financing arrangements as a source of liquidity or financing.", "sentB": "We do not utilize derivative financial instruments to manage our exchange rate risks.", "type": 2, "words": ["<tag1>", "We", "do", "not", "utilize", "off-balance", "sheet", "financing", "arrangements", "as", "a", "source", "of", "liquidity", "or", "financing.", "<tag2>", "We", "do", "not", "utilize", "derivative", "financial", "instruments", "to", "manage", "our", "exchange", "rate", "risks.", "<tag3>"], "wordsA": ["We", "do", "not", "utilize", "off-balance", "sheet", "financing", "arrangements", "as", "a", "source", "of", "liquidity", "or", "financing."], "wordsB": ["We", "do", "not", "utilize", "derivative", "financial", "instruments", "to", "manage", "our", "exchange", "rate", "risks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p11_s11", "idA": "906709_14_item7_p4_s0", "sentA": "The core Phase 3 clinical development program for naloxegol, which AstraZeneca calls the KODIAC program, is comprised of four clinical trials which are designed to investigate the safety and efficacy of naloxegol for the treatment of OIC in patients with non-cancer related pain.", "sentB": "We have an ongoing Phase 1 clinical development program for NKTR-171, a new sodium channel blocker being developed as a potential oral therapy for the treatment of peripheral neuropathic pain.", "type": 2, "words": ["<tag1>", "The", "core", "Phase", "3", "clinical", "development", "program", "for", "naloxegol,", "which", "AstraZeneca", "calls", "the", "KODIAC", "program,", "is", "comprised", "of", "four", "clinical", "trials", "which", "are", "designed", "to", "investigate", "the", "safety", "and", "efficacy", "of", "naloxegol", "for", "the", "treatment", "of", "OIC", "in", "patients", "with", "non-cancer", "related", "pain.", "<tag2>", "We", "have", "an", "ongoing", "Phase", "1", "clinical", "development", "program", "for", "NKTR-171,", "a", "new", "sodium", "channel", "blocker", "being", "developed", "as", "a", "potential", "oral", "therapy", "for", "the", "treatment", "of", "peripheral", "neuropathic", "pain.", "<tag3>"], "wordsA": ["The", "core", "Phase", "3", "clinical", "development", "program", "for", "naloxegol,", "which", "AstraZeneca", "calls", "the", "KODIAC", "program,", "is", "comprised", "of", "four", "clinical", "trials", "which", "are", "designed", "to", "investigate", "the", "safety", "and", "efficacy", "of", "naloxegol", "for", "the", "treatment", "of", "OIC", "in", "patients", "with", "non-cancer", "related", "pain."], "wordsB": ["We", "have", "an", "ongoing", "Phase", "1", "clinical", "development", "program", "for", "NKTR-171,", "a", "new", "sodium", "channel", "blocker", "being", "developed", "as", "a", "potential", "oral", "therapy", "for", "the", "treatment", "of", "peripheral", "neuropathic", "pain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p3_s1", "idA": "906709_14_item7_p4_s0", "sentA": "The core Phase 3 clinical development program for naloxegol, which AstraZeneca calls the KODIAC program, is comprised of four clinical trials which are designed to investigate the safety and efficacy of naloxegol for the treatment of OIC in patients with non-cancer related pain.", "sentB": "On December 9, 2014, the European Commission, or EC, granted Marketing Authorisation to MOVENTIG (the naloxegol brand name in the European Union, or EU) as the first once-daily oral PAMORA to be approved in the European Union (EU) for the treatment of OIC in adult patients who have had an inadequate response to laxative(s).", "type": 2, "words": ["<tag1>", "The", "core", "Phase", "3", "clinical", "development", "program", "for", "naloxegol,", "which", "AstraZeneca", "calls", "the", "KODIAC", "program,", "is", "comprised", "of", "four", "clinical", "trials", "which", "are", "designed", "to", "investigate", "the", "safety", "and", "efficacy", "of", "naloxegol", "for", "the", "treatment", "of", "OIC", "in", "patients", "with", "non-cancer", "related", "pain.", "<tag2>", "On", "December", "9,", "2014,", "the", "European", "Commission,", "or", "EC,", "granted", "Marketing", "Authorisation", "to", "MOVENTIG", "(the", "naloxegol", "brand", "name", "in", "the", "European", "Union,", "or", "EU)", "as", "the", "first", "once-daily", "oral", "PAMORA", "to", "be", "approved", "in", "the", "European", "Union", "(EU)", "for", "the", "treatment", "of", "OIC", "in", "adult", "patients", "who", "have", "had", "an", "inadequate", "response", "to", "laxative(s).", "<tag3>"], "wordsA": ["The", "core", "Phase", "3", "clinical", "development", "program", "for", "naloxegol,", "which", "AstraZeneca", "calls", "the", "KODIAC", "program,", "is", "comprised", "of", "four", "clinical", "trials", "which", "are", "designed", "to", "investigate", "the", "safety", "and", "efficacy", "of", "naloxegol", "for", "the", "treatment", "of", "OIC", "in", "patients", "with", "non-cancer", "related", "pain."], "wordsB": ["On", "December", "9,", "2014,", "the", "European", "Commission,", "or", "EC,", "granted", "Marketing", "Authorisation", "to", "MOVENTIG", "(the", "naloxegol", "brand", "name", "in", "the", "European", "Union,", "or", "EU)", "as", "the", "first", "once-daily", "oral", "PAMORA", "to", "be", "approved", "in", "the", "European", "Union", "(EU)", "for", "the", "treatment", "of", "OIC", "in", "adult", "patients", "who", "have", "had", "an", "inadequate", "response", "to", "laxative(s)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p44_s2", "idA": "906709_14_item7_p52_s1", "sentA": "Management makes its best estimate of the period over which we expect to fulfill our performance obligations, which may include technology transfer assistance, clinical development activities, or manufacturing activities through the completion of clinical development or the termination or expiration of the collaboration agreement.", "sentB": "Management makes its best estimate of the period over which we expect to fulfill our performance obligations, which may include technology transfer assistance, research and development activities, or manufacturing activities through the completion of clinical development or the termination or expiration of the collaboration agreement.", "type": 2, "words": ["<tag1>", "Management", "makes", "its", "best", "estimate", "of", "the", "period", "over", "which", "we", "expect", "to", "fulfill", "our", "performance", "obligations,", "which", "may", "include", "technology", "transfer", "assistance,", "clinical", "development", "activities,", "or", "manufacturing", "activities", "through", "the", "completion", "of", "clinical", "development", "or", "the", "termination", "or", "expiration", "of", "the", "collaboration", "agreement.", "<tag2>", "Management", "makes", "its", "best", "estimate", "of", "the", "period", "over", "which", "we", "expect", "to", "fulfill", "our", "performance", "obligations,", "which", "may", "include", "technology", "transfer", "assistance,", "research", "and", "development", "activities,", "or", "manufacturing", "activities", "through", "the", "completion", "of", "clinical", "development", "or", "the", "termination", "or", "expiration", "of", "the", "collaboration", "agreement.", "<tag3>"], "wordsA": ["Management", "makes", "its", "best", "estimate", "of", "the", "period", "over", "which", "we", "expect", "to", "fulfill", "our", "performance", "obligations,", "which", "may", "include", "technology", "transfer", "assistance,", "clinical", "development", "activities,", "or", "manufacturing", "activities", "through", "the", "completion", "of", "clinical", "development", "or", "the", "termination", "or", "expiration", "of", "the", "collaboration", "agreement."], "wordsB": ["Management", "makes", "its", "best", "estimate", "of", "the", "period", "over", "which", "we", "expect", "to", "fulfill", "our", "performance", "obligations,", "which", "may", "include", "technology", "transfer", "assistance,", "research", "and", "development", "activities,", "or", "manufacturing", "activities", "through", "the", "completion", "of", "clinical", "development", "or", "the", "termination", "or", "expiration", "of", "the", "collaboration", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p45_s0", "idA": "906709_14_item7_p53_s0", "sentA": "As of December 31, 2013, we had $23.5 million of deferred upfront fees related to two collaboration agreements that are being amortized over 11 to 19 years, or an average of 15.2 years.", "sentB": "As of December 31, 2014, we had $21.4 million of deferred upfront fees related to two collaboration agreements that include research and development obligations that are being amortized over 11 to 20 years, or an average of approximately 16 years.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2013,", "we", "had", "$23.5", "million", "of", "deferred", "upfront", "fees", "related", "to", "two", "collaboration", "agreements", "that", "are", "being", "amortized", "over", "11", "to", "19", "years,", "or", "an", "average", "of", "15.2", "years.", "<tag2>", "As", "of", "December", "31,", "2014,", "we", "had", "$21.4", "million", "of", "deferred", "upfront", "fees", "related", "to", "two", "collaboration", "agreements", "that", "include", "research", "and", "development", "obligations", "that", "are", "being", "amortized", "over", "11", "to", "20", "years,", "or", "an", "average", "of", "approximately", "16", "years.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2013,", "we", "had", "$23.5", "million", "of", "deferred", "upfront", "fees", "related", "to", "two", "collaboration", "agreements", "that", "are", "being", "amortized", "over", "11", "to", "19", "years,", "or", "an", "average", "of", "15.2", "years."], "wordsB": ["As", "of", "December", "31,", "2014,", "we", "had", "$21.4", "million", "of", "deferred", "upfront", "fees", "related", "to", "two", "collaboration", "agreements", "that", "include", "research", "and", "development", "obligations", "that", "are", "being", "amortized", "over", "11", "to", "20", "years,", "or", "an", "average", "of", "approximately", "16", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p47_s0", "idA": "906709_14_item7_p55_s0", "sentA": "only a 5% to 10% probability of reaching commercial success.", "sentB": "Given the statistical probability of drug development success in the bio-pharmaceutical industry, drug development programs have only a 5% to 10% probability of reaching commercial success.", "type": 2, "words": ["<tag1>", "only", "a", "5%", "to", "10%", "probability", "of", "reaching", "commercial", "success.", "<tag2>", "Given", "the", "statistical", "probability", "of", "drug", "development", "success", "in", "the", "bio-pharmaceutical", "industry,", "drug", "development", "programs", "have", "only", "a", "5%", "to", "10%", "probability", "of", "reaching", "commercial", "success.", "<tag3>"], "wordsA": ["only", "a", "5%", "to", "10%", "probability", "of", "reaching", "commercial", "success."], "wordsB": ["Given", "the", "statistical", "probability", "of", "drug", "development", "success", "in", "the", "bio-pharmaceutical", "industry,", "drug", "development", "programs", "have", "only", "a", "5%", "to", "10%", "probability", "of", "reaching", "commercial", "success."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p48_s1", "idA": "906709_14_item7_p55_s2", "sentA": "As of December 31, 2013, we also had $80.7 million of deferred upfront fees related to seven license, manufacturing and supply agreements that are being amortized over periods from 3 to 10 years.", "sentB": "As of December 31, 2014, we also had $78.4 million of deferred upfront fees related to seven license, manufacturing and supply agreements that are being amortized over periods from 3 to 14 years.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2013,", "we", "also", "had", "$80.7", "million", "of", "deferred", "upfront", "fees", "related", "to", "seven", "license,", "manufacturing", "and", "supply", "agreements", "that", "are", "being", "amortized", "over", "periods", "from", "3", "to", "10", "years.", "<tag2>", "As", "of", "December", "31,", "2014,", "we", "also", "had", "$78.4", "million", "of", "deferred", "upfront", "fees", "related", "to", "seven", "license,", "manufacturing", "and", "supply", "agreements", "that", "are", "being", "amortized", "over", "periods", "from", "3", "to", "14", "years.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2013,", "we", "also", "had", "$80.7", "million", "of", "deferred", "upfront", "fees", "related", "to", "seven", "license,", "manufacturing", "and", "supply", "agreements", "that", "are", "being", "amortized", "over", "periods", "from", "3", "to", "10", "years."], "wordsB": ["As", "of", "December", "31,", "2014,", "we", "also", "had", "$78.4", "million", "of", "deferred", "upfront", "fees", "related", "to", "seven", "license,", "manufacturing", "and", "supply", "agreements", "that", "are", "being", "amortized", "over", "periods", "from", "3", "to", "14", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p62_s2", "idA": "906709_14_item7_p55_s8", "sentA": "We determine ESP for the elements in our collaboration arrangements by considering multiple factors including, but not limited to, technical complexity of the performance obligation and similarity of elements to those performed under previous arrangements.", "sentB": "Our international operations are subject to risks typical of international operations, including, but not limited to, differing economic conditions, changes in political climate, differing tax structures, other regulations and restrictions, and foreign exchange rate volatility.", "type": 2, "words": ["<tag1>", "We", "determine", "ESP", "for", "the", "elements", "in", "our", "collaboration", "arrangements", "by", "considering", "multiple", "factors", "including,", "but", "not", "limited", "to,", "technical", "complexity", "of", "the", "performance", "obligation", "and", "similarity", "of", "elements", "to", "those", "performed", "under", "previous", "arrangements.", "<tag2>", "Our", "international", "operations", "are", "subject", "to", "risks", "typical", "of", "international", "operations,", "including,", "but", "not", "limited", "to,", "differing", "economic", "conditions,", "changes", "in", "political", "climate,", "differing", "tax", "structures,", "other", "regulations", "and", "restrictions,", "and", "foreign", "exchange", "rate", "volatility.", "<tag3>"], "wordsA": ["We", "determine", "ESP", "for", "the", "elements", "in", "our", "collaboration", "arrangements", "by", "considering", "multiple", "factors", "including,", "but", "not", "limited", "to,", "technical", "complexity", "of", "the", "performance", "obligation", "and", "similarity", "of", "elements", "to", "those", "performed", "under", "previous", "arrangements."], "wordsB": ["Our", "international", "operations", "are", "subject", "to", "risks", "typical", "of", "international", "operations,", "including,", "but", "not", "limited", "to,", "differing", "economic", "conditions,", "changes", "in", "political", "climate,", "differing", "tax", "structures,", "other", "regulations", "and", "restrictions,", "and", "foreign", "exchange", "rate", "volatility."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p50_s4", "idA": "906709_14_item7_p57_s0", "sentA": "We generally accrue costs associated with the treatment phase of clinical studies based on the total estimated cost of the treatment phase on a per patient basis and we expense the per patient cost ratably based on patient enrollment in the studies.", "sentB": "We generally accrue costs associated with the treatment phase of clinical studies based on the total estimated cost of the treatment phase on a per patient basis and we expense the per patient cost ratably over the estimated patient treatment period based on patient enrollment in the studies.", "type": 2, "words": ["<tag1>", "We", "generally", "accrue", "costs", "associated", "with", "the", "treatment", "phase", "of", "clinical", "studies", "based", "on", "the", "total", "estimated", "cost", "of", "the", "treatment", "phase", "on", "a", "per", "patient", "basis", "and", "we", "expense", "the", "per", "patient", "cost", "ratably", "based", "on", "patient", "enrollment", "in", "the", "studies.", "<tag2>", "We", "generally", "accrue", "costs", "associated", "with", "the", "treatment", "phase", "of", "clinical", "studies", "based", "on", "the", "total", "estimated", "cost", "of", "the", "treatment", "phase", "on", "a", "per", "patient", "basis", "and", "we", "expense", "the", "per", "patient", "cost", "ratably", "over", "the", "estimated", "patient", "treatment", "period", "based", "on", "patient", "enrollment", "in", "the", "studies.", "<tag3>"], "wordsA": ["We", "generally", "accrue", "costs", "associated", "with", "the", "treatment", "phase", "of", "clinical", "studies", "based", "on", "the", "total", "estimated", "cost", "of", "the", "treatment", "phase", "on", "a", "per", "patient", "basis", "and", "we", "expense", "the", "per", "patient", "cost", "ratably", "based", "on", "patient", "enrollment", "in", "the", "studies."], "wordsB": ["We", "generally", "accrue", "costs", "associated", "with", "the", "treatment", "phase", "of", "clinical", "studies", "based", "on", "the", "total", "estimated", "cost", "of", "the", "treatment", "phase", "on", "a", "per", "patient", "basis", "and", "we", "expense", "the", "per", "patient", "cost", "ratably", "over", "the", "estimated", "patient", "treatment", "period", "based", "on", "patient", "enrollment", "in", "the", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p50_s2", "idA": "906709_14_item7_p57_s1", "sentA": "In specific circumstances, such as for certain time-based costs, we recognize clinical trial expenses using a methodology that we consider to be more reflective of the timing of costs incurred.", "sentB": "Payments under the contracts depend on factors such as the achievement of certain events, successful enrollment of patients, and completion of portions of the clinical trial or similar conditions.", "type": 2, "words": ["<tag1>", "In", "specific", "circumstances,", "such", "as", "for", "certain", "time-based", "costs,", "we", "recognize", "clinical", "trial", "expenses", "using", "a", "methodology", "that", "we", "consider", "to", "be", "more", "reflective", "of", "the", "timing", "of", "costs", "incurred.", "<tag2>", "Payments", "under", "the", "contracts", "depend", "on", "factors", "such", "as", "the", "achievement", "of", "certain", "events,", "successful", "enrollment", "of", "patients,", "and", "completion", "of", "portions", "of", "the", "clinical", "trial", "or", "similar", "conditions.", "<tag3>"], "wordsA": ["In", "specific", "circumstances,", "such", "as", "for", "certain", "time-based", "costs,", "we", "recognize", "clinical", "trial", "expenses", "using", "a", "methodology", "that", "we", "consider", "to", "be", "more", "reflective", "of", "the", "timing", "of", "costs", "incurred."], "wordsB": ["Payments", "under", "the", "contracts", "depend", "on", "factors", "such", "as", "the", "achievement", "of", "certain", "events,", "successful", "enrollment", "of", "patients,", "and", "completion", "of", "portions", "of", "the", "clinical", "trial", "or", "similar", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p53_s0", "idA": "906709_14_item7_p59_s0", "sentA": "Stock-Based Compensation We use the Black-Scholes option valuation model for each respective grant to determine the estimated fair value of stock options on the date of grant (grant date fair value) and common stock purchased under our Employee Stock Purchase Plan (ESPP).", "sentB": "Stock-Based Compensation We use the Black-Scholes option pricing model for each respective grant to determine the estimated fair value of stock options on the date of grant (grant date fair value) and common stock purchased under our Employee Stock Purchase Plan (ESPP).", "type": 2, "words": ["<tag1>", "Stock-Based", "Compensation", "We", "use", "the", "Black-Scholes", "option", "valuation", "model", "for", "each", "respective", "grant", "to", "determine", "the", "estimated", "fair", "value", "of", "stock", "options", "on", "the", "date", "of", "grant", "(grant", "date", "fair", "value)", "and", "common", "stock", "purchased", "under", "our", "Employee", "Stock", "Purchase", "Plan", "(ESPP).", "<tag2>", "Stock-Based", "Compensation", "We", "use", "the", "Black-Scholes", "option", "pricing", "model", "for", "each", "respective", "grant", "to", "determine", "the", "estimated", "fair", "value", "of", "stock", "options", "on", "the", "date", "of", "grant", "(grant", "date", "fair", "value)", "and", "common", "stock", "purchased", "under", "our", "Employee", "Stock", "Purchase", "Plan", "(ESPP).", "<tag3>"], "wordsA": ["Stock-Based", "Compensation", "We", "use", "the", "Black-Scholes", "option", "valuation", "model", "for", "each", "respective", "grant", "to", "determine", "the", "estimated", "fair", "value", "of", "stock", "options", "on", "the", "date", "of", "grant", "(grant", "date", "fair", "value)", "and", "common", "stock", "purchased", "under", "our", "Employee", "Stock", "Purchase", "Plan", "(ESPP)."], "wordsB": ["Stock-Based", "Compensation", "We", "use", "the", "Black-Scholes", "option", "pricing", "model", "for", "each", "respective", "grant", "to", "determine", "the", "estimated", "fair", "value", "of", "stock", "options", "on", "the", "date", "of", "grant", "(grant", "date", "fair", "value)", "and", "common", "stock", "purchased", "under", "our", "Employee", "Stock", "Purchase", "Plan", "(ESPP)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p61_s1", "idA": "906709_14_item7_p60_s1", "sentA": "Because our employee stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect fair value estimates, in management s opinion, the existing models may not provide a reliable single measure of the fair value of our employee stock options or common stock purchased under our ESPP.", "sentB": "A hypothetical 50 basis point increase in interest rates would result in an approximate $0.5 million decrease, less than 1%, in the fair value of our available-for-sale securities at December 31, 2014.", "type": 2, "words": ["<tag1>", "Because", "our", "employee", "stock", "options", "have", "characteristics", "significantly", "different", "from", "those", "of", "traded", "options,", "and", "because", "changes", "in", "the", "subjective", "input", "assumptions", "can", "materially", "affect", "fair", "value", "estimates,", "in", "management", "s", "opinion,", "the", "existing", "models", "may", "not", "provide", "a", "reliable", "single", "measure", "of", "the", "fair", "value", "of", "our", "employee", "stock", "options", "or", "common", "stock", "purchased", "under", "our", "ESPP.", "<tag2>", "A", "hypothetical", "50", "basis", "point", "increase", "in", "interest", "rates", "would", "result", "in", "an", "approximate", "$0.5", "million", "decrease,", "less", "than", "1%,", "in", "the", "fair", "value", "of", "our", "available-for-sale", "securities", "at", "December", "31,", "2014.", "<tag3>"], "wordsA": ["Because", "our", "employee", "stock", "options", "have", "characteristics", "significantly", "different", "from", "those", "of", "traded", "options,", "and", "because", "changes", "in", "the", "subjective", "input", "assumptions", "can", "materially", "affect", "fair", "value", "estimates,", "in", "management", "s", "opinion,", "the", "existing", "models", "may", "not", "provide", "a", "reliable", "single", "measure", "of", "the", "fair", "value", "of", "our", "employee", "stock", "options", "or", "common", "stock", "purchased", "under", "our", "ESPP."], "wordsB": ["A", "hypothetical", "50", "basis", "point", "increase", "in", "interest", "rates", "would", "result", "in", "an", "approximate", "$0.5", "million", "decrease,", "less", "than", "1%,", "in", "the", "fair", "value", "of", "our", "available-for-sale", "securities", "at", "December", "31,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p56_s1", "idA": "906709_14_item7_p62_s1", "sentA": "Although we are required to make payments to the purchaser only in certain situations, including the event of our breach of a representation, warranty or covenant in the Purchase and Sale Agreement that gives rise to a liability in accordance with the terms and conditions of such agreement, this royalty sale transaction was recorded as a liability (Royalty Obligation) that we will amortize using the interest method over the estimated life of the Purchase and Sale Agreement.", "sentB": "Although we are required to make payments to the purchaser (RPI) only in certain situations, including the event of our breach of a representation, warranty or covenant in the Purchase and Sale Agreement that gives rise to a liability in accordance with the terms and conditions of such agreement, this royalty sale transaction was recorded as a liability (Royalty Obligation) that we will amortize using the interest method over the estimated life of the Purchase and Sale Agreement.", "type": 2, "words": ["<tag1>", "Although", "we", "are", "required", "to", "make", "payments", "to", "the", "purchaser", "only", "in", "certain", "situations,", "including", "the", "event", "of", "our", "breach", "of", "a", "representation,", "warranty", "or", "covenant", "in", "the", "Purchase", "and", "Sale", "Agreement", "that", "gives", "rise", "to", "a", "liability", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "such", "agreement,", "this", "royalty", "sale", "transaction", "was", "recorded", "as", "a", "liability", "(Royalty", "Obligation)", "that", "we", "will", "amortize", "using", "the", "interest", "method", "over", "the", "estimated", "life", "of", "the", "Purchase", "and", "Sale", "Agreement.", "<tag2>", "Although", "we", "are", "required", "to", "make", "payments", "to", "the", "purchaser", "(RPI)", "only", "in", "certain", "situations,", "including", "the", "event", "of", "our", "breach", "of", "a", "representation,", "warranty", "or", "covenant", "in", "the", "Purchase", "and", "Sale", "Agreement", "that", "gives", "rise", "to", "a", "liability", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "such", "agreement,", "this", "royalty", "sale", "transaction", "was", "recorded", "as", "a", "liability", "(Royalty", "Obligation)", "that", "we", "will", "amortize", "using", "the", "interest", "method", "over", "the", "estimated", "life", "of", "the", "Purchase", "and", "Sale", "Agreement.", "<tag3>"], "wordsA": ["Although", "we", "are", "required", "to", "make", "payments", "to", "the", "purchaser", "only", "in", "certain", "situations,", "including", "the", "event", "of", "our", "breach", "of", "a", "representation,", "warranty", "or", "covenant", "in", "the", "Purchase", "and", "Sale", "Agreement", "that", "gives", "rise", "to", "a", "liability", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "such", "agreement,", "this", "royalty", "sale", "transaction", "was", "recorded", "as", "a", "liability", "(Royalty", "Obligation)", "that", "we", "will", "amortize", "using", "the", "interest", "method", "over", "the", "estimated", "life", "of", "the", "Purchase", "and", "Sale", "Agreement."], "wordsB": ["Although", "we", "are", "required", "to", "make", "payments", "to", "the", "purchaser", "(RPI)", "only", "in", "certain", "situations,", "including", "the", "event", "of", "our", "breach", "of", "a", "representation,", "warranty", "or", "covenant", "in", "the", "Purchase", "and", "Sale", "Agreement", "that", "gives", "rise", "to", "a", "liability", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "such", "agreement,", "this", "royalty", "sale", "transaction", "was", "recorded", "as", "a", "liability", "(Royalty", "Obligation)", "that", "we", "will", "amortize", "using", "the", "interest", "method", "over", "the", "estimated", "life", "of", "the", "Purchase", "and", "Sale", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p52_s0", "idA": "906709_14_item7_p62_s2", "sentA": "As a result, we impute interest on the transaction and record interest expense at the estimated interest rate.", "sentB": "We base our estimates on the best information available at the time.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "we", "impute", "interest", "on", "the", "transaction", "and", "record", "interest", "expense", "at", "the", "estimated", "interest", "rate.", "<tag2>", "We", "base", "our", "estimates", "on", "the", "best", "information", "available", "at", "the", "time.", "<tag3>"], "wordsA": ["As", "a", "result,", "we", "impute", "interest", "on", "the", "transaction", "and", "record", "interest", "expense", "at", "the", "estimated", "interest", "rate."], "wordsB": ["We", "base", "our", "estimates", "on", "the", "best", "information", "available", "at", "the", "time."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p56_s3", "idA": "906709_14_item7_p62_s3", "sentA": "Our estimate of the interest rate under the agreement is based on the amount of royalty payments to be received by RPI over the life of the arrangement and payments we may be required to make to RPI under the agreement.", "sentB": "Our estimate of the interest rate under the agreement is based on the amount of royalty payments to be received by RPI over the life of the arrangement and payments we are required to make to RPI under the agreement.", "type": 2, "words": ["<tag1>", "Our", "estimate", "of", "the", "interest", "rate", "under", "the", "agreement", "is", "based", "on", "the", "amount", "of", "royalty", "payments", "to", "be", "received", "by", "RPI", "over", "the", "life", "of", "the", "arrangement", "and", "payments", "we", "may", "be", "required", "to", "make", "to", "RPI", "under", "the", "agreement.", "<tag2>", "Our", "estimate", "of", "the", "interest", "rate", "under", "the", "agreement", "is", "based", "on", "the", "amount", "of", "royalty", "payments", "to", "be", "received", "by", "RPI", "over", "the", "life", "of", "the", "arrangement", "and", "payments", "we", "are", "required", "to", "make", "to", "RPI", "under", "the", "agreement.", "<tag3>"], "wordsA": ["Our", "estimate", "of", "the", "interest", "rate", "under", "the", "agreement", "is", "based", "on", "the", "amount", "of", "royalty", "payments", "to", "be", "received", "by", "RPI", "over", "the", "life", "of", "the", "arrangement", "and", "payments", "we", "may", "be", "required", "to", "make", "to", "RPI", "under", "the", "agreement."], "wordsB": ["Our", "estimate", "of", "the", "interest", "rate", "under", "the", "agreement", "is", "based", "on", "the", "amount", "of", "royalty", "payments", "to", "be", "received", "by", "RPI", "over", "the", "life", "of", "the", "arrangement", "and", "payments", "we", "are", "required", "to", "make", "to", "RPI", "under", "the", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p57_s1", "idA": "906709_14_item7_p63_s1", "sentA": "Such factors include, but are not limited to, changing standards of care, the introduction of competing products, manufacturing or other delays, biosimilar competition, intellectual property matters, adverse events that result in health authority imposed restrictions on the use of the drug products, and other events or circumstances that result in reduced royalty payments from CIMZIA and MIRCERA , all of which would result in a reduction of non-cash royalty revenue and non-cash interest expense over the life of the Royalty Obligation.", "sentB": "Such factors include, but are not limited to, changing standards of care, the introduction of competing products, manufacturing or other delays, biosimilar competition, intellectual property matters, adverse events that result in health authority imposed restrictions on the use of the drug products, significant changes in foreign exchange rates as the royalties remitted to RPI are made in U.S. dollars (USD) while significant portions of the underlying sales of CIMZIA and MIRCERA are made in currencies other than USD, and other events or circumstances that result in reduced royalty payments from CIMZIA and MIRCERA , all of which would result in a reduction of non-cash royalty revenue and non-cash interest expense over the life of the Royalty Obligation.", "type": 2, "words": ["<tag1>", "Such", "factors", "include,", "but", "are", "not", "limited", "to,", "changing", "standards", "of", "care,", "the", "introduction", "of", "competing", "products,", "manufacturing", "or", "other", "delays,", "biosimilar", "competition,", "intellectual", "property", "matters,", "adverse", "events", "that", "result", "in", "health", "authority", "imposed", "restrictions", "on", "the", "use", "of", "the", "drug", "products,", "and", "other", "events", "or", "circumstances", "that", "result", "in", "reduced", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "all", "of", "which", "would", "result", "in", "a", "reduction", "of", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "over", "the", "life", "of", "the", "Royalty", "Obligation.", "<tag2>", "Such", "factors", "include,", "but", "are", "not", "limited", "to,", "changing", "standards", "of", "care,", "the", "introduction", "of", "competing", "products,", "manufacturing", "or", "other", "delays,", "biosimilar", "competition,", "intellectual", "property", "matters,", "adverse", "events", "that", "result", "in", "health", "authority", "imposed", "restrictions", "on", "the", "use", "of", "the", "drug", "products,", "significant", "changes", "in", "foreign", "exchange", "rates", "as", "the", "royalties", "remitted", "to", "RPI", "are", "made", "in", "U.S.", "dollars", "(USD)", "while", "significant", "portions", "of", "the", "underlying", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "made", "in", "currencies", "other", "than", "USD,", "and", "other", "events", "or", "circumstances", "that", "result", "in", "reduced", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "all", "of", "which", "would", "result", "in", "a", "reduction", "of", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "over", "the", "life", "of", "the", "Royalty", "Obligation.", "<tag3>"], "wordsA": ["Such", "factors", "include,", "but", "are", "not", "limited", "to,", "changing", "standards", "of", "care,", "the", "introduction", "of", "competing", "products,", "manufacturing", "or", "other", "delays,", "biosimilar", "competition,", "intellectual", "property", "matters,", "adverse", "events", "that", "result", "in", "health", "authority", "imposed", "restrictions", "on", "the", "use", "of", "the", "drug", "products,", "and", "other", "events", "or", "circumstances", "that", "result", "in", "reduced", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "all", "of", "which", "would", "result", "in", "a", "reduction", "of", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "over", "the", "life", "of", "the", "Royalty", "Obligation."], "wordsB": ["Such", "factors", "include,", "but", "are", "not", "limited", "to,", "changing", "standards", "of", "care,", "the", "introduction", "of", "competing", "products,", "manufacturing", "or", "other", "delays,", "biosimilar", "competition,", "intellectual", "property", "matters,", "adverse", "events", "that", "result", "in", "health", "authority", "imposed", "restrictions", "on", "the", "use", "of", "the", "drug", "products,", "significant", "changes", "in", "foreign", "exchange", "rates", "as", "the", "royalties", "remitted", "to", "RPI", "are", "made", "in", "U.S.", "dollars", "(USD)", "while", "significant", "portions", "of", "the", "underlying", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "made", "in", "currencies", "other", "than", "USD,", "and", "other", "events", "or", "circumstances", "that", "result", "in", "reduced", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "all", "of", "which", "would", "result", "in", "a", "reduction", "of", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "over", "the", "life", "of", "the", "Royalty", "Obligation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p54_s1", "idA": "906709_14_item7_p63_s2", "sentA": "Conversely, if sales of CIMZIA and MIRCERA are higher than expected, non-cash royalty revenue and non-cash interest expense would also be greater over the term of the Royalty Obligation.", "sentB": "These variables include, but are not limited to, our stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors.", "type": 2, "words": ["<tag1>", "Conversely,", "if", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "higher", "than", "expected,", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "would", "also", "be", "greater", "over", "the", "term", "of", "the", "Royalty", "Obligation.", "<tag2>", "These", "variables", "include,", "but", "are", "not", "limited", "to,", "our", "stock", "price", "volatility", "over", "the", "term", "of", "the", "awards,", "and", "actual", "and", "projected", "employee", "stock", "option", "exercise", "behaviors.", "<tag3>"], "wordsA": ["Conversely,", "if", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "higher", "than", "expected,", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "would", "also", "be", "greater", "over", "the", "term", "of", "the", "Royalty", "Obligation."], "wordsB": ["These", "variables", "include,", "but", "are", "not", "limited", "to,", "our", "stock", "price", "volatility", "over", "the", "term", "of", "the", "awards,", "and", "actual", "and", "projected", "employee", "stock", "option", "exercise", "behaviors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p57_s3", "idA": "906709_14_item7_p63_s3", "sentA": "If we had determined that the interest rate used in 2013 should have been one percentage point higher than our current estimate of 17%, the non-cash interest expense recognized in the year ended December 31, 2013 would have increased by $1.5 million.", "sentB": "If we had determined that the interest rate used in 2014 should have been one percentage point higher than our current estimate of 17%, the non-cash interest expense recognized in the year ended December 31, 2014 would have increased by $1.3 million.", "type": 2, "words": ["<tag1>", "If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2013", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2013", "would", "have", "increased", "by", "$1.5", "million.", "<tag2>", "If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2014", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2014", "would", "have", "increased", "by", "$1.3", "million.", "<tag3>"], "wordsA": ["If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2013", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2013", "would", "have", "increased", "by", "$1.5", "million."], "wordsB": ["If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2014", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2014", "would", "have", "increased", "by", "$1.3", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p61_s3", "idA": "906709_14_item7_p63_s3", "sentA": "If we had determined that the interest rate used in 2013 should have been one percentage point higher than our current estimate of 17%, the non-cash interest expense recognized in the year ended December 31, 2013 would have increased by $1.5 million.", "sentB": "The same hypothetical 50 basis point increase in interest rates would have resulted in an approximate $0.5 million decrease, less than 1%, in the fair value of our available-for-sale securities at December 31, 2013.", "type": 2, "words": ["<tag1>", "If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2013", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2013", "would", "have", "increased", "by", "$1.5", "million.", "<tag2>", "The", "same", "hypothetical", "50", "basis", "point", "increase", "in", "interest", "rates", "would", "have", "resulted", "in", "an", "approximate", "$0.5", "million", "decrease,", "less", "than", "1%,", "in", "the", "fair", "value", "of", "our", "available-for-sale", "securities", "at", "December", "31,", "2013.", "<tag3>"], "wordsA": ["If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2013", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2013", "would", "have", "increased", "by", "$1.5", "million."], "wordsB": ["The", "same", "hypothetical", "50", "basis", "point", "increase", "in", "interest", "rates", "would", "have", "resulted", "in", "an", "approximate", "$0.5", "million", "decrease,", "less", "than", "1%,", "in", "the", "fair", "value", "of", "our", "available-for-sale", "securities", "at", "December", "31,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p59_s3", "idA": "906709_14_item7_p64_s2", "sentA": "We do not believe the adoption of this guidance will have a material impact on our consolidated financial statements.", "sentB": "We do not believe the impact of adopting ASU 2014-15 on our consolidated financial statements will be significant.", "type": 2, "words": ["<tag1>", "We", "do", "not", "believe", "the", "adoption", "of", "this", "guidance", "will", "have", "a", "material", "impact", "on", "our", "consolidated", "financial", "statements.", "<tag2>", "We", "do", "not", "believe", "the", "impact", "of", "adopting", "ASU", "2014-15", "on", "our", "consolidated", "financial", "statements", "will", "be", "significant.", "<tag3>"], "wordsA": ["We", "do", "not", "believe", "the", "adoption", "of", "this", "guidance", "will", "have", "a", "material", "impact", "on", "our", "consolidated", "financial", "statements."], "wordsB": ["We", "do", "not", "believe", "the", "impact", "of", "adopting", "ASU", "2014-15", "on", "our", "consolidated", "financial", "statements", "will", "be", "significant."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p5_s1", "idA": "906709_14_item7_p64_s2", "sentA": "We do not believe the adoption of this guidance will have a material impact on our consolidated financial statements.", "sentB": "Given the significant milestones and royalty opportunity for us associated with MOVANTIK under our AstraZeneca license agreement, the level of sales achieved by AstraZeneca for MOVANTIK will have a significant impact on our operating results and financial condition over the coming years.", "type": 2, "words": ["<tag1>", "We", "do", "not", "believe", "the", "adoption", "of", "this", "guidance", "will", "have", "a", "material", "impact", "on", "our", "consolidated", "financial", "statements.", "<tag2>", "Given", "the", "significant", "milestones", "and", "royalty", "opportunity", "for", "us", "associated", "with", "MOVANTIK", "under", "our", "AstraZeneca", "license", "agreement,", "the", "level", "of", "sales", "achieved", "by", "AstraZeneca", "for", "MOVANTIK", "will", "have", "a", "significant", "impact", "on", "our", "operating", "results", "and", "financial", "condition", "over", "the", "coming", "years.", "<tag3>"], "wordsA": ["We", "do", "not", "believe", "the", "adoption", "of", "this", "guidance", "will", "have", "a", "material", "impact", "on", "our", "consolidated", "financial", "statements."], "wordsB": ["Given", "the", "significant", "milestones", "and", "royalty", "opportunity", "for", "us", "associated", "with", "MOVANTIK", "under", "our", "AstraZeneca", "license", "agreement,", "the", "level", "of", "sales", "achieved", "by", "AstraZeneca", "for", "MOVANTIK", "will", "have", "a", "significant", "impact", "on", "our", "operating", "results", "and", "financial", "condition", "over", "the", "coming", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p6_s7", "idA": "906709_14_item7_p64_s2", "sentA": "We do not believe the adoption of this guidance will have a material impact on our consolidated financial statements.", "sentB": "As a result, the outcome of the BEACON study will have a significant impact on whether or not we invest significant capital in building and maintaining a sales and market organization for the U.S. that we currently do not have in place.", "type": 2, "words": ["<tag1>", "We", "do", "not", "believe", "the", "adoption", "of", "this", "guidance", "will", "have", "a", "material", "impact", "on", "our", "consolidated", "financial", "statements.", "<tag2>", "As", "a", "result,", "the", "outcome", "of", "the", "BEACON", "study", "will", "have", "a", "significant", "impact", "on", "whether", "or", "not", "we", "invest", "significant", "capital", "in", "building", "and", "maintaining", "a", "sales", "and", "market", "organization", "for", "the", "U.S.", "that", "we", "currently", "do", "not", "have", "in", "place.", "<tag3>"], "wordsA": ["We", "do", "not", "believe", "the", "adoption", "of", "this", "guidance", "will", "have", "a", "material", "impact", "on", "our", "consolidated", "financial", "statements."], "wordsB": ["As", "a", "result,", "the", "outcome", "of", "the", "BEACON", "study", "will", "have", "a", "significant", "impact", "on", "whether", "or", "not", "we", "invest", "significant", "capital", "in", "building", "and", "maintaining", "a", "sales", "and", "market", "organization", "for", "the", "U.S.", "that", "we", "currently", "do", "not", "have", "in", "place."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p35_s1", "idA": "906709_14_item7_p7_s1", "sentA": "On September 16, 2013, AstraZeneca filed an NDA with the FDA for naloxegol, which was accepted for review by the FDA on November 16, 2013, resulting in a $70.0 million milestone payment to Nektar from AstraZeneca in November 2013.", "sentB": "During the year ended December 31, 2014, we recognized as revenue a $70.0 million payment made to us from AstraZeneca in November 2013, which was previously recorded in the line item Liability related to receipt of refundable milestone payment on our Consolidated Balance Sheet at December 31, 2013.", "type": 2, "words": ["<tag1>", "On", "September", "16,", "2013,", "AstraZeneca", "filed", "an", "NDA", "with", "the", "FDA", "for", "naloxegol,", "which", "was", "accepted", "for", "review", "by", "the", "FDA", "on", "November", "16,", "2013,", "resulting", "in", "a", "$70.0", "million", "milestone", "payment", "to", "Nektar", "from", "AstraZeneca", "in", "November", "2013.", "<tag2>", "During", "the", "year", "ended", "December", "31,", "2014,", "we", "recognized", "as", "revenue", "a", "$70.0", "million", "payment", "made", "to", "us", "from", "AstraZeneca", "in", "November", "2013,", "which", "was", "previously", "recorded", "in", "the", "line", "item", "Liability", "related", "to", "receipt", "of", "refundable", "milestone", "payment", "on", "our", "Consolidated", "Balance", "Sheet", "at", "December", "31,", "2013.", "<tag3>"], "wordsA": ["On", "September", "16,", "2013,", "AstraZeneca", "filed", "an", "NDA", "with", "the", "FDA", "for", "naloxegol,", "which", "was", "accepted", "for", "review", "by", "the", "FDA", "on", "November", "16,", "2013,", "resulting", "in", "a", "$70.0", "million", "milestone", "payment", "to", "Nektar", "from", "AstraZeneca", "in", "November", "2013."], "wordsB": ["During", "the", "year", "ended", "December", "31,", "2014,", "we", "recognized", "as", "revenue", "a", "$70.0", "million", "payment", "made", "to", "us", "from", "AstraZeneca", "in", "November", "2013,", "which", "was", "previously", "recorded", "in", "the", "line", "item", "Liability", "related", "to", "receipt", "of", "refundable", "milestone", "payment", "on", "our", "Consolidated", "Balance", "Sheet", "at", "December", "31,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p5_s0", "idA": "906709_14_item7_p7_s3", "sentA": "If the FDA does require a CV Safety Study, AstraZeneca may terminate the license agreement with us in its entirety or only with respect to its rights in the United States.", "sentB": "AstraZeneca is planning the commercial launch of MOVANTIK in the United States late in the first quarter of 2015 and MOVENTIG in the second half of 2015.", "type": 2, "words": ["<tag1>", "If", "the", "FDA", "does", "require", "a", "CV", "Safety", "Study,", "AstraZeneca", "may", "terminate", "the", "license", "agreement", "with", "us", "in", "its", "entirety", "or", "only", "with", "respect", "to", "its", "rights", "in", "the", "United", "States.", "<tag2>", "AstraZeneca", "is", "planning", "the", "commercial", "launch", "of", "MOVANTIK", "in", "the", "United", "States", "late", "in", "the", "first", "quarter", "of", "2015", "and", "MOVENTIG", "in", "the", "second", "half", "of", "2015.", "<tag3>"], "wordsA": ["If", "the", "FDA", "does", "require", "a", "CV", "Safety", "Study,", "AstraZeneca", "may", "terminate", "the", "license", "agreement", "with", "us", "in", "its", "entirety", "or", "only", "with", "respect", "to", "its", "rights", "in", "the", "United", "States."], "wordsB": ["AstraZeneca", "is", "planning", "the", "commercial", "launch", "of", "MOVANTIK", "in", "the", "United", "States", "late", "in", "the", "first", "quarter", "of", "2015", "and", "MOVENTIG", "in", "the", "second", "half", "of", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p11_s3", "idA": "906709_14_item7_p8_s1", "sentA": "Etirinotecan pegol is currently being evaluated as a single-agent therapy in a Phase 3 open-label, randomized, multicenter clinical study in patients with metastatic breast cancer.", "sentB": "Bayer is currently enrolling patients in a Phase 3 clinical study for Amikacin Inhale.", "type": 2, "words": ["<tag1>", "Etirinotecan", "pegol", "is", "currently", "being", "evaluated", "as", "a", "single-agent", "therapy", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "in", "patients", "with", "metastatic", "breast", "cancer.", "<tag2>", "Bayer", "is", "currently", "enrolling", "patients", "in", "a", "Phase", "3", "clinical", "study", "for", "Amikacin", "Inhale.", "<tag3>"], "wordsA": ["Etirinotecan", "pegol", "is", "currently", "being", "evaluated", "as", "a", "single-agent", "therapy", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "in", "patients", "with", "metastatic", "breast", "cancer."], "wordsB": ["Bayer", "is", "currently", "enrolling", "patients", "in", "a", "Phase", "3", "clinical", "study", "for", "Amikacin", "Inhale."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p11_s6", "idA": "906709_14_item7_p8_s1", "sentA": "Etirinotecan pegol is currently being evaluated as a single-agent therapy in a Phase 3 open-label, randomized, multicenter clinical study in patients with metastatic breast cancer.", "sentB": "In August 2012, Bayer initiated a global Phase 3 program called RESPIRE for the Cipro DPI product candidate in patients with non-cystic fibrosis bronchiectasis.", "type": 2, "words": ["<tag1>", "Etirinotecan", "pegol", "is", "currently", "being", "evaluated", "as", "a", "single-agent", "therapy", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "in", "patients", "with", "metastatic", "breast", "cancer.", "<tag2>", "In", "August", "2012,", "Bayer", "initiated", "a", "global", "Phase", "3", "program", "called", "RESPIRE", "for", "the", "Cipro", "DPI", "product", "candidate", "in", "patients", "with", "non-cystic", "fibrosis", "bronchiectasis.", "<tag3>"], "wordsA": ["Etirinotecan", "pegol", "is", "currently", "being", "evaluated", "as", "a", "single-agent", "therapy", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "in", "patients", "with", "metastatic", "breast", "cancer."], "wordsB": ["In", "August", "2012,", "Bayer", "initiated", "a", "global", "Phase", "3", "program", "called", "RESPIRE", "for", "the", "Cipro", "DPI", "product", "candidate", "in", "patients", "with", "non-cystic", "fibrosis", "bronchiectasis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p6_s0", "idA": "906709_14_item7_p8_s1", "sentA": "Etirinotecan pegol is currently being evaluated as a single-agent therapy in a Phase 3 open-label, randomized, multicenter clinical study in patients with metastatic breast cancer.", "sentB": "Etirinotecan pegol (also known as NKTR-102), is a next-generation topoisomerase I (topo I) inhibitor proprietary drug candidate, currently being evaluated in a Phase 3 open-label, randomized, multicenter clinical study as a single-agent therapy for women with metastatic breast cancer.", "type": 2, "words": ["<tag1>", "Etirinotecan", "pegol", "is", "currently", "being", "evaluated", "as", "a", "single-agent", "therapy", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "in", "patients", "with", "metastatic", "breast", "cancer.", "<tag2>", "Etirinotecan", "pegol", "(also", "known", "as", "NKTR-102),", "is", "a", "next-generation", "topoisomerase", "I", "(topo", "I)", "inhibitor", "proprietary", "drug", "candidate,", "currently", "being", "evaluated", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "as", "a", "single-agent", "therapy", "for", "women", "with", "metastatic", "breast", "cancer.", "<tag3>"], "wordsA": ["Etirinotecan", "pegol", "is", "currently", "being", "evaluated", "as", "a", "single-agent", "therapy", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "in", "patients", "with", "metastatic", "breast", "cancer."], "wordsB": ["Etirinotecan", "pegol", "(also", "known", "as", "NKTR-102),", "is", "a", "next-generation", "topoisomerase", "I", "(topo", "I)", "inhibitor", "proprietary", "drug", "candidate,", "currently", "being", "evaluated", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "as", "a", "single-agent", "therapy", "for", "women", "with", "metastatic", "breast", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p6_s1", "idA": "906709_14_item7_p8_s2", "sentA": "This Phase 3 clinical study, which we call the BEACON study (BrEAst Cancer Outcomes with NKTR-102), enrolled approximately 850 patients with metastatic breast cancer that have previously received treatment with an anthracycline, a taxane, and capecitabine.", "sentB": "This Phase 3 clinical study, which we call the BEACON study (BrEAst Cancer Outcomes with NKTR-102), has completed enrollment of approximately 850 women with locally recurrent or metastatic breast cancer who have had prior treatment with anthracycline, taxane and capecitabine in either the adjuvant or metastatic setting.", "type": 2, "words": ["<tag1>", "This", "Phase", "3", "clinical", "study,", "which", "we", "call", "the", "BEACON", "study", "(BrEAst", "Cancer", "Outcomes", "with", "NKTR-102),", "enrolled", "approximately", "850", "patients", "with", "metastatic", "breast", "cancer", "that", "have", "previously", "received", "treatment", "with", "an", "anthracycline,", "a", "taxane,", "and", "capecitabine.", "<tag2>", "This", "Phase", "3", "clinical", "study,", "which", "we", "call", "the", "BEACON", "study", "(BrEAst", "Cancer", "Outcomes", "with", "NKTR-102),", "has", "completed", "enrollment", "of", "approximately", "850", "women", "with", "locally", "recurrent", "or", "metastatic", "breast", "cancer", "who", "have", "had", "prior", "treatment", "with", "anthracycline,", "taxane", "and", "capecitabine", "in", "either", "the", "adjuvant", "or", "metastatic", "setting.", "<tag3>"], "wordsA": ["This", "Phase", "3", "clinical", "study,", "which", "we", "call", "the", "BEACON", "study", "(BrEAst", "Cancer", "Outcomes", "with", "NKTR-102),", "enrolled", "approximately", "850", "patients", "with", "metastatic", "breast", "cancer", "that", "have", "previously", "received", "treatment", "with", "an", "anthracycline,", "a", "taxane,", "and", "capecitabine."], "wordsB": ["This", "Phase", "3", "clinical", "study,", "which", "we", "call", "the", "BEACON", "study", "(BrEAst", "Cancer", "Outcomes", "with", "NKTR-102),", "has", "completed", "enrollment", "of", "approximately", "850", "women", "with", "locally", "recurrent", "or", "metastatic", "breast", "cancer", "who", "have", "had", "prior", "treatment", "with", "anthracycline,", "taxane", "and", "capecitabine", "in", "either", "the", "adjuvant", "or", "metastatic", "setting."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p6_s2", "idA": "906709_14_item7_p8_s3", "sentA": "We completed enrollment in the BEACON study in late July 2013.", "sentB": "Patients in the BEACON study were randomized on a 1:1 basis to receive either single-agent etirinotecan pegol or a single agent of physician s choice.", "type": 2, "words": ["<tag1>", "We", "completed", "enrollment", "in", "the", "BEACON", "study", "in", "late", "July", "2013.", "<tag2>", "Patients", "in", "the", "BEACON", "study", "were", "randomized", "on", "a", "1:1", "basis", "to", "receive", "either", "single-agent", "etirinotecan", "pegol", "or", "a", "single", "agent", "of", "physician", "s", "choice.", "<tag3>"], "wordsA": ["We", "completed", "enrollment", "in", "the", "BEACON", "study", "in", "late", "July", "2013."], "wordsB": ["Patients", "in", "the", "BEACON", "study", "were", "randomized", "on", "a", "1:1", "basis", "to", "receive", "either", "single-agent", "etirinotecan", "pegol", "or", "a", "single", "agent", "of", "physician", "s", "choice."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p6_s4", "idA": "906709_14_item7_p8_s3", "sentA": "We completed enrollment in the BEACON study in late July 2013.", "sentB": "We have now achieved the necessary number of events in the BEACON study to assess the overall survival endpoint and certain other topline data.", "type": 2, "words": ["<tag1>", "We", "completed", "enrollment", "in", "the", "BEACON", "study", "in", "late", "July", "2013.", "<tag2>", "We", "have", "now", "achieved", "the", "necessary", "number", "of", "events", "in", "the", "BEACON", "study", "to", "assess", "the", "overall", "survival", "endpoint", "and", "certain", "other", "topline", "data.", "<tag3>"], "wordsA": ["We", "completed", "enrollment", "in", "the", "BEACON", "study", "in", "late", "July", "2013."], "wordsB": ["We", "have", "now", "achieved", "the", "necessary", "number", "of", "events", "in", "the", "BEACON", "study", "to", "assess", "the", "overall", "survival", "endpoint", "and", "certain", "other", "topline", "data."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p6_s3", "idA": "906709_14_item7_p8_s4", "sentA": "On January 14, 2014, we announced that the Independent Data Monitoring Committee, or the DMC, created to provide safety oversight for the BEACON study recommended continuation of the Phase 3 BEACON study following an interim data analysis which was performed after reaching 50% of the events needed to achieve the primary endpoint of overall survival.", "sentB": "The primary endpoint of the BEACON study is overall survival, and secondary endpoints include progression-free survival and objective tumor response rate.", "type": 2, "words": ["<tag1>", "On", "January", "14,", "2014,", "we", "announced", "that", "the", "Independent", "Data", "Monitoring", "Committee,", "or", "the", "DMC,", "created", "to", "provide", "safety", "oversight", "for", "the", "BEACON", "study", "recommended", "continuation", "of", "the", "Phase", "3", "BEACON", "study", "following", "an", "interim", "data", "analysis", "which", "was", "performed", "after", "reaching", "50%", "of", "the", "events", "needed", "to", "achieve", "the", "primary", "endpoint", "of", "overall", "survival.", "<tag2>", "The", "primary", "endpoint", "of", "the", "BEACON", "study", "is", "overall", "survival,", "and", "secondary", "endpoints", "include", "progression-free", "survival", "and", "objective", "tumor", "response", "rate.", "<tag3>"], "wordsA": ["On", "January", "14,", "2014,", "we", "announced", "that", "the", "Independent", "Data", "Monitoring", "Committee,", "or", "the", "DMC,", "created", "to", "provide", "safety", "oversight", "for", "the", "BEACON", "study", "recommended", "continuation", "of", "the", "Phase", "3", "BEACON", "study", "following", "an", "interim", "data", "analysis", "which", "was", "performed", "after", "reaching", "50%", "of", "the", "events", "needed", "to", "achieve", "the", "primary", "endpoint", "of", "overall", "survival."], "wordsB": ["The", "primary", "endpoint", "of", "the", "BEACON", "study", "is", "overall", "survival,", "and", "secondary", "endpoints", "include", "progression-free", "survival", "and", "objective", "tumor", "response", "rate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p26_s2", "idA": "906709_14_item7_p8_s5", "sentA": "The BEACON study will require a substantial investment over the next two years.", "sentB": "Over the next two to three years, we expect that the NKTR-181 clinical development program will require a substantial investment.", "type": 2, "words": ["<tag1>", "The", "BEACON", "study", "will", "require", "a", "substantial", "investment", "over", "the", "next", "two", "years.", "<tag2>", "Over", "the", "next", "two", "to", "three", "years,", "we", "expect", "that", "the", "NKTR-181", "clinical", "development", "program", "will", "require", "a", "substantial", "investment.", "<tag3>"], "wordsA": ["The", "BEACON", "study", "will", "require", "a", "substantial", "investment", "over", "the", "next", "two", "years."], "wordsB": ["Over", "the", "next", "two", "to", "three", "years,", "we", "expect", "that", "the", "NKTR-181", "clinical", "development", "program", "will", "require", "a", "substantial", "investment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p9_s0", "idA": "906709_14_item7_p8_s5", "sentA": "The BEACON study will require a substantial investment over the next two years.", "sentB": "Over the next two to three years, the NKTR-181 clinical development program will require a substantial investment.", "type": 2, "words": ["<tag1>", "The", "BEACON", "study", "will", "require", "a", "substantial", "investment", "over", "the", "next", "two", "years.", "<tag2>", "Over", "the", "next", "two", "to", "three", "years,", "the", "NKTR-181", "clinical", "development", "program", "will", "require", "a", "substantial", "investment.", "<tag3>"], "wordsA": ["The", "BEACON", "study", "will", "require", "a", "substantial", "investment", "over", "the", "next", "two", "years."], "wordsB": ["Over", "the", "next", "two", "to", "three", "years,", "the", "NKTR-181", "clinical", "development", "program", "will", "require", "a", "substantial", "investment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p7_s0", "idA": "906709_14_item7_p9_s0", "sentA": "Our third most advanced proprietary drug candidate, NKTR-181, is a novel mu-opioid analgesic drug candidate for chronic pain conditions.", "sentB": "NKTR-181 is a novel mu-opioid analgesic drug candidate for chronic pain conditions.", "type": 2, "words": ["<tag1>", "Our", "third", "most", "advanced", "proprietary", "drug", "candidate,", "NKTR-181,", "is", "a", "novel", "mu-opioid", "analgesic", "drug", "candidate", "for", "chronic", "pain", "conditions.", "<tag2>", "NKTR-181", "is", "a", "novel", "mu-opioid", "analgesic", "drug", "candidate", "for", "chronic", "pain", "conditions.", "<tag3>"], "wordsA": ["Our", "third", "most", "advanced", "proprietary", "drug", "candidate,", "NKTR-181,", "is", "a", "novel", "mu-opioid", "analgesic", "drug", "candidate", "for", "chronic", "pain", "conditions."], "wordsB": ["NKTR-181", "is", "a", "novel", "mu-opioid", "analgesic", "drug", "candidate", "for", "chronic", "pain", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_15_item7_p7_s1", "idA": "906709_14_item7_p9_s1", "sentA": "The molecule has been designed to have a slow rate of entry into the brain, which is expected to reduce the attractiveness of the molecule as a target of abuse and reduce other serious central nervous system-related side effects, such as sedation and respiratory depression, which are commonly associated with standard opioid therapies.", "sentB": "NKTR-181 has been designed to have a slow rate of entry into the brain, which is expected to reduce the attractiveness of the molecule as a target of abuse and reduce other serious central nervous system-related side effects, such as sedation and respiratory depression, which are commonly associated with standard opioid therapies.", "type": 2, "words": ["<tag1>", "The", "molecule", "has", "been", "designed", "to", "have", "a", "slow", "rate", "of", "entry", "into", "the", "brain,", "which", "is", "expected", "to", "reduce", "the", "attractiveness", "of", "the", "molecule", "as", "a", "target", "of", "abuse", "and", "reduce", "other", "serious", "central", "nervous", "system-related", "side", "effects,", "such", "as", "sedation", "and", "respiratory", "depression,", "which", "are", "commonly", "associated", "with", "standard", "opioid", "therapies.", "<tag2>", "NKTR-181", "has", "been", "designed", "to", "have", "a", "slow", "rate", "of", "entry", "into", "the", "brain,", "which", "is", "expected", "to", "reduce", "the", "attractiveness", "of", "the", "molecule", "as", "a", "target", "of", "abuse", "and", "reduce", "other", "serious", "central", "nervous", "system-related", "side", "effects,", "such", "as", "sedation", "and", "respiratory", "depression,", "which", "are", "commonly", "associated", "with", "standard", "opioid", "therapies.", "<tag3>"], "wordsA": ["The", "molecule", "has", "been", "designed", "to", "have", "a", "slow", "rate", "of", "entry", "into", "the", "brain,", "which", "is", "expected", "to", "reduce", "the", "attractiveness", "of", "the", "molecule", "as", "a", "target", "of", "abuse", "and", "reduce", "other", "serious", "central", "nervous", "system-related", "side", "effects,", "such", "as", "sedation", "and", "respiratory", "depression,", "which", "are", "commonly", "associated", "with", "standard", "opioid", "therapies."], "wordsB": ["NKTR-181", "has", "been", "designed", "to", "have", "a", "slow", "rate", "of", "entry", "into", "the", "brain,", "which", "is", "expected", "to", "reduce", "the", "attractiveness", "of", "the", "molecule", "as", "a", "target", "of", "abuse", "and", "reduce", "other", "serious", "central", "nervous", "system-related", "side", "effects,", "such", "as", "sedation", "and", "respiratory", "depression,", "which", "are", "commonly", "associated", "with", "standard", "opioid", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p0_s2", "idA": "906709_15_item7_p0_s2", "sentA": "Our research and development activities involve small molecule drugs, peptides and other biologic drug candidates.", "sentB": "Our research and development activities involve small molecule drugs, peptides and protein biologic drug candidates.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "other", "biologic", "drug", "candidates.", "<tag2>", "Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "protein", "biologic", "drug", "candidates.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "other", "biologic", "drug", "candidates."], "wordsB": ["Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "protein", "biologic", "drug", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p3_s1", "idA": "906709_15_item7_p10_s0", "sentA": "The first drug candidate in this collaboration is BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)].", "sentB": "Under this collaboration, we worked with Baxalta to develop ADYNOVATE TM (previously referred to as BAX 855), an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for Hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)].", "type": 2, "words": ["<tag1>", "The", "first", "drug", "candidate", "in", "this", "collaboration", "is", "BAX", "855,", "an", "investigational,", "extended", "half-life", "recombinant", "factor", "VIII", "(rFVIII)", "treatment", "for", "hemophilia", "A", "based", "on", "ADVATE", "[Antihemophilic", "Factor", "(Recombinant)].", "<tag2>", "Under", "this", "collaboration,", "we", "worked", "with", "Baxalta", "to", "develop", "ADYNOVATE", "TM", "(previously", "referred", "to", "as", "BAX", "855),", "an", "investigational,", "extended", "half-life", "recombinant", "factor", "VIII", "(rFVIII)", "treatment", "for", "Hemophilia", "A", "based", "on", "ADVATE", "[Antihemophilic", "Factor", "(Recombinant)].", "<tag3>"], "wordsA": ["The", "first", "drug", "candidate", "in", "this", "collaboration", "is", "BAX", "855,", "an", "investigational,", "extended", "half-life", "recombinant", "factor", "VIII", "(rFVIII)", "treatment", "for", "hemophilia", "A", "based", "on", "ADVATE", "[Antihemophilic", "Factor", "(Recombinant)]."], "wordsB": ["Under", "this", "collaboration,", "we", "worked", "with", "Baxalta", "to", "develop", "ADYNOVATE", "TM", "(previously", "referred", "to", "as", "BAX", "855),", "an", "investigational,", "extended", "half-life", "recombinant", "factor", "VIII", "(rFVIII)", "treatment", "for", "Hemophilia", "A", "based", "on", "ADVATE", "[Antihemophilic", "Factor", "(Recombinant)]."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p3_s3", "idA": "906709_15_item7_p10_s1", "sentA": "In December 2014, Baxter announced that it filed a biologic license application with the FDA for BAX 855.", "sentB": "In December 2015, Baxalta announced positive study results in patients younger than 12 years of age with severe Hemophilia A. With the study results, Baxalta announced that it plans to file for marketing authorization in Europe and aims to file for a pediatric indication in the U.S. in early 2016.", "type": 2, "words": ["<tag1>", "In", "December", "2014,", "Baxter", "announced", "that", "it", "filed", "a", "biologic", "license", "application", "with", "the", "FDA", "for", "BAX", "855.", "<tag2>", "In", "December", "2015,", "Baxalta", "announced", "positive", "study", "results", "in", "patients", "younger", "than", "12", "years", "of", "age", "with", "severe", "Hemophilia", "A.", "With", "the", "study", "results,", "Baxalta", "announced", "that", "it", "plans", "to", "file", "for", "marketing", "authorization", "in", "Europe", "and", "aims", "to", "file", "for", "a", "pediatric", "indication", "in", "the", "U.S.", "in", "early", "2016.", "<tag3>"], "wordsA": ["In", "December", "2014,", "Baxter", "announced", "that", "it", "filed", "a", "biologic", "license", "application", "with", "the", "FDA", "for", "BAX", "855."], "wordsB": ["In", "December", "2015,", "Baxalta", "announced", "positive", "study", "results", "in", "patients", "younger", "than", "12", "years", "of", "age", "with", "severe", "Hemophilia", "A.", "With", "the", "study", "results,", "Baxalta", "announced", "that", "it", "plans", "to", "file", "for", "marketing", "authorization", "in", "Europe", "and", "aims", "to", "file", "for", "a", "pediatric", "indication", "in", "the", "U.S.", "in", "early", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p9_s13", "idA": "906709_15_item7_p10_s2", "sentA": "This regulatory submission was based on positive results from a prospective, global, multi-center, open-label, two-arm Phase 3 study of BAX 855 in 137 previously treated patients.", "sentB": "However, the FDA staff also indicated that positive results from a completed confirmatory trial for the MAA could also support an NDA filing.", "type": 2, "words": ["<tag1>", "This", "regulatory", "submission", "was", "based", "on", "positive", "results", "from", "a", "prospective,", "global,", "multi-center,", "open-label,", "two-arm", "Phase", "3", "study", "of", "BAX", "855", "in", "137", "previously", "treated", "patients.", "<tag2>", "However,", "the", "FDA", "staff", "also", "indicated", "that", "positive", "results", "from", "a", "completed", "confirmatory", "trial", "for", "the", "MAA", "could", "also", "support", "an", "NDA", "filing.", "<tag3>"], "wordsA": ["This", "regulatory", "submission", "was", "based", "on", "positive", "results", "from", "a", "prospective,", "global,", "multi-center,", "open-label,", "two-arm", "Phase", "3", "study", "of", "BAX", "855", "in", "137", "previously", "treated", "patients."], "wordsB": ["However,", "the", "FDA", "staff", "also", "indicated", "that", "positive", "results", "from", "a", "completed", "confirmatory", "trial", "for", "the", "MAA", "could", "also", "support", "an", "NDA", "filing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p9_s9", "idA": "906709_15_item7_p11_s0", "sentA": "We also have two significant drug development programs with Bayer.", "sentB": "We also met with the EMA to discuss filing an MAA.", "type": 2, "words": ["<tag1>", "We", "also", "have", "two", "significant", "drug", "development", "programs", "with", "Bayer.", "<tag2>", "We", "also", "met", "with", "the", "EMA", "to", "discuss", "filing", "an", "MAA.", "<tag3>"], "wordsA": ["We", "also", "have", "two", "significant", "drug", "development", "programs", "with", "Bayer."], "wordsB": ["We", "also", "met", "with", "the", "EMA", "to", "discuss", "filing", "an", "MAA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p9_s17", "idA": "906709_15_item7_p11_s1", "sentA": "This first is a collaboration to develop BAY41-6551 (Amikacin Inhale, formerly known as NKTR-061), which is an inhaled solution of amikacin, an aminoglycoside antibiotic.", "sentB": "The first is a collaboration to develop BAY41-6551 (Amikacin Inhale, formerly known as NKTR-061), which is an inhaled solution of amikacin, an aminoglycoside antibiotic.", "type": 2, "words": ["<tag1>", "This", "first", "is", "a", "collaboration", "to", "develop", "BAY41-6551", "(Amikacin", "Inhale,", "formerly", "known", "as", "NKTR-061),", "which", "is", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic.", "<tag2>", "The", "first", "is", "a", "collaboration", "to", "develop", "BAY41-6551", "(Amikacin", "Inhale,", "formerly", "known", "as", "NKTR-061),", "which", "is", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic.", "<tag3>"], "wordsA": ["This", "first", "is", "a", "collaboration", "to", "develop", "BAY41-6551", "(Amikacin", "Inhale,", "formerly", "known", "as", "NKTR-061),", "which", "is", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic."], "wordsB": ["The", "first", "is", "a", "collaboration", "to", "develop", "BAY41-6551", "(Amikacin", "Inhale,", "formerly", "known", "as", "NKTR-061),", "which", "is", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p9_s27", "idA": "906709_15_item7_p11_s15", "sentA": "While we believe that our substantial investment in research and development has the potential to create significant value if one or more of our drug candidates demonstrate positive clinical results, receive regulatory approval in one or more major markets and achieve commercialization success, drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval and the timing and outcome of clinical trial results are extremely difficult to predict.", "sentB": "While we believe that our substantial investment in research and development has the potential to create significant value if one or more of our drug candidates demonstrates positive clinical results, receives regulatory approval in one or more major markets and achieves commercial success, drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval and the timing and outcome of clinical trial results are extremely difficult to predict.", "type": 2, "words": ["<tag1>", "While", "we", "believe", "that", "our", "substantial", "investment", "in", "research", "and", "development", "has", "the", "potential", "to", "create", "significant", "value", "if", "one", "or", "more", "of", "our", "drug", "candidates", "demonstrate", "positive", "clinical", "results,", "receive", "regulatory", "approval", "in", "one", "or", "more", "major", "markets", "and", "achieve", "commercialization", "success,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "outcome", "of", "clinical", "trial", "results", "are", "extremely", "difficult", "to", "predict.", "<tag2>", "While", "we", "believe", "that", "our", "substantial", "investment", "in", "research", "and", "development", "has", "the", "potential", "to", "create", "significant", "value", "if", "one", "or", "more", "of", "our", "drug", "candidates", "demonstrates", "positive", "clinical", "results,", "receives", "regulatory", "approval", "in", "one", "or", "more", "major", "markets", "and", "achieves", "commercial", "success,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "outcome", "of", "clinical", "trial", "results", "are", "extremely", "difficult", "to", "predict.", "<tag3>"], "wordsA": ["While", "we", "believe", "that", "our", "substantial", "investment", "in", "research", "and", "development", "has", "the", "potential", "to", "create", "significant", "value", "if", "one", "or", "more", "of", "our", "drug", "candidates", "demonstrate", "positive", "clinical", "results,", "receive", "regulatory", "approval", "in", "one", "or", "more", "major", "markets", "and", "achieve", "commercialization", "success,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "outcome", "of", "clinical", "trial", "results", "are", "extremely", "difficult", "to", "predict."], "wordsB": ["While", "we", "believe", "that", "our", "substantial", "investment", "in", "research", "and", "development", "has", "the", "potential", "to", "create", "significant", "value", "if", "one", "or", "more", "of", "our", "drug", "candidates", "demonstrates", "positive", "clinical", "results,", "receives", "regulatory", "approval", "in", "one", "or", "more", "major", "markets", "and", "achieves", "commercial", "success,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "outcome", "of", "clinical", "trial", "results", "are", "extremely", "difficult", "to", "predict."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p9_s28", "idA": "906709_15_item7_p11_s16", "sentA": "Clinical development successes and failures can have a disproportionate positive or negative impact on our scientific and medical prospects, financial condition and prospects, results of operation and market value.", "sentB": "Clinical development successes and failures can have a disproportionately positive or negative impact on our scientific and medical prospects, financial condition and prospects, results of operations and market value.", "type": 2, "words": ["<tag1>", "Clinical", "development", "successes", "and", "failures", "can", "have", "a", "disproportionate", "positive", "or", "negative", "impact", "on", "our", "scientific", "and", "medical", "prospects,", "financial", "condition", "and", "prospects,", "results", "of", "operation", "and", "market", "value.", "<tag2>", "Clinical", "development", "successes", "and", "failures", "can", "have", "a", "disproportionately", "positive", "or", "negative", "impact", "on", "our", "scientific", "and", "medical", "prospects,", "financial", "condition", "and", "prospects,", "results", "of", "operations", "and", "market", "value.", "<tag3>"], "wordsA": ["Clinical", "development", "successes", "and", "failures", "can", "have", "a", "disproportionate", "positive", "or", "negative", "impact", "on", "our", "scientific", "and", "medical", "prospects,", "financial", "condition", "and", "prospects,", "results", "of", "operation", "and", "market", "value."], "wordsB": ["Clinical", "development", "successes", "and", "failures", "can", "have", "a", "disproportionately", "positive", "or", "negative", "impact", "on", "our", "scientific", "and", "medical", "prospects,", "financial", "condition", "and", "prospects,", "results", "of", "operations", "and", "market", "value."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p7_s0", "idA": "906709_15_item7_p11_s3", "sentA": "Bayer is currently enrolling patients in a Phase 3 clinical study for Amikacin Inhale.", "sentB": "In Decem ber 2015, we dosed the first patient in a Phase 1/2 clinical study for NKTR-214, which is our engineered immunostimulatory CD122-biased cytokine designed to preferentially activate the beta and gamma sub-units of the IL-2 receptor in order to proliferate t umor-killing T cells within the body (CD8-positive effector T cells and natural killer T cells) without stimulating regulatory T cells (CD4-positive T cells).", "type": 2, "words": ["<tag1>", "Bayer", "is", "currently", "enrolling", "patients", "in", "a", "Phase", "3", "clinical", "study", "for", "Amikacin", "Inhale.", "<tag2>", "In", "Decem", "ber", "2015,", "we", "dosed", "the", "first", "patient", "in", "a", "Phase", "1/2", "clinical", "study", "for", "NKTR-214,", "which", "is", "our", "engineered", "immunostimulatory", "CD122-biased", "cytokine", "designed", "to", "preferentially", "activate", "the", "beta", "and", "gamma", "sub-units", "of", "the", "IL-2", "receptor", "in", "order", "to", "proliferate", "t", "umor-killing", "T", "cells", "within", "the", "body", "(CD8-positive", "effector", "T", "cells", "and", "natural", "killer", "T", "cells)", "without", "stimulating", "regulatory", "T", "cells", "(CD4-positive", "T", "cells).", "<tag3>"], "wordsA": ["Bayer", "is", "currently", "enrolling", "patients", "in", "a", "Phase", "3", "clinical", "study", "for", "Amikacin", "Inhale."], "wordsB": ["In", "Decem", "ber", "2015,", "we", "dosed", "the", "first", "patient", "in", "a", "Phase", "1/2", "clinical", "study", "for", "NKTR-214,", "which", "is", "our", "engineered", "immunostimulatory", "CD122-biased", "cytokine", "designed", "to", "preferentially", "activate", "the", "beta", "and", "gamma", "sub-units", "of", "the", "IL-2", "receptor", "in", "order", "to", "proliferate", "t", "umor-killing", "T", "cells", "within", "the", "body", "(CD8-positive", "effector", "T", "cells", "and", "natural", "killer", "T", "cells)", "without", "stimulating", "regulatory", "T", "cells", "(CD4-positive", "T", "cells)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p9_s21", "idA": "906709_15_item7_p11_s5", "sentA": "The second is our significant royalty rights in Cipro DPI (Cipro Dry Powder Inhaler, previously called Cipro Inhale) program with Bayer that we transferred to Novartis as part of a 2008 asset divestiture transaction.", "sentB": "The second is our significant royalty rights in the Cipro DPI (Cipro Dry Powder Inhaler, previously called Cipro Inhale) program with Bayer that we transferred to Novartis as part of the 2008 pulmonary asset divestiture transaction.", "type": 2, "words": ["<tag1>", "The", "second", "is", "our", "significant", "royalty", "rights", "in", "Cipro", "DPI", "(Cipro", "Dry", "Powder", "Inhaler,", "previously", "called", "Cipro", "Inhale)", "program", "with", "Bayer", "that", "we", "transferred", "to", "Novartis", "as", "part", "of", "a", "2008", "asset", "divestiture", "transaction.", "<tag2>", "The", "second", "is", "our", "significant", "royalty", "rights", "in", "the", "Cipro", "DPI", "(Cipro", "Dry", "Powder", "Inhaler,", "previously", "called", "Cipro", "Inhale)", "program", "with", "Bayer", "that", "we", "transferred", "to", "Novartis", "as", "part", "of", "the", "2008", "pulmonary", "asset", "divestiture", "transaction.", "<tag3>"], "wordsA": ["The", "second", "is", "our", "significant", "royalty", "rights", "in", "Cipro", "DPI", "(Cipro", "Dry", "Powder", "Inhaler,", "previously", "called", "Cipro", "Inhale)", "program", "with", "Bayer", "that", "we", "transferred", "to", "Novartis", "as", "part", "of", "a", "2008", "asset", "divestiture", "transaction."], "wordsB": ["The", "second", "is", "our", "significant", "royalty", "rights", "in", "the", "Cipro", "DPI", "(Cipro", "Dry", "Powder", "Inhaler,", "previously", "called", "Cipro", "Inhale)", "program", "with", "Bayer", "that", "we", "transferred", "to", "Novartis", "as", "part", "of", "the", "2008", "pulmonary", "asset", "divestiture", "transaction."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p9_s24", "idA": "906709_15_item7_p11_s8", "sentA": "While the approved drugs and clinical development programs described above are key elements of the future success of our company, we believe it is critically important that we continue to make substantial investments in our earlier-stage drug candidate pipeline.", "sentB": "While the approved drugs and clinical development programs described above are key elements of our future success, we believe it is critically important that we continue to make substantial investments in our earlier-stage drug candidate pipeline.", "type": 2, "words": ["<tag1>", "While", "the", "approved", "drugs", "and", "clinical", "development", "programs", "described", "above", "are", "key", "elements", "of", "the", "future", "success", "of", "our", "company,", "we", "believe", "it", "is", "critically", "important", "that", "we", "continue", "to", "make", "substantial", "investments", "in", "our", "earlier-stage", "drug", "candidate", "pipeline.", "<tag2>", "While", "the", "approved", "drugs", "and", "clinical", "development", "programs", "described", "above", "are", "key", "elements", "of", "our", "future", "success,", "we", "believe", "it", "is", "critically", "important", "that", "we", "continue", "to", "make", "substantial", "investments", "in", "our", "earlier-stage", "drug", "candidate", "pipeline.", "<tag3>"], "wordsA": ["While", "the", "approved", "drugs", "and", "clinical", "development", "programs", "described", "above", "are", "key", "elements", "of", "the", "future", "success", "of", "our", "company,", "we", "believe", "it", "is", "critically", "important", "that", "we", "continue", "to", "make", "substantial", "investments", "in", "our", "earlier-stage", "drug", "candidate", "pipeline."], "wordsB": ["While", "the", "approved", "drugs", "and", "clinical", "development", "programs", "described", "above", "are", "key", "elements", "of", "our", "future", "success,", "we", "believe", "it", "is", "critically", "important", "that", "we", "continue", "to", "make", "substantial", "investments", "in", "our", "earlier-stage", "drug", "candidate", "pipeline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p11_s0", "idA": "906709_15_item7_p12_s2", "sentA": "Key Developments and Trends in Liquidity and Capital Resources As of December 31, 2014, we estimated that we had at least twelve months of working capital to fund our current business plans.", "sentB": "Key Developments and Trends in Liquidity and Capital Resources As of December 31, 2015, we estimated that we had at least twelve months of working capital to fund our current business plans.", "type": 2, "words": ["<tag1>", "Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "As", "of", "December", "31,", "2014,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans.", "<tag2>", "Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "As", "of", "December", "31,", "2015,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans.", "<tag3>"], "wordsA": ["Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "As", "of", "December", "31,", "2014,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans."], "wordsB": ["Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "As", "of", "December", "31,", "2015,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p11_s3", "idA": "906709_15_item7_p13_s1", "sentA": "As is further described in Note 7 to our Consolidated Financial Statements, this royalty obligation liability will not be settled in cash.", "sentB": "As is further described in Note 5 to our Consolidated Financial Statements, on October 5, 2015, we issued $250.0 million in aggregate principal amount of 7.75% senior secured notes due October 2020.", "type": 2, "words": ["<tag1>", "As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash.", "<tag2>", "As", "is", "further", "described", "in", "Note", "5", "to", "our", "Consolidated", "Financial", "Statements,", "on", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "October", "2020.", "<tag3>"], "wordsA": ["As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash."], "wordsB": ["As", "is", "further", "described", "in", "Note", "5", "to", "our", "Consolidated", "Financial", "Statements,", "on", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "October", "2020."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p36_s3", "idA": "906709_15_item7_p13_s1", "sentA": "As is further described in Note 7 to our Consolidated Financial Statements, this royalty obligation liability will not be settled in cash.", "sentB": "As is further described in Note 5 to our Consolidated Financial Statements, on October 5, 2015, we issued $250.0 million in aggregate principal amount of 7.75% senior secured notes due October 2020.", "type": 2, "words": ["<tag1>", "As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash.", "<tag2>", "As", "is", "further", "described", "in", "Note", "5", "to", "our", "Consolidated", "Financial", "Statements,", "on", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "October", "2020.", "<tag3>"], "wordsA": ["As", "is", "further", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "obligation", "liability", "will", "not", "be", "settled", "in", "cash."], "wordsB": ["As", "is", "further", "described", "in", "Note", "5", "to", "our", "Consolidated", "Financial", "Statements,", "on", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "October", "2020."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p12_s0", "idA": "906709_15_item7_p13_s2", "sentA": "Our revenue is derived from our collaboration agreements, under which we may receive product sales revenue, royalties, license fees, milestone payments or contract research payments.", "sentB": "Our revenue is derived from our collaboration agreements, under which we may receive product sales revenue, royalties, license fees, milestone and other contingent payments and/or contract research payments.", "type": 2, "words": ["<tag1>", "Our", "revenue", "is", "derived", "from", "our", "collaboration", "agreements,", "under", "which", "we", "may", "receive", "product", "sales", "revenue,", "royalties,", "license", "fees,", "milestone", "payments", "or", "contract", "research", "payments.", "<tag2>", "Our", "revenue", "is", "derived", "from", "our", "collaboration", "agreements,", "under", "which", "we", "may", "receive", "product", "sales", "revenue,", "royalties,", "license", "fees,", "milestone", "and", "other", "contingent", "payments", "and/or", "contract", "research", "payments.", "<tag3>"], "wordsA": ["Our", "revenue", "is", "derived", "from", "our", "collaboration", "agreements,", "under", "which", "we", "may", "receive", "product", "sales", "revenue,", "royalties,", "license", "fees,", "milestone", "payments", "or", "contract", "research", "payments."], "wordsB": ["Our", "revenue", "is", "derived", "from", "our", "collaboration", "agreements,", "under", "which", "we", "may", "receive", "product", "sales", "revenue,", "royalties,", "license", "fees,", "milestone", "and", "other", "contingent", "payments", "and/or", "contract", "research", "payments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p14_s0", "idA": "906709_15_item7_p14_s0", "sentA": "Product sales Product sales include fixed price and cost-plus manufacturing and supply agreements with our collaboration partners and result from the receipt of firm purchase orders from those partners.", "sentB": "Product sales Product sales include predominantly fixed price manufacturing and supply agreements with our collaboration partners and result from the receipt of firm purchase orders from those partners.", "type": 2, "words": ["<tag1>", "Product", "sales", "Product", "sales", "include", "fixed", "price", "and", "cost-plus", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners", "and", "result", "from", "the", "receipt", "of", "firm", "purchase", "orders", "from", "those", "partners.", "<tag2>", "Product", "sales", "Product", "sales", "include", "predominantly", "fixed", "price", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners", "and", "result", "from", "the", "receipt", "of", "firm", "purchase", "orders", "from", "those", "partners.", "<tag3>"], "wordsA": ["Product", "sales", "Product", "sales", "include", "fixed", "price", "and", "cost-plus", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners", "and", "result", "from", "the", "receipt", "of", "firm", "purchase", "orders", "from", "those", "partners."], "wordsB": ["Product", "sales", "Product", "sales", "include", "predominantly", "fixed", "price", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners", "and", "result", "from", "the", "receipt", "of", "firm", "purchase", "orders", "from", "those", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p14_s2", "idA": "906709_15_item7_p15_s0", "sentA": "Product sales decreased for the year ended December 31, 2014 compared to the year ended December 31, 2013 primarily as a result of decreased product demand from a number of our collaboration partners.", "sentB": "Product sales increased for the year ended December 31, 2015 compared to the year ended December 31, 2014 as a result of increased product demand primarily from one of our collaboration partners.", "type": 2, "words": ["<tag1>", "Product", "sales", "decreased", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "as", "a", "result", "of", "decreased", "product", "demand", "from", "a", "number", "of", "our", "collaboration", "partners.", "<tag2>", "Product", "sales", "increased", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "as", "a", "result", "of", "increased", "product", "demand", "primarily", "from", "one", "of", "our", "collaboration", "partners.", "<tag3>"], "wordsA": ["Product", "sales", "decreased", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "as", "a", "result", "of", "decreased", "product", "demand", "from", "a", "number", "of", "our", "collaboration", "partners."], "wordsB": ["Product", "sales", "increased", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "as", "a", "result", "of", "increased", "product", "demand", "primarily", "from", "one", "of", "our", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p35_s0", "idA": "906709_15_item7_p15_s1", "sentA": "Product sales increased for the year ended December 31, 2013 compared to the year ended December 31, 2012 primarily as a result of a $9.0 million increase in product sales to one of our collaboration partners.", "sentB": "Loss on Extinguishment of Debt As a result of the secured note financing transaction in October 2015 discussed above, in the quarter and year ended December 31, 2015, we recognized a $14.1 million loss on extinguishment of our 12% notes, which consists of a $11.3 million redemption premium payment, $1.2 million of incremental interest paid at redemption to the 12% note holders and the write-off of $1.6 million of unamortized issuance costs on the 12% notes.", "type": 2, "words": ["<tag1>", "Product", "sales", "increased", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "as", "a", "result", "of", "a", "$9.0", "million", "increase", "in", "product", "sales", "to", "one", "of", "our", "collaboration", "partners.", "<tag2>", "Loss", "on", "Extinguishment", "of", "Debt", "As", "a", "result", "of", "the", "secured", "note", "financing", "transaction", "in", "October", "2015", "discussed", "above,", "in", "the", "quarter", "and", "year", "ended", "December", "31,", "2015,", "we", "recognized", "a", "$14.1", "million", "loss", "on", "extinguishment", "of", "our", "12%", "notes,", "which", "consists", "of", "a", "$11.3", "million", "redemption", "premium", "payment,", "$1.2", "million", "of", "incremental", "interest", "paid", "at", "redemption", "to", "the", "12%", "note", "holders", "and", "the", "write-off", "of", "$1.6", "million", "of", "unamortized", "issuance", "costs", "on", "the", "12%", "notes.", "<tag3>"], "wordsA": ["Product", "sales", "increased", "for", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "as", "a", "result", "of", "a", "$9.0", "million", "increase", "in", "product", "sales", "to", "one", "of", "our", "collaboration", "partners."], "wordsB": ["Loss", "on", "Extinguishment", "of", "Debt", "As", "a", "result", "of", "the", "secured", "note", "financing", "transaction", "in", "October", "2015", "discussed", "above,", "in", "the", "quarter", "and", "year", "ended", "December", "31,", "2015,", "we", "recognized", "a", "$14.1", "million", "loss", "on", "extinguishment", "of", "our", "12%", "notes,", "which", "consists", "of", "a", "$11.3", "million", "redemption", "premium", "payment,", "$1.2", "million", "of", "incremental", "interest", "paid", "at", "redemption", "to", "the", "12%", "note", "holders", "and", "the", "write-off", "of", "$1.6", "million", "of", "unamortized", "issuance", "costs", "on", "the", "12%", "notes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p14_s4", "idA": "906709_15_item7_p15_s2", "sentA": "We currently expect product sales to increase in 2015 as compared to 2014 due to increased product demand from a number of our collaboration partners.", "sentB": "We currently expect product sales to increase in 2016 as compared to 2015 due to increased product demand primarily from one of our collaboration partners.", "type": 2, "words": ["<tag1>", "We", "currently", "expect", "product", "sales", "to", "increase", "in", "2015", "as", "compared", "to", "2014", "due", "to", "increased", "product", "demand", "from", "a", "number", "of", "our", "collaboration", "partners.", "<tag2>", "We", "currently", "expect", "product", "sales", "to", "increase", "in", "2016", "as", "compared", "to", "2015", "due", "to", "increased", "product", "demand", "primarily", "from", "one", "of", "our", "collaboration", "partners.", "<tag3>"], "wordsA": ["We", "currently", "expect", "product", "sales", "to", "increase", "in", "2015", "as", "compared", "to", "2014", "due", "to", "increased", "product", "demand", "from", "a", "number", "of", "our", "collaboration", "partners."], "wordsB": ["We", "currently", "expect", "product", "sales", "to", "increase", "in", "2016", "as", "compared", "to", "2015", "due", "to", "increased", "product", "demand", "primarily", "from", "one", "of", "our", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p15_s2", "idA": "906709_15_item7_p16_s0", "sentA": "as well as the completion of the royalty term for one product.", "sentB": "Royalty revenue received in cash decreased during the year ended December 31, 2014 compared to the year ended December 31, 2013 due primarily to decreases in the underlying net sales of the applicable products as well as the completion of the royalty term for one product.", "type": 2, "words": ["<tag1>", "as", "well", "as", "the", "completion", "of", "the", "royalty", "term", "for", "one", "product.", "<tag2>", "Royalty", "revenue", "received", "in", "cash", "decreased", "during", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "due", "primarily", "to", "decreases", "in", "the", "underlying", "net", "sales", "of", "the", "applicable", "products", "as", "well", "as", "the", "completion", "of", "the", "royalty", "term", "for", "one", "product.", "<tag3>"], "wordsA": ["as", "well", "as", "the", "completion", "of", "the", "royalty", "term", "for", "one", "product."], "wordsB": ["Royalty", "revenue", "received", "in", "cash", "decreased", "during", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "due", "primarily", "to", "decreases", "in", "the", "underlying", "net", "sales", "of", "the", "applicable", "products", "as", "well", "as", "the", "completion", "of", "the", "royalty", "term", "for", "one", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p15_s3", "idA": "906709_15_item7_p17_s1", "sentA": "If sales of MOVANTIK (and/or MOVENTIG ) are initiated during 2015, we expect royalty revenue received in cash will increase in 2015 as compared to 2014 due to royalties we expect to receive from net sales of MOVANTIK .", "sentB": "We expect royalty revenue in 2016 will increase as compared to 2015 due to royalties we expect to receive from net sales of MOVANTIK TM , MOVENTIG and ADYNOVATE TM .", "type": 2, "words": ["<tag1>", "If", "sales", "of", "MOVANTIK", "(and/or", "MOVENTIG", ")", "are", "initiated", "during", "2015,", "we", "expect", "royalty", "revenue", "received", "in", "cash", "will", "increase", "in", "2015", "as", "compared", "to", "2014", "due", "to", "royalties", "we", "expect", "to", "receive", "from", "net", "sales", "of", "MOVANTIK", ".", "<tag2>", "We", "expect", "royalty", "revenue", "in", "2016", "will", "increase", "as", "compared", "to", "2015", "due", "to", "royalties", "we", "expect", "to", "receive", "from", "net", "sales", "of", "MOVANTIK", "TM", ",", "MOVENTIG", "and", "ADYNOVATE", "TM", ".", "<tag3>"], "wordsA": ["If", "sales", "of", "MOVANTIK", "(and/or", "MOVENTIG", ")", "are", "initiated", "during", "2015,", "we", "expect", "royalty", "revenue", "received", "in", "cash", "will", "increase", "in", "2015", "as", "compared", "to", "2014", "due", "to", "royalties", "we", "expect", "to", "receive", "from", "net", "sales", "of", "MOVANTIK", "."], "wordsB": ["We", "expect", "royalty", "revenue", "in", "2016", "will", "increase", "as", "compared", "to", "2015", "due", "to", "royalties", "we", "expect", "to", "receive", "from", "net", "sales", "of", "MOVANTIK", "TM", ",", "MOVENTIG", "and", "ADYNOVATE", "TM", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p16_s9", "idA": "906709_15_item7_p17_s10", "sentA": "These increases in 2014 as compared to 2013 were partially offset by the recognition in 2013 of a $25.0 million payment from AstraZeneca achieved in September 2013 on the acceptance for review by the EMA of the MOVANTIK regulatory approval application filed by AstraZeneca as well as the recognition in July 2013 of the remaining $6.7 million deferred revenue balance related to our agreement with Affymax as a result of the termination of that agreement.", "sentB": "In 2013, we received and recognized a $25.0 million payment from AstraZeneca achieved in September 2013 on the acceptance for review by the EMA of the MOVANTIK TM regulatory approval application filed by AstraZeneca as well as the recognition in July 2013 of the remaining $6.7 million deferred revenue balance related to our agreement with Affymax as a result of the termination of that agreement.", "type": 2, "words": ["<tag1>", "These", "increases", "in", "2014", "as", "compared", "to", "2013", "were", "partially", "offset", "by", "the", "recognition", "in", "2013", "of", "a", "$25.0", "million", "payment", "from", "AstraZeneca", "achieved", "in", "September", "2013", "on", "the", "acceptance", "for", "review", "by", "the", "EMA", "of", "the", "MOVANTIK", "regulatory", "approval", "application", "filed", "by", "AstraZeneca", "as", "well", "as", "the", "recognition", "in", "July", "2013", "of", "the", "remaining", "$6.7", "million", "deferred", "revenue", "balance", "related", "to", "our", "agreement", "with", "Affymax", "as", "a", "result", "of", "the", "termination", "of", "that", "agreement.", "<tag2>", "In", "2013,", "we", "received", "and", "recognized", "a", "$25.0", "million", "payment", "from", "AstraZeneca", "achieved", "in", "September", "2013", "on", "the", "acceptance", "for", "review", "by", "the", "EMA", "of", "the", "MOVANTIK", "TM", "regulatory", "approval", "application", "filed", "by", "AstraZeneca", "as", "well", "as", "the", "recognition", "in", "July", "2013", "of", "the", "remaining", "$6.7", "million", "deferred", "revenue", "balance", "related", "to", "our", "agreement", "with", "Affymax", "as", "a", "result", "of", "the", "termination", "of", "that", "agreement.", "<tag3>"], "wordsA": ["These", "increases", "in", "2014", "as", "compared", "to", "2013", "were", "partially", "offset", "by", "the", "recognition", "in", "2013", "of", "a", "$25.0", "million", "payment", "from", "AstraZeneca", "achieved", "in", "September", "2013", "on", "the", "acceptance", "for", "review", "by", "the", "EMA", "of", "the", "MOVANTIK", "regulatory", "approval", "application", "filed", "by", "AstraZeneca", "as", "well", "as", "the", "recognition", "in", "July", "2013", "of", "the", "remaining", "$6.7", "million", "deferred", "revenue", "balance", "related", "to", "our", "agreement", "with", "Affymax", "as", "a", "result", "of", "the", "termination", "of", "that", "agreement."], "wordsB": ["In", "2013,", "we", "received", "and", "recognized", "a", "$25.0", "million", "payment", "from", "AstraZeneca", "achieved", "in", "September", "2013", "on", "the", "acceptance", "for", "review", "by", "the", "EMA", "of", "the", "MOVANTIK", "TM", "regulatory", "approval", "application", "filed", "by", "AstraZeneca", "as", "well", "as", "the", "recognition", "in", "July", "2013", "of", "the", "remaining", "$6.7", "million", "deferred", "revenue", "balance", "related", "to", "our", "agreement", "with", "Affymax", "as", "a", "result", "of", "the", "termination", "of", "that", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p16_s3", "idA": "906709_15_item7_p17_s11", "sentA": "In addition, in April 2013, we recognized a $10.0 million milestone achieved upon the start of the Amikacin Inhale Phase 3 clinical trial by Bayer.", "sentB": "In addition, in 2015, we recognized a $10.0 million milestone achieved in November 2015 as a result of the FDA s approval of Baxalta s ADYNOVATE TM .", "type": 2, "words": ["<tag1>", "In", "addition,", "in", "April", "2013,", "we", "recognized", "a", "$10.0", "million", "milestone", "achieved", "upon", "the", "start", "of", "the", "Amikacin", "Inhale", "Phase", "3", "clinical", "trial", "by", "Bayer.", "<tag2>", "In", "addition,", "in", "2015,", "we", "recognized", "a", "$10.0", "million", "milestone", "achieved", "in", "November", "2015", "as", "a", "result", "of", "the", "FDA", "s", "approval", "of", "Baxalta", "s", "ADYNOVATE", "TM", ".", "<tag3>"], "wordsA": ["In", "addition,", "in", "April", "2013,", "we", "recognized", "a", "$10.0", "million", "milestone", "achieved", "upon", "the", "start", "of", "the", "Amikacin", "Inhale", "Phase", "3", "clinical", "trial", "by", "Bayer."], "wordsB": ["In", "addition,", "in", "2015,", "we", "recognized", "a", "$10.0", "million", "milestone", "achieved", "in", "November", "2015", "as", "a", "result", "of", "the", "FDA", "s", "approval", "of", "Baxalta", "s", "ADYNOVATE", "TM", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p16_s11", "idA": "906709_15_item7_p17_s14", "sentA": "We expect license, collaboration and other revenue in 2015 will be significantly impacted by the outcome and timing of AstraZeneca s launch of MOVANTIK as we are entitled to $140.0 million of development milestone payments due upon the commercial launches of MOVANTIK in the U.S. ($100.0 million) and in the E.U. ($40.0 million).", "sentB": "We expect license, collaboration and other revenue in 2016 will decrease significantly compared to 2015 primarily due to the achievement in 2015 of the significant non-recurring payments noted above resulting from AstraZeneca s commercial launch of MOVANTIK TM and MOVENTIG .", "type": 2, "words": ["<tag1>", "We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2015", "will", "be", "significantly", "impacted", "by", "the", "outcome", "and", "timing", "of", "AstraZeneca", "s", "launch", "of", "MOVANTIK", "as", "we", "are", "entitled", "to", "$140.0", "million", "of", "development", "milestone", "payments", "due", "upon", "the", "commercial", "launches", "of", "MOVANTIK", "in", "the", "U.S.", "($100.0", "million)", "and", "in", "the", "E.U.", "($40.0", "million).", "<tag2>", "We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2016", "will", "decrease", "significantly", "compared", "to", "2015", "primarily", "due", "to", "the", "achievement", "in", "2015", "of", "the", "significant", "non-recurring", "payments", "noted", "above", "resulting", "from", "AstraZeneca", "s", "commercial", "launch", "of", "MOVANTIK", "TM", "and", "MOVENTIG", ".", "<tag3>"], "wordsA": ["We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2015", "will", "be", "significantly", "impacted", "by", "the", "outcome", "and", "timing", "of", "AstraZeneca", "s", "launch", "of", "MOVANTIK", "as", "we", "are", "entitled", "to", "$140.0", "million", "of", "development", "milestone", "payments", "due", "upon", "the", "commercial", "launches", "of", "MOVANTIK", "in", "the", "U.S.", "($100.0", "million)", "and", "in", "the", "E.U.", "($40.0", "million)."], "wordsB": ["We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2016", "will", "decrease", "significantly", "compared", "to", "2015", "primarily", "due", "to", "the", "achievement", "in", "2015", "of", "the", "significant", "non-recurring", "payments", "noted", "above", "resulting", "from", "AstraZeneca", "s", "commercial", "launch", "of", "MOVANTIK", "TM", "and", "MOVENTIG", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p16_s6", "idA": "906709_15_item7_p17_s15", "sentA": "If these activities occur in 2015, our license, collaboration and other revenue in 2015 will increase from 2014.", "sentB": "The increase in license, collaboration and other revenue in 2015 is offset by a total of $10.0 million that we agreed in March 2015 to pay AstraZeneca, including $5.0 million paid in July 2015 and $5.0 million to be paid in July 2016, to fund U.S. television advertising in consideration for certain additional commercial information rights.", "type": 2, "words": ["<tag1>", "If", "these", "activities", "occur", "in", "2015,", "our", "license,", "collaboration", "and", "other", "revenue", "in", "2015", "will", "increase", "from", "2014.", "<tag2>", "The", "increase", "in", "license,", "collaboration", "and", "other", "revenue", "in", "2015", "is", "offset", "by", "a", "total", "of", "$10.0", "million", "that", "we", "agreed", "in", "March", "2015", "to", "pay", "AstraZeneca,", "including", "$5.0", "million", "paid", "in", "July", "2015", "and", "$5.0", "million", "to", "be", "paid", "in", "July", "2016,", "to", "fund", "U.S.", "television", "advertising", "in", "consideration", "for", "certain", "additional", "commercial", "information", "rights.", "<tag3>"], "wordsA": ["If", "these", "activities", "occur", "in", "2015,", "our", "license,", "collaboration", "and", "other", "revenue", "in", "2015", "will", "increase", "from", "2014."], "wordsB": ["The", "increase", "in", "license,", "collaboration", "and", "other", "revenue", "in", "2015", "is", "offset", "by", "a", "total", "of", "$10.0", "million", "that", "we", "agreed", "in", "March", "2015", "to", "pay", "AstraZeneca,", "including", "$5.0", "million", "paid", "in", "July", "2015", "and", "$5.0", "million", "to", "be", "paid", "in", "July", "2016,", "to", "fund", "U.S.", "television", "advertising", "in", "consideration", "for", "certain", "additional", "commercial", "information", "rights."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p15_s7", "idA": "906709_15_item7_p17_s5", "sentA": "We expect non-cash royalties from net sales of CIMZIA and MIRCERA in 2015 to be consistent with 2014.", "sentB": "We expect non-cash royalties from net sales of CIMZIA and MIRCERA in 2016 to increase compared to 2015.", "type": 2, "words": ["<tag1>", "We", "expect", "non-cash", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "in", "2015", "to", "be", "consistent", "with", "2014.", "<tag2>", "We", "expect", "non-cash", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "in", "2016", "to", "increase", "compared", "to", "2015.", "<tag3>"], "wordsA": ["We", "expect", "non-cash", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "in", "2015", "to", "be", "consistent", "with", "2014."], "wordsB": ["We", "expect", "non-cash", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "in", "2016", "to", "increase", "compared", "to", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p16_s0", "idA": "906709_15_item7_p17_s6", "sentA": "License, collaboration and other revenue License, collaboration and other revenue includes the recognition of upfront payments and milestone payments received in connection with our license and collaboration agreements and reimbursed research and development expenses.", "sentB": "License, collaboration and other revenue License, collaboration and other revenue includes the recognition of upfront payments, milestone and other contingent payments received in connection with our license and collaboration agreements and reimbursed research and development expenses.", "type": 2, "words": ["<tag1>", "License,", "collaboration", "and", "other", "revenue", "License,", "collaboration", "and", "other", "revenue", "includes", "the", "recognition", "of", "upfront", "payments", "and", "milestone", "payments", "received", "in", "connection", "with", "our", "license", "and", "collaboration", "agreements", "and", "reimbursed", "research", "and", "development", "expenses.", "<tag2>", "License,", "collaboration", "and", "other", "revenue", "License,", "collaboration", "and", "other", "revenue", "includes", "the", "recognition", "of", "upfront", "payments,", "milestone", "and", "other", "contingent", "payments", "received", "in", "connection", "with", "our", "license", "and", "collaboration", "agreements", "and", "reimbursed", "research", "and", "development", "expenses.", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "revenue", "License,", "collaboration", "and", "other", "revenue", "includes", "the", "recognition", "of", "upfront", "payments", "and", "milestone", "payments", "received", "in", "connection", "with", "our", "license", "and", "collaboration", "agreements", "and", "reimbursed", "research", "and", "development", "expenses."], "wordsB": ["License,", "collaboration", "and", "other", "revenue", "License,", "collaboration", "and", "other", "revenue", "includes", "the", "recognition", "of", "upfront", "payments,", "milestone", "and", "other", "contingent", "payments", "received", "in", "connection", "with", "our", "license", "and", "collaboration", "agreements", "and", "reimbursed", "research", "and", "development", "expenses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p16_s1", "idA": "906709_15_item7_p17_s7", "sentA": "The level of license, collaboration and other revenue depends in part upon the estimated amortization period of the upfront payments, the achievement of milestones, the continuation of existing collaborations, the amount of reimbursed research and development work, and entering into new collaboration agreements, if any.", "sentB": "The level of license, collaboration and other revenue depends in part upon the estimated amortization period of the upfront payments, the achievement of milestones and other contingent events, the continuation of existing collaborations, the amount of reimbursed research and development work, and entering into new collaboration agreements, if any.", "type": 2, "words": ["<tag1>", "The", "level", "of", "license,", "collaboration", "and", "other", "revenue", "depends", "in", "part", "upon", "the", "estimated", "amortization", "period", "of", "the", "upfront", "payments,", "the", "achievement", "of", "milestones,", "the", "continuation", "of", "existing", "collaborations,", "the", "amount", "of", "reimbursed", "research", "and", "development", "work,", "and", "entering", "into", "new", "collaboration", "agreements,", "if", "any.", "<tag2>", "The", "level", "of", "license,", "collaboration", "and", "other", "revenue", "depends", "in", "part", "upon", "the", "estimated", "amortization", "period", "of", "the", "upfront", "payments,", "the", "achievement", "of", "milestones", "and", "other", "contingent", "events,", "the", "continuation", "of", "existing", "collaborations,", "the", "amount", "of", "reimbursed", "research", "and", "development", "work,", "and", "entering", "into", "new", "collaboration", "agreements,", "if", "any.", "<tag3>"], "wordsA": ["The", "level", "of", "license,", "collaboration", "and", "other", "revenue", "depends", "in", "part", "upon", "the", "estimated", "amortization", "period", "of", "the", "upfront", "payments,", "the", "achievement", "of", "milestones,", "the", "continuation", "of", "existing", "collaborations,", "the", "amount", "of", "reimbursed", "research", "and", "development", "work,", "and", "entering", "into", "new", "collaboration", "agreements,", "if", "any."], "wordsB": ["The", "level", "of", "license,", "collaboration", "and", "other", "revenue", "depends", "in", "part", "upon", "the", "estimated", "amortization", "period", "of", "the", "upfront", "payments,", "the", "achievement", "of", "milestones", "and", "other", "contingent", "events,", "the", "continuation", "of", "existing", "collaborations,", "the", "amount", "of", "reimbursed", "research", "and", "development", "work,", "and", "entering", "into", "new", "collaboration", "agreements,", "if", "any."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p16_s2", "idA": "906709_15_item7_p17_s8", "sentA": "License, collaboration and other revenue increased for the year ended December 31, 2014 compared to the year ended December 31, 2013 primarily as a result of the recognition in 2014 of the $35.0 million and $70.0 million milestone payments received in October 2014 and November 2013, respectively, from AstraZeneca as a result of the FDA s approval of MOVANTIK in September 2014.", "sentB": "License, collaboration and other revenue increased for the year ended December 31, 2015 compared to the year ended December 31, 2014 primarily as a result of the recognition of the $140.0 million of payments received from AstraZeneca as a result of the U.S. commercial launch of MOVANTIK TM and the EU commercial launch of MOVENTIG .", "type": 2, "words": ["<tag1>", "License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "as", "a", "result", "of", "the", "recognition", "in", "2014", "of", "the", "$35.0", "million", "and", "$70.0", "million", "milestone", "payments", "received", "in", "October", "2014", "and", "November", "2013,", "respectively,", "from", "AstraZeneca", "as", "a", "result", "of", "the", "FDA", "s", "approval", "of", "MOVANTIK", "in", "September", "2014.", "<tag2>", "License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "the", "$140.0", "million", "of", "payments", "received", "from", "AstraZeneca", "as", "a", "result", "of", "the", "U.S.", "commercial", "launch", "of", "MOVANTIK", "TM", "and", "the", "EU", "commercial", "launch", "of", "MOVENTIG", ".", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "as", "a", "result", "of", "the", "recognition", "in", "2014", "of", "the", "$35.0", "million", "and", "$70.0", "million", "milestone", "payments", "received", "in", "October", "2014", "and", "November", "2013,", "respectively,", "from", "AstraZeneca", "as", "a", "result", "of", "the", "FDA", "s", "approval", "of", "MOVANTIK", "in", "September", "2014."], "wordsB": ["License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "the", "$140.0", "million", "of", "payments", "received", "from", "AstraZeneca", "as", "a", "result", "of", "the", "U.S.", "commercial", "launch", "of", "MOVANTIK", "TM", "and", "the", "EU", "commercial", "launch", "of", "MOVENTIG", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p16_s4", "idA": "906709_15_item7_p17_s8", "sentA": "License, collaboration and other revenue increased for the year ended December 31, 2014 compared to the year ended December 31, 2013 primarily as a result of the recognition in 2014 of the $35.0 million and $70.0 million milestone payments received in October 2014 and November 2013, respectively, from AstraZeneca as a result of the FDA s approval of MOVANTIK in September 2014.", "sentB": "During the year-ended December 31, 2014, we recognized $105.0 million of payments from AstraZeneca as a result of the FDA s approval of MOVANTIK TM in September 2014 and recognized $9.0 million of milestone payments resulting from the transfer of our manufacturing technology to two of our collaboration partners.", "type": 2, "words": ["<tag1>", "License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "as", "a", "result", "of", "the", "recognition", "in", "2014", "of", "the", "$35.0", "million", "and", "$70.0", "million", "milestone", "payments", "received", "in", "October", "2014", "and", "November", "2013,", "respectively,", "from", "AstraZeneca", "as", "a", "result", "of", "the", "FDA", "s", "approval", "of", "MOVANTIK", "in", "September", "2014.", "<tag2>", "During", "the", "year-ended", "December", "31,", "2014,", "we", "recognized", "$105.0", "million", "of", "payments", "from", "AstraZeneca", "as", "a", "result", "of", "the", "FDA", "s", "approval", "of", "MOVANTIK", "TM", "in", "September", "2014", "and", "recognized", "$9.0", "million", "of", "milestone", "payments", "resulting", "from", "the", "transfer", "of", "our", "manufacturing", "technology", "to", "two", "of", "our", "collaboration", "partners.", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "as", "a", "result", "of", "the", "recognition", "in", "2014", "of", "the", "$35.0", "million", "and", "$70.0", "million", "milestone", "payments", "received", "in", "October", "2014", "and", "November", "2013,", "respectively,", "from", "AstraZeneca", "as", "a", "result", "of", "the", "FDA", "s", "approval", "of", "MOVANTIK", "in", "September", "2014."], "wordsB": ["During", "the", "year-ended", "December", "31,", "2014,", "we", "recognized", "$105.0", "million", "of", "payments", "from", "AstraZeneca", "as", "a", "result", "of", "the", "FDA", "s", "approval", "of", "MOVANTIK", "TM", "in", "September", "2014", "and", "recognized", "$9.0", "million", "of", "milestone", "payments", "resulting", "from", "the", "transfer", "of", "our", "manufacturing", "technology", "to", "two", "of", "our", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p16_s8", "idA": "906709_15_item7_p17_s8", "sentA": "License, collaboration and other revenue increased for the year ended December 31, 2014 compared to the year ended December 31, 2013 primarily as a result of the recognition in 2014 of the $35.0 million and $70.0 million milestone payments received in October 2014 and November 2013, respectively, from AstraZeneca as a result of the FDA s approval of MOVANTIK in September 2014.", "sentB": "License, collaboration and other revenue increased for the year ended December 31, 2014 compared to the year ended December 31, 2013 primarily as a result of the recognition in 2014 of the $105.0 million of payments from AstraZeneca noted above as a result of the FDA s approval of MOVANTIK TM in September 2014.", "type": 2, "words": ["<tag1>", "License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "as", "a", "result", "of", "the", "recognition", "in", "2014", "of", "the", "$35.0", "million", "and", "$70.0", "million", "milestone", "payments", "received", "in", "October", "2014", "and", "November", "2013,", "respectively,", "from", "AstraZeneca", "as", "a", "result", "of", "the", "FDA", "s", "approval", "of", "MOVANTIK", "in", "September", "2014.", "<tag2>", "License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "as", "a", "result", "of", "the", "recognition", "in", "2014", "of", "the", "$105.0", "million", "of", "payments", "from", "AstraZeneca", "noted", "above", "as", "a", "result", "of", "the", "FDA", "s", "approval", "of", "MOVANTIK", "TM", "in", "September", "2014.", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "as", "a", "result", "of", "the", "recognition", "in", "2014", "of", "the", "$35.0", "million", "and", "$70.0", "million", "milestone", "payments", "received", "in", "October", "2014", "and", "November", "2013,", "respectively,", "from", "AstraZeneca", "as", "a", "result", "of", "the", "FDA", "s", "approval", "of", "MOVANTIK", "in", "September", "2014."], "wordsB": ["License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "as", "a", "result", "of", "the", "recognition", "in", "2014", "of", "the", "$105.0", "million", "of", "payments", "from", "AstraZeneca", "noted", "above", "as", "a", "result", "of", "the", "FDA", "s", "approval", "of", "MOVANTIK", "TM", "in", "September", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p38_s10", "idA": "906709_15_item7_p17_s8", "sentA": "License, collaboration and other revenue increased for the year ended December 31, 2014 compared to the year ended December 31, 2013 primarily as a result of the recognition in 2014 of the $35.0 million and $70.0 million milestone payments received in October 2014 and November 2013, respectively, from AstraZeneca as a result of the FDA s approval of MOVANTIK in September 2014.", "sentB": "The accounts receivable balance in our Consolidated Balance Sheet as of December 31, 2015 includes a $10.0 million milestone receivable from Baxalta resulting from the FDA s approval of ADYNOVATE TM as well as $9.5 million in receivables from product sales, which were subsequently collected in 2016.", "type": 2, "words": ["<tag1>", "License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "as", "a", "result", "of", "the", "recognition", "in", "2014", "of", "the", "$35.0", "million", "and", "$70.0", "million", "milestone", "payments", "received", "in", "October", "2014", "and", "November", "2013,", "respectively,", "from", "AstraZeneca", "as", "a", "result", "of", "the", "FDA", "s", "approval", "of", "MOVANTIK", "in", "September", "2014.", "<tag2>", "The", "accounts", "receivable", "balance", "in", "our", "Consolidated", "Balance", "Sheet", "as", "of", "December", "31,", "2015", "includes", "a", "$10.0", "million", "milestone", "receivable", "from", "Baxalta", "resulting", "from", "the", "FDA", "s", "approval", "of", "ADYNOVATE", "TM", "as", "well", "as", "$9.5", "million", "in", "receivables", "from", "product", "sales,", "which", "were", "subsequently", "collected", "in", "2016.", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "as", "a", "result", "of", "the", "recognition", "in", "2014", "of", "the", "$35.0", "million", "and", "$70.0", "million", "milestone", "payments", "received", "in", "October", "2014", "and", "November", "2013,", "respectively,", "from", "AstraZeneca", "as", "a", "result", "of", "the", "FDA", "s", "approval", "of", "MOVANTIK", "in", "September", "2014."], "wordsB": ["The", "accounts", "receivable", "balance", "in", "our", "Consolidated", "Balance", "Sheet", "as", "of", "December", "31,", "2015", "includes", "a", "$10.0", "million", "milestone", "receivable", "from", "Baxalta", "resulting", "from", "the", "FDA", "s", "approval", "of", "ADYNOVATE", "TM", "as", "well", "as", "$9.5", "million", "in", "receivables", "from", "product", "sales,", "which", "were", "subsequently", "collected", "in", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p16_s5", "idA": "906709_15_item7_p17_s9", "sentA": "In addition, we recognized $8.0 million of milestones received in December 2014 related to positive results from Baxter s BAX 855 Phase 3 study.", "sentB": "In addition, in 2014, we recognized $8.0 million of milestones received in December 2014 related to positive results from Baxalta s ADYNOVATE TM Phase 3 study.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "recognized", "$8.0", "million", "of", "milestones", "received", "in", "December", "2014", "related", "to", "positive", "results", "from", "Baxter", "s", "BAX", "855", "Phase", "3", "study.", "<tag2>", "In", "addition,", "in", "2014,", "we", "recognized", "$8.0", "million", "of", "milestones", "received", "in", "December", "2014", "related", "to", "positive", "results", "from", "Baxalta", "s", "ADYNOVATE", "TM", "Phase", "3", "study.", "<tag3>"], "wordsA": ["In", "addition,", "we", "recognized", "$8.0", "million", "of", "milestones", "received", "in", "December", "2014", "related", "to", "positive", "results", "from", "Baxter", "s", "BAX", "855", "Phase", "3", "study."], "wordsB": ["In", "addition,", "in", "2014,", "we", "recognized", "$8.0", "million", "of", "milestones", "received", "in", "December", "2014", "related", "to", "positive", "results", "from", "Baxalta", "s", "ADYNOVATE", "TM", "Phase", "3", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p18_s0", "idA": "906709_15_item7_p19_s0", "sentA": "Revenue by geography Revenue by geographic area is based on locations of our partners.", "sentB": "Revenue by geographic area is based on the locations of our partners.", "type": 2, "words": ["<tag1>", "Revenue", "by", "geography", "Revenue", "by", "geographic", "area", "is", "based", "on", "locations", "of", "our", "partners.", "<tag2>", "Revenue", "by", "geographic", "area", "is", "based", "on", "the", "locations", "of", "our", "partners.", "<tag3>"], "wordsA": ["Revenue", "by", "geography", "Revenue", "by", "geographic", "area", "is", "based", "on", "locations", "of", "our", "partners."], "wordsB": ["Revenue", "by", "geographic", "area", "is", "based", "on", "the", "locations", "of", "our", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p18_s1", "idA": "906709_15_item7_p19_s1", "sentA": "The following table sets forth revenue by geographic area (in thousands):", "sentB": "The following table sets forth revenue by geographic area:", "type": 2, "words": ["<tag1>", "The", "following", "table", "sets", "forth", "revenue", "by", "geographic", "area", "(in", "thousands):", "<tag2>", "The", "following", "table", "sets", "forth", "revenue", "by", "geographic", "area:", "<tag3>"], "wordsA": ["The", "following", "table", "sets", "forth", "revenue", "by", "geographic", "area", "(in", "thousands):"], "wordsB": ["The", "following", "table", "sets", "forth", "revenue", "by", "geographic", "area:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p19_s0", "idA": "906709_15_item7_p20_s0", "sentA": "The increase in revenue attributable to European countries for the year ended December 31, 2014 compared to the year ended December 31, 2013 is primarily attributable to increased milestone and royalty revenues from our existing European based collaboration partners, including the recognition of the $105.0 million milestone payments from AstraZeneca described above.", "sentB": "The increase in revenue attributable to European countries for the year ended December 31, 2015 compared to the year ended December 31, 2014 is primarily attributable to increased milestone and other contingent payments from our existing European based collaboration partners, including the recognition of a total of $140.0 million payments from AstraZeneca in connection with its commercial launches of MOVANTIK TM described above.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "is", "primarily", "attributable", "to", "increased", "milestone", "and", "royalty", "revenues", "from", "our", "existing", "European", "based", "collaboration", "partners,", "including", "the", "recognition", "of", "the", "$105.0", "million", "milestone", "payments", "from", "AstraZeneca", "described", "above.", "<tag2>", "The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "is", "primarily", "attributable", "to", "increased", "milestone", "and", "other", "contingent", "payments", "from", "our", "existing", "European", "based", "collaboration", "partners,", "including", "the", "recognition", "of", "a", "total", "of", "$140.0", "million", "payments", "from", "AstraZeneca", "in", "connection", "with", "its", "commercial", "launches", "of", "MOVANTIK", "TM", "described", "above.", "<tag3>"], "wordsA": ["The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "is", "primarily", "attributable", "to", "increased", "milestone", "and", "royalty", "revenues", "from", "our", "existing", "European", "based", "collaboration", "partners,", "including", "the", "recognition", "of", "the", "$105.0", "million", "milestone", "payments", "from", "AstraZeneca", "described", "above."], "wordsB": ["The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "is", "primarily", "attributable", "to", "increased", "milestone", "and", "other", "contingent", "payments", "from", "our", "existing", "European", "based", "collaboration", "partners,", "including", "the", "recognition", "of", "a", "total", "of", "$140.0", "million", "payments", "from", "AstraZeneca", "in", "connection", "with", "its", "commercial", "launches", "of", "MOVANTIK", "TM", "described", "above."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p19_s1", "idA": "906709_15_item7_p20_s0", "sentA": "The increase in revenue attributable to European countries for the year ended December 31, 2014 compared to the year ended December 31, 2013 is primarily attributable to increased milestone and royalty revenues from our existing European based collaboration partners, including the recognition of the $105.0 million milestone payments from AstraZeneca described above.", "sentB": "The increase in revenue attributable to European countries for the year ended December 31, 2014 compared to the year ended December 31, 2013 is also primarily attributable to increased milestone and other contingent payments from our existing European based collaboration partners, including the recognition of a total of $105.0 million payments from AstraZeneca in connection with the FDA s approval of MOVANTIK TM described above.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "is", "primarily", "attributable", "to", "increased", "milestone", "and", "royalty", "revenues", "from", "our", "existing", "European", "based", "collaboration", "partners,", "including", "the", "recognition", "of", "the", "$105.0", "million", "milestone", "payments", "from", "AstraZeneca", "described", "above.", "<tag2>", "The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "is", "also", "primarily", "attributable", "to", "increased", "milestone", "and", "other", "contingent", "payments", "from", "our", "existing", "European", "based", "collaboration", "partners,", "including", "the", "recognition", "of", "a", "total", "of", "$105.0", "million", "payments", "from", "AstraZeneca", "in", "connection", "with", "the", "FDA", "s", "approval", "of", "MOVANTIK", "TM", "described", "above.", "<tag3>"], "wordsA": ["The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "is", "primarily", "attributable", "to", "increased", "milestone", "and", "royalty", "revenues", "from", "our", "existing", "European", "based", "collaboration", "partners,", "including", "the", "recognition", "of", "the", "$105.0", "million", "milestone", "payments", "from", "AstraZeneca", "described", "above."], "wordsB": ["The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "is", "also", "primarily", "attributable", "to", "increased", "milestone", "and", "other", "contingent", "payments", "from", "our", "existing", "European", "based", "collaboration", "partners,", "including", "the", "recognition", "of", "a", "total", "of", "$105.0", "million", "payments", "from", "AstraZeneca", "in", "connection", "with", "the", "FDA", "s", "approval", "of", "MOVANTIK", "TM", "described", "above."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p20_s0", "idA": "906709_15_item7_p20_s2", "sentA": "Cost of goods sold decreased during the year ended December 31, 2014 compared to the year ended December 31, 2013 primarily due to the decrease in product sales of $19.7 million in the year ended December 31, 2014 compared to the year ended December 31, 2013.", "sentB": "Cost of goods sold during the year ended December 31, 2015 increased compared to the year ended December 31, 2014 primarily due to the increase in product sales of $15.0 million in the year ended December 31, 2015 compared to the year ended December 31, 2014.", "type": 2, "words": ["<tag1>", "Cost", "of", "goods", "sold", "decreased", "during", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "due", "to", "the", "decrease", "in", "product", "sales", "of", "$19.7", "million", "in", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013.", "<tag2>", "Cost", "of", "goods", "sold", "during", "the", "year", "ended", "December", "31,", "2015", "increased", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "the", "increase", "in", "product", "sales", "of", "$15.0", "million", "in", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014.", "<tag3>"], "wordsA": ["Cost", "of", "goods", "sold", "decreased", "during", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "due", "to", "the", "decrease", "in", "product", "sales", "of", "$19.7", "million", "in", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013."], "wordsB": ["Cost", "of", "goods", "sold", "during", "the", "year", "ended", "December", "31,", "2015", "increased", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "the", "increase", "in", "product", "sales", "of", "$15.0", "million", "in", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p31_s1", "idA": "906709_15_item7_p20_s2", "sentA": "Cost of goods sold decreased during the year ended December 31, 2014 compared to the year ended December 31, 2013 primarily due to the decrease in product sales of $19.7 million in the year ended December 31, 2014 compared to the year ended December 31, 2013.", "sentB": "General and administrative expense increased during the year ended December 31, 2015 compared to the year ended December 31, 2014 primarily due to a $3.0 million payment obligation related to the settlement of a commercial litigation matter.", "type": 2, "words": ["<tag1>", "Cost", "of", "goods", "sold", "decreased", "during", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "due", "to", "the", "decrease", "in", "product", "sales", "of", "$19.7", "million", "in", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013.", "<tag2>", "General", "and", "administrative", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "a", "$3.0", "million", "payment", "obligation", "related", "to", "the", "settlement", "of", "a", "commercial", "litigation", "matter.", "<tag3>"], "wordsA": ["Cost", "of", "goods", "sold", "decreased", "during", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "due", "to", "the", "decrease", "in", "product", "sales", "of", "$19.7", "million", "in", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013."], "wordsB": ["General", "and", "administrative", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "a", "$3.0", "million", "payment", "obligation", "related", "to", "the", "settlement", "of", "a", "commercial", "litigation", "matter."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p20_s8", "idA": "906709_15_item7_p20_s3", "sentA": "During the year ended December 31, 2014, our gross profit was negative.", "sentB": "During the year ended December 31, 2013, our gross profit was positive due primarily to the higher level of product sales in 2013 as well as a more favorable product mix as compared to 2014.", "type": 2, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2014,", "our", "gross", "profit", "was", "negative.", "<tag2>", "During", "the", "year", "ended", "December", "31,", "2013,", "our", "gross", "profit", "was", "positive", "due", "primarily", "to", "the", "higher", "level", "of", "product", "sales", "in", "2013", "as", "well", "as", "a", "more", "favorable", "product", "mix", "as", "compared", "to", "2014.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2014,", "our", "gross", "profit", "was", "negative."], "wordsB": ["During", "the", "year", "ended", "December", "31,", "2013,", "our", "gross", "profit", "was", "positive", "due", "primarily", "to", "the", "higher", "level", "of", "product", "sales", "in", "2013", "as", "well", "as", "a", "more", "favorable", "product", "mix", "as", "compared", "to", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p20_s3", "idA": "906709_15_item7_p20_s4", "sentA": "The manufacturing arrangement with one of our collaboration partners includes a fixed price for proprietary pegylation reagent sales, which is less than the fully burdened manufacturing cost for the reagent in 2014 and this situation is expected to continue in future years.", "sentB": "In particular, the manufacturing arrangement with one of our collaboration partners includes a fixed price for proprietary PEGylation reagent sales, which is less than the fully burdened manufacturing cost for the reagent and we expect this situation to continue in future years.", "type": 2, "words": ["<tag1>", "The", "manufacturing", "arrangement", "with", "one", "of", "our", "collaboration", "partners", "includes", "a", "fixed", "price", "for", "proprietary", "pegylation", "reagent", "sales,", "which", "is", "less", "than", "the", "fully", "burdened", "manufacturing", "cost", "for", "the", "reagent", "in", "2014", "and", "this", "situation", "is", "expected", "to", "continue", "in", "future", "years.", "<tag2>", "In", "particular,", "the", "manufacturing", "arrangement", "with", "one", "of", "our", "collaboration", "partners", "includes", "a", "fixed", "price", "for", "proprietary", "PEGylation", "reagent", "sales,", "which", "is", "less", "than", "the", "fully", "burdened", "manufacturing", "cost", "for", "the", "reagent", "and", "we", "expect", "this", "situation", "to", "continue", "in", "future", "years.", "<tag3>"], "wordsA": ["The", "manufacturing", "arrangement", "with", "one", "of", "our", "collaboration", "partners", "includes", "a", "fixed", "price", "for", "proprietary", "pegylation", "reagent", "sales,", "which", "is", "less", "than", "the", "fully", "burdened", "manufacturing", "cost", "for", "the", "reagent", "in", "2014", "and", "this", "situation", "is", "expected", "to", "continue", "in", "future", "years."], "wordsB": ["In", "particular,", "the", "manufacturing", "arrangement", "with", "one", "of", "our", "collaboration", "partners", "includes", "a", "fixed", "price", "for", "proprietary", "PEGylation", "reagent", "sales,", "which", "is", "less", "than", "the", "fully", "burdened", "manufacturing", "cost", "for", "the", "reagent", "and", "we", "expect", "this", "situation", "to", "continue", "in", "future", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p20_s6", "idA": "906709_15_item7_p21_s0", "sentA": "In addition to product sales from the reagent, we also receive royalty revenues from this collaboration.", "sentB": "In addition to product sales from reagent shipments to this partner, we also receive royalty revenues from this collaboration.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "product", "sales", "from", "the", "reagent,", "we", "also", "receive", "royalty", "revenues", "from", "this", "collaboration.", "<tag2>", "In", "addition", "to", "product", "sales", "from", "reagent", "shipments", "to", "this", "partner,", "we", "also", "receive", "royalty", "revenues", "from", "this", "collaboration.", "<tag3>"], "wordsA": ["In", "addition", "to", "product", "sales", "from", "the", "reagent,", "we", "also", "receive", "royalty", "revenues", "from", "this", "collaboration."], "wordsB": ["In", "addition", "to", "product", "sales", "from", "reagent", "shipments", "to", "this", "partner,", "we", "also", "receive", "royalty", "revenues", "from", "this", "collaboration."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p20_s4", "idA": "906709_15_item7_p21_s1", "sentA": "In 2014, the royalty revenue from the collaboration exceeded the related negative gross profit.", "sentB": "This arrangement was the primary reason for our negative gross profit in 2014.", "type": 2, "words": ["<tag1>", "In", "2014,", "the", "royalty", "revenue", "from", "the", "collaboration", "exceeded", "the", "related", "negative", "gross", "profit.", "<tag2>", "This", "arrangement", "was", "the", "primary", "reason", "for", "our", "negative", "gross", "profit", "in", "2014.", "<tag3>"], "wordsA": ["In", "2014,", "the", "royalty", "revenue", "from", "the", "collaboration", "exceeded", "the", "related", "negative", "gross", "profit."], "wordsB": ["This", "arrangement", "was", "the", "primary", "reason", "for", "our", "negative", "gross", "profit", "in", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p20_s7", "idA": "906709_15_item7_p21_s1", "sentA": "In 2014, the royalty revenue from the collaboration exceeded the related negative gross profit.", "sentB": "In the years ended December 31, 2015 and 2014, the royalty revenue from the collaboration exceeded the related negative gross profit on product sales.", "type": 2, "words": ["<tag1>", "In", "2014,", "the", "royalty", "revenue", "from", "the", "collaboration", "exceeded", "the", "related", "negative", "gross", "profit.", "<tag2>", "In", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "the", "royalty", "revenue", "from", "the", "collaboration", "exceeded", "the", "related", "negative", "gross", "profit", "on", "product", "sales.", "<tag3>"], "wordsA": ["In", "2014,", "the", "royalty", "revenue", "from", "the", "collaboration", "exceeded", "the", "related", "negative", "gross", "profit."], "wordsB": ["In", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "the", "royalty", "revenue", "from", "the", "collaboration", "exceeded", "the", "related", "negative", "gross", "profit", "on", "product", "sales."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p20_s2", "idA": "906709_15_item7_p21_s2", "sentA": "Cost of goods sold and product gross profit increased during the year ended December 31, 2013 compared to the year ended December 31, 2012 primarily due to the $9.4 million increase in product sales in the year ended December 31, 2013 compared to the year ended December 31, 2012.", "sentB": "The improvement in product gross profit (loss) and product gross margin during the year ended December 31, 2015 compared to the year ended December 31, 2014 is primarily due to a more favorable product mix in 2015 compared to 2014.", "type": 2, "words": ["<tag1>", "Cost", "of", "goods", "sold", "and", "product", "gross", "profit", "increased", "during", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "due", "to", "the", "$9.4", "million", "increase", "in", "product", "sales", "in", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012.", "<tag2>", "The", "improvement", "in", "product", "gross", "profit", "(loss)", "and", "product", "gross", "margin", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "is", "primarily", "due", "to", "a", "more", "favorable", "product", "mix", "in", "2015", "compared", "to", "2014.", "<tag3>"], "wordsA": ["Cost", "of", "goods", "sold", "and", "product", "gross", "profit", "increased", "during", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012", "primarily", "due", "to", "the", "$9.4", "million", "increase", "in", "product", "sales", "in", "the", "year", "ended", "December", "31,", "2013", "compared", "to", "the", "year", "ended", "December", "31,", "2012."], "wordsB": ["The", "improvement", "in", "product", "gross", "profit", "(loss)", "and", "product", "gross", "margin", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "is", "primarily", "due", "to", "a", "more", "favorable", "product", "mix", "in", "2015", "compared", "to", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p20_s10", "idA": "906709_15_item7_p21_s5", "sentA": "We currently expect product gross margin to increase in 2015 as compared to 2014 as a result of the anticipated increase in product sales, as well as based on the anticipated product mix.", "sentB": "We currently expect product gross margin to increase in 2016 as compared to 2015 as a result of an anticipated increase in product sales, as well as based on the anticipated product mix.", "type": 2, "words": ["<tag1>", "We", "currently", "expect", "product", "gross", "margin", "to", "increase", "in", "2015", "as", "compared", "to", "2014", "as", "a", "result", "of", "the", "anticipated", "increase", "in", "product", "sales,", "as", "well", "as", "based", "on", "the", "anticipated", "product", "mix.", "<tag2>", "We", "currently", "expect", "product", "gross", "margin", "to", "increase", "in", "2016", "as", "compared", "to", "2015", "as", "a", "result", "of", "an", "anticipated", "increase", "in", "product", "sales,", "as", "well", "as", "based", "on", "the", "anticipated", "product", "mix.", "<tag3>"], "wordsA": ["We", "currently", "expect", "product", "gross", "margin", "to", "increase", "in", "2015", "as", "compared", "to", "2014", "as", "a", "result", "of", "the", "anticipated", "increase", "in", "product", "sales,", "as", "well", "as", "based", "on", "the", "anticipated", "product", "mix."], "wordsB": ["We", "currently", "expect", "product", "gross", "margin", "to", "increase", "in", "2016", "as", "compared", "to", "2015", "as", "a", "result", "of", "an", "anticipated", "increase", "in", "product", "sales,", "as", "well", "as", "based", "on", "the", "anticipated", "product", "mix."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p33_s1", "idA": "906709_15_item7_p21_s5", "sentA": "We currently expect product gross margin to increase in 2015 as compared to 2014 as a result of the anticipated increase in product sales, as well as based on the anticipated product mix.", "sentB": "We expect interest expense to increase in 2016 compared to 2015 as a result of the increase to our outstanding secured notes principal balance from the October 2015 note transaction, partially offset by the reduction in the interest rate on our notes from 12% to 7.75%.", "type": 2, "words": ["<tag1>", "We", "currently", "expect", "product", "gross", "margin", "to", "increase", "in", "2015", "as", "compared", "to", "2014", "as", "a", "result", "of", "the", "anticipated", "increase", "in", "product", "sales,", "as", "well", "as", "based", "on", "the", "anticipated", "product", "mix.", "<tag2>", "We", "expect", "interest", "expense", "to", "increase", "in", "2016", "compared", "to", "2015", "as", "a", "result", "of", "the", "increase", "to", "our", "outstanding", "secured", "notes", "principal", "balance", "from", "the", "October", "2015", "note", "transaction,", "partially", "offset", "by", "the", "reduction", "in", "the", "interest", "rate", "on", "our", "notes", "from", "12%", "to", "7.75%.", "<tag3>"], "wordsA": ["We", "currently", "expect", "product", "gross", "margin", "to", "increase", "in", "2015", "as", "compared", "to", "2014", "as", "a", "result", "of", "the", "anticipated", "increase", "in", "product", "sales,", "as", "well", "as", "based", "on", "the", "anticipated", "product", "mix."], "wordsB": ["We", "expect", "interest", "expense", "to", "increase", "in", "2016", "compared", "to", "2015", "as", "a", "result", "of", "the", "increase", "to", "our", "outstanding", "secured", "notes", "principal", "balance", "from", "the", "October", "2015", "note", "transaction,", "partially", "offset", "by", "the", "reduction", "in", "the", "interest", "rate", "on", "our", "notes", "from", "12%", "to", "7.75%."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p21_s2", "idA": "906709_15_item7_p22_s2", "sentA": "Research and development expense decreased during the year ended December 31, 2014 compared to the year ended December 31, 2013 primarily due to reduced activities on our ongoing Phase 3 BEACON study for etirinotecan pegol as the study progresses toward completion as well as the completion of our Phase 2 clinical study for NKTR-181 in the third quarter of 2013.", "sentB": "Research and development expense increased during the year ended December 31, 2015 compared to the year ended December 31, 2014 primarily due to the initiation of Phase 3 clinical studies for NKTR-181 in the first quarter of 2015.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expense", "decreased", "during", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "due", "to", "reduced", "activities", "on", "our", "ongoing", "Phase", "3", "BEACON", "study", "for", "etirinotecan", "pegol", "as", "the", "study", "progresses", "toward", "completion", "as", "well", "as", "the", "completion", "of", "our", "Phase", "2", "clinical", "study", "for", "NKTR-181", "in", "the", "third", "quarter", "of", "2013.", "<tag2>", "Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "the", "initiation", "of", "Phase", "3", "clinical", "studies", "for", "NKTR-181", "in", "the", "first", "quarter", "of", "2015.", "<tag3>"], "wordsA": ["Research", "and", "development", "expense", "decreased", "during", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "due", "to", "reduced", "activities", "on", "our", "ongoing", "Phase", "3", "BEACON", "study", "for", "etirinotecan", "pegol", "as", "the", "study", "progresses", "toward", "completion", "as", "well", "as", "the", "completion", "of", "our", "Phase", "2", "clinical", "study", "for", "NKTR-181", "in", "the", "third", "quarter", "of", "2013."], "wordsB": ["Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "the", "initiation", "of", "Phase", "3", "clinical", "studies", "for", "NKTR-181", "in", "the", "first", "quarter", "of", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p21_s3", "idA": "906709_15_item7_p22_s2", "sentA": "Research and development expense decreased during the year ended December 31, 2014 compared to the year ended December 31, 2013 primarily due to reduced activities on our ongoing Phase 3 BEACON study for etirinotecan pegol as the study progresses toward completion as well as the completion of our Phase 2 clinical study for NKTR-181 in the third quarter of 2013.", "sentB": "Research and development expense decreased during the year ended December 31, 2014 compared to the year ended December 31, 2013 primarily due to reduced activities on our Phase 3 BEACON study for NKTR-102 as the study progressed toward completion as well as the completion of our Phase 2 clinical study for NKTR-181 in the third quarter of 2013.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expense", "decreased", "during", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "due", "to", "reduced", "activities", "on", "our", "ongoing", "Phase", "3", "BEACON", "study", "for", "etirinotecan", "pegol", "as", "the", "study", "progresses", "toward", "completion", "as", "well", "as", "the", "completion", "of", "our", "Phase", "2", "clinical", "study", "for", "NKTR-181", "in", "the", "third", "quarter", "of", "2013.", "<tag2>", "Research", "and", "development", "expense", "decreased", "during", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "due", "to", "reduced", "activities", "on", "our", "Phase", "3", "BEACON", "study", "for", "NKTR-102", "as", "the", "study", "progressed", "toward", "completion", "as", "well", "as", "the", "completion", "of", "our", "Phase", "2", "clinical", "study", "for", "NKTR-181", "in", "the", "third", "quarter", "of", "2013.", "<tag3>"], "wordsA": ["Research", "and", "development", "expense", "decreased", "during", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "due", "to", "reduced", "activities", "on", "our", "ongoing", "Phase", "3", "BEACON", "study", "for", "etirinotecan", "pegol", "as", "the", "study", "progresses", "toward", "completion", "as", "well", "as", "the", "completion", "of", "our", "Phase", "2", "clinical", "study", "for", "NKTR-181", "in", "the", "third", "quarter", "of", "2013."], "wordsB": ["Research", "and", "development", "expense", "decreased", "during", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "due", "to", "reduced", "activities", "on", "our", "Phase", "3", "BEACON", "study", "for", "NKTR-102", "as", "the", "study", "progressed", "toward", "completion", "as", "well", "as", "the", "completion", "of", "our", "Phase", "2", "clinical", "study", "for", "NKTR-181", "in", "the", "third", "quarter", "of", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p21_s4", "idA": "906709_15_item7_p22_s3", "sentA": "In addition, during the year ended December 31, 2013, we recorded a charge of $11.3 million resulting from the settlement of a dispute with the Research Foundation of the State University of New York related to our collaboration with Bayer to develop inhaled amikacin.", "sentB": "In addition, during the year ended December 31, 2013, we recorded a charge of $11.3 million resulting from the settlement of a dispute with the Research Foundation of the State University of New York related to our collaboration with Bayer to develop Amikacin Inhale.", "type": 2, "words": ["<tag1>", "In", "addition,", "during", "the", "year", "ended", "December", "31,", "2013,", "we", "recorded", "a", "charge", "of", "$11.3", "million", "resulting", "from", "the", "settlement", "of", "a", "dispute", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "related", "to", "our", "collaboration", "with", "Bayer", "to", "develop", "inhaled", "amikacin.", "<tag2>", "In", "addition,", "during", "the", "year", "ended", "December", "31,", "2013,", "we", "recorded", "a", "charge", "of", "$11.3", "million", "resulting", "from", "the", "settlement", "of", "a", "dispute", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "related", "to", "our", "collaboration", "with", "Bayer", "to", "develop", "Amikacin", "Inhale.", "<tag3>"], "wordsA": ["In", "addition,", "during", "the", "year", "ended", "December", "31,", "2013,", "we", "recorded", "a", "charge", "of", "$11.3", "million", "resulting", "from", "the", "settlement", "of", "a", "dispute", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "related", "to", "our", "collaboration", "with", "Bayer", "to", "develop", "inhaled", "amikacin."], "wordsB": ["In", "addition,", "during", "the", "year", "ended", "December", "31,", "2013,", "we", "recorded", "a", "charge", "of", "$11.3", "million", "resulting", "from", "the", "settlement", "of", "a", "dispute", "with", "the", "Research", "Foundation", "of", "the", "State", "University", "of", "New", "York", "related", "to", "our", "collaboration", "with", "Bayer", "to", "develop", "Amikacin", "Inhale."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p23_s0", "idA": "906709_15_item7_p24_s0", "sentA": "(1) Clinical Study Status definitions are provided in the chart found in Part I, Item 1.", "sentB": "Clinical Study Status definitions are provided in the chart found in Part I, Item 1.", "type": 2, "words": ["<tag1>", "(1)", "Clinical", "Study", "Status", "definitions", "are", "provided", "in", "the", "chart", "found", "in", "Part", "I,", "Item", "1.", "<tag2>", "Clinical", "Study", "Status", "definitions", "are", "provided", "in", "the", "chart", "found", "in", "Part", "I,", "Item", "1.", "<tag3>"], "wordsA": ["(1)", "Clinical", "Study", "Status", "definitions", "are", "provided", "in", "the", "chart", "found", "in", "Part", "I,", "Item", "1."], "wordsB": ["Clinical", "Study", "Status", "definitions", "are", "provided", "in", "the", "chart", "found", "in", "Part", "I,", "Item", "1."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p24_s0", "idA": "906709_15_item7_p25_s0", "sentA": "(2) We partnered this program with Bayer Healthcare LLC in August 2007.", "sentB": "We partnered this program with Bayer Healthcare LLC in August 2007.", "type": 2, "words": ["<tag1>", "(2)", "We", "partnered", "this", "program", "with", "Bayer", "Healthcare", "LLC", "in", "August", "2007.", "<tag2>", "We", "partnered", "this", "program", "with", "Bayer", "Healthcare", "LLC", "in", "August", "2007.", "<tag3>"], "wordsA": ["(2)", "We", "partnered", "this", "program", "with", "Bayer", "Healthcare", "LLC", "in", "August", "2007."], "wordsB": ["We", "partnered", "this", "program", "with", "Bayer", "Healthcare", "LLC", "in", "August", "2007."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p25_s0", "idA": "906709_15_item7_p26_s0", "sentA": "We expect research and development expense to increase in 2015 as compared to 2014.", "sentB": "We expect research and development expense in 2016 to be consistent with 2015.", "type": 2, "words": ["<tag1>", "We", "expect", "research", "and", "development", "expense", "to", "increase", "in", "2015", "as", "compared", "to", "2014.", "<tag2>", "We", "expect", "research", "and", "development", "expense", "in", "2016", "to", "be", "consistent", "with", "2015.", "<tag3>"], "wordsA": ["We", "expect", "research", "and", "development", "expense", "to", "increase", "in", "2015", "as", "compared", "to", "2014."], "wordsB": ["We", "expect", "research", "and", "development", "expense", "in", "2016", "to", "be", "consistent", "with", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p25_s1", "idA": "906709_15_item7_p26_s1", "sentA": "In particular, in 2015, we are commencing Phase 3 clinical studies for NKTR-181.", "sentB": "In particular, in 2016, we are continuing Phase 3 clinical studies for NKTR-181.", "type": 2, "words": ["<tag1>", "In", "particular,", "in", "2015,", "we", "are", "commencing", "Phase", "3", "clinical", "studies", "for", "NKTR-181.", "<tag2>", "In", "particular,", "in", "2016,", "we", "are", "continuing", "Phase", "3", "clinical", "studies", "for", "NKTR-181.", "<tag3>"], "wordsA": ["In", "particular,", "in", "2015,", "we", "are", "commencing", "Phase", "3", "clinical", "studies", "for", "NKTR-181."], "wordsB": ["In", "particular,", "in", "2016,", "we", "are", "continuing", "Phase", "3", "clinical", "studies", "for", "NKTR-181."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p25_s7", "idA": "906709_15_item7_p26_s11", "sentA": "We do not expect to have any significant future research and development costs associated with MOVANTIK or the MOVANTIK fixed-dose combination products as AstraZeneca is responsible for all further development and commercialization costs for these drug candidates.", "sentB": "We do not expect to have any significant future research and development costs associated with MOVANTIK TM or the MOVANTIK TM fixed-dose combination products as AstraZeneca is responsible for all further development and commercialization costs for these drug candidates.", "type": 2, "words": ["<tag1>", "We", "do", "not", "expect", "to", "have", "any", "significant", "future", "research", "and", "development", "costs", "associated", "with", "MOVANTIK", "or", "the", "MOVANTIK", "fixed-dose", "combination", "products", "as", "AstraZeneca", "is", "responsible", "for", "all", "further", "development", "and", "commercialization", "costs", "for", "these", "drug", "candidates.", "<tag2>", "We", "do", "not", "expect", "to", "have", "any", "significant", "future", "research", "and", "development", "costs", "associated", "with", "MOVANTIK", "TM", "or", "the", "MOVANTIK", "TM", "fixed-dose", "combination", "products", "as", "AstraZeneca", "is", "responsible", "for", "all", "further", "development", "and", "commercialization", "costs", "for", "these", "drug", "candidates.", "<tag3>"], "wordsA": ["We", "do", "not", "expect", "to", "have", "any", "significant", "future", "research", "and", "development", "costs", "associated", "with", "MOVANTIK", "or", "the", "MOVANTIK", "fixed-dose", "combination", "products", "as", "AstraZeneca", "is", "responsible", "for", "all", "further", "development", "and", "commercialization", "costs", "for", "these", "drug", "candidates."], "wordsB": ["We", "do", "not", "expect", "to", "have", "any", "significant", "future", "research", "and", "development", "costs", "associated", "with", "MOVANTIK", "TM", "or", "the", "MOVANTIK", "TM", "fixed-dose", "combination", "products", "as", "AstraZeneca", "is", "responsible", "for", "all", "further", "development", "and", "commercialization", "costs", "for", "these", "drug", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p25_s3", "idA": "906709_15_item7_p26_s5", "sentA": "We estimate that the total third party and direct material costs over the life of the BEACON study will be approximately $85.0 million, of which $72.7 million was incurred through the end of 2014.", "sentB": "We currently estimate that the total third party and direct material costs over the life of our NKTR-181 Phase 3 program will be approximately $130.0 million, of which $40.3 million was incurred through the end of 2015.", "type": 2, "words": ["<tag1>", "We", "estimate", "that", "the", "total", "third", "party", "and", "direct", "material", "costs", "over", "the", "life", "of", "the", "BEACON", "study", "will", "be", "approximately", "$85.0", "million,", "of", "which", "$72.7", "million", "was", "incurred", "through", "the", "end", "of", "2014.", "<tag2>", "We", "currently", "estimate", "that", "the", "total", "third", "party", "and", "direct", "material", "costs", "over", "the", "life", "of", "our", "NKTR-181", "Phase", "3", "program", "will", "be", "approximately", "$130.0", "million,", "of", "which", "$40.3", "million", "was", "incurred", "through", "the", "end", "of", "2015.", "<tag3>"], "wordsA": ["We", "estimate", "that", "the", "total", "third", "party", "and", "direct", "material", "costs", "over", "the", "life", "of", "the", "BEACON", "study", "will", "be", "approximately", "$85.0", "million,", "of", "which", "$72.7", "million", "was", "incurred", "through", "the", "end", "of", "2014."], "wordsB": ["We", "currently", "estimate", "that", "the", "total", "third", "party", "and", "direct", "material", "costs", "over", "the", "life", "of", "our", "NKTR-181", "Phase", "3", "program", "will", "be", "approximately", "$130.0", "million,", "of", "which", "$40.3", "million", "was", "incurred", "through", "the", "end", "of", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p8_s3", "idA": "906709_15_item7_p26_s6", "sentA": "We have also studied or have ongoing studies being conducted for etirinotecan pegol, including investigator-initiated clinical studies, in bevacizumab (Avastin)-resistant high-grade glioma, colorectal cancer, relapsed or refractory small-cell lung cancer, metastatic and recurrent non-small cell lung cancer, and ovarian cancer.", "sentB": "Following the dose-escalation stage of the study, dose expansion cohorts are planned to evaluate NKTR-214 in specific tumor types, including melanoma, renal cell carcinoma and non-small cell lung cancer .", "type": 2, "words": ["<tag1>", "We", "have", "also", "studied", "or", "have", "ongoing", "studies", "being", "conducted", "for", "etirinotecan", "pegol,", "including", "investigator-initiated", "clinical", "studies,", "in", "bevacizumab", "(Avastin)-resistant", "high-grade", "glioma,", "colorectal", "cancer,", "relapsed", "or", "refractory", "small-cell", "lung", "cancer,", "metastatic", "and", "recurrent", "non-small", "cell", "lung", "cancer,", "and", "ovarian", "cancer.", "<tag2>", "Following", "the", "dose-escalation", "stage", "of", "the", "study,", "dose", "expansion", "cohorts", "are", "planned", "to", "evaluate", "NKTR-214", "in", "specific", "tumor", "types,", "including", "melanoma,", "renal", "cell", "carcinoma", "and", "non-small", "cell", "lung", "cancer", ".", "<tag3>"], "wordsA": ["We", "have", "also", "studied", "or", "have", "ongoing", "studies", "being", "conducted", "for", "etirinotecan", "pegol,", "including", "investigator-initiated", "clinical", "studies,", "in", "bevacizumab", "(Avastin)-resistant", "high-grade", "glioma,", "colorectal", "cancer,", "relapsed", "or", "refractory", "small-cell", "lung", "cancer,", "metastatic", "and", "recurrent", "non-small", "cell", "lung", "cancer,", "and", "ovarian", "cancer."], "wordsB": ["Following", "the", "dose-escalation", "stage", "of", "the", "study,", "dose", "expansion", "cohorts", "are", "planned", "to", "evaluate", "NKTR-214", "in", "specific", "tumor", "types,", "including", "melanoma,", "renal", "cell", "carcinoma", "and", "non-small", "cell", "lung", "cancer", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p25_s4", "idA": "906709_15_item7_p26_s8", "sentA": "In addition to our NKTR-181 and etirinotecan pegol development activities, in 2015, we plan to continue to advance the development of NKTR-171 and NKTR-214.", "sentB": "In addition to our NKTR-181 development activities, in 2016, we plan to continue to advance the development of NKTR-214, which entered Phase 1/2 clinical development in December 2015.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "our", "NKTR-181", "and", "etirinotecan", "pegol", "development", "activities,", "in", "2015,", "we", "plan", "to", "continue", "to", "advance", "the", "development", "of", "NKTR-171", "and", "NKTR-214.", "<tag2>", "In", "addition", "to", "our", "NKTR-181", "development", "activities,", "in", "2016,", "we", "plan", "to", "continue", "to", "advance", "the", "development", "of", "NKTR-214,", "which", "entered", "Phase", "1/2", "clinical", "development", "in", "December", "2015.", "<tag3>"], "wordsA": ["In", "addition", "to", "our", "NKTR-181", "and", "etirinotecan", "pegol", "development", "activities,", "in", "2015,", "we", "plan", "to", "continue", "to", "advance", "the", "development", "of", "NKTR-171", "and", "NKTR-214."], "wordsB": ["In", "addition", "to", "our", "NKTR-181", "development", "activities,", "in", "2016,", "we", "plan", "to", "continue", "to", "advance", "the", "development", "of", "NKTR-214,", "which", "entered", "Phase", "1/2", "clinical", "development", "in", "December", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p9_s15", "idA": "906709_15_item7_p26_s8", "sentA": "In addition to our NKTR-181 and etirinotecan pegol development activities, in 2015, we plan to continue to advance the development of NKTR-171 and NKTR-214.", "sentB": "At this time, we do not plan to advance development of NKTR-102 without a collaboration partner.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "our", "NKTR-181", "and", "etirinotecan", "pegol", "development", "activities,", "in", "2015,", "we", "plan", "to", "continue", "to", "advance", "the", "development", "of", "NKTR-171", "and", "NKTR-214.", "<tag2>", "At", "this", "time,", "we", "do", "not", "plan", "to", "advance", "development", "of", "NKTR-102", "without", "a", "collaboration", "partner.", "<tag3>"], "wordsA": ["In", "addition", "to", "our", "NKTR-181", "and", "etirinotecan", "pegol", "development", "activities,", "in", "2015,", "we", "plan", "to", "continue", "to", "advance", "the", "development", "of", "NKTR-171", "and", "NKTR-214."], "wordsB": ["At", "this", "time,", "we", "do", "not", "plan", "to", "advance", "development", "of", "NKTR-102", "without", "a", "collaboration", "partner."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p2_s2", "idA": "906709_15_item7_p2_s2", "sentA": "In 2014, we achieved the first approval of one of our proprietary drug candidates, MOVANTIK (previously referred to as naloxegol and NKTR-118), under a global license agreement with AstraZeneca.", "sentB": "In 2014, we achieved the first approval of one of our proprietary drug candidates, MOVANTIK TM (previously referred to as naloxegol and NKTR-118), under a global license agreement with AstraZeneca.", "type": 2, "words": ["<tag1>", "In", "2014,", "we", "achieved", "the", "first", "approval", "of", "one", "of", "our", "proprietary", "drug", "candidates,", "MOVANTIK", "(previously", "referred", "to", "as", "naloxegol", "and", "NKTR-118),", "under", "a", "global", "license", "agreement", "with", "AstraZeneca.", "<tag2>", "In", "2014,", "we", "achieved", "the", "first", "approval", "of", "one", "of", "our", "proprietary", "drug", "candidates,", "MOVANTIK", "TM", "(previously", "referred", "to", "as", "naloxegol", "and", "NKTR-118),", "under", "a", "global", "license", "agreement", "with", "AstraZeneca.", "<tag3>"], "wordsA": ["In", "2014,", "we", "achieved", "the", "first", "approval", "of", "one", "of", "our", "proprietary", "drug", "candidates,", "MOVANTIK", "(previously", "referred", "to", "as", "naloxegol", "and", "NKTR-118),", "under", "a", "global", "license", "agreement", "with", "AstraZeneca."], "wordsB": ["In", "2014,", "we", "achieved", "the", "first", "approval", "of", "one", "of", "our", "proprietary", "drug", "candidates,", "MOVANTIK", "TM", "(previously", "referred", "to", "as", "naloxegol", "and", "NKTR-118),", "under", "a", "global", "license", "agreement", "with", "AstraZeneca."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p2_s3", "idA": "906709_15_item7_p2_s3", "sentA": "MOVANTIK is an oral peripherally-acting opioid antagonist, for the treatment of opioid-induced constipation, or OIC, a side effect caused by chronic administration of prescription opioid pain medicines.", "sentB": "MOVANTIK TM is an oral peripherally-acting opioid antagonist, for the treatment of opioid-induced constipation, or OIC, a side effect caused by chronic administration of prescription opioid pain medicines.", "type": 2, "words": ["<tag1>", "MOVANTIK", "is", "an", "oral", "peripherally-acting", "opioid", "antagonist,", "for", "the", "treatment", "of", "opioid-induced", "constipation,", "or", "OIC,", "a", "side", "effect", "caused", "by", "chronic", "administration", "of", "prescription", "opioid", "pain", "medicines.", "<tag2>", "MOVANTIK", "TM", "is", "an", "oral", "peripherally-acting", "opioid", "antagonist,", "for", "the", "treatment", "of", "opioid-induced", "constipation,", "or", "OIC,", "a", "side", "effect", "caused", "by", "chronic", "administration", "of", "prescription", "opioid", "pain", "medicines.", "<tag3>"], "wordsA": ["MOVANTIK", "is", "an", "oral", "peripherally-acting", "opioid", "antagonist,", "for", "the", "treatment", "of", "opioid-induced", "constipation,", "or", "OIC,", "a", "side", "effect", "caused", "by", "chronic", "administration", "of", "prescription", "opioid", "pain", "medicines."], "wordsB": ["MOVANTIK", "TM", "is", "an", "oral", "peripherally-acting", "opioid", "antagonist,", "for", "the", "treatment", "of", "opioid-induced", "constipation,", "or", "OIC,", "a", "side", "effect", "caused", "by", "chronic", "administration", "of", "prescription", "opioid", "pain", "medicines."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p2_s4", "idA": "906709_15_item7_p2_s4", "sentA": "MOVANTIK was developed using our oral small molecule polymer conjugate technology and we advanced this drug through the completion of Phase 2 clinical studies prior to licensing it to AstraZeneca.", "sentB": "MOVANTIK TM was developed using our oral small molecule polymer conjugate technology and we advanced this drug through the completion of Phase 2 clinical studies prior to licensing it to AstraZeneca.", "type": 2, "words": ["<tag1>", "MOVANTIK", "was", "developed", "using", "our", "oral", "small", "molecule", "polymer", "conjugate", "technology", "and", "we", "advanced", "this", "drug", "through", "the", "completion", "of", "Phase", "2", "clinical", "studies", "prior", "to", "licensing", "it", "to", "AstraZeneca.", "<tag2>", "MOVANTIK", "TM", "was", "developed", "using", "our", "oral", "small", "molecule", "polymer", "conjugate", "technology", "and", "we", "advanced", "this", "drug", "through", "the", "completion", "of", "Phase", "2", "clinical", "studies", "prior", "to", "licensing", "it", "to", "AstraZeneca.", "<tag3>"], "wordsA": ["MOVANTIK", "was", "developed", "using", "our", "oral", "small", "molecule", "polymer", "conjugate", "technology", "and", "we", "advanced", "this", "drug", "through", "the", "completion", "of", "Phase", "2", "clinical", "studies", "prior", "to", "licensing", "it", "to", "AstraZeneca."], "wordsB": ["MOVANTIK", "TM", "was", "developed", "using", "our", "oral", "small", "molecule", "polymer", "conjugate", "technology", "and", "we", "advanced", "this", "drug", "through", "the", "completion", "of", "Phase", "2", "clinical", "studies", "prior", "to", "licensing", "it", "to", "AstraZeneca."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p31_s2", "idA": "906709_15_item7_p30_s1", "sentA": "General and administrative expense was consistent during the years ended December 31, 2014, 2013 and 2012.", "sentB": "General and administrative expense was consistent during the years ended December 31, 2014 and 2013.", "type": 2, "words": ["<tag1>", "General", "and", "administrative", "expense", "was", "consistent", "during", "the", "years", "ended", "December", "31,", "2014,", "2013", "and", "2012.", "<tag2>", "General", "and", "administrative", "expense", "was", "consistent", "during", "the", "years", "ended", "December", "31,", "2014", "and", "2013.", "<tag3>"], "wordsA": ["General", "and", "administrative", "expense", "was", "consistent", "during", "the", "years", "ended", "December", "31,", "2014,", "2013", "and", "2012."], "wordsB": ["General", "and", "administrative", "expense", "was", "consistent", "during", "the", "years", "ended", "December", "31,", "2014", "and", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p31_s3", "idA": "906709_15_item7_p30_s2", "sentA": "In 2015, we expect general and administrative expenses to increase compared with 2014.", "sentB": "In 2016, we expect general and administrative expenses to decrease marginally compared to 2015.", "type": 2, "words": ["<tag1>", "In", "2015,", "we", "expect", "general", "and", "administrative", "expenses", "to", "increase", "compared", "with", "2014.", "<tag2>", "In", "2016,", "we", "expect", "general", "and", "administrative", "expenses", "to", "decrease", "marginally", "compared", "to", "2015.", "<tag3>"], "wordsA": ["In", "2015,", "we", "expect", "general", "and", "administrative", "expenses", "to", "increase", "compared", "with", "2014."], "wordsB": ["In", "2016,", "we", "expect", "general", "and", "administrative", "expenses", "to", "decrease", "marginally", "compared", "to", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p15_s1", "idA": "906709_15_item7_p31_s0", "sentA": "Interest expense for the year ended December 31, 2014 decreased marginally as compared to the year ended December 31, 2013.", "sentB": "Royalty revenue received in cash increased for the year ended December 31, 2015 compared to the year ended December 31, 2014 due primarily to the launch of commercial sales by AstraZeneca of MOVANTIK TM in March 2015 and MOVENTIG in the EU in August 2015.", "type": 2, "words": ["<tag1>", "Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2014", "decreased", "marginally", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2013.", "<tag2>", "Royalty", "revenue", "received", "in", "cash", "increased", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "due", "primarily", "to", "the", "launch", "of", "commercial", "sales", "by", "AstraZeneca", "of", "MOVANTIK", "TM", "in", "March", "2015", "and", "MOVENTIG", "in", "the", "EU", "in", "August", "2015.", "<tag3>"], "wordsA": ["Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2014", "decreased", "marginally", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2013."], "wordsB": ["Royalty", "revenue", "received", "in", "cash", "increased", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "due", "primarily", "to", "the", "launch", "of", "commercial", "sales", "by", "AstraZeneca", "of", "MOVANTIK", "TM", "in", "March", "2015", "and", "MOVENTIG", "in", "the", "EU", "in", "August", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p20_s5", "idA": "906709_15_item7_p31_s0", "sentA": "Interest expense for the year ended December 31, 2014 decreased marginally as compared to the year ended December 31, 2013.", "sentB": "There were fewer shipments to this partner in total and relative to shipments to other customers during the year ended December 31, 2015 compared to the year ended December 31, 2014.", "type": 2, "words": ["<tag1>", "Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2014", "decreased", "marginally", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2013.", "<tag2>", "There", "were", "fewer", "shipments", "to", "this", "partner", "in", "total", "and", "relative", "to", "shipments", "to", "other", "customers", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014.", "<tag3>"], "wordsA": ["Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2014", "decreased", "marginally", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2013."], "wordsB": ["There", "were", "fewer", "shipments", "to", "this", "partner", "in", "total", "and", "relative", "to", "shipments", "to", "other", "customers", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p32_s0", "idA": "906709_15_item7_p31_s0", "sentA": "Interest expense for the year ended December 31, 2014 decreased marginally as compared to the year ended December 31, 2013.", "sentB": "Interest expense for the year ended December 31, 2015 increased marginally compared to the year ended December 31, 2014 primarily due to our secured note financing transaction in October 2015.", "type": 2, "words": ["<tag1>", "Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2014", "decreased", "marginally", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2013.", "<tag2>", "Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2015", "increased", "marginally", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "our", "secured", "note", "financing", "transaction", "in", "October", "2015.", "<tag3>"], "wordsA": ["Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2014", "decreased", "marginally", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2013."], "wordsB": ["Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2015", "increased", "marginally", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "our", "secured", "note", "financing", "transaction", "in", "October", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p34_s5", "idA": "906709_15_item7_p32_s10", "sentA": "Unless we adjust our estimated interest rate, we expect non-cash interest expense on the liability related to sale of future royalties during the full year of 2015 to be consistent with 2014.", "sentB": "Unless we adjust our estimated interest rate, we expect non-cash interest expense on the liability related to sale of future royalties for 2016 to decrease marginally compared with 2015 as a result of the expected decrease in 2016 of the royalty liability balance.", "type": 2, "words": ["<tag1>", "Unless", "we", "adjust", "our", "estimated", "interest", "rate,", "we", "expect", "non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "during", "the", "full", "year", "of", "2015", "to", "be", "consistent", "with", "2014.", "<tag2>", "Unless", "we", "adjust", "our", "estimated", "interest", "rate,", "we", "expect", "non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "2016", "to", "decrease", "marginally", "compared", "with", "2015", "as", "a", "result", "of", "the", "expected", "decrease", "in", "2016", "of", "the", "royalty", "liability", "balance.", "<tag3>"], "wordsA": ["Unless", "we", "adjust", "our", "estimated", "interest", "rate,", "we", "expect", "non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "during", "the", "full", "year", "of", "2015", "to", "be", "consistent", "with", "2014."], "wordsB": ["Unless", "we", "adjust", "our", "estimated", "interest", "rate,", "we", "expect", "non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "2016", "to", "decrease", "marginally", "compared", "with", "2015", "as", "a", "result", "of", "the", "expected", "decrease", "in", "2016", "of", "the", "royalty", "liability", "balance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p33_s2", "idA": "906709_15_item7_p32_s3", "sentA": "Non-cash interest expense on the liability related to sale of future royalties for the year ended December 31, 2014 decreased marginally as compared to the year ended December 31, 2013 due to the decrease in 2014 of the average balance of the related liability.", "sentB": "Non-cash interest expense on the liability related to sale of future royalties for the year ended December 31, 2015 and 2014 decreased marginally as compared to the year ended December 31, 2014 and 2013, respectively, due to the decrease in 2015 and 2014, respectively, of the average balance of the related liability as that liability balance amortizes.", "type": 2, "words": ["<tag1>", "Non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2014", "decreased", "marginally", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "due", "to", "the", "decrease", "in", "2014", "of", "the", "average", "balance", "of", "the", "related", "liability.", "<tag2>", "Non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2015", "and", "2014", "decreased", "marginally", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "and", "2013,", "respectively,", "due", "to", "the", "decrease", "in", "2015", "and", "2014,", "respectively,", "of", "the", "average", "balance", "of", "the", "related", "liability", "as", "that", "liability", "balance", "amortizes.", "<tag3>"], "wordsA": ["Non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2014", "decreased", "marginally", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "due", "to", "the", "decrease", "in", "2014", "of", "the", "average", "balance", "of", "the", "related", "liability."], "wordsB": ["Non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2015", "and", "2014", "decreased", "marginally", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "and", "2013,", "respectively,", "due", "to", "the", "decrease", "in", "2015", "and", "2014,", "respectively,", "of", "the", "average", "balance", "of", "the", "related", "liability", "as", "that", "liability", "balance", "amortizes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p11_s1", "idA": "906709_15_item7_p33_s1", "sentA": "At December 31, 2014, we had approximately $262.8 million in cash and investments in marketable securities, of which $25.0 million was restricted as required by our 12% senior secured notes, and $151.8 million in indebtedness.", "sentB": "At December 31, 2015, we had approximately $308.9 million in cash and investments in marketable securities.", "type": 2, "words": ["<tag1>", "At", "December", "31,", "2014,", "we", "had", "approximately", "$262.8", "million", "in", "cash", "and", "investments", "in", "marketable", "securities,", "of", "which", "$25.0", "million", "was", "restricted", "as", "required", "by", "our", "12%", "senior", "secured", "notes,", "and", "$151.8", "million", "in", "indebtedness.", "<tag2>", "At", "December", "31,", "2015,", "we", "had", "approximately", "$308.9", "million", "in", "cash", "and", "investments", "in", "marketable", "securities.", "<tag3>"], "wordsA": ["At", "December", "31,", "2014,", "we", "had", "approximately", "$262.8", "million", "in", "cash", "and", "investments", "in", "marketable", "securities,", "of", "which", "$25.0", "million", "was", "restricted", "as", "required", "by", "our", "12%", "senior", "secured", "notes,", "and", "$151.8", "million", "in", "indebtedness."], "wordsB": ["At", "December", "31,", "2015,", "we", "had", "approximately", "$308.9", "million", "in", "cash", "and", "investments", "in", "marketable", "securities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p36_s1", "idA": "906709_15_item7_p33_s1", "sentA": "At December 31, 2014, we had approximately $262.8 million in cash and investments in marketable securities, of which $25.0 million was restricted as required by our 12% senior secured notes, and $151.8 million in indebtedness.", "sentB": "At December 31, 2015, we had approximately $308.9 million in cash and investments in marketable securities.", "type": 2, "words": ["<tag1>", "At", "December", "31,", "2014,", "we", "had", "approximately", "$262.8", "million", "in", "cash", "and", "investments", "in", "marketable", "securities,", "of", "which", "$25.0", "million", "was", "restricted", "as", "required", "by", "our", "12%", "senior", "secured", "notes,", "and", "$151.8", "million", "in", "indebtedness.", "<tag2>", "At", "December", "31,", "2015,", "we", "had", "approximately", "$308.9", "million", "in", "cash", "and", "investments", "in", "marketable", "securities.", "<tag3>"], "wordsA": ["At", "December", "31,", "2014,", "we", "had", "approximately", "$262.8", "million", "in", "cash", "and", "investments", "in", "marketable", "securities,", "of", "which", "$25.0", "million", "was", "restricted", "as", "required", "by", "our", "12%", "senior", "secured", "notes,", "and", "$151.8", "million", "in", "indebtedness."], "wordsB": ["At", "December", "31,", "2015,", "we", "had", "approximately", "$308.9", "million", "in", "cash", "and", "investments", "in", "marketable", "securities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p38_s0", "idA": "906709_15_item7_p33_s10", "sentA": "The availability and terms of various financing alternatives substantially depend on many factors including the success or failure of drug development programs in our pipeline, including etirinotecan pegol, BAX 855, Amikacin Inhale, NKTR-181, NKTR-171, NKTR-214, as well as other early stage development programs.", "sentB": "The availability and terms of various financing alternatives substantially depend on many factors including the success or failure of drug development programs in our pipeline, including NKTR-181, Amikacin Inhale and NKTR-214, as well as other early stage development programs.", "type": 2, "words": ["<tag1>", "The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "many", "factors", "including", "the", "success", "or", "failure", "of", "drug", "development", "programs", "in", "our", "pipeline,", "including", "etirinotecan", "pegol,", "BAX", "855,", "Amikacin", "Inhale,", "NKTR-181,", "NKTR-171,", "NKTR-214,", "as", "well", "as", "other", "early", "stage", "development", "programs.", "<tag2>", "The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "many", "factors", "including", "the", "success", "or", "failure", "of", "drug", "development", "programs", "in", "our", "pipeline,", "including", "NKTR-181,", "Amikacin", "Inhale", "and", "NKTR-214,", "as", "well", "as", "other", "early", "stage", "development", "programs.", "<tag3>"], "wordsA": ["The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "many", "factors", "including", "the", "success", "or", "failure", "of", "drug", "development", "programs", "in", "our", "pipeline,", "including", "etirinotecan", "pegol,", "BAX", "855,", "Amikacin", "Inhale,", "NKTR-181,", "NKTR-171,", "NKTR-214,", "as", "well", "as", "other", "early", "stage", "development", "programs."], "wordsB": ["The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "many", "factors", "including", "the", "success", "or", "failure", "of", "drug", "development", "programs", "in", "our", "pipeline,", "including", "NKTR-181,", "Amikacin", "Inhale", "and", "NKTR-214,", "as", "well", "as", "other", "early", "stage", "development", "programs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p11_s4", "idA": "906709_15_item7_p33_s2", "sentA": "The indebtedness includes $125.0 million in aggregate principal amount of 12.0% senior secured notes due July 15, 2017, but excludes our long-term liability related to the sale of future royalties.", "sentB": "We used a portion of the proceeds from these notes to redeem the $125.0 million in aggregate principal amount of 12.0% senior secured notes due July 2017 and to make a $12.5 million redemption payment and to pay $3.3 million in accrued interest, due upon redemption of the 12% senior secured notes.", "type": 2, "words": ["<tag1>", "The", "indebtedness", "includes", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "15,", "2017,", "but", "excludes", "our", "long-term", "liability", "related", "to", "the", "sale", "of", "future", "royalties.", "<tag2>", "We", "used", "a", "portion", "of", "the", "proceeds", "from", "these", "notes", "to", "redeem", "the", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "2017", "and", "to", "make", "a", "$12.5", "million", "redemption", "payment", "and", "to", "pay", "$3.3", "million", "in", "accrued", "interest,", "due", "upon", "redemption", "of", "the", "12%", "senior", "secured", "notes.", "<tag3>"], "wordsA": ["The", "indebtedness", "includes", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "15,", "2017,", "but", "excludes", "our", "long-term", "liability", "related", "to", "the", "sale", "of", "future", "royalties."], "wordsB": ["We", "used", "a", "portion", "of", "the", "proceeds", "from", "these", "notes", "to", "redeem", "the", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "2017", "and", "to", "make", "a", "$12.5", "million", "redemption", "payment", "and", "to", "pay", "$3.3", "million", "in", "accrued", "interest,", "due", "upon", "redemption", "of", "the", "12%", "senior", "secured", "notes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p32_s1", "idA": "906709_15_item7_p33_s2", "sentA": "The indebtedness includes $125.0 million in aggregate principal amount of 12.0% senior secured notes due July 15, 2017, but excludes our long-term liability related to the sale of future royalties.", "sentB": "As is further described in Note 5 to our Consolidated Financial Statements, on October 5, 2015, we issued $250.0 million in aggregate principal amount of 7.75% senior secured notes due October 2020 and used a portion of the proceeds from these notes to redeem the $125.0 million in aggregate principal amount of 12.0% senior secured notes due July 2017.", "type": 2, "words": ["<tag1>", "The", "indebtedness", "includes", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "15,", "2017,", "but", "excludes", "our", "long-term", "liability", "related", "to", "the", "sale", "of", "future", "royalties.", "<tag2>", "As", "is", "further", "described", "in", "Note", "5", "to", "our", "Consolidated", "Financial", "Statements,", "on", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "October", "2020", "and", "used", "a", "portion", "of", "the", "proceeds", "from", "these", "notes", "to", "redeem", "the", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "2017.", "<tag3>"], "wordsA": ["The", "indebtedness", "includes", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "15,", "2017,", "but", "excludes", "our", "long-term", "liability", "related", "to", "the", "sale", "of", "future", "royalties."], "wordsB": ["As", "is", "further", "described", "in", "Note", "5", "to", "our", "Consolidated", "Financial", "Statements,", "on", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "October", "2020", "and", "used", "a", "portion", "of", "the", "proceeds", "from", "these", "notes", "to", "redeem", "the", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p36_s4", "idA": "906709_15_item7_p33_s2", "sentA": "The indebtedness includes $125.0 million in aggregate principal amount of 12.0% senior secured notes due July 15, 2017, but excludes our long-term liability related to the sale of future royalties.", "sentB": "We used a portion of the proceeds from these notes to redeem the $125.0 million in aggregate principal amount of 12.0% senior secured notes due July 2017 and to make a $12.5 million redemption payment and pay $3.3 million in accrued interest, due upon redemption of the 12% senior secured notes.", "type": 2, "words": ["<tag1>", "The", "indebtedness", "includes", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "15,", "2017,", "but", "excludes", "our", "long-term", "liability", "related", "to", "the", "sale", "of", "future", "royalties.", "<tag2>", "We", "used", "a", "portion", "of", "the", "proceeds", "from", "these", "notes", "to", "redeem", "the", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "2017", "and", "to", "make", "a", "$12.5", "million", "redemption", "payment", "and", "pay", "$3.3", "million", "in", "accrued", "interest,", "due", "upon", "redemption", "of", "the", "12%", "senior", "secured", "notes.", "<tag3>"], "wordsA": ["The", "indebtedness", "includes", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "15,", "2017,", "but", "excludes", "our", "long-term", "liability", "related", "to", "the", "sale", "of", "future", "royalties."], "wordsB": ["We", "used", "a", "portion", "of", "the", "proceeds", "from", "these", "notes", "to", "redeem", "the", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "2017", "and", "to", "make", "a", "$12.5", "million", "redemption", "payment", "and", "pay", "$3.3", "million", "in", "accrued", "interest,", "due", "upon", "redemption", "of", "the", "12%", "senior", "secured", "notes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p39_s0", "idA": "906709_15_item7_p33_s2", "sentA": "The indebtedness includes $125.0 million in aggregate principal amount of 12.0% senior secured notes due July 15, 2017, but excludes our long-term liability related to the sale of future royalties.", "sentB": "Ca sh flows used in financing activities On October 5, 2015, we issued $250.0 million in aggregate principal amount of 7.75% senior secured notes due 2020 ( Notes ).", "type": 2, "words": ["<tag1>", "The", "indebtedness", "includes", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "15,", "2017,", "but", "excludes", "our", "long-term", "liability", "related", "to", "the", "sale", "of", "future", "royalties.", "<tag2>", "Ca", "sh", "flows", "used", "in", "financing", "activities", "On", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "2020", "(", "Notes", ").", "<tag3>"], "wordsA": ["The", "indebtedness", "includes", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "15,", "2017,", "but", "excludes", "our", "long-term", "liability", "related", "to", "the", "sale", "of", "future", "royalties."], "wordsB": ["Ca", "sh", "flows", "used", "in", "financing", "activities", "On", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "2020", "(", "Notes", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p39_s5", "idA": "906709_15_item7_p33_s2", "sentA": "The indebtedness includes $125.0 million in aggregate principal amount of 12.0% senior secured notes due July 15, 2017, but excludes our long-term liability related to the sale of future royalties.", "sentB": "On October 5, 2015, we used a portion of the proceeds from the Notes to redeem the $125.0 million in aggregate principal amount of 12.0% senior secured notes due in 2017.", "type": 2, "words": ["<tag1>", "The", "indebtedness", "includes", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "15,", "2017,", "but", "excludes", "our", "long-term", "liability", "related", "to", "the", "sale", "of", "future", "royalties.", "<tag2>", "On", "October", "5,", "2015,", "we", "used", "a", "portion", "of", "the", "proceeds", "from", "the", "Notes", "to", "redeem", "the", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "in", "2017.", "<tag3>"], "wordsA": ["The", "indebtedness", "includes", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "15,", "2017,", "but", "excludes", "our", "long-term", "liability", "related", "to", "the", "sale", "of", "future", "royalties."], "wordsB": ["On", "October", "5,", "2015,", "we", "used", "a", "portion", "of", "the", "proceeds", "from", "the", "Notes", "to", "redeem", "the", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "in", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p37_s0", "idA": "906709_15_item7_p33_s4", "sentA": "As of December 31, 2014, we estimated that we had at least twelve months of working capital to fund our current business plans.", "sentB": "As of December 31, 2015, we estimated that we had at least twelve months of working capital to f und our current business plans.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2014,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans.", "<tag2>", "As", "of", "December", "31,", "2015,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "f", "und", "our", "current", "business", "plans.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2014,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans."], "wordsB": ["As", "of", "December", "31,", "2015,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "f", "und", "our", "current", "business", "plans."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p37_s1", "idA": "906709_15_item7_p33_s5", "sentA": "We expect the clinical development of our proprietary drug candidates, including etirinotecan pegol, Amikacin Inhale, NKTR-181, and NKTR-171, will require significant investment in order to continue to advance in clinical development with the objective of entering into a collaboration partnership or obtaining regulatory approval.", "sentB": "We expect the clinical development of our proprietary drug candidates including NKTR-181 , Amikacin Inhale, and NKTR- 214 , will require significant investment in order to continue to advance in clinical development with the ob jective of entering into a collaboration partnership or obtaining regulatory approval.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates,", "including", "etirinotecan", "pegol,", "Amikacin", "Inhale,", "NKTR-181,", "and", "NKTR-171,", "will", "require", "significant", "investment", "in", "order", "to", "continue", "to", "advance", "in", "clinical", "development", "with", "the", "objective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval.", "<tag2>", "We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates", "including", "NKTR-181", ",", "Amikacin", "Inhale,", "and", "NKTR-", "214", ",", "will", "require", "significant", "investment", "in", "order", "to", "continue", "to", "advance", "in", "clinical", "development", "with", "the", "ob", "jective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval.", "<tag3>"], "wordsA": ["We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates,", "including", "etirinotecan", "pegol,", "Amikacin", "Inhale,", "NKTR-181,", "and", "NKTR-171,", "will", "require", "significant", "investment", "in", "order", "to", "continue", "to", "advance", "in", "clinical", "development", "with", "the", "objective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval."], "wordsB": ["We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates", "including", "NKTR-181", ",", "Amikacin", "Inhale,", "and", "NKTR-", "214", ",", "will", "require", "significant", "investment", "in", "order", "to", "continue", "to", "advance", "in", "clinical", "development", "with", "the", "ob", "jective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p37_s3", "idA": "906709_15_item7_p33_s7", "sentA": "In the past we have received a number of significant payments from collaboration agreements and other significant transactions.", "sentB": "In the past we have received a number of significant payments from collaboration agreement s and other significant transactions.", "type": 2, "words": ["<tag1>", "In", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "collaboration", "agreements", "and", "other", "significant", "transactions.", "<tag2>", "In", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "collaboration", "agreement", "s", "and", "other", "significant", "transactions.", "<tag3>"], "wordsA": ["In", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "collaboration", "agreements", "and", "other", "significant", "transactions."], "wordsB": ["In", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "collaboration", "agreement", "s", "and", "other", "significant", "transactions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p37_s4", "idA": "906709_15_item7_p33_s8", "sentA": "In the future we expect to receive royalties from commercial sales of products such as MOVANTIK and BAX 855 (if approved) and substantial payments from future collaboration transactions if our later stage clinical development programs such as etirinotecan pegol and NKTR-181 have positive clinical outcomes.", "sentB": "In the future , we expect to receive royalties from commercial sales of products such as MOVANTIK TM and ADYNOVATE TM and potential substantial payments from future collaboration transactions if drug candidates in our pi peline achieve positive clinical or regulatory outcomes.", "type": 2, "words": ["<tag1>", "In", "the", "future", "we", "expect", "to", "receive", "royalties", "from", "commercial", "sales", "of", "products", "such", "as", "MOVANTIK", "and", "BAX", "855", "(if", "approved)", "and", "substantial", "payments", "from", "future", "collaboration", "transactions", "if", "our", "later", "stage", "clinical", "development", "programs", "such", "as", "etirinotecan", "pegol", "and", "NKTR-181", "have", "positive", "clinical", "outcomes.", "<tag2>", "In", "the", "future", ",", "we", "expect", "to", "receive", "royalties", "from", "commercial", "sales", "of", "products", "such", "as", "MOVANTIK", "TM", "and", "ADYNOVATE", "TM", "and", "potential", "substantial", "payments", "from", "future", "collaboration", "transactions", "if", "drug", "candidates", "in", "our", "pi", "peline", "achieve", "positive", "clinical", "or", "regulatory", "outcomes.", "<tag3>"], "wordsA": ["In", "the", "future", "we", "expect", "to", "receive", "royalties", "from", "commercial", "sales", "of", "products", "such", "as", "MOVANTIK", "and", "BAX", "855", "(if", "approved)", "and", "substantial", "payments", "from", "future", "collaboration", "transactions", "if", "our", "later", "stage", "clinical", "development", "programs", "such", "as", "etirinotecan", "pegol", "and", "NKTR-181", "have", "positive", "clinical", "outcomes."], "wordsB": ["In", "the", "future", ",", "we", "expect", "to", "receive", "royalties", "from", "commercial", "sales", "of", "products", "such", "as", "MOVANTIK", "TM", "and", "ADYNOVATE", "TM", "and", "potential", "substantial", "payments", "from", "future", "collaboration", "transactions", "if", "drug", "candidates", "in", "our", "pi", "peline", "achieve", "positive", "clinical", "or", "regulatory", "outcomes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p37_s5", "idA": "906709_15_item7_p33_s9", "sentA": "Our current business plan is also subject to significant uncertainties and risks as a result of, among other factors, the sales levels of products for which we are entitled to royalties such as MOVANTIK , clinical program outcomes, whether, when and on what terms we are able to enter into new collaboration transactions, expenses being higher than anticipated, unplanned expenses, cash receipts being lower than anticipated, and the need to satisfy contingent liabilities, including litigation matters and indemnification obligations.", "sentB": "Our current business plan is also subject to significant uncertainties and risks as a result of, among other factors, the sales levels of products for which we are entitled to royalties such as MOVAN TIK TM , clinical program outcomes, whether, when and on what terms we are able to enter into new collaboration transactions, expenses being higher than anticipated, unplanned expenses, cash receipts being lower than anticipated, and the need to satisfy cont ingent liabilities, including litigation matters and indemnification obligations.", "type": 2, "words": ["<tag1>", "Our", "current", "business", "plan", "is", "also", "subject", "to", "significant", "uncertainties", "and", "risks", "as", "a", "result", "of,", "among", "other", "factors,", "the", "sales", "levels", "of", "products", "for", "which", "we", "are", "entitled", "to", "royalties", "such", "as", "MOVANTIK", ",", "clinical", "program", "outcomes,", "whether,", "when", "and", "on", "what", "terms", "we", "are", "able", "to", "enter", "into", "new", "collaboration", "transactions,", "expenses", "being", "higher", "than", "anticipated,", "unplanned", "expenses,", "cash", "receipts", "being", "lower", "than", "anticipated,", "and", "the", "need", "to", "satisfy", "contingent", "liabilities,", "including", "litigation", "matters", "and", "indemnification", "obligations.", "<tag2>", "Our", "current", "business", "plan", "is", "also", "subject", "to", "significant", "uncertainties", "and", "risks", "as", "a", "result", "of,", "among", "other", "factors,", "the", "sales", "levels", "of", "products", "for", "which", "we", "are", "entitled", "to", "royalties", "such", "as", "MOVAN", "TIK", "TM", ",", "clinical", "program", "outcomes,", "whether,", "when", "and", "on", "what", "terms", "we", "are", "able", "to", "enter", "into", "new", "collaboration", "transactions,", "expenses", "being", "higher", "than", "anticipated,", "unplanned", "expenses,", "cash", "receipts", "being", "lower", "than", "anticipated,", "and", "the", "need", "to", "satisfy", "cont", "ingent", "liabilities,", "including", "litigation", "matters", "and", "indemnification", "obligations.", "<tag3>"], "wordsA": ["Our", "current", "business", "plan", "is", "also", "subject", "to", "significant", "uncertainties", "and", "risks", "as", "a", "result", "of,", "among", "other", "factors,", "the", "sales", "levels", "of", "products", "for", "which", "we", "are", "entitled", "to", "royalties", "such", "as", "MOVANTIK", ",", "clinical", "program", "outcomes,", "whether,", "when", "and", "on", "what", "terms", "we", "are", "able", "to", "enter", "into", "new", "collaboration", "transactions,", "expenses", "being", "higher", "than", "anticipated,", "unplanned", "expenses,", "cash", "receipts", "being", "lower", "than", "anticipated,", "and", "the", "need", "to", "satisfy", "contingent", "liabilities,", "including", "litigation", "matters", "and", "indemnification", "obligations."], "wordsB": ["Our", "current", "business", "plan", "is", "also", "subject", "to", "significant", "uncertainties", "and", "risks", "as", "a", "result", "of,", "among", "other", "factors,", "the", "sales", "levels", "of", "products", "for", "which", "we", "are", "entitled", "to", "royalties", "such", "as", "MOVAN", "TIK", "TM", ",", "clinical", "program", "outcomes,", "whether,", "when", "and", "on", "what", "terms", "we", "are", "able", "to", "enter", "into", "new", "collaboration", "transactions,", "expenses", "being", "higher", "than", "anticipated,", "unplanned", "expenses,", "cash", "receipts", "being", "lower", "than", "anticipated,", "and", "the", "need", "to", "satisfy", "cont", "ingent", "liabilities,", "including", "litigation", "matters", "and", "indemnification", "obligations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p38_s1", "idA": "906709_15_item7_p34_s0", "sentA": "are successful in obtaining health authority approvals in major markets, and if approved, the commercial success of these drugs, as well as general capital market conditions.", "sentB": "The availability and terms of financing alternatives and any future significant payments from existing or new collaborations depend on the positive outcome of ongoing or planned clinical studies, whether we or our partners are successful in obtaining regulatory authority approvals in major markets, and if approved, the commercial success of these drugs, as well as general capital market conditions.", "type": 2, "words": ["<tag1>", "are", "successful", "in", "obtaining", "health", "authority", "approvals", "in", "major", "markets,", "and", "if", "approved,", "the", "commercial", "success", "of", "these", "drugs,", "as", "well", "as", "general", "capital", "market", "conditions.", "<tag2>", "The", "availability", "and", "terms", "of", "financing", "alternatives", "and", "any", "future", "significant", "payments", "from", "existing", "or", "new", "collaborations", "depend", "on", "the", "positive", "outcome", "of", "ongoing", "or", "planned", "clinical", "studies,", "whether", "we", "or", "our", "partners", "are", "successful", "in", "obtaining", "regulatory", "authority", "approvals", "in", "major", "markets,", "and", "if", "approved,", "the", "commercial", "success", "of", "these", "drugs,", "as", "well", "as", "general", "capital", "market", "conditions.", "<tag3>"], "wordsA": ["are", "successful", "in", "obtaining", "health", "authority", "approvals", "in", "major", "markets,", "and", "if", "approved,", "the", "commercial", "success", "of", "these", "drugs,", "as", "well", "as", "general", "capital", "market", "conditions."], "wordsB": ["The", "availability", "and", "terms", "of", "financing", "alternatives", "and", "any", "future", "significant", "payments", "from", "existing", "or", "new", "collaborations", "depend", "on", "the", "positive", "outcome", "of", "ongoing", "or", "planned", "clinical", "studies,", "whether", "we", "or", "our", "partners", "are", "successful", "in", "obtaining", "regulatory", "authority", "approvals", "in", "major", "markets,", "and", "if", "approved,", "the", "commercial", "success", "of", "these", "drugs,", "as", "well", "as", "general", "capital", "market", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p38_s2", "idA": "906709_15_item7_p34_s1", "sentA": "We will pursue various financing alternatives, including equity and debt, as needed to continue to fund our research and development activities and to fund the expansion of our business as appropriate.", "sentB": "We will pursue various financing alternatives as needed to continue to fund our research and development activities and to fund the expansion of our business as appropriate.", "type": 2, "words": ["<tag1>", "We", "will", "pursue", "various", "financing", "alternatives,", "including", "equity", "and", "debt,", "as", "needed", "to", "continue", "to", "fund", "our", "research", "and", "development", "activities", "and", "to", "fund", "the", "expansion", "of", "our", "business", "as", "appropriate.", "<tag2>", "We", "will", "pursue", "various", "financing", "alternatives", "as", "needed", "to", "continue", "to", "fund", "our", "research", "and", "development", "activities", "and", "to", "fund", "the", "expansion", "of", "our", "business", "as", "appropriate.", "<tag3>"], "wordsA": ["We", "will", "pursue", "various", "financing", "alternatives,", "including", "equity", "and", "debt,", "as", "needed", "to", "continue", "to", "fund", "our", "research", "and", "development", "activities", "and", "to", "fund", "the", "expansion", "of", "our", "business", "as", "appropriate."], "wordsB": ["We", "will", "pursue", "various", "financing", "alternatives", "as", "needed", "to", "continue", "to", "fund", "our", "research", "and", "development", "activities", "and", "to", "fund", "the", "expansion", "of", "our", "business", "as", "appropriate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p38_s3", "idA": "906709_15_item7_p34_s2", "sentA": "Due to the potential for adverse developments in the credit markets in 2015 and thereafter, we may experience reduced liquidity with respect to some of our investments in marketable securities.", "sentB": "Due to the potential for adverse developments in the credit markets in 2016 and thereafter, we may experience reduced liquidity with respect to some of our investments in marketable securities.", "type": 2, "words": ["<tag1>", "Due", "to", "the", "potential", "for", "adverse", "developments", "in", "the", "credit", "markets", "in", "2015", "and", "thereafter,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities.", "<tag2>", "Due", "to", "the", "potential", "for", "adverse", "developments", "in", "the", "credit", "markets", "in", "2016", "and", "thereafter,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities.", "<tag3>"], "wordsA": ["Due", "to", "the", "potential", "for", "adverse", "developments", "in", "the", "credit", "markets", "in", "2015", "and", "thereafter,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities."], "wordsB": ["Due", "to", "the", "potential", "for", "adverse", "developments", "in", "the", "credit", "markets", "in", "2016", "and", "thereafter,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p38_s6", "idA": "906709_15_item7_p34_s5", "sentA": "At December 31, 2014, the average time to maturity of the investments held in our portfolio was approximately five months and the maturity of any single investment did not exceed one year.", "sentB": "At December 31, 2015, the average time to maturity of the investments held in our portfolio was approximately five months and the maturity of any single investment did not exceed one year.", "type": 2, "words": ["<tag1>", "At", "December", "31,", "2014,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "five", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "one", "year.", "<tag2>", "At", "December", "31,", "2015,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "five", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "one", "year.", "<tag3>"], "wordsA": ["At", "December", "31,", "2014,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "five", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "one", "year."], "wordsB": ["At", "December", "31,", "2015,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "five", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "one", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p38_s12", "idA": "906709_15_item7_p35_s0", "sentA": "Cash flows from operating activities Cash flows used in operating activities for the year ended December 31, 2014 totaled $142.0 million, which includes $199.0 million of net operating cash uses as well as $15.0 million for interest payments on our senior secured notes, partially offset by the receipt of $72.0 million of milestones from collaboration agreements.", "sentB": "Cash flows used in operating activities for the year ended December 31, 2014 totaled $142.0 million, which includes $199.0 million of net operating cash uses as well as $15.0 million for interest payments on our senior secured notes, partially offset by the receipt of $72.0 million of milestones and other contingent payments from collaboration agreements.", "type": 2, "words": ["<tag1>", "Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2014", "totaled", "$142.0", "million,", "which", "includes", "$199.0", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$15.0", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$72.0", "million", "of", "milestones", "from", "collaboration", "agreements.", "<tag2>", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2014", "totaled", "$142.0", "million,", "which", "includes", "$199.0", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$15.0", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$72.0", "million", "of", "milestones", "and", "other", "contingent", "payments", "from", "collaboration", "agreements.", "<tag3>"], "wordsA": ["Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2014", "totaled", "$142.0", "million,", "which", "includes", "$199.0", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$15.0", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$72.0", "million", "of", "milestones", "from", "collaboration", "agreements."], "wordsB": ["Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2014", "totaled", "$142.0", "million,", "which", "includes", "$199.0", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$15.0", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$72.0", "million", "of", "milestones", "and", "other", "contingent", "payments", "from", "collaboration", "agreements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p38_s9", "idA": "906709_15_item7_p35_s0", "sentA": "Cash flows from operating activities Cash flows used in operating activities for the year ended December 31, 2014 totaled $142.0 million, which includes $199.0 million of net operating cash uses as well as $15.0 million for interest payments on our senior secured notes, partially offset by the receipt of $72.0 million of milestones from collaboration agreements.", "sentB": "Cash flows from operating activities Cash flows used in operating activities for the year ended December 31, 2015 totaled $73.1 million, which includes $196.3 million of net operating cash uses as well as $18.8 million for interest payments on our senior secured notes, partially offset by the receipt of $142.0 million of milestones and other contingent payments from collaboration agreements.", "type": 2, "words": ["<tag1>", "Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2014", "totaled", "$142.0", "million,", "which", "includes", "$199.0", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$15.0", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$72.0", "million", "of", "milestones", "from", "collaboration", "agreements.", "<tag2>", "Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2015", "totaled", "$73.1", "million,", "which", "includes", "$196.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$18.8", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$142.0", "million", "of", "milestones", "and", "other", "contingent", "payments", "from", "collaboration", "agreements.", "<tag3>"], "wordsA": ["Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2014", "totaled", "$142.0", "million,", "which", "includes", "$199.0", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$15.0", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$72.0", "million", "of", "milestones", "from", "collaboration", "agreements."], "wordsB": ["Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2015", "totaled", "$73.1", "million,", "which", "includes", "$196.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$18.8", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$142.0", "million", "of", "milestones", "and", "other", "contingent", "payments", "from", "collaboration", "agreements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p38_s13", "idA": "906709_15_item7_p35_s1", "sentA": "During the year ended December 31, 2014, we recognized as revenue a $70.0 million payment made to us from AstraZeneca in November 2013, which was previously recorded in the line item Liability related to receipt of refundable milestone payment on our Consolidated Balance Sheet at December 31, 2013.", "sentB": "During the year ended December 31, 2014, we recognized as revenue a $70.0 million payment made to us from AstraZeneca in November 2013.", "type": 2, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2014,", "we", "recognized", "as", "revenue", "a", "$70.0", "million", "payment", "made", "to", "us", "from", "AstraZeneca", "in", "November", "2013,", "which", "was", "previously", "recorded", "in", "the", "line", "item", "Liability", "related", "to", "receipt", "of", "refundable", "milestone", "payment", "on", "our", "Consolidated", "Balance", "Sheet", "at", "December", "31,", "2013.", "<tag2>", "During", "the", "year", "ended", "December", "31,", "2014,", "we", "recognized", "as", "revenue", "a", "$70.0", "million", "payment", "made", "to", "us", "from", "AstraZeneca", "in", "November", "2013.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2014,", "we", "recognized", "as", "revenue", "a", "$70.0", "million", "payment", "made", "to", "us", "from", "AstraZeneca", "in", "November", "2013,", "which", "was", "previously", "recorded", "in", "the", "line", "item", "Liability", "related", "to", "receipt", "of", "refundable", "milestone", "payment", "on", "our", "Consolidated", "Balance", "Sheet", "at", "December", "31,", "2013."], "wordsB": ["During", "the", "year", "ended", "December", "31,", "2014,", "we", "recognized", "as", "revenue", "a", "$70.0", "million", "payment", "made", "to", "us", "from", "AstraZeneca", "in", "November", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p39_s4", "idA": "906709_15_item7_p35_s1", "sentA": "During the year ended December 31, 2014, we recognized as revenue a $70.0 million payment made to us from AstraZeneca in November 2013, which was previously recorded in the line item Liability related to receipt of refundable milestone payment on our Consolidated Balance Sheet at December 31, 2013.", "sentB": "An additional $0.4 million of direct issuance costs was capitalized and recorded in Other Assets in our Consolidated Balance Sheet.", "type": 2, "words": ["<tag1>", "During", "the", "year", "ended", "December", "31,", "2014,", "we", "recognized", "as", "revenue", "a", "$70.0", "million", "payment", "made", "to", "us", "from", "AstraZeneca", "in", "November", "2013,", "which", "was", "previously", "recorded", "in", "the", "line", "item", "Liability", "related", "to", "receipt", "of", "refundable", "milestone", "payment", "on", "our", "Consolidated", "Balance", "Sheet", "at", "December", "31,", "2013.", "<tag2>", "An", "additional", "$0.4", "million", "of", "direct", "issuance", "costs", "was", "capitalized", "and", "recorded", "in", "Other", "Assets", "in", "our", "Consolidated", "Balance", "Sheet.", "<tag3>"], "wordsA": ["During", "the", "year", "ended", "December", "31,", "2014,", "we", "recognized", "as", "revenue", "a", "$70.0", "million", "payment", "made", "to", "us", "from", "AstraZeneca", "in", "November", "2013,", "which", "was", "previously", "recorded", "in", "the", "line", "item", "Liability", "related", "to", "receipt", "of", "refundable", "milestone", "payment", "on", "our", "Consolidated", "Balance", "Sheet", "at", "December", "31,", "2013."], "wordsB": ["An", "additional", "$0.4", "million", "of", "direct", "issuance", "costs", "was", "capitalized", "and", "recorded", "in", "Other", "Assets", "in", "our", "Consolidated", "Balance", "Sheet."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p38_s11", "idA": "906709_15_item7_p35_s2", "sentA": "We expect that cash flows used in operating activities, excluding upfront and milestone payments received, if any, will increase in 2015 as a result of increased spending on our proprietary research and development programs, including the initiation of the Phase 3 clinical program for NKTR-181.", "sentB": "We expect that cash flows used in operating activities, excluding upfront, milestone and other contingent payments received, if any, will decrease in 2016 compared to 2015 primarily as a result of increased cash receipts from product sales and royalties.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront", "and", "milestone", "payments", "received,", "if", "any,", "will", "increase", "in", "2015", "as", "a", "result", "of", "increased", "spending", "on", "our", "proprietary", "research", "and", "development", "programs,", "including", "the", "initiation", "of", "the", "Phase", "3", "clinical", "program", "for", "NKTR-181.", "<tag2>", "We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront,", "milestone", "and", "other", "contingent", "payments", "received,", "if", "any,", "will", "decrease", "in", "2016", "compared", "to", "2015", "primarily", "as", "a", "result", "of", "increased", "cash", "receipts", "from", "product", "sales", "and", "royalties.", "<tag3>"], "wordsA": ["We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront", "and", "milestone", "payments", "received,", "if", "any,", "will", "increase", "in", "2015", "as", "a", "result", "of", "increased", "spending", "on", "our", "proprietary", "research", "and", "development", "programs,", "including", "the", "initiation", "of", "the", "Phase", "3", "clinical", "program", "for", "NKTR-181."], "wordsB": ["We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront,", "milestone", "and", "other", "contingent", "payments", "received,", "if", "any,", "will", "decrease", "in", "2016", "compared", "to", "2015", "primarily", "as", "a", "result", "of", "increased", "cash", "receipts", "from", "product", "sales", "and", "royalties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p38_s14", "idA": "906709_15_item7_p35_s3", "sentA": "Cash flows used in operating activities for the year ended December 31, 2013 totaled $38.5 million, which includes $158.3 million of net operating cash uses as well as $15.2 million for interest payments on our senior secured notes, partially offset by the receipt of $135.0 million for milestones from collaboration agreements.", "sentB": "Cash flows used in operating activities for the year ended December 31, 2013 totaled $38.5 million, which includes $158.3 million of net operating cash uses as well as $15.2 million for interest payments on our senior secured notes, partially offset by the receipt of $135.0 million for milestones and other contingent payments from collaboration agreements.", "type": 2, "words": ["<tag1>", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2013", "totaled", "$38.5", "million,", "which", "includes", "$158.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$15.2", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$135.0", "million", "for", "milestones", "from", "collaboration", "agreements.", "<tag2>", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2013", "totaled", "$38.5", "million,", "which", "includes", "$158.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$15.2", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$135.0", "million", "for", "milestones", "and", "other", "contingent", "payments", "from", "collaboration", "agreements.", "<tag3>"], "wordsA": ["Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2013", "totaled", "$38.5", "million,", "which", "includes", "$158.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$15.2", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$135.0", "million", "for", "milestones", "from", "collaboration", "agreements."], "wordsB": ["Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2013", "totaled", "$38.5", "million,", "which", "includes", "$158.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$15.2", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$135.0", "million", "for", "milestones", "and", "other", "contingent", "payments", "from", "collaboration", "agreements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p38_s15", "idA": "906709_15_item7_p35_s6", "sentA": "Cash flows from investing activities We paid $10.0 million, $4.1 million, and $10.6 million to purchase property and equipment in the years ended December 31, 2014, 2013, and 2012, respectively.", "sentB": "Cash flows from investing activities We paid $11.2 million, $10.0 million, and $4.1 million to purchase property, plant and equipment in the years ended December 31, 2015, 2014, and 2013, respectively.", "type": 2, "words": ["<tag1>", "Cash", "flows", "from", "investing", "activities", "We", "paid", "$10.0", "million,", "$4.1", "million,", "and", "$10.6", "million", "to", "purchase", "property", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2014,", "2013,", "and", "2012,", "respectively.", "<tag2>", "Cash", "flows", "from", "investing", "activities", "We", "paid", "$11.2", "million,", "$10.0", "million,", "and", "$4.1", "million", "to", "purchase", "property,", "plant", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2015,", "2014,", "and", "2013,", "respectively.", "<tag3>"], "wordsA": ["Cash", "flows", "from", "investing", "activities", "We", "paid", "$10.0", "million,", "$4.1", "million,", "and", "$10.6", "million", "to", "purchase", "property", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2014,", "2013,", "and", "2012,", "respectively."], "wordsB": ["Cash", "flows", "from", "investing", "activities", "We", "paid", "$11.2", "million,", "$10.0", "million,", "and", "$4.1", "million", "to", "purchase", "property,", "plant", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2015,", "2014,", "and", "2013,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p38_s16", "idA": "906709_15_item7_p35_s7", "sentA": "We expect our capital expenditures in 2015 to increase as compared to 2014 primarily as a result of our plan to continue to build commercial manufacturing capacity for Amikacin Inhale devices.", "sentB": "We expect our capital expenditures in 2016 to decrease marginally compared to 2015.", "type": 2, "words": ["<tag1>", "We", "expect", "our", "capital", "expenditures", "in", "2015", "to", "increase", "as", "compared", "to", "2014", "primarily", "as", "a", "result", "of", "our", "plan", "to", "continue", "to", "build", "commercial", "manufacturing", "capacity", "for", "Amikacin", "Inhale", "devices.", "<tag2>", "We", "expect", "our", "capital", "expenditures", "in", "2016", "to", "decrease", "marginally", "compared", "to", "2015.", "<tag3>"], "wordsA": ["We", "expect", "our", "capital", "expenditures", "in", "2015", "to", "increase", "as", "compared", "to", "2014", "primarily", "as", "a", "result", "of", "our", "plan", "to", "continue", "to", "build", "commercial", "manufacturing", "capacity", "for", "Amikacin", "Inhale", "devices."], "wordsB": ["We", "expect", "our", "capital", "expenditures", "in", "2016", "to", "decrease", "marginally", "compared", "to", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p40_s4", "idA": "906709_15_item7_p36_s3", "sentA": "The remaining $120.5 million royalty obligation liability at December 31, 2014 will not be settled in cash.", "sentB": "The remaining $119.0 million royalty obligation liability at December 31, 2015 will not be settled in cash.", "type": 2, "words": ["<tag1>", "The", "remaining", "$120.5", "million", "royalty", "obligation", "liability", "at", "December", "31,", "2014", "will", "not", "be", "settled", "in", "cash.", "<tag2>", "The", "remaining", "$119.0", "million", "royalty", "obligation", "liability", "at", "December", "31,", "2015", "will", "not", "be", "settled", "in", "cash.", "<tag3>"], "wordsA": ["The", "remaining", "$120.5", "million", "royalty", "obligation", "liability", "at", "December", "31,", "2014", "will", "not", "be", "settled", "in", "cash."], "wordsB": ["The", "remaining", "$119.0", "million", "royalty", "obligation", "liability", "at", "December", "31,", "2015", "will", "not", "be", "settled", "in", "cash."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p11_s2", "idA": "906709_15_item7_p36_s4", "sentA": "On July 11, 2012, we issued $125.0 million of senior secured notes maturing on July 15, 2017.", "sentB": "Also, as of December 31, 2015, we had $255.8 million in debt, including $250.0 million in principal of senior secured notes and $5.8 million of capital lease obligations.", "type": 2, "words": ["<tag1>", "On", "July", "11,", "2012,", "we", "issued", "$125.0", "million", "of", "senior", "secured", "notes", "maturing", "on", "July", "15,", "2017.", "<tag2>", "Also,", "as", "of", "December", "31,", "2015,", "we", "had", "$255.8", "million", "in", "debt,", "including", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "and", "$5.8", "million", "of", "capital", "lease", "obligations.", "<tag3>"], "wordsA": ["On", "July", "11,", "2012,", "we", "issued", "$125.0", "million", "of", "senior", "secured", "notes", "maturing", "on", "July", "15,", "2017."], "wordsB": ["Also,", "as", "of", "December", "31,", "2015,", "we", "had", "$255.8", "million", "in", "debt,", "including", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "and", "$5.8", "million", "of", "capital", "lease", "obligations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p36_s2", "idA": "906709_15_item7_p36_s4", "sentA": "On July 11, 2012, we issued $125.0 million of senior secured notes maturing on July 15, 2017.", "sentB": "Also, as of December 31, 2015, we had $255.8 million in debt, including $250.0 million in principal of senior secured notes and $5.8 million of capital lease obligations.", "type": 2, "words": ["<tag1>", "On", "July", "11,", "2012,", "we", "issued", "$125.0", "million", "of", "senior", "secured", "notes", "maturing", "on", "July", "15,", "2017.", "<tag2>", "Also,", "as", "of", "December", "31,", "2015,", "we", "had", "$255.8", "million", "in", "debt,", "including", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "and", "$5.8", "million", "of", "capital", "lease", "obligations.", "<tag3>"], "wordsA": ["On", "July", "11,", "2012,", "we", "issued", "$125.0", "million", "of", "senior", "secured", "notes", "maturing", "on", "July", "15,", "2017."], "wordsB": ["Also,", "as", "of", "December", "31,", "2015,", "we", "had", "$255.8", "million", "in", "debt,", "including", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "and", "$5.8", "million", "of", "capital", "lease", "obligations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p39_s3", "idA": "906709_15_item7_p36_s6", "sentA": "In connection with this transaction, we retired the principal amount of $42.5 million of our $215.0 million in aggregate principal amount of convertible subordinated notes in exchange for $42.5 million in principal amount of the senior secured notes.", "sentB": "In connection with the issuance of the Notes, we paid fees and expenses of approximately $8.9 million, of which $8.3 million of transaction and facility fees paid to the purchasers of the Notes was capitalized as a debt discount and recorded as a reduction to the note payable liability.", "type": 2, "words": ["<tag1>", "In", "connection", "with", "this", "transaction,", "we", "retired", "the", "principal", "amount", "of", "$42.5", "million", "of", "our", "$215.0", "million", "in", "aggregate", "principal", "amount", "of", "convertible", "subordinated", "notes", "in", "exchange", "for", "$42.5", "million", "in", "principal", "amount", "of", "the", "senior", "secured", "notes.", "<tag2>", "In", "connection", "with", "the", "issuance", "of", "the", "Notes,", "we", "paid", "fees", "and", "expenses", "of", "approximately", "$8.9", "million,", "of", "which", "$8.3", "million", "of", "transaction", "and", "facility", "fees", "paid", "to", "the", "purchasers", "of", "the", "Notes", "was", "capitalized", "as", "a", "debt", "discount", "and", "recorded", "as", "a", "reduction", "to", "the", "note", "payable", "liability.", "<tag3>"], "wordsA": ["In", "connection", "with", "this", "transaction,", "we", "retired", "the", "principal", "amount", "of", "$42.5", "million", "of", "our", "$215.0", "million", "in", "aggregate", "principal", "amount", "of", "convertible", "subordinated", "notes", "in", "exchange", "for", "$42.5", "million", "in", "principal", "amount", "of", "the", "senior", "secured", "notes."], "wordsB": ["In", "connection", "with", "the", "issuance", "of", "the", "Notes,", "we", "paid", "fees", "and", "expenses", "of", "approximately", "$8.9", "million,", "of", "which", "$8.3", "million", "of", "transaction", "and", "facility", "fees", "paid", "to", "the", "purchasers", "of", "the", "Notes", "was", "capitalized", "as", "a", "debt", "discount", "and", "recorded", "as", "a", "reduction", "to", "the", "note", "payable", "liability."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p38_s17", "idA": "906709_15_item7_p36_s7", "sentA": "In addition, $25.0 million of the proceeds from the senior secured notes issuance is required to be maintained in a restricted account until July 1, 2015.", "sentB": "Restricted cash of $25.0 million was required to be maintained in a separate account until July 1, 2015 under the terms of our 12% senior secured notes due July 2017.", "type": 2, "words": ["<tag1>", "In", "addition,", "$25.0", "million", "of", "the", "proceeds", "from", "the", "senior", "secured", "notes", "issuance", "is", "required", "to", "be", "maintained", "in", "a", "restricted", "account", "until", "July", "1,", "2015.", "<tag2>", "Restricted", "cash", "of", "$25.0", "million", "was", "required", "to", "be", "maintained", "in", "a", "separate", "account", "until", "July", "1,", "2015", "under", "the", "terms", "of", "our", "12%", "senior", "secured", "notes", "due", "July", "2017.", "<tag3>"], "wordsA": ["In", "addition,", "$25.0", "million", "of", "the", "proceeds", "from", "the", "senior", "secured", "notes", "issuance", "is", "required", "to", "be", "maintained", "in", "a", "restricted", "account", "until", "July", "1,", "2015."], "wordsB": ["Restricted", "cash", "of", "$25.0", "million", "was", "required", "to", "be", "maintained", "in", "a", "separate", "account", "until", "July", "1,", "2015", "under", "the", "terms", "of", "our", "12%", "senior", "secured", "notes", "due", "July", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p38_s18", "idA": "906709_15_item7_p36_s7", "sentA": "In addition, $25.0 million of the proceeds from the senior secured notes issuance is required to be maintained in a restricted account until July 1, 2015.", "sentB": "This restriction expired on July 1, 2015 and the restricted funds were returned to us.", "type": 2, "words": ["<tag1>", "In", "addition,", "$25.0", "million", "of", "the", "proceeds", "from", "the", "senior", "secured", "notes", "issuance", "is", "required", "to", "be", "maintained", "in", "a", "restricted", "account", "until", "July", "1,", "2015.", "<tag2>", "This", "restriction", "expired", "on", "July", "1,", "2015", "and", "the", "restricted", "funds", "were", "returned", "to", "us.", "<tag3>"], "wordsA": ["In", "addition,", "$25.0", "million", "of", "the", "proceeds", "from", "the", "senior", "secured", "notes", "issuance", "is", "required", "to", "be", "maintained", "in", "a", "restricted", "account", "until", "July", "1,", "2015."], "wordsB": ["This", "restriction", "expired", "on", "July", "1,", "2015", "and", "the", "restricted", "funds", "were", "returned", "to", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p40_s5", "idA": "906709_15_item7_p36_s9", "sentA": "We received proceeds from issuance of common stock related to our employee option and stock purchase plans of $47.0 million, $8.2 million, and $4.1 million in the years ended December 31, 2014, 2013, and 2012, respectively.", "sentB": "We received proceeds from issuance of common stock related to our employee option and stock purchase plans of $32.2 million, $47.0 million, and $8.2 million in the years ended December 31, 2015, 2014, and 2013, respectively.", "type": 2, "words": ["<tag1>", "We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$47.0", "million,", "$8.2", "million,", "and", "$4.1", "million", "in", "the", "years", "ended", "December", "31,", "2014,", "2013,", "and", "2012,", "respectively.", "<tag2>", "We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$32.2", "million,", "$47.0", "million,", "and", "$8.2", "million", "in", "the", "years", "ended", "December", "31,", "2015,", "2014,", "and", "2013,", "respectively.", "<tag3>"], "wordsA": ["We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$47.0", "million,", "$8.2", "million,", "and", "$4.1", "million", "in", "the", "years", "ended", "December", "31,", "2014,", "2013,", "and", "2012,", "respectively."], "wordsB": ["We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$32.2", "million,", "$47.0", "million,", "and", "$8.2", "million", "in", "the", "years", "ended", "December", "31,", "2015,", "2014,", "and", "2013,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p41_s0", "idA": "906709_15_item7_p37_s0", "sentA": "(1) The above table does not include certain commitments and contingencies which are discussed in Note 8 of Item 8.", "sentB": "The above table does not include certain commitments and contingencies which are discussed in Note 8 of Item 8.", "type": 2, "words": ["<tag1>", "(1)", "The", "above", "table", "does", "not", "include", "certain", "commitments", "and", "contingencies", "which", "are", "discussed", "in", "Note", "8", "of", "Item", "8.", "<tag2>", "The", "above", "table", "does", "not", "include", "certain", "commitments", "and", "contingencies", "which", "are", "discussed", "in", "Note", "8", "of", "Item", "8.", "<tag3>"], "wordsA": ["(1)", "The", "above", "table", "does", "not", "include", "certain", "commitments", "and", "contingencies", "which", "are", "discussed", "in", "Note", "8", "of", "Item", "8."], "wordsB": ["The", "above", "table", "does", "not", "include", "certain", "commitments", "and", "contingencies", "which", "are", "discussed", "in", "Note", "8", "of", "Item", "8."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p43_s1", "idA": "906709_15_item7_p39_s0", "sentA": "(3) These amounts primarily result from capital lease obligations arising from our office space lease at 201 Industrial Road in San Carlos, California.", "sentB": "In addition, these amounts include capital lease obligations arising from our office space lease at 201 Industrial Road in San Carlos, California.", "type": 2, "words": ["<tag1>", "(3)", "These", "amounts", "primarily", "result", "from", "capital", "lease", "obligations", "arising", "from", "our", "office", "space", "lease", "at", "201", "Industrial", "Road", "in", "San", "Carlos,", "California.", "<tag2>", "In", "addition,", "these", "amounts", "include", "capital", "lease", "obligations", "arising", "from", "our", "office", "space", "lease", "at", "201", "Industrial", "Road", "in", "San", "Carlos,", "California.", "<tag3>"], "wordsA": ["(3)", "These", "amounts", "primarily", "result", "from", "capital", "lease", "obligations", "arising", "from", "our", "office", "space", "lease", "at", "201", "Industrial", "Road", "in", "San", "Carlos,", "California."], "wordsB": ["In", "addition,", "these", "amounts", "include", "capital", "lease", "obligations", "arising", "from", "our", "office", "space", "lease", "at", "201", "Industrial", "Road", "in", "San", "Carlos,", "California."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p43_s0", "idA": "906709_15_item7_p39_s4", "sentA": "In addition, these amounts include our obligation to purchase manufacturing equipment supporting our Amikacin Inhale program, which is further discussed in Note 4 of Item 8.", "sentB": "These amounts primarily result from our purchase of manufacturing equipment supporting our Amikacin Inhale program, including our obligation to purchase certain equipment which is further discussed in Note 4 of Item 8.", "type": 2, "words": ["<tag1>", "In", "addition,", "these", "amounts", "include", "our", "obligation", "to", "purchase", "manufacturing", "equipment", "supporting", "our", "Amikacin", "Inhale", "program,", "which", "is", "further", "discussed", "in", "Note", "4", "of", "Item", "8.", "<tag2>", "These", "amounts", "primarily", "result", "from", "our", "purchase", "of", "manufacturing", "equipment", "supporting", "our", "Amikacin", "Inhale", "program,", "including", "our", "obligation", "to", "purchase", "certain", "equipment", "which", "is", "further", "discussed", "in", "Note", "4", "of", "Item", "8.", "<tag3>"], "wordsA": ["In", "addition,", "these", "amounts", "include", "our", "obligation", "to", "purchase", "manufacturing", "equipment", "supporting", "our", "Amikacin", "Inhale", "program,", "which", "is", "further", "discussed", "in", "Note", "4", "of", "Item", "8."], "wordsB": ["These", "amounts", "primarily", "result", "from", "our", "purchase", "of", "manufacturing", "equipment", "supporting", "our", "Amikacin", "Inhale", "program,", "including", "our", "obligation", "to", "purchase", "certain", "equipment", "which", "is", "further", "discussed", "in", "Note", "4", "of", "Item", "8."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p44_s0", "idA": "906709_15_item7_p40_s0", "sentA": "(4) Substantially all of this amount was subject to open purchase orders as of December 31, 2014 that were issued under existing contracts.", "sentB": "Substantially all of this amount was subject to open purchase orders as of December 31, 2015 that were issued under existing contracts.", "type": 2, "words": ["<tag1>", "(4)", "Substantially", "all", "of", "this", "amount", "was", "subject", "to", "open", "purchase", "orders", "as", "of", "December", "31,", "2014", "that", "were", "issued", "under", "existing", "contracts.", "<tag2>", "Substantially", "all", "of", "this", "amount", "was", "subject", "to", "open", "purchase", "orders", "as", "of", "December", "31,", "2015", "that", "were", "issued", "under", "existing", "contracts.", "<tag3>"], "wordsA": ["(4)", "Substantially", "all", "of", "this", "amount", "was", "subject", "to", "open", "purchase", "orders", "as", "of", "December", "31,", "2014", "that", "were", "issued", "under", "existing", "contracts."], "wordsB": ["Substantially", "all", "of", "this", "amount", "was", "subject", "to", "open", "purchase", "orders", "as", "of", "December", "31,", "2015", "that", "were", "issued", "under", "existing", "contracts."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p2_s6", "idA": "906709_15_item7_p46_s1", "sentA": "For these, the shortest reasonable period is the end of the development period (estimated to be 4 to 8 years) and the longest period is the contractual life of the agreement, which is generally 10-12 years from the first commercial sale.", "sentB": "In August 2015, we received an additional $40.0 million payment triggered by the first commercial sale of MOVENTIG by AstraZeneca in Germany.", "type": 2, "words": ["<tag1>", "For", "these,", "the", "shortest", "reasonable", "period", "is", "the", "end", "of", "the", "development", "period", "(estimated", "to", "be", "4", "to", "8", "years)", "and", "the", "longest", "period", "is", "the", "contractual", "life", "of", "the", "agreement,", "which", "is", "generally", "10-12", "years", "from", "the", "first", "commercial", "sale.", "<tag2>", "In", "August", "2015,", "we", "received", "an", "additional", "$40.0", "million", "payment", "triggered", "by", "the", "first", "commercial", "sale", "of", "MOVENTIG", "by", "AstraZeneca", "in", "Germany.", "<tag3>"], "wordsA": ["For", "these,", "the", "shortest", "reasonable", "period", "is", "the", "end", "of", "the", "development", "period", "(estimated", "to", "be", "4", "to", "8", "years)", "and", "the", "longest", "period", "is", "the", "contractual", "life", "of", "the", "agreement,", "which", "is", "generally", "10-12", "years", "from", "the", "first", "commercial", "sale."], "wordsB": ["In", "August", "2015,", "we", "received", "an", "additional", "$40.0", "million", "payment", "triggered", "by", "the", "first", "commercial", "sale", "of", "MOVENTIG", "by", "AstraZeneca", "in", "Germany."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p51_s1", "idA": "906709_15_item7_p48_s0", "sentA": "If we had determined a longer or shorter amortization period was appropriate, our annual upfront fee amortization for these agreements could be as low as $2.0 million or as high as $11.0 million as compared to the $2.1 million recognized in the year ended December 31, 2014.", "sentB": "If we had determined a longer or shorter amortization period was appropriate, our annual upfront fee amortization for these agreements could have been as low as $2.0 million or as high as $11.0 million as compared to the approximately $2.0 million recognized in the year ended December 31, 2015.", "type": 2, "words": ["<tag1>", "If", "we", "had", "determined", "a", "longer", "or", "shorter", "amortization", "period", "was", "appropriate,", "our", "annual", "upfront", "fee", "amortization", "for", "these", "agreements", "could", "be", "as", "low", "as", "$2.0", "million", "or", "as", "high", "as", "$11.0", "million", "as", "compared", "to", "the", "$2.1", "million", "recognized", "in", "the", "year", "ended", "December", "31,", "2014.", "<tag2>", "If", "we", "had", "determined", "a", "longer", "or", "shorter", "amortization", "period", "was", "appropriate,", "our", "annual", "upfront", "fee", "amortization", "for", "these", "agreements", "could", "have", "been", "as", "low", "as", "$2.0", "million", "or", "as", "high", "as", "$11.0", "million", "as", "compared", "to", "the", "approximately", "$2.0", "million", "recognized", "in", "the", "year", "ended", "December", "31,", "2015.", "<tag3>"], "wordsA": ["If", "we", "had", "determined", "a", "longer", "or", "shorter", "amortization", "period", "was", "appropriate,", "our", "annual", "upfront", "fee", "amortization", "for", "these", "agreements", "could", "be", "as", "low", "as", "$2.0", "million", "or", "as", "high", "as", "$11.0", "million", "as", "compared", "to", "the", "$2.1", "million", "recognized", "in", "the", "year", "ended", "December", "31,", "2014."], "wordsB": ["If", "we", "had", "determined", "a", "longer", "or", "shorter", "amortization", "period", "was", "appropriate,", "our", "annual", "upfront", "fee", "amortization", "for", "these", "agreements", "could", "have", "been", "as", "low", "as", "$2.0", "million", "or", "as", "high", "as", "$11.0", "million", "as", "compared", "to", "the", "approximately", "$2.0", "million", "recognized", "in", "the", "year", "ended", "December", "31,", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p51_s2", "idA": "906709_15_item7_p48_s1", "sentA": "As of December 31, 2014, we also had $78.4 million of deferred upfront fees related to seven license, manufacturing and supply agreements that are being amortized over periods from 3 to 14 years.", "sentB": "As of December 31, 2015, we also had $58.6 million of deferred upfront fees related to seven license, manufacturing and supply agreements that are being amortized over periods from 3 to 15 years.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2014,", "we", "also", "had", "$78.4", "million", "of", "deferred", "upfront", "fees", "related", "to", "seven", "license,", "manufacturing", "and", "supply", "agreements", "that", "are", "being", "amortized", "over", "periods", "from", "3", "to", "14", "years.", "<tag2>", "As", "of", "December", "31,", "2015,", "we", "also", "had", "$58.6", "million", "of", "deferred", "upfront", "fees", "related", "to", "seven", "license,", "manufacturing", "and", "supply", "agreements", "that", "are", "being", "amortized", "over", "periods", "from", "3", "to", "15", "years.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2014,", "we", "also", "had", "$78.4", "million", "of", "deferred", "upfront", "fees", "related", "to", "seven", "license,", "manufacturing", "and", "supply", "agreements", "that", "are", "being", "amortized", "over", "periods", "from", "3", "to", "14", "years."], "wordsB": ["As", "of", "December", "31,", "2015,", "we", "also", "had", "$58.6", "million", "of", "deferred", "upfront", "fees", "related", "to", "seven", "license,", "manufacturing", "and", "supply", "agreements", "that", "are", "being", "amortized", "over", "periods", "from", "3", "to", "15", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p57_s0", "idA": "906709_15_item7_p55_s0", "sentA": "In addition, for awards that vest upon the achievement of performance milestones, we estimate the vesting period based on our evaluation of the probability of achievement of each respective milestone and the related estimated date of achievement.", "sentB": "In addition, for awards that vest upon the achievement of performance milestones, we estimate whether the awards will vest and the vesting period based on our evaluation of the probability of achievement of each respective milestone and the related estimated date of achievement.", "type": 2, "words": ["<tag1>", "In", "addition,", "for", "awards", "that", "vest", "upon", "the", "achievement", "of", "performance", "milestones,", "we", "estimate", "the", "vesting", "period", "based", "on", "our", "evaluation", "of", "the", "probability", "of", "achievement", "of", "each", "respective", "milestone", "and", "the", "related", "estimated", "date", "of", "achievement.", "<tag2>", "In", "addition,", "for", "awards", "that", "vest", "upon", "the", "achievement", "of", "performance", "milestones,", "we", "estimate", "whether", "the", "awards", "will", "vest", "and", "the", "vesting", "period", "based", "on", "our", "evaluation", "of", "the", "probability", "of", "achievement", "of", "each", "respective", "milestone", "and", "the", "related", "estimated", "date", "of", "achievement.", "<tag3>"], "wordsA": ["In", "addition,", "for", "awards", "that", "vest", "upon", "the", "achievement", "of", "performance", "milestones,", "we", "estimate", "the", "vesting", "period", "based", "on", "our", "evaluation", "of", "the", "probability", "of", "achievement", "of", "each", "respective", "milestone", "and", "the", "related", "estimated", "date", "of", "achievement."], "wordsB": ["In", "addition,", "for", "awards", "that", "vest", "upon", "the", "achievement", "of", "performance", "milestones,", "we", "estimate", "whether", "the", "awards", "will", "vest", "and", "the", "vesting", "period", "based", "on", "our", "evaluation", "of", "the", "probability", "of", "achievement", "of", "each", "respective", "milestone", "and", "the", "related", "estimated", "date", "of", "achievement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p11_s5", "idA": "906709_15_item7_p56_s2", "sentA": "As a result, we impute interest on the transaction and record interest expense at the estimated interest rate.", "sentB": "As a result, we received $100.3 million in net proceeds in connection with these transactions.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "we", "impute", "interest", "on", "the", "transaction", "and", "record", "interest", "expense", "at", "the", "estimated", "interest", "rate.", "<tag2>", "As", "a", "result,", "we", "received", "$100.3", "million", "in", "net", "proceeds", "in", "connection", "with", "these", "transactions.", "<tag3>"], "wordsA": ["As", "a", "result,", "we", "impute", "interest", "on", "the", "transaction", "and", "record", "interest", "expense", "at", "the", "estimated", "interest", "rate."], "wordsB": ["As", "a", "result,", "we", "received", "$100.3", "million", "in", "net", "proceeds", "in", "connection", "with", "these", "transactions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p36_s5", "idA": "906709_15_item7_p56_s2", "sentA": "As a result, we impute interest on the transaction and record interest expense at the estimated interest rate.", "sentB": "As a result, we received $100.3 million in net proceeds in connection with these transactions.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "we", "impute", "interest", "on", "the", "transaction", "and", "record", "interest", "expense", "at", "the", "estimated", "interest", "rate.", "<tag2>", "As", "a", "result,", "we", "received", "$100.3", "million", "in", "net", "proceeds", "in", "connection", "with", "these", "transactions.", "<tag3>"], "wordsA": ["As", "a", "result,", "we", "impute", "interest", "on", "the", "transaction", "and", "record", "interest", "expense", "at", "the", "estimated", "interest", "rate."], "wordsB": ["As", "a", "result,", "we", "received", "$100.3", "million", "in", "net", "proceeds", "in", "connection", "with", "these", "transactions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p59_s3", "idA": "906709_15_item7_p57_s3", "sentA": "If we had determined that the interest rate used in 2014 should have been one percentage point higher than our current estimate of 17%, the non-cash interest expense recognized in the year ended December 31, 2014 would have increased by $1.3 million.", "sentB": "If we had determined that the interest rate used in 2015 should have been one percentage point higher than our current estimate of 17%, the non-cash interest expense recognized in the year ended December 31, 2015 would have increased by $1.3 million.", "type": 2, "words": ["<tag1>", "If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2014", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2014", "would", "have", "increased", "by", "$1.3", "million.", "<tag2>", "If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2015", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2015", "would", "have", "increased", "by", "$1.3", "million.", "<tag3>"], "wordsA": ["If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2014", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2014", "would", "have", "increased", "by", "$1.3", "million."], "wordsB": ["If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2015", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2015", "would", "have", "increased", "by", "$1.3", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p60_s0", "idA": "906709_15_item7_p58_s0", "sentA": "In May 2014, the Financial Accounting Standards Board (FASB) issued guidance codified in ASC 606, Revenue Recognition Revenue from Contracts with Customers , which amends the guidance in former ASC 605, Revenue Recognition, and is effective for public companies for fiscal years beginning after December 15, 2016.", "sentB": "Recent Accounting Pronouncemen ts In May 2014, the Financial Accounting Standards Board (FASB) issued guidance codified in Accounting Standards Codification (ASC) 606, Revenue Recognition Revenue from Contracts with Customers , which amends the guidance in former ASC 605, Revenue Recognition , and is effective for public companies for fiscal years beginning after December 15, 2017.", "type": 2, "words": ["<tag1>", "In", "May", "2014,", "the", "Financial", "Accounting", "Standards", "Board", "(FASB)", "issued", "guidance", "codified", "in", "ASC", "606,", "Revenue", "Recognition", "Revenue", "from", "Contracts", "with", "Customers", ",", "which", "amends", "the", "guidance", "in", "former", "ASC", "605,", "Revenue", "Recognition,", "and", "is", "effective", "for", "public", "companies", "for", "fiscal", "years", "beginning", "after", "December", "15,", "2016.", "<tag2>", "Recent", "Accounting", "Pronouncemen", "ts", "In", "May", "2014,", "the", "Financial", "Accounting", "Standards", "Board", "(FASB)", "issued", "guidance", "codified", "in", "Accounting", "Standards", "Codification", "(ASC)", "606,", "Revenue", "Recognition", "Revenue", "from", "Contracts", "with", "Customers", ",", "which", "amends", "the", "guidance", "in", "former", "ASC", "605,", "Revenue", "Recognition", ",", "and", "is", "effective", "for", "public", "companies", "for", "fiscal", "years", "beginning", "after", "December", "15,", "2017.", "<tag3>"], "wordsA": ["In", "May", "2014,", "the", "Financial", "Accounting", "Standards", "Board", "(FASB)", "issued", "guidance", "codified", "in", "ASC", "606,", "Revenue", "Recognition", "Revenue", "from", "Contracts", "with", "Customers", ",", "which", "amends", "the", "guidance", "in", "former", "ASC", "605,", "Revenue", "Recognition,", "and", "is", "effective", "for", "public", "companies", "for", "fiscal", "years", "beginning", "after", "December", "15,", "2016."], "wordsB": ["Recent", "Accounting", "Pronouncemen", "ts", "In", "May", "2014,", "the", "Financial", "Accounting", "Standards", "Board", "(FASB)", "issued", "guidance", "codified", "in", "Accounting", "Standards", "Codification", "(ASC)", "606,", "Revenue", "Recognition", "Revenue", "from", "Contracts", "with", "Customers", ",", "which", "amends", "the", "guidance", "in", "former", "ASC", "605,", "Revenue", "Recognition", ",", "and", "is", "effective", "for", "public", "companies", "for", "fiscal", "years", "beginning", "after", "December", "15,", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p9_s14", "idA": "906709_15_item7_p58_s1", "sentA": "We are currently evaluating the impact of the provisions of ASC 606.", "sentB": "We are currently evaluating next steps and potential designs and costs for a confirmatory trial.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "evaluating", "the", "impact", "of", "the", "provisions", "of", "ASC", "606.", "<tag2>", "We", "are", "currently", "evaluating", "next", "steps", "and", "potential", "designs", "and", "costs", "for", "a", "confirmatory", "trial.", "<tag3>"], "wordsA": ["We", "are", "currently", "evaluating", "the", "impact", "of", "the", "provisions", "of", "ASC", "606."], "wordsB": ["We", "are", "currently", "evaluating", "next", "steps", "and", "potential", "designs", "and", "costs", "for", "a", "confirmatory", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p9_s7", "idA": "906709_15_item7_p58_s1", "sentA": "We are currently evaluating the impact of the provisions of ASC 606.", "sentB": "We are currently exploring various future regulatory and development paths forward for NKTR-102 with the EU and U.S. regulatory authorities.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "evaluating", "the", "impact", "of", "the", "provisions", "of", "ASC", "606.", "<tag2>", "We", "are", "currently", "exploring", "various", "future", "regulatory", "and", "development", "paths", "forward", "for", "NKTR-102", "with", "the", "EU", "and", "U.S.", "regulatory", "authorities.", "<tag3>"], "wordsA": ["We", "are", "currently", "evaluating", "the", "impact", "of", "the", "provisions", "of", "ASC", "606."], "wordsB": ["We", "are", "currently", "exploring", "various", "future", "regulatory", "and", "development", "paths", "forward", "for", "NKTR-102", "with", "the", "EU", "and", "U.S.", "regulatory", "authorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p62_s0", "idA": "906709_15_item7_p59_s0", "sentA": "In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Disclosure of Uncertainties about an Entity s Ability to Continue as a Going Concern (ASU 2014-15).", "sentB": "In April 2015, the FASB issued guidance to simplify the presentation of debt issuance costs by requiring debt issuance costs to be presented as a deduction from the corresponding debt liability.", "type": 2, "words": ["<tag1>", "In", "August", "2014,", "the", "FASB", "issued", "Accounting", "Standards", "Update", "No.", "2014-15,", "Disclosure", "of", "Uncertainties", "about", "an", "Entity", "s", "Ability", "to", "Continue", "as", "a", "Going", "Concern", "(ASU", "2014-15).", "<tag2>", "In", "April", "2015,", "the", "FASB", "issued", "guidance", "to", "simplify", "the", "presentation", "of", "debt", "issuance", "costs", "by", "requiring", "debt", "issuance", "costs", "to", "be", "presented", "as", "a", "deduction", "from", "the", "corresponding", "debt", "liability.", "<tag3>"], "wordsA": ["In", "August", "2014,", "the", "FASB", "issued", "Accounting", "Standards", "Update", "No.", "2014-15,", "Disclosure", "of", "Uncertainties", "about", "an", "Entity", "s", "Ability", "to", "Continue", "as", "a", "Going", "Concern", "(ASU", "2014-15)."], "wordsB": ["In", "April", "2015,", "the", "FASB", "issued", "guidance", "to", "simplify", "the", "presentation", "of", "debt", "issuance", "costs", "by", "requiring", "debt", "issuance", "costs", "to", "be", "presented", "as", "a", "deduction", "from", "the", "corresponding", "debt", "liability."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p62_s1", "idA": "906709_15_item7_p59_s2", "sentA": "ASU 2014-15 is effective in 2016 with early adoption permitted.", "sentB": "This guidance is effective for our interim and annual periods beginning January 1, 2016 and early adoption is permitted.", "type": 2, "words": ["<tag1>", "ASU", "2014-15", "is", "effective", "in", "2016", "with", "early", "adoption", "permitted.", "<tag2>", "This", "guidance", "is", "effective", "for", "our", "interim", "and", "annual", "periods", "beginning", "January", "1,", "2016", "and", "early", "adoption", "is", "permitted.", "<tag3>"], "wordsA": ["ASU", "2014-15", "is", "effective", "in", "2016", "with", "early", "adoption", "permitted."], "wordsB": ["This", "guidance", "is", "effective", "for", "our", "interim", "and", "annual", "periods", "beginning", "January", "1,", "2016", "and", "early", "adoption", "is", "permitted."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p62_s3", "idA": "906709_15_item7_p59_s3", "sentA": "We do not believe the impact of adopting ASU 2014-15 on our consolidated financial statements will be significant.", "sentB": "We do not believe the adoption of this guidance will have a material impact on our consolidated financial statements.", "type": 2, "words": ["<tag1>", "We", "do", "not", "believe", "the", "impact", "of", "adopting", "ASU", "2014-15", "on", "our", "consolidated", "financial", "statements", "will", "be", "significant.", "<tag2>", "We", "do", "not", "believe", "the", "adoption", "of", "this", "guidance", "will", "have", "a", "material", "impact", "on", "our", "consolidated", "financial", "statements.", "<tag3>"], "wordsA": ["We", "do", "not", "believe", "the", "impact", "of", "adopting", "ASU", "2014-15", "on", "our", "consolidated", "financial", "statements", "will", "be", "significant."], "wordsB": ["We", "do", "not", "believe", "the", "adoption", "of", "this", "guidance", "will", "have", "a", "material", "impact", "on", "our", "consolidated", "financial", "statements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p2_s5", "idA": "906709_15_item7_p5_s0", "sentA": "AstraZeneca is planning the commercial launch of MOVANTIK in the United States late in the first quarter of 2015 and MOVENTIG in the second half of 2015.", "sentB": "On March 31, 2015, AstraZeneca announced that it launched MOVANTIK TM in the United States, as a result of which we received a $100 million commercial launch milestone on March 31, 2015.", "type": 2, "words": ["<tag1>", "AstraZeneca", "is", "planning", "the", "commercial", "launch", "of", "MOVANTIK", "in", "the", "United", "States", "late", "in", "the", "first", "quarter", "of", "2015", "and", "MOVENTIG", "in", "the", "second", "half", "of", "2015.", "<tag2>", "On", "March", "31,", "2015,", "AstraZeneca", "announced", "that", "it", "launched", "MOVANTIK", "TM", "in", "the", "United", "States,", "as", "a", "result", "of", "which", "we", "received", "a", "$100", "million", "commercial", "launch", "milestone", "on", "March", "31,", "2015.", "<tag3>"], "wordsA": ["AstraZeneca", "is", "planning", "the", "commercial", "launch", "of", "MOVANTIK", "in", "the", "United", "States", "late", "in", "the", "first", "quarter", "of", "2015", "and", "MOVENTIG", "in", "the", "second", "half", "of", "2015."], "wordsB": ["On", "March", "31,", "2015,", "AstraZeneca", "announced", "that", "it", "launched", "MOVANTIK", "TM", "in", "the", "United", "States,", "as", "a", "result", "of", "which", "we", "received", "a", "$100", "million", "commercial", "launch", "milestone", "on", "March", "31,", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p2_s7", "idA": "906709_15_item7_p5_s1", "sentA": "Given the significant milestones and royalty opportunity for us associated with MOVANTIK under our AstraZeneca license agreement, the level of sales achieved by AstraZeneca for MOVANTIK will have a significant impact on our operating results and financial condition over the coming years.", "sentB": "Given the significant sales milestone and royalty opportunity for us associated with MOVANTIK TM under our AstraZeneca license agreement, the level of sales achieved by AstraZeneca for MOVANTIK TM will have a significant impact on our operating results and financial condition over the coming years.", "type": 2, "words": ["<tag1>", "Given", "the", "significant", "milestones", "and", "royalty", "opportunity", "for", "us", "associated", "with", "MOVANTIK", "under", "our", "AstraZeneca", "license", "agreement,", "the", "level", "of", "sales", "achieved", "by", "AstraZeneca", "for", "MOVANTIK", "will", "have", "a", "significant", "impact", "on", "our", "operating", "results", "and", "financial", "condition", "over", "the", "coming", "years.", "<tag2>", "Given", "the", "significant", "sales", "milestone", "and", "royalty", "opportunity", "for", "us", "associated", "with", "MOVANTIK", "TM", "under", "our", "AstraZeneca", "license", "agreement,", "the", "level", "of", "sales", "achieved", "by", "AstraZeneca", "for", "MOVANTIK", "TM", "will", "have", "a", "significant", "impact", "on", "our", "operating", "results", "and", "financial", "condition", "over", "the", "coming", "years.", "<tag3>"], "wordsA": ["Given", "the", "significant", "milestones", "and", "royalty", "opportunity", "for", "us", "associated", "with", "MOVANTIK", "under", "our", "AstraZeneca", "license", "agreement,", "the", "level", "of", "sales", "achieved", "by", "AstraZeneca", "for", "MOVANTIK", "will", "have", "a", "significant", "impact", "on", "our", "operating", "results", "and", "financial", "condition", "over", "the", "coming", "years."], "wordsB": ["Given", "the", "significant", "sales", "milestone", "and", "royalty", "opportunity", "for", "us", "associated", "with", "MOVANTIK", "TM", "under", "our", "AstraZeneca", "license", "agreement,", "the", "level", "of", "sales", "achieved", "by", "AstraZeneca", "for", "MOVANTIK", "TM", "will", "have", "a", "significant", "impact", "on", "our", "operating", "results", "and", "financial", "condition", "over", "the", "coming", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p4_s1", "idA": "906709_15_item7_p5_s1", "sentA": "Given the significant milestones and royalty opportunity for us associated with MOVANTIK under our AstraZeneca license agreement, the level of sales achieved by AstraZeneca for MOVANTIK will have a significant impact on our operating results and financial condition over the coming years.", "sentB": "The level of sales achieved by Baxalta for ADYNOVATE TM and our related royalties will be important to our operating results and financial condition over the coming years.", "type": 2, "words": ["<tag1>", "Given", "the", "significant", "milestones", "and", "royalty", "opportunity", "for", "us", "associated", "with", "MOVANTIK", "under", "our", "AstraZeneca", "license", "agreement,", "the", "level", "of", "sales", "achieved", "by", "AstraZeneca", "for", "MOVANTIK", "will", "have", "a", "significant", "impact", "on", "our", "operating", "results", "and", "financial", "condition", "over", "the", "coming", "years.", "<tag2>", "The", "level", "of", "sales", "achieved", "by", "Baxalta", "for", "ADYNOVATE", "TM", "and", "our", "related", "royalties", "will", "be", "important", "to", "our", "operating", "results", "and", "financial", "condition", "over", "the", "coming", "years.", "<tag3>"], "wordsA": ["Given", "the", "significant", "milestones", "and", "royalty", "opportunity", "for", "us", "associated", "with", "MOVANTIK", "under", "our", "AstraZeneca", "license", "agreement,", "the", "level", "of", "sales", "achieved", "by", "AstraZeneca", "for", "MOVANTIK", "will", "have", "a", "significant", "impact", "on", "our", "operating", "results", "and", "financial", "condition", "over", "the", "coming", "years."], "wordsB": ["The", "level", "of", "sales", "achieved", "by", "Baxalta", "for", "ADYNOVATE", "TM", "and", "our", "related", "royalties", "will", "be", "important", "to", "our", "operating", "results", "and", "financial", "condition", "over", "the", "coming", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p9_s0", "idA": "906709_15_item7_p6_s0", "sentA": "Etirinotecan pegol (also known as NKTR-102), is a next-generation topoisomerase I (topo I) inhibitor proprietary drug candidate, currently being evaluated in a Phase 3 open-label, randomized, multicenter clinical study as a single-agent therapy for women with metastatic breast cancer.", "sentB": "NKTR-102 is our next-generation topoisomerase I inhibitor proprietary drug candidate.", "type": 2, "words": ["<tag1>", "Etirinotecan", "pegol", "(also", "known", "as", "NKTR-102),", "is", "a", "next-generation", "topoisomerase", "I", "(topo", "I)", "inhibitor", "proprietary", "drug", "candidate,", "currently", "being", "evaluated", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "as", "a", "single-agent", "therapy", "for", "women", "with", "metastatic", "breast", "cancer.", "<tag2>", "NKTR-102", "is", "our", "next-generation", "topoisomerase", "I", "inhibitor", "proprietary", "drug", "candidate.", "<tag3>"], "wordsA": ["Etirinotecan", "pegol", "(also", "known", "as", "NKTR-102),", "is", "a", "next-generation", "topoisomerase", "I", "(topo", "I)", "inhibitor", "proprietary", "drug", "candidate,", "currently", "being", "evaluated", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "as", "a", "single-agent", "therapy", "for", "women", "with", "metastatic", "breast", "cancer."], "wordsB": ["NKTR-102", "is", "our", "next-generation", "topoisomerase", "I", "inhibitor", "proprietary", "drug", "candidate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p9_s10", "idA": "906709_15_item7_p6_s0", "sentA": "Etirinotecan pegol (also known as NKTR-102), is a next-generation topoisomerase I (topo I) inhibitor proprietary drug candidate, currently being evaluated in a Phase 3 open-label, randomized, multicenter clinical study as a single-agent therapy for women with metastatic breast cancer.", "sentB": "Based on the outcome of these meetings, we believe that there is a path forward to file an MAA for conditional approval of NKTR-102 for patients with metastatic breast cancer with brain metastases.", "type": 2, "words": ["<tag1>", "Etirinotecan", "pegol", "(also", "known", "as", "NKTR-102),", "is", "a", "next-generation", "topoisomerase", "I", "(topo", "I)", "inhibitor", "proprietary", "drug", "candidate,", "currently", "being", "evaluated", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "as", "a", "single-agent", "therapy", "for", "women", "with", "metastatic", "breast", "cancer.", "<tag2>", "Based", "on", "the", "outcome", "of", "these", "meetings,", "we", "believe", "that", "there", "is", "a", "path", "forward", "to", "file", "an", "MAA", "for", "conditional", "approval", "of", "NKTR-102", "for", "patients", "with", "metastatic", "breast", "cancer", "with", "brain", "metastases.", "<tag3>"], "wordsA": ["Etirinotecan", "pegol", "(also", "known", "as", "NKTR-102),", "is", "a", "next-generation", "topoisomerase", "I", "(topo", "I)", "inhibitor", "proprietary", "drug", "candidate,", "currently", "being", "evaluated", "in", "a", "Phase", "3", "open-label,", "randomized,", "multicenter", "clinical", "study", "as", "a", "single-agent", "therapy", "for", "women", "with", "metastatic", "breast", "cancer."], "wordsB": ["Based", "on", "the", "outcome", "of", "these", "meetings,", "we", "believe", "that", "there", "is", "a", "path", "forward", "to", "file", "an", "MAA", "for", "conditional", "approval", "of", "NKTR-102", "for", "patients", "with", "metastatic", "breast", "cancer", "with", "brain", "metastases."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p9_s1", "idA": "906709_15_item7_p6_s1", "sentA": "This Phase 3 clinical study, which we call the BEACON study (BrEAst Cancer Outcomes with NKTR-102), has completed enrollment of approximately 850 women with locally recurrent or metastatic breast cancer who have had prior treatment with anthracycline, taxane and capecitabine in either the adjuvant or metastatic setting.", "sentB": "On March 17, 2015, we announced topline data from a Phase 3 clinical study for NKTR-102, which we call the BEACON study (BrEAst Cancer Outcomes with NKTR-102), as a single-agent therapy for women with advanced metastatic breast cancer.", "type": 2, "words": ["<tag1>", "This", "Phase", "3", "clinical", "study,", "which", "we", "call", "the", "BEACON", "study", "(BrEAst", "Cancer", "Outcomes", "with", "NKTR-102),", "has", "completed", "enrollment", "of", "approximately", "850", "women", "with", "locally", "recurrent", "or", "metastatic", "breast", "cancer", "who", "have", "had", "prior", "treatment", "with", "anthracycline,", "taxane", "and", "capecitabine", "in", "either", "the", "adjuvant", "or", "metastatic", "setting.", "<tag2>", "On", "March", "17,", "2015,", "we", "announced", "topline", "data", "from", "a", "Phase", "3", "clinical", "study", "for", "NKTR-102,", "which", "we", "call", "the", "BEACON", "study", "(BrEAst", "Cancer", "Outcomes", "with", "NKTR-102),", "as", "a", "single-agent", "therapy", "for", "women", "with", "advanced", "metastatic", "breast", "cancer.", "<tag3>"], "wordsA": ["This", "Phase", "3", "clinical", "study,", "which", "we", "call", "the", "BEACON", "study", "(BrEAst", "Cancer", "Outcomes", "with", "NKTR-102),", "has", "completed", "enrollment", "of", "approximately", "850", "women", "with", "locally", "recurrent", "or", "metastatic", "breast", "cancer", "who", "have", "had", "prior", "treatment", "with", "anthracycline,", "taxane", "and", "capecitabine", "in", "either", "the", "adjuvant", "or", "metastatic", "setting."], "wordsB": ["On", "March", "17,", "2015,", "we", "announced", "topline", "data", "from", "a", "Phase", "3", "clinical", "study", "for", "NKTR-102,", "which", "we", "call", "the", "BEACON", "study", "(BrEAst", "Cancer", "Outcomes", "with", "NKTR-102),", "as", "a", "single-agent", "therapy", "for", "women", "with", "advanced", "metastatic", "breast", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p9_s2", "idA": "906709_15_item7_p6_s2", "sentA": "Patients in the BEACON study were randomized on a 1:1 basis to receive either single-agent etirinotecan pegol or a single agent of physician s choice.", "sentB": "The BEACON study compared NKTR-102 to an active control arm comprised of a single chemotherapy agent of physician s choice (TPC) in patients who were heavily pre-treated with a median of three prior therapies for metastatic disease.", "type": 2, "words": ["<tag1>", "Patients", "in", "the", "BEACON", "study", "were", "randomized", "on", "a", "1:1", "basis", "to", "receive", "either", "single-agent", "etirinotecan", "pegol", "or", "a", "single", "agent", "of", "physician", "s", "choice.", "<tag2>", "The", "BEACON", "study", "compared", "NKTR-102", "to", "an", "active", "control", "arm", "comprised", "of", "a", "single", "chemotherapy", "agent", "of", "physician", "s", "choice", "(TPC)", "in", "patients", "who", "were", "heavily", "pre-treated", "with", "a", "median", "of", "three", "prior", "therapies", "for", "metastatic", "disease.", "<tag3>"], "wordsA": ["Patients", "in", "the", "BEACON", "study", "were", "randomized", "on", "a", "1:1", "basis", "to", "receive", "either", "single-agent", "etirinotecan", "pegol", "or", "a", "single", "agent", "of", "physician", "s", "choice."], "wordsB": ["The", "BEACON", "study", "compared", "NKTR-102", "to", "an", "active", "control", "arm", "comprised", "of", "a", "single", "chemotherapy", "agent", "of", "physician", "s", "choice", "(TPC)", "in", "patients", "who", "were", "heavily", "pre-treated", "with", "a", "median", "of", "three", "prior", "therapies", "for", "metastatic", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p8_s1", "idA": "906709_15_item7_p6_s3", "sentA": "The primary endpoint of the BEACON study is overall survival, and secondary endpoints include progression-free survival and objective tumor response rate.", "sentB": "In addition to a determination of the recommended Phase 2 dose, the study will assess preliminary anti-tumor activity, includi ng objective response rate .", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "of", "the", "BEACON", "study", "is", "overall", "survival,", "and", "secondary", "endpoints", "include", "progression-free", "survival", "and", "objective", "tumor", "response", "rate.", "<tag2>", "In", "addition", "to", "a", "determination", "of", "the", "recommended", "Phase", "2", "dose,", "the", "study", "will", "assess", "preliminary", "anti-tumor", "activity,", "includi", "ng", "objective", "response", "rate", ".", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "of", "the", "BEACON", "study", "is", "overall", "survival,", "and", "secondary", "endpoints", "include", "progression-free", "survival", "and", "objective", "tumor", "response", "rate."], "wordsB": ["In", "addition", "to", "a", "determination", "of", "the", "recommended", "Phase", "2", "dose,", "the", "study", "will", "assess", "preliminary", "anti-tumor", "activity,", "includi", "ng", "objective", "response", "rate", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p9_s5", "idA": "906709_15_item7_p6_s3", "sentA": "The primary endpoint of the BEACON study is overall survival, and secondary endpoints include progression-free survival and objective tumor response rate.", "sentB": "Secondary endpoints in the BEACON study included objective response rate and progression-free survival, which did not achieve statistical significance in the study.", "type": 2, "words": ["<tag1>", "The", "primary", "endpoint", "of", "the", "BEACON", "study", "is", "overall", "survival,", "and", "secondary", "endpoints", "include", "progression-free", "survival", "and", "objective", "tumor", "response", "rate.", "<tag2>", "Secondary", "endpoints", "in", "the", "BEACON", "study", "included", "objective", "response", "rate", "and", "progression-free", "survival,", "which", "did", "not", "achieve", "statistical", "significance", "in", "the", "study.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "of", "the", "BEACON", "study", "is", "overall", "survival,", "and", "secondary", "endpoints", "include", "progression-free", "survival", "and", "objective", "tumor", "response", "rate."], "wordsB": ["Secondary", "endpoints", "in", "the", "BEACON", "study", "included", "objective", "response", "rate", "and", "progression-free", "survival,", "which", "did", "not", "achieve", "statistical", "significance", "in", "the", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p5_s0", "idA": "906709_15_item7_p7_s0", "sentA": "NKTR-181 is a novel mu-opioid analgesic drug candidate for chronic pain conditions.", "sentB": "NKTR-181 is a novel mu-opioid analgesic drug candidate for chronic pain conditions and is currently in Phase 3 clinical development.", "type": 2, "words": ["<tag1>", "NKTR-181", "is", "a", "novel", "mu-opioid", "analgesic", "drug", "candidate", "for", "chronic", "pain", "conditions.", "<tag2>", "NKTR-181", "is", "a", "novel", "mu-opioid", "analgesic", "drug", "candidate", "for", "chronic", "pain", "conditions", "and", "is", "currently", "in", "Phase", "3", "clinical", "development.", "<tag3>"], "wordsA": ["NKTR-181", "is", "a", "novel", "mu-opioid", "analgesic", "drug", "candidate", "for", "chronic", "pain", "conditions."], "wordsB": ["NKTR-181", "is", "a", "novel", "mu-opioid", "analgesic", "drug", "candidate", "for", "chronic", "pain", "conditions", "and", "is", "currently", "in", "Phase", "3", "clinical", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p6_s0", "idA": "906709_15_item7_p8_s10", "sentA": "The study design also includes a single interim analysis for sample size reassessment which will be conducted by an independent data monitoring committee.", "sentB": "The NKTR-181 Phase 3 study design includes a single interim sample size assessment to be conducted by an independent analysis center (IAC) after approximately fifty percent of the initially planned 416 patients completed the study.", "type": 2, "words": ["<tag1>", "The", "study", "design", "also", "includes", "a", "single", "interim", "analysis", "for", "sample", "size", "reassessment", "which", "will", "be", "conducted", "by", "an", "independent", "data", "monitoring", "committee.", "<tag2>", "The", "NKTR-181", "Phase", "3", "study", "design", "includes", "a", "single", "interim", "sample", "size", "assessment", "to", "be", "conducted", "by", "an", "independent", "analysis", "center", "(IAC)", "after", "approximately", "fifty", "percent", "of", "the", "initially", "planned", "416", "patients", "completed", "the", "study.", "<tag3>"], "wordsA": ["The", "study", "design", "also", "includes", "a", "single", "interim", "analysis", "for", "sample", "size", "reassessment", "which", "will", "be", "conducted", "by", "an", "independent", "data", "monitoring", "committee."], "wordsB": ["The", "NKTR-181", "Phase", "3", "study", "design", "includes", "a", "single", "interim", "sample", "size", "assessment", "to", "be", "conducted", "by", "an", "independent", "analysis", "center", "(IAC)", "after", "approximately", "fifty", "percent", "of", "the", "initially", "planned", "416", "patients", "completed", "the", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p8_s0", "idA": "906709_15_item7_p8_s5", "sentA": "This lack of a placebo rebound in the maintenance phase of the trial caused the Phase 2 study to miss the primary endpoint.", "sentB": "The dose-escalation stage of the Phase 1/2 study is designed to evaluate safety, efficacy, and define the recommended Phase 2 dose of NKTR-214 in approximately 20 patients with solid tumors.", "type": 2, "words": ["<tag1>", "This", "lack", "of", "a", "placebo", "rebound", "in", "the", "maintenance", "phase", "of", "the", "trial", "caused", "the", "Phase", "2", "study", "to", "miss", "the", "primary", "endpoint.", "<tag2>", "The", "dose-escalation", "stage", "of", "the", "Phase", "1/2", "study", "is", "designed", "to", "evaluate", "safety,", "efficacy,", "and", "define", "the", "recommended", "Phase", "2", "dose", "of", "NKTR-214", "in", "approximately", "20", "patients", "with", "solid", "tumors.", "<tag3>"], "wordsA": ["This", "lack", "of", "a", "placebo", "rebound", "in", "the", "maintenance", "phase", "of", "the", "trial", "caused", "the", "Phase", "2", "study", "to", "miss", "the", "primary", "endpoint."], "wordsB": ["The", "dose-escalation", "stage", "of", "the", "Phase", "1/2", "study", "is", "designed", "to", "evaluate", "safety,", "efficacy,", "and", "define", "the", "recommended", "Phase", "2", "dose", "of", "NKTR-214", "in", "approximately", "20", "patients", "with", "solid", "tumors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p9_s4", "idA": "906709_15_item7_p8_s5", "sentA": "This lack of a placebo rebound in the maintenance phase of the trial caused the Phase 2 study to miss the primary endpoint.", "sentB": "Based on a stratified log-rank analysis, the primary endpoint measuring the Hazard Ratio (HR) for survival in the NKTR-102 group compared to the active control arm was 0.87 with a p-value of 0.08, which did not achieve statistical significance.", "type": 2, "words": ["<tag1>", "This", "lack", "of", "a", "placebo", "rebound", "in", "the", "maintenance", "phase", "of", "the", "trial", "caused", "the", "Phase", "2", "study", "to", "miss", "the", "primary", "endpoint.", "<tag2>", "Based", "on", "a", "stratified", "log-rank", "analysis,", "the", "primary", "endpoint", "measuring", "the", "Hazard", "Ratio", "(HR)", "for", "survival", "in", "the", "NKTR-102", "group", "compared", "to", "the", "active", "control", "arm", "was", "0.87", "with", "a", "p-value", "of", "0.08,", "which", "did", "not", "achieve", "statistical", "significance.", "<tag3>"], "wordsA": ["This", "lack", "of", "a", "placebo", "rebound", "in", "the", "maintenance", "phase", "of", "the", "trial", "caused", "the", "Phase", "2", "study", "to", "miss", "the", "primary", "endpoint."], "wordsB": ["Based", "on", "a", "stratified", "log-rank", "analysis,", "the", "primary", "endpoint", "measuring", "the", "Hazard", "Ratio", "(HR)", "for", "survival", "in", "the", "NKTR-102", "group", "compared", "to", "the", "active", "control", "arm", "was", "0.87", "with", "a", "p-value", "of", "0.08,", "which", "did", "not", "achieve", "statistical", "significance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p5_s1", "idA": "906709_15_item7_p8_s8", "sentA": "We enrolled the first patient in this first Phase 3 study on February 24, 2015.", "sentB": "We enrolled the first patient in the first Phase 3 efficacy study in February 2015 and the study continues to enroll patients.", "type": 2, "words": ["<tag1>", "We", "enrolled", "the", "first", "patient", "in", "this", "first", "Phase", "3", "study", "on", "February", "24,", "2015.", "<tag2>", "We", "enrolled", "the", "first", "patient", "in", "the", "first", "Phase", "3", "efficacy", "study", "in", "February", "2015", "and", "the", "study", "continues", "to", "enroll", "patients.", "<tag3>"], "wordsA": ["We", "enrolled", "the", "first", "patient", "in", "this", "first", "Phase", "3", "study", "on", "February", "24,", "2015."], "wordsB": ["We", "enrolled", "the", "first", "patient", "in", "the", "first", "Phase", "3", "efficacy", "study", "in", "February", "2015", "and", "the", "study", "continues", "to", "enroll", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p5_s2", "idA": "906709_15_item7_p8_s9", "sentA": "In this first efficacy study, we plan to enroll approximately 416 patients in an enriched enrollment randomized withdrawal design which will include a qualifying screening period, an open-label titration period where NKTR-181 is given to all patients, followed by a 12 week double-blind randomized period where subjects will be randomized on a 1:1 basis to receive either NKTR-181 or placebo.", "sentB": "In this study, we are randomizing patients with chronic low back pain in an enriched enrollment randomized withdrawal design which will include a qualifying screening period, an open-label titration period where NKTR-181 is given to all patients, followed by a 12 week double-blind randomized period where subjects will be randomized on a 1:1 basis to receive either NKTR-181 or placebo.", "type": 2, "words": ["<tag1>", "In", "this", "first", "efficacy", "study,", "we", "plan", "to", "enroll", "approximately", "416", "patients", "in", "an", "enriched", "enrollment", "randomized", "withdrawal", "design", "which", "will", "include", "a", "qualifying", "screening", "period,", "an", "open-label", "titration", "period", "where", "NKTR-181", "is", "given", "to", "all", "patients,", "followed", "by", "a", "12", "week", "double-blind", "randomized", "period", "where", "subjects", "will", "be", "randomized", "on", "a", "1:1", "basis", "to", "receive", "either", "NKTR-181", "or", "placebo.", "<tag2>", "In", "this", "study,", "we", "are", "randomizing", "patients", "with", "chronic", "low", "back", "pain", "in", "an", "enriched", "enrollment", "randomized", "withdrawal", "design", "which", "will", "include", "a", "qualifying", "screening", "period,", "an", "open-label", "titration", "period", "where", "NKTR-181", "is", "given", "to", "all", "patients,", "followed", "by", "a", "12", "week", "double-blind", "randomized", "period", "where", "subjects", "will", "be", "randomized", "on", "a", "1:1", "basis", "to", "receive", "either", "NKTR-181", "or", "placebo.", "<tag3>"], "wordsA": ["In", "this", "first", "efficacy", "study,", "we", "plan", "to", "enroll", "approximately", "416", "patients", "in", "an", "enriched", "enrollment", "randomized", "withdrawal", "design", "which", "will", "include", "a", "qualifying", "screening", "period,", "an", "open-label", "titration", "period", "where", "NKTR-181", "is", "given", "to", "all", "patients,", "followed", "by", "a", "12", "week", "double-blind", "randomized", "period", "where", "subjects", "will", "be", "randomized", "on", "a", "1:1", "basis", "to", "receive", "either", "NKTR-181", "or", "placebo."], "wordsB": ["In", "this", "study,", "we", "are", "randomizing", "patients", "with", "chronic", "low", "back", "pain", "in", "an", "enriched", "enrollment", "randomized", "withdrawal", "design", "which", "will", "include", "a", "qualifying", "screening", "period,", "an", "open-label", "titration", "period", "where", "NKTR-181", "is", "given", "to", "all", "patients,", "followed", "by", "a", "12", "week", "double-blind", "randomized", "period", "where", "subjects", "will", "be", "randomized", "on", "a", "1:1", "basis", "to", "receive", "either", "NKTR-181", "or", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_16_item7_p3_s0", "idA": "906709_15_item7_p9_s1", "sentA": "We have a collaboration with Baxter Healthcare (Baxter), to identify and develop PEGylated drug candidates with the objective of providing new long-acting therapies for hemophilia patients.", "sentB": "We have a collaboration with Baxalta to identify and develop PEGylated drug candidates with the objective of providing new long-acting therapies for hemophilia patients.", "type": 2, "words": ["<tag1>", "We", "have", "a", "collaboration", "with", "Baxter", "Healthcare", "(Baxter),", "to", "identify", "and", "develop", "PEGylated", "drug", "candidates", "with", "the", "objective", "of", "providing", "new", "long-acting", "therapies", "for", "hemophilia", "patients.", "<tag2>", "We", "have", "a", "collaboration", "with", "Baxalta", "to", "identify", "and", "develop", "PEGylated", "drug", "candidates", "with", "the", "objective", "of", "providing", "new", "long-acting", "therapies", "for", "hemophilia", "patients.", "<tag3>"], "wordsA": ["We", "have", "a", "collaboration", "with", "Baxter", "Healthcare", "(Baxter),", "to", "identify", "and", "develop", "PEGylated", "drug", "candidates", "with", "the", "objective", "of", "providing", "new", "long-acting", "therapies", "for", "hemophilia", "patients."], "wordsB": ["We", "have", "a", "collaboration", "with", "Baxalta", "to", "identify", "and", "develop", "PEGylated", "drug", "candidates", "with", "the", "objective", "of", "providing", "new", "long-acting", "therapies", "for", "hemophilia", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p0_s3", "idA": "906709_16_item7_p0_s0", "sentA": "We are a biopharmaceutical company developing a pipeline of drug candidates that utilize our PEGylation and advanced polymer conjugate technology platforms, which are designed to enable the development of new molecular entities that target known mechanisms of action.", "sentB": "These drug candidates utilize our advanced polymer conjugate technology platforms, which are designed to enable the development of new molecular entities that target known mechanisms of action.", "type": 2, "words": ["<tag1>", "We", "are", "a", "biopharmaceutical", "company", "developing", "a", "pipeline", "of", "drug", "candidates", "that", "utilize", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "technology", "platforms,", "which", "are", "designed", "to", "enable", "the", "development", "of", "new", "molecular", "entities", "that", "target", "known", "mechanisms", "of", "action.", "<tag2>", "These", "drug", "candidates", "utilize", "our", "advanced", "polymer", "conjugate", "technology", "platforms,", "which", "are", "designed", "to", "enable", "the", "development", "of", "new", "molecular", "entities", "that", "target", "known", "mechanisms", "of", "action.", "<tag3>"], "wordsA": ["We", "are", "a", "biopharmaceutical", "company", "developing", "a", "pipeline", "of", "drug", "candidates", "that", "utilize", "our", "PEGylation", "and", "advanced", "polymer", "conjugate", "technology", "platforms,", "which", "are", "designed", "to", "enable", "the", "development", "of", "new", "molecular", "entities", "that", "target", "known", "mechanisms", "of", "action."], "wordsB": ["These", "drug", "candidates", "utilize", "our", "advanced", "polymer", "conjugate", "technology", "platforms,", "which", "are", "designed", "to", "enable", "the", "development", "of", "new", "molecular", "entities", "that", "target", "known", "mechanisms", "of", "action."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p0_s1", "idA": "906709_16_item7_p0_s2", "sentA": "Our research and development activities involve small molecule drugs, peptides and protein biologic drug candidates.", "sentB": "Our research and development pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and chronic pain.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "protein", "biologic", "drug", "candidates.", "<tag2>", "Our", "research", "and", "development", "pipeline", "of", "new", "investigational", "drugs", "includes", "treatments", "for", "cancer,", "auto-immune", "disease", "and", "chronic", "pain.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "activities", "involve", "small", "molecule", "drugs,", "peptides", "and", "protein", "biologic", "drug", "candidates."], "wordsB": ["Our", "research", "and", "development", "pipeline", "of", "new", "investigational", "drugs", "includes", "treatments", "for", "cancer,", "auto-immune", "disease", "and", "chronic", "pain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p2_s0", "idA": "906709_16_item7_p10_s0", "sentA": "Historically, we have entered into a number of license and supply contracts under which we manufactured and supplied our proprietary PEGylation reagents on a fixed price or cost-plus basis.", "sentB": "Historically, we have entered into a number of license and supply contracts under which we manufactured and supplied our proprietary polymer reagents on a fixed price or cost-plus basis.", "type": 2, "words": ["<tag1>", "Historically,", "we", "have", "entered", "into", "a", "number", "of", "license", "and", "supply", "contracts", "under", "which", "we", "manufactured", "and", "supplied", "our", "proprietary", "PEGylation", "reagents", "on", "a", "fixed", "price", "or", "cost-plus", "basis.", "<tag2>", "Historically,", "we", "have", "entered", "into", "a", "number", "of", "license", "and", "supply", "contracts", "under", "which", "we", "manufactured", "and", "supplied", "our", "proprietary", "polymer", "reagents", "on", "a", "fixed", "price", "or", "cost-plus", "basis.", "<tag3>"], "wordsA": ["Historically,", "we", "have", "entered", "into", "a", "number", "of", "license", "and", "supply", "contracts", "under", "which", "we", "manufactured", "and", "supplied", "our", "proprietary", "PEGylation", "reagents", "on", "a", "fixed", "price", "or", "cost-plus", "basis."], "wordsB": ["Historically,", "we", "have", "entered", "into", "a", "number", "of", "license", "and", "supply", "contracts", "under", "which", "we", "manufactured", "and", "supplied", "our", "proprietary", "polymer", "reagents", "on", "a", "fixed", "price", "or", "cost-plus", "basis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p2_s1", "idA": "906709_16_item7_p10_s1", "sentA": "Our current strategy is to manufacture and supply PEGylation reagents to support our proprietary drug candidates or our third-party collaborators where we have a strategic development and commercialization relationship or where we derive substantial economic benefit.", "sentB": "Our current strategy is to manufacture and supply polymer reagents to support our proprietary drug candidates or our third-party collaborators where we have a strategic development and commercialization relationship or where we derive substantial economic benefit.", "type": 2, "words": ["<tag1>", "Our", "current", "strategy", "is", "to", "manufacture", "and", "supply", "PEGylation", "reagents", "to", "support", "our", "proprietary", "drug", "candidates", "or", "our", "third-party", "collaborators", "where", "we", "have", "a", "strategic", "development", "and", "commercialization", "relationship", "or", "where", "we", "derive", "substantial", "economic", "benefit.", "<tag2>", "Our", "current", "strategy", "is", "to", "manufacture", "and", "supply", "polymer", "reagents", "to", "support", "our", "proprietary", "drug", "candidates", "or", "our", "third-party", "collaborators", "where", "we", "have", "a", "strategic", "development", "and", "commercialization", "relationship", "or", "where", "we", "derive", "substantial", "economic", "benefit.", "<tag3>"], "wordsA": ["Our", "current", "strategy", "is", "to", "manufacture", "and", "supply", "PEGylation", "reagents", "to", "support", "our", "proprietary", "drug", "candidates", "or", "our", "third-party", "collaborators", "where", "we", "have", "a", "strategic", "development", "and", "commercialization", "relationship", "or", "where", "we", "derive", "substantial", "economic", "benefit."], "wordsB": ["Our", "current", "strategy", "is", "to", "manufacture", "and", "supply", "polymer", "reagents", "to", "support", "our", "proprietary", "drug", "candidates", "or", "our", "third-party", "collaborators", "where", "we", "have", "a", "strategic", "development", "and", "commercialization", "relationship", "or", "where", "we", "derive", "substantial", "economic", "benefit."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p29_s4", "idA": "906709_16_item7_p11_s0", "sentA": "Key Developments and Trends in Liquidity and Capital Resources As of December 31, 2015, we estimated that we had at least twelve months of working capital to fund our current business plans.", "sentB": "We estimate that we have working capital to fund our current business plans at least through March 1, 2018.", "type": 2, "words": ["<tag1>", "Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "As", "of", "December", "31,", "2015,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans.", "<tag2>", "We", "estimate", "that", "we", "have", "working", "capital", "to", "fund", "our", "current", "business", "plans", "at", "least", "through", "March", "1,", "2018.", "<tag3>"], "wordsA": ["Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "As", "of", "December", "31,", "2015,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans."], "wordsB": ["We", "estimate", "that", "we", "have", "working", "capital", "to", "fund", "our", "current", "business", "plans", "at", "least", "through", "March", "1,", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p2_s2", "idA": "906709_16_item7_p11_s0", "sentA": "Key Developments and Trends in Liquidity and Capital Resources As of December 31, 2015, we estimated that we had at least twelve months of working capital to fund our current business plans.", "sentB": "Key Developments and Trends in Liquidity and Capital Resources We estimate that we have working capital to fund our current business plans through at least March 1, 2018.", "type": 2, "words": ["<tag1>", "Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "As", "of", "December", "31,", "2015,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans.", "<tag2>", "Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "We", "estimate", "that", "we", "have", "working", "capital", "to", "fund", "our", "current", "business", "plans", "through", "at", "least", "March", "1,", "2018.", "<tag3>"], "wordsA": ["Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "As", "of", "December", "31,", "2015,", "we", "estimated", "that", "we", "had", "at", "least", "twelve", "months", "of", "working", "capital", "to", "fund", "our", "current", "business", "plans."], "wordsB": ["Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "We", "estimate", "that", "we", "have", "working", "capital", "to", "fund", "our", "current", "business", "plans", "through", "at", "least", "March", "1,", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p29_s3", "idA": "906709_16_item7_p11_s3", "sentA": "As is further described in Note 5 to our Consolidated Financial Statements, on October 5, 2015, we issued $250.0 million in aggregate principal amount of 7.75% senior secured notes due October 2020.", "sentB": "As described in Note 9 to our Consolidated Financial Statements, on October 24, 2016, we completed a public offering of common stock with net proceeds of approximately $189.3 million.", "type": 2, "words": ["<tag1>", "As", "is", "further", "described", "in", "Note", "5", "to", "our", "Consolidated", "Financial", "Statements,", "on", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "October", "2020.", "<tag2>", "As", "described", "in", "Note", "9", "to", "our", "Consolidated", "Financial", "Statements,", "on", "October", "24,", "2016,", "we", "completed", "a", "public", "offering", "of", "common", "stock", "with", "net", "proceeds", "of", "approximately", "$189.3", "million.", "<tag3>"], "wordsA": ["As", "is", "further", "described", "in", "Note", "5", "to", "our", "Consolidated", "Financial", "Statements,", "on", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "October", "2020."], "wordsB": ["As", "described", "in", "Note", "9", "to", "our", "Consolidated", "Financial", "Statements,", "on", "October", "24,", "2016,", "we", "completed", "a", "public", "offering", "of", "common", "stock", "with", "net", "proceeds", "of", "approximately", "$189.3", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p0_s12", "idA": "906709_16_item7_p14_s0", "sentA": "Product sales Product sales include predominantly fixed price manufacturing and supply agreements with our collaboration partners and result from the receipt of firm purchase orders from those partners.", "sentB": "We have significant milestone and royalty economic interests in approved drugs and drug candidates in late stage development with our collaboration partners.", "type": 2, "words": ["<tag1>", "Product", "sales", "Product", "sales", "include", "predominantly", "fixed", "price", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners", "and", "result", "from", "the", "receipt", "of", "firm", "purchase", "orders", "from", "those", "partners.", "<tag2>", "We", "have", "significant", "milestone", "and", "royalty", "economic", "interests", "in", "approved", "drugs", "and", "drug", "candidates", "in", "late", "stage", "development", "with", "our", "collaboration", "partners.", "<tag3>"], "wordsA": ["Product", "sales", "Product", "sales", "include", "predominantly", "fixed", "price", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners", "and", "result", "from", "the", "receipt", "of", "firm", "purchase", "orders", "from", "those", "partners."], "wordsB": ["We", "have", "significant", "milestone", "and", "royalty", "economic", "interests", "in", "approved", "drugs", "and", "drug", "candidates", "in", "late", "stage", "development", "with", "our", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p5_s0", "idA": "906709_16_item7_p14_s0", "sentA": "Product sales Product sales include predominantly fixed price manufacturing and supply agreements with our collaboration partners and result from the receipt of firm purchase orders from those partners.", "sentB": "Product sales Product sales include predominantly fixed price manufacturing and supply agreements with our collaboration partners and are the result of firm purchase orders from those partners.", "type": 2, "words": ["<tag1>", "Product", "sales", "Product", "sales", "include", "predominantly", "fixed", "price", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners", "and", "result", "from", "the", "receipt", "of", "firm", "purchase", "orders", "from", "those", "partners.", "<tag2>", "Product", "sales", "Product", "sales", "include", "predominantly", "fixed", "price", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners", "and", "are", "the", "result", "of", "firm", "purchase", "orders", "from", "those", "partners.", "<tag3>"], "wordsA": ["Product", "sales", "Product", "sales", "include", "predominantly", "fixed", "price", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners", "and", "result", "from", "the", "receipt", "of", "firm", "purchase", "orders", "from", "those", "partners."], "wordsB": ["Product", "sales", "Product", "sales", "include", "predominantly", "fixed", "price", "manufacturing", "and", "supply", "agreements", "with", "our", "collaboration", "partners", "and", "are", "the", "result", "of", "firm", "purchase", "orders", "from", "those", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p5_s2", "idA": "906709_16_item7_p14_s2", "sentA": "Product sales increased for the year ended December 31, 2015 compared to the year ended December 31, 2014 as a result of increased product demand primarily from one of our collaboration partners.", "sentB": "Product sales increased for the years ended December 31, 2016 and 2015 compared to the years ended December 31, 2015 and 2014 primarily as a result of increased product demand from our collaboration partner Ophthotech related to its drug candidate Fovista .", "type": 2, "words": ["<tag1>", "Product", "sales", "increased", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "as", "a", "result", "of", "increased", "product", "demand", "primarily", "from", "one", "of", "our", "collaboration", "partners.", "<tag2>", "Product", "sales", "increased", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014", "primarily", "as", "a", "result", "of", "increased", "product", "demand", "from", "our", "collaboration", "partner", "Ophthotech", "related", "to", "its", "drug", "candidate", "Fovista", ".", "<tag3>"], "wordsA": ["Product", "sales", "increased", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "as", "a", "result", "of", "increased", "product", "demand", "primarily", "from", "one", "of", "our", "collaboration", "partners."], "wordsB": ["Product", "sales", "increased", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014", "primarily", "as", "a", "result", "of", "increased", "product", "demand", "from", "our", "collaboration", "partner", "Ophthotech", "related", "to", "its", "drug", "candidate", "Fovista", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p53_s1", "idA": "906709_16_item7_p14_s3", "sentA": "Product sales decreased for the year ended December 31, 2014 compared to the year ended December 31, 2013 primarily as a result of decreased product demand from a number of our collaboration partners.", "sentB": "Numerous updates have been issued subsequent to the initial FASB guidance that provide clarification on a number of specific issues as well as requiring additional disclosures.", "type": 2, "words": ["<tag1>", "Product", "sales", "decreased", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "as", "a", "result", "of", "decreased", "product", "demand", "from", "a", "number", "of", "our", "collaboration", "partners.", "<tag2>", "Numerous", "updates", "have", "been", "issued", "subsequent", "to", "the", "initial", "FASB", "guidance", "that", "provide", "clarification", "on", "a", "number", "of", "specific", "issues", "as", "well", "as", "requiring", "additional", "disclosures.", "<tag3>"], "wordsA": ["Product", "sales", "decreased", "for", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "as", "a", "result", "of", "decreased", "product", "demand", "from", "a", "number", "of", "our", "collaboration", "partners."], "wordsB": ["Numerous", "updates", "have", "been", "issued", "subsequent", "to", "the", "initial", "FASB", "guidance", "that", "provide", "clarification", "on", "a", "number", "of", "specific", "issues", "as", "well", "as", "requiring", "additional", "disclosures."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p13_s3", "idA": "906709_16_item7_p14_s4", "sentA": "We currently expect product sales to increase in 2016 as compared to 2015 due to increased product demand primarily from one of our collaboration partners.", "sentB": "In particular, the increased demand from our collaboration partners in 2016 and 2015 results in product sales where we have a relatively higher gross margin.", "type": 2, "words": ["<tag1>", "We", "currently", "expect", "product", "sales", "to", "increase", "in", "2016", "as", "compared", "to", "2015", "due", "to", "increased", "product", "demand", "primarily", "from", "one", "of", "our", "collaboration", "partners.", "<tag2>", "In", "particular,", "the", "increased", "demand", "from", "our", "collaboration", "partners", "in", "2016", "and", "2015", "results", "in", "product", "sales", "where", "we", "have", "a", "relatively", "higher", "gross", "margin.", "<tag3>"], "wordsA": ["We", "currently", "expect", "product", "sales", "to", "increase", "in", "2016", "as", "compared", "to", "2015", "due", "to", "increased", "product", "demand", "primarily", "from", "one", "of", "our", "collaboration", "partners."], "wordsB": ["In", "particular,", "the", "increased", "demand", "from", "our", "collaboration", "partners", "in", "2016", "and", "2015", "results", "in", "product", "sales", "where", "we", "have", "a", "relatively", "higher", "gross", "margin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p7_s0", "idA": "906709_16_item7_p15_s0", "sentA": "We receive royalty revenue from certain of our collaboration partners based on their net sales of commercial products.", "sentB": "Royalty revenue We receive royalty revenue from certain of our collaboration partners based on their net sales of commercial products.", "type": 2, "words": ["<tag1>", "We", "receive", "royalty", "revenue", "from", "certain", "of", "our", "collaboration", "partners", "based", "on", "their", "net", "sales", "of", "commercial", "products.", "<tag2>", "Royalty", "revenue", "We", "receive", "royalty", "revenue", "from", "certain", "of", "our", "collaboration", "partners", "based", "on", "their", "net", "sales", "of", "commercial", "products.", "<tag3>"], "wordsA": ["We", "receive", "royalty", "revenue", "from", "certain", "of", "our", "collaboration", "partners", "based", "on", "their", "net", "sales", "of", "commercial", "products."], "wordsB": ["Royalty", "revenue", "We", "receive", "royalty", "revenue", "from", "certain", "of", "our", "collaboration", "partners", "based", "on", "their", "net", "sales", "of", "commercial", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p7_s1", "idA": "906709_16_item7_p15_s1", "sentA": "Royalty revenue received in cash increased for the year ended December 31, 2015 compared to the year ended December 31, 2014 due primarily to the launch of commercial sales by AstraZeneca of MOVANTIK TM in March 2015 and MOVENTIG in the EU in August 2015.", "sentB": "Royalty revenue received in cash increased for the years ended December 31, 2016 and 2015 compared to the years ended December 31, 2015 and 2014 due primarily to the commercial launch by AstraZeneca of MOVANTIK in the U.S. in March 2015 and MOVENTIG in the EU in August 2015 and the launch of ADYNOVATE by Baxalta in the U.S. in November 2015.", "type": 2, "words": ["<tag1>", "Royalty", "revenue", "received", "in", "cash", "increased", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "due", "primarily", "to", "the", "launch", "of", "commercial", "sales", "by", "AstraZeneca", "of", "MOVANTIK", "TM", "in", "March", "2015", "and", "MOVENTIG", "in", "the", "EU", "in", "August", "2015.", "<tag2>", "Royalty", "revenue", "received", "in", "cash", "increased", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014", "due", "primarily", "to", "the", "commercial", "launch", "by", "AstraZeneca", "of", "MOVANTIK", "in", "the", "U.S.", "in", "March", "2015", "and", "MOVENTIG", "in", "the", "EU", "in", "August", "2015", "and", "the", "launch", "of", "ADYNOVATE", "by", "Baxalta", "in", "the", "U.S.", "in", "November", "2015.", "<tag3>"], "wordsA": ["Royalty", "revenue", "received", "in", "cash", "increased", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "due", "primarily", "to", "the", "launch", "of", "commercial", "sales", "by", "AstraZeneca", "of", "MOVANTIK", "TM", "in", "March", "2015", "and", "MOVENTIG", "in", "the", "EU", "in", "August", "2015."], "wordsB": ["Royalty", "revenue", "received", "in", "cash", "increased", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014", "due", "primarily", "to", "the", "commercial", "launch", "by", "AstraZeneca", "of", "MOVANTIK", "in", "the", "U.S.", "in", "March", "2015", "and", "MOVENTIG", "in", "the", "EU", "in", "August", "2015", "and", "the", "launch", "of", "ADYNOVATE", "by", "Baxalta", "in", "the", "U.S.", "in", "November", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p7_s2", "idA": "906709_16_item7_p15_s3", "sentA": "We expect royalty revenue in 2016 will increase as compared to 2015 due to royalties we expect to receive from net sales of MOVANTIK TM , MOVENTIG and ADYNOVATE TM .", "sentB": "We expect royalty revenue in 2017 will increase as compared to 2016 due to royalties we expect to receive from net sales of MOVANTIK , MOVENTIG and ADYNOVATE as a result of sales growth of these partnered products.", "type": 2, "words": ["<tag1>", "We", "expect", "royalty", "revenue", "in", "2016", "will", "increase", "as", "compared", "to", "2015", "due", "to", "royalties", "we", "expect", "to", "receive", "from", "net", "sales", "of", "MOVANTIK", "TM", ",", "MOVENTIG", "and", "ADYNOVATE", "TM", ".", "<tag2>", "We", "expect", "royalty", "revenue", "in", "2017", "will", "increase", "as", "compared", "to", "2016", "due", "to", "royalties", "we", "expect", "to", "receive", "from", "net", "sales", "of", "MOVANTIK", ",", "MOVENTIG", "and", "ADYNOVATE", "as", "a", "result", "of", "sales", "growth", "of", "these", "partnered", "products.", "<tag3>"], "wordsA": ["We", "expect", "royalty", "revenue", "in", "2016", "will", "increase", "as", "compared", "to", "2015", "due", "to", "royalties", "we", "expect", "to", "receive", "from", "net", "sales", "of", "MOVANTIK", "TM", ",", "MOVENTIG", "and", "ADYNOVATE", "TM", "."], "wordsB": ["We", "expect", "royalty", "revenue", "in", "2017", "will", "increase", "as", "compared", "to", "2016", "due", "to", "royalties", "we", "expect", "to", "receive", "from", "net", "sales", "of", "MOVANTIK", ",", "MOVENTIG", "and", "ADYNOVATE", "as", "a", "result", "of", "sales", "growth", "of", "these", "partnered", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p7_s6", "idA": "906709_16_item7_p15_s7", "sentA": "We expect non-cash royalties from net sales of CIMZIA and MIRCERA in 2016 to increase compared to 2015.", "sentB": "We expect non-cash royalties from net sales of CIMZIA and MIRCERA in 2017 to increase marginally compared to 2016.", "type": 2, "words": ["<tag1>", "We", "expect", "non-cash", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "in", "2016", "to", "increase", "compared", "to", "2015.", "<tag2>", "We", "expect", "non-cash", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "in", "2017", "to", "increase", "marginally", "compared", "to", "2016.", "<tag3>"], "wordsA": ["We", "expect", "non-cash", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "in", "2016", "to", "increase", "compared", "to", "2015."], "wordsB": ["We", "expect", "non-cash", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "in", "2017", "to", "increase", "marginally", "compared", "to", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p8_s6", "idA": "906709_16_item7_p16_s11", "sentA": "We expect license, collaboration and other revenue in 2016 will decrease significantly compared to 2015 primarily due to the achievement in 2015 of the significant non-recurring payments noted above resulting from AstraZeneca s commercial launch of MOVANTIK TM and MOVENTIG .", "sentB": "We expect license, collaboration and other revenue in 2017 to decrease compared to 2016.", "type": 2, "words": ["<tag1>", "We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2016", "will", "decrease", "significantly", "compared", "to", "2015", "primarily", "due", "to", "the", "achievement", "in", "2015", "of", "the", "significant", "non-recurring", "payments", "noted", "above", "resulting", "from", "AstraZeneca", "s", "commercial", "launch", "of", "MOVANTIK", "TM", "and", "MOVENTIG", ".", "<tag2>", "We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2017", "to", "decrease", "compared", "to", "2016.", "<tag3>"], "wordsA": ["We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2016", "will", "decrease", "significantly", "compared", "to", "2015", "primarily", "due", "to", "the", "achievement", "in", "2015", "of", "the", "significant", "non-recurring", "payments", "noted", "above", "resulting", "from", "AstraZeneca", "s", "commercial", "launch", "of", "MOVANTIK", "TM", "and", "MOVENTIG", "."], "wordsB": ["We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2017", "to", "decrease", "compared", "to", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p8_s2", "idA": "906709_16_item7_p16_s2", "sentA": "License, collaboration and other revenue increased for the year ended December 31, 2015 compared to the year ended December 31, 2014 primarily as a result of the recognition of the $140.0 million of payments received from AstraZeneca as a result of the U.S. commercial launch of MOVANTIK TM and the EU commercial launch of MOVENTIG .", "sentB": "License, collaboration and other revenue decreased for the year ended December 31, 2016 compared to the year ended December 31, 2015 primarily as a result of the recognition in March 2015 of the $100.0 million milestone payment received from AstraZeneca as a result of the U.S. commercial launch of MOVANTIK and the $40.0 million milestone payment received from AstraZeneca in August 2015 as a result of the EU commercial launch of MOVENTIG partially offset by the recognition of $28.0 million in March 2016 for our 40% share of the $70.0 million sublicense payment received by AstraZeneca from Kirin.", "type": 2, "words": ["<tag1>", "License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "the", "$140.0", "million", "of", "payments", "received", "from", "AstraZeneca", "as", "a", "result", "of", "the", "U.S.", "commercial", "launch", "of", "MOVANTIK", "TM", "and", "the", "EU", "commercial", "launch", "of", "MOVENTIG", ".", "<tag2>", "License,", "collaboration", "and", "other", "revenue", "decreased", "for", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "primarily", "as", "a", "result", "of", "the", "recognition", "in", "March", "2015", "of", "the", "$100.0", "million", "milestone", "payment", "received", "from", "AstraZeneca", "as", "a", "result", "of", "the", "U.S.", "commercial", "launch", "of", "MOVANTIK", "and", "the", "$40.0", "million", "milestone", "payment", "received", "from", "AstraZeneca", "in", "August", "2015", "as", "a", "result", "of", "the", "EU", "commercial", "launch", "of", "MOVENTIG", "partially", "offset", "by", "the", "recognition", "of", "$28.0", "million", "in", "March", "2016", "for", "our", "40%", "share", "of", "the", "$70.0", "million", "sublicense", "payment", "received", "by", "AstraZeneca", "from", "Kirin.", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "the", "$140.0", "million", "of", "payments", "received", "from", "AstraZeneca", "as", "a", "result", "of", "the", "U.S.", "commercial", "launch", "of", "MOVANTIK", "TM", "and", "the", "EU", "commercial", "launch", "of", "MOVENTIG", "."], "wordsB": ["License,", "collaboration", "and", "other", "revenue", "decreased", "for", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "primarily", "as", "a", "result", "of", "the", "recognition", "in", "March", "2015", "of", "the", "$100.0", "million", "milestone", "payment", "received", "from", "AstraZeneca", "as", "a", "result", "of", "the", "U.S.", "commercial", "launch", "of", "MOVANTIK", "and", "the", "$40.0", "million", "milestone", "payment", "received", "from", "AstraZeneca", "in", "August", "2015", "as", "a", "result", "of", "the", "EU", "commercial", "launch", "of", "MOVENTIG", "partially", "offset", "by", "the", "recognition", "of", "$28.0", "million", "in", "March", "2016", "for", "our", "40%", "share", "of", "the", "$70.0", "million", "sublicense", "payment", "received", "by", "AstraZeneca", "from", "Kirin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p8_s3", "idA": "906709_16_item7_p16_s2", "sentA": "License, collaboration and other revenue increased for the year ended December 31, 2015 compared to the year ended December 31, 2014 primarily as a result of the recognition of the $140.0 million of payments received from AstraZeneca as a result of the U.S. commercial launch of MOVANTIK TM and the EU commercial launch of MOVENTIG .", "sentB": "License, collaboration and other revenue increased for the year ended December 31, 2015 compared to the year ended December 31, 2014 primarily as a result of increased revenue from payments received from AstraZeneca in 2015 as compared to 2014.", "type": 2, "words": ["<tag1>", "License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "the", "$140.0", "million", "of", "payments", "received", "from", "AstraZeneca", "as", "a", "result", "of", "the", "U.S.", "commercial", "launch", "of", "MOVANTIK", "TM", "and", "the", "EU", "commercial", "launch", "of", "MOVENTIG", ".", "<tag2>", "License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "as", "a", "result", "of", "increased", "revenue", "from", "payments", "received", "from", "AstraZeneca", "in", "2015", "as", "compared", "to", "2014.", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "as", "a", "result", "of", "the", "recognition", "of", "the", "$140.0", "million", "of", "payments", "received", "from", "AstraZeneca", "as", "a", "result", "of", "the", "U.S.", "commercial", "launch", "of", "MOVANTIK", "TM", "and", "the", "EU", "commercial", "launch", "of", "MOVENTIG", "."], "wordsB": ["License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "as", "a", "result", "of", "increased", "revenue", "from", "payments", "received", "from", "AstraZeneca", "in", "2015", "as", "compared", "to", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p53_s4", "idA": "906709_16_item7_p16_s4", "sentA": "During the year-ended December 31, 2014, we recognized $105.0 million of payments from AstraZeneca as a result of the FDA s approval of MOVANTIK TM in September 2014 and recognized $9.0 million of milestone payments resulting from the transfer of our manufacturing technology to two of our collaboration partners.", "sentB": "Specifically, the new standard differs from the current accounting standard in many respects, such as in the accounting for variable consideration, including milestone payments or contingent payments from our collaboration partners.", "type": 2, "words": ["<tag1>", "During", "the", "year-ended", "December", "31,", "2014,", "we", "recognized", "$105.0", "million", "of", "payments", "from", "AstraZeneca", "as", "a", "result", "of", "the", "FDA", "s", "approval", "of", "MOVANTIK", "TM", "in", "September", "2014", "and", "recognized", "$9.0", "million", "of", "milestone", "payments", "resulting", "from", "the", "transfer", "of", "our", "manufacturing", "technology", "to", "two", "of", "our", "collaboration", "partners.", "<tag2>", "Specifically,", "the", "new", "standard", "differs", "from", "the", "current", "accounting", "standard", "in", "many", "respects,", "such", "as", "in", "the", "accounting", "for", "variable", "consideration,", "including", "milestone", "payments", "or", "contingent", "payments", "from", "our", "collaboration", "partners.", "<tag3>"], "wordsA": ["During", "the", "year-ended", "December", "31,", "2014,", "we", "recognized", "$105.0", "million", "of", "payments", "from", "AstraZeneca", "as", "a", "result", "of", "the", "FDA", "s", "approval", "of", "MOVANTIK", "TM", "in", "September", "2014", "and", "recognized", "$9.0", "million", "of", "milestone", "payments", "resulting", "from", "the", "transfer", "of", "our", "manufacturing", "technology", "to", "two", "of", "our", "collaboration", "partners."], "wordsB": ["Specifically,", "the", "new", "standard", "differs", "from", "the", "current", "accounting", "standard", "in", "many", "respects,", "such", "as", "in", "the", "accounting", "for", "variable", "consideration,", "including", "milestone", "payments", "or", "contingent", "payments", "from", "our", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p8_s4", "idA": "906709_16_item7_p16_s4", "sentA": "During the year-ended December 31, 2014, we recognized $105.0 million of payments from AstraZeneca as a result of the FDA s approval of MOVANTIK TM in September 2014 and recognized $9.0 million of milestone payments resulting from the transfer of our manufacturing technology to two of our collaboration partners.", "sentB": "During the year-ended December 31, 2014, we recognized $105.0 million of payments from AstraZeneca as a result of the FDA s approval of MOVANTIK in September 2014 and recognized $9.0 million of milestone payments resulting from the transfer of our manufacturing technology to two of our collaboration partners.", "type": 2, "words": ["<tag1>", "During", "the", "year-ended", "December", "31,", "2014,", "we", "recognized", "$105.0", "million", "of", "payments", "from", "AstraZeneca", "as", "a", "result", "of", "the", "FDA", "s", "approval", "of", "MOVANTIK", "TM", "in", "September", "2014", "and", "recognized", "$9.0", "million", "of", "milestone", "payments", "resulting", "from", "the", "transfer", "of", "our", "manufacturing", "technology", "to", "two", "of", "our", "collaboration", "partners.", "<tag2>", "During", "the", "year-ended", "December", "31,", "2014,", "we", "recognized", "$105.0", "million", "of", "payments", "from", "AstraZeneca", "as", "a", "result", "of", "the", "FDA", "s", "approval", "of", "MOVANTIK", "in", "September", "2014", "and", "recognized", "$9.0", "million", "of", "milestone", "payments", "resulting", "from", "the", "transfer", "of", "our", "manufacturing", "technology", "to", "two", "of", "our", "collaboration", "partners.", "<tag3>"], "wordsA": ["During", "the", "year-ended", "December", "31,", "2014,", "we", "recognized", "$105.0", "million", "of", "payments", "from", "AstraZeneca", "as", "a", "result", "of", "the", "FDA", "s", "approval", "of", "MOVANTIK", "TM", "in", "September", "2014", "and", "recognized", "$9.0", "million", "of", "milestone", "payments", "resulting", "from", "the", "transfer", "of", "our", "manufacturing", "technology", "to", "two", "of", "our", "collaboration", "partners."], "wordsB": ["During", "the", "year-ended", "December", "31,", "2014,", "we", "recognized", "$105.0", "million", "of", "payments", "from", "AstraZeneca", "as", "a", "result", "of", "the", "FDA", "s", "approval", "of", "MOVANTIK", "in", "September", "2014", "and", "recognized", "$9.0", "million", "of", "milestone", "payments", "resulting", "from", "the", "transfer", "of", "our", "manufacturing", "technology", "to", "two", "of", "our", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p8_s5", "idA": "906709_16_item7_p16_s5", "sentA": "In addition, in 2014, we recognized $8.0 million of milestones received in December 2014 related to positive results from Baxalta s ADYNOVATE TM Phase 3 study.", "sentB": "In addition, in 2014, we recognized $8.0 million of milestones received in December 2014 related to positive results from Baxalta s ADYNOVATE Phase 3 study.", "type": 2, "words": ["<tag1>", "In", "addition,", "in", "2014,", "we", "recognized", "$8.0", "million", "of", "milestones", "received", "in", "December", "2014", "related", "to", "positive", "results", "from", "Baxalta", "s", "ADYNOVATE", "TM", "Phase", "3", "study.", "<tag2>", "In", "addition,", "in", "2014,", "we", "recognized", "$8.0", "million", "of", "milestones", "received", "in", "December", "2014", "related", "to", "positive", "results", "from", "Baxalta", "s", "ADYNOVATE", "Phase", "3", "study.", "<tag3>"], "wordsA": ["In", "addition,", "in", "2014,", "we", "recognized", "$8.0", "million", "of", "milestones", "received", "in", "December", "2014", "related", "to", "positive", "results", "from", "Baxalta", "s", "ADYNOVATE", "TM", "Phase", "3", "study."], "wordsB": ["In", "addition,", "in", "2014,", "we", "recognized", "$8.0", "million", "of", "milestones", "received", "in", "December", "2014", "related", "to", "positive", "results", "from", "Baxalta", "s", "ADYNOVATE", "Phase", "3", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p0_s11", "idA": "906709_16_item7_p17_s0", "sentA": "The timing and future success of our drug development programs and those of our collaboration partners are subject to a number of risks and uncertainties.", "sentB": "The level of our future research and development investment will depend on a number of trends and uncertainties including clinical outcomes, future studies required to advance programs to regulatory approval, and the economics related to potential future collaborations that may include up-front payments, development funding, milestones, and royalties.", "type": 2, "words": ["<tag1>", "The", "timing", "and", "future", "success", "of", "our", "drug", "development", "programs", "and", "those", "of", "our", "collaboration", "partners", "are", "subject", "to", "a", "number", "of", "risks", "and", "uncertainties.", "<tag2>", "The", "level", "of", "our", "future", "research", "and", "development", "investment", "will", "depend", "on", "a", "number", "of", "trends", "and", "uncertainties", "including", "clinical", "outcomes,", "future", "studies", "required", "to", "advance", "programs", "to", "regulatory", "approval,", "and", "the", "economics", "related", "to", "potential", "future", "collaborations", "that", "may", "include", "up-front", "payments,", "development", "funding,", "milestones,", "and", "royalties.", "<tag3>"], "wordsA": ["The", "timing", "and", "future", "success", "of", "our", "drug", "development", "programs", "and", "those", "of", "our", "collaboration", "partners", "are", "subject", "to", "a", "number", "of", "risks", "and", "uncertainties."], "wordsB": ["The", "level", "of", "our", "future", "research", "and", "development", "investment", "will", "depend", "on", "a", "number", "of", "trends", "and", "uncertainties", "including", "clinical", "outcomes,", "future", "studies", "required", "to", "advance", "programs", "to", "regulatory", "approval,", "and", "the", "economics", "related", "to", "potential", "future", "collaborations", "that", "may", "include", "up-front", "payments,", "development", "funding,", "milestones,", "and", "royalties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p19_s3", "idA": "906709_16_item7_p17_s0", "sentA": "The timing and future success of our drug development programs and those of our collaboration partners are subject to a number of risks and uncertainties.", "sentB": "The timing and amount of our future clinical investments in NKTR-214 and NKTR-358 will vary significantly based upon our evaluation of ongoing clinical results and the structure, timing, and scope of potential collaboration partnerships (if any) for these programs.", "type": 2, "words": ["<tag1>", "The", "timing", "and", "future", "success", "of", "our", "drug", "development", "programs", "and", "those", "of", "our", "collaboration", "partners", "are", "subject", "to", "a", "number", "of", "risks", "and", "uncertainties.", "<tag2>", "The", "timing", "and", "amount", "of", "our", "future", "clinical", "investments", "in", "NKTR-214", "and", "NKTR-358", "will", "vary", "significantly", "based", "upon", "our", "evaluation", "of", "ongoing", "clinical", "results", "and", "the", "structure,", "timing,", "and", "scope", "of", "potential", "collaboration", "partnerships", "(if", "any)", "for", "these", "programs.", "<tag3>"], "wordsA": ["The", "timing", "and", "future", "success", "of", "our", "drug", "development", "programs", "and", "those", "of", "our", "collaboration", "partners", "are", "subject", "to", "a", "number", "of", "risks", "and", "uncertainties."], "wordsB": ["The", "timing", "and", "amount", "of", "our", "future", "clinical", "investments", "in", "NKTR-214", "and", "NKTR-358", "will", "vary", "significantly", "based", "upon", "our", "evaluation", "of", "ongoing", "clinical", "results", "and", "the", "structure,", "timing,", "and", "scope", "of", "potential", "collaboration", "partnerships", "(if", "any)", "for", "these", "programs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p0_s23", "idA": "906709_16_item7_p17_s1", "sentA": "See Part I, Item 1A Risk Factors for discussion of the risks associated with the complex nature of our collaboration agreements.", "sentB": "Our business is subject to significant risks, including the risks inherent in our development efforts, the results of our clinical trials, the marketing of our dependence on collaborative parties, uncertainties associated with obtaining and enforcing patents, the lengthy and expensive regulatory approval process and competition from other products.", "type": 2, "words": ["<tag1>", "See", "Part", "I,", "Item", "1A", "Risk", "Factors", "for", "discussion", "of", "the", "risks", "associated", "with", "the", "complex", "nature", "of", "our", "collaboration", "agreements.", "<tag2>", "Our", "business", "is", "subject", "to", "significant", "risks,", "including", "the", "risks", "inherent", "in", "our", "development", "efforts,", "the", "results", "of", "our", "clinical", "trials,", "the", "marketing", "of", "our", "dependence", "on", "collaborative", "parties,", "uncertainties", "associated", "with", "obtaining", "and", "enforcing", "patents,", "the", "lengthy", "and", "expensive", "regulatory", "approval", "process", "and", "competition", "from", "other", "products.", "<tag3>"], "wordsA": ["See", "Part", "I,", "Item", "1A", "Risk", "Factors", "for", "discussion", "of", "the", "risks", "associated", "with", "the", "complex", "nature", "of", "our", "collaboration", "agreements."], "wordsB": ["Our", "business", "is", "subject", "to", "significant", "risks,", "including", "the", "risks", "inherent", "in", "our", "development", "efforts,", "the", "results", "of", "our", "clinical", "trials,", "the", "marketing", "of", "our", "dependence", "on", "collaborative", "parties,", "uncertainties", "associated", "with", "obtaining", "and", "enforcing", "patents,", "the", "lengthy", "and", "expensive", "regulatory", "approval", "process", "and", "competition", "from", "other", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p11_s0", "idA": "906709_16_item7_p19_s0", "sentA": "The increase in revenue attributable to European countries for the year ended December 31, 2015 compared to the year ended December 31, 2014 is primarily attributable to increased milestone and other contingent payments from our existing European based collaboration partners, including the recognition of a total of $140.0 million payments from AstraZeneca in connection with its commercial launches of MOVANTIK TM described above.", "sentB": "The decrease in revenue attributable to European countries for the year ended December 31, 2016 compared to the year ended December 31, 2015 is primarily attributable to decreased milestone and other contingent payments from our existing European based collaboration partners, including the recognition in 2015 of a total of $140.0 million payments from AstraZeneca in connection with its commercial launches of MOVANTIK described above.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "is", "primarily", "attributable", "to", "increased", "milestone", "and", "other", "contingent", "payments", "from", "our", "existing", "European", "based", "collaboration", "partners,", "including", "the", "recognition", "of", "a", "total", "of", "$140.0", "million", "payments", "from", "AstraZeneca", "in", "connection", "with", "its", "commercial", "launches", "of", "MOVANTIK", "TM", "described", "above.", "<tag2>", "The", "decrease", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "is", "primarily", "attributable", "to", "decreased", "milestone", "and", "other", "contingent", "payments", "from", "our", "existing", "European", "based", "collaboration", "partners,", "including", "the", "recognition", "in", "2015", "of", "a", "total", "of", "$140.0", "million", "payments", "from", "AstraZeneca", "in", "connection", "with", "its", "commercial", "launches", "of", "MOVANTIK", "described", "above.", "<tag3>"], "wordsA": ["The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "is", "primarily", "attributable", "to", "increased", "milestone", "and", "other", "contingent", "payments", "from", "our", "existing", "European", "based", "collaboration", "partners,", "including", "the", "recognition", "of", "a", "total", "of", "$140.0", "million", "payments", "from", "AstraZeneca", "in", "connection", "with", "its", "commercial", "launches", "of", "MOVANTIK", "TM", "described", "above."], "wordsB": ["The", "decrease", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "is", "primarily", "attributable", "to", "decreased", "milestone", "and", "other", "contingent", "payments", "from", "our", "existing", "European", "based", "collaboration", "partners,", "including", "the", "recognition", "in", "2015", "of", "a", "total", "of", "$140.0", "million", "payments", "from", "AstraZeneca", "in", "connection", "with", "its", "commercial", "launches", "of", "MOVANTIK", "described", "above."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p12_s0", "idA": "906709_16_item7_p19_s0", "sentA": "The increase in revenue attributable to European countries for the year ended December 31, 2015 compared to the year ended December 31, 2014 is primarily attributable to increased milestone and other contingent payments from our existing European based collaboration partners, including the recognition of a total of $140.0 million payments from AstraZeneca in connection with its commercial launches of MOVANTIK TM described above.", "sentB": "contingent payments from our existin g European based collaboration partners, including the recognition of the payments from AstraZeneca in connection with its commercial launches of MOVANTIK described above.", "type": 2, "words": ["<tag1>", "The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "is", "primarily", "attributable", "to", "increased", "milestone", "and", "other", "contingent", "payments", "from", "our", "existing", "European", "based", "collaboration", "partners,", "including", "the", "recognition", "of", "a", "total", "of", "$140.0", "million", "payments", "from", "AstraZeneca", "in", "connection", "with", "its", "commercial", "launches", "of", "MOVANTIK", "TM", "described", "above.", "<tag2>", "contingent", "payments", "from", "our", "existin", "g", "European", "based", "collaboration", "partners,", "including", "the", "recognition", "of", "the", "payments", "from", "AstraZeneca", "in", "connection", "with", "its", "commercial", "launches", "of", "MOVANTIK", "described", "above.", "<tag3>"], "wordsA": ["The", "increase", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "is", "primarily", "attributable", "to", "increased", "milestone", "and", "other", "contingent", "payments", "from", "our", "existing", "European", "based", "collaboration", "partners,", "including", "the", "recognition", "of", "a", "total", "of", "$140.0", "million", "payments", "from", "AstraZeneca", "in", "connection", "with", "its", "commercial", "launches", "of", "MOVANTIK", "TM", "described", "above."], "wordsB": ["contingent", "payments", "from", "our", "existin", "g", "European", "based", "collaboration", "partners,", "including", "the", "recognition", "of", "the", "payments", "from", "AstraZeneca", "in", "connection", "with", "its", "commercial", "launches", "of", "MOVANTIK", "described", "above."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p13_s0", "idA": "906709_16_item7_p20_s1", "sentA": "Cost of goods sold decreased during the year ended December 31, 2014 compared to the year ended December 31, 2013 primarily due to the decrease in product sales of $19.7 million in the year ended December 31, 2014 compared to the year ended December 31, 2013.", "sentB": "Cost of goods sold decreased during the year ended December 31, 2016 compared to the year ended December 31, 2015 primarily due to the mix of product sales, which resulted in decreases to cost of goods sold even though product sales increased during the same period.", "type": 2, "words": ["<tag1>", "Cost", "of", "goods", "sold", "decreased", "during", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "due", "to", "the", "decrease", "in", "product", "sales", "of", "$19.7", "million", "in", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013.", "<tag2>", "Cost", "of", "goods", "sold", "decreased", "during", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "primarily", "due", "to", "the", "mix", "of", "product", "sales,", "which", "resulted", "in", "decreases", "to", "cost", "of", "goods", "sold", "even", "though", "product", "sales", "increased", "during", "the", "same", "period.", "<tag3>"], "wordsA": ["Cost", "of", "goods", "sold", "decreased", "during", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013", "primarily", "due", "to", "the", "decrease", "in", "product", "sales", "of", "$19.7", "million", "in", "the", "year", "ended", "December", "31,", "2014", "compared", "to", "the", "year", "ended", "December", "31,", "2013."], "wordsB": ["Cost", "of", "goods", "sold", "decreased", "during", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "primarily", "due", "to", "the", "mix", "of", "product", "sales,", "which", "resulted", "in", "decreases", "to", "cost", "of", "goods", "sold", "even", "though", "product", "sales", "increased", "during", "the", "same", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p14_s3", "idA": "906709_16_item7_p20_s10", "sentA": "We currently expect product gross margin to increase in 2016 as compared to 2015 as a result of an anticipated increase in product sales, as well as based on the anticipated product mix.", "sentB": "We currently expect product gross margin to decrease significantly in 2017 as compared to 2016 and gross margin may approximate breakeven in 2017 as a result of the anticipated decrease in product sales from our collaboration partner Ophthotech as described above.", "type": 2, "words": ["<tag1>", "We", "currently", "expect", "product", "gross", "margin", "to", "increase", "in", "2016", "as", "compared", "to", "2015", "as", "a", "result", "of", "an", "anticipated", "increase", "in", "product", "sales,", "as", "well", "as", "based", "on", "the", "anticipated", "product", "mix.", "<tag2>", "We", "currently", "expect", "product", "gross", "margin", "to", "decrease", "significantly", "in", "2017", "as", "compared", "to", "2016", "and", "gross", "margin", "may", "approximate", "breakeven", "in", "2017", "as", "a", "result", "of", "the", "anticipated", "decrease", "in", "product", "sales", "from", "our", "collaboration", "partner", "Ophthotech", "as", "described", "above.", "<tag3>"], "wordsA": ["We", "currently", "expect", "product", "gross", "margin", "to", "increase", "in", "2016", "as", "compared", "to", "2015", "as", "a", "result", "of", "an", "anticipated", "increase", "in", "product", "sales,", "as", "well", "as", "based", "on", "the", "anticipated", "product", "mix."], "wordsB": ["We", "currently", "expect", "product", "gross", "margin", "to", "decrease", "significantly", "in", "2017", "as", "compared", "to", "2016", "and", "gross", "margin", "may", "approximate", "breakeven", "in", "2017", "as", "a", "result", "of", "the", "anticipated", "decrease", "in", "product", "sales", "from", "our", "collaboration", "partner", "Ophthotech", "as", "described", "above."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p13_s2", "idA": "906709_16_item7_p20_s2", "sentA": "The improvement in product gross profit (loss) and product gross margin during the year ended December 31, 2015 compared to the year ended December 31, 2014 is primarily due to a more favorable product mix in 2015 compared to 2014.", "sentB": "The improvement in product gross profit and product gross margin during the years ended December 31, 2016 and 2015 compared to the years ended December 31, 2015 and 2014, respectively, is primarily due to a more favorable product mix.", "type": 2, "words": ["<tag1>", "The", "improvement", "in", "product", "gross", "profit", "(loss)", "and", "product", "gross", "margin", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "is", "primarily", "due", "to", "a", "more", "favorable", "product", "mix", "in", "2015", "compared", "to", "2014.", "<tag2>", "The", "improvement", "in", "product", "gross", "profit", "and", "product", "gross", "margin", "during", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "respectively,", "is", "primarily", "due", "to", "a", "more", "favorable", "product", "mix.", "<tag3>"], "wordsA": ["The", "improvement", "in", "product", "gross", "profit", "(loss)", "and", "product", "gross", "margin", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "is", "primarily", "due", "to", "a", "more", "favorable", "product", "mix", "in", "2015", "compared", "to", "2014."], "wordsB": ["The", "improvement", "in", "product", "gross", "profit", "and", "product", "gross", "margin", "during", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "respectively,", "is", "primarily", "due", "to", "a", "more", "favorable", "product", "mix."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p13_s4", "idA": "906709_16_item7_p20_s3", "sentA": "In particular, the manufacturing arrangement with one of our collaboration partners includes a fixed price for proprietary PEGylation reagent sales, which is less than the fully burdened manufacturing cost for the reagent and we expect this situation to continue in future years.", "sentB": "This increased margin is partially offset by a manufacturing arrangement with another partner that includes a fixed price which is less than the fully burdened manufacturing cost for the reagent and we expect this situation to continue with this partner in future years.", "type": 2, "words": ["<tag1>", "In", "particular,", "the", "manufacturing", "arrangement", "with", "one", "of", "our", "collaboration", "partners", "includes", "a", "fixed", "price", "for", "proprietary", "PEGylation", "reagent", "sales,", "which", "is", "less", "than", "the", "fully", "burdened", "manufacturing", "cost", "for", "the", "reagent", "and", "we", "expect", "this", "situation", "to", "continue", "in", "future", "years.", "<tag2>", "This", "increased", "margin", "is", "partially", "offset", "by", "a", "manufacturing", "arrangement", "with", "another", "partner", "that", "includes", "a", "fixed", "price", "which", "is", "less", "than", "the", "fully", "burdened", "manufacturing", "cost", "for", "the", "reagent", "and", "we", "expect", "this", "situation", "to", "continue", "with", "this", "partner", "in", "future", "years.", "<tag3>"], "wordsA": ["In", "particular,", "the", "manufacturing", "arrangement", "with", "one", "of", "our", "collaboration", "partners", "includes", "a", "fixed", "price", "for", "proprietary", "PEGylation", "reagent", "sales,", "which", "is", "less", "than", "the", "fully", "burdened", "manufacturing", "cost", "for", "the", "reagent", "and", "we", "expect", "this", "situation", "to", "continue", "in", "future", "years."], "wordsB": ["This", "increased", "margin", "is", "partially", "offset", "by", "a", "manufacturing", "arrangement", "with", "another", "partner", "that", "includes", "a", "fixed", "price", "which", "is", "less", "than", "the", "fully", "burdened", "manufacturing", "cost", "for", "the", "reagent", "and", "we", "expect", "this", "situation", "to", "continue", "with", "this", "partner", "in", "future", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p13_s5", "idA": "906709_16_item7_p20_s5", "sentA": "There were fewer shipments to this partner in total and relative to shipments to other customers during the year ended December 31, 2015 compared to the year ended December 31, 2014.", "sentB": "There were fewer shipments to this partner relative to shipments to other customers during the years ended December 31, 2016 and 2015 compared to the years ended December 31, 2015 and 2014, respectively.", "type": 2, "words": ["<tag1>", "There", "were", "fewer", "shipments", "to", "this", "partner", "in", "total", "and", "relative", "to", "shipments", "to", "other", "customers", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014.", "<tag2>", "There", "were", "fewer", "shipments", "to", "this", "partner", "relative", "to", "shipments", "to", "other", "customers", "during", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "respectively.", "<tag3>"], "wordsA": ["There", "were", "fewer", "shipments", "to", "this", "partner", "in", "total", "and", "relative", "to", "shipments", "to", "other", "customers", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014."], "wordsB": ["There", "were", "fewer", "shipments", "to", "this", "partner", "relative", "to", "shipments", "to", "other", "customers", "during", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p14_s0", "idA": "906709_16_item7_p20_s6", "sentA": "In addition to product sales from reagent shipments to this partner, we also receive royalty revenues from this collaboration.", "sentB": "In addition to product sales from reagent materials supplied to the partner where our sales are less than our fully burdened manufacturing cost, we also receive royalty revenue from this collaboration.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "product", "sales", "from", "reagent", "shipments", "to", "this", "partner,", "we", "also", "receive", "royalty", "revenues", "from", "this", "collaboration.", "<tag2>", "In", "addition", "to", "product", "sales", "from", "reagent", "materials", "supplied", "to", "the", "partner", "where", "our", "sales", "are", "less", "than", "our", "fully", "burdened", "manufacturing", "cost,", "we", "also", "receive", "royalty", "revenue", "from", "this", "collaboration.", "<tag3>"], "wordsA": ["In", "addition", "to", "product", "sales", "from", "reagent", "shipments", "to", "this", "partner,", "we", "also", "receive", "royalty", "revenues", "from", "this", "collaboration."], "wordsB": ["In", "addition", "to", "product", "sales", "from", "reagent", "materials", "supplied", "to", "the", "partner", "where", "our", "sales", "are", "less", "than", "our", "fully", "burdened", "manufacturing", "cost,", "we", "also", "receive", "royalty", "revenue", "from", "this", "collaboration."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p14_s1", "idA": "906709_16_item7_p20_s7", "sentA": "In the years ended December 31, 2015 and 2014, the royalty revenue from the collaboration exceeded the related negative gross profit on product sales.", "sentB": "In the years ended December 31, 2016, 2015 and 2014, the royalty revenue from this collaboration exceeded the related negative gross profit.", "type": 2, "words": ["<tag1>", "In", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "the", "royalty", "revenue", "from", "the", "collaboration", "exceeded", "the", "related", "negative", "gross", "profit", "on", "product", "sales.", "<tag2>", "In", "the", "years", "ended", "December", "31,", "2016,", "2015", "and", "2014,", "the", "royalty", "revenue", "from", "this", "collaboration", "exceeded", "the", "related", "negative", "gross", "profit.", "<tag3>"], "wordsA": ["In", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "the", "royalty", "revenue", "from", "the", "collaboration", "exceeded", "the", "related", "negative", "gross", "profit", "on", "product", "sales."], "wordsB": ["In", "the", "years", "ended", "December", "31,", "2016,", "2015", "and", "2014,", "the", "royalty", "revenue", "from", "this", "collaboration", "exceeded", "the", "related", "negative", "gross", "profit."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p15_s2", "idA": "906709_16_item7_p21_s2", "sentA": "Research and development expense increased during the year ended December 31, 2015 compared to the year ended December 31, 2014 primarily due to the initiation of Phase 3 clinical studies for NKTR-181 in the first quarter of 2015.", "sentB": "Research and development expense increased during the year ended December 31, 2016 compared to the year ended December 31, 2015 primarily due to costs incurred in our NKTR-214 clinical and NKTR-358 pre-clinical programs as well as increased headcount costs, partially offset by a decrease to our ONZEALD TM program costs.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "the", "initiation", "of", "Phase", "3", "clinical", "studies", "for", "NKTR-181", "in", "the", "first", "quarter", "of", "2015.", "<tag2>", "Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "primarily", "due", "to", "costs", "incurred", "in", "our", "NKTR-214", "clinical", "and", "NKTR-358", "pre-clinical", "programs", "as", "well", "as", "increased", "headcount", "costs,", "partially", "offset", "by", "a", "decrease", "to", "our", "ONZEALD", "TM", "program", "costs.", "<tag3>"], "wordsA": ["Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "the", "initiation", "of", "Phase", "3", "clinical", "studies", "for", "NKTR-181", "in", "the", "first", "quarter", "of", "2015."], "wordsB": ["Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "primarily", "due", "to", "costs", "incurred", "in", "our", "NKTR-214", "clinical", "and", "NKTR-358", "pre-clinical", "programs", "as", "well", "as", "increased", "headcount", "costs,", "partially", "offset", "by", "a", "decrease", "to", "our", "ONZEALD", "TM", "program", "costs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p53_s2", "idA": "906709_16_item7_p21_s2", "sentA": "Research and development expense increased during the year ended December 31, 2015 compared to the year ended December 31, 2014 primarily due to the initiation of Phase 3 clinical studies for NKTR-181 in the first quarter of 2015.", "sentB": "We plan to adopt the standard in the first quarter of 2018 using the modified retrospective method.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "the", "initiation", "of", "Phase", "3", "clinical", "studies", "for", "NKTR-181", "in", "the", "first", "quarter", "of", "2015.", "<tag2>", "We", "plan", "to", "adopt", "the", "standard", "in", "the", "first", "quarter", "of", "2018", "using", "the", "modified", "retrospective", "method.", "<tag3>"], "wordsA": ["Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "the", "initiation", "of", "Phase", "3", "clinical", "studies", "for", "NKTR-181", "in", "the", "first", "quarter", "of", "2015."], "wordsB": ["We", "plan", "to", "adopt", "the", "standard", "in", "the", "first", "quarter", "of", "2018", "using", "the", "modified", "retrospective", "method."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p55_s1", "idA": "906709_16_item7_p21_s2", "sentA": "Research and development expense increased during the year ended December 31, 2015 compared to the year ended December 31, 2014 primarily due to the initiation of Phase 3 clinical studies for NKTR-181 in the first quarter of 2015.", "sentB": "This guidance will become effective for us beginning in the first quarter of 2017.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "the", "initiation", "of", "Phase", "3", "clinical", "studies", "for", "NKTR-181", "in", "the", "first", "quarter", "of", "2015.", "<tag2>", "This", "guidance", "will", "become", "effective", "for", "us", "beginning", "in", "the", "first", "quarter", "of", "2017.", "<tag3>"], "wordsA": ["Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "the", "initiation", "of", "Phase", "3", "clinical", "studies", "for", "NKTR-181", "in", "the", "first", "quarter", "of", "2015."], "wordsB": ["This", "guidance", "will", "become", "effective", "for", "us", "beginning", "in", "the", "first", "quarter", "of", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p56_s1", "idA": "906709_16_item7_p21_s2", "sentA": "Research and development expense increased during the year ended December 31, 2015 compared to the year ended December 31, 2014 primarily due to the initiation of Phase 3 clinical studies for NKTR-181 in the first quarter of 2015.", "sentB": "The guidance will become effective for us beginning in the first quarter of 2019 and is required to be adopted using a modified retrospective approach.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "the", "initiation", "of", "Phase", "3", "clinical", "studies", "for", "NKTR-181", "in", "the", "first", "quarter", "of", "2015.", "<tag2>", "The", "guidance", "will", "become", "effective", "for", "us", "beginning", "in", "the", "first", "quarter", "of", "2019", "and", "is", "required", "to", "be", "adopted", "using", "a", "modified", "retrospective", "approach.", "<tag3>"], "wordsA": ["Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "the", "initiation", "of", "Phase", "3", "clinical", "studies", "for", "NKTR-181", "in", "the", "first", "quarter", "of", "2015."], "wordsB": ["The", "guidance", "will", "become", "effective", "for", "us", "beginning", "in", "the", "first", "quarter", "of", "2019", "and", "is", "required", "to", "be", "adopted", "using", "a", "modified", "retrospective", "approach."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p16_s2", "idA": "906709_16_item7_p22_s2", "sentA": "The table also presents other costs and overhead consisting of personnel, facilities and other indirect costs (in thousands):", "sentB": "The table also presents other costs and overh ead consisting of personnel, facilities and other indirect costs (in thousands):", "type": 2, "words": ["<tag1>", "The", "table", "also", "presents", "other", "costs", "and", "overhead", "consisting", "of", "personnel,", "facilities", "and", "other", "indirect", "costs", "(in", "thousands):", "<tag2>", "The", "table", "also", "presents", "other", "costs", "and", "overh", "ead", "consisting", "of", "personnel,", "facilities", "and", "other", "indirect", "costs", "(in", "thousands):", "<tag3>"], "wordsA": ["The", "table", "also", "presents", "other", "costs", "and", "overhead", "consisting", "of", "personnel,", "facilities", "and", "other", "indirect", "costs", "(in", "thousands):"], "wordsB": ["The", "table", "also", "presents", "other", "costs", "and", "overh", "ead", "consisting", "of", "personnel,", "facilities", "and", "other", "indirect", "costs", "(in", "thousands):"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p19_s0", "idA": "906709_16_item7_p25_s0", "sentA": "We expect research and development expense in 2016 to be consistent with 2015.", "sentB": "We expect research and development expense to continue to increase in 2017 compared to 2016.", "type": 2, "words": ["<tag1>", "We", "expect", "research", "and", "development", "expense", "in", "2016", "to", "be", "consistent", "with", "2015.", "<tag2>", "We", "expect", "research", "and", "development", "expense", "to", "continue", "to", "increase", "in", "2017", "compared", "to", "2016.", "<tag3>"], "wordsA": ["We", "expect", "research", "and", "development", "expense", "in", "2016", "to", "be", "consistent", "with", "2015."], "wordsB": ["We", "expect", "research", "and", "development", "expense", "to", "continue", "to", "increase", "in", "2017", "compared", "to", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p25_s4", "idA": "906709_16_item7_p25_s0", "sentA": "We expect research and development expense in 2016 to be consistent with 2015.", "sentB": "We expect interest expense in 2017 to be consistent with 2016.", "type": 2, "words": ["<tag1>", "We", "expect", "research", "and", "development", "expense", "in", "2016", "to", "be", "consistent", "with", "2015.", "<tag2>", "We", "expect", "interest", "expense", "in", "2017", "to", "be", "consistent", "with", "2016.", "<tag3>"], "wordsA": ["We", "expect", "research", "and", "development", "expense", "in", "2016", "to", "be", "consistent", "with", "2015."], "wordsB": ["We", "expect", "interest", "expense", "in", "2017", "to", "be", "consistent", "with", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p6_s0", "idA": "906709_16_item7_p25_s1", "sentA": "In particular, in 2016, we are continuing Phase 3 clinical studies for NKTR-181.", "sentB": "In December 2016, Ophthotech announced that two pivotal Phase 3 clinical trials for Fovista failed to meet their primary endpoints although a separate Phase 3 trial for Fovista remains ongoing.", "type": 2, "words": ["<tag1>", "In", "particular,", "in", "2016,", "we", "are", "continuing", "Phase", "3", "clinical", "studies", "for", "NKTR-181.", "<tag2>", "In", "December", "2016,", "Ophthotech", "announced", "that", "two", "pivotal", "Phase", "3", "clinical", "trials", "for", "Fovista", "failed", "to", "meet", "their", "primary", "endpoints", "although", "a", "separate", "Phase", "3", "trial", "for", "Fovista", "remains", "ongoing.", "<tag3>"], "wordsA": ["In", "particular,", "in", "2016,", "we", "are", "continuing", "Phase", "3", "clinical", "studies", "for", "NKTR-181."], "wordsB": ["In", "December", "2016,", "Ophthotech", "announced", "that", "two", "pivotal", "Phase", "3", "clinical", "trials", "for", "Fovista", "failed", "to", "meet", "their", "primary", "endpoints", "although", "a", "separate", "Phase", "3", "trial", "for", "Fovista", "remains", "ongoing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p19_s1", "idA": "906709_16_item7_p25_s4", "sentA": "In addition to our NKTR-181 development activities, in 2016, we plan to continue to advance the development of NKTR-214, which entered Phase 1/2 clinical development in December 2015.", "sentB": "In 2017, we plan to continue and expand a broad Phase 1/2 clinical development program for NKTR-214 in combination with other immune-oncology therapies including but not limited to Opdivo in collaboration with BMS.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "our", "NKTR-181", "development", "activities,", "in", "2016,", "we", "plan", "to", "continue", "to", "advance", "the", "development", "of", "NKTR-214,", "which", "entered", "Phase", "1/2", "clinical", "development", "in", "December", "2015.", "<tag2>", "In", "2017,", "we", "plan", "to", "continue", "and", "expand", "a", "broad", "Phase", "1/2", "clinical", "development", "program", "for", "NKTR-214", "in", "combination", "with", "other", "immune-oncology", "therapies", "including", "but", "not", "limited", "to", "Opdivo", "in", "collaboration", "with", "BMS.", "<tag3>"], "wordsA": ["In", "addition", "to", "our", "NKTR-181", "development", "activities,", "in", "2016,", "we", "plan", "to", "continue", "to", "advance", "the", "development", "of", "NKTR-214,", "which", "entered", "Phase", "1/2", "clinical", "development", "in", "December", "2015."], "wordsB": ["In", "2017,", "we", "plan", "to", "continue", "and", "expand", "a", "broad", "Phase", "1/2", "clinical", "development", "program", "for", "NKTR-214", "in", "combination", "with", "other", "immune-oncology", "therapies", "including", "but", "not", "limited", "to", "Opdivo", "in", "collaboration", "with", "BMS."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p19_s7", "idA": "906709_16_item7_p25_s6", "sentA": "Under our collaboration agreement with Bayer, we are responsible for all clinical and commercial supply of the nebulizer devices for this drug candidate.", "sentB": "Under our collaboration agreement with Bayer for Amikacin, we are responsible for all clinical and commercial supply of the nebulizer devices for this drug candidate and we will continue to fund our contractual obligation to support manufacturing activities for the Amikacin Inhale program.", "type": 2, "words": ["<tag1>", "Under", "our", "collaboration", "agreement", "with", "Bayer,", "we", "are", "responsible", "for", "all", "clinical", "and", "commercial", "supply", "of", "the", "nebulizer", "devices", "for", "this", "drug", "candidate.", "<tag2>", "Under", "our", "collaboration", "agreement", "with", "Bayer", "for", "Amikacin,", "we", "are", "responsible", "for", "all", "clinical", "and", "commercial", "supply", "of", "the", "nebulizer", "devices", "for", "this", "drug", "candidate", "and", "we", "will", "continue", "to", "fund", "our", "contractual", "obligation", "to", "support", "manufacturing", "activities", "for", "the", "Amikacin", "Inhale", "program.", "<tag3>"], "wordsA": ["Under", "our", "collaboration", "agreement", "with", "Bayer,", "we", "are", "responsible", "for", "all", "clinical", "and", "commercial", "supply", "of", "the", "nebulizer", "devices", "for", "this", "drug", "candidate."], "wordsB": ["Under", "our", "collaboration", "agreement", "with", "Bayer", "for", "Amikacin,", "we", "are", "responsible", "for", "all", "clinical", "and", "commercial", "supply", "of", "the", "nebulizer", "devices", "for", "this", "drug", "candidate", "and", "we", "will", "continue", "to", "fund", "our", "contractual", "obligation", "to", "support", "manufacturing", "activities", "for", "the", "Amikacin", "Inhale", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p19_s9", "idA": "906709_16_item7_p26_s0", "sentA": "Our discovery research organization is identifying new drug candidates by applying our PEGylation technology platform to a wide range of molecule classes, including small molecules and large proteins, peptides and antibodies, across multiple therapeutic areas.", "sentB": "Our discovery research organization is identifying new drug candidates by applying our polymer conjugation technology platform to a wide range of molecule classes, including small molecules and large proteins, peptides and antibodies, across multiple therapeutic areas.", "type": 2, "words": ["<tag1>", "Our", "discovery", "research", "organization", "is", "identifying", "new", "drug", "candidates", "by", "applying", "our", "PEGylation", "technology", "platform", "to", "a", "wide", "range", "of", "molecule", "classes,", "including", "small", "molecules", "and", "large", "proteins,", "peptides", "and", "antibodies,", "across", "multiple", "therapeutic", "areas.", "<tag2>", "Our", "discovery", "research", "organization", "is", "identifying", "new", "drug", "candidates", "by", "applying", "our", "polymer", "conjugation", "technology", "platform", "to", "a", "wide", "range", "of", "molecule", "classes,", "including", "small", "molecules", "and", "large", "proteins,", "peptides", "and", "antibodies,", "across", "multiple", "therapeutic", "areas.", "<tag3>"], "wordsA": ["Our", "discovery", "research", "organization", "is", "identifying", "new", "drug", "candidates", "by", "applying", "our", "PEGylation", "technology", "platform", "to", "a", "wide", "range", "of", "molecule", "classes,", "including", "small", "molecules", "and", "large", "proteins,", "peptides", "and", "antibodies,", "across", "multiple", "therapeutic", "areas."], "wordsB": ["Our", "discovery", "research", "organization", "is", "identifying", "new", "drug", "candidates", "by", "applying", "our", "polymer", "conjugation", "technology", "platform", "to", "a", "wide", "range", "of", "molecule", "classes,", "including", "small", "molecules", "and", "large", "proteins,", "peptides", "and", "antibodies,", "across", "multiple", "therapeutic", "areas."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p22_s0", "idA": "906709_16_item7_p29_s0", "sentA": "Furthermore, our strategy includes the potential of entering into collaborations with third parties to participate in the development and commercialization of some of our drug candidates such as those collaborations that we have already completed for MOVANTIK TM and Amikacin Inhale.", "sentB": "Furthermore, our strategy includes the potential of entering into collaborations with third parties to participate in the development and commercialization of some of our drug candidates such as those collaborations that we have already completed for MOVANTIK and Amikacin Inhale.", "type": 2, "words": ["<tag1>", "Furthermore,", "our", "strategy", "includes", "the", "potential", "of", "entering", "into", "collaborations", "with", "third", "parties", "to", "participate", "in", "the", "development", "and", "commercialization", "of", "some", "of", "our", "drug", "candidates", "such", "as", "those", "collaborations", "that", "we", "have", "already", "completed", "for", "MOVANTIK", "TM", "and", "Amikacin", "Inhale.", "<tag2>", "Furthermore,", "our", "strategy", "includes", "the", "potential", "of", "entering", "into", "collaborations", "with", "third", "parties", "to", "participate", "in", "the", "development", "and", "commercialization", "of", "some", "of", "our", "drug", "candidates", "such", "as", "those", "collaborations", "that", "we", "have", "already", "completed", "for", "MOVANTIK", "and", "Amikacin", "Inhale.", "<tag3>"], "wordsA": ["Furthermore,", "our", "strategy", "includes", "the", "potential", "of", "entering", "into", "collaborations", "with", "third", "parties", "to", "participate", "in", "the", "development", "and", "commercialization", "of", "some", "of", "our", "drug", "candidates", "such", "as", "those", "collaborations", "that", "we", "have", "already", "completed", "for", "MOVANTIK", "TM", "and", "Amikacin", "Inhale."], "wordsB": ["Furthermore,", "our", "strategy", "includes", "the", "potential", "of", "entering", "into", "collaborations", "with", "third", "parties", "to", "participate", "in", "the", "development", "and", "commercialization", "of", "some", "of", "our", "drug", "candidates", "such", "as", "those", "collaborations", "that", "we", "have", "already", "completed", "for", "MOVANTIK", "and", "Amikacin", "Inhale."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p0_s2", "idA": "906709_16_item7_p2_s1", "sentA": "Our objective is to apply our advanced polymer conjugate technology platform to create new drug candidates in multiple therapeutic areas that address large potential markets.", "sentB": "We leverage our proprietary and proven chemistry platform to discover and design new drug candidates.", "type": 2, "words": ["<tag1>", "Our", "objective", "is", "to", "apply", "our", "advanced", "polymer", "conjugate", "technology", "platform", "to", "create", "new", "drug", "candidates", "in", "multiple", "therapeutic", "areas", "that", "address", "large", "potential", "markets.", "<tag2>", "We", "leverage", "our", "proprietary", "and", "proven", "chemistry", "platform", "to", "discover", "and", "design", "new", "drug", "candidates.", "<tag3>"], "wordsA": ["Our", "objective", "is", "to", "apply", "our", "advanced", "polymer", "conjugate", "technology", "platform", "to", "create", "new", "drug", "candidates", "in", "multiple", "therapeutic", "areas", "that", "address", "large", "potential", "markets."], "wordsB": ["We", "leverage", "our", "proprietary", "and", "proven", "chemistry", "platform", "to", "discover", "and", "design", "new", "drug", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p0_s13", "idA": "906709_16_item7_p2_s3", "sentA": "MOVANTIK TM is an oral peripherally-acting opioid antagonist, for the treatment of opioid-induced constipation, or OIC, a side effect caused by chronic administration of prescription opioid pain medicines.", "sentB": "With AstraZeneca, we have a collaboration for MOVANTIK , an oral peripherally-acting mu-opioid antagonist for the treatment of opioid-induced constipation in adult patients with non-cancer pain.", "type": 2, "words": ["<tag1>", "MOVANTIK", "TM", "is", "an", "oral", "peripherally-acting", "opioid", "antagonist,", "for", "the", "treatment", "of", "opioid-induced", "constipation,", "or", "OIC,", "a", "side", "effect", "caused", "by", "chronic", "administration", "of", "prescription", "opioid", "pain", "medicines.", "<tag2>", "With", "AstraZeneca,", "we", "have", "a", "collaboration", "for", "MOVANTIK", ",", "an", "oral", "peripherally-acting", "mu-opioid", "antagonist", "for", "the", "treatment", "of", "opioid-induced", "constipation", "in", "adult", "patients", "with", "non-cancer", "pain.", "<tag3>"], "wordsA": ["MOVANTIK", "TM", "is", "an", "oral", "peripherally-acting", "opioid", "antagonist,", "for", "the", "treatment", "of", "opioid-induced", "constipation,", "or", "OIC,", "a", "side", "effect", "caused", "by", "chronic", "administration", "of", "prescription", "opioid", "pain", "medicines."], "wordsB": ["With", "AstraZeneca,", "we", "have", "a", "collaboration", "for", "MOVANTIK", ",", "an", "oral", "peripherally-acting", "mu-opioid", "antagonist", "for", "the", "treatment", "of", "opioid-induced", "constipation", "in", "adult", "patients", "with", "non-cancer", "pain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p24_s1", "idA": "906709_16_item7_p31_s1", "sentA": "General and administrative expense increased during the year ended December 31, 2015 compared to the year ended December 31, 2014 primarily due to a $3.0 million payment obligation related to the settlement of a commercial litigation matter.", "sentB": "General and administrative expense increased marginally during the year ended December 31, 2016 compared to the year ended December 31, 2015.", "type": 2, "words": ["<tag1>", "General", "and", "administrative", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "a", "$3.0", "million", "payment", "obligation", "related", "to", "the", "settlement", "of", "a", "commercial", "litigation", "matter.", "<tag2>", "General", "and", "administrative", "expense", "increased", "marginally", "during", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015.", "<tag3>"], "wordsA": ["General", "and", "administrative", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "a", "$3.0", "million", "payment", "obligation", "related", "to", "the", "settlement", "of", "a", "commercial", "litigation", "matter."], "wordsB": ["General", "and", "administrative", "expense", "increased", "marginally", "during", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p24_s3", "idA": "906709_16_item7_p31_s3", "sentA": "In 2016, we expect general and administrative expenses to decrease marginally compared to 2015.", "sentB": "In 2017, we expect general and administrative expenses to increase compared to 2016.", "type": 2, "words": ["<tag1>", "In", "2016,", "we", "expect", "general", "and", "administrative", "expenses", "to", "decrease", "marginally", "compared", "to", "2015.", "<tag2>", "In", "2017,", "we", "expect", "general", "and", "administrative", "expenses", "to", "increase", "compared", "to", "2016.", "<tag3>"], "wordsA": ["In", "2016,", "we", "expect", "general", "and", "administrative", "expenses", "to", "decrease", "marginally", "compared", "to", "2015."], "wordsB": ["In", "2017,", "we", "expect", "general", "and", "administrative", "expenses", "to", "increase", "compared", "to", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p25_s0", "idA": "906709_16_item7_p32_s0", "sentA": "Interest expense for the year ended December 31, 2015 increased marginally compared to the year ended December 31, 2014 primarily due to our secured note financing transaction in October 2015.", "sentB": "Interest expense for the year ended December 31, 2016 increased compared to the year ended December 31, 2015 due primarily to our secured notes transaction completed in October 2015.", "type": 2, "words": ["<tag1>", "Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2015", "increased", "marginally", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "our", "secured", "note", "financing", "transaction", "in", "October", "2015.", "<tag2>", "Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2016", "increased", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "due", "primarily", "to", "our", "secured", "notes", "transaction", "completed", "in", "October", "2015.", "<tag3>"], "wordsA": ["Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2015", "increased", "marginally", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "our", "secured", "note", "financing", "transaction", "in", "October", "2015."], "wordsB": ["Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2016", "increased", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "due", "primarily", "to", "our", "secured", "notes", "transaction", "completed", "in", "October", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p25_s1", "idA": "906709_16_item7_p32_s0", "sentA": "Interest expense for the year ended December 31, 2015 increased marginally compared to the year ended December 31, 2014 primarily due to our secured note financing transaction in October 2015.", "sentB": "Interest expense for the year ended December 31, 2015 increased marginally compared to the year ended December 31, 2014.", "type": 2, "words": ["<tag1>", "Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2015", "increased", "marginally", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "our", "secured", "note", "financing", "transaction", "in", "October", "2015.", "<tag2>", "Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2015", "increased", "marginally", "compared", "to", "the", "year", "ended", "December", "31,", "2014.", "<tag3>"], "wordsA": ["Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2015", "increased", "marginally", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "our", "secured", "note", "financing", "transaction", "in", "October", "2015."], "wordsB": ["Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2015", "increased", "marginally", "compared", "to", "the", "year", "ended", "December", "31,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p5_s3", "idA": "906709_16_item7_p33_s0", "sentA": "Interest expense for the year ended December 31, 2014 decreased marginally as compared to the year ended December 31, 2013.", "sentB": "In the year ended December 31, 2016, product sales to Ophthotech totaled $30.1 million.", "type": 2, "words": ["<tag1>", "Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2014", "decreased", "marginally", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2013.", "<tag2>", "In", "the", "year", "ended", "December", "31,", "2016,", "product", "sales", "to", "Ophthotech", "totaled", "$30.1", "million.", "<tag3>"], "wordsA": ["Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2014", "decreased", "marginally", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2013."], "wordsB": ["In", "the", "year", "ended", "December", "31,", "2016,", "product", "sales", "to", "Ophthotech", "totaled", "$30.1", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p26_s0", "idA": "906709_16_item7_p33_s2", "sentA": "Non-cash interest expense on the liability related to sale of future royalties for the year ended December 31, 2015 and 2014 decreased marginally as compared to the year ended December 31, 2014 and 2013, respectively, due to the decrease in 2015 and 2014, respectively, of the average balance of the related liability as that liability balance amortizes.", "sentB": "Non-cash interest expense on the liability related to sale of future royalties for the years ended December 31, 2016 and 2015 decreased marginally as compared to the years ended December 31, 2015 and 2014, respectively, due to the decrease in 2016 and 2 015, respectively, of the average balance of the related liability as that liability balance amortizes.", "type": 2, "words": ["<tag1>", "Non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2015", "and", "2014", "decreased", "marginally", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "and", "2013,", "respectively,", "due", "to", "the", "decrease", "in", "2015", "and", "2014,", "respectively,", "of", "the", "average", "balance", "of", "the", "related", "liability", "as", "that", "liability", "balance", "amortizes.", "<tag2>", "Non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "decreased", "marginally", "as", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "respectively,", "due", "to", "the", "decrease", "in", "2016", "and", "2", "015,", "respectively,", "of", "the", "average", "balance", "of", "the", "related", "liability", "as", "that", "liability", "balance", "amortizes.", "<tag3>"], "wordsA": ["Non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "year", "ended", "December", "31,", "2015", "and", "2014", "decreased", "marginally", "as", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "and", "2013,", "respectively,", "due", "to", "the", "decrease", "in", "2015", "and", "2014,", "respectively,", "of", "the", "average", "balance", "of", "the", "related", "liability", "as", "that", "liability", "balance", "amortizes."], "wordsB": ["Non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "decreased", "marginally", "as", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "respectively,", "due", "to", "the", "decrease", "in", "2016", "and", "2", "015,", "respectively,", "of", "the", "average", "balance", "of", "the", "related", "liability", "as", "that", "liability", "balance", "amortizes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p27_s3", "idA": "906709_16_item7_p34_s3", "sentA": "There are a number of factors that could materially affect the estimated interest rate, in particular, the amount and timing of royalty payments from future net sales of CIMZIA and MIRCERA , and we will assess this estimate on a periodic basis.", "sentB": "There are a number of factors that could materially af fect the estimated interest rate, in particular, the amount and timing of royalty payments from future net sales of CIMZIA and MIRCERA , and we will assess this estimate on a periodic basis.", "type": 2, "words": ["<tag1>", "There", "are", "a", "number", "of", "factors", "that", "could", "materially", "affect", "the", "estimated", "interest", "rate,", "in", "particular,", "the", "amount", "and", "timing", "of", "royalty", "payments", "from", "future", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", ",", "and", "we", "will", "assess", "this", "estimate", "on", "a", "periodic", "basis.", "<tag2>", "There", "are", "a", "number", "of", "factors", "that", "could", "materially", "af", "fect", "the", "estimated", "interest", "rate,", "in", "particular,", "the", "amount", "and", "timing", "of", "royalty", "payments", "from", "future", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", ",", "and", "we", "will", "assess", "this", "estimate", "on", "a", "periodic", "basis.", "<tag3>"], "wordsA": ["There", "are", "a", "number", "of", "factors", "that", "could", "materially", "affect", "the", "estimated", "interest", "rate,", "in", "particular,", "the", "amount", "and", "timing", "of", "royalty", "payments", "from", "future", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", ",", "and", "we", "will", "assess", "this", "estimate", "on", "a", "periodic", "basis."], "wordsB": ["There", "are", "a", "number", "of", "factors", "that", "could", "materially", "af", "fect", "the", "estimated", "interest", "rate,", "in", "particular,", "the", "amount", "and", "timing", "of", "royalty", "payments", "from", "future", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", ",", "and", "we", "will", "assess", "this", "estimate", "on", "a", "periodic", "basis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p27_s4", "idA": "906709_16_item7_p34_s4", "sentA": "As a result, future interest rates could differ significantly and any such change in interest rate will be adjusted prospectively.", "sentB": "As a result, future interest rates could differ significantly an d any such change in interest rate will be adjusted prospectively.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "future", "interest", "rates", "could", "differ", "significantly", "and", "any", "such", "change", "in", "interest", "rate", "will", "be", "adjusted", "prospectively.", "<tag2>", "As", "a", "result,", "future", "interest", "rates", "could", "differ", "significantly", "an", "d", "any", "such", "change", "in", "interest", "rate", "will", "be", "adjusted", "prospectively.", "<tag3>"], "wordsA": ["As", "a", "result,", "future", "interest", "rates", "could", "differ", "significantly", "and", "any", "such", "change", "in", "interest", "rate", "will", "be", "adjusted", "prospectively."], "wordsB": ["As", "a", "result,", "future", "interest", "rates", "could", "differ", "significantly", "an", "d", "any", "such", "change", "in", "interest", "rate", "will", "be", "adjusted", "prospectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p27_s5", "idA": "906709_16_item7_p34_s5", "sentA": "Unless we adjust our estimated interest rate, we expect non-cash interest expense on the liability related to sale of future royalties for 2016 to decrease marginally compared with 2015 as a result of the expected decrease in 2016 of the royalty liability balance.", "sentB": "Unless we adjust our estimated interest rate, we expect non-cash interest expense on the liability related to sale of future royalties for 2017 to decrease marginally compared with 2016 as a result of the decreasing royalty liability balance.", "type": 2, "words": ["<tag1>", "Unless", "we", "adjust", "our", "estimated", "interest", "rate,", "we", "expect", "non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "2016", "to", "decrease", "marginally", "compared", "with", "2015", "as", "a", "result", "of", "the", "expected", "decrease", "in", "2016", "of", "the", "royalty", "liability", "balance.", "<tag2>", "Unless", "we", "adjust", "our", "estimated", "interest", "rate,", "we", "expect", "non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "2017", "to", "decrease", "marginally", "compared", "with", "2016", "as", "a", "result", "of", "the", "decreasing", "royalty", "liability", "balance.", "<tag3>"], "wordsA": ["Unless", "we", "adjust", "our", "estimated", "interest", "rate,", "we", "expect", "non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "2016", "to", "decrease", "marginally", "compared", "with", "2015", "as", "a", "result", "of", "the", "expected", "decrease", "in", "2016", "of", "the", "royalty", "liability", "balance."], "wordsB": ["Unless", "we", "adjust", "our", "estimated", "interest", "rate,", "we", "expect", "non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "2017", "to", "decrease", "marginally", "compared", "with", "2016", "as", "a", "result", "of", "the", "decreasing", "royalty", "liability", "balance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p29_s0", "idA": "906709_16_item7_p36_s0", "sentA": "Liquidity and Capital Resources We have financed our operations primarily through revenue from product sales, royalties and research and development contracts, as well as public offering and private placements of debt and equity securities.", "sentB": "Liquidity and Capital Resources We have financed our operations primarily through revenue from product sales, royalties and strategic collaboration agreements, as well as public offering and private placements of debt and equity securities.", "type": 2, "words": ["<tag1>", "Liquidity", "and", "Capital", "Resources", "We", "have", "financed", "our", "operations", "primarily", "through", "revenue", "from", "product", "sales,", "royalties", "and", "research", "and", "development", "contracts,", "as", "well", "as", "public", "offering", "and", "private", "placements", "of", "debt", "and", "equity", "securities.", "<tag2>", "Liquidity", "and", "Capital", "Resources", "We", "have", "financed", "our", "operations", "primarily", "through", "revenue", "from", "product", "sales,", "royalties", "and", "strategic", "collaboration", "agreements,", "as", "well", "as", "public", "offering", "and", "private", "placements", "of", "debt", "and", "equity", "securities.", "<tag3>"], "wordsA": ["Liquidity", "and", "Capital", "Resources", "We", "have", "financed", "our", "operations", "primarily", "through", "revenue", "from", "product", "sales,", "royalties", "and", "research", "and", "development", "contracts,", "as", "well", "as", "public", "offering", "and", "private", "placements", "of", "debt", "and", "equity", "securities."], "wordsB": ["Liquidity", "and", "Capital", "Resources", "We", "have", "financed", "our", "operations", "primarily", "through", "revenue", "from", "product", "sales,", "royalties", "and", "strategic", "collaboration", "agreements,", "as", "well", "as", "public", "offering", "and", "private", "placements", "of", "debt", "and", "equity", "securities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p29_s1", "idA": "906709_16_item7_p36_s1", "sentA": "At December 31, 2015, we had approximately $308.9 million in cash and investments in marketable securities.", "sentB": "At December 31, 2016, we had approximately $389.1 million in cash and investments in marketable securities.", "type": 2, "words": ["<tag1>", "At", "December", "31,", "2015,", "we", "had", "approximately", "$308.9", "million", "in", "cash", "and", "investments", "in", "marketable", "securities.", "<tag2>", "At", "December", "31,", "2016,", "we", "had", "approximately", "$389.1", "million", "in", "cash", "and", "investments", "in", "marketable", "securities.", "<tag3>"], "wordsA": ["At", "December", "31,", "2015,", "we", "had", "approximately", "$308.9", "million", "in", "cash", "and", "investments", "in", "marketable", "securities."], "wordsB": ["At", "December", "31,", "2016,", "we", "had", "approximately", "$389.1", "million", "in", "cash", "and", "investments", "in", "marketable", "securities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p2_s3", "idA": "906709_16_item7_p36_s1", "sentA": "At December 31, 2015, we had approximately $308.9 million in cash and investments in marketable securities.", "sentB": "At December 31, 2016, we had approximately $389.1 million in cash and investments in marketable securities.", "type": 2, "words": ["<tag1>", "At", "December", "31,", "2015,", "we", "had", "approximately", "$308.9", "million", "in", "cash", "and", "investments", "in", "marketable", "securities.", "<tag2>", "At", "December", "31,", "2016,", "we", "had", "approximately", "$389.1", "million", "in", "cash", "and", "investments", "in", "marketable", "securities.", "<tag3>"], "wordsA": ["At", "December", "31,", "2015,", "we", "had", "approximately", "$308.9", "million", "in", "cash", "and", "investments", "in", "marketable", "securities."], "wordsB": ["At", "December", "31,", "2016,", "we", "had", "approximately", "$389.1", "million", "in", "cash", "and", "investments", "in", "marketable", "securities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p29_s2", "idA": "906709_16_item7_p36_s2", "sentA": "Also, as of December 31, 2015, we had $255.8 million in debt, including $250.0 million in principal of senior secured notes and $5.8 million of capital lease obligations.", "sentB": "Also, as of December 31, 2016, we had $255.1 million in debt, including $250.0 million in principal of senior secured notes and $5.1 million of capital lease obligations.", "type": 2, "words": ["<tag1>", "Also,", "as", "of", "December", "31,", "2015,", "we", "had", "$255.8", "million", "in", "debt,", "including", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "and", "$5.8", "million", "of", "capital", "lease", "obligations.", "<tag2>", "Also,", "as", "of", "December", "31,", "2016,", "we", "had", "$255.1", "million", "in", "debt,", "including", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "and", "$5.1", "million", "of", "capital", "lease", "obligations.", "<tag3>"], "wordsA": ["Also,", "as", "of", "December", "31,", "2015,", "we", "had", "$255.8", "million", "in", "debt,", "including", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "and", "$5.8", "million", "of", "capital", "lease", "obligations."], "wordsB": ["Also,", "as", "of", "December", "31,", "2016,", "we", "had", "$255.1", "million", "in", "debt,", "including", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "and", "$5.1", "million", "of", "capital", "lease", "obligations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p2_s4", "idA": "906709_16_item7_p36_s2", "sentA": "Also, as of December 31, 2015, we had $255.8 million in debt, including $250.0 million in principal of senior secured notes and $5.8 million of capital lease obligations.", "sentB": "Also, as of December 31, 2016, we had $255.1 million in debt, including $250.0 million in principal of senior secured notes and $5.1 million of capital lease obligations.", "type": 2, "words": ["<tag1>", "Also,", "as", "of", "December", "31,", "2015,", "we", "had", "$255.8", "million", "in", "debt,", "including", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "and", "$5.8", "million", "of", "capital", "lease", "obligations.", "<tag2>", "Also,", "as", "of", "December", "31,", "2016,", "we", "had", "$255.1", "million", "in", "debt,", "including", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "and", "$5.1", "million", "of", "capital", "lease", "obligations.", "<tag3>"], "wordsA": ["Also,", "as", "of", "December", "31,", "2015,", "we", "had", "$255.8", "million", "in", "debt,", "including", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "and", "$5.8", "million", "of", "capital", "lease", "obligations."], "wordsB": ["Also,", "as", "of", "December", "31,", "2016,", "we", "had", "$255.1", "million", "in", "debt,", "including", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "and", "$5.1", "million", "of", "capital", "lease", "obligations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p2_s5", "idA": "906709_16_item7_p36_s3", "sentA": "As is further described in Note 5 to our Consolidated Financial Statements, on October 5, 2015, we issued $250.0 million in aggregate principal amount of 7.75% senior secured notes due October 2020.", "sentB": "As is further described in Note 9 to our Consolidated Financial Statements, on October 24, 2016, we completed a public offering of common stock with net proceeds of approximately $189.3 million.", "type": 2, "words": ["<tag1>", "As", "is", "further", "described", "in", "Note", "5", "to", "our", "Consolidated", "Financial", "Statements,", "on", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "October", "2020.", "<tag2>", "As", "is", "further", "described", "in", "Note", "9", "to", "our", "Consolidated", "Financial", "Statements,", "on", "October", "24,", "2016,", "we", "completed", "a", "public", "offering", "of", "common", "stock", "with", "net", "proceeds", "of", "approximately", "$189.3", "million.", "<tag3>"], "wordsA": ["As", "is", "further", "described", "in", "Note", "5", "to", "our", "Consolidated", "Financial", "Statements,", "on", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "October", "2020."], "wordsB": ["As", "is", "further", "described", "in", "Note", "9", "to", "our", "Consolidated", "Financial", "Statements,", "on", "October", "24,", "2016,", "we", "completed", "a", "public", "offering", "of", "common", "stock", "with", "net", "proceeds", "of", "approximately", "$189.3", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p29_s5", "idA": "906709_16_item7_p37_s1", "sentA": "We expect the clinical development of our proprietary drug candidates including NKTR-181 , Amikacin Inhale, and NKTR- 214 , will require significant investment in order to continue to advance in clinical development with the ob jective of entering into a collaboration partnership or obtaining regulatory approval.", "sentB": "We expect the clinical development of our proprietary drug candidates including NKTR-181, Amikacin Inhale, ONZEALD TM , NKTR-214, and NKTR-358, will require significant investment in order to continue to advance in clinical development with the objective of entering into a collaboration partnership or obtaining regulatory approval.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates", "including", "NKTR-181", ",", "Amikacin", "Inhale,", "and", "NKTR-", "214", ",", "will", "require", "significant", "investment", "in", "order", "to", "continue", "to", "advance", "in", "clinical", "development", "with", "the", "ob", "jective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval.", "<tag2>", "We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates", "including", "NKTR-181,", "Amikacin", "Inhale,", "ONZEALD", "TM", ",", "NKTR-214,", "and", "NKTR-358,", "will", "require", "significant", "investment", "in", "order", "to", "continue", "to", "advance", "in", "clinical", "development", "with", "the", "objective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval.", "<tag3>"], "wordsA": ["We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates", "including", "NKTR-181", ",", "Amikacin", "Inhale,", "and", "NKTR-", "214", ",", "will", "require", "significant", "investment", "in", "order", "to", "continue", "to", "advance", "in", "clinical", "development", "with", "the", "ob", "jective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval."], "wordsB": ["We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates", "including", "NKTR-181,", "Amikacin", "Inhale,", "ONZEALD", "TM", ",", "NKTR-214,", "and", "NKTR-358,", "will", "require", "significant", "investment", "in", "order", "to", "continue", "to", "advance", "in", "clinical", "development", "with", "the", "objective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p29_s7", "idA": "906709_16_item7_p37_s3", "sentA": "In the past we have received a number of significant payments from collaboration agreement s and other significant transactions.", "sentB": "In the past we have received a number of significant payments from collaboration agreements and other significant transactions.", "type": 2, "words": ["<tag1>", "In", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "collaboration", "agreement", "s", "and", "other", "significant", "transactions.", "<tag2>", "In", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "collaboration", "agreements", "and", "other", "significant", "transactions.", "<tag3>"], "wordsA": ["In", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "collaboration", "agreement", "s", "and", "other", "significant", "transactions."], "wordsB": ["In", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "collaboration", "agreements", "and", "other", "significant", "transactions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p29_s8", "idA": "906709_16_item7_p37_s4", "sentA": "In the future , we expect to receive royalties from commercial sales of products such as MOVANTIK TM and ADYNOVATE TM and potential substantial payments from future collaboration transactions if drug candidates in our pi peline achieve positive clinical or regulatory outcomes.", "sentB": "In the future, we expect to continue to receive increasing royalties from commercial sales of products such as MOVANTIK , MOVENTIG and ADYNOVATE as they continue to increase sales after their recent product launches and potential substantial payments from future collaboration transactions if drug candidates in our pipeline achieve positive clinical or regulatory outcomes.", "type": 2, "words": ["<tag1>", "In", "the", "future", ",", "we", "expect", "to", "receive", "royalties", "from", "commercial", "sales", "of", "products", "such", "as", "MOVANTIK", "TM", "and", "ADYNOVATE", "TM", "and", "potential", "substantial", "payments", "from", "future", "collaboration", "transactions", "if", "drug", "candidates", "in", "our", "pi", "peline", "achieve", "positive", "clinical", "or", "regulatory", "outcomes.", "<tag2>", "In", "the", "future,", "we", "expect", "to", "continue", "to", "receive", "increasing", "royalties", "from", "commercial", "sales", "of", "products", "such", "as", "MOVANTIK", ",", "MOVENTIG", "and", "ADYNOVATE", "as", "they", "continue", "to", "increase", "sales", "after", "their", "recent", "product", "launches", "and", "potential", "substantial", "payments", "from", "future", "collaboration", "transactions", "if", "drug", "candidates", "in", "our", "pipeline", "achieve", "positive", "clinical", "or", "regulatory", "outcomes.", "<tag3>"], "wordsA": ["In", "the", "future", ",", "we", "expect", "to", "receive", "royalties", "from", "commercial", "sales", "of", "products", "such", "as", "MOVANTIK", "TM", "and", "ADYNOVATE", "TM", "and", "potential", "substantial", "payments", "from", "future", "collaboration", "transactions", "if", "drug", "candidates", "in", "our", "pi", "peline", "achieve", "positive", "clinical", "or", "regulatory", "outcomes."], "wordsB": ["In", "the", "future,", "we", "expect", "to", "continue", "to", "receive", "increasing", "royalties", "from", "commercial", "sales", "of", "products", "such", "as", "MOVANTIK", ",", "MOVENTIG", "and", "ADYNOVATE", "as", "they", "continue", "to", "increase", "sales", "after", "their", "recent", "product", "launches", "and", "potential", "substantial", "payments", "from", "future", "collaboration", "transactions", "if", "drug", "candidates", "in", "our", "pipeline", "achieve", "positive", "clinical", "or", "regulatory", "outcomes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p29_s9", "idA": "906709_16_item7_p37_s5", "sentA": "Our current business plan is also subject to significant uncertainties and risks as a result of, among other factors, the sales levels of products for which we are entitled to royalties such as MOVAN TIK TM , clinical program outcomes, whether, when and on what terms we are able to enter into new collaboration transactions, expenses being higher than anticipated, unplanned expenses, cash receipts being lower than anticipated, and the need to satisfy cont ingent liabilities, including litigation matters and indemnification obligations.", "sentB": "Our current business plan is also subject to significant uncertainties and risks as a result of, among other factors, the sales levels of products for which we are entitled to royalties such as MOVANTIK , MOVENTIG and ADYNOVATE , clinical program outcomes, whether, when and on what terms we are able to enter into new collaboration transactions, expenses being higher than anticipated, unplanned expenses, cash receipts being lower than anticipated, and the need to satisfy contingent liabilities, including litigation matters and indemnification obligations.", "type": 2, "words": ["<tag1>", "Our", "current", "business", "plan", "is", "also", "subject", "to", "significant", "uncertainties", "and", "risks", "as", "a", "result", "of,", "among", "other", "factors,", "the", "sales", "levels", "of", "products", "for", "which", "we", "are", "entitled", "to", "royalties", "such", "as", "MOVAN", "TIK", "TM", ",", "clinical", "program", "outcomes,", "whether,", "when", "and", "on", "what", "terms", "we", "are", "able", "to", "enter", "into", "new", "collaboration", "transactions,", "expenses", "being", "higher", "than", "anticipated,", "unplanned", "expenses,", "cash", "receipts", "being", "lower", "than", "anticipated,", "and", "the", "need", "to", "satisfy", "cont", "ingent", "liabilities,", "including", "litigation", "matters", "and", "indemnification", "obligations.", "<tag2>", "Our", "current", "business", "plan", "is", "also", "subject", "to", "significant", "uncertainties", "and", "risks", "as", "a", "result", "of,", "among", "other", "factors,", "the", "sales", "levels", "of", "products", "for", "which", "we", "are", "entitled", "to", "royalties", "such", "as", "MOVANTIK", ",", "MOVENTIG", "and", "ADYNOVATE", ",", "clinical", "program", "outcomes,", "whether,", "when", "and", "on", "what", "terms", "we", "are", "able", "to", "enter", "into", "new", "collaboration", "transactions,", "expenses", "being", "higher", "than", "anticipated,", "unplanned", "expenses,", "cash", "receipts", "being", "lower", "than", "anticipated,", "and", "the", "need", "to", "satisfy", "contingent", "liabilities,", "including", "litigation", "matters", "and", "indemnification", "obligations.", "<tag3>"], "wordsA": ["Our", "current", "business", "plan", "is", "also", "subject", "to", "significant", "uncertainties", "and", "risks", "as", "a", "result", "of,", "among", "other", "factors,", "the", "sales", "levels", "of", "products", "for", "which", "we", "are", "entitled", "to", "royalties", "such", "as", "MOVAN", "TIK", "TM", ",", "clinical", "program", "outcomes,", "whether,", "when", "and", "on", "what", "terms", "we", "are", "able", "to", "enter", "into", "new", "collaboration", "transactions,", "expenses", "being", "higher", "than", "anticipated,", "unplanned", "expenses,", "cash", "receipts", "being", "lower", "than", "anticipated,", "and", "the", "need", "to", "satisfy", "cont", "ingent", "liabilities,", "including", "litigation", "matters", "and", "indemnification", "obligations."], "wordsB": ["Our", "current", "business", "plan", "is", "also", "subject", "to", "significant", "uncertainties", "and", "risks", "as", "a", "result", "of,", "among", "other", "factors,", "the", "sales", "levels", "of", "products", "for", "which", "we", "are", "entitled", "to", "royalties", "such", "as", "MOVANTIK", ",", "MOVENTIG", "and", "ADYNOVATE", ",", "clinical", "program", "outcomes,", "whether,", "when", "and", "on", "what", "terms", "we", "are", "able", "to", "enter", "into", "new", "collaboration", "transactions,", "expenses", "being", "higher", "than", "anticipated,", "unplanned", "expenses,", "cash", "receipts", "being", "lower", "than", "anticipated,", "and", "the", "need", "to", "satisfy", "contingent", "liabilities,", "including", "litigation", "matters", "and", "indemnification", "obligations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p29_s10", "idA": "906709_16_item7_p38_s0", "sentA": "The availability and terms of various financing alternatives substantially depend on many factors including the success or failure of drug development programs in our pipeline, including NKTR-181, Amikacin Inhale and NKTR-214, as well as other early stage development programs.", "sentB": "The availability and terms of various financing alternatives substantially depend on many factors including the success or failure of drug development programs in our pipeline, including NKTR-181, Amikacin Inhale, CIPRO DPI, Fovista , ONZEALD TM , NKTR-214 and NKTR-358, as well as other early stage development programs.", "type": 2, "words": ["<tag1>", "The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "many", "factors", "including", "the", "success", "or", "failure", "of", "drug", "development", "programs", "in", "our", "pipeline,", "including", "NKTR-181,", "Amikacin", "Inhale", "and", "NKTR-214,", "as", "well", "as", "other", "early", "stage", "development", "programs.", "<tag2>", "The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "many", "factors", "including", "the", "success", "or", "failure", "of", "drug", "development", "programs", "in", "our", "pipeline,", "including", "NKTR-181,", "Amikacin", "Inhale,", "CIPRO", "DPI,", "Fovista", ",", "ONZEALD", "TM", ",", "NKTR-214", "and", "NKTR-358,", "as", "well", "as", "other", "early", "stage", "development", "programs.", "<tag3>"], "wordsA": ["The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "many", "factors", "including", "the", "success", "or", "failure", "of", "drug", "development", "programs", "in", "our", "pipeline,", "including", "NKTR-181,", "Amikacin", "Inhale", "and", "NKTR-214,", "as", "well", "as", "other", "early", "stage", "development", "programs."], "wordsB": ["The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "many", "factors", "including", "the", "success", "or", "failure", "of", "drug", "development", "programs", "in", "our", "pipeline,", "including", "NKTR-181,", "Amikacin", "Inhale,", "CIPRO", "DPI,", "Fovista", ",", "ONZEALD", "TM", ",", "NKTR-214", "and", "NKTR-358,", "as", "well", "as", "other", "early", "stage", "development", "programs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p30_s1", "idA": "906709_16_item7_p38_s11", "sentA": "We expect that cash flows used in operating activities, excluding upfront, milestone and other contingent payments received, if any, will decrease in 2016 compared to 2015 primarily as a result of increased cash receipts from product sales and royalties.", "sentB": "We expect that cash flows used in operating activities, excluding upfront, milestone and other contingent payments received, if any, will increase in the full year of 2017 compared to 2016 primarily as a result of increased research and development expenses.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront,", "milestone", "and", "other", "contingent", "payments", "received,", "if", "any,", "will", "decrease", "in", "2016", "compared", "to", "2015", "primarily", "as", "a", "result", "of", "increased", "cash", "receipts", "from", "product", "sales", "and", "royalties.", "<tag2>", "We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront,", "milestone", "and", "other", "contingent", "payments", "received,", "if", "any,", "will", "increase", "in", "the", "full", "year", "of", "2017", "compared", "to", "2016", "primarily", "as", "a", "result", "of", "increased", "research", "and", "development", "expenses.", "<tag3>"], "wordsA": ["We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront,", "milestone", "and", "other", "contingent", "payments", "received,", "if", "any,", "will", "decrease", "in", "2016", "compared", "to", "2015", "primarily", "as", "a", "result", "of", "increased", "cash", "receipts", "from", "product", "sales", "and", "royalties."], "wordsB": ["We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront,", "milestone", "and", "other", "contingent", "payments", "received,", "if", "any,", "will", "increase", "in", "the", "full", "year", "of", "2017", "compared", "to", "2016", "primarily", "as", "a", "result", "of", "increased", "research", "and", "development", "expenses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p30_s5", "idA": "906709_16_item7_p38_s15", "sentA": "Cash flows from investing activities We paid $11.2 million, $10.0 million, and $4.1 million to purchase property, plant and equipment in the years ended December 31, 2015, 2014, and 2013, respectively.", "sentB": "Cash flows from investing activities We paid $6.4 million, $11.2 million, and $10.0 million to purchase property, plant and equipment in the years ended December 31, 2016, 2015, and 2014, respectively.", "type": 2, "words": ["<tag1>", "Cash", "flows", "from", "investing", "activities", "We", "paid", "$11.2", "million,", "$10.0", "million,", "and", "$4.1", "million", "to", "purchase", "property,", "plant", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2015,", "2014,", "and", "2013,", "respectively.", "<tag2>", "Cash", "flows", "from", "investing", "activities", "We", "paid", "$6.4", "million,", "$11.2", "million,", "and", "$10.0", "million", "to", "purchase", "property,", "plant", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2016,", "2015,", "and", "2014,", "respectively.", "<tag3>"], "wordsA": ["Cash", "flows", "from", "investing", "activities", "We", "paid", "$11.2", "million,", "$10.0", "million,", "and", "$4.1", "million", "to", "purchase", "property,", "plant", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2015,", "2014,", "and", "2013,", "respectively."], "wordsB": ["Cash", "flows", "from", "investing", "activities", "We", "paid", "$6.4", "million,", "$11.2", "million,", "and", "$10.0", "million", "to", "purchase", "property,", "plant", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2016,", "2015,", "and", "2014,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p30_s6", "idA": "906709_16_item7_p38_s16", "sentA": "We expect our capital expenditures in 2016 to decrease marginally compared to 2015.", "sentB": "We expect our capital expenditures in 2017 to increase compared to 2016.", "type": 2, "words": ["<tag1>", "We", "expect", "our", "capital", "expenditures", "in", "2016", "to", "decrease", "marginally", "compared", "to", "2015.", "<tag2>", "We", "expect", "our", "capital", "expenditures", "in", "2017", "to", "increase", "compared", "to", "2016.", "<tag3>"], "wordsA": ["We", "expect", "our", "capital", "expenditures", "in", "2016", "to", "decrease", "marginally", "compared", "to", "2015."], "wordsB": ["We", "expect", "our", "capital", "expenditures", "in", "2017", "to", "increase", "compared", "to", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p29_s13", "idA": "906709_16_item7_p38_s3", "sentA": "Due to the potential for adverse developments in the credit markets in 2016 and thereafter, we may experience reduced liquidity with respect to some of our investments in marketable securities.", "sentB": "Due to the potential for adverse developments in the credit markets in 2017 and thereafter, we may experience reduced liquidity with respect to some of our investments in marketable securities.", "type": 2, "words": ["<tag1>", "Due", "to", "the", "potential", "for", "adverse", "developments", "in", "the", "credit", "markets", "in", "2016", "and", "thereafter,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities.", "<tag2>", "Due", "to", "the", "potential", "for", "adverse", "developments", "in", "the", "credit", "markets", "in", "2017", "and", "thereafter,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities.", "<tag3>"], "wordsA": ["Due", "to", "the", "potential", "for", "adverse", "developments", "in", "the", "credit", "markets", "in", "2016", "and", "thereafter,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities."], "wordsB": ["Due", "to", "the", "potential", "for", "adverse", "developments", "in", "the", "credit", "markets", "in", "2017", "and", "thereafter,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p29_s16", "idA": "906709_16_item7_p38_s6", "sentA": "At December 31, 2015, the average time to maturity of the investments held in our portfolio was approximately five months and the maturity of any single investment did not exceed one year.", "sentB": "At December 31, 2016, the average time to maturity of the investments held in our portfolio was approximately five months and the maturity of any single investment did not exceed one year.", "type": 2, "words": ["<tag1>", "At", "December", "31,", "2015,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "five", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "one", "year.", "<tag2>", "At", "December", "31,", "2016,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "five", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "one", "year.", "<tag3>"], "wordsA": ["At", "December", "31,", "2015,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "five", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "one", "year."], "wordsB": ["At", "December", "31,", "2016,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "five", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "one", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p29_s17", "idA": "906709_16_item7_p38_s7", "sentA": "To date we have not experienced any liquidity issues with respect to these securities, but if such issues arise, we may be required to hold some, or all, of these securities until maturity.", "sentB": "To date we have not experienced any liquidity issues with respect to these securities.", "type": 2, "words": ["<tag1>", "To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "if", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity.", "<tag2>", "To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities.", "<tag3>"], "wordsA": ["To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities,", "but", "if", "such", "issues", "arise,", "we", "may", "be", "required", "to", "hold", "some,", "or", "all,", "of", "these", "securities", "until", "maturity."], "wordsB": ["To", "date", "we", "have", "not", "experienced", "any", "liquidity", "issues", "with", "respect", "to", "these", "securities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p30_s0", "idA": "906709_16_item7_p38_s9", "sentA": "Cash flows from operating activities Cash flows used in operating activities for the year ended December 31, 2015 totaled $73.1 million, which includes $196.3 million of net operating cash uses as well as $18.8 million for interest payments on our senior secured notes, partially offset by the receipt of $142.0 million of milestones and other contingent payments from collaboration agreements.", "sentB": "Cash flows from operating activities Cash flows used in operating activities for the year ended December 31, 2016 totaled $117.0 million, which includes $158.3 million of net operating cash uses as well as $19.7 million for interest payments on our senior secured notes, partially offset by the receipt of $31.0 million of payments from AstraZeneca related to its sub-license to Kirin, the receipt of a $20.0 million upfront payment in August 2016 from Daiichi Sankyo related to our ONZEALD TM collaboration arrangement in Europe, as well as the receipt of a $10.0 million milestone in January 2016 from our Baxalta collaboration agreement, which was recorded in accounts receivable in our Consolidated Balance Sheet at December 31, 2015.", "type": 2, "words": ["<tag1>", "Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2015", "totaled", "$73.1", "million,", "which", "includes", "$196.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$18.8", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$142.0", "million", "of", "milestones", "and", "other", "contingent", "payments", "from", "collaboration", "agreements.", "<tag2>", "Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2016", "totaled", "$117.0", "million,", "which", "includes", "$158.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$19.7", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$31.0", "million", "of", "payments", "from", "AstraZeneca", "related", "to", "its", "sub-license", "to", "Kirin,", "the", "receipt", "of", "a", "$20.0", "million", "upfront", "payment", "in", "August", "2016", "from", "Daiichi", "Sankyo", "related", "to", "our", "ONZEALD", "TM", "collaboration", "arrangement", "in", "Europe,", "as", "well", "as", "the", "receipt", "of", "a", "$10.0", "million", "milestone", "in", "January", "2016", "from", "our", "Baxalta", "collaboration", "agreement,", "which", "was", "recorded", "in", "accounts", "receivable", "in", "our", "Consolidated", "Balance", "Sheet", "at", "December", "31,", "2015.", "<tag3>"], "wordsA": ["Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2015", "totaled", "$73.1", "million,", "which", "includes", "$196.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$18.8", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$142.0", "million", "of", "milestones", "and", "other", "contingent", "payments", "from", "collaboration", "agreements."], "wordsB": ["Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2016", "totaled", "$117.0", "million,", "which", "includes", "$158.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$19.7", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$31.0", "million", "of", "payments", "from", "AstraZeneca", "related", "to", "its", "sub-license", "to", "Kirin,", "the", "receipt", "of", "a", "$20.0", "million", "upfront", "payment", "in", "August", "2016", "from", "Daiichi", "Sankyo", "related", "to", "our", "ONZEALD", "TM", "collaboration", "arrangement", "in", "Europe,", "as", "well", "as", "the", "receipt", "of", "a", "$10.0", "million", "milestone", "in", "January", "2016", "from", "our", "Baxalta", "collaboration", "agreement,", "which", "was", "recorded", "in", "accounts", "receivable", "in", "our", "Consolidated", "Balance", "Sheet", "at", "December", "31,", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p30_s2", "idA": "906709_16_item7_p38_s9", "sentA": "Cash flows from operating activities Cash flows used in operating activities for the year ended December 31, 2015 totaled $73.1 million, which includes $196.3 million of net operating cash uses as well as $18.8 million for interest payments on our senior secured notes, partially offset by the receipt of $142.0 million of milestones and other contingent payments from collaboration agreements.", "sentB": "Cash flows used in operating activities for the year ended December 31, 2015 totaled $73.1 million, which includes $196.3 million of net operating cash uses as well as $18.8 million for interest payments on our senior secured notes, partially offset by the receipt of $142.0 million of milestones and other contingent payments from collaboration agreements.", "type": 2, "words": ["<tag1>", "Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2015", "totaled", "$73.1", "million,", "which", "includes", "$196.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$18.8", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$142.0", "million", "of", "milestones", "and", "other", "contingent", "payments", "from", "collaboration", "agreements.", "<tag2>", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2015", "totaled", "$73.1", "million,", "which", "includes", "$196.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$18.8", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$142.0", "million", "of", "milestones", "and", "other", "contingent", "payments", "from", "collaboration", "agreements.", "<tag3>"], "wordsA": ["Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2015", "totaled", "$73.1", "million,", "which", "includes", "$196.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$18.8", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$142.0", "million", "of", "milestones", "and", "other", "contingent", "payments", "from", "collaboration", "agreements."], "wordsB": ["Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2015", "totaled", "$73.1", "million,", "which", "includes", "$196.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$18.8", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$142.0", "million", "of", "milestones", "and", "other", "contingent", "payments", "from", "collaboration", "agreements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p31_s2", "idA": "906709_16_item7_p39_s0", "sentA": "Ca sh flows used in financing activities On October 5, 2015, we issued $250.0 million in aggregate principal amount of 7.75% senior secured notes due 2020 ( Notes ).", "sentB": "On October 5, 2015, we issued $250.0 million in aggregate principal amount of 7.75% senior secured notes due 2020.", "type": 2, "words": ["<tag1>", "Ca", "sh", "flows", "used", "in", "financing", "activities", "On", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "2020", "(", "Notes", ").", "<tag2>", "On", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "2020.", "<tag3>"], "wordsA": ["Ca", "sh", "flows", "used", "in", "financing", "activities", "On", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "2020", "(", "Notes", ")."], "wordsB": ["On", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "2020."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p31_s3", "idA": "906709_16_item7_p39_s1", "sentA": "The Notes bear interest at a rate of 7.75% per annum payable in cash quarterly in arrears on January 15, April 15, July 15, and October 15 of each year, beginning on October 15, 2015.", "sentB": "The notes bear interest at a rate of 7.75% per annum payable in cash quarterly in arrears on January 15, April 15, July 15, and October 15 of each year.", "type": 2, "words": ["<tag1>", "The", "Notes", "bear", "interest", "at", "a", "rate", "of", "7.75%", "per", "annum", "payable", "in", "cash", "quarterly", "in", "arrears", "on", "January", "15,", "April", "15,", "July", "15,", "and", "October", "15", "of", "each", "year,", "beginning", "on", "October", "15,", "2015.", "<tag2>", "The", "notes", "bear", "interest", "at", "a", "rate", "of", "7.75%", "per", "annum", "payable", "in", "cash", "quarterly", "in", "arrears", "on", "January", "15,", "April", "15,", "July", "15,", "and", "October", "15", "of", "each", "year.", "<tag3>"], "wordsA": ["The", "Notes", "bear", "interest", "at", "a", "rate", "of", "7.75%", "per", "annum", "payable", "in", "cash", "quarterly", "in", "arrears", "on", "January", "15,", "April", "15,", "July", "15,", "and", "October", "15", "of", "each", "year,", "beginning", "on", "October", "15,", "2015."], "wordsB": ["The", "notes", "bear", "interest", "at", "a", "rate", "of", "7.75%", "per", "annum", "payable", "in", "cash", "quarterly", "in", "arrears", "on", "January", "15,", "April", "15,", "July", "15,", "and", "October", "15", "of", "each", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p25_s3", "idA": "906709_16_item7_p39_s2", "sentA": "Interest is calculated based on actual days outstanding over a 360 day year.", "sentB": "Interest on the 7.75% senior secured notes is calculated based on actual days outstanding over a 360 day year.", "type": 2, "words": ["<tag1>", "Interest", "is", "calculated", "based", "on", "actual", "days", "outstanding", "over", "a", "360", "day", "year.", "<tag2>", "Interest", "on", "the", "7.75%", "senior", "secured", "notes", "is", "calculated", "based", "on", "actual", "days", "outstanding", "over", "a", "360", "day", "year.", "<tag3>"], "wordsA": ["Interest", "is", "calculated", "based", "on", "actual", "days", "outstanding", "over", "a", "360", "day", "year."], "wordsB": ["Interest", "on", "the", "7.75%", "senior", "secured", "notes", "is", "calculated", "based", "on", "actual", "days", "outstanding", "over", "a", "360", "day", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p31_s4", "idA": "906709_16_item7_p39_s3", "sentA": "In connection with the issuance of the Notes, we paid fees and expenses of approximately $8.9 million, of which $8.3 million of transaction and facility fees paid to the purchasers of the Notes was capitalized as a debt discount and recorded as a reduction to the note payable liability.", "sentB": "In connection with the issuance of the notes, we paid $8.7 million of transaction and facility fees paid to the purchasers of the notes and other direct costs, which were capitalized as a debt discount and issuance costs and are recorded as a reduction to the note payable liability.", "type": 2, "words": ["<tag1>", "In", "connection", "with", "the", "issuance", "of", "the", "Notes,", "we", "paid", "fees", "and", "expenses", "of", "approximately", "$8.9", "million,", "of", "which", "$8.3", "million", "of", "transaction", "and", "facility", "fees", "paid", "to", "the", "purchasers", "of", "the", "Notes", "was", "capitalized", "as", "a", "debt", "discount", "and", "recorded", "as", "a", "reduction", "to", "the", "note", "payable", "liability.", "<tag2>", "In", "connection", "with", "the", "issuance", "of", "the", "notes,", "we", "paid", "$8.7", "million", "of", "transaction", "and", "facility", "fees", "paid", "to", "the", "purchasers", "of", "the", "notes", "and", "other", "direct", "costs,", "which", "were", "capitalized", "as", "a", "debt", "discount", "and", "issuance", "costs", "and", "are", "recorded", "as", "a", "reduction", "to", "the", "note", "payable", "liability.", "<tag3>"], "wordsA": ["In", "connection", "with", "the", "issuance", "of", "the", "Notes,", "we", "paid", "fees", "and", "expenses", "of", "approximately", "$8.9", "million,", "of", "which", "$8.3", "million", "of", "transaction", "and", "facility", "fees", "paid", "to", "the", "purchasers", "of", "the", "Notes", "was", "capitalized", "as", "a", "debt", "discount", "and", "recorded", "as", "a", "reduction", "to", "the", "note", "payable", "liability."], "wordsB": ["In", "connection", "with", "the", "issuance", "of", "the", "notes,", "we", "paid", "$8.7", "million", "of", "transaction", "and", "facility", "fees", "paid", "to", "the", "purchasers", "of", "the", "notes", "and", "other", "direct", "costs,", "which", "were", "capitalized", "as", "a", "debt", "discount", "and", "issuance", "costs", "and", "are", "recorded", "as", "a", "reduction", "to", "the", "note", "payable", "liability."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p31_s5", "idA": "906709_16_item7_p39_s5", "sentA": "On October 5, 2015, we used a portion of the proceeds from the Notes to redeem the $125.0 million in aggregate principal amount of 12.0% senior secured notes due in 2017.", "sentB": "On October 5, 2015, we used a portion of the proceeds from these notes to redeem the $125.0 million in aggregate principal amount of 12.0% senior secured notes due in 2017.", "type": 2, "words": ["<tag1>", "On", "October", "5,", "2015,", "we", "used", "a", "portion", "of", "the", "proceeds", "from", "the", "Notes", "to", "redeem", "the", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "in", "2017.", "<tag2>", "On", "October", "5,", "2015,", "we", "used", "a", "portion", "of", "the", "proceeds", "from", "these", "notes", "to", "redeem", "the", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "in", "2017.", "<tag3>"], "wordsA": ["On", "October", "5,", "2015,", "we", "used", "a", "portion", "of", "the", "proceeds", "from", "the", "Notes", "to", "redeem", "the", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "in", "2017."], "wordsB": ["On", "October", "5,", "2015,", "we", "used", "a", "portion", "of", "the", "proceeds", "from", "these", "notes", "to", "redeem", "the", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "in", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p0_s14", "idA": "906709_16_item7_p3_s2", "sentA": "In November 2015, ADYNOVATE TM was approved by the FDA for use in adults and adolescents, aged 12 years and older, who have Hemophilia A. Baxalta announced the launch and first shipments of ADYNOVATE TM on November 30, 2015.", "sentB": "We have a collaboration with Baxalta (a wholly-owned subsidiary of Shire plc) for ADYNOVATE , that was approved by the FDA in late 2015 for use in adults and adolescents, aged 12 years and older, who have Hemophilia A.", "type": 2, "words": ["<tag1>", "In", "November", "2015,", "ADYNOVATE", "TM", "was", "approved", "by", "the", "FDA", "for", "use", "in", "adults", "and", "adolescents,", "aged", "12", "years", "and", "older,", "who", "have", "Hemophilia", "A.", "Baxalta", "announced", "the", "launch", "and", "first", "shipments", "of", "ADYNOVATE", "TM", "on", "November", "30,", "2015.", "<tag2>", "We", "have", "a", "collaboration", "with", "Baxalta", "(a", "wholly-owned", "subsidiary", "of", "Shire", "plc)", "for", "ADYNOVATE", ",", "that", "was", "approved", "by", "the", "FDA", "in", "late", "2015", "for", "use", "in", "adults", "and", "adolescents,", "aged", "12", "years", "and", "older,", "who", "have", "Hemophilia", "A.", "<tag3>"], "wordsA": ["In", "November", "2015,", "ADYNOVATE", "TM", "was", "approved", "by", "the", "FDA", "for", "use", "in", "adults", "and", "adolescents,", "aged", "12", "years", "and", "older,", "who", "have", "Hemophilia", "A.", "Baxalta", "announced", "the", "launch", "and", "first", "shipments", "of", "ADYNOVATE", "TM", "on", "November", "30,", "2015."], "wordsB": ["We", "have", "a", "collaboration", "with", "Baxalta", "(a", "wholly-owned", "subsidiary", "of", "Shire", "plc)", "for", "ADYNOVATE", ",", "that", "was", "approved", "by", "the", "FDA", "in", "late", "2015", "for", "use", "in", "adults", "and", "adolescents,", "aged", "12", "years", "and", "older,", "who", "have", "Hemophilia", "A."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p0_s15", "idA": "906709_16_item7_p3_s2", "sentA": "In November 2015, ADYNOVATE TM was approved by the FDA for use in adults and adolescents, aged 12 years and older, who have Hemophilia A. Baxalta announced the launch and first shipments of ADYNOVATE TM on November 30, 2015.", "sentB": "The FDA approved recently expanded the approval of ADYNOVATE for the treatment of Hemophilia A in patients under 12 years of age, and for the use in surgical settings for both adult and pediatric patients.", "type": 2, "words": ["<tag1>", "In", "November", "2015,", "ADYNOVATE", "TM", "was", "approved", "by", "the", "FDA", "for", "use", "in", "adults", "and", "adolescents,", "aged", "12", "years", "and", "older,", "who", "have", "Hemophilia", "A.", "Baxalta", "announced", "the", "launch", "and", "first", "shipments", "of", "ADYNOVATE", "TM", "on", "November", "30,", "2015.", "<tag2>", "The", "FDA", "approved", "recently", "expanded", "the", "approval", "of", "ADYNOVATE", "for", "the", "treatment", "of", "Hemophilia", "A", "in", "patients", "under", "12", "years", "of", "age,", "and", "for", "the", "use", "in", "surgical", "settings", "for", "both", "adult", "and", "pediatric", "patients.", "<tag3>"], "wordsA": ["In", "November", "2015,", "ADYNOVATE", "TM", "was", "approved", "by", "the", "FDA", "for", "use", "in", "adults", "and", "adolescents,", "aged", "12", "years", "and", "older,", "who", "have", "Hemophilia", "A.", "Baxalta", "announced", "the", "launch", "and", "first", "shipments", "of", "ADYNOVATE", "TM", "on", "November", "30,", "2015."], "wordsB": ["The", "FDA", "approved", "recently", "expanded", "the", "approval", "of", "ADYNOVATE", "for", "the", "treatment", "of", "Hemophilia", "A", "in", "patients", "under", "12", "years", "of", "age,", "and", "for", "the", "use", "in", "surgical", "settings", "for", "both", "adult", "and", "pediatric", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p31_s0", "idA": "906709_16_item7_p40_s0", "sentA": "On January 28, 2014, we completed the issuance and sale of 9,775,000 shares of our common stock in a public offering with total proceeds of approximately $117.2 million after deducting the underwriting commissions and discounts of approximately $7.5 million.", "sentB": "Cash flows from financing activities On October 24, 2016, we completed the issuance and sale of 14,950,000 shares of our common stock in an underwritten public offering with total proceeds of approximately $189.7 million after deducting the underwriting commissions and discounts of approximately $12.1 million.", "type": 2, "words": ["<tag1>", "On", "January", "28,", "2014,", "we", "completed", "the", "issuance", "and", "sale", "of", "9,775,000", "shares", "of", "our", "common", "stock", "in", "a", "public", "offering", "with", "total", "proceeds", "of", "approximately", "$117.2", "million", "after", "deducting", "the", "underwriting", "commissions", "and", "discounts", "of", "approximately", "$7.5", "million.", "<tag2>", "Cash", "flows", "from", "financing", "activities", "On", "October", "24,", "2016,", "we", "completed", "the", "issuance", "and", "sale", "of", "14,950,000", "shares", "of", "our", "common", "stock", "in", "an", "underwritten", "public", "offering", "with", "total", "proceeds", "of", "approximately", "$189.7", "million", "after", "deducting", "the", "underwriting", "commissions", "and", "discounts", "of", "approximately", "$12.1", "million.", "<tag3>"], "wordsA": ["On", "January", "28,", "2014,", "we", "completed", "the", "issuance", "and", "sale", "of", "9,775,000", "shares", "of", "our", "common", "stock", "in", "a", "public", "offering", "with", "total", "proceeds", "of", "approximately", "$117.2", "million", "after", "deducting", "the", "underwriting", "commissions", "and", "discounts", "of", "approximately", "$7.5", "million."], "wordsB": ["Cash", "flows", "from", "financing", "activities", "On", "October", "24,", "2016,", "we", "completed", "the", "issuance", "and", "sale", "of", "14,950,000", "shares", "of", "our", "common", "stock", "in", "an", "underwritten", "public", "offering", "with", "total", "proceeds", "of", "approximately", "$189.7", "million", "after", "deducting", "the", "underwriting", "commissions", "and", "discounts", "of", "approximately", "$12.1", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p31_s1", "idA": "906709_16_item7_p40_s1", "sentA": "In addition, we incurred approximately $0.6 million in legal and accounting fees, filing fees, and other costs in connection with this offering.", "sentB": "In addition, we incurred approximately $0.4 million in legal and accounting fees, filing fees, and other costs in connection with this offering.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "costs", "in", "connection", "with", "this", "offering.", "<tag2>", "In", "addition,", "we", "incurred", "approximately", "$0.4", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "costs", "in", "connection", "with", "this", "offering.", "<tag3>"], "wordsA": ["In", "addition,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "costs", "in", "connection", "with", "this", "offering."], "wordsB": ["In", "addition,", "we", "incurred", "approximately", "$0.4", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "costs", "in", "connection", "with", "this", "offering."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p32_s3", "idA": "906709_16_item7_p40_s3", "sentA": "During the years ended December 31, 2014 and 2013, we made payments of $7.0 million and $3.0 million, respectively, to the purchaser of these royalties because certain minimum MIRCERA net sales thresholds were not met.", "sentB": "During the year ended December 31, 2014, we made a payment of $7.0 million to the purchaser of these royalties because a certain minimum MIRCERA net sales threshold was not met.", "type": 2, "words": ["<tag1>", "During", "the", "years", "ended", "December", "31,", "2014", "and", "2013,", "we", "made", "payments", "of", "$7.0", "million", "and", "$3.0", "million,", "respectively,", "to", "the", "purchaser", "of", "these", "royalties", "because", "certain", "minimum", "MIRCERA", "net", "sales", "thresholds", "were", "not", "met.", "<tag2>", "During", "the", "year", "ended", "December", "31,", "2014,", "we", "made", "a", "payment", "of", "$7.0", "million", "to", "the", "purchaser", "of", "these", "royalties", "because", "a", "certain", "minimum", "MIRCERA", "net", "sales", "threshold", "was", "not", "met.", "<tag3>"], "wordsA": ["During", "the", "years", "ended", "December", "31,", "2014", "and", "2013,", "we", "made", "payments", "of", "$7.0", "million", "and", "$3.0", "million,", "respectively,", "to", "the", "purchaser", "of", "these", "royalties", "because", "certain", "minimum", "MIRCERA", "net", "sales", "thresholds", "were", "not", "met."], "wordsB": ["During", "the", "year", "ended", "December", "31,", "2014,", "we", "made", "a", "payment", "of", "$7.0", "million", "to", "the", "purchaser", "of", "these", "royalties", "because", "a", "certain", "minimum", "MIRCERA", "net", "sales", "threshold", "was", "not", "met."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p32_s4", "idA": "906709_16_item7_p40_s4", "sentA": "The remaining $119.0 million royalty obligation liability at December 31, 2015 will not be settled in cash.", "sentB": "The remaining $108.6 million royalty obligation liability at December 31, 2016 will not be settled in cash.", "type": 2, "words": ["<tag1>", "The", "remaining", "$119.0", "million", "royalty", "obligation", "liability", "at", "December", "31,", "2015", "will", "not", "be", "settled", "in", "cash.", "<tag2>", "The", "remaining", "$108.6", "million", "royalty", "obligation", "liability", "at", "December", "31,", "2016", "will", "not", "be", "settled", "in", "cash.", "<tag3>"], "wordsA": ["The", "remaining", "$119.0", "million", "royalty", "obligation", "liability", "at", "December", "31,", "2015", "will", "not", "be", "settled", "in", "cash."], "wordsB": ["The", "remaining", "$108.6", "million", "royalty", "obligation", "liability", "at", "December", "31,", "2016", "will", "not", "be", "settled", "in", "cash."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p32_s5", "idA": "906709_16_item7_p40_s5", "sentA": "We received proceeds from issuance of common stock related to our employee option and stock purchase plans of $32.2 million, $47.0 million, and $8.2 million in the years ended December 31, 2015, 2014, and 2013, respectively.", "sentB": "We received proceeds from issuance of common stock related to our employee option and stock purchase plans of $20.3 million, $32.2 million, and $47.0 million in the years ended December 31, 2016, 2015, and 2014, respectively.", "type": 2, "words": ["<tag1>", "We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$32.2", "million,", "$47.0", "million,", "and", "$8.2", "million", "in", "the", "years", "ended", "December", "31,", "2015,", "2014,", "and", "2013,", "respectively.", "<tag2>", "We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$20.3", "million,", "$32.2", "million,", "and", "$47.0", "million", "in", "the", "years", "ended", "December", "31,", "2016,", "2015,", "and", "2014,", "respectively.", "<tag3>"], "wordsA": ["We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$32.2", "million,", "$47.0", "million,", "and", "$8.2", "million", "in", "the", "years", "ended", "December", "31,", "2015,", "2014,", "and", "2013,", "respectively."], "wordsB": ["We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$20.3", "million,", "$32.2", "million,", "and", "$47.0", "million", "in", "the", "years", "ended", "December", "31,", "2016,", "2015,", "and", "2014,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p35_s0", "idA": "906709_16_item7_p43_s0", "sentA": "These amounts primarily result from our purchase of manufacturing equipment supporting our Amikacin Inhale program, including our obligation to purchase certain equipment which is further discussed in Note 4 of Item 8.", "sentB": "These amounts primarily result from our purchase of manufacturing equipment supporting our Amikacin Inhale program.", "type": 2, "words": ["<tag1>", "These", "amounts", "primarily", "result", "from", "our", "purchase", "of", "manufacturing", "equipment", "supporting", "our", "Amikacin", "Inhale", "program,", "including", "our", "obligation", "to", "purchase", "certain", "equipment", "which", "is", "further", "discussed", "in", "Note", "4", "of", "Item", "8.", "<tag2>", "These", "amounts", "primarily", "result", "from", "our", "purchase", "of", "manufacturing", "equipment", "supporting", "our", "Amikacin", "Inhale", "program.", "<tag3>"], "wordsA": ["These", "amounts", "primarily", "result", "from", "our", "purchase", "of", "manufacturing", "equipment", "supporting", "our", "Amikacin", "Inhale", "program,", "including", "our", "obligation", "to", "purchase", "certain", "equipment", "which", "is", "further", "discussed", "in", "Note", "4", "of", "Item", "8."], "wordsB": ["These", "amounts", "primarily", "result", "from", "our", "purchase", "of", "manufacturing", "equipment", "supporting", "our", "Amikacin", "Inhale", "program."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p36_s0", "idA": "906709_16_item7_p44_s0", "sentA": "Substantially all of this amount was subject to open purchase orders as of December 31, 2015 that were issued under existing contracts.", "sentB": "Substantially all of this amount was subject to open purchase orders as of December 31, 2016 that were issued under existing contracts.", "type": 2, "words": ["<tag1>", "Substantially", "all", "of", "this", "amount", "was", "subject", "to", "open", "purchase", "orders", "as", "of", "December", "31,", "2015", "that", "were", "issued", "under", "existing", "contracts.", "<tag2>", "Substantially", "all", "of", "this", "amount", "was", "subject", "to", "open", "purchase", "orders", "as", "of", "December", "31,", "2016", "that", "were", "issued", "under", "existing", "contracts.", "<tag3>"], "wordsA": ["Substantially", "all", "of", "this", "amount", "was", "subject", "to", "open", "purchase", "orders", "as", "of", "December", "31,", "2015", "that", "were", "issued", "under", "existing", "contracts."], "wordsB": ["Substantially", "all", "of", "this", "amount", "was", "subject", "to", "open", "purchase", "orders", "as", "of", "December", "31,", "2016", "that", "were", "issued", "under", "existing", "contracts."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p38_s0", "idA": "906709_16_item7_p46_s0", "sentA": "The preparation and presentation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (GAAP) requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.", "sentB": "The preparation and presentation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.", "type": 2, "words": ["<tag1>", "The", "preparation", "and", "presentation", "of", "financial", "statements", "in", "conformity", "with", "U.S.", "Generally", "Accepted", "Accounting", "Principles", "(GAAP)", "requires", "management", "to", "make", "judgments,", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period.", "<tag2>", "The", "preparation", "and", "presentation", "of", "financial", "statements", "in", "conformity", "with", "U.S.", "generally", "accepted", "accounting", "principles", "(GAAP)", "requires", "management", "to", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period.", "<tag3>"], "wordsA": ["The", "preparation", "and", "presentation", "of", "financial", "statements", "in", "conformity", "with", "U.S.", "Generally", "Accepted", "Accounting", "Principles", "(GAAP)", "requires", "management", "to", "make", "judgments,", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period."], "wordsB": ["The", "preparation", "and", "presentation", "of", "financial", "statements", "in", "conformity", "with", "U.S.", "generally", "accepted", "accounting", "principles", "(GAAP)", "requires", "management", "to", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p0_s16", "idA": "906709_16_item7_p4_s0", "sentA": "ADYNOVATE TM is currently under regulatory review in Japan, Canada and Switzerland.", "sentB": "ADYNOVATE is also under regulatory review in the European Union, Switzerland and Canada.", "type": 2, "words": ["<tag1>", "ADYNOVATE", "TM", "is", "currently", "under", "regulatory", "review", "in", "Japan,", "Canada", "and", "Switzerland.", "<tag2>", "ADYNOVATE", "is", "also", "under", "regulatory", "review", "in", "the", "European", "Union,", "Switzerland", "and", "Canada.", "<tag3>"], "wordsA": ["ADYNOVATE", "TM", "is", "currently", "under", "regulatory", "review", "in", "Japan,", "Canada", "and", "Switzerland."], "wordsB": ["ADYNOVATE", "is", "also", "under", "regulatory", "review", "in", "the", "European", "Union,", "Switzerland", "and", "Canada."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p43_s0", "idA": "906709_16_item7_p51_s1", "sentA": "If we had determined a longer or shorter amortization period was appropriate, our annual upfront fee amortization for these agreements could have been as low as $2.0 million or as high as $11.0 million as compared to the approximately $2.0 million recognized in the year ended December 31, 2015.", "sentB": "have been as low as $2 million or as high as $11 million as compared to the approximately $2.0 million recognized in th e year ended December 31, 2016.", "type": 2, "words": ["<tag1>", "If", "we", "had", "determined", "a", "longer", "or", "shorter", "amortization", "period", "was", "appropriate,", "our", "annual", "upfront", "fee", "amortization", "for", "these", "agreements", "could", "have", "been", "as", "low", "as", "$2.0", "million", "or", "as", "high", "as", "$11.0", "million", "as", "compared", "to", "the", "approximately", "$2.0", "million", "recognized", "in", "the", "year", "ended", "December", "31,", "2015.", "<tag2>", "have", "been", "as", "low", "as", "$2", "million", "or", "as", "high", "as", "$11", "million", "as", "compared", "to", "the", "approximately", "$2.0", "million", "recognized", "in", "th", "e", "year", "ended", "December", "31,", "2016.", "<tag3>"], "wordsA": ["If", "we", "had", "determined", "a", "longer", "or", "shorter", "amortization", "period", "was", "appropriate,", "our", "annual", "upfront", "fee", "amortization", "for", "these", "agreements", "could", "have", "been", "as", "low", "as", "$2.0", "million", "or", "as", "high", "as", "$11.0", "million", "as", "compared", "to", "the", "approximately", "$2.0", "million", "recognized", "in", "the", "year", "ended", "December", "31,", "2015."], "wordsB": ["have", "been", "as", "low", "as", "$2", "million", "or", "as", "high", "as", "$11", "million", "as", "compared", "to", "the", "approximately", "$2.0", "million", "recognized", "in", "th", "e", "year", "ended", "December", "31,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p43_s1", "idA": "906709_16_item7_p51_s2", "sentA": "As of December 31, 2015, we also had $58.6 million of deferred upfront fees related to seven license, manufacturing and supply agreements that are being amortized over periods from 3 to 15 years.", "sentB": "As of December 31, 2016, we also had $41.3 million of deferred upfront fees related to six license, manufacturing and supply agreements that are being amortized over periods from 3 to 15 years.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2015,", "we", "also", "had", "$58.6", "million", "of", "deferred", "upfront", "fees", "related", "to", "seven", "license,", "manufacturing", "and", "supply", "agreements", "that", "are", "being", "amortized", "over", "periods", "from", "3", "to", "15", "years.", "<tag2>", "As", "of", "December", "31,", "2016,", "we", "also", "had", "$41.3", "million", "of", "deferred", "upfront", "fees", "related", "to", "six", "license,", "manufacturing", "and", "supply", "agreements", "that", "are", "being", "amortized", "over", "periods", "from", "3", "to", "15", "years.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2015,", "we", "also", "had", "$58.6", "million", "of", "deferred", "upfront", "fees", "related", "to", "seven", "license,", "manufacturing", "and", "supply", "agreements", "that", "are", "being", "amortized", "over", "periods", "from", "3", "to", "15", "years."], "wordsB": ["As", "of", "December", "31,", "2016,", "we", "also", "had", "$41.3", "million", "of", "deferred", "upfront", "fees", "related", "to", "six", "license,", "manufacturing", "and", "supply", "agreements", "that", "are", "being", "amortized", "over", "periods", "from", "3", "to", "15", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p47_s0", "idA": "906709_16_item7_p55_s0", "sentA": "Stock-Based Compensation We use the Black-Scholes option pricing model for each respective grant to determine the estimated fair value of stock options on the date of grant (grant date fair value) and common stock purchased under our Employee Stock Purchase Plan (ESPP).", "sentB": "Stock-Based Compensation We use the Black-Scholes option pricing model for each respective grant to determine the estimated fair value of stock options on the date of grant (grant date fair value).", "type": 2, "words": ["<tag1>", "Stock-Based", "Compensation", "We", "use", "the", "Black-Scholes", "option", "pricing", "model", "for", "each", "respective", "grant", "to", "determine", "the", "estimated", "fair", "value", "of", "stock", "options", "on", "the", "date", "of", "grant", "(grant", "date", "fair", "value)", "and", "common", "stock", "purchased", "under", "our", "Employee", "Stock", "Purchase", "Plan", "(ESPP).", "<tag2>", "Stock-Based", "Compensation", "We", "use", "the", "Black-Scholes", "option", "pricing", "model", "for", "each", "respective", "grant", "to", "determine", "the", "estimated", "fair", "value", "of", "stock", "options", "on", "the", "date", "of", "grant", "(grant", "date", "fair", "value).", "<tag3>"], "wordsA": ["Stock-Based", "Compensation", "We", "use", "the", "Black-Scholes", "option", "pricing", "model", "for", "each", "respective", "grant", "to", "determine", "the", "estimated", "fair", "value", "of", "stock", "options", "on", "the", "date", "of", "grant", "(grant", "date", "fair", "value)", "and", "common", "stock", "purchased", "under", "our", "Employee", "Stock", "Purchase", "Plan", "(ESPP)."], "wordsB": ["Stock-Based", "Compensation", "We", "use", "the", "Black-Scholes", "option", "pricing", "model", "for", "each", "respective", "grant", "to", "determine", "the", "estimated", "fair", "value", "of", "stock", "options", "on", "the", "date", "of", "grant", "(grant", "date", "fair", "value)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p48_s2", "idA": "906709_16_item7_p56_s2", "sentA": "Because our employee stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect fair value estimates, in management s opinion, the existing models may not provide a reliable single measure of the fair value of our employee stock options or common stock purchased under our ESPP.", "sentB": "Because our employee stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect fair value estimates, in management s opinion, the existing models may not provide a reliable single measure of the fair value of our employee stock options.", "type": 2, "words": ["<tag1>", "Because", "our", "employee", "stock", "options", "have", "characteristics", "significantly", "different", "from", "those", "of", "traded", "options,", "and", "because", "changes", "in", "the", "subjective", "input", "assumptions", "can", "materially", "affect", "fair", "value", "estimates,", "in", "management", "s", "opinion,", "the", "existing", "models", "may", "not", "provide", "a", "reliable", "single", "measure", "of", "the", "fair", "value", "of", "our", "employee", "stock", "options", "or", "common", "stock", "purchased", "under", "our", "ESPP.", "<tag2>", "Because", "our", "employee", "stock", "options", "have", "characteristics", "significantly", "different", "from", "those", "of", "traded", "options,", "and", "because", "changes", "in", "the", "subjective", "input", "assumptions", "can", "materially", "affect", "fair", "value", "estimates,", "in", "management", "s", "opinion,", "the", "existing", "models", "may", "not", "provide", "a", "reliable", "single", "measure", "of", "the", "fair", "value", "of", "our", "employee", "stock", "options.", "<tag3>"], "wordsA": ["Because", "our", "employee", "stock", "options", "have", "characteristics", "significantly", "different", "from", "those", "of", "traded", "options,", "and", "because", "changes", "in", "the", "subjective", "input", "assumptions", "can", "materially", "affect", "fair", "value", "estimates,", "in", "management", "s", "opinion,", "the", "existing", "models", "may", "not", "provide", "a", "reliable", "single", "measure", "of", "the", "fair", "value", "of", "our", "employee", "stock", "options", "or", "common", "stock", "purchased", "under", "our", "ESPP."], "wordsB": ["Because", "our", "employee", "stock", "options", "have", "characteristics", "significantly", "different", "from", "those", "of", "traded", "options,", "and", "because", "changes", "in", "the", "subjective", "input", "assumptions", "can", "materially", "affect", "fair", "value", "estimates,", "in", "management", "s", "opinion,", "the", "existing", "models", "may", "not", "provide", "a", "reliable", "single", "measure", "of", "the", "fair", "value", "of", "our", "employee", "stock", "options."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p49_s0", "idA": "906709_16_item7_p56_s3", "sentA": "In addition, management continually assesses the assumptions and methodologies used to calculate the estimated fair value of stock-based compensation.", "sentB": "Management continually assesses the assumptions and methodologies used to calculate the estimated fair value of stock-based compensation.", "type": 2, "words": ["<tag1>", "In", "addition,", "management", "continually", "assesses", "the", "assumptions", "and", "methodologies", "used", "to", "calculate", "the", "estimated", "fair", "value", "of", "stock-based", "compensation.", "<tag2>", "Management", "continually", "assesses", "the", "assumptions", "and", "methodologies", "used", "to", "calculate", "the", "estimated", "fair", "value", "of", "stock-based", "compensation.", "<tag3>"], "wordsA": ["In", "addition,", "management", "continually", "assesses", "the", "assumptions", "and", "methodologies", "used", "to", "calculate", "the", "estimated", "fair", "value", "of", "stock-based", "compensation."], "wordsB": ["Management", "continually", "assesses", "the", "assumptions", "and", "methodologies", "used", "to", "calculate", "the", "estimated", "fair", "value", "of", "stock-based", "compensation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p51_s0", "idA": "906709_16_item7_p58_s1", "sentA": "Although we are required to make payments to the purchaser (RPI) only in certain situations, including the event of our breach of a representation, warranty or covenant in the Purchase and Sale Agreement that gives rise to a liability in accordance with the terms and conditions of such agreement, this royalty sale transaction was recorded as a liability (Royalty Obligation) that we will amortize using the interest method over the estimated life of the Purchase and Sale Agreement.", "sentB": "liability (Royalty Obligation) that we will amortize using the interest method over the estimated life of the Purchase and Sale Agreement.", "type": 2, "words": ["<tag1>", "Although", "we", "are", "required", "to", "make", "payments", "to", "the", "purchaser", "(RPI)", "only", "in", "certain", "situations,", "including", "the", "event", "of", "our", "breach", "of", "a", "representation,", "warranty", "or", "covenant", "in", "the", "Purchase", "and", "Sale", "Agreement", "that", "gives", "rise", "to", "a", "liability", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "such", "agreement,", "this", "royalty", "sale", "transaction", "was", "recorded", "as", "a", "liability", "(Royalty", "Obligation)", "that", "we", "will", "amortize", "using", "the", "interest", "method", "over", "the", "estimated", "life", "of", "the", "Purchase", "and", "Sale", "Agreement.", "<tag2>", "liability", "(Royalty", "Obligation)", "that", "we", "will", "amortize", "using", "the", "interest", "method", "over", "the", "estimated", "life", "of", "the", "Purchase", "and", "Sale", "Agreement.", "<tag3>"], "wordsA": ["Although", "we", "are", "required", "to", "make", "payments", "to", "the", "purchaser", "(RPI)", "only", "in", "certain", "situations,", "including", "the", "event", "of", "our", "breach", "of", "a", "representation,", "warranty", "or", "covenant", "in", "the", "Purchase", "and", "Sale", "Agreement", "that", "gives", "rise", "to", "a", "liability", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "such", "agreement,", "this", "royalty", "sale", "transaction", "was", "recorded", "as", "a", "liability", "(Royalty", "Obligation)", "that", "we", "will", "amortize", "using", "the", "interest", "method", "over", "the", "estimated", "life", "of", "the", "Purchase", "and", "Sale", "Agreement."], "wordsB": ["liability", "(Royalty", "Obligation)", "that", "we", "will", "amortize", "using", "the", "interest", "method", "over", "the", "estimated", "life", "of", "the", "Purchase", "and", "Sale", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p51_s2", "idA": "906709_16_item7_p58_s3", "sentA": "Our estimate of the interest rate under the agreement is based on the amount of royalty payments to be received by RPI over the life of the arrangement and payments we are required to make to RPI under the agreement.", "sentB": "Our estimate of the interest rate under the agreement is based on the amount of royalty payments to be received by RPI over the life of the arrangem ent and payments we are required to make to RPI under the agreement.", "type": 2, "words": ["<tag1>", "Our", "estimate", "of", "the", "interest", "rate", "under", "the", "agreement", "is", "based", "on", "the", "amount", "of", "royalty", "payments", "to", "be", "received", "by", "RPI", "over", "the", "life", "of", "the", "arrangement", "and", "payments", "we", "are", "required", "to", "make", "to", "RPI", "under", "the", "agreement.", "<tag2>", "Our", "estimate", "of", "the", "interest", "rate", "under", "the", "agreement", "is", "based", "on", "the", "amount", "of", "royalty", "payments", "to", "be", "received", "by", "RPI", "over", "the", "life", "of", "the", "arrangem", "ent", "and", "payments", "we", "are", "required", "to", "make", "to", "RPI", "under", "the", "agreement.", "<tag3>"], "wordsA": ["Our", "estimate", "of", "the", "interest", "rate", "under", "the", "agreement", "is", "based", "on", "the", "amount", "of", "royalty", "payments", "to", "be", "received", "by", "RPI", "over", "the", "life", "of", "the", "arrangement", "and", "payments", "we", "are", "required", "to", "make", "to", "RPI", "under", "the", "agreement."], "wordsB": ["Our", "estimate", "of", "the", "interest", "rate", "under", "the", "agreement", "is", "based", "on", "the", "amount", "of", "royalty", "payments", "to", "be", "received", "by", "RPI", "over", "the", "life", "of", "the", "arrangem", "ent", "and", "payments", "we", "are", "required", "to", "make", "to", "RPI", "under", "the", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p51_s4", "idA": "906709_16_item7_p58_s5", "sentA": "To the extent such payments are greater or less than our initial estimates or the timing of such payments is materially different than our original estimates, we will prospectively adjust the amortization of the Royalty Obligation.", "sentB": "To the extent such pa yments are greater or less than our initial estimates or the timing of such payments is materially different than our original estimates, we will prospectively adjust the amortization of the Royalty Obligation.", "type": 2, "words": ["<tag1>", "To", "the", "extent", "such", "payments", "are", "greater", "or", "less", "than", "our", "initial", "estimates", "or", "the", "timing", "of", "such", "payments", "is", "materially", "different", "than", "our", "original", "estimates,", "we", "will", "prospectively", "adjust", "the", "amortization", "of", "the", "Royalty", "Obligation.", "<tag2>", "To", "the", "extent", "such", "pa", "yments", "are", "greater", "or", "less", "than", "our", "initial", "estimates", "or", "the", "timing", "of", "such", "payments", "is", "materially", "different", "than", "our", "original", "estimates,", "we", "will", "prospectively", "adjust", "the", "amortization", "of", "the", "Royalty", "Obligation.", "<tag3>"], "wordsA": ["To", "the", "extent", "such", "payments", "are", "greater", "or", "less", "than", "our", "initial", "estimates", "or", "the", "timing", "of", "such", "payments", "is", "materially", "different", "than", "our", "original", "estimates,", "we", "will", "prospectively", "adjust", "the", "amortization", "of", "the", "Royalty", "Obligation."], "wordsB": ["To", "the", "extent", "such", "pa", "yments", "are", "greater", "or", "less", "than", "our", "initial", "estimates", "or", "the", "timing", "of", "such", "payments", "is", "materially", "different", "than", "our", "original", "estimates,", "we", "will", "prospectively", "adjust", "the", "amortization", "of", "the", "Royalty", "Obligation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p52_s0", "idA": "906709_16_item7_p59_s0", "sentA": "There are a number of factors that could materially affect the amount and timing of royalty payments from CIMZIA and MIRCERA , most of which are not within our control.", "sentB": "There are a number of factors that could mate rially affect the amount and timing of royalty payments from CIMZIA and MIRCERA , most of which are not within our control.", "type": 2, "words": ["<tag1>", "There", "are", "a", "number", "of", "factors", "that", "could", "materially", "affect", "the", "amount", "and", "timing", "of", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "most", "of", "which", "are", "not", "within", "our", "control.", "<tag2>", "There", "are", "a", "number", "of", "factors", "that", "could", "mate", "rially", "affect", "the", "amount", "and", "timing", "of", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "most", "of", "which", "are", "not", "within", "our", "control.", "<tag3>"], "wordsA": ["There", "are", "a", "number", "of", "factors", "that", "could", "materially", "affect", "the", "amount", "and", "timing", "of", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "most", "of", "which", "are", "not", "within", "our", "control."], "wordsB": ["There", "are", "a", "number", "of", "factors", "that", "could", "mate", "rially", "affect", "the", "amount", "and", "timing", "of", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "most", "of", "which", "are", "not", "within", "our", "control."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p52_s1", "idA": "906709_16_item7_p59_s1", "sentA": "Such factors include, but are not limited to, changing standards of care, the introduction of competing products, manufacturing or other delays, biosimilar competition, intellectual property matters, adverse events that result in health authority imposed restrictions on the use of the drug products, significant changes in foreign exchange rates as the royalties remitted to RPI are made in U.S. dollars (USD) while significant portions of the underlying sales of CIMZIA and MIRCERA are made in currencies other than USD, and other events or circumstances that result in reduced royalty payments from CIMZIA and MIRCERA , all of which would result in a reduction of non-cash royalty revenue and non-cash interest expense over the life of the Royalty Obligation.", "sentB": "Such factors include, but are not limited to, changing standards of care, the introduction of competing products, manufacturing or other delays, biosimilar competition, intellectual property matters, adverse events that result in health authority imposed restrictions on the use of the drug products, significant changes in foreign exchange rates as the royalties remitted to RPI are mad e in U.S. dollars (USD) while significant portions of the underlying sales of CIMZIA and MIRCERA are made in currencies other than USD, and other events or circumstances that result in reduced royalty payments from CIMZIA and MIRCERA , all of which woul d result in a reduction of non-cash royalty revenue and non-cash interest expense over the life of the Royalty Obligation.", "type": 2, "words": ["<tag1>", "Such", "factors", "include,", "but", "are", "not", "limited", "to,", "changing", "standards", "of", "care,", "the", "introduction", "of", "competing", "products,", "manufacturing", "or", "other", "delays,", "biosimilar", "competition,", "intellectual", "property", "matters,", "adverse", "events", "that", "result", "in", "health", "authority", "imposed", "restrictions", "on", "the", "use", "of", "the", "drug", "products,", "significant", "changes", "in", "foreign", "exchange", "rates", "as", "the", "royalties", "remitted", "to", "RPI", "are", "made", "in", "U.S.", "dollars", "(USD)", "while", "significant", "portions", "of", "the", "underlying", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "made", "in", "currencies", "other", "than", "USD,", "and", "other", "events", "or", "circumstances", "that", "result", "in", "reduced", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "all", "of", "which", "would", "result", "in", "a", "reduction", "of", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "over", "the", "life", "of", "the", "Royalty", "Obligation.", "<tag2>", "Such", "factors", "include,", "but", "are", "not", "limited", "to,", "changing", "standards", "of", "care,", "the", "introduction", "of", "competing", "products,", "manufacturing", "or", "other", "delays,", "biosimilar", "competition,", "intellectual", "property", "matters,", "adverse", "events", "that", "result", "in", "health", "authority", "imposed", "restrictions", "on", "the", "use", "of", "the", "drug", "products,", "significant", "changes", "in", "foreign", "exchange", "rates", "as", "the", "royalties", "remitted", "to", "RPI", "are", "mad", "e", "in", "U.S.", "dollars", "(USD)", "while", "significant", "portions", "of", "the", "underlying", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "made", "in", "currencies", "other", "than", "USD,", "and", "other", "events", "or", "circumstances", "that", "result", "in", "reduced", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "all", "of", "which", "woul", "d", "result", "in", "a", "reduction", "of", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "over", "the", "life", "of", "the", "Royalty", "Obligation.", "<tag3>"], "wordsA": ["Such", "factors", "include,", "but", "are", "not", "limited", "to,", "changing", "standards", "of", "care,", "the", "introduction", "of", "competing", "products,", "manufacturing", "or", "other", "delays,", "biosimilar", "competition,", "intellectual", "property", "matters,", "adverse", "events", "that", "result", "in", "health", "authority", "imposed", "restrictions", "on", "the", "use", "of", "the", "drug", "products,", "significant", "changes", "in", "foreign", "exchange", "rates", "as", "the", "royalties", "remitted", "to", "RPI", "are", "made", "in", "U.S.", "dollars", "(USD)", "while", "significant", "portions", "of", "the", "underlying", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "made", "in", "currencies", "other", "than", "USD,", "and", "other", "events", "or", "circumstances", "that", "result", "in", "reduced", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "all", "of", "which", "would", "result", "in", "a", "reduction", "of", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "over", "the", "life", "of", "the", "Royalty", "Obligation."], "wordsB": ["Such", "factors", "include,", "but", "are", "not", "limited", "to,", "changing", "standards", "of", "care,", "the", "introduction", "of", "competing", "products,", "manufacturing", "or", "other", "delays,", "biosimilar", "competition,", "intellectual", "property", "matters,", "adverse", "events", "that", "result", "in", "health", "authority", "imposed", "restrictions", "on", "the", "use", "of", "the", "drug", "products,", "significant", "changes", "in", "foreign", "exchange", "rates", "as", "the", "royalties", "remitted", "to", "RPI", "are", "mad", "e", "in", "U.S.", "dollars", "(USD)", "while", "significant", "portions", "of", "the", "underlying", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "made", "in", "currencies", "other", "than", "USD,", "and", "other", "events", "or", "circumstances", "that", "result", "in", "reduced", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "all", "of", "which", "woul", "d", "result", "in", "a", "reduction", "of", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "over", "the", "life", "of", "the", "Royalty", "Obligation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p52_s2", "idA": "906709_16_item7_p59_s2", "sentA": "Conversely, if sales of CIMZIA and MIRCERA are higher than expected, non-cash royalty revenue and non-cash interest expense would also be greater over the term of the Royalty Obligation.", "sentB": "Conversely, if sales of CIMZIA and MIRCERA are higher than expected, non-cash royalty revenue and non-cash interest expense would b e greater over the term of the Royalty Obligation.", "type": 2, "words": ["<tag1>", "Conversely,", "if", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "higher", "than", "expected,", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "would", "also", "be", "greater", "over", "the", "term", "of", "the", "Royalty", "Obligation.", "<tag2>", "Conversely,", "if", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "higher", "than", "expected,", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "would", "b", "e", "greater", "over", "the", "term", "of", "the", "Royalty", "Obligation.", "<tag3>"], "wordsA": ["Conversely,", "if", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "higher", "than", "expected,", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "would", "also", "be", "greater", "over", "the", "term", "of", "the", "Royalty", "Obligation."], "wordsB": ["Conversely,", "if", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "higher", "than", "expected,", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "would", "b", "e", "greater", "over", "the", "term", "of", "the", "Royalty", "Obligation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p52_s3", "idA": "906709_16_item7_p59_s3", "sentA": "If we had determined that the interest rate used in 2015 should have been one percentage point higher than our current estimate of 17%, the non-cash interest expense recognized in the year ended December 31, 2015 would have increased by $1.3 million.", "sentB": "If we had determined that the interest rate used in 2016 should have been one percentage point higher than our current estimate of 17%, the non-cash interest expense recognized in the year ended December 3 1, 2016 would have increased by $1.2 million.", "type": 2, "words": ["<tag1>", "If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2015", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2015", "would", "have", "increased", "by", "$1.3", "million.", "<tag2>", "If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2016", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "3", "1,", "2016", "would", "have", "increased", "by", "$1.2", "million.", "<tag3>"], "wordsA": ["If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2015", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2015", "would", "have", "increased", "by", "$1.3", "million."], "wordsB": ["If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2016", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "3", "1,", "2016", "would", "have", "increased", "by", "$1.2", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p54_s0", "idA": "906709_16_item7_p59_s3", "sentA": "If we had determined that the interest rate used in 2015 should have been one percentage point higher than our current estimate of 17%, the non-cash interest expense recognized in the year ended December 31, 2015 would have increased by $1.3 million.", "sentB": "Under our current accounting policy, we recognize contingent or milestone payments as revenue in the period that the payment-triggering event occurred or is achieved.", "type": 2, "words": ["<tag1>", "If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2015", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2015", "would", "have", "increased", "by", "$1.3", "million.", "<tag2>", "Under", "our", "current", "accounting", "policy,", "we", "recognize", "contingent", "or", "milestone", "payments", "as", "revenue", "in", "the", "period", "that", "the", "payment-triggering", "event", "occurred", "or", "is", "achieved.", "<tag3>"], "wordsA": ["If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2015", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2015", "would", "have", "increased", "by", "$1.3", "million."], "wordsB": ["Under", "our", "current", "accounting", "policy,", "we", "recognize", "contingent", "or", "milestone", "payments", "as", "revenue", "in", "the", "period", "that", "the", "payment-triggering", "event", "occurred", "or", "is", "achieved."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p0_s7", "idA": "906709_16_item7_p5_s1", "sentA": "We enrolled the first patient in the first Phase 3 efficacy study in February 2015 and the study continues to enroll patients.", "sentB": "We completed enrollment in the SUMMIT-07 Phase 3 efficacy study for NKTR-181 in late 2016 and expect to announce the top-line data in March 2017.", "type": 2, "words": ["<tag1>", "We", "enrolled", "the", "first", "patient", "in", "the", "first", "Phase", "3", "efficacy", "study", "in", "February", "2015", "and", "the", "study", "continues", "to", "enroll", "patients.", "<tag2>", "We", "completed", "enrollment", "in", "the", "SUMMIT-07", "Phase", "3", "efficacy", "study", "for", "NKTR-181", "in", "late", "2016", "and", "expect", "to", "announce", "the", "top-line", "data", "in", "March", "2017.", "<tag3>"], "wordsA": ["We", "enrolled", "the", "first", "patient", "in", "the", "first", "Phase", "3", "efficacy", "study", "in", "February", "2015", "and", "the", "study", "continues", "to", "enroll", "patients."], "wordsB": ["We", "completed", "enrollment", "in", "the", "SUMMIT-07", "Phase", "3", "efficacy", "study", "for", "NKTR-181", "in", "late", "2016", "and", "expect", "to", "announce", "the", "top-line", "data", "in", "March", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p19_s4", "idA": "906709_16_item7_p5_s1", "sentA": "We enrolled the first patient in the first Phase 3 efficacy study in February 2015 and the study continues to enroll patients.", "sentB": "If our NKTR-181 Phase 3 efficacy study results are positive, we plan to pursue a collaboration to secure a development and commercialization partner to fund further development for NKTR-181 through direct program funding, up-front payments, milestones, or a combination thereof.", "type": 2, "words": ["<tag1>", "We", "enrolled", "the", "first", "patient", "in", "the", "first", "Phase", "3", "efficacy", "study", "in", "February", "2015", "and", "the", "study", "continues", "to", "enroll", "patients.", "<tag2>", "If", "our", "NKTR-181", "Phase", "3", "efficacy", "study", "results", "are", "positive,", "we", "plan", "to", "pursue", "a", "collaboration", "to", "secure", "a", "development", "and", "commercialization", "partner", "to", "fund", "further", "development", "for", "NKTR-181", "through", "direct", "program", "funding,", "up-front", "payments,", "milestones,", "or", "a", "combination", "thereof.", "<tag3>"], "wordsA": ["We", "enrolled", "the", "first", "patient", "in", "the", "first", "Phase", "3", "efficacy", "study", "in", "February", "2015", "and", "the", "study", "continues", "to", "enroll", "patients."], "wordsB": ["If", "our", "NKTR-181", "Phase", "3", "efficacy", "study", "results", "are", "positive,", "we", "plan", "to", "pursue", "a", "collaboration", "to", "secure", "a", "development", "and", "commercialization", "partner", "to", "fund", "further", "development", "for", "NKTR-181", "through", "direct", "program", "funding,", "up-front", "payments,", "milestones,", "or", "a", "combination", "thereof."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p53_s0", "idA": "906709_16_item7_p60_s0", "sentA": "Recent Accounting Pronouncemen ts In May 2014, the Financial Accounting Standards Board (FASB) issued guidance codified in Accounting Standards Codification (ASC) 606, Revenue Recognition Revenue from Contracts with Customers , which amends the guidance in former ASC 605, Revenue Recognition , and is effective for public companies for fiscal years beginning after December 15, 2017.", "sentB": "In May 2014, the FASB issued guidance codified in Accounting Standards Codification (ASC) 606, Revenue Recognition Revenue from Contracts with Customers, which amends the guidance in former ASC 605, Revenue Recognition, and is effective for public companies for annual and interim periods beginning after December 15, 2017.", "type": 2, "words": ["<tag1>", "Recent", "Accounting", "Pronouncemen", "ts", "In", "May", "2014,", "the", "Financial", "Accounting", "Standards", "Board", "(FASB)", "issued", "guidance", "codified", "in", "Accounting", "Standards", "Codification", "(ASC)", "606,", "Revenue", "Recognition", "Revenue", "from", "Contracts", "with", "Customers", ",", "which", "amends", "the", "guidance", "in", "former", "ASC", "605,", "Revenue", "Recognition", ",", "and", "is", "effective", "for", "public", "companies", "for", "fiscal", "years", "beginning", "after", "December", "15,", "2017.", "<tag2>", "In", "May", "2014,", "the", "FASB", "issued", "guidance", "codified", "in", "Accounting", "Standards", "Codification", "(ASC)", "606,", "Revenue", "Recognition", "Revenue", "from", "Contracts", "with", "Customers,", "which", "amends", "the", "guidance", "in", "former", "ASC", "605,", "Revenue", "Recognition,", "and", "is", "effective", "for", "public", "companies", "for", "annual", "and", "interim", "periods", "beginning", "after", "December", "15,", "2017.", "<tag3>"], "wordsA": ["Recent", "Accounting", "Pronouncemen", "ts", "In", "May", "2014,", "the", "Financial", "Accounting", "Standards", "Board", "(FASB)", "issued", "guidance", "codified", "in", "Accounting", "Standards", "Codification", "(ASC)", "606,", "Revenue", "Recognition", "Revenue", "from", "Contracts", "with", "Customers", ",", "which", "amends", "the", "guidance", "in", "former", "ASC", "605,", "Revenue", "Recognition", ",", "and", "is", "effective", "for", "public", "companies", "for", "fiscal", "years", "beginning", "after", "December", "15,", "2017."], "wordsB": ["In", "May", "2014,", "the", "FASB", "issued", "guidance", "codified", "in", "Accounting", "Standards", "Codification", "(ASC)", "606,", "Revenue", "Recognition", "Revenue", "from", "Contracts", "with", "Customers,", "which", "amends", "the", "guidance", "in", "former", "ASC", "605,", "Revenue", "Recognition,", "and", "is", "effective", "for", "public", "companies", "for", "annual", "and", "interim", "periods", "beginning", "after", "December", "15,", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p56_s2", "idA": "906709_16_item7_p61_s0", "sentA": "We are currently evaluating the impact of the provisions of ASC 606.", "sentB": "We are currently evaluating the impact of the adoption of this standard.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "evaluating", "the", "impact", "of", "the", "provisions", "of", "ASC", "606.", "<tag2>", "We", "are", "currently", "evaluating", "the", "impact", "of", "the", "adoption", "of", "this", "standard.", "<tag3>"], "wordsA": ["We", "are", "currently", "evaluating", "the", "impact", "of", "the", "provisions", "of", "ASC", "606."], "wordsB": ["We", "are", "currently", "evaluating", "the", "impact", "of", "the", "adoption", "of", "this", "standard."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p55_s0", "idA": "906709_16_item7_p62_s0", "sentA": "In April 2015, the FASB issued guidance to simplify the presentation of debt issuance costs by requiring debt issuance costs to be presented as a deduction from the corresponding debt liability.", "sentB": "In March 2016, the FASB issued guidance to simplify several aspects of employee share-based payment accounting, including income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows.", "type": 2, "words": ["<tag1>", "In", "April", "2015,", "the", "FASB", "issued", "guidance", "to", "simplify", "the", "presentation", "of", "debt", "issuance", "costs", "by", "requiring", "debt", "issuance", "costs", "to", "be", "presented", "as", "a", "deduction", "from", "the", "corresponding", "debt", "liability.", "<tag2>", "In", "March", "2016,", "the", "FASB", "issued", "guidance", "to", "simplify", "several", "aspects", "of", "employee", "share-based", "payment", "accounting,", "including", "income", "tax", "consequences,", "classification", "of", "awards", "as", "either", "equity", "or", "liabilities,", "and", "classification", "on", "the", "statement", "of", "cash", "flows.", "<tag3>"], "wordsA": ["In", "April", "2015,", "the", "FASB", "issued", "guidance", "to", "simplify", "the", "presentation", "of", "debt", "issuance", "costs", "by", "requiring", "debt", "issuance", "costs", "to", "be", "presented", "as", "a", "deduction", "from", "the", "corresponding", "debt", "liability."], "wordsB": ["In", "March", "2016,", "the", "FASB", "issued", "guidance", "to", "simplify", "several", "aspects", "of", "employee", "share-based", "payment", "accounting,", "including", "income", "tax", "consequences,", "classification", "of", "awards", "as", "either", "equity", "or", "liabilities,", "and", "classification", "on", "the", "statement", "of", "cash", "flows."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p56_s0", "idA": "906709_16_item7_p62_s0", "sentA": "In April 2015, the FASB issued guidance to simplify the presentation of debt issuance costs by requiring debt issuance costs to be presented as a deduction from the corresponding debt liability.", "sentB": "In February 2016, the FASB issued guidance to amend a number of aspects of lease accounting, including requiring lessees to recognize almost all leases with a term greater than one year as a right-of-use asset and corresponding liability, measured at the present value of the lease payments.", "type": 2, "words": ["<tag1>", "In", "April", "2015,", "the", "FASB", "issued", "guidance", "to", "simplify", "the", "presentation", "of", "debt", "issuance", "costs", "by", "requiring", "debt", "issuance", "costs", "to", "be", "presented", "as", "a", "deduction", "from", "the", "corresponding", "debt", "liability.", "<tag2>", "In", "February", "2016,", "the", "FASB", "issued", "guidance", "to", "amend", "a", "number", "of", "aspects", "of", "lease", "accounting,", "including", "requiring", "lessees", "to", "recognize", "almost", "all", "leases", "with", "a", "term", "greater", "than", "one", "year", "as", "a", "right-of-use", "asset", "and", "corresponding", "liability,", "measured", "at", "the", "present", "value", "of", "the", "lease", "payments.", "<tag3>"], "wordsA": ["In", "April", "2015,", "the", "FASB", "issued", "guidance", "to", "simplify", "the", "presentation", "of", "debt", "issuance", "costs", "by", "requiring", "debt", "issuance", "costs", "to", "be", "presented", "as", "a", "deduction", "from", "the", "corresponding", "debt", "liability."], "wordsB": ["In", "February", "2016,", "the", "FASB", "issued", "guidance", "to", "amend", "a", "number", "of", "aspects", "of", "lease", "accounting,", "including", "requiring", "lessees", "to", "recognize", "almost", "all", "leases", "with", "a", "term", "greater", "than", "one", "year", "as", "a", "right-of-use", "asset", "and", "corresponding", "liability,", "measured", "at", "the", "present", "value", "of", "the", "lease", "payments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p0_s22", "idA": "906709_16_item7_p62_s3", "sentA": "We do not believe the adoption of this guidance will have a material impact on our consolidated financial statements.", "sentB": "The level of sales growth of MOVANTIK and ADYNOVATE , together with the future clinical trial results and potential subsequent approvals of these collaboration partner drug candidates, will have a material impact on our future financial results and financial position.", "type": 2, "words": ["<tag1>", "We", "do", "not", "believe", "the", "adoption", "of", "this", "guidance", "will", "have", "a", "material", "impact", "on", "our", "consolidated", "financial", "statements.", "<tag2>", "The", "level", "of", "sales", "growth", "of", "MOVANTIK", "and", "ADYNOVATE", ",", "together", "with", "the", "future", "clinical", "trial", "results", "and", "potential", "subsequent", "approvals", "of", "these", "collaboration", "partner", "drug", "candidates,", "will", "have", "a", "material", "impact", "on", "our", "future", "financial", "results", "and", "financial", "position.", "<tag3>"], "wordsA": ["We", "do", "not", "believe", "the", "adoption", "of", "this", "guidance", "will", "have", "a", "material", "impact", "on", "our", "consolidated", "financial", "statements."], "wordsB": ["The", "level", "of", "sales", "growth", "of", "MOVANTIK", "and", "ADYNOVATE", ",", "together", "with", "the", "future", "clinical", "trial", "results", "and", "potential", "subsequent", "approvals", "of", "these", "collaboration", "partner", "drug", "candidates,", "will", "have", "a", "material", "impact", "on", "our", "future", "financial", "results", "and", "financial", "position."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p53_s3", "idA": "906709_16_item7_p62_s3", "sentA": "We do not believe the adoption of this guidance will have a material impact on our consolidated financial statements.", "sentB": "Although we are still evaluating our contracts and assessing all the potential impacts of the standard on existing arrangements we anticipate the adoption may have a material impact on our consolidated financial statements.", "type": 2, "words": ["<tag1>", "We", "do", "not", "believe", "the", "adoption", "of", "this", "guidance", "will", "have", "a", "material", "impact", "on", "our", "consolidated", "financial", "statements.", "<tag2>", "Although", "we", "are", "still", "evaluating", "our", "contracts", "and", "assessing", "all", "the", "potential", "impacts", "of", "the", "standard", "on", "existing", "arrangements", "we", "anticipate", "the", "adoption", "may", "have", "a", "material", "impact", "on", "our", "consolidated", "financial", "statements.", "<tag3>"], "wordsA": ["We", "do", "not", "believe", "the", "adoption", "of", "this", "guidance", "will", "have", "a", "material", "impact", "on", "our", "consolidated", "financial", "statements."], "wordsB": ["Although", "we", "are", "still", "evaluating", "our", "contracts", "and", "assessing", "all", "the", "potential", "impacts", "of", "the", "standard", "on", "existing", "arrangements", "we", "anticipate", "the", "adoption", "may", "have", "a", "material", "impact", "on", "our", "consolidated", "financial", "statements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p19_s5", "idA": "906709_16_item7_p9_s11", "sentA": "In connection with any MAA filing, we would be required to start a confirmatory trial in conjunction with the MAA review.", "sentB": "In connection with our European Union collaboration partnership with Daiichi-Sankyo and our filing of a conditional approval application for ONZEALD TM with the European Medicines Agency in June 2016, we have initiated a Phase 3 confirmatory study of ONZEALD TM to support our conditional approval application.", "type": 2, "words": ["<tag1>", "In", "connection", "with", "any", "MAA", "filing,", "we", "would", "be", "required", "to", "start", "a", "confirmatory", "trial", "in", "conjunction", "with", "the", "MAA", "review.", "<tag2>", "In", "connection", "with", "our", "European", "Union", "collaboration", "partnership", "with", "Daiichi-Sankyo", "and", "our", "filing", "of", "a", "conditional", "approval", "application", "for", "ONZEALD", "TM", "with", "the", "European", "Medicines", "Agency", "in", "June", "2016,", "we", "have", "initiated", "a", "Phase", "3", "confirmatory", "study", "of", "ONZEALD", "TM", "to", "support", "our", "conditional", "approval", "application.", "<tag3>"], "wordsA": ["In", "connection", "with", "any", "MAA", "filing,", "we", "would", "be", "required", "to", "start", "a", "confirmatory", "trial", "in", "conjunction", "with", "the", "MAA", "review."], "wordsB": ["In", "connection", "with", "our", "European", "Union", "collaboration", "partnership", "with", "Daiichi-Sankyo", "and", "our", "filing", "of", "a", "conditional", "approval", "application", "for", "ONZEALD", "TM", "with", "the", "European", "Medicines", "Agency", "in", "June", "2016,", "we", "have", "initiated", "a", "Phase", "3", "confirmatory", "study", "of", "ONZEALD", "TM", "to", "support", "our", "conditional", "approval", "application."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p19_s2", "idA": "906709_16_item7_p9_s12", "sentA": "In the United States, we met with the FDA and the Oncology Division indicated that we would not be able to use the BEACON data to support an accelerated approval for an NDA.", "sentB": "For NKTR-358, we have filed an IND with the FDA and plan to begin clinical studies in the near-term.", "type": 2, "words": ["<tag1>", "In", "the", "United", "States,", "we", "met", "with", "the", "FDA", "and", "the", "Oncology", "Division", "indicated", "that", "we", "would", "not", "be", "able", "to", "use", "the", "BEACON", "data", "to", "support", "an", "accelerated", "approval", "for", "an", "NDA.", "<tag2>", "For", "NKTR-358,", "we", "have", "filed", "an", "IND", "with", "the", "FDA", "and", "plan", "to", "begin", "clinical", "studies", "in", "the", "near-term.", "<tag3>"], "wordsA": ["In", "the", "United", "States,", "we", "met", "with", "the", "FDA", "and", "the", "Oncology", "Division", "indicated", "that", "we", "would", "not", "be", "able", "to", "use", "the", "BEACON", "data", "to", "support", "an", "accelerated", "approval", "for", "an", "NDA."], "wordsB": ["For", "NKTR-358,", "we", "have", "filed", "an", "IND", "with", "the", "FDA", "and", "plan", "to", "begin", "clinical", "studies", "in", "the", "near-term."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p0_s9", "idA": "906709_16_item7_p9_s15", "sentA": "At this time, we do not plan to advance development of NKTR-102 without a collaboration partner.", "sentB": "If the NKTR-181 Phase 3 program is successful, we plan to seek a collaboration partner to support future development and commercialization activities.", "type": 2, "words": ["<tag1>", "At", "this", "time,", "we", "do", "not", "plan", "to", "advance", "development", "of", "NKTR-102", "without", "a", "collaboration", "partner.", "<tag2>", "If", "the", "NKTR-181", "Phase", "3", "program", "is", "successful,", "we", "plan", "to", "seek", "a", "collaboration", "partner", "to", "support", "future", "development", "and", "commercialization", "activities.", "<tag3>"], "wordsA": ["At", "this", "time,", "we", "do", "not", "plan", "to", "advance", "development", "of", "NKTR-102", "without", "a", "collaboration", "partner."], "wordsB": ["If", "the", "NKTR-181", "Phase", "3", "program", "is", "successful,", "we", "plan", "to", "seek", "a", "collaboration", "partner", "to", "support", "future", "development", "and", "commercialization", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p0_s17", "idA": "906709_16_item7_p9_s16", "sentA": "We also have two significant drug development programs with Bayer.", "sentB": "We also have significant milestone and royalty interests in two drug development programs with Bayer.", "type": 2, "words": ["<tag1>", "We", "also", "have", "two", "significant", "drug", "development", "programs", "with", "Bayer.", "<tag2>", "We", "also", "have", "significant", "milestone", "and", "royalty", "interests", "in", "two", "drug", "development", "programs", "with", "Bayer.", "<tag3>"], "wordsA": ["We", "also", "have", "two", "significant", "drug", "development", "programs", "with", "Bayer."], "wordsB": ["We", "also", "have", "significant", "milestone", "and", "royalty", "interests", "in", "two", "drug", "development", "programs", "with", "Bayer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p0_s8", "idA": "906709_16_item7_p9_s16", "sentA": "We also have two significant drug development programs with Bayer.", "sentB": "We also have an ongoing pivotal human abuse liability study (HAL) for NKTR-181 that is expected to complete enrollment in the first half of 2017.", "type": 2, "words": ["<tag1>", "We", "also", "have", "two", "significant", "drug", "development", "programs", "with", "Bayer.", "<tag2>", "We", "also", "have", "an", "ongoing", "pivotal", "human", "abuse", "liability", "study", "(HAL)", "for", "NKTR-181", "that", "is", "expected", "to", "complete", "enrollment", "in", "the", "first", "half", "of", "2017.", "<tag3>"], "wordsA": ["We", "also", "have", "two", "significant", "drug", "development", "programs", "with", "Bayer."], "wordsB": ["We", "also", "have", "an", "ongoing", "pivotal", "human", "abuse", "liability", "study", "(HAL)", "for", "NKTR-181", "that", "is", "expected", "to", "complete", "enrollment", "in", "the", "first", "half", "of", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p0_s18", "idA": "906709_16_item7_p9_s17", "sentA": "The first is a collaboration to develop BAY41-6551 (Amikacin Inhale, formerly known as NKTR-061), which is an inhaled solution of amikacin, an aminoglycoside antibiotic.", "sentB": "BAY41-6551 (Amikacin Inhale), which is an inhaled solution of amikacin, an aminoglycoside antibiotic in Phase 3 clinical development to treat ventilated associated pneumonia and we expect topline results from this program in the first half of 2017.", "type": 2, "words": ["<tag1>", "The", "first", "is", "a", "collaboration", "to", "develop", "BAY41-6551", "(Amikacin", "Inhale,", "formerly", "known", "as", "NKTR-061),", "which", "is", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic.", "<tag2>", "BAY41-6551", "(Amikacin", "Inhale),", "which", "is", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic", "in", "Phase", "3", "clinical", "development", "to", "treat", "ventilated", "associated", "pneumonia", "and", "we", "expect", "topline", "results", "from", "this", "program", "in", "the", "first", "half", "of", "2017.", "<tag3>"], "wordsA": ["The", "first", "is", "a", "collaboration", "to", "develop", "BAY41-6551", "(Amikacin", "Inhale,", "formerly", "known", "as", "NKTR-061),", "which", "is", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic."], "wordsB": ["BAY41-6551", "(Amikacin", "Inhale),", "which", "is", "an", "inhaled", "solution", "of", "amikacin,", "an", "aminoglycoside", "antibiotic", "in", "Phase", "3", "clinical", "development", "to", "treat", "ventilated", "associated", "pneumonia", "and", "we", "expect", "topline", "results", "from", "this", "program", "in", "the", "first", "half", "of", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p0_s20", "idA": "906709_16_item7_p9_s19", "sentA": "Bayer is currently enrolling patients in a Phase 3 clinical study for Amikacin Inhale.", "sentB": "The first Phase 3 clinical study for CIPRO DPI met its co-primary endpoints for the every 14-day dosing arm of Cipro DPI and we expect top-line results from the second Phase 3 clinical study in 2017.", "type": 2, "words": ["<tag1>", "Bayer", "is", "currently", "enrolling", "patients", "in", "a", "Phase", "3", "clinical", "study", "for", "Amikacin", "Inhale.", "<tag2>", "The", "first", "Phase", "3", "clinical", "study", "for", "CIPRO", "DPI", "met", "its", "co-primary", "endpoints", "for", "the", "every", "14-day", "dosing", "arm", "of", "Cipro", "DPI", "and", "we", "expect", "top-line", "results", "from", "the", "second", "Phase", "3", "clinical", "study", "in", "2017.", "<tag3>"], "wordsA": ["Bayer", "is", "currently", "enrolling", "patients", "in", "a", "Phase", "3", "clinical", "study", "for", "Amikacin", "Inhale."], "wordsB": ["The", "first", "Phase", "3", "clinical", "study", "for", "CIPRO", "DPI", "met", "its", "co-primary", "endpoints", "for", "the", "every", "14-day", "dosing", "arm", "of", "Cipro", "DPI", "and", "we", "expect", "top-line", "results", "from", "the", "second", "Phase", "3", "clinical", "study", "in", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p0_s19", "idA": "906709_16_item7_p9_s21", "sentA": "The second is our significant royalty rights in the Cipro DPI (Cipro Dry Powder Inhaler, previously called Cipro Inhale) program with Bayer that we transferred to Novartis as part of the 2008 pulmonary asset divestiture transaction.", "sentB": "The second program with Bayer Schering is the Cipro DPI (Cipro Dry Powder Inhaler, previously called Cipro Inhale) which is an inhaled dry powder ciprofloxacin in Phase 3 development to treat non-cystic fibrosis bronchiectasis.", "type": 2, "words": ["<tag1>", "The", "second", "is", "our", "significant", "royalty", "rights", "in", "the", "Cipro", "DPI", "(Cipro", "Dry", "Powder", "Inhaler,", "previously", "called", "Cipro", "Inhale)", "program", "with", "Bayer", "that", "we", "transferred", "to", "Novartis", "as", "part", "of", "the", "2008", "pulmonary", "asset", "divestiture", "transaction.", "<tag2>", "The", "second", "program", "with", "Bayer", "Schering", "is", "the", "Cipro", "DPI", "(Cipro", "Dry", "Powder", "Inhaler,", "previously", "called", "Cipro", "Inhale)", "which", "is", "an", "inhaled", "dry", "powder", "ciprofloxacin", "in", "Phase", "3", "development", "to", "treat", "non-cystic", "fibrosis", "bronchiectasis.", "<tag3>"], "wordsA": ["The", "second", "is", "our", "significant", "royalty", "rights", "in", "the", "Cipro", "DPI", "(Cipro", "Dry", "Powder", "Inhaler,", "previously", "called", "Cipro", "Inhale)", "program", "with", "Bayer", "that", "we", "transferred", "to", "Novartis", "as", "part", "of", "the", "2008", "pulmonary", "asset", "divestiture", "transaction."], "wordsB": ["The", "second", "program", "with", "Bayer", "Schering", "is", "the", "Cipro", "DPI", "(Cipro", "Dry", "Powder", "Inhaler,", "previously", "called", "Cipro", "Inhale)", "which", "is", "an", "inhaled", "dry", "powder", "ciprofloxacin", "in", "Phase", "3", "development", "to", "treat", "non-cystic", "fibrosis", "bronchiectasis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p0_s24", "idA": "906709_16_item7_p9_s24", "sentA": "While the approved drugs and clinical development programs described above are key elements of our future success, we believe it is critically important that we continue to make substantial investments in our earlier-stage drug candidate pipeline.", "sentB": "For a discussion of these and some of the other risks and uncertainties affecting our business, see Item 1A \"Risk Factors\" of this Annual Report on Form 10-K. While the approved drugs and clinical development programs described above are key elements of our future success, we believe it is critically important that we continue to make substantial investments in our earlier-stage drug candidate pipeline.", "type": 2, "words": ["<tag1>", "While", "the", "approved", "drugs", "and", "clinical", "development", "programs", "described", "above", "are", "key", "elements", "of", "our", "future", "success,", "we", "believe", "it", "is", "critically", "important", "that", "we", "continue", "to", "make", "substantial", "investments", "in", "our", "earlier-stage", "drug", "candidate", "pipeline.", "<tag2>", "For", "a", "discussion", "of", "these", "and", "some", "of", "the", "other", "risks", "and", "uncertainties", "affecting", "our", "business,", "see", "Item", "1A", "\"Risk", "Factors\"", "of", "this", "Annual", "Report", "on", "Form", "10-K.", "While", "the", "approved", "drugs", "and", "clinical", "development", "programs", "described", "above", "are", "key", "elements", "of", "our", "future", "success,", "we", "believe", "it", "is", "critically", "important", "that", "we", "continue", "to", "make", "substantial", "investments", "in", "our", "earlier-stage", "drug", "candidate", "pipeline.", "<tag3>"], "wordsA": ["While", "the", "approved", "drugs", "and", "clinical", "development", "programs", "described", "above", "are", "key", "elements", "of", "our", "future", "success,", "we", "believe", "it", "is", "critically", "important", "that", "we", "continue", "to", "make", "substantial", "investments", "in", "our", "earlier-stage", "drug", "candidate", "pipeline."], "wordsB": ["For", "a", "discussion", "of", "these", "and", "some", "of", "the", "other", "risks", "and", "uncertainties", "affecting", "our", "business,", "see", "Item", "1A", "\"Risk", "Factors\"", "of", "this", "Annual", "Report", "on", "Form", "10-K.", "While", "the", "approved", "drugs", "and", "clinical", "development", "programs", "described", "above", "are", "key", "elements", "of", "our", "future", "success,", "we", "believe", "it", "is", "critically", "important", "that", "we", "continue", "to", "make", "substantial", "investments", "in", "our", "earlier-stage", "drug", "candidate", "pipeline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p0_s4", "idA": "906709_16_item7_p9_s24", "sentA": "While the approved drugs and clinical development programs described above are key elements of our future success, we believe it is critically important that we continue to make substantial investments in our earlier-stage drug candidate pipeline.", "sentB": "We continue to make significant investments in building and advancing our pipeline of proprietary drug candidates as we believe that this is the best strategy to build shareholder value.", "type": 2, "words": ["<tag1>", "While", "the", "approved", "drugs", "and", "clinical", "development", "programs", "described", "above", "are", "key", "elements", "of", "our", "future", "success,", "we", "believe", "it", "is", "critically", "important", "that", "we", "continue", "to", "make", "substantial", "investments", "in", "our", "earlier-stage", "drug", "candidate", "pipeline.", "<tag2>", "We", "continue", "to", "make", "significant", "investments", "in", "building", "and", "advancing", "our", "pipeline", "of", "proprietary", "drug", "candidates", "as", "we", "believe", "that", "this", "is", "the", "best", "strategy", "to", "build", "shareholder", "value.", "<tag3>"], "wordsA": ["While", "the", "approved", "drugs", "and", "clinical", "development", "programs", "described", "above", "are", "key", "elements", "of", "our", "future", "success,", "we", "believe", "it", "is", "critically", "important", "that", "we", "continue", "to", "make", "substantial", "investments", "in", "our", "earlier-stage", "drug", "candidate", "pipeline."], "wordsB": ["We", "continue", "to", "make", "significant", "investments", "in", "building", "and", "advancing", "our", "pipeline", "of", "proprietary", "drug", "candidates", "as", "we", "believe", "that", "this", "is", "the", "best", "strategy", "to", "build", "shareholder", "value."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p19_s8", "idA": "906709_16_item7_p9_s24", "sentA": "While the approved drugs and clinical development programs described above are key elements of our future success, we believe it is critically important that we continue to make substantial investments in our earlier-stage drug candidate pipeline.", "sentB": "In addition to our drug candidates that we plan to have in clinical development during 2017 and beyond, we believe it is vitally important to continue our substantial investment in a diverse pipeline of new drug candidates to continue to build the value of our drug candidate pipeline and our business.", "type": 2, "words": ["<tag1>", "While", "the", "approved", "drugs", "and", "clinical", "development", "programs", "described", "above", "are", "key", "elements", "of", "our", "future", "success,", "we", "believe", "it", "is", "critically", "important", "that", "we", "continue", "to", "make", "substantial", "investments", "in", "our", "earlier-stage", "drug", "candidate", "pipeline.", "<tag2>", "In", "addition", "to", "our", "drug", "candidates", "that", "we", "plan", "to", "have", "in", "clinical", "development", "during", "2017", "and", "beyond,", "we", "believe", "it", "is", "vitally", "important", "to", "continue", "our", "substantial", "investment", "in", "a", "diverse", "pipeline", "of", "new", "drug", "candidates", "to", "continue", "to", "build", "the", "value", "of", "our", "drug", "candidate", "pipeline", "and", "our", "business.", "<tag3>"], "wordsA": ["While", "the", "approved", "drugs", "and", "clinical", "development", "programs", "described", "above", "are", "key", "elements", "of", "our", "future", "success,", "we", "believe", "it", "is", "critically", "important", "that", "we", "continue", "to", "make", "substantial", "investments", "in", "our", "earlier-stage", "drug", "candidate", "pipeline."], "wordsB": ["In", "addition", "to", "our", "drug", "candidates", "that", "we", "plan", "to", "have", "in", "clinical", "development", "during", "2017", "and", "beyond,", "we", "believe", "it", "is", "vitally", "important", "to", "continue", "our", "substantial", "investment", "in", "a", "diverse", "pipeline", "of", "new", "drug", "candidates", "to", "continue", "to", "build", "the", "value", "of", "our", "drug", "candidate", "pipeline", "and", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p0_s10", "idA": "906709_16_item7_p9_s26", "sentA": "We are also advancing several other drug candidates in preclinical development in the areas of cancer immunotherapy, pain and other therapeutic indications.", "sentB": "We are also completing preclinical research and IND-enabling work for NKTR-262 and NKTR-255 with the goal of advancing those programs into the clinic later this year or in the early part of next year.", "type": 2, "words": ["<tag1>", "We", "are", "also", "advancing", "several", "other", "drug", "candidates", "in", "preclinical", "development", "in", "the", "areas", "of", "cancer", "immunotherapy,", "pain", "and", "other", "therapeutic", "indications.", "<tag2>", "We", "are", "also", "completing", "preclinical", "research", "and", "IND-enabling", "work", "for", "NKTR-262", "and", "NKTR-255", "with", "the", "goal", "of", "advancing", "those", "programs", "into", "the", "clinic", "later", "this", "year", "or", "in", "the", "early", "part", "of", "next", "year.", "<tag3>"], "wordsA": ["We", "are", "also", "advancing", "several", "other", "drug", "candidates", "in", "preclinical", "development", "in", "the", "areas", "of", "cancer", "immunotherapy,", "pain", "and", "other", "therapeutic", "indications."], "wordsB": ["We", "are", "also", "completing", "preclinical", "research", "and", "IND-enabling", "work", "for", "NKTR-262", "and", "NKTR-255", "with", "the", "goal", "of", "advancing", "those", "programs", "into", "the", "clinic", "later", "this", "year", "or", "in", "the", "early", "part", "of", "next", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p0_s26", "idA": "906709_16_item7_p9_s26", "sentA": "We are also advancing several other drug candidates in preclinical development in the areas of cancer immunotherapy, pain and other therapeutic indications.", "sentB": "We are also advancing several other drug candidates in preclinical development in the areas of cancer immunotherapy, immunology, and other therapeutic indications.", "type": 2, "words": ["<tag1>", "We", "are", "also", "advancing", "several", "other", "drug", "candidates", "in", "preclinical", "development", "in", "the", "areas", "of", "cancer", "immunotherapy,", "pain", "and", "other", "therapeutic", "indications.", "<tag2>", "We", "are", "also", "advancing", "several", "other", "drug", "candidates", "in", "preclinical", "development", "in", "the", "areas", "of", "cancer", "immunotherapy,", "immunology,", "and", "other", "therapeutic", "indications.", "<tag3>"], "wordsA": ["We", "are", "also", "advancing", "several", "other", "drug", "candidates", "in", "preclinical", "development", "in", "the", "areas", "of", "cancer", "immunotherapy,", "pain", "and", "other", "therapeutic", "indications."], "wordsB": ["We", "are", "also", "advancing", "several", "other", "drug", "candidates", "in", "preclinical", "development", "in", "the", "areas", "of", "cancer", "immunotherapy,", "immunology,", "and", "other", "therapeutic", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_17_item7_p1_s0", "idA": "906709_16_item7_p9_s27", "sentA": "While we believe that our substantial investment in research and development has the potential to create significant value if one or more of our drug candidates demonstrates positive clinical results, receives regulatory approval in one or more major markets and achieves commercial success, drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval and the timing and outcome of clinical trial results are extremely difficult to predict.", "sentB": "trial results are extremely difficult to predict.", "type": 2, "words": ["<tag1>", "While", "we", "believe", "that", "our", "substantial", "investment", "in", "research", "and", "development", "has", "the", "potential", "to", "create", "significant", "value", "if", "one", "or", "more", "of", "our", "drug", "candidates", "demonstrates", "positive", "clinical", "results,", "receives", "regulatory", "approval", "in", "one", "or", "more", "major", "markets", "and", "achieves", "commercial", "success,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "outcome", "of", "clinical", "trial", "results", "are", "extremely", "difficult", "to", "predict.", "<tag2>", "trial", "results", "are", "extremely", "difficult", "to", "predict.", "<tag3>"], "wordsA": ["While", "we", "believe", "that", "our", "substantial", "investment", "in", "research", "and", "development", "has", "the", "potential", "to", "create", "significant", "value", "if", "one", "or", "more", "of", "our", "drug", "candidates", "demonstrates", "positive", "clinical", "results,", "receives", "regulatory", "approval", "in", "one", "or", "more", "major", "markets", "and", "achieves", "commercial", "success,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "outcome", "of", "clinical", "trial", "results", "are", "extremely", "difficult", "to", "predict."], "wordsB": ["trial", "results", "are", "extremely", "difficult", "to", "predict."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p0_s1", "idA": "906709_17_item7_p0_s1", "sentA": "Our research and development pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and chronic pain.", "sentB": "Our research and development pipeline of new investigational drugs includes treatments for cancer, autoimmune disease and chronic pain.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "pipeline", "of", "new", "investigational", "drugs", "includes", "treatments", "for", "cancer,", "auto-immune", "disease", "and", "chronic", "pain.", "<tag2>", "Our", "research", "and", "development", "pipeline", "of", "new", "investigational", "drugs", "includes", "treatments", "for", "cancer,", "autoimmune", "disease", "and", "chronic", "pain.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "pipeline", "of", "new", "investigational", "drugs", "includes", "treatments", "for", "cancer,", "auto-immune", "disease", "and", "chronic", "pain."], "wordsB": ["Our", "research", "and", "development", "pipeline", "of", "new", "investigational", "drugs", "includes", "treatments", "for", "cancer,", "autoimmune", "disease", "and", "chronic", "pain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p0_s5", "idA": "906709_17_item7_p0_s1", "sentA": "Our research and development pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and chronic pain.", "sentB": "Described below are certain key events and activities where we are making investments in advancing our research and development pipeline.", "type": 2, "words": ["<tag1>", "Our", "research", "and", "development", "pipeline", "of", "new", "investigational", "drugs", "includes", "treatments", "for", "cancer,", "auto-immune", "disease", "and", "chronic", "pain.", "<tag2>", "Described", "below", "are", "certain", "key", "events", "and", "activities", "where", "we", "are", "making", "investments", "in", "advancing", "our", "research", "and", "development", "pipeline.", "<tag3>"], "wordsA": ["Our", "research", "and", "development", "pipeline", "of", "new", "investigational", "drugs", "includes", "treatments", "for", "cancer,", "auto-immune", "disease", "and", "chronic", "pain."], "wordsB": ["Described", "below", "are", "certain", "key", "events", "and", "activities", "where", "we", "are", "making", "investments", "in", "advancing", "our", "research", "and", "development", "pipeline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p9_s1", "idA": "906709_17_item7_p0_s10", "sentA": "We are also completing preclinical research and IND-enabling work for NKTR-262 and NKTR-255 with the goal of advancing those programs into the clinic later this year or in the early part of next year.", "sentB": "We are also completing preclinical research for NKTR-255 with the goal of advancing this program into the clinic in 2019.", "type": 2, "words": ["<tag1>", "We", "are", "also", "completing", "preclinical", "research", "and", "IND-enabling", "work", "for", "NKTR-262", "and", "NKTR-255", "with", "the", "goal", "of", "advancing", "those", "programs", "into", "the", "clinic", "later", "this", "year", "or", "in", "the", "early", "part", "of", "next", "year.", "<tag2>", "We", "are", "also", "completing", "preclinical", "research", "for", "NKTR-255", "with", "the", "goal", "of", "advancing", "this", "program", "into", "the", "clinic", "in", "2019.", "<tag3>"], "wordsA": ["We", "are", "also", "completing", "preclinical", "research", "and", "IND-enabling", "work", "for", "NKTR-262", "and", "NKTR-255", "with", "the", "goal", "of", "advancing", "those", "programs", "into", "the", "clinic", "later", "this", "year", "or", "in", "the", "early", "part", "of", "next", "year."], "wordsB": ["We", "are", "also", "completing", "preclinical", "research", "for", "NKTR-255", "with", "the", "goal", "of", "advancing", "this", "program", "into", "the", "clinic", "in", "2019."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p10_s1", "idA": "906709_17_item7_p0_s12", "sentA": "We have significant milestone and royalty economic interests in approved drugs and drug candidates in late stage development with our collaboration partners.", "sentB": "We also have significant milestone and royalty economic interests in approved drugs and drug candidates in late stage development with our collaboration partners.", "type": 2, "words": ["<tag1>", "We", "have", "significant", "milestone", "and", "royalty", "economic", "interests", "in", "approved", "drugs", "and", "drug", "candidates", "in", "late", "stage", "development", "with", "our", "collaboration", "partners.", "<tag2>", "We", "also", "have", "significant", "milestone", "and", "royalty", "economic", "interests", "in", "approved", "drugs", "and", "drug", "candidates", "in", "late", "stage", "development", "with", "our", "collaboration", "partners.", "<tag3>"], "wordsA": ["We", "have", "significant", "milestone", "and", "royalty", "economic", "interests", "in", "approved", "drugs", "and", "drug", "candidates", "in", "late", "stage", "development", "with", "our", "collaboration", "partners."], "wordsB": ["We", "also", "have", "significant", "milestone", "and", "royalty", "economic", "interests", "in", "approved", "drugs", "and", "drug", "candidates", "in", "late", "stage", "development", "with", "our", "collaboration", "partners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p17_s0", "idA": "906709_17_item7_p0_s13", "sentA": "With AstraZeneca, we have a collaboration for MOVANTIK , an oral peripherally-acting mu-opioid antagonist for the treatment of opioid-induced constipation in adult patients with non-cancer pain.", "sentB": "As part of its approval of MOVANTIK , the FDA required AstraZeneca to perform a post-marketing, observational epidemiological study comparing MOVANTIK to other treatments of OIC in patients with chronic, non-cancer pain.", "type": 2, "words": ["<tag1>", "With", "AstraZeneca,", "we", "have", "a", "collaboration", "for", "MOVANTIK", ",", "an", "oral", "peripherally-acting", "mu-opioid", "antagonist", "for", "the", "treatment", "of", "opioid-induced", "constipation", "in", "adult", "patients", "with", "non-cancer", "pain.", "<tag2>", "As", "part", "of", "its", "approval", "of", "MOVANTIK", ",", "the", "FDA", "required", "AstraZeneca", "to", "perform", "a", "post-marketing,", "observational", "epidemiological", "study", "comparing", "MOVANTIK", "to", "other", "treatments", "of", "OIC", "in", "patients", "with", "chronic,", "non-cancer", "pain.", "<tag3>"], "wordsA": ["With", "AstraZeneca,", "we", "have", "a", "collaboration", "for", "MOVANTIK", ",", "an", "oral", "peripherally-acting", "mu-opioid", "antagonist", "for", "the", "treatment", "of", "opioid-induced", "constipation", "in", "adult", "patients", "with", "non-cancer", "pain."], "wordsB": ["As", "part", "of", "its", "approval", "of", "MOVANTIK", ",", "the", "FDA", "required", "AstraZeneca", "to", "perform", "a", "post-marketing,", "observational", "epidemiological", "study", "comparing", "MOVANTIK", "to", "other", "treatments", "of", "OIC", "in", "patients", "with", "chronic,", "non-cancer", "pain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p10_s4", "idA": "906709_17_item7_p0_s14", "sentA": "We have a collaboration with Baxalta (a wholly-owned subsidiary of Shire plc) for ADYNOVATE , that was approved by the FDA in late 2015 for use in adults and adolescents, aged 12 years and older, who have Hemophilia A.", "sentB": "We have a collaboration with Baxalta (a wholly-owned subsidiary of Shire plc) for ADYNOVATE , that was approved by the FDA in late 2015 for use in adults and adolescents, aged 12 years and older, who have Hemophilia A. ADYNOVATE is approved by health authorities in the United States, European Union, and many other countries.", "type": 2, "words": ["<tag1>", "We", "have", "a", "collaboration", "with", "Baxalta", "(a", "wholly-owned", "subsidiary", "of", "Shire", "plc)", "for", "ADYNOVATE", ",", "that", "was", "approved", "by", "the", "FDA", "in", "late", "2015", "for", "use", "in", "adults", "and", "adolescents,", "aged", "12", "years", "and", "older,", "who", "have", "Hemophilia", "A.", "<tag2>", "We", "have", "a", "collaboration", "with", "Baxalta", "(a", "wholly-owned", "subsidiary", "of", "Shire", "plc)", "for", "ADYNOVATE", ",", "that", "was", "approved", "by", "the", "FDA", "in", "late", "2015", "for", "use", "in", "adults", "and", "adolescents,", "aged", "12", "years", "and", "older,", "who", "have", "Hemophilia", "A.", "ADYNOVATE", "is", "approved", "by", "health", "authorities", "in", "the", "United", "States,", "European", "Union,", "and", "many", "other", "countries.", "<tag3>"], "wordsA": ["We", "have", "a", "collaboration", "with", "Baxalta", "(a", "wholly-owned", "subsidiary", "of", "Shire", "plc)", "for", "ADYNOVATE", ",", "that", "was", "approved", "by", "the", "FDA", "in", "late", "2015", "for", "use", "in", "adults", "and", "adolescents,", "aged", "12", "years", "and", "older,", "who", "have", "Hemophilia", "A."], "wordsB": ["We", "have", "a", "collaboration", "with", "Baxalta", "(a", "wholly-owned", "subsidiary", "of", "Shire", "plc)", "for", "ADYNOVATE", ",", "that", "was", "approved", "by", "the", "FDA", "in", "late", "2015", "for", "use", "in", "adults", "and", "adolescents,", "aged", "12", "years", "and", "older,", "who", "have", "Hemophilia", "A.", "ADYNOVATE", "is", "approved", "by", "health", "authorities", "in", "the", "United", "States,", "European", "Union,", "and", "many", "other", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p10_s3", "idA": "906709_17_item7_p0_s16", "sentA": "ADYNOVATE is also under regulatory review in the European Union, Switzerland and Canada.", "sentB": "MOVANTIK is approved by health authorities in the United States, European Union, and many other countries.", "type": 2, "words": ["<tag1>", "ADYNOVATE", "is", "also", "under", "regulatory", "review", "in", "the", "European", "Union,", "Switzerland", "and", "Canada.", "<tag2>", "MOVANTIK", "is", "approved", "by", "health", "authorities", "in", "the", "United", "States,", "European", "Union,", "and", "many", "other", "countries.", "<tag3>"], "wordsA": ["ADYNOVATE", "is", "also", "under", "regulatory", "review", "in", "the", "European", "Union,", "Switzerland", "and", "Canada."], "wordsB": ["MOVANTIK", "is", "approved", "by", "health", "authorities", "in", "the", "United", "States,", "European", "Union,", "and", "many", "other", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p11_s0", "idA": "906709_17_item7_p0_s23", "sentA": "Our business is subject to significant risks, including the risks inherent in our development efforts, the results of our clinical trials, the marketing of our dependence on collaborative parties, uncertainties associated with obtaining and enforcing patents, the lengthy and expensive regulatory approval process and competition from other products.", "sentB": "Our business is subject to significant risks, including the risks inherent in our development efforts, the results of our clinical trials, our dependence on the marketing efforts by our collaboration partners, uncertainties associated with obtaining and enforcing patents, the lengthy and expensive regulatory approval process and competition from other products.", "type": 2, "words": ["<tag1>", "Our", "business", "is", "subject", "to", "significant", "risks,", "including", "the", "risks", "inherent", "in", "our", "development", "efforts,", "the", "results", "of", "our", "clinical", "trials,", "the", "marketing", "of", "our", "dependence", "on", "collaborative", "parties,", "uncertainties", "associated", "with", "obtaining", "and", "enforcing", "patents,", "the", "lengthy", "and", "expensive", "regulatory", "approval", "process", "and", "competition", "from", "other", "products.", "<tag2>", "Our", "business", "is", "subject", "to", "significant", "risks,", "including", "the", "risks", "inherent", "in", "our", "development", "efforts,", "the", "results", "of", "our", "clinical", "trials,", "our", "dependence", "on", "the", "marketing", "efforts", "by", "our", "collaboration", "partners,", "uncertainties", "associated", "with", "obtaining", "and", "enforcing", "patents,", "the", "lengthy", "and", "expensive", "regulatory", "approval", "process", "and", "competition", "from", "other", "products.", "<tag3>"], "wordsA": ["Our", "business", "is", "subject", "to", "significant", "risks,", "including", "the", "risks", "inherent", "in", "our", "development", "efforts,", "the", "results", "of", "our", "clinical", "trials,", "the", "marketing", "of", "our", "dependence", "on", "collaborative", "parties,", "uncertainties", "associated", "with", "obtaining", "and", "enforcing", "patents,", "the", "lengthy", "and", "expensive", "regulatory", "approval", "process", "and", "competition", "from", "other", "products."], "wordsB": ["Our", "business", "is", "subject", "to", "significant", "risks,", "including", "the", "risks", "inherent", "in", "our", "development", "efforts,", "the", "results", "of", "our", "clinical", "trials,", "our", "dependence", "on", "the", "marketing", "efforts", "by", "our", "collaboration", "partners,", "uncertainties", "associated", "with", "obtaining", "and", "enforcing", "patents,", "the", "lengthy", "and", "expensive", "regulatory", "approval", "process", "and", "competition", "from", "other", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p0_s4", "idA": "906709_17_item7_p0_s4", "sentA": "We continue to make significant investments in building and advancing our pipeline of proprietary drug candidates as we believe that this is the best strategy to build shareholder value.", "sentB": "We continue to make significant investments in building and advancing our pipeline of proprietary drug candidates as we believe that this is the best strategy to build stockholder value.", "type": 2, "words": ["<tag1>", "We", "continue", "to", "make", "significant", "investments", "in", "building", "and", "advancing", "our", "pipeline", "of", "proprietary", "drug", "candidates", "as", "we", "believe", "that", "this", "is", "the", "best", "strategy", "to", "build", "shareholder", "value.", "<tag2>", "We", "continue", "to", "make", "significant", "investments", "in", "building", "and", "advancing", "our", "pipeline", "of", "proprietary", "drug", "candidates", "as", "we", "believe", "that", "this", "is", "the", "best", "strategy", "to", "build", "stockholder", "value.", "<tag3>"], "wordsA": ["We", "continue", "to", "make", "significant", "investments", "in", "building", "and", "advancing", "our", "pipeline", "of", "proprietary", "drug", "candidates", "as", "we", "believe", "that", "this", "is", "the", "best", "strategy", "to", "build", "shareholder", "value."], "wordsB": ["We", "continue", "to", "make", "significant", "investments", "in", "building", "and", "advancing", "our", "pipeline", "of", "proprietary", "drug", "candidates", "as", "we", "believe", "that", "this", "is", "the", "best", "strategy", "to", "build", "stockholder", "value."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p2_s0", "idA": "906709_17_item7_p0_s5", "sentA": "In 2017, our plan is to execute a broad clinical development program for NKTR-214 in combination with other immuno-oncology agents including Opdivo (nivolumab) as part of our broad Phase 1/2 clinical collaboration with BMS in five tumor types and eight potential indications, a dose-escalation study with atezolizumab, and numerous preclinical collaboration programs.", "sentB": "In early 2017, we commenced a broad clinical development program for NKTR-214, our lead immuno-oncology drug candidate in combination with other immuno-oncology agents including Opdivo (nivolumab) as part of our broad Phase 1/2 clinical collaboration with BMS in five tumor types and eight potential indications, a dose-escalation study with atezolizumab, and numerous preclinical collaboration programs.", "type": 2, "words": ["<tag1>", "In", "2017,", "our", "plan", "is", "to", "execute", "a", "broad", "clinical", "development", "program", "for", "NKTR-214", "in", "combination", "with", "other", "immuno-oncology", "agents", "including", "Opdivo", "(nivolumab)", "as", "part", "of", "our", "broad", "Phase", "1/2", "clinical", "collaboration", "with", "BMS", "in", "five", "tumor", "types", "and", "eight", "potential", "indications,", "a", "dose-escalation", "study", "with", "atezolizumab,", "and", "numerous", "preclinical", "collaboration", "programs.", "<tag2>", "In", "early", "2017,", "we", "commenced", "a", "broad", "clinical", "development", "program", "for", "NKTR-214,", "our", "lead", "immuno-oncology", "drug", "candidate", "in", "combination", "with", "other", "immuno-oncology", "agents", "including", "Opdivo", "(nivolumab)", "as", "part", "of", "our", "broad", "Phase", "1/2", "clinical", "collaboration", "with", "BMS", "in", "five", "tumor", "types", "and", "eight", "potential", "indications,", "a", "dose-escalation", "study", "with", "atezolizumab,", "and", "numerous", "preclinical", "collaboration", "programs.", "<tag3>"], "wordsA": ["In", "2017,", "our", "plan", "is", "to", "execute", "a", "broad", "clinical", "development", "program", "for", "NKTR-214", "in", "combination", "with", "other", "immuno-oncology", "agents", "including", "Opdivo", "(nivolumab)", "as", "part", "of", "our", "broad", "Phase", "1/2", "clinical", "collaboration", "with", "BMS", "in", "five", "tumor", "types", "and", "eight", "potential", "indications,", "a", "dose-escalation", "study", "with", "atezolizumab,", "and", "numerous", "preclinical", "collaboration", "programs."], "wordsB": ["In", "early", "2017,", "we", "commenced", "a", "broad", "clinical", "development", "program", "for", "NKTR-214,", "our", "lead", "immuno-oncology", "drug", "candidate", "in", "combination", "with", "other", "immuno-oncology", "agents", "including", "Opdivo", "(nivolumab)", "as", "part", "of", "our", "broad", "Phase", "1/2", "clinical", "collaboration", "with", "BMS", "in", "five", "tumor", "types", "and", "eight", "potential", "indications,", "a", "dose-escalation", "study", "with", "atezolizumab,", "and", "numerous", "preclinical", "collaboration", "programs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p6_s0", "idA": "906709_17_item7_p0_s6", "sentA": "In February 2017, we filed an IND for NKTR-358, our auto-immune disease drug candidate, and plan to start the Phase 1 study for this program in healthy volunteers and then advance the program into Phase 1b in patients with systemic lupus erythematous (SLE), and other potential immune disease indications.", "sentB": "In February 2017, we filed an investigational new drug (IND) application for NKTR-358, our autoimmune disease drug candidate.", "type": 2, "words": ["<tag1>", "In", "February", "2017,", "we", "filed", "an", "IND", "for", "NKTR-358,", "our", "auto-immune", "disease", "drug", "candidate,", "and", "plan", "to", "start", "the", "Phase", "1", "study", "for", "this", "program", "in", "healthy", "volunteers", "and", "then", "advance", "the", "program", "into", "Phase", "1b", "in", "patients", "with", "systemic", "lupus", "erythematous", "(SLE),", "and", "other", "potential", "immune", "disease", "indications.", "<tag2>", "In", "February", "2017,", "we", "filed", "an", "investigational", "new", "drug", "(IND)", "application", "for", "NKTR-358,", "our", "autoimmune", "disease", "drug", "candidate.", "<tag3>"], "wordsA": ["In", "February", "2017,", "we", "filed", "an", "IND", "for", "NKTR-358,", "our", "auto-immune", "disease", "drug", "candidate,", "and", "plan", "to", "start", "the", "Phase", "1", "study", "for", "this", "program", "in", "healthy", "volunteers", "and", "then", "advance", "the", "program", "into", "Phase", "1b", "in", "patients", "with", "systemic", "lupus", "erythematous", "(SLE),", "and", "other", "potential", "immune", "disease", "indications."], "wordsB": ["In", "February", "2017,", "we", "filed", "an", "investigational", "new", "drug", "(IND)", "application", "for", "NKTR-358,", "our", "autoimmune", "disease", "drug", "candidate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p6_s1", "idA": "906709_17_item7_p0_s7", "sentA": "We completed enrollment in the SUMMIT-07 Phase 3 efficacy study for NKTR-181 in late 2016 and expect to announce the top-line data in March 2017.", "sentB": "We began the Phase 1 clinical study to evaluate single-ascending doses of NKTR-358 in healthy volunteers in March 2017.", "type": 2, "words": ["<tag1>", "We", "completed", "enrollment", "in", "the", "SUMMIT-07", "Phase", "3", "efficacy", "study", "for", "NKTR-181", "in", "late", "2016", "and", "expect", "to", "announce", "the", "top-line", "data", "in", "March", "2017.", "<tag2>", "We", "began", "the", "Phase", "1", "clinical", "study", "to", "evaluate", "single-ascending", "doses", "of", "NKTR-358", "in", "healthy", "volunteers", "in", "March", "2017.", "<tag3>"], "wordsA": ["We", "completed", "enrollment", "in", "the", "SUMMIT-07", "Phase", "3", "efficacy", "study", "for", "NKTR-181", "in", "late", "2016", "and", "expect", "to", "announce", "the", "top-line", "data", "in", "March", "2017."], "wordsB": ["We", "began", "the", "Phase", "1", "clinical", "study", "to", "evaluate", "single-ascending", "doses", "of", "NKTR-358", "in", "healthy", "volunteers", "in", "March", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p7_s0", "idA": "906709_17_item7_p0_s7", "sentA": "We completed enrollment in the SUMMIT-07 Phase 3 efficacy study for NKTR-181 in late 2016 and expect to announce the top-line data in March 2017.", "sentB": "On March 20, 2017, we announced that NKTR-181, met its primary and secondary endpoints in the SUMMIT-07 Phase 3 efficacy study.", "type": 2, "words": ["<tag1>", "We", "completed", "enrollment", "in", "the", "SUMMIT-07", "Phase", "3", "efficacy", "study", "for", "NKTR-181", "in", "late", "2016", "and", "expect", "to", "announce", "the", "top-line", "data", "in", "March", "2017.", "<tag2>", "On", "March", "20,", "2017,", "we", "announced", "that", "NKTR-181,", "met", "its", "primary", "and", "secondary", "endpoints", "in", "the", "SUMMIT-07", "Phase", "3", "efficacy", "study.", "<tag3>"], "wordsA": ["We", "completed", "enrollment", "in", "the", "SUMMIT-07", "Phase", "3", "efficacy", "study", "for", "NKTR-181", "in", "late", "2016", "and", "expect", "to", "announce", "the", "top-line", "data", "in", "March", "2017."], "wordsB": ["On", "March", "20,", "2017,", "we", "announced", "that", "NKTR-181,", "met", "its", "primary", "and", "secondary", "endpoints", "in", "the", "SUMMIT-07", "Phase", "3", "efficacy", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p3_s0", "idA": "906709_17_item7_p0_s8", "sentA": "We also have an ongoing pivotal human abuse liability study (HAL) for NKTR-181 that is expected to complete enrollment in the first half of 2017.", "sentB": "In the last half of 2017 we completed enrollment in the dose-escalation phase of the NKTR-214 study evaluating NKTR-214 in combination with Opdivo (nivolumab) in patients with melanoma, renal cell carcinoma and non-small cell lung cancer which we call the PIVOT-02 study.", "type": 2, "words": ["<tag1>", "We", "also", "have", "an", "ongoing", "pivotal", "human", "abuse", "liability", "study", "(HAL)", "for", "NKTR-181", "that", "is", "expected", "to", "complete", "enrollment", "in", "the", "first", "half", "of", "2017.", "<tag2>", "In", "the", "last", "half", "of", "2017", "we", "completed", "enrollment", "in", "the", "dose-escalation", "phase", "of", "the", "NKTR-214", "study", "evaluating", "NKTR-214", "in", "combination", "with", "Opdivo", "(nivolumab)", "in", "patients", "with", "melanoma,", "renal", "cell", "carcinoma", "and", "non-small", "cell", "lung", "cancer", "which", "we", "call", "the", "PIVOT-02", "study.", "<tag3>"], "wordsA": ["We", "also", "have", "an", "ongoing", "pivotal", "human", "abuse", "liability", "study", "(HAL)", "for", "NKTR-181", "that", "is", "expected", "to", "complete", "enrollment", "in", "the", "first", "half", "of", "2017."], "wordsB": ["In", "the", "last", "half", "of", "2017", "we", "completed", "enrollment", "in", "the", "dose-escalation", "phase", "of", "the", "NKTR-214", "study", "evaluating", "NKTR-214", "in", "combination", "with", "Opdivo", "(nivolumab)", "in", "patients", "with", "melanoma,", "renal", "cell", "carcinoma", "and", "non-small", "cell", "lung", "cancer", "which", "we", "call", "the", "PIVOT-02", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p7_s1", "idA": "906709_17_item7_p0_s8", "sentA": "We also have an ongoing pivotal human abuse liability study (HAL) for NKTR-181 that is expected to complete enrollment in the first half of 2017.", "sentB": "On July 18, 2017, we announced positive top-line data for our pivotal human abuse potential study (the HAP study) for NKTR-181.", "type": 2, "words": ["<tag1>", "We", "also", "have", "an", "ongoing", "pivotal", "human", "abuse", "liability", "study", "(HAL)", "for", "NKTR-181", "that", "is", "expected", "to", "complete", "enrollment", "in", "the", "first", "half", "of", "2017.", "<tag2>", "On", "July", "18,", "2017,", "we", "announced", "positive", "top-line", "data", "for", "our", "pivotal", "human", "abuse", "potential", "study", "(the", "HAP", "study)", "for", "NKTR-181.", "<tag3>"], "wordsA": ["We", "also", "have", "an", "ongoing", "pivotal", "human", "abuse", "liability", "study", "(HAL)", "for", "NKTR-181", "that", "is", "expected", "to", "complete", "enrollment", "in", "the", "first", "half", "of", "2017."], "wordsB": ["On", "July", "18,", "2017,", "we", "announced", "positive", "top-line", "data", "for", "our", "pivotal", "human", "abuse", "potential", "study", "(the", "HAP", "study)", "for", "NKTR-181."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p8_s1", "idA": "906709_17_item7_p0_s8", "sentA": "We also have an ongoing pivotal human abuse liability study (HAL) for NKTR-181 that is expected to complete enrollment in the first half of 2017.", "sentB": "We are currently planning to file the NDA for NKTR-181 in the first half of 2018.", "type": 2, "words": ["<tag1>", "We", "also", "have", "an", "ongoing", "pivotal", "human", "abuse", "liability", "study", "(HAL)", "for", "NKTR-181", "that", "is", "expected", "to", "complete", "enrollment", "in", "the", "first", "half", "of", "2017.", "<tag2>", "We", "are", "currently", "planning", "to", "file", "the", "NDA", "for", "NKTR-181", "in", "the", "first", "half", "of", "2018.", "<tag3>"], "wordsA": ["We", "also", "have", "an", "ongoing", "pivotal", "human", "abuse", "liability", "study", "(HAL)", "for", "NKTR-181", "that", "is", "expected", "to", "complete", "enrollment", "in", "the", "first", "half", "of", "2017."], "wordsB": ["We", "are", "currently", "planning", "to", "file", "the", "NDA", "for", "NKTR-181", "in", "the", "first", "half", "of", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p8_s0", "idA": "906709_17_item7_p0_s9", "sentA": "If the NKTR-181 Phase 3 program is successful, we plan to seek a collaboration partner to support future development and commercialization activities.", "sentB": "Following the success of the SUMMIT-07 Phase 3 efficacy study and the HAP study, we are seeking a partner to support future development and commercialization activities for NKTR-181.", "type": 2, "words": ["<tag1>", "If", "the", "NKTR-181", "Phase", "3", "program", "is", "successful,", "we", "plan", "to", "seek", "a", "collaboration", "partner", "to", "support", "future", "development", "and", "commercialization", "activities.", "<tag2>", "Following", "the", "success", "of", "the", "SUMMIT-07", "Phase", "3", "efficacy", "study", "and", "the", "HAP", "study,", "we", "are", "seeking", "a", "partner", "to", "support", "future", "development", "and", "commercialization", "activities", "for", "NKTR-181.", "<tag3>"], "wordsA": ["If", "the", "NKTR-181", "Phase", "3", "program", "is", "successful,", "we", "plan", "to", "seek", "a", "collaboration", "partner", "to", "support", "future", "development", "and", "commercialization", "activities."], "wordsB": ["Following", "the", "success", "of", "the", "SUMMIT-07", "Phase", "3", "efficacy", "study", "and", "the", "HAP", "study,", "we", "are", "seeking", "a", "partner", "to", "support", "future", "development", "and", "commercialization", "activities", "for", "NKTR-181."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p22_s0", "idA": "906709_17_item7_p11_s0", "sentA": "The decrease in revenue attributable to European countries for the year ended December 31, 2016 compared to the year ended December 31, 2015 is primarily attributable to decreased milestone and other contingent payments from our existing European based collaboration partners, including the recognition in 2015 of a total of $140.0 million payments from AstraZeneca in connection with its commercial launches of MOVANTIK described above.", "sentB": "The increase in revenue attributable to the United States for the year ended December 31, 2017 compared to the year ended December 31, 2016 is primarily attributable to the recognition of $130.1 million of the $150.0 million upfront payment we received in September 2017 from our collaboration agreement with Lilly for NKTR-358.", "type": 2, "words": ["<tag1>", "The", "decrease", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "is", "primarily", "attributable", "to", "decreased", "milestone", "and", "other", "contingent", "payments", "from", "our", "existing", "European", "based", "collaboration", "partners,", "including", "the", "recognition", "in", "2015", "of", "a", "total", "of", "$140.0", "million", "payments", "from", "AstraZeneca", "in", "connection", "with", "its", "commercial", "launches", "of", "MOVANTIK", "described", "above.", "<tag2>", "The", "increase", "in", "revenue", "attributable", "to", "the", "United", "States", "for", "the", "year", "ended", "December", "31,", "2017", "compared", "to", "the", "year", "ended", "December", "31,", "2016", "is", "primarily", "attributable", "to", "the", "recognition", "of", "$130.1", "million", "of", "the", "$150.0", "million", "upfront", "payment", "we", "received", "in", "September", "2017", "from", "our", "collaboration", "agreement", "with", "Lilly", "for", "NKTR-358.", "<tag3>"], "wordsA": ["The", "decrease", "in", "revenue", "attributable", "to", "European", "countries", "for", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "is", "primarily", "attributable", "to", "decreased", "milestone", "and", "other", "contingent", "payments", "from", "our", "existing", "European", "based", "collaboration", "partners,", "including", "the", "recognition", "in", "2015", "of", "a", "total", "of", "$140.0", "million", "payments", "from", "AstraZeneca", "in", "connection", "with", "its", "commercial", "launches", "of", "MOVANTIK", "described", "above."], "wordsB": ["The", "increase", "in", "revenue", "attributable", "to", "the", "United", "States", "for", "the", "year", "ended", "December", "31,", "2017", "compared", "to", "the", "year", "ended", "December", "31,", "2016", "is", "primarily", "attributable", "to", "the", "recognition", "of", "$130.1", "million", "of", "the", "$150.0", "million", "upfront", "payment", "we", "received", "in", "September", "2017", "from", "our", "collaboration", "agreement", "with", "Lilly", "for", "NKTR-358."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p23_s4", "idA": "906709_17_item7_p13_s1", "sentA": "Cost of goods sold during the year ended December 31, 2015 increased compared to the year ended December 31, 2014 primarily due to the increase in product sales of $15.0 million in the year ended December 31, 2015 compared to the year ended December 31, 2014.", "sentB": "Cost of goods sold during the year ended December 31, 2017 was consistent with the year ended December 31, 2016.", "type": 2, "words": ["<tag1>", "Cost", "of", "goods", "sold", "during", "the", "year", "ended", "December", "31,", "2015", "increased", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "the", "increase", "in", "product", "sales", "of", "$15.0", "million", "in", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014.", "<tag2>", "Cost", "of", "goods", "sold", "during", "the", "year", "ended", "December", "31,", "2017", "was", "consistent", "with", "the", "year", "ended", "December", "31,", "2016.", "<tag3>"], "wordsA": ["Cost", "of", "goods", "sold", "during", "the", "year", "ended", "December", "31,", "2015", "increased", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "the", "increase", "in", "product", "sales", "of", "$15.0", "million", "in", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014."], "wordsB": ["Cost", "of", "goods", "sold", "during", "the", "year", "ended", "December", "31,", "2017", "was", "consistent", "with", "the", "year", "ended", "December", "31,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p62_s15", "idA": "906709_17_item7_p13_s1", "sentA": "Cost of goods sold during the year ended December 31, 2015 increased compared to the year ended December 31, 2014 primarily due to the increase in product sales of $15.0 million in the year ended December 31, 2015 compared to the year ended December 31, 2014.", "sentB": "This estimated adjustment primarily consists of approximately $11.0 million for the accrual of royalties due to us related to net sales in the three months ended December 31, 2017 that we would have recognized in 2018 under current guidance.", "type": 2, "words": ["<tag1>", "Cost", "of", "goods", "sold", "during", "the", "year", "ended", "December", "31,", "2015", "increased", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "the", "increase", "in", "product", "sales", "of", "$15.0", "million", "in", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014.", "<tag2>", "This", "estimated", "adjustment", "primarily", "consists", "of", "approximately", "$11.0", "million", "for", "the", "accrual", "of", "royalties", "due", "to", "us", "related", "to", "net", "sales", "in", "the", "three", "months", "ended", "December", "31,", "2017", "that", "we", "would", "have", "recognized", "in", "2018", "under", "current", "guidance.", "<tag3>"], "wordsA": ["Cost", "of", "goods", "sold", "during", "the", "year", "ended", "December", "31,", "2015", "increased", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "the", "increase", "in", "product", "sales", "of", "$15.0", "million", "in", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014."], "wordsB": ["This", "estimated", "adjustment", "primarily", "consists", "of", "approximately", "$11.0", "million", "for", "the", "accrual", "of", "royalties", "due", "to", "us", "related", "to", "net", "sales", "in", "the", "three", "months", "ended", "December", "31,", "2017", "that", "we", "would", "have", "recognized", "in", "2018", "under", "current", "guidance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p23_s3", "idA": "906709_17_item7_p13_s2", "sentA": "The improvement in product gross profit and product gross margin during the years ended December 31, 2016 and 2015 compared to the years ended December 31, 2015 and 2014, respectively, is primarily due to a more favorable product mix.", "sentB": "As a result, our product gross profit and margin are significantly impacted by the mix and volume of products sold in each period.", "type": 2, "words": ["<tag1>", "The", "improvement", "in", "product", "gross", "profit", "and", "product", "gross", "margin", "during", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "respectively,", "is", "primarily", "due", "to", "a", "more", "favorable", "product", "mix.", "<tag2>", "As", "a", "result,", "our", "product", "gross", "profit", "and", "margin", "are", "significantly", "impacted", "by", "the", "mix", "and", "volume", "of", "products", "sold", "in", "each", "period.", "<tag3>"], "wordsA": ["The", "improvement", "in", "product", "gross", "profit", "and", "product", "gross", "margin", "during", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "respectively,", "is", "primarily", "due", "to", "a", "more", "favorable", "product", "mix."], "wordsB": ["As", "a", "result,", "our", "product", "gross", "profit", "and", "margin", "are", "significantly", "impacted", "by", "the", "mix", "and", "volume", "of", "products", "sold", "in", "each", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p23_s6", "idA": "906709_17_item7_p13_s2", "sentA": "The improvement in product gross profit and product gross margin during the years ended December 31, 2016 and 2015 compared to the years ended December 31, 2015 and 2014, respectively, is primarily due to a more favorable product mix.", "sentB": "The decrease in product gross profit and product gross margin during the year ended December 31, 2017 compared to the year ended December 31, 2016 is primarily due to decreased product sales as well as a less favorable product mix in 2017 compared to 2016.", "type": 2, "words": ["<tag1>", "The", "improvement", "in", "product", "gross", "profit", "and", "product", "gross", "margin", "during", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "respectively,", "is", "primarily", "due", "to", "a", "more", "favorable", "product", "mix.", "<tag2>", "The", "decrease", "in", "product", "gross", "profit", "and", "product", "gross", "margin", "during", "the", "year", "ended", "December", "31,", "2017", "compared", "to", "the", "year", "ended", "December", "31,", "2016", "is", "primarily", "due", "to", "decreased", "product", "sales", "as", "well", "as", "a", "less", "favorable", "product", "mix", "in", "2017", "compared", "to", "2016.", "<tag3>"], "wordsA": ["The", "improvement", "in", "product", "gross", "profit", "and", "product", "gross", "margin", "during", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "respectively,", "is", "primarily", "due", "to", "a", "more", "favorable", "product", "mix."], "wordsB": ["The", "decrease", "in", "product", "gross", "profit", "and", "product", "gross", "margin", "during", "the", "year", "ended", "December", "31,", "2017", "compared", "to", "the", "year", "ended", "December", "31,", "2016", "is", "primarily", "due", "to", "decreased", "product", "sales", "as", "well", "as", "a", "less", "favorable", "product", "mix", "in", "2017", "compared", "to", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p23_s9", "idA": "906709_17_item7_p13_s2", "sentA": "The improvement in product gross profit and product gross margin during the years ended December 31, 2016 and 2015 compared to the years ended December 31, 2015 and 2014, respectively, is primarily due to a more favorable product mix.", "sentB": "The improvement in product gross profit and product gross margin during the year ended December 31, 2016 compared to the year ended December 31, 2015 is primarily due to a more favorable product mix.", "type": 2, "words": ["<tag1>", "The", "improvement", "in", "product", "gross", "profit", "and", "product", "gross", "margin", "during", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "respectively,", "is", "primarily", "due", "to", "a", "more", "favorable", "product", "mix.", "<tag2>", "The", "improvement", "in", "product", "gross", "profit", "and", "product", "gross", "margin", "during", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "is", "primarily", "due", "to", "a", "more", "favorable", "product", "mix.", "<tag3>"], "wordsA": ["The", "improvement", "in", "product", "gross", "profit", "and", "product", "gross", "margin", "during", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "respectively,", "is", "primarily", "due", "to", "a", "more", "favorable", "product", "mix."], "wordsB": ["The", "improvement", "in", "product", "gross", "profit", "and", "product", "gross", "margin", "during", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "is", "primarily", "due", "to", "a", "more", "favorable", "product", "mix."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p23_s10", "idA": "906709_17_item7_p13_s3", "sentA": "In particular, the increased demand from our collaboration partners in 2016 and 2015 results in product sales where we have a relatively higher gross margin.", "sentB": "In particular, the increased demand from our collaboration partners in 2016 resulted in product sales where we have a relatively higher gross margin.", "type": 2, "words": ["<tag1>", "In", "particular,", "the", "increased", "demand", "from", "our", "collaboration", "partners", "in", "2016", "and", "2015", "results", "in", "product", "sales", "where", "we", "have", "a", "relatively", "higher", "gross", "margin.", "<tag2>", "In", "particular,", "the", "increased", "demand", "from", "our", "collaboration", "partners", "in", "2016", "resulted", "in", "product", "sales", "where", "we", "have", "a", "relatively", "higher", "gross", "margin.", "<tag3>"], "wordsA": ["In", "particular,", "the", "increased", "demand", "from", "our", "collaboration", "partners", "in", "2016", "and", "2015", "results", "in", "product", "sales", "where", "we", "have", "a", "relatively", "higher", "gross", "margin."], "wordsB": ["In", "particular,", "the", "increased", "demand", "from", "our", "collaboration", "partners", "in", "2016", "resulted", "in", "product", "sales", "where", "we", "have", "a", "relatively", "higher", "gross", "margin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p23_s11", "idA": "906709_17_item7_p13_s4", "sentA": "This increased margin is partially offset by a manufacturing arrangement with another partner that includes a fixed price which is less than the fully burdened manufacturing cost for the reagent and we expect this situation to continue with this partner in future years.", "sentB": "This increased margin was partially offset by the manufacturing arrangement mentioned above.", "type": 2, "words": ["<tag1>", "This", "increased", "margin", "is", "partially", "offset", "by", "a", "manufacturing", "arrangement", "with", "another", "partner", "that", "includes", "a", "fixed", "price", "which", "is", "less", "than", "the", "fully", "burdened", "manufacturing", "cost", "for", "the", "reagent", "and", "we", "expect", "this", "situation", "to", "continue", "with", "this", "partner", "in", "future", "years.", "<tag2>", "This", "increased", "margin", "was", "partially", "offset", "by", "the", "manufacturing", "arrangement", "mentioned", "above.", "<tag3>"], "wordsA": ["This", "increased", "margin", "is", "partially", "offset", "by", "a", "manufacturing", "arrangement", "with", "another", "partner", "that", "includes", "a", "fixed", "price", "which", "is", "less", "than", "the", "fully", "burdened", "manufacturing", "cost", "for", "the", "reagent", "and", "we", "expect", "this", "situation", "to", "continue", "with", "this", "partner", "in", "future", "years."], "wordsB": ["This", "increased", "margin", "was", "partially", "offset", "by", "the", "manufacturing", "arrangement", "mentioned", "above."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p23_s7", "idA": "906709_17_item7_p13_s4", "sentA": "This increased margin is partially offset by a manufacturing arrangement with another partner that includes a fixed price which is less than the fully burdened manufacturing cost for the reagent and we expect this situation to continue with this partner in future years.", "sentB": "In particular, we have a manufacturing arrangement with a partner that includes a fixed price which is less than the fully burdened manufacturing cost for the reagent, and we expect this situation to continue with this partner in future years.", "type": 2, "words": ["<tag1>", "This", "increased", "margin", "is", "partially", "offset", "by", "a", "manufacturing", "arrangement", "with", "another", "partner", "that", "includes", "a", "fixed", "price", "which", "is", "less", "than", "the", "fully", "burdened", "manufacturing", "cost", "for", "the", "reagent", "and", "we", "expect", "this", "situation", "to", "continue", "with", "this", "partner", "in", "future", "years.", "<tag2>", "In", "particular,", "we", "have", "a", "manufacturing", "arrangement", "with", "a", "partner", "that", "includes", "a", "fixed", "price", "which", "is", "less", "than", "the", "fully", "burdened", "manufacturing", "cost", "for", "the", "reagent,", "and", "we", "expect", "this", "situation", "to", "continue", "with", "this", "partner", "in", "future", "years.", "<tag3>"], "wordsA": ["This", "increased", "margin", "is", "partially", "offset", "by", "a", "manufacturing", "arrangement", "with", "another", "partner", "that", "includes", "a", "fixed", "price", "which", "is", "less", "than", "the", "fully", "burdened", "manufacturing", "cost", "for", "the", "reagent", "and", "we", "expect", "this", "situation", "to", "continue", "with", "this", "partner", "in", "future", "years."], "wordsB": ["In", "particular,", "we", "have", "a", "manufacturing", "arrangement", "with", "a", "partner", "that", "includes", "a", "fixed", "price", "which", "is", "less", "than", "the", "fully", "burdened", "manufacturing", "cost", "for", "the", "reagent,", "and", "we", "expect", "this", "situation", "to", "continue", "with", "this", "partner", "in", "future", "years."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p23_s8", "idA": "906709_17_item7_p13_s5", "sentA": "There were fewer shipments to this partner relative to shipments to other customers during the years ended December 31, 2016 and 2015 compared to the years ended December 31, 2015 and 2014, respectively.", "sentB": "There were more shipments to this partner relative to shipments to other customers during the year ended December 31, 2017 compared to the year ended December 31, 2016.", "type": 2, "words": ["<tag1>", "There", "were", "fewer", "shipments", "to", "this", "partner", "relative", "to", "shipments", "to", "other", "customers", "during", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "respectively.", "<tag2>", "There", "were", "more", "shipments", "to", "this", "partner", "relative", "to", "shipments", "to", "other", "customers", "during", "the", "year", "ended", "December", "31,", "2017", "compared", "to", "the", "year", "ended", "December", "31,", "2016.", "<tag3>"], "wordsA": ["There", "were", "fewer", "shipments", "to", "this", "partner", "relative", "to", "shipments", "to", "other", "customers", "during", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "respectively."], "wordsB": ["There", "were", "more", "shipments", "to", "this", "partner", "relative", "to", "shipments", "to", "other", "customers", "during", "the", "year", "ended", "December", "31,", "2017", "compared", "to", "the", "year", "ended", "December", "31,", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p24_s1", "idA": "906709_17_item7_p14_s1", "sentA": "In the years ended December 31, 2016, 2015 and 2014, the royalty revenue from this collaboration exceeded the related negative gross profit.", "sentB": "In the years ended December 31, 2017, 2016 and 2015, the royalty revenue from this collaboration exceeded the related negative gross profit.", "type": 2, "words": ["<tag1>", "In", "the", "years", "ended", "December", "31,", "2016,", "2015", "and", "2014,", "the", "royalty", "revenue", "from", "this", "collaboration", "exceeded", "the", "related", "negative", "gross", "profit.", "<tag2>", "In", "the", "years", "ended", "December", "31,", "2017,", "2016", "and", "2015,", "the", "royalty", "revenue", "from", "this", "collaboration", "exceeded", "the", "related", "negative", "gross", "profit.", "<tag3>"], "wordsA": ["In", "the", "years", "ended", "December", "31,", "2016,", "2015", "and", "2014,", "the", "royalty", "revenue", "from", "this", "collaboration", "exceeded", "the", "related", "negative", "gross", "profit."], "wordsB": ["In", "the", "years", "ended", "December", "31,", "2017,", "2016", "and", "2015,", "the", "royalty", "revenue", "from", "this", "collaboration", "exceeded", "the", "related", "negative", "gross", "profit."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p23_s2", "idA": "906709_17_item7_p14_s2", "sentA": "We expect product gross margin to continue to fluctuate in future periods depending on the level and mix of manufacturing orders from our customers due to the predominantly fixed cost base associated with our manufacturing activities.", "sentB": "We have a predominantly fixed cost base associated with our manufacturing activities, which generally results in similar total cost of goods sold amounts each year.", "type": 2, "words": ["<tag1>", "We", "expect", "product", "gross", "margin", "to", "continue", "to", "fluctuate", "in", "future", "periods", "depending", "on", "the", "level", "and", "mix", "of", "manufacturing", "orders", "from", "our", "customers", "due", "to", "the", "predominantly", "fixed", "cost", "base", "associated", "with", "our", "manufacturing", "activities.", "<tag2>", "We", "have", "a", "predominantly", "fixed", "cost", "base", "associated", "with", "our", "manufacturing", "activities,", "which", "generally", "results", "in", "similar", "total", "cost", "of", "goods", "sold", "amounts", "each", "year.", "<tag3>"], "wordsA": ["We", "expect", "product", "gross", "margin", "to", "continue", "to", "fluctuate", "in", "future", "periods", "depending", "on", "the", "level", "and", "mix", "of", "manufacturing", "orders", "from", "our", "customers", "due", "to", "the", "predominantly", "fixed", "cost", "base", "associated", "with", "our", "manufacturing", "activities."], "wordsB": ["We", "have", "a", "predominantly", "fixed", "cost", "base", "associated", "with", "our", "manufacturing", "activities,", "which", "generally", "results", "in", "similar", "total", "cost", "of", "goods", "sold", "amounts", "each", "year."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p24_s2", "idA": "906709_17_item7_p14_s2", "sentA": "We expect product gross margin to continue to fluctuate in future periods depending on the level and mix of manufacturing orders from our customers due to the predominantly fixed cost base associated with our manufacturing activities.", "sentB": "We expect product gross margin to continue to fluctuate in future periods depending on the level and mix of manufacturing orders from our customers.", "type": 2, "words": ["<tag1>", "We", "expect", "product", "gross", "margin", "to", "continue", "to", "fluctuate", "in", "future", "periods", "depending", "on", "the", "level", "and", "mix", "of", "manufacturing", "orders", "from", "our", "customers", "due", "to", "the", "predominantly", "fixed", "cost", "base", "associated", "with", "our", "manufacturing", "activities.", "<tag2>", "We", "expect", "product", "gross", "margin", "to", "continue", "to", "fluctuate", "in", "future", "periods", "depending", "on", "the", "level", "and", "mix", "of", "manufacturing", "orders", "from", "our", "customers.", "<tag3>"], "wordsA": ["We", "expect", "product", "gross", "margin", "to", "continue", "to", "fluctuate", "in", "future", "periods", "depending", "on", "the", "level", "and", "mix", "of", "manufacturing", "orders", "from", "our", "customers", "due", "to", "the", "predominantly", "fixed", "cost", "base", "associated", "with", "our", "manufacturing", "activities."], "wordsB": ["We", "expect", "product", "gross", "margin", "to", "continue", "to", "fluctuate", "in", "future", "periods", "depending", "on", "the", "level", "and", "mix", "of", "manufacturing", "orders", "from", "our", "customers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p24_s3", "idA": "906709_17_item7_p14_s3", "sentA": "We currently expect product gross margin to decrease significantly in 2017 as compared to 2016 and gross margin may approximate breakeven in 2017 as a result of the anticipated decrease in product sales from our collaboration partner Ophthotech as described above.", "sentB": "We currently expect product gross margin to decrease in 2018 as compared to 2017 and gross margin may be negative in 2018 as a result of the anticipated decrease in product sales described above.", "type": 2, "words": ["<tag1>", "We", "currently", "expect", "product", "gross", "margin", "to", "decrease", "significantly", "in", "2017", "as", "compared", "to", "2016", "and", "gross", "margin", "may", "approximate", "breakeven", "in", "2017", "as", "a", "result", "of", "the", "anticipated", "decrease", "in", "product", "sales", "from", "our", "collaboration", "partner", "Ophthotech", "as", "described", "above.", "<tag2>", "We", "currently", "expect", "product", "gross", "margin", "to", "decrease", "in", "2018", "as", "compared", "to", "2017", "and", "gross", "margin", "may", "be", "negative", "in", "2018", "as", "a", "result", "of", "the", "anticipated", "decrease", "in", "product", "sales", "described", "above.", "<tag3>"], "wordsA": ["We", "currently", "expect", "product", "gross", "margin", "to", "decrease", "significantly", "in", "2017", "as", "compared", "to", "2016", "and", "gross", "margin", "may", "approximate", "breakeven", "in", "2017", "as", "a", "result", "of", "the", "anticipated", "decrease", "in", "product", "sales", "from", "our", "collaboration", "partner", "Ophthotech", "as", "described", "above."], "wordsB": ["We", "currently", "expect", "product", "gross", "margin", "to", "decrease", "in", "2018", "as", "compared", "to", "2017", "and", "gross", "margin", "may", "be", "negative", "in", "2018", "as", "a", "result", "of", "the", "anticipated", "decrease", "in", "product", "sales", "described", "above."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p26_s0", "idA": "906709_17_item7_p15_s2", "sentA": "Research and development expense increased during the year ended December 31, 2016 compared to the year ended December 31, 2015 primarily due to costs incurred in our NKTR-214 clinical and NKTR-358 pre-clinical programs as well as increased headcount costs, partially offset by a decrease to our ONZEALD TM program costs.", "sentB": "expense increased during the year ended December 31, 2016 compared to the year ended December 31, 2015 p rimarily due to costs incurred in our NKTR-214 clinical and NKTR-358 pre-clinical programs as well as increased headcount costs, partially offset by a decrease in our ONZEALD TM program costs.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "primarily", "due", "to", "costs", "incurred", "in", "our", "NKTR-214", "clinical", "and", "NKTR-358", "pre-clinical", "programs", "as", "well", "as", "increased", "headcount", "costs,", "partially", "offset", "by", "a", "decrease", "to", "our", "ONZEALD", "TM", "program", "costs.", "<tag2>", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "p", "rimarily", "due", "to", "costs", "incurred", "in", "our", "NKTR-214", "clinical", "and", "NKTR-358", "pre-clinical", "programs", "as", "well", "as", "increased", "headcount", "costs,", "partially", "offset", "by", "a", "decrease", "in", "our", "ONZEALD", "TM", "program", "costs.", "<tag3>"], "wordsA": ["Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "primarily", "due", "to", "costs", "incurred", "in", "our", "NKTR-214", "clinical", "and", "NKTR-358", "pre-clinical", "programs", "as", "well", "as", "increased", "headcount", "costs,", "partially", "offset", "by", "a", "decrease", "to", "our", "ONZEALD", "TM", "program", "costs."], "wordsB": ["expense", "increased", "during", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "p", "rimarily", "due", "to", "costs", "incurred", "in", "our", "NKTR-214", "clinical", "and", "NKTR-358", "pre-clinical", "programs", "as", "well", "as", "increased", "headcount", "costs,", "partially", "offset", "by", "a", "decrease", "in", "our", "ONZEALD", "TM", "program", "costs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p25_s3", "idA": "906709_17_item7_p15_s3", "sentA": "Research and development expense increased during the year ended December 31, 2015 compared to the year ended December 31, 2014 primarily due to the initiation of Phase 3 clinical studies for NKTR-181 in the first quarter of 2015.", "sentB": "Research and development expense increased during the year ended December 31, 2017 compared to the year ended December 31, 2016 and includes increased costs for our clinical development of NKTR-214, NKTR-358, NKTR-262, and preclinical activities for NKTR-255.", "type": 2, "words": ["<tag1>", "Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "the", "initiation", "of", "Phase", "3", "clinical", "studies", "for", "NKTR-181", "in", "the", "first", "quarter", "of", "2015.", "<tag2>", "Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2017", "compared", "to", "the", "year", "ended", "December", "31,", "2016", "and", "includes", "increased", "costs", "for", "our", "clinical", "development", "of", "NKTR-214,", "NKTR-358,", "NKTR-262,", "and", "preclinical", "activities", "for", "NKTR-255.", "<tag3>"], "wordsA": ["Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "due", "to", "the", "initiation", "of", "Phase", "3", "clinical", "studies", "for", "NKTR-181", "in", "the", "first", "quarter", "of", "2015."], "wordsB": ["Research", "and", "development", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2017", "compared", "to", "the", "year", "ended", "December", "31,", "2016", "and", "includes", "increased", "costs", "for", "our", "clinical", "development", "of", "NKTR-214,", "NKTR-358,", "NKTR-262,", "and", "preclinical", "activities", "for", "NKTR-255."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p27_s2", "idA": "906709_17_item7_p16_s2", "sentA": "The table also presents other costs and overh ead consisting of personnel, facilities and other indirect costs (in thousands):", "sentB": "The table also presents other costs and overhead consisting of personnel, facilities and other indirect costs (in thousands):", "type": 2, "words": ["<tag1>", "The", "table", "also", "presents", "other", "costs", "and", "overh", "ead", "consisting", "of", "personnel,", "facilities", "and", "other", "indirect", "costs", "(in", "thousands):", "<tag2>", "The", "table", "also", "presents", "other", "costs", "and", "overhead", "consisting", "of", "personnel,", "facilities", "and", "other", "indirect", "costs", "(in", "thousands):", "<tag3>"], "wordsA": ["The", "table", "also", "presents", "other", "costs", "and", "overh", "ead", "consisting", "of", "personnel,", "facilities", "and", "other", "indirect", "costs", "(in", "thousands):"], "wordsB": ["The", "table", "also", "presents", "other", "costs", "and", "overhead", "consisting", "of", "personnel,", "facilities", "and", "other", "indirect", "costs", "(in", "thousands):"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p30_s0", "idA": "906709_17_item7_p19_s0", "sentA": "We expect research and development expense to continue to increase in 2017 compared to 2016.", "sentB": "We expect research and development expense to increase significantly in 2018 compared to 2017 primarily as a result of the development of NKTR-214 under the BMS Collaboration Agreement.", "type": 2, "words": ["<tag1>", "We", "expect", "research", "and", "development", "expense", "to", "continue", "to", "increase", "in", "2017", "compared", "to", "2016.", "<tag2>", "We", "expect", "research", "and", "development", "expense", "to", "increase", "significantly", "in", "2018", "compared", "to", "2017", "primarily", "as", "a", "result", "of", "the", "development", "of", "NKTR-214", "under", "the", "BMS", "Collaboration", "Agreement.", "<tag3>"], "wordsA": ["We", "expect", "research", "and", "development", "expense", "to", "continue", "to", "increase", "in", "2017", "compared", "to", "2016."], "wordsB": ["We", "expect", "research", "and", "development", "expense", "to", "increase", "significantly", "in", "2018", "compared", "to", "2017", "primarily", "as", "a", "result", "of", "the", "development", "of", "NKTR-214", "under", "the", "BMS", "Collaboration", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p30_s8", "idA": "906709_17_item7_p19_s0", "sentA": "We expect research and development expense to continue to increase in 2017 compared to 2016.", "sentB": "In addition, we expect non-cash stock-based compensation expense to increase in 2018 due to the increase in our stock price.", "type": 2, "words": ["<tag1>", "We", "expect", "research", "and", "development", "expense", "to", "continue", "to", "increase", "in", "2017", "compared", "to", "2016.", "<tag2>", "In", "addition,", "we", "expect", "non-cash", "stock-based", "compensation", "expense", "to", "increase", "in", "2018", "due", "to", "the", "increase", "in", "our", "stock", "price.", "<tag3>"], "wordsA": ["We", "expect", "research", "and", "development", "expense", "to", "continue", "to", "increase", "in", "2017", "compared", "to", "2016."], "wordsB": ["In", "addition,", "we", "expect", "non-cash", "stock-based", "compensation", "expense", "to", "increase", "in", "2018", "due", "to", "the", "increase", "in", "our", "stock", "price."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p30_s1", "idA": "906709_17_item7_p19_s1", "sentA": "In 2017, we plan to continue and expand a broad Phase 1/2 clinical development program for NKTR-214 in combination with other immune-oncology therapies including but not limited to Opdivo in collaboration with BMS.", "sentB": "In 2018, we plan to continue and expand a broad clinical development program for NKTR-214.", "type": 2, "words": ["<tag1>", "In", "2017,", "we", "plan", "to", "continue", "and", "expand", "a", "broad", "Phase", "1/2", "clinical", "development", "program", "for", "NKTR-214", "in", "combination", "with", "other", "immune-oncology", "therapies", "including", "but", "not", "limited", "to", "Opdivo", "in", "collaboration", "with", "BMS.", "<tag2>", "In", "2018,", "we", "plan", "to", "continue", "and", "expand", "a", "broad", "clinical", "development", "program", "for", "NKTR-214.", "<tag3>"], "wordsA": ["In", "2017,", "we", "plan", "to", "continue", "and", "expand", "a", "broad", "Phase", "1/2", "clinical", "development", "program", "for", "NKTR-214", "in", "combination", "with", "other", "immune-oncology", "therapies", "including", "but", "not", "limited", "to", "Opdivo", "in", "collaboration", "with", "BMS."], "wordsB": ["In", "2018,", "we", "plan", "to", "continue", "and", "expand", "a", "broad", "clinical", "development", "program", "for", "NKTR-214."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p30_s2", "idA": "906709_17_item7_p19_s1", "sentA": "In 2017, we plan to continue and expand a broad Phase 1/2 clinical development program for NKTR-214 in combination with other immune-oncology therapies including but not limited to Opdivo in collaboration with BMS.", "sentB": "Under the BMS Collaboration Agreement, we and BMS will jointly develop NKTR-214 in combination with BMS s Opdivo (nivolumab) and Opdivo plus Yervoy (ipilimumab), in more than 20 indications across nine tumor types, as well as potential combinations with other anti-cancer agents from BMS, us and third parties.", "type": 2, "words": ["<tag1>", "In", "2017,", "we", "plan", "to", "continue", "and", "expand", "a", "broad", "Phase", "1/2", "clinical", "development", "program", "for", "NKTR-214", "in", "combination", "with", "other", "immune-oncology", "therapies", "including", "but", "not", "limited", "to", "Opdivo", "in", "collaboration", "with", "BMS.", "<tag2>", "Under", "the", "BMS", "Collaboration", "Agreement,", "we", "and", "BMS", "will", "jointly", "develop", "NKTR-214", "in", "combination", "with", "BMS", "s", "Opdivo", "(nivolumab)", "and", "Opdivo", "plus", "Yervoy", "(ipilimumab),", "in", "more", "than", "20", "indications", "across", "nine", "tumor", "types,", "as", "well", "as", "potential", "combinations", "with", "other", "anti-cancer", "agents", "from", "BMS,", "us", "and", "third", "parties.", "<tag3>"], "wordsA": ["In", "2017,", "we", "plan", "to", "continue", "and", "expand", "a", "broad", "Phase", "1/2", "clinical", "development", "program", "for", "NKTR-214", "in", "combination", "with", "other", "immune-oncology", "therapies", "including", "but", "not", "limited", "to", "Opdivo", "in", "collaboration", "with", "BMS."], "wordsB": ["Under", "the", "BMS", "Collaboration", "Agreement,", "we", "and", "BMS", "will", "jointly", "develop", "NKTR-214", "in", "combination", "with", "BMS", "s", "Opdivo", "(nivolumab)", "and", "Opdivo", "plus", "Yervoy", "(ipilimumab),", "in", "more", "than", "20", "indications", "across", "nine", "tumor", "types,", "as", "well", "as", "potential", "combinations", "with", "other", "anti-cancer", "agents", "from", "BMS,", "us", "and", "third", "parties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p5_s0", "idA": "906709_17_item7_p19_s1", "sentA": "In 2017, we plan to continue and expand a broad Phase 1/2 clinical development program for NKTR-214 in combination with other immune-oncology therapies including but not limited to Opdivo in collaboration with BMS.", "sentB": "On September 12, 2017, we announced that we had begun dosing in a clinical study evaluating the efficacy and safety of NKTR-214 in combination with approved checkpoint inhibitors, TECENTRIQ (atezolizumab) and KEYTRUDA (pembrolizumab).", "type": 2, "words": ["<tag1>", "In", "2017,", "we", "plan", "to", "continue", "and", "expand", "a", "broad", "Phase", "1/2", "clinical", "development", "program", "for", "NKTR-214", "in", "combination", "with", "other", "immune-oncology", "therapies", "including", "but", "not", "limited", "to", "Opdivo", "in", "collaboration", "with", "BMS.", "<tag2>", "On", "September", "12,", "2017,", "we", "announced", "that", "we", "had", "begun", "dosing", "in", "a", "clinical", "study", "evaluating", "the", "efficacy", "and", "safety", "of", "NKTR-214", "in", "combination", "with", "approved", "checkpoint", "inhibitors,", "TECENTRIQ", "(atezolizumab)", "and", "KEYTRUDA", "(pembrolizumab).", "<tag3>"], "wordsA": ["In", "2017,", "we", "plan", "to", "continue", "and", "expand", "a", "broad", "Phase", "1/2", "clinical", "development", "program", "for", "NKTR-214", "in", "combination", "with", "other", "immune-oncology", "therapies", "including", "but", "not", "limited", "to", "Opdivo", "in", "collaboration", "with", "BMS."], "wordsB": ["On", "September", "12,", "2017,", "we", "announced", "that", "we", "had", "begun", "dosing", "in", "a", "clinical", "study", "evaluating", "the", "efficacy", "and", "safety", "of", "NKTR-214", "in", "combination", "with", "approved", "checkpoint", "inhibitors,", "TECENTRIQ", "(atezolizumab)", "and", "KEYTRUDA", "(pembrolizumab)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p30_s6", "idA": "906709_17_item7_p19_s3", "sentA": "The timing and amount of our future clinical investments in NKTR-214 and NKTR-358 will vary significantly based upon our evaluation of ongoing clinical results and the structure, timing, and scope of potential collaboration partnerships (if any) for these programs.", "sentB": "The timing and amount of our future clinical investments will vary significantly based upon our evaluation of ongoing clinical results and the structure, timing, and scope of potential collaboration partnerships (if any) for these programs.", "type": 2, "words": ["<tag1>", "The", "timing", "and", "amount", "of", "our", "future", "clinical", "investments", "in", "NKTR-214", "and", "NKTR-358", "will", "vary", "significantly", "based", "upon", "our", "evaluation", "of", "ongoing", "clinical", "results", "and", "the", "structure,", "timing,", "and", "scope", "of", "potential", "collaboration", "partnerships", "(if", "any)", "for", "these", "programs.", "<tag2>", "The", "timing", "and", "amount", "of", "our", "future", "clinical", "investments", "will", "vary", "significantly", "based", "upon", "our", "evaluation", "of", "ongoing", "clinical", "results", "and", "the", "structure,", "timing,", "and", "scope", "of", "potential", "collaboration", "partnerships", "(if", "any)", "for", "these", "programs.", "<tag3>"], "wordsA": ["The", "timing", "and", "amount", "of", "our", "future", "clinical", "investments", "in", "NKTR-214", "and", "NKTR-358", "will", "vary", "significantly", "based", "upon", "our", "evaluation", "of", "ongoing", "clinical", "results", "and", "the", "structure,", "timing,", "and", "scope", "of", "potential", "collaboration", "partnerships", "(if", "any)", "for", "these", "programs."], "wordsB": ["The", "timing", "and", "amount", "of", "our", "future", "clinical", "investments", "will", "vary", "significantly", "based", "upon", "our", "evaluation", "of", "ongoing", "clinical", "results", "and", "the", "structure,", "timing,", "and", "scope", "of", "potential", "collaboration", "partnerships", "(if", "any)", "for", "these", "programs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p30_s7", "idA": "906709_17_item7_p19_s4", "sentA": "If our NKTR-181 Phase 3 efficacy study results are positive, we plan to pursue a collaboration to secure a development and commercialization partner to fund further development for NKTR-181 through direct program funding, up-front payments, milestones, or a combination thereof.", "sentB": "We plan to file an NDA for NKTR-181 in the first half of 2018 and plan to pursue a collaboration to secure a development and commercialization partner to fund further development for NKTR-181 through direct program funding, up-front payments, milestones, or a combination thereof.", "type": 2, "words": ["<tag1>", "If", "our", "NKTR-181", "Phase", "3", "efficacy", "study", "results", "are", "positive,", "we", "plan", "to", "pursue", "a", "collaboration", "to", "secure", "a", "development", "and", "commercialization", "partner", "to", "fund", "further", "development", "for", "NKTR-181", "through", "direct", "program", "funding,", "up-front", "payments,", "milestones,", "or", "a", "combination", "thereof.", "<tag2>", "We", "plan", "to", "file", "an", "NDA", "for", "NKTR-181", "in", "the", "first", "half", "of", "2018", "and", "plan", "to", "pursue", "a", "collaboration", "to", "secure", "a", "development", "and", "commercialization", "partner", "to", "fund", "further", "development", "for", "NKTR-181", "through", "direct", "program", "funding,", "up-front", "payments,", "milestones,", "or", "a", "combination", "thereof.", "<tag3>"], "wordsA": ["If", "our", "NKTR-181", "Phase", "3", "efficacy", "study", "results", "are", "positive,", "we", "plan", "to", "pursue", "a", "collaboration", "to", "secure", "a", "development", "and", "commercialization", "partner", "to", "fund", "further", "development", "for", "NKTR-181", "through", "direct", "program", "funding,", "up-front", "payments,", "milestones,", "or", "a", "combination", "thereof."], "wordsB": ["We", "plan", "to", "file", "an", "NDA", "for", "NKTR-181", "in", "the", "first", "half", "of", "2018", "and", "plan", "to", "pursue", "a", "collaboration", "to", "secure", "a", "development", "and", "commercialization", "partner", "to", "fund", "further", "development", "for", "NKTR-181", "through", "direct", "program", "funding,", "up-front", "payments,", "milestones,", "or", "a", "combination", "thereof."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p30_s9", "idA": "906709_17_item7_p19_s8", "sentA": "In addition to our drug candidates that we plan to have in clinical development during 2017 and beyond, we believe it is vitally important to continue our substantial investment in a diverse pipeline of new drug candidates to continue to build the value of our drug candidate pipeline and our business.", "sentB": "In addition to our drug candidates that we plan to evaluate in clinical development during 2018 and beyond, we believe it is vitally important to continue our substantial investment in a pipeline of new drug candidates to continue to build the value of our drug candidate pipeline and our business.", "type": 2, "words": ["<tag1>", "In", "addition", "to", "our", "drug", "candidates", "that", "we", "plan", "to", "have", "in", "clinical", "development", "during", "2017", "and", "beyond,", "we", "believe", "it", "is", "vitally", "important", "to", "continue", "our", "substantial", "investment", "in", "a", "diverse", "pipeline", "of", "new", "drug", "candidates", "to", "continue", "to", "build", "the", "value", "of", "our", "drug", "candidate", "pipeline", "and", "our", "business.", "<tag2>", "In", "addition", "to", "our", "drug", "candidates", "that", "we", "plan", "to", "evaluate", "in", "clinical", "development", "during", "2018", "and", "beyond,", "we", "believe", "it", "is", "vitally", "important", "to", "continue", "our", "substantial", "investment", "in", "a", "pipeline", "of", "new", "drug", "candidates", "to", "continue", "to", "build", "the", "value", "of", "our", "drug", "candidate", "pipeline", "and", "our", "business.", "<tag3>"], "wordsA": ["In", "addition", "to", "our", "drug", "candidates", "that", "we", "plan", "to", "have", "in", "clinical", "development", "during", "2017", "and", "beyond,", "we", "believe", "it", "is", "vitally", "important", "to", "continue", "our", "substantial", "investment", "in", "a", "diverse", "pipeline", "of", "new", "drug", "candidates", "to", "continue", "to", "build", "the", "value", "of", "our", "drug", "candidate", "pipeline", "and", "our", "business."], "wordsB": ["In", "addition", "to", "our", "drug", "candidates", "that", "we", "plan", "to", "evaluate", "in", "clinical", "development", "during", "2018", "and", "beyond,", "we", "believe", "it", "is", "vitally", "important", "to", "continue", "our", "substantial", "investment", "in", "a", "pipeline", "of", "new", "drug", "candidates", "to", "continue", "to", "build", "the", "value", "of", "our", "drug", "candidate", "pipeline", "and", "our", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p11_s4", "idA": "906709_17_item7_p1_s0", "sentA": "trial results are extremely difficult to predict.", "sentB": "We believe that our substantial investment in research and development has the potential to create significant value if one or more of our drug candidates demonstrates positive clinical results, receives regulatory approval in one or more major markets and achieves commercial success, drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval and the timing and outcome of clinical trial results are extremely difficult to predict.", "type": 2, "words": ["<tag1>", "trial", "results", "are", "extremely", "difficult", "to", "predict.", "<tag2>", "We", "believe", "that", "our", "substantial", "investment", "in", "research", "and", "development", "has", "the", "potential", "to", "create", "significant", "value", "if", "one", "or", "more", "of", "our", "drug", "candidates", "demonstrates", "positive", "clinical", "results,", "receives", "regulatory", "approval", "in", "one", "or", "more", "major", "markets", "and", "achieves", "commercial", "success,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "outcome", "of", "clinical", "trial", "results", "are", "extremely", "difficult", "to", "predict.", "<tag3>"], "wordsA": ["trial", "results", "are", "extremely", "difficult", "to", "predict."], "wordsB": ["We", "believe", "that", "our", "substantial", "investment", "in", "research", "and", "development", "has", "the", "potential", "to", "create", "significant", "value", "if", "one", "or", "more", "of", "our", "drug", "candidates", "demonstrates", "positive", "clinical", "results,", "receives", "regulatory", "approval", "in", "one", "or", "more", "major", "markets", "and", "achieves", "commercial", "success,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval", "and", "the", "timing", "and", "outcome", "of", "clinical", "trial", "results", "are", "extremely", "difficult", "to", "predict."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p31_s0", "idA": "906709_17_item7_p20_s0", "sentA": "In order to advance our drug candidates through clinical development, each drug candidate must be tested in numerous preclinical safety, toxicology and efficacy studies.", "sentB": "tested in numerous preclinical s afety, toxicology and efficacy studies.", "type": 2, "words": ["<tag1>", "In", "order", "to", "advance", "our", "drug", "candidates", "through", "clinical", "development,", "each", "drug", "candidate", "must", "be", "tested", "in", "numerous", "preclinical", "safety,", "toxicology", "and", "efficacy", "studies.", "<tag2>", "tested", "in", "numerous", "preclinical", "s", "afety,", "toxicology", "and", "efficacy", "studies.", "<tag3>"], "wordsA": ["In", "order", "to", "advance", "our", "drug", "candidates", "through", "clinical", "development,", "each", "drug", "candidate", "must", "be", "tested", "in", "numerous", "preclinical", "safety,", "toxicology", "and", "efficacy", "studies."], "wordsB": ["tested", "in", "numerous", "preclinical", "s", "afety,", "toxicology", "and", "efficacy", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p31_s2", "idA": "906709_17_item7_p20_s2", "sentA": "The cost and time required to complete clinical trials may vary significantly over the life of a clinical development program as a result of a variety of factors, including but not limited to:", "sentB": "The cost and time required to complete clinical trials may vary significantly over the life of a clinical development prog ram as a result of a variety of factors, including but not limited to:", "type": 2, "words": ["<tag1>", "The", "cost", "and", "time", "required", "to", "complete", "clinical", "trials", "may", "vary", "significantly", "over", "the", "life", "of", "a", "clinical", "development", "program", "as", "a", "result", "of", "a", "variety", "of", "factors,", "including", "but", "not", "limited", "to:", "<tag2>", "The", "cost", "and", "time", "required", "to", "complete", "clinical", "trials", "may", "vary", "significantly", "over", "the", "life", "of", "a", "clinical", "development", "prog", "ram", "as", "a", "result", "of", "a", "variety", "of", "factors,", "including", "but", "not", "limited", "to:", "<tag3>"], "wordsA": ["The", "cost", "and", "time", "required", "to", "complete", "clinical", "trials", "may", "vary", "significantly", "over", "the", "life", "of", "a", "clinical", "development", "program", "as", "a", "result", "of", "a", "variety", "of", "factors,", "including", "but", "not", "limited", "to:"], "wordsB": ["The", "cost", "and", "time", "required", "to", "complete", "clinical", "trials", "may", "vary", "significantly", "over", "the", "life", "of", "a", "clinical", "development", "prog", "ram", "as", "a", "result", "of", "a", "variety", "of", "factors,", "including", "but", "not", "limited", "to:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p33_s0", "idA": "906709_17_item7_p22_s0", "sentA": "Furthermore, our strategy includes the potential of entering into collaborations with third parties to participate in the development and commercialization of some of our drug candidates such as those collaborations that we have already completed for MOVANTIK and Amikacin Inhale.", "sentB": "Furthermore, our strategy includes the potential of entering into collaborations with third parties to participate in the development and commercialization of some of our drug candidates such as those collaborations that we have already completed for NKTR-214 and MOVANTIK .", "type": 2, "words": ["<tag1>", "Furthermore,", "our", "strategy", "includes", "the", "potential", "of", "entering", "into", "collaborations", "with", "third", "parties", "to", "participate", "in", "the", "development", "and", "commercialization", "of", "some", "of", "our", "drug", "candidates", "such", "as", "those", "collaborations", "that", "we", "have", "already", "completed", "for", "MOVANTIK", "and", "Amikacin", "Inhale.", "<tag2>", "Furthermore,", "our", "strategy", "includes", "the", "potential", "of", "entering", "into", "collaborations", "with", "third", "parties", "to", "participate", "in", "the", "development", "and", "commercialization", "of", "some", "of", "our", "drug", "candidates", "such", "as", "those", "collaborations", "that", "we", "have", "already", "completed", "for", "NKTR-214", "and", "MOVANTIK", ".", "<tag3>"], "wordsA": ["Furthermore,", "our", "strategy", "includes", "the", "potential", "of", "entering", "into", "collaborations", "with", "third", "parties", "to", "participate", "in", "the", "development", "and", "commercialization", "of", "some", "of", "our", "drug", "candidates", "such", "as", "those", "collaborations", "that", "we", "have", "already", "completed", "for", "MOVANTIK", "and", "Amikacin", "Inhale."], "wordsB": ["Furthermore,", "our", "strategy", "includes", "the", "potential", "of", "entering", "into", "collaborations", "with", "third", "parties", "to", "participate", "in", "the", "development", "and", "commercialization", "of", "some", "of", "our", "drug", "candidates", "such", "as", "those", "collaborations", "that", "we", "have", "already", "completed", "for", "NKTR-214", "and", "MOVANTIK", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p25_s4", "idA": "906709_17_item7_p24_s1", "sentA": "General and administrative expense increased marginally during the year ended December 31, 2016 compared to the year ended December 31, 2015.", "sentB": "In addition, the increase in research and development expense during the year ended December 31, 2017 compared with the year ended December 31, 2016 includes increased costs related to personnel and outside services.", "type": 2, "words": ["<tag1>", "General", "and", "administrative", "expense", "increased", "marginally", "during", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015.", "<tag2>", "In", "addition,", "the", "increase", "in", "research", "and", "development", "expense", "during", "the", "year", "ended", "December", "31,", "2017", "compared", "with", "the", "year", "ended", "December", "31,", "2016", "includes", "increased", "costs", "related", "to", "personnel", "and", "outside", "services.", "<tag3>"], "wordsA": ["General", "and", "administrative", "expense", "increased", "marginally", "during", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015."], "wordsB": ["In", "addition,", "the", "increase", "in", "research", "and", "development", "expense", "during", "the", "year", "ended", "December", "31,", "2017", "compared", "with", "the", "year", "ended", "December", "31,", "2016", "includes", "increased", "costs", "related", "to", "personnel", "and", "outside", "services."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p35_s1", "idA": "906709_17_item7_p24_s1", "sentA": "General and administrative expense increased marginally during the year ended December 31, 2016 compared to the year ended December 31, 2015.", "sentB": "General and administrative expense increased during the year ended December 31, 2017 compared with the year ended December 31, 2016 primarily due to increased costs related to personnel, facilities and outside services.", "type": 2, "words": ["<tag1>", "General", "and", "administrative", "expense", "increased", "marginally", "during", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015.", "<tag2>", "General", "and", "administrative", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2017", "compared", "with", "the", "year", "ended", "December", "31,", "2016", "primarily", "due", "to", "increased", "costs", "related", "to", "personnel,", "facilities", "and", "outside", "services.", "<tag3>"], "wordsA": ["General", "and", "administrative", "expense", "increased", "marginally", "during", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015."], "wordsB": ["General", "and", "administrative", "expense", "increased", "during", "the", "year", "ended", "December", "31,", "2017", "compared", "with", "the", "year", "ended", "December", "31,", "2016", "primarily", "due", "to", "increased", "costs", "related", "to", "personnel,", "facilities", "and", "outside", "services."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p35_s3", "idA": "906709_17_item7_p24_s3", "sentA": "In 2017, we expect general and administrative expenses to increase compared to 2016.", "sentB": "In 2018, we expect general and administrative expenses to increase compared to 2017, including an increase in non-cash stock-based compensation expense due to the increase in our stock price.", "type": 2, "words": ["<tag1>", "In", "2017,", "we", "expect", "general", "and", "administrative", "expenses", "to", "increase", "compared", "to", "2016.", "<tag2>", "In", "2018,", "we", "expect", "general", "and", "administrative", "expenses", "to", "increase", "compared", "to", "2017,", "including", "an", "increase", "in", "non-cash", "stock-based", "compensation", "expense", "due", "to", "the", "increase", "in", "our", "stock", "price.", "<tag3>"], "wordsA": ["In", "2017,", "we", "expect", "general", "and", "administrative", "expenses", "to", "increase", "compared", "to", "2016."], "wordsB": ["In", "2018,", "we", "expect", "general", "and", "administrative", "expenses", "to", "increase", "compared", "to", "2017,", "including", "an", "increase", "in", "non-cash", "stock-based", "compensation", "expense", "due", "to", "the", "increase", "in", "our", "stock", "price."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p36_s0", "idA": "906709_17_item7_p25_s1", "sentA": "Interest expense for the year ended December 31, 2015 increased marginally compared to the year ended December 31, 2014.", "sentB": "Interest expense for the year ended December 31, 2017 decrease d marginally compared with the year ended December 31, 2016 due to decreased interest expense from our capital leases.", "type": 2, "words": ["<tag1>", "Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2015", "increased", "marginally", "compared", "to", "the", "year", "ended", "December", "31,", "2014.", "<tag2>", "Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2017", "decrease", "d", "marginally", "compared", "with", "the", "year", "ended", "December", "31,", "2016", "due", "to", "decreased", "interest", "expense", "from", "our", "capital", "leases.", "<tag3>"], "wordsA": ["Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2015", "increased", "marginally", "compared", "to", "the", "year", "ended", "December", "31,", "2014."], "wordsB": ["Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2017", "decrease", "d", "marginally", "compared", "with", "the", "year", "ended", "December", "31,", "2016", "due", "to", "decreased", "interest", "expense", "from", "our", "capital", "leases."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p38_s2", "idA": "906709_17_item7_p25_s1", "sentA": "Interest expense for the year ended December 31, 2015 increased marginally compared to the year ended December 31, 2014.", "sentB": "In addition, in the year ended December 31, 2017, we incurred approximately $0.9 million of other program termination costs related to our manufacturing obligations.", "type": 2, "words": ["<tag1>", "Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2015", "increased", "marginally", "compared", "to", "the", "year", "ended", "December", "31,", "2014.", "<tag2>", "In", "addition,", "in", "the", "year", "ended", "December", "31,", "2017,", "we", "incurred", "approximately", "$0.9", "million", "of", "other", "program", "termination", "costs", "related", "to", "our", "manufacturing", "obligations.", "<tag3>"], "wordsA": ["Interest", "expense", "for", "the", "year", "ended", "December", "31,", "2015", "increased", "marginally", "compared", "to", "the", "year", "ended", "December", "31,", "2014."], "wordsB": ["In", "addition,", "in", "the", "year", "ended", "December", "31,", "2017,", "we", "incurred", "approximately", "$0.9", "million", "of", "other", "program", "termination", "costs", "related", "to", "our", "manufacturing", "obligations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p36_s2", "idA": "906709_17_item7_p25_s2", "sentA": "As is further described in Note 5 to our Consolidated Financial Statements, on October 5, 2015, we issued $250.0 million in aggregate principal amount of 7.75% senior secured notes due October 2020 and used a portion of the proceeds from these notes to redeem the $125.0 million in aggregate principal amount of 12.0% senior secured notes due July 2017.", "sentB": "As is further described in Note 5 to our Consolidated Financial Statements, on October 5, 2015, we issued $250.0 million in aggregate principal amount of 7.75% senior secured notes due October 2020 and used a p ortion of the proceeds from these notes to redeem the $125.0 million in aggregate principal amount of 12.0% senior secured notes due July 2017.", "type": 2, "words": ["<tag1>", "As", "is", "further", "described", "in", "Note", "5", "to", "our", "Consolidated", "Financial", "Statements,", "on", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "October", "2020", "and", "used", "a", "portion", "of", "the", "proceeds", "from", "these", "notes", "to", "redeem", "the", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "2017.", "<tag2>", "As", "is", "further", "described", "in", "Note", "5", "to", "our", "Consolidated", "Financial", "Statements,", "on", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "October", "2020", "and", "used", "a", "p", "ortion", "of", "the", "proceeds", "from", "these", "notes", "to", "redeem", "the", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "2017.", "<tag3>"], "wordsA": ["As", "is", "further", "described", "in", "Note", "5", "to", "our", "Consolidated", "Financial", "Statements,", "on", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "October", "2020", "and", "used", "a", "portion", "of", "the", "proceeds", "from", "these", "notes", "to", "redeem", "the", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "2017."], "wordsB": ["As", "is", "further", "described", "in", "Note", "5", "to", "our", "Consolidated", "Financial", "Statements,", "on", "October", "5,", "2015,", "we", "issued", "$250.0", "million", "in", "aggregate", "principal", "amount", "of", "7.75%", "senior", "secured", "notes", "due", "October", "2020", "and", "used", "a", "p", "ortion", "of", "the", "proceeds", "from", "these", "notes", "to", "redeem", "the", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "July", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p36_s4", "idA": "906709_17_item7_p25_s4", "sentA": "We expect interest expense in 2017 to be consistent with 2016.", "sentB": "W e expect interest expense in 2018 to decrease marginally compared to 2017.", "type": 2, "words": ["<tag1>", "We", "expect", "interest", "expense", "in", "2017", "to", "be", "consistent", "with", "2016.", "<tag2>", "W", "e", "expect", "interest", "expense", "in", "2018", "to", "decrease", "marginally", "compared", "to", "2017.", "<tag3>"], "wordsA": ["We", "expect", "interest", "expense", "in", "2017", "to", "be", "consistent", "with", "2016."], "wordsB": ["W", "e", "expect", "interest", "expense", "in", "2018", "to", "decrease", "marginally", "compared", "to", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p36_s5", "idA": "906709_17_item7_p26_s0", "sentA": "Non-cash interest expense on the liability related to sale of future royalties for the years ended December 31, 2016 and 2015 decreased marginally as compared to the years ended December 31, 2015 and 2014, respectively, due to the decrease in 2016 and 2 015, respectively, of the average balance of the related liability as that liability balance amortizes.", "sentB": "Non-cash interest expense on the liability related to sale of future royalties for the years ended December 31, 2017 and 2016 decreased marginally as compared to the years ended December 31, 2016 and 2015, respectively, due to the decrease in 2017 and 2016, respectively, of the average balance of the related liability as that liability balance amortizes.", "type": 2, "words": ["<tag1>", "Non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "decreased", "marginally", "as", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "respectively,", "due", "to", "the", "decrease", "in", "2016", "and", "2", "015,", "respectively,", "of", "the", "average", "balance", "of", "the", "related", "liability", "as", "that", "liability", "balance", "amortizes.", "<tag2>", "Non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "years", "ended", "December", "31,", "2017", "and", "2016", "decreased", "marginally", "as", "compared", "to", "the", "years", "ended", "December", "31,", "2016", "and", "2015,", "respectively,", "due", "to", "the", "decrease", "in", "2017", "and", "2016,", "respectively,", "of", "the", "average", "balance", "of", "the", "related", "liability", "as", "that", "liability", "balance", "amortizes.", "<tag3>"], "wordsA": ["Non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "decreased", "marginally", "as", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014,", "respectively,", "due", "to", "the", "decrease", "in", "2016", "and", "2", "015,", "respectively,", "of", "the", "average", "balance", "of", "the", "related", "liability", "as", "that", "liability", "balance", "amortizes."], "wordsB": ["Non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "the", "years", "ended", "December", "31,", "2017", "and", "2016", "decreased", "marginally", "as", "compared", "to", "the", "years", "ended", "December", "31,", "2016", "and", "2015,", "respectively,", "due", "to", "the", "decrease", "in", "2017", "and", "2016,", "respectively,", "of", "the", "average", "balance", "of", "the", "related", "liability", "as", "that", "liability", "balance", "amortizes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p37_s2", "idA": "906709_17_item7_p27_s2", "sentA": "We impute interest on the transaction and record interest expense at the effective interest rate, which we currently estimate to be approximately 17%.", "sentB": "We impute interest on the transaction and record interest expense at the effective interest rate, which we estimated to be approximately 17% from inception to 2017.", "type": 2, "words": ["<tag1>", "We", "impute", "interest", "on", "the", "transaction", "and", "record", "interest", "expense", "at", "the", "effective", "interest", "rate,", "which", "we", "currently", "estimate", "to", "be", "approximately", "17%.", "<tag2>", "We", "impute", "interest", "on", "the", "transaction", "and", "record", "interest", "expense", "at", "the", "effective", "interest", "rate,", "which", "we", "estimated", "to", "be", "approximately", "17%", "from", "inception", "to", "2017.", "<tag3>"], "wordsA": ["We", "impute", "interest", "on", "the", "transaction", "and", "record", "interest", "expense", "at", "the", "effective", "interest", "rate,", "which", "we", "currently", "estimate", "to", "be", "approximately", "17%."], "wordsB": ["We", "impute", "interest", "on", "the", "transaction", "and", "record", "interest", "expense", "at", "the", "effective", "interest", "rate,", "which", "we", "estimated", "to", "be", "approximately", "17%", "from", "inception", "to", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p37_s4", "idA": "906709_17_item7_p27_s3", "sentA": "There are a number of factors that could materially af fect the estimated interest rate, in particular, the amount and timing of royalty payments from future net sales of CIMZIA and MIRCERA , and we will assess this estimate on a periodic basis.", "sentB": "There are a number of factors that could materially affect the estimated interest rate, in particular, the amount and timing of royalty payments from future net sales of CIMZIA and MIRCERA , and we will assess this estimate on a periodic basis.", "type": 2, "words": ["<tag1>", "There", "are", "a", "number", "of", "factors", "that", "could", "materially", "af", "fect", "the", "estimated", "interest", "rate,", "in", "particular,", "the", "amount", "and", "timing", "of", "royalty", "payments", "from", "future", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", ",", "and", "we", "will", "assess", "this", "estimate", "on", "a", "periodic", "basis.", "<tag2>", "There", "are", "a", "number", "of", "factors", "that", "could", "materially", "affect", "the", "estimated", "interest", "rate,", "in", "particular,", "the", "amount", "and", "timing", "of", "royalty", "payments", "from", "future", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", ",", "and", "we", "will", "assess", "this", "estimate", "on", "a", "periodic", "basis.", "<tag3>"], "wordsA": ["There", "are", "a", "number", "of", "factors", "that", "could", "materially", "af", "fect", "the", "estimated", "interest", "rate,", "in", "particular,", "the", "amount", "and", "timing", "of", "royalty", "payments", "from", "future", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", ",", "and", "we", "will", "assess", "this", "estimate", "on", "a", "periodic", "basis."], "wordsB": ["There", "are", "a", "number", "of", "factors", "that", "could", "materially", "affect", "the", "estimated", "interest", "rate,", "in", "particular,", "the", "amount", "and", "timing", "of", "royalty", "payments", "from", "future", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", ",", "and", "we", "will", "assess", "this", "estimate", "on", "a", "periodic", "basis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p37_s5", "idA": "906709_17_item7_p27_s4", "sentA": "As a result, future interest rates could differ significantly an d any such change in interest rate will be adjusted prospectively.", "sentB": "As a result, future interest rates could differ significantly and any such change in interest rate will be adjusted prospectively.", "type": 2, "words": ["<tag1>", "As", "a", "result,", "future", "interest", "rates", "could", "differ", "significantly", "an", "d", "any", "such", "change", "in", "interest", "rate", "will", "be", "adjusted", "prospectively.", "<tag2>", "As", "a", "result,", "future", "interest", "rates", "could", "differ", "significantly", "and", "any", "such", "change", "in", "interest", "rate", "will", "be", "adjusted", "prospectively.", "<tag3>"], "wordsA": ["As", "a", "result,", "future", "interest", "rates", "could", "differ", "significantly", "an", "d", "any", "such", "change", "in", "interest", "rate", "will", "be", "adjusted", "prospectively."], "wordsB": ["As", "a", "result,", "future", "interest", "rates", "could", "differ", "significantly", "and", "any", "such", "change", "in", "interest", "rate", "will", "be", "adjusted", "prospectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p37_s6", "idA": "906709_17_item7_p27_s5", "sentA": "Unless we adjust our estimated interest rate, we expect non-cash interest expense on the liability related to sale of future royalties for 2017 to decrease marginally compared with 2016 as a result of the decreasing royalty liability balance.", "sentB": "Unless we adjust our estimated interest rate, we expect non-cash interest expense on the liability related to sale of future royalties for 2018 to increase marginally compared with 2017 as a result of the increase of the estimated prospective interest rate noted above.", "type": 2, "words": ["<tag1>", "Unless", "we", "adjust", "our", "estimated", "interest", "rate,", "we", "expect", "non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "2017", "to", "decrease", "marginally", "compared", "with", "2016", "as", "a", "result", "of", "the", "decreasing", "royalty", "liability", "balance.", "<tag2>", "Unless", "we", "adjust", "our", "estimated", "interest", "rate,", "we", "expect", "non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "2018", "to", "increase", "marginally", "compared", "with", "2017", "as", "a", "result", "of", "the", "increase", "of", "the", "estimated", "prospective", "interest", "rate", "noted", "above.", "<tag3>"], "wordsA": ["Unless", "we", "adjust", "our", "estimated", "interest", "rate,", "we", "expect", "non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "2017", "to", "decrease", "marginally", "compared", "with", "2016", "as", "a", "result", "of", "the", "decreasing", "royalty", "liability", "balance."], "wordsB": ["Unless", "we", "adjust", "our", "estimated", "interest", "rate,", "we", "expect", "non-cash", "interest", "expense", "on", "the", "liability", "related", "to", "sale", "of", "future", "royalties", "for", "2018", "to", "increase", "marginally", "compared", "with", "2017", "as", "a", "result", "of", "the", "increase", "of", "the", "estimated", "prospective", "interest", "rate", "noted", "above."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p39_s6", "idA": "906709_17_item7_p28_s0", "sentA": "Loss on Extinguishment of Debt As a result of the secured note financing transaction in October 2015 discussed above, in the year ended December 31, 2015, we recognized a $14.1 million loss on extinguishment of our 12% notes, which consists of a $11.3 million redemption premium payment, $1.2 million of incremental interest paid at redemption to the 12% note holders and the write-off of $1.6 million of unamortized issuance costs on the 12% notes.", "sentB": "Subject to the closing of the BMS Collaboration Agreement and the Purchase Agreement, BMS will pay us a non-refundable upfront cash payment of $1.0 billion and purchase $850.0 million of shares of our common stock at a purchase price of $102.60 per share.", "type": 2, "words": ["<tag1>", "Loss", "on", "Extinguishment", "of", "Debt", "As", "a", "result", "of", "the", "secured", "note", "financing", "transaction", "in", "October", "2015", "discussed", "above,", "in", "the", "year", "ended", "December", "31,", "2015,", "we", "recognized", "a", "$14.1", "million", "loss", "on", "extinguishment", "of", "our", "12%", "notes,", "which", "consists", "of", "a", "$11.3", "million", "redemption", "premium", "payment,", "$1.2", "million", "of", "incremental", "interest", "paid", "at", "redemption", "to", "the", "12%", "note", "holders", "and", "the", "write-off", "of", "$1.6", "million", "of", "unamortized", "issuance", "costs", "on", "the", "12%", "notes.", "<tag2>", "Subject", "to", "the", "closing", "of", "the", "BMS", "Collaboration", "Agreement", "and", "the", "Purchase", "Agreement,", "BMS", "will", "pay", "us", "a", "non-refundable", "upfront", "cash", "payment", "of", "$1.0", "billion", "and", "purchase", "$850.0", "million", "of", "shares", "of", "our", "common", "stock", "at", "a", "purchase", "price", "of", "$102.60", "per", "share.", "<tag3>"], "wordsA": ["Loss", "on", "Extinguishment", "of", "Debt", "As", "a", "result", "of", "the", "secured", "note", "financing", "transaction", "in", "October", "2015", "discussed", "above,", "in", "the", "year", "ended", "December", "31,", "2015,", "we", "recognized", "a", "$14.1", "million", "loss", "on", "extinguishment", "of", "our", "12%", "notes,", "which", "consists", "of", "a", "$11.3", "million", "redemption", "premium", "payment,", "$1.2", "million", "of", "incremental", "interest", "paid", "at", "redemption", "to", "the", "12%", "note", "holders", "and", "the", "write-off", "of", "$1.6", "million", "of", "unamortized", "issuance", "costs", "on", "the", "12%", "notes."], "wordsB": ["Subject", "to", "the", "closing", "of", "the", "BMS", "Collaboration", "Agreement", "and", "the", "Purchase", "Agreement,", "BMS", "will", "pay", "us", "a", "non-refundable", "upfront", "cash", "payment", "of", "$1.0", "billion", "and", "purchase", "$850.0", "million", "of", "shares", "of", "our", "common", "stock", "at", "a", "purchase", "price", "of", "$102.60", "per", "share."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p12_s3", "idA": "906709_17_item7_p29_s1", "sentA": "At December 31, 2016, we had approximately $389.1 million in cash and investments in marketable securities.", "sentB": "At December 31, 2017, we had approximately $353.2 million in cash and investments in marketable securities and had debt of $250.0 million in principal of senior secured notes due in October 2020.", "type": 2, "words": ["<tag1>", "At", "December", "31,", "2016,", "we", "had", "approximately", "$389.1", "million", "in", "cash", "and", "investments", "in", "marketable", "securities.", "<tag2>", "At", "December", "31,", "2017,", "we", "had", "approximately", "$353.2", "million", "in", "cash", "and", "investments", "in", "marketable", "securities", "and", "had", "debt", "of", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "due", "in", "October", "2020.", "<tag3>"], "wordsA": ["At", "December", "31,", "2016,", "we", "had", "approximately", "$389.1", "million", "in", "cash", "and", "investments", "in", "marketable", "securities."], "wordsB": ["At", "December", "31,", "2017,", "we", "had", "approximately", "$353.2", "million", "in", "cash", "and", "investments", "in", "marketable", "securities", "and", "had", "debt", "of", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "due", "in", "October", "2020."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p39_s1", "idA": "906709_17_item7_p29_s1", "sentA": "At December 31, 2016, we had approximately $389.1 million in cash and investments in marketable securities.", "sentB": "At December 31, 2017, we had approximately $353.2 million in cash and investments in marketable securities and had debt of $250.0 million in principal of senior secured notes due in October 2020.", "type": 2, "words": ["<tag1>", "At", "December", "31,", "2016,", "we", "had", "approximately", "$389.1", "million", "in", "cash", "and", "investments", "in", "marketable", "securities.", "<tag2>", "At", "December", "31,", "2017,", "we", "had", "approximately", "$353.2", "million", "in", "cash", "and", "investments", "in", "marketable", "securities", "and", "had", "debt", "of", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "due", "in", "October", "2020.", "<tag3>"], "wordsA": ["At", "December", "31,", "2016,", "we", "had", "approximately", "$389.1", "million", "in", "cash", "and", "investments", "in", "marketable", "securities."], "wordsB": ["At", "December", "31,", "2017,", "we", "had", "approximately", "$353.2", "million", "in", "cash", "and", "investments", "in", "marketable", "securities", "and", "had", "debt", "of", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "due", "in", "October", "2020."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p41_s0", "idA": "906709_17_item7_p29_s10", "sentA": "The availability and terms of various financing alternatives substantially depend on many factors including the success or failure of drug development programs in our pipeline, including NKTR-181, Amikacin Inhale, CIPRO DPI, Fovista , ONZEALD TM , NKTR-214 and NKTR-358, as well as other early stage development programs.", "sentB": "The availability and terms of various financing alternatives substantially depend on many factors including the success or failure of drug development programs in our pipeline, including NKTR-214, NKTR-181, NKTR-358, NKTR-262, and NKTR-255 as well as other early stage development programs.", "type": 2, "words": ["<tag1>", "The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "many", "factors", "including", "the", "success", "or", "failure", "of", "drug", "development", "programs", "in", "our", "pipeline,", "including", "NKTR-181,", "Amikacin", "Inhale,", "CIPRO", "DPI,", "Fovista", ",", "ONZEALD", "TM", ",", "NKTR-214", "and", "NKTR-358,", "as", "well", "as", "other", "early", "stage", "development", "programs.", "<tag2>", "The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "many", "factors", "including", "the", "success", "or", "failure", "of", "drug", "development", "programs", "in", "our", "pipeline,", "including", "NKTR-214,", "NKTR-181,", "NKTR-358,", "NKTR-262,", "and", "NKTR-255", "as", "well", "as", "other", "early", "stage", "development", "programs.", "<tag3>"], "wordsA": ["The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "many", "factors", "including", "the", "success", "or", "failure", "of", "drug", "development", "programs", "in", "our", "pipeline,", "including", "NKTR-181,", "Amikacin", "Inhale,", "CIPRO", "DPI,", "Fovista", ",", "ONZEALD", "TM", ",", "NKTR-214", "and", "NKTR-358,", "as", "well", "as", "other", "early", "stage", "development", "programs."], "wordsB": ["The", "availability", "and", "terms", "of", "various", "financing", "alternatives", "substantially", "depend", "on", "many", "factors", "including", "the", "success", "or", "failure", "of", "drug", "development", "programs", "in", "our", "pipeline,", "including", "NKTR-214,", "NKTR-181,", "NKTR-358,", "NKTR-262,", "and", "NKTR-255", "as", "well", "as", "other", "early", "stage", "development", "programs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p41_s3", "idA": "906709_17_item7_p29_s13", "sentA": "Due to the potential for adverse developments in the credit markets in 2017 and thereafter, we may experience reduced liquidity with respect to some of our investments in marketable securities.", "sentB": "Due to the potential for adverse developments in the credit markets, we may experience reduced liquidity with respect to some of our investments in marketable securities.", "type": 2, "words": ["<tag1>", "Due", "to", "the", "potential", "for", "adverse", "developments", "in", "the", "credit", "markets", "in", "2017", "and", "thereafter,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities.", "<tag2>", "Due", "to", "the", "potential", "for", "adverse", "developments", "in", "the", "credit", "markets,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities.", "<tag3>"], "wordsA": ["Due", "to", "the", "potential", "for", "adverse", "developments", "in", "the", "credit", "markets", "in", "2017", "and", "thereafter,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities."], "wordsB": ["Due", "to", "the", "potential", "for", "adverse", "developments", "in", "the", "credit", "markets,", "we", "may", "experience", "reduced", "liquidity", "with", "respect", "to", "some", "of", "our", "investments", "in", "marketable", "securities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p41_s6", "idA": "906709_17_item7_p29_s16", "sentA": "At December 31, 2016, the average time to maturity of the investments held in our portfolio was approximately five months and the maturity of any single investment did not exceed one year.", "sentB": "At December 31, 2017, the average time to maturity of the investments held in our portfolio was approximately eight months.", "type": 2, "words": ["<tag1>", "At", "December", "31,", "2016,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "five", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "one", "year.", "<tag2>", "At", "December", "31,", "2017,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "eight", "months.", "<tag3>"], "wordsA": ["At", "December", "31,", "2016,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "five", "months", "and", "the", "maturity", "of", "any", "single", "investment", "did", "not", "exceed", "one", "year."], "wordsB": ["At", "December", "31,", "2017,", "the", "average", "time", "to", "maturity", "of", "the", "investments", "held", "in", "our", "portfolio", "was", "approximately", "eight", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p62_s14", "idA": "906709_17_item7_p29_s2", "sentA": "Also, as of December 31, 2016, we had $255.1 million in debt, including $250.0 million in principal of senior secured notes and $5.1 million of capital lease obligations.", "sentB": "We currently estimate that, upon adoption on January 1, 2018, we will record an adjustment to decrease our accumulated deficit by approximately $11.0 million to $13.0 million for amounts that would be recognized as of December 31, 2017 under ASC 606, but are not recognized under the current ASC 605 guidance.", "type": 2, "words": ["<tag1>", "Also,", "as", "of", "December", "31,", "2016,", "we", "had", "$255.1", "million", "in", "debt,", "including", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "and", "$5.1", "million", "of", "capital", "lease", "obligations.", "<tag2>", "We", "currently", "estimate", "that,", "upon", "adoption", "on", "January", "1,", "2018,", "we", "will", "record", "an", "adjustment", "to", "decrease", "our", "accumulated", "deficit", "by", "approximately", "$11.0", "million", "to", "$13.0", "million", "for", "amounts", "that", "would", "be", "recognized", "as", "of", "December", "31,", "2017", "under", "ASC", "606,", "but", "are", "not", "recognized", "under", "the", "current", "ASC", "605", "guidance.", "<tag3>"], "wordsA": ["Also,", "as", "of", "December", "31,", "2016,", "we", "had", "$255.1", "million", "in", "debt,", "including", "$250.0", "million", "in", "principal", "of", "senior", "secured", "notes", "and", "$5.1", "million", "of", "capital", "lease", "obligations."], "wordsB": ["We", "currently", "estimate", "that,", "upon", "adoption", "on", "January", "1,", "2018,", "we", "will", "record", "an", "adjustment", "to", "decrease", "our", "accumulated", "deficit", "by", "approximately", "$11.0", "million", "to", "$13.0", "million", "for", "amounts", "that", "would", "be", "recognized", "as", "of", "December", "31,", "2017", "under", "ASC", "606,", "but", "are", "not", "recognized", "under", "the", "current", "ASC", "605", "guidance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p12_s4", "idA": "906709_17_item7_p29_s3", "sentA": "As described in Note 9 to our Consolidated Financial Statements, on October 24, 2016, we completed a public offering of common stock with net proceeds of approximately $189.3 million.", "sentB": "In addition, as described above and in Note 14 to our Consolidated Financial Statements, in February 2018, we entered into a collaboration agreement with BMS under which BMS will pay us a non-refundable upfront cash payment of $1.0 billion and a share purchase agreement under which BMS will purchase $850.0 million of shares of our common stock.", "type": 2, "words": ["<tag1>", "As", "described", "in", "Note", "9", "to", "our", "Consolidated", "Financial", "Statements,", "on", "October", "24,", "2016,", "we", "completed", "a", "public", "offering", "of", "common", "stock", "with", "net", "proceeds", "of", "approximately", "$189.3", "million.", "<tag2>", "In", "addition,", "as", "described", "above", "and", "in", "Note", "14", "to", "our", "Consolidated", "Financial", "Statements,", "in", "February", "2018,", "we", "entered", "into", "a", "collaboration", "agreement", "with", "BMS", "under", "which", "BMS", "will", "pay", "us", "a", "non-refundable", "upfront", "cash", "payment", "of", "$1.0", "billion", "and", "a", "share", "purchase", "agreement", "under", "which", "BMS", "will", "purchase", "$850.0", "million", "of", "shares", "of", "our", "common", "stock.", "<tag3>"], "wordsA": ["As", "described", "in", "Note", "9", "to", "our", "Consolidated", "Financial", "Statements,", "on", "October", "24,", "2016,", "we", "completed", "a", "public", "offering", "of", "common", "stock", "with", "net", "proceeds", "of", "approximately", "$189.3", "million."], "wordsB": ["In", "addition,", "as", "described", "above", "and", "in", "Note", "14", "to", "our", "Consolidated", "Financial", "Statements,", "in", "February", "2018,", "we", "entered", "into", "a", "collaboration", "agreement", "with", "BMS", "under", "which", "BMS", "will", "pay", "us", "a", "non-refundable", "upfront", "cash", "payment", "of", "$1.0", "billion", "and", "a", "share", "purchase", "agreement", "under", "which", "BMS", "will", "purchase", "$850.0", "million", "of", "shares", "of", "our", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p39_s2", "idA": "906709_17_item7_p29_s4", "sentA": "We estimate that we have working capital to fund our current business plans at least through March 1, 2018.", "sentB": "We estimate that we have working capital to fund our current business plans through at least March 1, 2019.", "type": 2, "words": ["<tag1>", "We", "estimate", "that", "we", "have", "working", "capital", "to", "fund", "our", "current", "business", "plans", "at", "least", "through", "March", "1,", "2018.", "<tag2>", "We", "estimate", "that", "we", "have", "working", "capital", "to", "fund", "our", "current", "business", "plans", "through", "at", "least", "March", "1,", "2019.", "<tag3>"], "wordsA": ["We", "estimate", "that", "we", "have", "working", "capital", "to", "fund", "our", "current", "business", "plans", "at", "least", "through", "March", "1,", "2018."], "wordsB": ["We", "estimate", "that", "we", "have", "working", "capital", "to", "fund", "our", "current", "business", "plans", "through", "at", "least", "March", "1,", "2019."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p39_s3", "idA": "906709_17_item7_p29_s5", "sentA": "We expect the clinical development of our proprietary drug candidates including NKTR-181, Amikacin Inhale, ONZEALD TM , NKTR-214, and NKTR-358, will require significant investment in order to continue to advance in clinical development with the objective of entering into a collaboration partnership or obtaining regulatory approval.", "sentB": "We expect the clinical development of our proprietary drug candidates including NKTR-214, NKTR-358, NKTR-262, NKTR-255, NKTR-181, and ONZEALD TM will continue to require significant investment in order to continue to advance in clinical development with the objective of entering into a collaboration partnership or obtaining regulatory approval.", "type": 2, "words": ["<tag1>", "We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates", "including", "NKTR-181,", "Amikacin", "Inhale,", "ONZEALD", "TM", ",", "NKTR-214,", "and", "NKTR-358,", "will", "require", "significant", "investment", "in", "order", "to", "continue", "to", "advance", "in", "clinical", "development", "with", "the", "objective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval.", "<tag2>", "We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates", "including", "NKTR-214,", "NKTR-358,", "NKTR-262,", "NKTR-255,", "NKTR-181,", "and", "ONZEALD", "TM", "will", "continue", "to", "require", "significant", "investment", "in", "order", "to", "continue", "to", "advance", "in", "clinical", "development", "with", "the", "objective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval.", "<tag3>"], "wordsA": ["We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates", "including", "NKTR-181,", "Amikacin", "Inhale,", "ONZEALD", "TM", ",", "NKTR-214,", "and", "NKTR-358,", "will", "require", "significant", "investment", "in", "order", "to", "continue", "to", "advance", "in", "clinical", "development", "with", "the", "objective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval."], "wordsB": ["We", "expect", "the", "clinical", "development", "of", "our", "proprietary", "drug", "candidates", "including", "NKTR-214,", "NKTR-358,", "NKTR-262,", "NKTR-255,", "NKTR-181,", "and", "ONZEALD", "TM", "will", "continue", "to", "require", "significant", "investment", "in", "order", "to", "continue", "to", "advance", "in", "clinical", "development", "with", "the", "objective", "of", "entering", "into", "a", "collaboration", "partnership", "or", "obtaining", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p39_s7", "idA": "906709_17_item7_p29_s6", "sentA": "However, we have no credit facility or any other sources of committed capital.", "sentB": "We have no credit facility or any other sources of committed capital.", "type": 2, "words": ["<tag1>", "However,", "we", "have", "no", "credit", "facility", "or", "any", "other", "sources", "of", "committed", "capital.", "<tag2>", "We", "have", "no", "credit", "facility", "or", "any", "other", "sources", "of", "committed", "capital.", "<tag3>"], "wordsA": ["However,", "we", "have", "no", "credit", "facility", "or", "any", "other", "sources", "of", "committed", "capital."], "wordsB": ["We", "have", "no", "credit", "facility", "or", "any", "other", "sources", "of", "committed", "capital."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p39_s4", "idA": "906709_17_item7_p29_s7", "sentA": "In the past we have received a number of significant payments from collaboration agreements and other significant transactions.", "sentB": "In the past, we have received a number of significant payments from collaboration agreements and other significant transactions.", "type": 2, "words": ["<tag1>", "In", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "collaboration", "agreements", "and", "other", "significant", "transactions.", "<tag2>", "In", "the", "past,", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "collaboration", "agreements", "and", "other", "significant", "transactions.", "<tag3>"], "wordsA": ["In", "the", "past", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "collaboration", "agreements", "and", "other", "significant", "transactions."], "wordsB": ["In", "the", "past,", "we", "have", "received", "a", "number", "of", "significant", "payments", "from", "collaboration", "agreements", "and", "other", "significant", "transactions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p39_s8", "idA": "906709_17_item7_p29_s8", "sentA": "In the future, we expect to continue to receive increasing royalties from commercial sales of products such as MOVANTIK , MOVENTIG and ADYNOVATE as they continue to increase sales after their recent product launches and potential substantial payments from future collaboration transactions if drug candidates in our pipeline achieve positive clinical or regulatory outcomes.", "sentB": "In the future, we expect to receive increasing royalties from commercial sales of products such as MOVANTIK , MOVENTIG and ADYNOVATE as they continue to increase sales.", "type": 2, "words": ["<tag1>", "In", "the", "future,", "we", "expect", "to", "continue", "to", "receive", "increasing", "royalties", "from", "commercial", "sales", "of", "products", "such", "as", "MOVANTIK", ",", "MOVENTIG", "and", "ADYNOVATE", "as", "they", "continue", "to", "increase", "sales", "after", "their", "recent", "product", "launches", "and", "potential", "substantial", "payments", "from", "future", "collaboration", "transactions", "if", "drug", "candidates", "in", "our", "pipeline", "achieve", "positive", "clinical", "or", "regulatory", "outcomes.", "<tag2>", "In", "the", "future,", "we", "expect", "to", "receive", "increasing", "royalties", "from", "commercial", "sales", "of", "products", "such", "as", "MOVANTIK", ",", "MOVENTIG", "and", "ADYNOVATE", "as", "they", "continue", "to", "increase", "sales.", "<tag3>"], "wordsA": ["In", "the", "future,", "we", "expect", "to", "continue", "to", "receive", "increasing", "royalties", "from", "commercial", "sales", "of", "products", "such", "as", "MOVANTIK", ",", "MOVENTIG", "and", "ADYNOVATE", "as", "they", "continue", "to", "increase", "sales", "after", "their", "recent", "product", "launches", "and", "potential", "substantial", "payments", "from", "future", "collaboration", "transactions", "if", "drug", "candidates", "in", "our", "pipeline", "achieve", "positive", "clinical", "or", "regulatory", "outcomes."], "wordsB": ["In", "the", "future,", "we", "expect", "to", "receive", "increasing", "royalties", "from", "commercial", "sales", "of", "products", "such", "as", "MOVANTIK", ",", "MOVENTIG", "and", "ADYNOVATE", "as", "they", "continue", "to", "increase", "sales."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p39_s9", "idA": "906709_17_item7_p29_s8", "sentA": "In the future, we expect to continue to receive increasing royalties from commercial sales of products such as MOVANTIK , MOVENTIG and ADYNOVATE as they continue to increase sales after their recent product launches and potential substantial payments from future collaboration transactions if drug candidates in our pipeline achieve positive clinical or regulatory outcomes.", "sentB": "We also expect potential substantial payments from future collaboration transactions if drug candidates in our pipeline achieve positive clinical or regulatory outcomes.", "type": 2, "words": ["<tag1>", "In", "the", "future,", "we", "expect", "to", "continue", "to", "receive", "increasing", "royalties", "from", "commercial", "sales", "of", "products", "such", "as", "MOVANTIK", ",", "MOVENTIG", "and", "ADYNOVATE", "as", "they", "continue", "to", "increase", "sales", "after", "their", "recent", "product", "launches", "and", "potential", "substantial", "payments", "from", "future", "collaboration", "transactions", "if", "drug", "candidates", "in", "our", "pipeline", "achieve", "positive", "clinical", "or", "regulatory", "outcomes.", "<tag2>", "We", "also", "expect", "potential", "substantial", "payments", "from", "future", "collaboration", "transactions", "if", "drug", "candidates", "in", "our", "pipeline", "achieve", "positive", "clinical", "or", "regulatory", "outcomes.", "<tag3>"], "wordsA": ["In", "the", "future,", "we", "expect", "to", "continue", "to", "receive", "increasing", "royalties", "from", "commercial", "sales", "of", "products", "such", "as", "MOVANTIK", ",", "MOVENTIG", "and", "ADYNOVATE", "as", "they", "continue", "to", "increase", "sales", "after", "their", "recent", "product", "launches", "and", "potential", "substantial", "payments", "from", "future", "collaboration", "transactions", "if", "drug", "candidates", "in", "our", "pipeline", "achieve", "positive", "clinical", "or", "regulatory", "outcomes."], "wordsB": ["We", "also", "expect", "potential", "substantial", "payments", "from", "future", "collaboration", "transactions", "if", "drug", "candidates", "in", "our", "pipeline", "achieve", "positive", "clinical", "or", "regulatory", "outcomes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p40_s0", "idA": "906709_17_item7_p29_s9", "sentA": "Our current business plan is also subject to significant uncertainties and risks as a result of, among other factors, the sales levels of products for which we are entitled to royalties such as MOVANTIK , MOVENTIG and ADYNOVATE , clinical program outcomes, whether, when and on what terms we are able to enter into new collaboration transactions, expenses being higher than anticipated, unplanned expenses, cash receipts being lower than anticipated, and the need to satisfy contingent liabilities, including litigation matters and indemnification obligations.", "sentB": "ADYNOVATE , clinical program outcomes, whether, when and on what terms we are able to enter into new collaboration transactions, expenses being higher than anticipated, unplanned expenses, cash receipts being lower than anticipated, and th e need to satisfy contingent liabilities, including litigation matters and indemnification obligations.", "type": 2, "words": ["<tag1>", "Our", "current", "business", "plan", "is", "also", "subject", "to", "significant", "uncertainties", "and", "risks", "as", "a", "result", "of,", "among", "other", "factors,", "the", "sales", "levels", "of", "products", "for", "which", "we", "are", "entitled", "to", "royalties", "such", "as", "MOVANTIK", ",", "MOVENTIG", "and", "ADYNOVATE", ",", "clinical", "program", "outcomes,", "whether,", "when", "and", "on", "what", "terms", "we", "are", "able", "to", "enter", "into", "new", "collaboration", "transactions,", "expenses", "being", "higher", "than", "anticipated,", "unplanned", "expenses,", "cash", "receipts", "being", "lower", "than", "anticipated,", "and", "the", "need", "to", "satisfy", "contingent", "liabilities,", "including", "litigation", "matters", "and", "indemnification", "obligations.", "<tag2>", "ADYNOVATE", ",", "clinical", "program", "outcomes,", "whether,", "when", "and", "on", "what", "terms", "we", "are", "able", "to", "enter", "into", "new", "collaboration", "transactions,", "expenses", "being", "higher", "than", "anticipated,", "unplanned", "expenses,", "cash", "receipts", "being", "lower", "than", "anticipated,", "and", "th", "e", "need", "to", "satisfy", "contingent", "liabilities,", "including", "litigation", "matters", "and", "indemnification", "obligations.", "<tag3>"], "wordsA": ["Our", "current", "business", "plan", "is", "also", "subject", "to", "significant", "uncertainties", "and", "risks", "as", "a", "result", "of,", "among", "other", "factors,", "the", "sales", "levels", "of", "products", "for", "which", "we", "are", "entitled", "to", "royalties", "such", "as", "MOVANTIK", ",", "MOVENTIG", "and", "ADYNOVATE", ",", "clinical", "program", "outcomes,", "whether,", "when", "and", "on", "what", "terms", "we", "are", "able", "to", "enter", "into", "new", "collaboration", "transactions,", "expenses", "being", "higher", "than", "anticipated,", "unplanned", "expenses,", "cash", "receipts", "being", "lower", "than", "anticipated,", "and", "the", "need", "to", "satisfy", "contingent", "liabilities,", "including", "litigation", "matters", "and", "indemnification", "obligations."], "wordsB": ["ADYNOVATE", ",", "clinical", "program", "outcomes,", "whether,", "when", "and", "on", "what", "terms", "we", "are", "able", "to", "enter", "into", "new", "collaboration", "transactions,", "expenses", "being", "higher", "than", "anticipated,", "unplanned", "expenses,", "cash", "receipts", "being", "lower", "than", "anticipated,", "and", "th", "e", "need", "to", "satisfy", "contingent", "liabilities,", "including", "litigation", "matters", "and", "indemnification", "obligations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p39_s5", "idA": "906709_17_item7_p2_s0", "sentA": "Historically, we have entered into a number of license and supply contracts under which we manufactured and supplied our proprietary polymer reagents on a fixed price or cost-plus basis.", "sentB": "In July 2017, we entered into a collaboration agreement for NKTR-358 with Lilly, under which we received a $150.0 million upfront payment.", "type": 2, "words": ["<tag1>", "Historically,", "we", "have", "entered", "into", "a", "number", "of", "license", "and", "supply", "contracts", "under", "which", "we", "manufactured", "and", "supplied", "our", "proprietary", "polymer", "reagents", "on", "a", "fixed", "price", "or", "cost-plus", "basis.", "<tag2>", "In", "July", "2017,", "we", "entered", "into", "a", "collaboration", "agreement", "for", "NKTR-358", "with", "Lilly,", "under", "which", "we", "received", "a", "$150.0", "million", "upfront", "payment.", "<tag3>"], "wordsA": ["Historically,", "we", "have", "entered", "into", "a", "number", "of", "license", "and", "supply", "contracts", "under", "which", "we", "manufactured", "and", "supplied", "our", "proprietary", "polymer", "reagents", "on", "a", "fixed", "price", "or", "cost-plus", "basis."], "wordsB": ["In", "July", "2017,", "we", "entered", "into", "a", "collaboration", "agreement", "for", "NKTR-358", "with", "Lilly,", "under", "which", "we", "received", "a", "$150.0", "million", "upfront", "payment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p6_s4", "idA": "906709_17_item7_p2_s0", "sentA": "Historically, we have entered into a number of license and supply contracts under which we manufactured and supplied our proprietary polymer reagents on a fixed price or cost-plus basis.", "sentB": "On July 24, 2017, we entered into a license agreement with Lilly to co-develop NKTR-358.", "type": 2, "words": ["<tag1>", "Historically,", "we", "have", "entered", "into", "a", "number", "of", "license", "and", "supply", "contracts", "under", "which", "we", "manufactured", "and", "supplied", "our", "proprietary", "polymer", "reagents", "on", "a", "fixed", "price", "or", "cost-plus", "basis.", "<tag2>", "On", "July", "24,", "2017,", "we", "entered", "into", "a", "license", "agreement", "with", "Lilly", "to", "co-develop", "NKTR-358.", "<tag3>"], "wordsA": ["Historically,", "we", "have", "entered", "into", "a", "number", "of", "license", "and", "supply", "contracts", "under", "which", "we", "manufactured", "and", "supplied", "our", "proprietary", "polymer", "reagents", "on", "a", "fixed", "price", "or", "cost-plus", "basis."], "wordsB": ["On", "July", "24,", "2017,", "we", "entered", "into", "a", "license", "agreement", "with", "Lilly", "to", "co-develop", "NKTR-358."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p23_s0", "idA": "906709_17_item7_p2_s1", "sentA": "Our current strategy is to manufacture and supply polymer reagents to support our proprietary drug candidates or our third-party collaborators where we have a strategic development and commercialization relationship or where we derive substantial economic benefit.", "sentB": "As noted above, our strategy is to manufacture and supply polymer reagents to sup port our proprietary drug candidates or our third-party collaborators where we have a strategic development and commercialization relationship or where we derive substantial economic benefit.", "type": 2, "words": ["<tag1>", "Our", "current", "strategy", "is", "to", "manufacture", "and", "supply", "polymer", "reagents", "to", "support", "our", "proprietary", "drug", "candidates", "or", "our", "third-party", "collaborators", "where", "we", "have", "a", "strategic", "development", "and", "commercialization", "relationship", "or", "where", "we", "derive", "substantial", "economic", "benefit.", "<tag2>", "As", "noted", "above,", "our", "strategy", "is", "to", "manufacture", "and", "supply", "polymer", "reagents", "to", "sup", "port", "our", "proprietary", "drug", "candidates", "or", "our", "third-party", "collaborators", "where", "we", "have", "a", "strategic", "development", "and", "commercialization", "relationship", "or", "where", "we", "derive", "substantial", "economic", "benefit.", "<tag3>"], "wordsA": ["Our", "current", "strategy", "is", "to", "manufacture", "and", "supply", "polymer", "reagents", "to", "support", "our", "proprietary", "drug", "candidates", "or", "our", "third-party", "collaborators", "where", "we", "have", "a", "strategic", "development", "and", "commercialization", "relationship", "or", "where", "we", "derive", "substantial", "economic", "benefit."], "wordsB": ["As", "noted", "above,", "our", "strategy", "is", "to", "manufacture", "and", "supply", "polymer", "reagents", "to", "sup", "port", "our", "proprietary", "drug", "candidates", "or", "our", "third-party", "collaborators", "where", "we", "have", "a", "strategic", "development", "and", "commercialization", "relationship", "or", "where", "we", "derive", "substantial", "economic", "benefit."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p12_s2", "idA": "906709_17_item7_p2_s2", "sentA": "Key Developments and Trends in Liquidity and Capital Resources We estimate that we have working capital to fund our current business plans through at least March 1, 2018.", "sentB": "Key Developments and Trends in Liquidity and Capital Resources We estimate that we have working capital to fund our current business plans through at least March 1, 2019.", "type": 2, "words": ["<tag1>", "Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "We", "estimate", "that", "we", "have", "working", "capital", "to", "fund", "our", "current", "business", "plans", "through", "at", "least", "March", "1,", "2018.", "<tag2>", "Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "We", "estimate", "that", "we", "have", "working", "capital", "to", "fund", "our", "current", "business", "plans", "through", "at", "least", "March", "1,", "2019.", "<tag3>"], "wordsA": ["Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "We", "estimate", "that", "we", "have", "working", "capital", "to", "fund", "our", "current", "business", "plans", "through", "at", "least", "March", "1,", "2018."], "wordsB": ["Key", "Developments", "and", "Trends", "in", "Liquidity", "and", "Capital", "Resources", "We", "estimate", "that", "we", "have", "working", "capital", "to", "fund", "our", "current", "business", "plans", "through", "at", "least", "March", "1,", "2019."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p41_s10", "idA": "906709_17_item7_p30_s0", "sentA": "Cash flows from operating activities Cash flows used in operating activities for the year ended December 31, 2016 totaled $117.0 million, which includes $158.3 million of net operating cash uses as well as $19.7 million for interest payments on our senior secured notes, partially offset by the receipt of $31.0 million of payments from AstraZeneca related to its sub-license to Kirin, the receipt of a $20.0 million upfront payment in August 2016 from Daiichi Sankyo related to our ONZEALD TM collaboration arrangement in Europe, as well as the receipt of a $10.0 million milestone in January 2016 from our Baxalta collaboration agreement, which was recorded in accounts receivable in our Consolidated Balance Sheet at December 31, 2015.", "sentB": "Cash flows used in operating activities for the year ended December 31, 2016 totaled $117.0 million, which includes $158.3 million of net operating cash uses as well as $19.7 million for interest payments on our senior secured notes, partially offset by the receipt of $31.0 million of payments from AstraZeneca related to its sub-license to Kirin, the receipt of a $20.0 million upfront payment in August 2016 from Daiichi related to our ONZEALD TM collaboration arrangement in Europe, as well as the receipt of a $10.0 million milestone in January 2016 from our Baxalta collaboration agreement, which was recorded in accounts receivable in our Consolidated Balance Sheet at December 31, 2015.", "type": 2, "words": ["<tag1>", "Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2016", "totaled", "$117.0", "million,", "which", "includes", "$158.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$19.7", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$31.0", "million", "of", "payments", "from", "AstraZeneca", "related", "to", "its", "sub-license", "to", "Kirin,", "the", "receipt", "of", "a", "$20.0", "million", "upfront", "payment", "in", "August", "2016", "from", "Daiichi", "Sankyo", "related", "to", "our", "ONZEALD", "TM", "collaboration", "arrangement", "in", "Europe,", "as", "well", "as", "the", "receipt", "of", "a", "$10.0", "million", "milestone", "in", "January", "2016", "from", "our", "Baxalta", "collaboration", "agreement,", "which", "was", "recorded", "in", "accounts", "receivable", "in", "our", "Consolidated", "Balance", "Sheet", "at", "December", "31,", "2015.", "<tag2>", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2016", "totaled", "$117.0", "million,", "which", "includes", "$158.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$19.7", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$31.0", "million", "of", "payments", "from", "AstraZeneca", "related", "to", "its", "sub-license", "to", "Kirin,", "the", "receipt", "of", "a", "$20.0", "million", "upfront", "payment", "in", "August", "2016", "from", "Daiichi", "related", "to", "our", "ONZEALD", "TM", "collaboration", "arrangement", "in", "Europe,", "as", "well", "as", "the", "receipt", "of", "a", "$10.0", "million", "milestone", "in", "January", "2016", "from", "our", "Baxalta", "collaboration", "agreement,", "which", "was", "recorded", "in", "accounts", "receivable", "in", "our", "Consolidated", "Balance", "Sheet", "at", "December", "31,", "2015.", "<tag3>"], "wordsA": ["Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2016", "totaled", "$117.0", "million,", "which", "includes", "$158.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$19.7", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$31.0", "million", "of", "payments", "from", "AstraZeneca", "related", "to", "its", "sub-license", "to", "Kirin,", "the", "receipt", "of", "a", "$20.0", "million", "upfront", "payment", "in", "August", "2016", "from", "Daiichi", "Sankyo", "related", "to", "our", "ONZEALD", "TM", "collaboration", "arrangement", "in", "Europe,", "as", "well", "as", "the", "receipt", "of", "a", "$10.0", "million", "milestone", "in", "January", "2016", "from", "our", "Baxalta", "collaboration", "agreement,", "which", "was", "recorded", "in", "accounts", "receivable", "in", "our", "Consolidated", "Balance", "Sheet", "at", "December", "31,", "2015."], "wordsB": ["Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2016", "totaled", "$117.0", "million,", "which", "includes", "$158.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$19.7", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$31.0", "million", "of", "payments", "from", "AstraZeneca", "related", "to", "its", "sub-license", "to", "Kirin,", "the", "receipt", "of", "a", "$20.0", "million", "upfront", "payment", "in", "August", "2016", "from", "Daiichi", "related", "to", "our", "ONZEALD", "TM", "collaboration", "arrangement", "in", "Europe,", "as", "well", "as", "the", "receipt", "of", "a", "$10.0", "million", "milestone", "in", "January", "2016", "from", "our", "Baxalta", "collaboration", "agreement,", "which", "was", "recorded", "in", "accounts", "receivable", "in", "our", "Consolidated", "Balance", "Sheet", "at", "December", "31,", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p41_s9", "idA": "906709_17_item7_p30_s0", "sentA": "Cash flows from operating activities Cash flows used in operating activities for the year ended December 31, 2016 totaled $117.0 million, which includes $158.3 million of net operating cash uses as well as $19.7 million for interest payments on our senior secured notes, partially offset by the receipt of $31.0 million of payments from AstraZeneca related to its sub-license to Kirin, the receipt of a $20.0 million upfront payment in August 2016 from Daiichi Sankyo related to our ONZEALD TM collaboration arrangement in Europe, as well as the receipt of a $10.0 million milestone in January 2016 from our Baxalta collaboration agreement, which was recorded in accounts receivable in our Consolidated Balance Sheet at December 31, 2015.", "sentB": "Cash flows from operating activities Cash flows used in operating activities for the year ended December 31, 2017 totaled $80.4 million, which includes $225.3 million of net operating cash uses as well as $19.6 million for interest payments on our senior secured notes and the $12.5 million termination payment to Daiichi in December 2017 related to our ONZEALD TM collaboration arrangement in Europe, partially offset by the receipt of $150.0 million upfront payment in September 2017 from our collaboration agreement with Lilly for NKTR-358, the receipt of $12.0 million in November 2017 related to our collaboration agreement with Baxalta and the receipt of $15.0 million in December 2017 resulting from a settlement agreement related to our collaboration agreement with MAP Pharmaceuticals, Inc.", "type": 2, "words": ["<tag1>", "Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2016", "totaled", "$117.0", "million,", "which", "includes", "$158.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$19.7", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$31.0", "million", "of", "payments", "from", "AstraZeneca", "related", "to", "its", "sub-license", "to", "Kirin,", "the", "receipt", "of", "a", "$20.0", "million", "upfront", "payment", "in", "August", "2016", "from", "Daiichi", "Sankyo", "related", "to", "our", "ONZEALD", "TM", "collaboration", "arrangement", "in", "Europe,", "as", "well", "as", "the", "receipt", "of", "a", "$10.0", "million", "milestone", "in", "January", "2016", "from", "our", "Baxalta", "collaboration", "agreement,", "which", "was", "recorded", "in", "accounts", "receivable", "in", "our", "Consolidated", "Balance", "Sheet", "at", "December", "31,", "2015.", "<tag2>", "Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2017", "totaled", "$80.4", "million,", "which", "includes", "$225.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$19.6", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes", "and", "the", "$12.5", "million", "termination", "payment", "to", "Daiichi", "in", "December", "2017", "related", "to", "our", "ONZEALD", "TM", "collaboration", "arrangement", "in", "Europe,", "partially", "offset", "by", "the", "receipt", "of", "$150.0", "million", "upfront", "payment", "in", "September", "2017", "from", "our", "collaboration", "agreement", "with", "Lilly", "for", "NKTR-358,", "the", "receipt", "of", "$12.0", "million", "in", "November", "2017", "related", "to", "our", "collaboration", "agreement", "with", "Baxalta", "and", "the", "receipt", "of", "$15.0", "million", "in", "December", "2017", "resulting", "from", "a", "settlement", "agreement", "related", "to", "our", "collaboration", "agreement", "with", "MAP", "Pharmaceuticals,", "Inc.", "<tag3>"], "wordsA": ["Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2016", "totaled", "$117.0", "million,", "which", "includes", "$158.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$19.7", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes,", "partially", "offset", "by", "the", "receipt", "of", "$31.0", "million", "of", "payments", "from", "AstraZeneca", "related", "to", "its", "sub-license", "to", "Kirin,", "the", "receipt", "of", "a", "$20.0", "million", "upfront", "payment", "in", "August", "2016", "from", "Daiichi", "Sankyo", "related", "to", "our", "ONZEALD", "TM", "collaboration", "arrangement", "in", "Europe,", "as", "well", "as", "the", "receipt", "of", "a", "$10.0", "million", "milestone", "in", "January", "2016", "from", "our", "Baxalta", "collaboration", "agreement,", "which", "was", "recorded", "in", "accounts", "receivable", "in", "our", "Consolidated", "Balance", "Sheet", "at", "December", "31,", "2015."], "wordsB": ["Cash", "flows", "from", "operating", "activities", "Cash", "flows", "used", "in", "operating", "activities", "for", "the", "year", "ended", "December", "31,", "2017", "totaled", "$80.4", "million,", "which", "includes", "$225.3", "million", "of", "net", "operating", "cash", "uses", "as", "well", "as", "$19.6", "million", "for", "interest", "payments", "on", "our", "senior", "secured", "notes", "and", "the", "$12.5", "million", "termination", "payment", "to", "Daiichi", "in", "December", "2017", "related", "to", "our", "ONZEALD", "TM", "collaboration", "arrangement", "in", "Europe,", "partially", "offset", "by", "the", "receipt", "of", "$150.0", "million", "upfront", "payment", "in", "September", "2017", "from", "our", "collaboration", "agreement", "with", "Lilly", "for", "NKTR-358,", "the", "receipt", "of", "$12.0", "million", "in", "November", "2017", "related", "to", "our", "collaboration", "agreement", "with", "Baxalta", "and", "the", "receipt", "of", "$15.0", "million", "in", "December", "2017", "resulting", "from", "a", "settlement", "agreement", "related", "to", "our", "collaboration", "agreement", "with", "MAP", "Pharmaceuticals,", "Inc."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p41_s12", "idA": "906709_17_item7_p30_s1", "sentA": "We expect that cash flows used in operating activities, excluding upfront, milestone and other contingent payments received, if any, will increase in the full year of 2017 compared to 2016 primarily as a result of increased research and development expenses.", "sentB": "We expect that cash flows used in operating activities, excluding upfront, milestone and other contingent payments received, if any, will increase in the full year of 2018 compared to 2017 primarily as a result of increased research and development expenses.", "type": 2, "words": ["<tag1>", "We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront,", "milestone", "and", "other", "contingent", "payments", "received,", "if", "any,", "will", "increase", "in", "the", "full", "year", "of", "2017", "compared", "to", "2016", "primarily", "as", "a", "result", "of", "increased", "research", "and", "development", "expenses.", "<tag2>", "We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront,", "milestone", "and", "other", "contingent", "payments", "received,", "if", "any,", "will", "increase", "in", "the", "full", "year", "of", "2018", "compared", "to", "2017", "primarily", "as", "a", "result", "of", "increased", "research", "and", "development", "expenses.", "<tag3>"], "wordsA": ["We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront,", "milestone", "and", "other", "contingent", "payments", "received,", "if", "any,", "will", "increase", "in", "the", "full", "year", "of", "2017", "compared", "to", "2016", "primarily", "as", "a", "result", "of", "increased", "research", "and", "development", "expenses."], "wordsB": ["We", "expect", "that", "cash", "flows", "used", "in", "operating", "activities,", "excluding", "upfront,", "milestone", "and", "other", "contingent", "payments", "received,", "if", "any,", "will", "increase", "in", "the", "full", "year", "of", "2018", "compared", "to", "2017", "primarily", "as", "a", "result", "of", "increased", "research", "and", "development", "expenses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p41_s13", "idA": "906709_17_item7_p30_s5", "sentA": "Cash flows from investing activities We paid $6.4 million, $11.2 million, and $10.0 million to purchase property, plant and equipment in the years ended December 31, 2016, 2015, and 2014, respectively.", "sentB": "Cash flows from investing activities We paid $9.7 million, $6.4 million, and $11.2 million to purchase property, plant and equipment in the years ended December 31, 2017, 2016, and 2015, respectively.", "type": 2, "words": ["<tag1>", "Cash", "flows", "from", "investing", "activities", "We", "paid", "$6.4", "million,", "$11.2", "million,", "and", "$10.0", "million", "to", "purchase", "property,", "plant", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2016,", "2015,", "and", "2014,", "respectively.", "<tag2>", "Cash", "flows", "from", "investing", "activities", "We", "paid", "$9.7", "million,", "$6.4", "million,", "and", "$11.2", "million", "to", "purchase", "property,", "plant", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2017,", "2016,", "and", "2015,", "respectively.", "<tag3>"], "wordsA": ["Cash", "flows", "from", "investing", "activities", "We", "paid", "$6.4", "million,", "$11.2", "million,", "and", "$10.0", "million", "to", "purchase", "property,", "plant", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2016,", "2015,", "and", "2014,", "respectively."], "wordsB": ["Cash", "flows", "from", "investing", "activities", "We", "paid", "$9.7", "million,", "$6.4", "million,", "and", "$11.2", "million", "to", "purchase", "property,", "plant", "and", "equipment", "in", "the", "years", "ended", "December", "31,", "2017,", "2016,", "and", "2015,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p41_s14", "idA": "906709_17_item7_p30_s6", "sentA": "We expect our capital expenditures in 2017 to increase compared to 2016.", "sentB": "We expect our capital expenditures in 2018 to increase compared to 2017.", "type": 2, "words": ["<tag1>", "We", "expect", "our", "capital", "expenditures", "in", "2017", "to", "increase", "compared", "to", "2016.", "<tag2>", "We", "expect", "our", "capital", "expenditures", "in", "2018", "to", "increase", "compared", "to", "2017.", "<tag3>"], "wordsA": ["We", "expect", "our", "capital", "expenditures", "in", "2017", "to", "increase", "compared", "to", "2016."], "wordsB": ["We", "expect", "our", "capital", "expenditures", "in", "2018", "to", "increase", "compared", "to", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p17_s3", "idA": "906709_17_item7_p30_s8", "sentA": "This restriction expired on July 1, 2015 and the restricted funds were returned to us.", "sentB": "Any costs incurred by AstraZeneca can only be recovered by the reduction of the royalty paid to us.", "type": 2, "words": ["<tag1>", "This", "restriction", "expired", "on", "July", "1,", "2015", "and", "the", "restricted", "funds", "were", "returned", "to", "us.", "<tag2>", "Any", "costs", "incurred", "by", "AstraZeneca", "can", "only", "be", "recovered", "by", "the", "reduction", "of", "the", "royalty", "paid", "to", "us.", "<tag3>"], "wordsA": ["This", "restriction", "expired", "on", "July", "1,", "2015", "and", "the", "restricted", "funds", "were", "returned", "to", "us."], "wordsB": ["Any", "costs", "incurred", "by", "AstraZeneca", "can", "only", "be", "recovered", "by", "the", "reduction", "of", "the", "royalty", "paid", "to", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p43_s3", "idA": "906709_17_item7_p31_s5", "sentA": "On October 5, 2015, we used a portion of the proceeds from these notes to redeem the $125.0 million in aggregate principal amount of 12.0% senior secured notes due in 2017.", "sentB": "On October 5, 2015, we used a portion of the proceeds from these notes to redeem the $125.0 million in aggregate principal amount of 12.0% seni or secured notes due in 2017.", "type": 2, "words": ["<tag1>", "On", "October", "5,", "2015,", "we", "used", "a", "portion", "of", "the", "proceeds", "from", "these", "notes", "to", "redeem", "the", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "in", "2017.", "<tag2>", "On", "October", "5,", "2015,", "we", "used", "a", "portion", "of", "the", "proceeds", "from", "these", "notes", "to", "redeem", "the", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "seni", "or", "secured", "notes", "due", "in", "2017.", "<tag3>"], "wordsA": ["On", "October", "5,", "2015,", "we", "used", "a", "portion", "of", "the", "proceeds", "from", "these", "notes", "to", "redeem", "the", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "senior", "secured", "notes", "due", "in", "2017."], "wordsB": ["On", "October", "5,", "2015,", "we", "used", "a", "portion", "of", "the", "proceeds", "from", "these", "notes", "to", "redeem", "the", "$125.0", "million", "in", "aggregate", "principal", "amount", "of", "12.0%", "seni", "or", "secured", "notes", "due", "in", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p1_s1", "idA": "906709_17_item7_p32_s0", "sentA": "On January 28, 2014, we completed the issuance and sale of 9,775,000 shares of our common stock in a public offering with total proceeds of approximately $117.2 million after deducting the underwriting commissions and discounts of approximately $7.5 million.", "sentB": "We also entered into a Share Purchase Agreement (Purchase Agreement) with BMS, pursuant to which BMS has agreed to purchase $850.0 million of shares of our common stock at a purchase price of $102.60 per share.", "type": 2, "words": ["<tag1>", "On", "January", "28,", "2014,", "we", "completed", "the", "issuance", "and", "sale", "of", "9,775,000", "shares", "of", "our", "common", "stock", "in", "a", "public", "offering", "with", "total", "proceeds", "of", "approximately", "$117.2", "million", "after", "deducting", "the", "underwriting", "commissions", "and", "discounts", "of", "approximately", "$7.5", "million.", "<tag2>", "We", "also", "entered", "into", "a", "Share", "Purchase", "Agreement", "(Purchase", "Agreement)", "with", "BMS,", "pursuant", "to", "which", "BMS", "has", "agreed", "to", "purchase", "$850.0", "million", "of", "shares", "of", "our", "common", "stock", "at", "a", "purchase", "price", "of", "$102.60", "per", "share.", "<tag3>"], "wordsA": ["On", "January", "28,", "2014,", "we", "completed", "the", "issuance", "and", "sale", "of", "9,775,000", "shares", "of", "our", "common", "stock", "in", "a", "public", "offering", "with", "total", "proceeds", "of", "approximately", "$117.2", "million", "after", "deducting", "the", "underwriting", "commissions", "and", "discounts", "of", "approximately", "$7.5", "million."], "wordsB": ["We", "also", "entered", "into", "a", "Share", "Purchase", "Agreement", "(Purchase", "Agreement)", "with", "BMS,", "pursuant", "to", "which", "BMS", "has", "agreed", "to", "purchase", "$850.0", "million", "of", "shares", "of", "our", "common", "stock", "at", "a", "purchase", "price", "of", "$102.60", "per", "share."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p30_s3", "idA": "906709_17_item7_p32_s1", "sentA": "In addition, we incurred approximately $0.6 million in legal and accounting fees, filing fees, and other costs in connection with this offering.", "sentB": "In addition, we are collaborating with Lilly to develop NKTR-358 and are continuing its Phase 1 clinical development program in 2018.", "type": 2, "words": ["<tag1>", "In", "addition,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "costs", "in", "connection", "with", "this", "offering.", "<tag2>", "In", "addition,", "we", "are", "collaborating", "with", "Lilly", "to", "develop", "NKTR-358", "and", "are", "continuing", "its", "Phase", "1", "clinical", "development", "program", "in", "2018.", "<tag3>"], "wordsA": ["In", "addition,", "we", "incurred", "approximately", "$0.6", "million", "in", "legal", "and", "accounting", "fees,", "filing", "fees,", "and", "other", "costs", "in", "connection", "with", "this", "offering."], "wordsB": ["In", "addition,", "we", "are", "collaborating", "with", "Lilly", "to", "develop", "NKTR-358", "and", "are", "continuing", "its", "Phase", "1", "clinical", "development", "program", "in", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p43_s5", "idA": "906709_17_item7_p32_s5", "sentA": "We received proceeds from issuance of common stock related to our employee option and stock purchase plans of $20.3 million, $32.2 million, and $47.0 million in the years ended December 31, 2016, 2015, and 2014, respectively.", "sentB": "We received proceeds from issuance of common stock related to our employee option and stock purchase plans of $59.5 million, $20.3 million, and $32.2 million in the years ended December 31, 2017, 2016, and 2015, respectively.", "type": 2, "words": ["<tag1>", "We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$20.3", "million,", "$32.2", "million,", "and", "$47.0", "million", "in", "the", "years", "ended", "December", "31,", "2016,", "2015,", "and", "2014,", "respectively.", "<tag2>", "We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$59.5", "million,", "$20.3", "million,", "and", "$32.2", "million", "in", "the", "years", "ended", "December", "31,", "2017,", "2016,", "and", "2015,", "respectively.", "<tag3>"], "wordsA": ["We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$20.3", "million,", "$32.2", "million,", "and", "$47.0", "million", "in", "the", "years", "ended", "December", "31,", "2016,", "2015,", "and", "2014,", "respectively."], "wordsB": ["We", "received", "proceeds", "from", "issuance", "of", "common", "stock", "related", "to", "our", "employee", "option", "and", "stock", "purchase", "plans", "of", "$59.5", "million,", "$20.3", "million,", "and", "$32.2", "million", "in", "the", "years", "ended", "December", "31,", "2017,", "2016,", "and", "2015,", "respectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p45_s1", "idA": "906709_17_item7_p34_s2", "sentA": "The sublease is discussed in Note 6 of Item 8.", "sentB": "The lease is discussed in Note 6 of Item 8.", "type": 2, "words": ["<tag1>", "The", "sublease", "is", "discussed", "in", "Note", "6", "of", "Item", "8.", "<tag2>", "The", "lease", "is", "discussed", "in", "Note", "6", "of", "Item", "8.", "<tag3>"], "wordsA": ["The", "sublease", "is", "discussed", "in", "Note", "6", "of", "Item", "8."], "wordsB": ["The", "lease", "is", "discussed", "in", "Note", "6", "of", "Item", "8."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p45_s0", "idA": "906709_17_item7_p35_s0", "sentA": "These amounts primarily result from our purchase of manufacturing equipment supporting our Amikacin Inhale program.", "sentB": "These amounts primarily result from our Mission Bay Facility lease, which expires in 2030.", "type": 2, "words": ["<tag1>", "These", "amounts", "primarily", "result", "from", "our", "purchase", "of", "manufacturing", "equipment", "supporting", "our", "Amikacin", "Inhale", "program.", "<tag2>", "These", "amounts", "primarily", "result", "from", "our", "Mission", "Bay", "Facility", "lease,", "which", "expires", "in", "2030.", "<tag3>"], "wordsA": ["These", "amounts", "primarily", "result", "from", "our", "purchase", "of", "manufacturing", "equipment", "supporting", "our", "Amikacin", "Inhale", "program."], "wordsB": ["These", "amounts", "primarily", "result", "from", "our", "Mission", "Bay", "Facility", "lease,", "which", "expires", "in", "2030."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p46_s0", "idA": "906709_17_item7_p36_s0", "sentA": "Substantially all of this amount was subject to open purchase orders as of December 31, 2016 that were issued under existing contracts.", "sentB": "Substantially all of this amount was subject to open purchase orders as of December 31, 2017 that were issued under existing contracts.", "type": 2, "words": ["<tag1>", "Substantially", "all", "of", "this", "amount", "was", "subject", "to", "open", "purchase", "orders", "as", "of", "December", "31,", "2016", "that", "were", "issued", "under", "existing", "contracts.", "<tag2>", "Substantially", "all", "of", "this", "amount", "was", "subject", "to", "open", "purchase", "orders", "as", "of", "December", "31,", "2017", "that", "were", "issued", "under", "existing", "contracts.", "<tag3>"], "wordsA": ["Substantially", "all", "of", "this", "amount", "was", "subject", "to", "open", "purchase", "orders", "as", "of", "December", "31,", "2016", "that", "were", "issued", "under", "existing", "contracts."], "wordsB": ["Substantially", "all", "of", "this", "amount", "was", "subject", "to", "open", "purchase", "orders", "as", "of", "December", "31,", "2017", "that", "were", "issued", "under", "existing", "contracts."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p46_s1", "idA": "906709_17_item7_p36_s1", "sentA": "This amount does not represent any minimum contract termination liabilities for our existing contracts.", "sentB": "This amount does not represent minimum contract termination liabilities for our existing contracts.", "type": 2, "words": ["<tag1>", "This", "amount", "does", "not", "represent", "any", "minimum", "contract", "termination", "liabilities", "for", "our", "existing", "contracts.", "<tag2>", "This", "amount", "does", "not", "represent", "minimum", "contract", "termination", "liabilities", "for", "our", "existing", "contracts.", "<tag3>"], "wordsA": ["This", "amount", "does", "not", "represent", "any", "minimum", "contract", "termination", "liabilities", "for", "our", "existing", "contracts."], "wordsB": ["This", "amount", "does", "not", "represent", "minimum", "contract", "termination", "liabilities", "for", "our", "existing", "contracts."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p50_s1", "idA": "906709_17_item7_p40_s1", "sentA": "The amount of upfront fees and other payments received under our license and collaboration agreements that are allocated to our continuing obligations are recognized ratably over our expected performance period under each arrangement.", "sentB": "The amount of upfront fees and other payments received under our license and collaboration agreements that are allocated to our continuing obligations are generally recognized ratably over our expected performance period under each arrangement.", "type": 2, "words": ["<tag1>", "The", "amount", "of", "upfront", "fees", "and", "other", "payments", "received", "under", "our", "license", "and", "collaboration", "agreements", "that", "are", "allocated", "to", "our", "continuing", "obligations", "are", "recognized", "ratably", "over", "our", "expected", "performance", "period", "under", "each", "arrangement.", "<tag2>", "The", "amount", "of", "upfront", "fees", "and", "other", "payments", "received", "under", "our", "license", "and", "collaboration", "agreements", "that", "are", "allocated", "to", "our", "continuing", "obligations", "are", "generally", "recognized", "ratably", "over", "our", "expected", "performance", "period", "under", "each", "arrangement.", "<tag3>"], "wordsA": ["The", "amount", "of", "upfront", "fees", "and", "other", "payments", "received", "under", "our", "license", "and", "collaboration", "agreements", "that", "are", "allocated", "to", "our", "continuing", "obligations", "are", "recognized", "ratably", "over", "our", "expected", "performance", "period", "under", "each", "arrangement."], "wordsB": ["The", "amount", "of", "upfront", "fees", "and", "other", "payments", "received", "under", "our", "license", "and", "collaboration", "agreements", "that", "are", "allocated", "to", "our", "continuing", "obligations", "are", "generally", "recognized", "ratably", "over", "our", "expected", "performance", "period", "under", "each", "arrangement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p51_s0", "idA": "906709_17_item7_p40_s3", "sentA": "Given the complexities and uncertainties of collaboration arrangements, significant judgment is required by management to determine the duration of the performance period.", "sentB": "to determine the duration of the performance period.", "type": 2, "words": ["<tag1>", "Given", "the", "complexities", "and", "uncertainties", "of", "collaboration", "arrangements,", "significant", "judgment", "is", "required", "by", "management", "to", "determine", "the", "duration", "of", "the", "performance", "period.", "<tag2>", "to", "determine", "the", "duration", "of", "the", "performance", "period.", "<tag3>"], "wordsA": ["Given", "the", "complexities", "and", "uncertainties", "of", "collaboration", "arrangements,", "significant", "judgment", "is", "required", "by", "management", "to", "determine", "the", "duration", "of", "the", "performance", "period."], "wordsB": ["to", "determine", "the", "duration", "of", "the", "performance", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p17_s2", "idA": "906709_17_item7_p41_s0", "sentA": "As of December 31, 2016, we had $21.7 million of deferred upfront fees related to two collaboration agreements that include research and development obligations that are being amortized over 5 to 22 years, or an average of approximately 13 years.", "sentB": "As of December 31, 2017, our cumulative share of the post-approval study expenses has been $0.7 million.", "type": 2, "words": ["<tag1>", "As", "of", "December", "31,", "2016,", "we", "had", "$21.7", "million", "of", "deferred", "upfront", "fees", "related", "to", "two", "collaboration", "agreements", "that", "include", "research", "and", "development", "obligations", "that", "are", "being", "amortized", "over", "5", "to", "22", "years,", "or", "an", "average", "of", "approximately", "13", "years.", "<tag2>", "As", "of", "December", "31,", "2017,", "our", "cumulative", "share", "of", "the", "post-approval", "study", "expenses", "has", "been", "$0.7", "million.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2016,", "we", "had", "$21.7", "million", "of", "deferred", "upfront", "fees", "related", "to", "two", "collaboration", "agreements", "that", "include", "research", "and", "development", "obligations", "that", "are", "being", "amortized", "over", "5", "to", "22", "years,", "or", "an", "average", "of", "approximately", "13", "years."], "wordsB": ["As", "of", "December", "31,", "2017,", "our", "cumulative", "share", "of", "the", "post-approval", "study", "expenses", "has", "been", "$0.7", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p25_s2", "idA": "906709_17_item7_p41_s1", "sentA": "For our collaboration agreements, our performance obligations may span the life of the agreement.", "sentB": "Where we perform research and development activities under a clinical joint development collaboration, such as our collaboration with Bristol-Myers Squibb, we record the cost reimbursement from our partner as a reduction to research and development expense when reimbursement amounts are due to us under the agreement.", "type": 2, "words": ["<tag1>", "For", "our", "collaboration", "agreements,", "our", "performance", "obligations", "may", "span", "the", "life", "of", "the", "agreement.", "<tag2>", "Where", "we", "perform", "research", "and", "development", "activities", "under", "a", "clinical", "joint", "development", "collaboration,", "such", "as", "our", "collaboration", "with", "Bristol-Myers", "Squibb,", "we", "record", "the", "cost", "reimbursement", "from", "our", "partner", "as", "a", "reduction", "to", "research", "and", "development", "expense", "when", "reimbursement", "amounts", "are", "due", "to", "us", "under", "the", "agreement.", "<tag3>"], "wordsA": ["For", "our", "collaboration", "agreements,", "our", "performance", "obligations", "may", "span", "the", "life", "of", "the", "agreement."], "wordsB": ["Where", "we", "perform", "research", "and", "development", "activities", "under", "a", "clinical", "joint", "development", "collaboration,", "such", "as", "our", "collaboration", "with", "Bristol-Myers", "Squibb,", "we", "record", "the", "cost", "reimbursement", "from", "our", "partner", "as", "a", "reduction", "to", "research", "and", "development", "expense", "when", "reimbursement", "amounts", "are", "due", "to", "us", "under", "the", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p62_s16", "idA": "906709_17_item7_p43_s0", "sentA": "have been as low as $2 million or as high as $11 million as compared to the approximately $2.0 million recognized in th e year ended December 31, 2016.", "sentB": "The estimated adjustment also includes up to approximately $2.0 million related to the recognition of the unamortized portion of upfront payments under ASC 606 that are required to be deferred as of December 31, 2017 under current guidance.", "type": 2, "words": ["<tag1>", "have", "been", "as", "low", "as", "$2", "million", "or", "as", "high", "as", "$11", "million", "as", "compared", "to", "the", "approximately", "$2.0", "million", "recognized", "in", "th", "e", "year", "ended", "December", "31,", "2016.", "<tag2>", "The", "estimated", "adjustment", "also", "includes", "up", "to", "approximately", "$2.0", "million", "related", "to", "the", "recognition", "of", "the", "unamortized", "portion", "of", "upfront", "payments", "under", "ASC", "606", "that", "are", "required", "to", "be", "deferred", "as", "of", "December", "31,", "2017", "under", "current", "guidance.", "<tag3>"], "wordsA": ["have", "been", "as", "low", "as", "$2", "million", "or", "as", "high", "as", "$11", "million", "as", "compared", "to", "the", "approximately", "$2.0", "million", "recognized", "in", "th", "e", "year", "ended", "December", "31,", "2016."], "wordsB": ["The", "estimated", "adjustment", "also", "includes", "up", "to", "approximately", "$2.0", "million", "related", "to", "the", "recognition", "of", "the", "unamortized", "portion", "of", "upfront", "payments", "under", "ASC", "606", "that", "are", "required", "to", "be", "deferred", "as", "of", "December", "31,", "2017", "under", "current", "guidance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p51_s1", "idA": "906709_17_item7_p43_s4", "sentA": "Our original estimates are periodically evaluated to determine if circumstances have caused the estimates to change and if so, amortization of revenue is adjusted prospectively.", "sentB": "Our original estimates are periodi cally evaluated to determine if circumstances have caused the estimates to change and if so, amortization of revenue is adjusted prospectively.", "type": 2, "words": ["<tag1>", "Our", "original", "estimates", "are", "periodically", "evaluated", "to", "determine", "if", "circumstances", "have", "caused", "the", "estimates", "to", "change", "and", "if", "so,", "amortization", "of", "revenue", "is", "adjusted", "prospectively.", "<tag2>", "Our", "original", "estimates", "are", "periodi", "cally", "evaluated", "to", "determine", "if", "circumstances", "have", "caused", "the", "estimates", "to", "change", "and", "if", "so,", "amortization", "of", "revenue", "is", "adjusted", "prospectively.", "<tag3>"], "wordsA": ["Our", "original", "estimates", "are", "periodically", "evaluated", "to", "determine", "if", "circumstances", "have", "caused", "the", "estimates", "to", "change", "and", "if", "so,", "amortization", "of", "revenue", "is", "adjusted", "prospectively."], "wordsB": ["Our", "original", "estimates", "are", "periodi", "cally", "evaluated", "to", "determine", "if", "circumstances", "have", "caused", "the", "estimates", "to", "change", "and", "if", "so,", "amortization", "of", "revenue", "is", "adjusted", "prospectively."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p52_s2", "idA": "906709_17_item7_p44_s2", "sentA": "Payments under the contracts depend on factors such as the achievement of certain events, successful enrollment of patients and completion of portions of the clinical trial or similar conditions.", "sentB": "Payments under the contracts depend on factors such as the achievement of certain events, successful enrollment of patients and completion of certain clinical trial activities.", "type": 2, "words": ["<tag1>", "Payments", "under", "the", "contracts", "depend", "on", "factors", "such", "as", "the", "achievement", "of", "certain", "events,", "successful", "enrollment", "of", "patients", "and", "completion", "of", "portions", "of", "the", "clinical", "trial", "or", "similar", "conditions.", "<tag2>", "Payments", "under", "the", "contracts", "depend", "on", "factors", "such", "as", "the", "achievement", "of", "certain", "events,", "successful", "enrollment", "of", "patients", "and", "completion", "of", "certain", "clinical", "trial", "activities.", "<tag3>"], "wordsA": ["Payments", "under", "the", "contracts", "depend", "on", "factors", "such", "as", "the", "achievement", "of", "certain", "events,", "successful", "enrollment", "of", "patients", "and", "completion", "of", "portions", "of", "the", "clinical", "trial", "or", "similar", "conditions."], "wordsB": ["Payments", "under", "the", "contracts", "depend", "on", "factors", "such", "as", "the", "achievement", "of", "certain", "events,", "successful", "enrollment", "of", "patients", "and", "completion", "of", "certain", "clinical", "trial", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p62_s2", "idA": "906709_17_item7_p44_s5", "sentA": "In specific circumstances, such as for certain time-based costs, we recognize clinical trial expenses using a methodology that we consider to be more reflective of the timing of costs incurred.", "sentB": "The new guidance requires the application of a five-step model to determine the amount and timing of revenue to be recognized and requires that we recognize revenue in a manner that reasonably reflects the delivery of our goods or services to customers in return for expected consideration.", "type": 2, "words": ["<tag1>", "In", "specific", "circumstances,", "such", "as", "for", "certain", "time-based", "costs,", "we", "recognize", "clinical", "trial", "expenses", "using", "a", "methodology", "that", "we", "consider", "to", "be", "more", "reflective", "of", "the", "timing", "of", "costs", "incurred.", "<tag2>", "The", "new", "guidance", "requires", "the", "application", "of", "a", "five-step", "model", "to", "determine", "the", "amount", "and", "timing", "of", "revenue", "to", "be", "recognized", "and", "requires", "that", "we", "recognize", "revenue", "in", "a", "manner", "that", "reasonably", "reflects", "the", "delivery", "of", "our", "goods", "or", "services", "to", "customers", "in", "return", "for", "expected", "consideration.", "<tag3>"], "wordsA": ["In", "specific", "circumstances,", "such", "as", "for", "certain", "time-based", "costs,", "we", "recognize", "clinical", "trial", "expenses", "using", "a", "methodology", "that", "we", "consider", "to", "be", "more", "reflective", "of", "the", "timing", "of", "costs", "incurred."], "wordsB": ["The", "new", "guidance", "requires", "the", "application", "of", "a", "five-step", "model", "to", "determine", "the", "amount", "and", "timing", "of", "revenue", "to", "be", "recognized", "and", "requires", "that", "we", "recognize", "revenue", "in", "a", "manner", "that", "reasonably", "reflects", "the", "delivery", "of", "our", "goods", "or", "services", "to", "customers", "in", "return", "for", "expected", "consideration."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p54_s3", "idA": "906709_17_item7_p46_s3", "sentA": "Such increases or decreases in cost are generally considered to be changes in estimates and will be reflected in research and development expenses in the period first identified.", "sentB": "Such increases or decreases in cost are generally considered to be changes in estimates and will be reflected in research and development expenses in the period identified.", "type": 2, "words": ["<tag1>", "Such", "increases", "or", "decreases", "in", "cost", "are", "generally", "considered", "to", "be", "changes", "in", "estimates", "and", "will", "be", "reflected", "in", "research", "and", "development", "expenses", "in", "the", "period", "first", "identified.", "<tag2>", "Such", "increases", "or", "decreases", "in", "cost", "are", "generally", "considered", "to", "be", "changes", "in", "estimates", "and", "will", "be", "reflected", "in", "research", "and", "development", "expenses", "in", "the", "period", "identified.", "<tag3>"], "wordsA": ["Such", "increases", "or", "decreases", "in", "cost", "are", "generally", "considered", "to", "be", "changes", "in", "estimates", "and", "will", "be", "reflected", "in", "research", "and", "development", "expenses", "in", "the", "period", "first", "identified."], "wordsB": ["Such", "increases", "or", "decreases", "in", "cost", "are", "generally", "considered", "to", "be", "changes", "in", "estimates", "and", "will", "be", "reflected", "in", "research", "and", "development", "expenses", "in", "the", "period", "identified."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p55_s1", "idA": "906709_17_item7_p47_s1", "sentA": "We expense the estimated fair value of each award, as adjusted by the estimated historical forfeiture rate, ratably over the expected service period of the award.", "sentB": "We expense the estimated fair value of each award ratably over the expected service period of the award and recognize forfeitures as they occur.", "type": 2, "words": ["<tag1>", "We", "expense", "the", "estimated", "fair", "value", "of", "each", "award,", "as", "adjusted", "by", "the", "estimated", "historical", "forfeiture", "rate,", "ratably", "over", "the", "expected", "service", "period", "of", "the", "award.", "<tag2>", "We", "expense", "the", "estimated", "fair", "value", "of", "each", "award", "ratably", "over", "the", "expected", "service", "period", "of", "the", "award", "and", "recognize", "forfeitures", "as", "they", "occur.", "<tag3>"], "wordsA": ["We", "expense", "the", "estimated", "fair", "value", "of", "each", "award,", "as", "adjusted", "by", "the", "estimated", "historical", "forfeiture", "rate,", "ratably", "over", "the", "expected", "service", "period", "of", "the", "award."], "wordsB": ["We", "expense", "the", "estimated", "fair", "value", "of", "each", "award", "ratably", "over", "the", "expected", "service", "period", "of", "the", "award", "and", "recognize", "forfeitures", "as", "they", "occur."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p62_s13", "idA": "906709_17_item7_p47_s1", "sentA": "We expense the estimated fair value of each award, as adjusted by the estimated historical forfeiture rate, ratably over the expected service period of the award.", "sentB": "(iii) We will recognize revenue for sales-based royalties and commercial sales-based milestones in the period of the related sale based on estimates, rather than recording them as reported by the customer.", "type": 2, "words": ["<tag1>", "We", "expense", "the", "estimated", "fair", "value", "of", "each", "award,", "as", "adjusted", "by", "the", "estimated", "historical", "forfeiture", "rate,", "ratably", "over", "the", "expected", "service", "period", "of", "the", "award.", "<tag2>", "(iii)", "We", "will", "recognize", "revenue", "for", "sales-based", "royalties", "and", "commercial", "sales-based", "milestones", "in", "the", "period", "of", "the", "related", "sale", "based", "on", "estimates,", "rather", "than", "recording", "them", "as", "reported", "by", "the", "customer.", "<tag3>"], "wordsA": ["We", "expense", "the", "estimated", "fair", "value", "of", "each", "award,", "as", "adjusted", "by", "the", "estimated", "historical", "forfeiture", "rate,", "ratably", "over", "the", "expected", "service", "period", "of", "the", "award."], "wordsB": ["(iii)", "We", "will", "recognize", "revenue", "for", "sales-based", "royalties", "and", "commercial", "sales-based", "milestones", "in", "the", "period", "of", "the", "related", "sale", "based", "on", "estimates,", "rather", "than", "recording", "them", "as", "reported", "by", "the", "customer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p14_s1", "idA": "906709_17_item7_p4_s1", "sentA": "The amount of upfront fees received under our license and collaboration agreements allocated to continuing obligations, such as manufacturing and supply commitments, is recognized ratably over our expected performance period under the arrangement.", "sentB": "The amount of upfront fees received under our license and collaboration agreements allocated to continuing obligations, such as manufacturing and supply commitments, is generally recognized ratably over our expected performance period under the arrangement.", "type": 2, "words": ["<tag1>", "The", "amount", "of", "upfront", "fees", "received", "under", "our", "license", "and", "collaboration", "agreements", "allocated", "to", "continuing", "obligations,", "such", "as", "manufacturing", "and", "supply", "commitments,", "is", "recognized", "ratably", "over", "our", "expected", "performance", "period", "under", "the", "arrangement.", "<tag2>", "The", "amount", "of", "upfront", "fees", "received", "under", "our", "license", "and", "collaboration", "agreements", "allocated", "to", "continuing", "obligations,", "such", "as", "manufacturing", "and", "supply", "commitments,", "is", "generally", "recognized", "ratably", "over", "our", "expected", "performance", "period", "under", "the", "arrangement.", "<tag3>"], "wordsA": ["The", "amount", "of", "upfront", "fees", "received", "under", "our", "license", "and", "collaboration", "agreements", "allocated", "to", "continuing", "obligations,", "such", "as", "manufacturing", "and", "supply", "commitments,", "is", "recognized", "ratably", "over", "our", "expected", "performance", "period", "under", "the", "arrangement."], "wordsB": ["The", "amount", "of", "upfront", "fees", "received", "under", "our", "license", "and", "collaboration", "agreements", "allocated", "to", "continuing", "obligations,", "such", "as", "manufacturing", "and", "supply", "commitments,", "is", "generally", "recognized", "ratably", "over", "our", "expected", "performance", "period", "under", "the", "arrangement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p58_s1", "idA": "906709_17_item7_p51_s0", "sentA": "liability (Royalty Obligation) that we will amortize using the interest method over the estimated life of the Purchase and Sale Agreement.", "sentB": "Although we are required to make payments to the purchaser (RPI) only in certain situations, including the event of our breach of a representation, warranty or covenant in the Purchase and Sale Agreement that gives rise to a liability in accordance with the terms and conditions of such agreement, this royalty sale transaction was recorded as a liability (Royalty Obligation) that we will amortize using the interest method over the estimated life of the Purchase and Sale Agreement.", "type": 2, "words": ["<tag1>", "liability", "(Royalty", "Obligation)", "that", "we", "will", "amortize", "using", "the", "interest", "method", "over", "the", "estimated", "life", "of", "the", "Purchase", "and", "Sale", "Agreement.", "<tag2>", "Although", "we", "are", "required", "to", "make", "payments", "to", "the", "purchaser", "(RPI)", "only", "in", "certain", "situations,", "including", "the", "event", "of", "our", "breach", "of", "a", "representation,", "warranty", "or", "covenant", "in", "the", "Purchase", "and", "Sale", "Agreement", "that", "gives", "rise", "to", "a", "liability", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "such", "agreement,", "this", "royalty", "sale", "transaction", "was", "recorded", "as", "a", "liability", "(Royalty", "Obligation)", "that", "we", "will", "amortize", "using", "the", "interest", "method", "over", "the", "estimated", "life", "of", "the", "Purchase", "and", "Sale", "Agreement.", "<tag3>"], "wordsA": ["liability", "(Royalty", "Obligation)", "that", "we", "will", "amortize", "using", "the", "interest", "method", "over", "the", "estimated", "life", "of", "the", "Purchase", "and", "Sale", "Agreement."], "wordsB": ["Although", "we", "are", "required", "to", "make", "payments", "to", "the", "purchaser", "(RPI)", "only", "in", "certain", "situations,", "including", "the", "event", "of", "our", "breach", "of", "a", "representation,", "warranty", "or", "covenant", "in", "the", "Purchase", "and", "Sale", "Agreement", "that", "gives", "rise", "to", "a", "liability", "in", "accordance", "with", "the", "terms", "and", "conditions", "of", "such", "agreement,", "this", "royalty", "sale", "transaction", "was", "recorded", "as", "a", "liability", "(Royalty", "Obligation)", "that", "we", "will", "amortize", "using", "the", "interest", "method", "over", "the", "estimated", "life", "of", "the", "Purchase", "and", "Sale", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p37_s3", "idA": "906709_17_item7_p51_s2", "sentA": "Our estimate of the interest rate under the agreement is based on the amount of royalty payments to be received by RPI over the life of the arrangem ent and payments we are required to make to RPI under the agreement.", "sentB": "During the three month period ended December 31, 2017, as a result of increases in the forecasted sales of CIMZIA , our estimate of the effective annual interest rate over the life of the agreement increased to approximately 17.6%, which results in a prospective interest rate of 21%.", "type": 2, "words": ["<tag1>", "Our", "estimate", "of", "the", "interest", "rate", "under", "the", "agreement", "is", "based", "on", "the", "amount", "of", "royalty", "payments", "to", "be", "received", "by", "RPI", "over", "the", "life", "of", "the", "arrangem", "ent", "and", "payments", "we", "are", "required", "to", "make", "to", "RPI", "under", "the", "agreement.", "<tag2>", "During", "the", "three", "month", "period", "ended", "December", "31,", "2017,", "as", "a", "result", "of", "increases", "in", "the", "forecasted", "sales", "of", "CIMZIA", ",", "our", "estimate", "of", "the", "effective", "annual", "interest", "rate", "over", "the", "life", "of", "the", "agreement", "increased", "to", "approximately", "17.6%,", "which", "results", "in", "a", "prospective", "interest", "rate", "of", "21%.", "<tag3>"], "wordsA": ["Our", "estimate", "of", "the", "interest", "rate", "under", "the", "agreement", "is", "based", "on", "the", "amount", "of", "royalty", "payments", "to", "be", "received", "by", "RPI", "over", "the", "life", "of", "the", "arrangem", "ent", "and", "payments", "we", "are", "required", "to", "make", "to", "RPI", "under", "the", "agreement."], "wordsB": ["During", "the", "three", "month", "period", "ended", "December", "31,", "2017,", "as", "a", "result", "of", "increases", "in", "the", "forecasted", "sales", "of", "CIMZIA", ",", "our", "estimate", "of", "the", "effective", "annual", "interest", "rate", "over", "the", "life", "of", "the", "agreement", "increased", "to", "approximately", "17.6%,", "which", "results", "in", "a", "prospective", "interest", "rate", "of", "21%."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p58_s3", "idA": "906709_17_item7_p51_s2", "sentA": "Our estimate of the interest rate under the agreement is based on the amount of royalty payments to be received by RPI over the life of the arrangem ent and payments we are required to make to RPI under the agreement.", "sentB": "Our estimate of the interest rate under the agreement is based on the amount of royalty payments to be received by RPI over the life of the arrangement and payments we are required to make to RPI under the agreement.", "type": 2, "words": ["<tag1>", "Our", "estimate", "of", "the", "interest", "rate", "under", "the", "agreement", "is", "based", "on", "the", "amount", "of", "royalty", "payments", "to", "be", "received", "by", "RPI", "over", "the", "life", "of", "the", "arrangem", "ent", "and", "payments", "we", "are", "required", "to", "make", "to", "RPI", "under", "the", "agreement.", "<tag2>", "Our", "estimate", "of", "the", "interest", "rate", "under", "the", "agreement", "is", "based", "on", "the", "amount", "of", "royalty", "payments", "to", "be", "received", "by", "RPI", "over", "the", "life", "of", "the", "arrangement", "and", "payments", "we", "are", "required", "to", "make", "to", "RPI", "under", "the", "agreement.", "<tag3>"], "wordsA": ["Our", "estimate", "of", "the", "interest", "rate", "under", "the", "agreement", "is", "based", "on", "the", "amount", "of", "royalty", "payments", "to", "be", "received", "by", "RPI", "over", "the", "life", "of", "the", "arrangem", "ent", "and", "payments", "we", "are", "required", "to", "make", "to", "RPI", "under", "the", "agreement."], "wordsB": ["Our", "estimate", "of", "the", "interest", "rate", "under", "the", "agreement", "is", "based", "on", "the", "amount", "of", "royalty", "payments", "to", "be", "received", "by", "RPI", "over", "the", "life", "of", "the", "arrangement", "and", "payments", "we", "are", "required", "to", "make", "to", "RPI", "under", "the", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p60_s2", "idA": "906709_17_item7_p51_s2", "sentA": "Our estimate of the interest rate under the agreement is based on the amount of royalty payments to be received by RPI over the life of the arrangem ent and payments we are required to make to RPI under the agreement.", "sentB": "During the three month period ended December 31, 2017, as a result of increases in the forecasted sales of CIMZIA , our estimate of the effective annual interest rate over the life of the agreement increased from 17% to approximately 17.6%, which results in a prospective interest rate of 21%.", "type": 2, "words": ["<tag1>", "Our", "estimate", "of", "the", "interest", "rate", "under", "the", "agreement", "is", "based", "on", "the", "amount", "of", "royalty", "payments", "to", "be", "received", "by", "RPI", "over", "the", "life", "of", "the", "arrangem", "ent", "and", "payments", "we", "are", "required", "to", "make", "to", "RPI", "under", "the", "agreement.", "<tag2>", "During", "the", "three", "month", "period", "ended", "December", "31,", "2017,", "as", "a", "result", "of", "increases", "in", "the", "forecasted", "sales", "of", "CIMZIA", ",", "our", "estimate", "of", "the", "effective", "annual", "interest", "rate", "over", "the", "life", "of", "the", "agreement", "increased", "from", "17%", "to", "approximately", "17.6%,", "which", "results", "in", "a", "prospective", "interest", "rate", "of", "21%.", "<tag3>"], "wordsA": ["Our", "estimate", "of", "the", "interest", "rate", "under", "the", "agreement", "is", "based", "on", "the", "amount", "of", "royalty", "payments", "to", "be", "received", "by", "RPI", "over", "the", "life", "of", "the", "arrangem", "ent", "and", "payments", "we", "are", "required", "to", "make", "to", "RPI", "under", "the", "agreement."], "wordsB": ["During", "the", "three", "month", "period", "ended", "December", "31,", "2017,", "as", "a", "result", "of", "increases", "in", "the", "forecasted", "sales", "of", "CIMZIA", ",", "our", "estimate", "of", "the", "effective", "annual", "interest", "rate", "over", "the", "life", "of", "the", "agreement", "increased", "from", "17%", "to", "approximately", "17.6%,", "which", "results", "in", "a", "prospective", "interest", "rate", "of", "21%."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p58_s5", "idA": "906709_17_item7_p51_s4", "sentA": "To the extent such pa yments are greater or less than our initial estimates or the timing of such payments is materially different than our original estimates, we will prospectively adjust the amortization of the Royalty Obligation.", "sentB": "To the extent such payments are greater or less than our initial estimates or the timing of such payments is materially different than our original estimates, we will prospectively adjust the amortization of the Royalty Obligation.", "type": 2, "words": ["<tag1>", "To", "the", "extent", "such", "pa", "yments", "are", "greater", "or", "less", "than", "our", "initial", "estimates", "or", "the", "timing", "of", "such", "payments", "is", "materially", "different", "than", "our", "original", "estimates,", "we", "will", "prospectively", "adjust", "the", "amortization", "of", "the", "Royalty", "Obligation.", "<tag2>", "To", "the", "extent", "such", "payments", "are", "greater", "or", "less", "than", "our", "initial", "estimates", "or", "the", "timing", "of", "such", "payments", "is", "materially", "different", "than", "our", "original", "estimates,", "we", "will", "prospectively", "adjust", "the", "amortization", "of", "the", "Royalty", "Obligation.", "<tag3>"], "wordsA": ["To", "the", "extent", "such", "pa", "yments", "are", "greater", "or", "less", "than", "our", "initial", "estimates", "or", "the", "timing", "of", "such", "payments", "is", "materially", "different", "than", "our", "original", "estimates,", "we", "will", "prospectively", "adjust", "the", "amortization", "of", "the", "Royalty", "Obligation."], "wordsB": ["To", "the", "extent", "such", "payments", "are", "greater", "or", "less", "than", "our", "initial", "estimates", "or", "the", "timing", "of", "such", "payments", "is", "materially", "different", "than", "our", "original", "estimates,", "we", "will", "prospectively", "adjust", "the", "amortization", "of", "the", "Royalty", "Obligation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p59_s0", "idA": "906709_17_item7_p52_s0", "sentA": "There are a number of factors that could mate rially affect the amount and timing of royalty payments from CIMZIA and MIRCERA , most of which are not within our control.", "sentB": "There are a number of factors that could materially affect the amount and timing of royalty payments from CIMZIA and MIRCERA , most of which are not within our control.", "type": 2, "words": ["<tag1>", "There", "are", "a", "number", "of", "factors", "that", "could", "mate", "rially", "affect", "the", "amount", "and", "timing", "of", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "most", "of", "which", "are", "not", "within", "our", "control.", "<tag2>", "There", "are", "a", "number", "of", "factors", "that", "could", "materially", "affect", "the", "amount", "and", "timing", "of", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "most", "of", "which", "are", "not", "within", "our", "control.", "<tag3>"], "wordsA": ["There", "are", "a", "number", "of", "factors", "that", "could", "mate", "rially", "affect", "the", "amount", "and", "timing", "of", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "most", "of", "which", "are", "not", "within", "our", "control."], "wordsB": ["There", "are", "a", "number", "of", "factors", "that", "could", "materially", "affect", "the", "amount", "and", "timing", "of", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "most", "of", "which", "are", "not", "within", "our", "control."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p60_s0", "idA": "906709_17_item7_p52_s1", "sentA": "Such factors include, but are not limited to, changing standards of care, the introduction of competing products, manufacturing or other delays, biosimilar competition, intellectual property matters, adverse events that result in health authority imposed restrictions on the use of the drug products, significant changes in foreign exchange rates as the royalties remitted to RPI are mad e in U.S. dollars (USD) while significant portions of the underlying sales of CIMZIA and MIRCERA are made in currencies other than USD, and other events or circumstances that result in reduced royalty payments from CIMZIA and MIRCERA , all of which woul d result in a reduction of non-cash royalty revenue and non-cash interest expense over the life of the Royalty Obligation.", "sentB": "while significant portions of the underlying sales of CIMZIA and MIRCER A are made in currencies other than USD, and other events or circumstances that result in reduced royalty payments from CIMZIA and MIRCERA , all of which would result in a reduction of non-cash royalty revenue and non-cash interest expense over the life of the Royalty Obligation.", "type": 2, "words": ["<tag1>", "Such", "factors", "include,", "but", "are", "not", "limited", "to,", "changing", "standards", "of", "care,", "the", "introduction", "of", "competing", "products,", "manufacturing", "or", "other", "delays,", "biosimilar", "competition,", "intellectual", "property", "matters,", "adverse", "events", "that", "result", "in", "health", "authority", "imposed", "restrictions", "on", "the", "use", "of", "the", "drug", "products,", "significant", "changes", "in", "foreign", "exchange", "rates", "as", "the", "royalties", "remitted", "to", "RPI", "are", "mad", "e", "in", "U.S.", "dollars", "(USD)", "while", "significant", "portions", "of", "the", "underlying", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "made", "in", "currencies", "other", "than", "USD,", "and", "other", "events", "or", "circumstances", "that", "result", "in", "reduced", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "all", "of", "which", "woul", "d", "result", "in", "a", "reduction", "of", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "over", "the", "life", "of", "the", "Royalty", "Obligation.", "<tag2>", "while", "significant", "portions", "of", "the", "underlying", "sales", "of", "CIMZIA", "and", "MIRCER", "A", "are", "made", "in", "currencies", "other", "than", "USD,", "and", "other", "events", "or", "circumstances", "that", "result", "in", "reduced", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "all", "of", "which", "would", "result", "in", "a", "reduction", "of", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "over", "the", "life", "of", "the", "Royalty", "Obligation.", "<tag3>"], "wordsA": ["Such", "factors", "include,", "but", "are", "not", "limited", "to,", "changing", "standards", "of", "care,", "the", "introduction", "of", "competing", "products,", "manufacturing", "or", "other", "delays,", "biosimilar", "competition,", "intellectual", "property", "matters,", "adverse", "events", "that", "result", "in", "health", "authority", "imposed", "restrictions", "on", "the", "use", "of", "the", "drug", "products,", "significant", "changes", "in", "foreign", "exchange", "rates", "as", "the", "royalties", "remitted", "to", "RPI", "are", "mad", "e", "in", "U.S.", "dollars", "(USD)", "while", "significant", "portions", "of", "the", "underlying", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "made", "in", "currencies", "other", "than", "USD,", "and", "other", "events", "or", "circumstances", "that", "result", "in", "reduced", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "all", "of", "which", "woul", "d", "result", "in", "a", "reduction", "of", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "over", "the", "life", "of", "the", "Royalty", "Obligation."], "wordsB": ["while", "significant", "portions", "of", "the", "underlying", "sales", "of", "CIMZIA", "and", "MIRCER", "A", "are", "made", "in", "currencies", "other", "than", "USD,", "and", "other", "events", "or", "circumstances", "that", "result", "in", "reduced", "royalty", "payments", "from", "CIMZIA", "and", "MIRCERA", ",", "all", "of", "which", "would", "result", "in", "a", "reduction", "of", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "over", "the", "life", "of", "the", "Royalty", "Obligation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p60_s1", "idA": "906709_17_item7_p52_s2", "sentA": "Conversely, if sales of CIMZIA and MIRCERA are higher than expected, non-cash royalty revenue and non-cash interest expense would b e greater over the term of the Royalty Obligation.", "sentB": "Conversely, if sales of CIMZIA and MIRCERA are higher than expected, non-cash royalty revenue and non-cash interest expense would be greater over the term of the Royalty Obligation.", "type": 2, "words": ["<tag1>", "Conversely,", "if", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "higher", "than", "expected,", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "would", "b", "e", "greater", "over", "the", "term", "of", "the", "Royalty", "Obligation.", "<tag2>", "Conversely,", "if", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "higher", "than", "expected,", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "would", "be", "greater", "over", "the", "term", "of", "the", "Royalty", "Obligation.", "<tag3>"], "wordsA": ["Conversely,", "if", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "higher", "than", "expected,", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "would", "b", "e", "greater", "over", "the", "term", "of", "the", "Royalty", "Obligation."], "wordsB": ["Conversely,", "if", "sales", "of", "CIMZIA", "and", "MIRCERA", "are", "higher", "than", "expected,", "non-cash", "royalty", "revenue", "and", "non-cash", "interest", "expense", "would", "be", "greater", "over", "the", "term", "of", "the", "Royalty", "Obligation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p60_s3", "idA": "906709_17_item7_p52_s3", "sentA": "If we had determined that the interest rate used in 2016 should have been one percentage point higher than our current estimate of 17%, the non-cash interest expense recognized in the year ended December 3 1, 2016 would have increased by $1.2 million.", "sentB": "If we had determined that the interest rate used in 2017 should have been one percentage point higher than our quarterly estimates during 2017, the non-cash interest expense recognized in the year ended December 31, 2017 and the Royalty Obligation balance as of December 31, 2017 would have increased by $1.1 million.", "type": 2, "words": ["<tag1>", "If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2016", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "3", "1,", "2016", "would", "have", "increased", "by", "$1.2", "million.", "<tag2>", "If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2017", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "quarterly", "estimates", "during", "2017,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2017", "and", "the", "Royalty", "Obligation", "balance", "as", "of", "December", "31,", "2017", "would", "have", "increased", "by", "$1.1", "million.", "<tag3>"], "wordsA": ["If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2016", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "3", "1,", "2016", "would", "have", "increased", "by", "$1.2", "million."], "wordsB": ["If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2017", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "quarterly", "estimates", "during", "2017,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2017", "and", "the", "Royalty", "Obligation", "balance", "as", "of", "December", "31,", "2017", "would", "have", "increased", "by", "$1.1", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p60_s4", "idA": "906709_17_item7_p52_s3", "sentA": "If we had determined that the interest rate used in 2016 should have been one percentage point higher than our current estimate of 17%, the non-cash interest expense recognized in the year ended December 3 1, 2016 would have increased by $1.2 million.", "sentB": "If we had determined that the interest rate used in 2017 should have been 21% during 2017, the non-cash interest expense recognized in the year ended December 31, 2017 and the Royalty Obligation balan ce as of December 31, 2017 would have increased by $3.5 million.", "type": 2, "words": ["<tag1>", "If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2016", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "3", "1,", "2016", "would", "have", "increased", "by", "$1.2", "million.", "<tag2>", "If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2017", "should", "have", "been", "21%", "during", "2017,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2017", "and", "the", "Royalty", "Obligation", "balan", "ce", "as", "of", "December", "31,", "2017", "would", "have", "increased", "by", "$3.5", "million.", "<tag3>"], "wordsA": ["If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2016", "should", "have", "been", "one", "percentage", "point", "higher", "than", "our", "current", "estimate", "of", "17%,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "3", "1,", "2016", "would", "have", "increased", "by", "$1.2", "million."], "wordsB": ["If", "we", "had", "determined", "that", "the", "interest", "rate", "used", "in", "2017", "should", "have", "been", "21%", "during", "2017,", "the", "non-cash", "interest", "expense", "recognized", "in", "the", "year", "ended", "December", "31,", "2017", "and", "the", "Royalty", "Obligation", "balan", "ce", "as", "of", "December", "31,", "2017", "would", "have", "increased", "by", "$3.5", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p61_s0", "idA": "906709_17_item7_p53_s0", "sentA": "In May 2014, the FASB issued guidance codified in Accounting Standards Codification (ASC) 606, Revenue Recognition Revenue from Contracts with Customers, which amends the guidance in former ASC 605, Revenue Recognition, and is effective for public companies for annual and interim periods beginning after December 15, 2017.", "sentB": "In May 2014, the FASB issued guidance codified in Accounting Standards Codification (ASC) 606, Revenue Recognition Revenue from Contracts with Customers , which supersedes the guidance in ASC 605, Revenue Recognition , and is effective for public companies for annual and interim periods beginning after December 15, 2017.", "type": 2, "words": ["<tag1>", "In", "May", "2014,", "the", "FASB", "issued", "guidance", "codified", "in", "Accounting", "Standards", "Codification", "(ASC)", "606,", "Revenue", "Recognition", "Revenue", "from", "Contracts", "with", "Customers,", "which", "amends", "the", "guidance", "in", "former", "ASC", "605,", "Revenue", "Recognition,", "and", "is", "effective", "for", "public", "companies", "for", "annual", "and", "interim", "periods", "beginning", "after", "December", "15,", "2017.", "<tag2>", "In", "May", "2014,", "the", "FASB", "issued", "guidance", "codified", "in", "Accounting", "Standards", "Codification", "(ASC)", "606,", "Revenue", "Recognition", "Revenue", "from", "Contracts", "with", "Customers", ",", "which", "supersedes", "the", "guidance", "in", "ASC", "605,", "Revenue", "Recognition", ",", "and", "is", "effective", "for", "public", "companies", "for", "annual", "and", "interim", "periods", "beginning", "after", "December", "15,", "2017.", "<tag3>"], "wordsA": ["In", "May", "2014,", "the", "FASB", "issued", "guidance", "codified", "in", "Accounting", "Standards", "Codification", "(ASC)", "606,", "Revenue", "Recognition", "Revenue", "from", "Contracts", "with", "Customers,", "which", "amends", "the", "guidance", "in", "former", "ASC", "605,", "Revenue", "Recognition,", "and", "is", "effective", "for", "public", "companies", "for", "annual", "and", "interim", "periods", "beginning", "after", "December", "15,", "2017."], "wordsB": ["In", "May", "2014,", "the", "FASB", "issued", "guidance", "codified", "in", "Accounting", "Standards", "Codification", "(ASC)", "606,", "Revenue", "Recognition", "Revenue", "from", "Contracts", "with", "Customers", ",", "which", "supersedes", "the", "guidance", "in", "ASC", "605,", "Revenue", "Recognition", ",", "and", "is", "effective", "for", "public", "companies", "for", "annual", "and", "interim", "periods", "beginning", "after", "December", "15,", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p62_s0", "idA": "906709_17_item7_p53_s1", "sentA": "Numerous updates have been issued subsequent to the initial FASB guidance that provide clarification on a number of specific issues as well as requiring additional disclosures.", "sentB": "The FASB has issued numerous updates that provide clarification on a number of specific issues as well as requiring additional disclosures.", "type": 2, "words": ["<tag1>", "Numerous", "updates", "have", "been", "issued", "subsequent", "to", "the", "initial", "FASB", "guidance", "that", "provide", "clarification", "on", "a", "number", "of", "specific", "issues", "as", "well", "as", "requiring", "additional", "disclosures.", "<tag2>", "The", "FASB", "has", "issued", "numerous", "updates", "that", "provide", "clarification", "on", "a", "number", "of", "specific", "issues", "as", "well", "as", "requiring", "additional", "disclosures.", "<tag3>"], "wordsA": ["Numerous", "updates", "have", "been", "issued", "subsequent", "to", "the", "initial", "FASB", "guidance", "that", "provide", "clarification", "on", "a", "number", "of", "specific", "issues", "as", "well", "as", "requiring", "additional", "disclosures."], "wordsB": ["The", "FASB", "has", "issued", "numerous", "updates", "that", "provide", "clarification", "on", "a", "number", "of", "specific", "issues", "as", "well", "as", "requiring", "additional", "disclosures."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p12_s5", "idA": "906709_17_item7_p53_s2", "sentA": "We plan to adopt the standard in the first quarter of 2018 using the modified retrospective method.", "sentB": "The closings under the two agreements, subject to satisfaction of certain closing conditions, are expected to occur during the second quarter of 2018.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "adopt", "the", "standard", "in", "the", "first", "quarter", "of", "2018", "using", "the", "modified", "retrospective", "method.", "<tag2>", "The", "closings", "under", "the", "two", "agreements,", "subject", "to", "satisfaction", "of", "certain", "closing", "conditions,", "are", "expected", "to", "occur", "during", "the", "second", "quarter", "of", "2018.", "<tag3>"], "wordsA": ["We", "plan", "to", "adopt", "the", "standard", "in", "the", "first", "quarter", "of", "2018", "using", "the", "modified", "retrospective", "method."], "wordsB": ["The", "closings", "under", "the", "two", "agreements,", "subject", "to", "satisfaction", "of", "certain", "closing", "conditions,", "are", "expected", "to", "occur", "during", "the", "second", "quarter", "of", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p1_s2", "idA": "906709_17_item7_p53_s2", "sentA": "We plan to adopt the standard in the first quarter of 2018 using the modified retrospective method.", "sentB": "The closings under the two agreements, subject to satisfaction of certain closing conditions, are expected to occur during the second quarter of 2018.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "adopt", "the", "standard", "in", "the", "first", "quarter", "of", "2018", "using", "the", "modified", "retrospective", "method.", "<tag2>", "The", "closings", "under", "the", "two", "agreements,", "subject", "to", "satisfaction", "of", "certain", "closing", "conditions,", "are", "expected", "to", "occur", "during", "the", "second", "quarter", "of", "2018.", "<tag3>"], "wordsA": ["We", "plan", "to", "adopt", "the", "standard", "in", "the", "first", "quarter", "of", "2018", "using", "the", "modified", "retrospective", "method."], "wordsB": ["The", "closings", "under", "the", "two", "agreements,", "subject", "to", "satisfaction", "of", "certain", "closing", "conditions,", "are", "expected", "to", "occur", "during", "the", "second", "quarter", "of", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p30_s4", "idA": "906709_17_item7_p53_s2", "sentA": "We plan to adopt the standard in the first quarter of 2018 using the modified retrospective method.", "sentB": "We have initiated start-up activities on our Phase 1/2 program for NKTR-262 and plan to enroll the initial patients in the second quarter of 2018.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "adopt", "the", "standard", "in", "the", "first", "quarter", "of", "2018", "using", "the", "modified", "retrospective", "method.", "<tag2>", "We", "have", "initiated", "start-up", "activities", "on", "our", "Phase", "1/2", "program", "for", "NKTR-262", "and", "plan", "to", "enroll", "the", "initial", "patients", "in", "the", "second", "quarter", "of", "2018.", "<tag3>"], "wordsA": ["We", "plan", "to", "adopt", "the", "standard", "in", "the", "first", "quarter", "of", "2018", "using", "the", "modified", "retrospective", "method."], "wordsB": ["We", "have", "initiated", "start-up", "activities", "on", "our", "Phase", "1/2", "program", "for", "NKTR-262", "and", "plan", "to", "enroll", "the", "initial", "patients", "in", "the", "second", "quarter", "of", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p30_s5", "idA": "906709_17_item7_p53_s2", "sentA": "We plan to adopt the standard in the first quarter of 2018 using the modified retrospective method.", "sentB": "We plan to file an IND for NKTR-255 in 2019.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "adopt", "the", "standard", "in", "the", "first", "quarter", "of", "2018", "using", "the", "modified", "retrospective", "method.", "<tag2>", "We", "plan", "to", "file", "an", "IND", "for", "NKTR-255", "in", "2019.", "<tag3>"], "wordsA": ["We", "plan", "to", "adopt", "the", "standard", "in", "the", "first", "quarter", "of", "2018", "using", "the", "modified", "retrospective", "method."], "wordsB": ["We", "plan", "to", "file", "an", "IND", "for", "NKTR-255", "in", "2019."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p62_s17", "idA": "906709_17_item7_p53_s2", "sentA": "We plan to adopt the standard in the first quarter of 2018 using the modified retrospective method.", "sentB": "We will finalize our assessments in the first quarter of 2018 as we adopt ASC 606.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "adopt", "the", "standard", "in", "the", "first", "quarter", "of", "2018", "using", "the", "modified", "retrospective", "method.", "<tag2>", "We", "will", "finalize", "our", "assessments", "in", "the", "first", "quarter", "of", "2018", "as", "we", "adopt", "ASC", "606.", "<tag3>"], "wordsA": ["We", "plan", "to", "adopt", "the", "standard", "in", "the", "first", "quarter", "of", "2018", "using", "the", "modified", "retrospective", "method."], "wordsB": ["We", "will", "finalize", "our", "assessments", "in", "the", "first", "quarter", "of", "2018", "as", "we", "adopt", "ASC", "606."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p6_s3", "idA": "906709_17_item7_p53_s2", "sentA": "We plan to adopt the standard in the first quarter of 2018 using the modified retrospective method.", "sentB": "A Phase 1 multiple-ascending dose trial is expected to be initiated in the second quarter of 2018 in lupus patients.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "adopt", "the", "standard", "in", "the", "first", "quarter", "of", "2018", "using", "the", "modified", "retrospective", "method.", "<tag2>", "A", "Phase", "1", "multiple-ascending", "dose", "trial", "is", "expected", "to", "be", "initiated", "in", "the", "second", "quarter", "of", "2018", "in", "lupus", "patients.", "<tag3>"], "wordsA": ["We", "plan", "to", "adopt", "the", "standard", "in", "the", "first", "quarter", "of", "2018", "using", "the", "modified", "retrospective", "method."], "wordsB": ["A", "Phase", "1", "multiple-ascending", "dose", "trial", "is", "expected", "to", "be", "initiated", "in", "the", "second", "quarter", "of", "2018", "in", "lupus", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p9_s0", "idA": "906709_17_item7_p53_s2", "sentA": "We plan to adopt the standard in the first quarter of 2018 using the modified retrospective method.", "sentB": "We filed the IND for NKTR-262 in December 2017 and expect to begin enrolling patients in the initial Phase 1 study by the e nd of the first quarter of 2018.", "type": 2, "words": ["<tag1>", "We", "plan", "to", "adopt", "the", "standard", "in", "the", "first", "quarter", "of", "2018", "using", "the", "modified", "retrospective", "method.", "<tag2>", "We", "filed", "the", "IND", "for", "NKTR-262", "in", "December", "2017", "and", "expect", "to", "begin", "enrolling", "patients", "in", "the", "initial", "Phase", "1", "study", "by", "the", "e", "nd", "of", "the", "first", "quarter", "of", "2018.", "<tag3>"], "wordsA": ["We", "plan", "to", "adopt", "the", "standard", "in", "the", "first", "quarter", "of", "2018", "using", "the", "modified", "retrospective", "method."], "wordsB": ["We", "filed", "the", "IND", "for", "NKTR-262", "in", "December", "2017", "and", "expect", "to", "begin", "enrolling", "patients", "in", "the", "initial", "Phase", "1", "study", "by", "the", "e", "nd", "of", "the", "first", "quarter", "of", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p62_s11", "idA": "906709_17_item7_p54_s0", "sentA": "Under our current accounting policy, we recognize contingent or milestone payments as revenue in the period that the payment-triggering event occurred or is achieved.", "sentB": "For other consideration, including milestone payments or contingent payments from our collaboration partners, under our current accounting policy, we recognize such payments as revenue in the period that the payment-triggering event occurred or is achieved.", "type": 2, "words": ["<tag1>", "Under", "our", "current", "accounting", "policy,", "we", "recognize", "contingent", "or", "milestone", "payments", "as", "revenue", "in", "the", "period", "that", "the", "payment-triggering", "event", "occurred", "or", "is", "achieved.", "<tag2>", "For", "other", "consideration,", "including", "milestone", "payments", "or", "contingent", "payments", "from", "our", "collaboration", "partners,", "under", "our", "current", "accounting", "policy,", "we", "recognize", "such", "payments", "as", "revenue", "in", "the", "period", "that", "the", "payment-triggering", "event", "occurred", "or", "is", "achieved.", "<tag3>"], "wordsA": ["Under", "our", "current", "accounting", "policy,", "we", "recognize", "contingent", "or", "milestone", "payments", "as", "revenue", "in", "the", "period", "that", "the", "payment-triggering", "event", "occurred", "or", "is", "achieved."], "wordsB": ["For", "other", "consideration,", "including", "milestone", "payments", "or", "contingent", "payments", "from", "our", "collaboration", "partners,", "under", "our", "current", "accounting", "policy,", "we", "recognize", "such", "payments", "as", "revenue", "in", "the", "period", "that", "the", "payment-triggering", "event", "occurred", "or", "is", "achieved."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p62_s7", "idA": "906709_17_item7_p55_s2", "sentA": "We do not believe the adoption of this guidance will have a material impact on our consolidated financial statements.", "sentB": "We anticipate that the adoption of ASC 606 will have the following impact to our revenue recognition for a collaboration agreement: (i) Changes in revenue recognition for distinct licenses of functional intellectual property may result in a timing difference of revenue recognition between the current literature and ASC 606.", "type": 2, "words": ["<tag1>", "We", "do", "not", "believe", "the", "adoption", "of", "this", "guidance", "will", "have", "a", "material", "impact", "on", "our", "consolidated", "financial", "statements.", "<tag2>", "We", "anticipate", "that", "the", "adoption", "of", "ASC", "606", "will", "have", "the", "following", "impact", "to", "our", "revenue", "recognition", "for", "a", "collaboration", "agreement:", "(i)", "Changes", "in", "revenue", "recognition", "for", "distinct", "licenses", "of", "functional", "intellectual", "property", "may", "result", "in", "a", "timing", "difference", "of", "revenue", "recognition", "between", "the", "current", "literature", "and", "ASC", "606.", "<tag3>"], "wordsA": ["We", "do", "not", "believe", "the", "adoption", "of", "this", "guidance", "will", "have", "a", "material", "impact", "on", "our", "consolidated", "financial", "statements."], "wordsB": ["We", "anticipate", "that", "the", "adoption", "of", "ASC", "606", "will", "have", "the", "following", "impact", "to", "our", "revenue", "recognition", "for", "a", "collaboration", "agreement:", "(i)", "Changes", "in", "revenue", "recognition", "for", "distinct", "licenses", "of", "functional", "intellectual", "property", "may", "result", "in", "a", "timing", "difference", "of", "revenue", "recognition", "between", "the", "current", "literature", "and", "ASC", "606."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p63_s0", "idA": "906709_17_item7_p56_s0", "sentA": "In February 2016, the FASB issued guidance to amend a number of aspects of lease accounting, including requiring lessees to recognize almost all leases with a term greater than one year as a right-of-use asset and corresponding liability, measured at the present value of the lease payments.", "sentB": "In February 2016, the FASB issued guidance to amend a number of aspects of lease accounting, including requiring lessees to recognize almo st all leases with a term greater than one year as a right-of-use asset and corresponding liability, measured at the present value of the lease payments.", "type": 2, "words": ["<tag1>", "In", "February", "2016,", "the", "FASB", "issued", "guidance", "to", "amend", "a", "number", "of", "aspects", "of", "lease", "accounting,", "including", "requiring", "lessees", "to", "recognize", "almost", "all", "leases", "with", "a", "term", "greater", "than", "one", "year", "as", "a", "right-of-use", "asset", "and", "corresponding", "liability,", "measured", "at", "the", "present", "value", "of", "the", "lease", "payments.", "<tag2>", "In", "February", "2016,", "the", "FASB", "issued", "guidance", "to", "amend", "a", "number", "of", "aspects", "of", "lease", "accounting,", "including", "requiring", "lessees", "to", "recognize", "almo", "st", "all", "leases", "with", "a", "term", "greater", "than", "one", "year", "as", "a", "right-of-use", "asset", "and", "corresponding", "liability,", "measured", "at", "the", "present", "value", "of", "the", "lease", "payments.", "<tag3>"], "wordsA": ["In", "February", "2016,", "the", "FASB", "issued", "guidance", "to", "amend", "a", "number", "of", "aspects", "of", "lease", "accounting,", "including", "requiring", "lessees", "to", "recognize", "almost", "all", "leases", "with", "a", "term", "greater", "than", "one", "year", "as", "a", "right-of-use", "asset", "and", "corresponding", "liability,", "measured", "at", "the", "present", "value", "of", "the", "lease", "payments."], "wordsB": ["In", "February", "2016,", "the", "FASB", "issued", "guidance", "to", "amend", "a", "number", "of", "aspects", "of", "lease", "accounting,", "including", "requiring", "lessees", "to", "recognize", "almo", "st", "all", "leases", "with", "a", "term", "greater", "than", "one", "year", "as", "a", "right-of-use", "asset", "and", "corresponding", "liability,", "measured", "at", "the", "present", "value", "of", "the", "lease", "payments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p3_s2", "idA": "906709_17_item7_p56_s2", "sentA": "We are currently evaluating the impact of the adoption of this standard.", "sentB": "We have identified the Phase 2 dose for NKTR-214 and are currently enrolling subjects in the expansion phase of the study.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "evaluating", "the", "impact", "of", "the", "adoption", "of", "this", "standard.", "<tag2>", "We", "have", "identified", "the", "Phase", "2", "dose", "for", "NKTR-214", "and", "are", "currently", "enrolling", "subjects", "in", "the", "expansion", "phase", "of", "the", "study.", "<tag3>"], "wordsA": ["We", "are", "currently", "evaluating", "the", "impact", "of", "the", "adoption", "of", "this", "standard."], "wordsB": ["We", "have", "identified", "the", "Phase", "2", "dose", "for", "NKTR-214", "and", "are", "currently", "enrolling", "subjects", "in", "the", "expansion", "phase", "of", "the", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p62_s5", "idA": "906709_17_item7_p56_s2", "sentA": "We are currently evaluating the impact of the adoption of this standard.", "sentB": "We are continuing to assess the impact of the new guidance on our accounting policies and procedures and are evaluating the new requirements as applied to existing collaboration agreements, both in terms of the cumulative adjustment to opening accumulated deficit and our subsequent recognition of revenue.", "type": 2, "words": ["<tag1>", "We", "are", "currently", "evaluating", "the", "impact", "of", "the", "adoption", "of", "this", "standard.", "<tag2>", "We", "are", "continuing", "to", "assess", "the", "impact", "of", "the", "new", "guidance", "on", "our", "accounting", "policies", "and", "procedures", "and", "are", "evaluating", "the", "new", "requirements", "as", "applied", "to", "existing", "collaboration", "agreements,", "both", "in", "terms", "of", "the", "cumulative", "adjustment", "to", "opening", "accumulated", "deficit", "and", "our", "subsequent", "recognition", "of", "revenue.", "<tag3>"], "wordsA": ["We", "are", "currently", "evaluating", "the", "impact", "of", "the", "adoption", "of", "this", "standard."], "wordsB": ["We", "are", "continuing", "to", "assess", "the", "impact", "of", "the", "new", "guidance", "on", "our", "accounting", "policies", "and", "procedures", "and", "are", "evaluating", "the", "new", "requirements", "as", "applied", "to", "existing", "collaboration", "agreements,", "both", "in", "terms", "of", "the", "cumulative", "adjustment", "to", "opening", "accumulated", "deficit", "and", "our", "subsequent", "recognition", "of", "revenue."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p15_s2", "idA": "906709_17_item7_p5_s2", "sentA": "Product sales increased for the years ended December 31, 2016 and 2015 compared to the years ended December 31, 2015 and 2014 primarily as a result of increased product demand from our collaboration partner Ophthotech related to its drug candidate Fovista .", "sentB": "Product sales decreased for the year ended December 31, 2017 compared to the year ended December 31, 2016 primarily due to decreased product demand from our collaboration partner Ophthotech related to its drug candidate Fovista .", "type": 2, "words": ["<tag1>", "Product", "sales", "increased", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014", "primarily", "as", "a", "result", "of", "increased", "product", "demand", "from", "our", "collaboration", "partner", "Ophthotech", "related", "to", "its", "drug", "candidate", "Fovista", ".", "<tag2>", "Product", "sales", "decreased", "for", "the", "year", "ended", "December", "31,", "2017", "compared", "to", "the", "year", "ended", "December", "31,", "2016", "primarily", "due", "to", "decreased", "product", "demand", "from", "our", "collaboration", "partner", "Ophthotech", "related", "to", "its", "drug", "candidate", "Fovista", ".", "<tag3>"], "wordsA": ["Product", "sales", "increased", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014", "primarily", "as", "a", "result", "of", "increased", "product", "demand", "from", "our", "collaboration", "partner", "Ophthotech", "related", "to", "its", "drug", "candidate", "Fovista", "."], "wordsB": ["Product", "sales", "decreased", "for", "the", "year", "ended", "December", "31,", "2017", "compared", "to", "the", "year", "ended", "December", "31,", "2016", "primarily", "due", "to", "decreased", "product", "demand", "from", "our", "collaboration", "partner", "Ophthotech", "related", "to", "its", "drug", "candidate", "Fovista", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p15_s3", "idA": "906709_17_item7_p5_s2", "sentA": "Product sales increased for the years ended December 31, 2016 and 2015 compared to the years ended December 31, 2015 and 2014 primarily as a result of increased product demand from our collaboration partner Ophthotech related to its drug candidate Fovista .", "sentB": "Product sales increased for the year ended December 31, 2016 compared to the year ended December 31, 2015 primarily as a result of increased product demand from Ophthotech.", "type": 2, "words": ["<tag1>", "Product", "sales", "increased", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014", "primarily", "as", "a", "result", "of", "increased", "product", "demand", "from", "our", "collaboration", "partner", "Ophthotech", "related", "to", "its", "drug", "candidate", "Fovista", ".", "<tag2>", "Product", "sales", "increased", "for", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "primarily", "as", "a", "result", "of", "increased", "product", "demand", "from", "Ophthotech.", "<tag3>"], "wordsA": ["Product", "sales", "increased", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014", "primarily", "as", "a", "result", "of", "increased", "product", "demand", "from", "our", "collaboration", "partner", "Ophthotech", "related", "to", "its", "drug", "candidate", "Fovista", "."], "wordsB": ["Product", "sales", "increased", "for", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "primarily", "as", "a", "result", "of", "increased", "product", "demand", "from", "Ophthotech."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p16_s1", "idA": "906709_17_item7_p5_s3", "sentA": "In the year ended December 31, 2016, product sales to Ophthotech totaled $30.1 million.", "sentB": "In the year ended December 31, 2017, we recognized $10.4 million of product sales to Ophthotech based on prior binding purchase commitments.", "type": 2, "words": ["<tag1>", "In", "the", "year", "ended", "December", "31,", "2016,", "product", "sales", "to", "Ophthotech", "totaled", "$30.1", "million.", "<tag2>", "In", "the", "year", "ended", "December", "31,", "2017,", "we", "recognized", "$10.4", "million", "of", "product", "sales", "to", "Ophthotech", "based", "on", "prior", "binding", "purchase", "commitments.", "<tag3>"], "wordsA": ["In", "the", "year", "ended", "December", "31,", "2016,", "product", "sales", "to", "Ophthotech", "totaled", "$30.1", "million."], "wordsB": ["In", "the", "year", "ended", "December", "31,", "2017,", "we", "recognized", "$10.4", "million", "of", "product", "sales", "to", "Ophthotech", "based", "on", "prior", "binding", "purchase", "commitments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p38_s1", "idA": "906709_17_item7_p5_s3", "sentA": "In the year ended December 31, 2016, product sales to Ophthotech totaled $30.1 million.", "sentB": "As a result of the termination of the program, in the year ended December 31, 2017, we wrote off program-specific manufacturing equipment with a net book value of $15.1 million.", "type": 2, "words": ["<tag1>", "In", "the", "year", "ended", "December", "31,", "2016,", "product", "sales", "to", "Ophthotech", "totaled", "$30.1", "million.", "<tag2>", "As", "a", "result", "of", "the", "termination", "of", "the", "program,", "in", "the", "year", "ended", "December", "31,", "2017,", "we", "wrote", "off", "program-specific", "manufacturing", "equipment", "with", "a", "net", "book", "value", "of", "$15.1", "million.", "<tag3>"], "wordsA": ["In", "the", "year", "ended", "December", "31,", "2016,", "product", "sales", "to", "Ophthotech", "totaled", "$30.1", "million."], "wordsB": ["As", "a", "result", "of", "the", "termination", "of", "the", "program,", "in", "the", "year", "ended", "December", "31,", "2017,", "we", "wrote", "off", "program-specific", "manufacturing", "equipment", "with", "a", "net", "book", "value", "of", "$15.1", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p16_s0", "idA": "906709_17_item7_p6_s0", "sentA": "In December 2016, Ophthotech announced that two pivotal Phase 3 clinical trials for Fovista failed to meet their primary endpoints although a separate Phase 3 trial for Fovista remains ongoing.", "sentB": "In December 2016, Ophthotech announced that two pivotal Phase 3 clinical trials for Fovista failed to meet their primary endpoints.", "type": 2, "words": ["<tag1>", "In", "December", "2016,", "Ophthotech", "announced", "that", "two", "pivotal", "Phase", "3", "clinical", "trials", "for", "Fovista", "failed", "to", "meet", "their", "primary", "endpoints", "although", "a", "separate", "Phase", "3", "trial", "for", "Fovista", "remains", "ongoing.", "<tag2>", "In", "December", "2016,", "Ophthotech", "announced", "that", "two", "pivotal", "Phase", "3", "clinical", "trials", "for", "Fovista", "failed", "to", "meet", "their", "primary", "endpoints.", "<tag3>"], "wordsA": ["In", "December", "2016,", "Ophthotech", "announced", "that", "two", "pivotal", "Phase", "3", "clinical", "trials", "for", "Fovista", "failed", "to", "meet", "their", "primary", "endpoints", "although", "a", "separate", "Phase", "3", "trial", "for", "Fovista", "remains", "ongoing."], "wordsB": ["In", "December", "2016,", "Ophthotech", "announced", "that", "two", "pivotal", "Phase", "3", "clinical", "trials", "for", "Fovista", "failed", "to", "meet", "their", "primary", "endpoints."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p16_s2", "idA": "906709_17_item7_p6_s0", "sentA": "In December 2016, Ophthotech announced that two pivotal Phase 3 clinical trials for Fovista failed to meet their primary endpoints although a separate Phase 3 trial for Fovista remains ongoing.", "sentB": "In August 2017, Ophthotech announced that the third Fovista Phase 3 trial also failed to meet its primary endpoint and, in October 2017, our agreement with Ophthotech was terminated.", "type": 2, "words": ["<tag1>", "In", "December", "2016,", "Ophthotech", "announced", "that", "two", "pivotal", "Phase", "3", "clinical", "trials", "for", "Fovista", "failed", "to", "meet", "their", "primary", "endpoints", "although", "a", "separate", "Phase", "3", "trial", "for", "Fovista", "remains", "ongoing.", "<tag2>", "In", "August", "2017,", "Ophthotech", "announced", "that", "the", "third", "Fovista", "Phase", "3", "trial", "also", "failed", "to", "meet", "its", "primary", "endpoint", "and,", "in", "October", "2017,", "our", "agreement", "with", "Ophthotech", "was", "terminated.", "<tag3>"], "wordsA": ["In", "December", "2016,", "Ophthotech", "announced", "that", "two", "pivotal", "Phase", "3", "clinical", "trials", "for", "Fovista", "failed", "to", "meet", "their", "primary", "endpoints", "although", "a", "separate", "Phase", "3", "trial", "for", "Fovista", "remains", "ongoing."], "wordsB": ["In", "August", "2017,", "Ophthotech", "announced", "that", "the", "third", "Fovista", "Phase", "3", "trial", "also", "failed", "to", "meet", "its", "primary", "endpoint", "and,", "in", "October", "2017,", "our", "agreement", "with", "Ophthotech", "was", "terminated."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p29_s2", "idA": "906709_17_item7_p6_s0", "sentA": "In December 2016, Ophthotech announced that two pivotal Phase 3 clinical trials for Fovista failed to meet their primary endpoints although a separate Phase 3 trial for Fovista remains ongoing.", "sentB": "In November 2017, Bayer announced that its two Phase 3 studies of Amikacin Inhale both failed to meet their primary and secondary endpoints and, in December 2017, Bayer terminated our collaboration to develop Amikacin Inhale.", "type": 2, "words": ["<tag1>", "In", "December", "2016,", "Ophthotech", "announced", "that", "two", "pivotal", "Phase", "3", "clinical", "trials", "for", "Fovista", "failed", "to", "meet", "their", "primary", "endpoints", "although", "a", "separate", "Phase", "3", "trial", "for", "Fovista", "remains", "ongoing.", "<tag2>", "In", "November", "2017,", "Bayer", "announced", "that", "its", "two", "Phase", "3", "studies", "of", "Amikacin", "Inhale", "both", "failed", "to", "meet", "their", "primary", "and", "secondary", "endpoints", "and,", "in", "December", "2017,", "Bayer", "terminated", "our", "collaboration", "to", "develop", "Amikacin", "Inhale.", "<tag3>"], "wordsA": ["In", "December", "2016,", "Ophthotech", "announced", "that", "two", "pivotal", "Phase", "3", "clinical", "trials", "for", "Fovista", "failed", "to", "meet", "their", "primary", "endpoints", "although", "a", "separate", "Phase", "3", "trial", "for", "Fovista", "remains", "ongoing."], "wordsB": ["In", "November", "2017,", "Bayer", "announced", "that", "its", "two", "Phase", "3", "studies", "of", "Amikacin", "Inhale", "both", "failed", "to", "meet", "their", "primary", "and", "secondary", "endpoints", "and,", "in", "December", "2017,", "Bayer", "terminated", "our", "collaboration", "to", "develop", "Amikacin", "Inhale."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p16_s4", "idA": "906709_17_item7_p7_s0", "sentA": "Royalty revenue We receive royalty revenue from certain of our collaboration partners based on their net sales of commercial products.", "sentB": "We receive royalty revenue from certain of our collaboration partners based on their net sales of commercial products.", "type": 2, "words": ["<tag1>", "Royalty", "revenue", "We", "receive", "royalty", "revenue", "from", "certain", "of", "our", "collaboration", "partners", "based", "on", "their", "net", "sales", "of", "commercial", "products.", "<tag2>", "We", "receive", "royalty", "revenue", "from", "certain", "of", "our", "collaboration", "partners", "based", "on", "their", "net", "sales", "of", "commercial", "products.", "<tag3>"], "wordsA": ["Royalty", "revenue", "We", "receive", "royalty", "revenue", "from", "certain", "of", "our", "collaboration", "partners", "based", "on", "their", "net", "sales", "of", "commercial", "products."], "wordsB": ["We", "receive", "royalty", "revenue", "from", "certain", "of", "our", "collaboration", "partners", "based", "on", "their", "net", "sales", "of", "commercial", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p16_s5", "idA": "906709_17_item7_p7_s1", "sentA": "Royalty revenue received in cash increased for the years ended December 31, 2016 and 2015 compared to the years ended December 31, 2015 and 2014 due primarily to the commercial launch by AstraZeneca of MOVANTIK in the U.S. in March 2015 and MOVENTIG in the EU in August 2015 and the launch of ADYNOVATE by Baxalta in the U.S. in November 2015.", "sentB": "Royalty revenue received in cash increased for the years ended December 31, 2017 and 2016 compared to the years ended December 31, 2016 and 2015, respectively, due primarily to the commercial launch by AstraZeneca of MOVANTIK in the U.S. in March 2015 and MOVENTIG in the EU in August 2015 and the launch of ADYNOVATE by Baxalta in the U.S. in November 2015.", "type": 2, "words": ["<tag1>", "Royalty", "revenue", "received", "in", "cash", "increased", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014", "due", "primarily", "to", "the", "commercial", "launch", "by", "AstraZeneca", "of", "MOVANTIK", "in", "the", "U.S.", "in", "March", "2015", "and", "MOVENTIG", "in", "the", "EU", "in", "August", "2015", "and", "the", "launch", "of", "ADYNOVATE", "by", "Baxalta", "in", "the", "U.S.", "in", "November", "2015.", "<tag2>", "Royalty", "revenue", "received", "in", "cash", "increased", "for", "the", "years", "ended", "December", "31,", "2017", "and", "2016", "compared", "to", "the", "years", "ended", "December", "31,", "2016", "and", "2015,", "respectively,", "due", "primarily", "to", "the", "commercial", "launch", "by", "AstraZeneca", "of", "MOVANTIK", "in", "the", "U.S.", "in", "March", "2015", "and", "MOVENTIG", "in", "the", "EU", "in", "August", "2015", "and", "the", "launch", "of", "ADYNOVATE", "by", "Baxalta", "in", "the", "U.S.", "in", "November", "2015.", "<tag3>"], "wordsA": ["Royalty", "revenue", "received", "in", "cash", "increased", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014", "due", "primarily", "to", "the", "commercial", "launch", "by", "AstraZeneca", "of", "MOVANTIK", "in", "the", "U.S.", "in", "March", "2015", "and", "MOVENTIG", "in", "the", "EU", "in", "August", "2015", "and", "the", "launch", "of", "ADYNOVATE", "by", "Baxalta", "in", "the", "U.S.", "in", "November", "2015."], "wordsB": ["Royalty", "revenue", "received", "in", "cash", "increased", "for", "the", "years", "ended", "December", "31,", "2017", "and", "2016", "compared", "to", "the", "years", "ended", "December", "31,", "2016", "and", "2015,", "respectively,", "due", "primarily", "to", "the", "commercial", "launch", "by", "AstraZeneca", "of", "MOVANTIK", "in", "the", "U.S.", "in", "March", "2015", "and", "MOVENTIG", "in", "the", "EU", "in", "August", "2015", "and", "the", "launch", "of", "ADYNOVATE", "by", "Baxalta", "in", "the", "U.S.", "in", "November", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p17_s1", "idA": "906709_17_item7_p7_s1", "sentA": "Royalty revenue received in cash increased for the years ended December 31, 2016 and 2015 compared to the years ended December 31, 2015 and 2014 due primarily to the commercial launch by AstraZeneca of MOVANTIK in the U.S. in March 2015 and MOVENTIG in the EU in August 2015 and the launch of ADYNOVATE by Baxalta in the U.S. in November 2015.", "sentB": "As a result, the royalty rate payable to us from net sales of MOVANTIK in the U.S. by AstraZeneca can be reduced by up to two percentage points to fund 33% of the external costs incurred by AstraZeneca to fund such post approval study, subject to a $35.0 million aggregate cap.", "type": 2, "words": ["<tag1>", "Royalty", "revenue", "received", "in", "cash", "increased", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014", "due", "primarily", "to", "the", "commercial", "launch", "by", "AstraZeneca", "of", "MOVANTIK", "in", "the", "U.S.", "in", "March", "2015", "and", "MOVENTIG", "in", "the", "EU", "in", "August", "2015", "and", "the", "launch", "of", "ADYNOVATE", "by", "Baxalta", "in", "the", "U.S.", "in", "November", "2015.", "<tag2>", "As", "a", "result,", "the", "royalty", "rate", "payable", "to", "us", "from", "net", "sales", "of", "MOVANTIK", "in", "the", "U.S.", "by", "AstraZeneca", "can", "be", "reduced", "by", "up", "to", "two", "percentage", "points", "to", "fund", "33%", "of", "the", "external", "costs", "incurred", "by", "AstraZeneca", "to", "fund", "such", "post", "approval", "study,", "subject", "to", "a", "$35.0", "million", "aggregate", "cap.", "<tag3>"], "wordsA": ["Royalty", "revenue", "received", "in", "cash", "increased", "for", "the", "years", "ended", "December", "31,", "2016", "and", "2015", "compared", "to", "the", "years", "ended", "December", "31,", "2015", "and", "2014", "due", "primarily", "to", "the", "commercial", "launch", "by", "AstraZeneca", "of", "MOVANTIK", "in", "the", "U.S.", "in", "March", "2015", "and", "MOVENTIG", "in", "the", "EU", "in", "August", "2015", "and", "the", "launch", "of", "ADYNOVATE", "by", "Baxalta", "in", "the", "U.S.", "in", "November", "2015."], "wordsB": ["As", "a", "result,", "the", "royalty", "rate", "payable", "to", "us", "from", "net", "sales", "of", "MOVANTIK", "in", "the", "U.S.", "by", "AstraZeneca", "can", "be", "reduced", "by", "up", "to", "two", "percentage", "points", "to", "fund", "33%", "of", "the", "external", "costs", "incurred", "by", "AstraZeneca", "to", "fund", "such", "post", "approval", "study,", "subject", "to", "a", "$35.0", "million", "aggregate", "cap."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p16_s6", "idA": "906709_17_item7_p7_s2", "sentA": "We expect royalty revenue in 2017 will increase as compared to 2016 due to royalties we expect to receive from net sales of MOVANTIK , MOVENTIG and ADYNOVATE as a result of sales growth of these partnered products.", "sentB": "We expect royalty revenue in 2018 will increase as compared to 2017 due to royalties we expect to receive as a result of sales growth of these partnered products.", "type": 2, "words": ["<tag1>", "We", "expect", "royalty", "revenue", "in", "2017", "will", "increase", "as", "compared", "to", "2016", "due", "to", "royalties", "we", "expect", "to", "receive", "from", "net", "sales", "of", "MOVANTIK", ",", "MOVENTIG", "and", "ADYNOVATE", "as", "a", "result", "of", "sales", "growth", "of", "these", "partnered", "products.", "<tag2>", "We", "expect", "royalty", "revenue", "in", "2018", "will", "increase", "as", "compared", "to", "2017", "due", "to", "royalties", "we", "expect", "to", "receive", "as", "a", "result", "of", "sales", "growth", "of", "these", "partnered", "products.", "<tag3>"], "wordsA": ["We", "expect", "royalty", "revenue", "in", "2017", "will", "increase", "as", "compared", "to", "2016", "due", "to", "royalties", "we", "expect", "to", "receive", "from", "net", "sales", "of", "MOVANTIK", ",", "MOVENTIG", "and", "ADYNOVATE", "as", "a", "result", "of", "sales", "growth", "of", "these", "partnered", "products."], "wordsB": ["We", "expect", "royalty", "revenue", "in", "2018", "will", "increase", "as", "compared", "to", "2017", "due", "to", "royalties", "we", "expect", "to", "receive", "as", "a", "result", "of", "sales", "growth", "of", "these", "partnered", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p38_s0", "idA": "906709_17_item7_p7_s4", "sentA": "As described in Note 7 to our Consolidated Financial Statements, this royalty sale transaction has been recorded as a liability that amortizes over the estimated royalty payment period.", "sentB": "Impairment of equipment and other costs for terminated program As described in Note 4 to our Consolidated Financial Statements, in December 2017, Bayer terminated our collaboration to develop Amikacin Inhale.", "type": 2, "words": ["<tag1>", "As", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "sale", "transaction", "has", "been", "recorded", "as", "a", "liability", "that", "amortizes", "over", "the", "estimated", "royalty", "payment", "period.", "<tag2>", "Impairment", "of", "equipment", "and", "other", "costs", "for", "terminated", "program", "As", "described", "in", "Note", "4", "to", "our", "Consolidated", "Financial", "Statements,", "in", "December", "2017,", "Bayer", "terminated", "our", "collaboration", "to", "develop", "Amikacin", "Inhale.", "<tag3>"], "wordsA": ["As", "described", "in", "Note", "7", "to", "our", "Consolidated", "Financial", "Statements,", "this", "royalty", "sale", "transaction", "has", "been", "recorded", "as", "a", "liability", "that", "amortizes", "over", "the", "estimated", "royalty", "payment", "period."], "wordsB": ["Impairment", "of", "equipment", "and", "other", "costs", "for", "terminated", "program", "As", "described", "in", "Note", "4", "to", "our", "Consolidated", "Financial", "Statements,", "in", "December", "2017,", "Bayer", "terminated", "our", "collaboration", "to", "develop", "Amikacin", "Inhale."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p18_s3", "idA": "906709_17_item7_p7_s6", "sentA": "We expect non-cash royalties from net sales of CIMZIA and MIRCERA in 2017 to increase marginally compared to 2016.", "sentB": "We expect non-cash royalties from net sales of CIMZIA and MIRCERA in 2018 to increase marginally compared to 2017.", "type": 2, "words": ["<tag1>", "We", "expect", "non-cash", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "in", "2017", "to", "increase", "marginally", "compared", "to", "2016.", "<tag2>", "We", "expect", "non-cash", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "in", "2018", "to", "increase", "marginally", "compared", "to", "2017.", "<tag3>"], "wordsA": ["We", "expect", "non-cash", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "in", "2017", "to", "increase", "marginally", "compared", "to", "2016."], "wordsB": ["We", "expect", "non-cash", "royalties", "from", "net", "sales", "of", "CIMZIA", "and", "MIRCERA", "in", "2018", "to", "increase", "marginally", "compared", "to", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p19_s0", "idA": "906709_17_item7_p8_s0", "sentA": "License, collaboration and other revenue License, collaboration and other revenue includes the recognition of upfront payments, milestone and other contingent payments received in connection with our license and collaboration agreements and reimbursed research and development expenses.", "sentB": "License, collaboration and other revenue License, collaboration and other revenue includes the recognition of upfront payments, milestone and other contingent payments received in connection with our license and collaboration agreements and certain research and development activities.", "type": 2, "words": ["<tag1>", "License,", "collaboration", "and", "other", "revenue", "License,", "collaboration", "and", "other", "revenue", "includes", "the", "recognition", "of", "upfront", "payments,", "milestone", "and", "other", "contingent", "payments", "received", "in", "connection", "with", "our", "license", "and", "collaboration", "agreements", "and", "reimbursed", "research", "and", "development", "expenses.", "<tag2>", "License,", "collaboration", "and", "other", "revenue", "License,", "collaboration", "and", "other", "revenue", "includes", "the", "recognition", "of", "upfront", "payments,", "milestone", "and", "other", "contingent", "payments", "received", "in", "connection", "with", "our", "license", "and", "collaboration", "agreements", "and", "certain", "research", "and", "development", "activities.", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "revenue", "License,", "collaboration", "and", "other", "revenue", "includes", "the", "recognition", "of", "upfront", "payments,", "milestone", "and", "other", "contingent", "payments", "received", "in", "connection", "with", "our", "license", "and", "collaboration", "agreements", "and", "reimbursed", "research", "and", "development", "expenses."], "wordsB": ["License,", "collaboration", "and", "other", "revenue", "License,", "collaboration", "and", "other", "revenue", "includes", "the", "recognition", "of", "upfront", "payments,", "milestone", "and", "other", "contingent", "payments", "received", "in", "connection", "with", "our", "license", "and", "collaboration", "agreements", "and", "certain", "research", "and", "development", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p19_s1", "idA": "906709_17_item7_p8_s1", "sentA": "The level of license, collaboration and other revenue depends in part upon the estimated amortization period of the upfront payments, the achievement of milestones and other contingent events, the continuation of existing collaborations, the amount of reimbursed research and development work, and entering into new collaboration agreements, if any.", "sentB": "The level of license, collaboration and other revenue depends in part upon the estimated amortization period of the upfront payments, the achievement of milestones and other contingent events, the continuation of existing collaborations, the amount of research and development work, and entering into new collaboration agreements, if any.", "type": 2, "words": ["<tag1>", "The", "level", "of", "license,", "collaboration", "and", "other", "revenue", "depends", "in", "part", "upon", "the", "estimated", "amortization", "period", "of", "the", "upfront", "payments,", "the", "achievement", "of", "milestones", "and", "other", "contingent", "events,", "the", "continuation", "of", "existing", "collaborations,", "the", "amount", "of", "reimbursed", "research", "and", "development", "work,", "and", "entering", "into", "new", "collaboration", "agreements,", "if", "any.", "<tag2>", "The", "level", "of", "license,", "collaboration", "and", "other", "revenue", "depends", "in", "part", "upon", "the", "estimated", "amortization", "period", "of", "the", "upfront", "payments,", "the", "achievement", "of", "milestones", "and", "other", "contingent", "events,", "the", "continuation", "of", "existing", "collaborations,", "the", "amount", "of", "research", "and", "development", "work,", "and", "entering", "into", "new", "collaboration", "agreements,", "if", "any.", "<tag3>"], "wordsA": ["The", "level", "of", "license,", "collaboration", "and", "other", "revenue", "depends", "in", "part", "upon", "the", "estimated", "amortization", "period", "of", "the", "upfront", "payments,", "the", "achievement", "of", "milestones", "and", "other", "contingent", "events,", "the", "continuation", "of", "existing", "collaborations,", "the", "amount", "of", "reimbursed", "research", "and", "development", "work,", "and", "entering", "into", "new", "collaboration", "agreements,", "if", "any."], "wordsB": ["The", "level", "of", "license,", "collaboration", "and", "other", "revenue", "depends", "in", "part", "upon", "the", "estimated", "amortization", "period", "of", "the", "upfront", "payments,", "the", "achievement", "of", "milestones", "and", "other", "contingent", "events,", "the", "continuation", "of", "existing", "collaborations,", "the", "amount", "of", "research", "and", "development", "work,", "and", "entering", "into", "new", "collaboration", "agreements,", "if", "any."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p19_s4", "idA": "906709_17_item7_p8_s2", "sentA": "License, collaboration and other revenue decreased for the year ended December 31, 2016 compared to the year ended December 31, 2015 primarily as a result of the recognition in March 2015 of the $100.0 million milestone payment received from AstraZeneca as a result of the U.S. commercial launch of MOVANTIK and the $40.0 million milestone payment received from AstraZeneca in August 2015 as a result of the EU commercial launch of MOVENTIG partially offset by the recognition of $28.0 million in March 2016 for our 40% share of the $70.0 million sublicense payment received by AstraZeneca from Kirin.", "sentB": "These increases in 2017 were partially offset by the recognition of $28.0 million in March 2016 for our 40% share of the $70.0 million sublicense payment received by AstraZeneca from Kirin.", "type": 2, "words": ["<tag1>", "License,", "collaboration", "and", "other", "revenue", "decreased", "for", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "primarily", "as", "a", "result", "of", "the", "recognition", "in", "March", "2015", "of", "the", "$100.0", "million", "milestone", "payment", "received", "from", "AstraZeneca", "as", "a", "result", "of", "the", "U.S.", "commercial", "launch", "of", "MOVANTIK", "and", "the", "$40.0", "million", "milestone", "payment", "received", "from", "AstraZeneca", "in", "August", "2015", "as", "a", "result", "of", "the", "EU", "commercial", "launch", "of", "MOVENTIG", "partially", "offset", "by", "the", "recognition", "of", "$28.0", "million", "in", "March", "2016", "for", "our", "40%", "share", "of", "the", "$70.0", "million", "sublicense", "payment", "received", "by", "AstraZeneca", "from", "Kirin.", "<tag2>", "These", "increases", "in", "2017", "were", "partially", "offset", "by", "the", "recognition", "of", "$28.0", "million", "in", "March", "2016", "for", "our", "40%", "share", "of", "the", "$70.0", "million", "sublicense", "payment", "received", "by", "AstraZeneca", "from", "Kirin.", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "revenue", "decreased", "for", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "primarily", "as", "a", "result", "of", "the", "recognition", "in", "March", "2015", "of", "the", "$100.0", "million", "milestone", "payment", "received", "from", "AstraZeneca", "as", "a", "result", "of", "the", "U.S.", "commercial", "launch", "of", "MOVANTIK", "and", "the", "$40.0", "million", "milestone", "payment", "received", "from", "AstraZeneca", "in", "August", "2015", "as", "a", "result", "of", "the", "EU", "commercial", "launch", "of", "MOVENTIG", "partially", "offset", "by", "the", "recognition", "of", "$28.0", "million", "in", "March", "2016", "for", "our", "40%", "share", "of", "the", "$70.0", "million", "sublicense", "payment", "received", "by", "AstraZeneca", "from", "Kirin."], "wordsB": ["These", "increases", "in", "2017", "were", "partially", "offset", "by", "the", "recognition", "of", "$28.0", "million", "in", "March", "2016", "for", "our", "40%", "share", "of", "the", "$70.0", "million", "sublicense", "payment", "received", "by", "AstraZeneca", "from", "Kirin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p19_s5", "idA": "906709_17_item7_p8_s2", "sentA": "License, collaboration and other revenue decreased for the year ended December 31, 2016 compared to the year ended December 31, 2015 primarily as a result of the recognition in March 2015 of the $100.0 million milestone payment received from AstraZeneca as a result of the U.S. commercial launch of MOVANTIK and the $40.0 million milestone payment received from AstraZeneca in August 2015 as a result of the EU commercial launch of MOVENTIG partially offset by the recognition of $28.0 million in March 2016 for our 40% share of the $70.0 million sublicense payment received by AstraZeneca from Kirin.", "sentB": "License, collaboration and other revenue decreased for the year ended December 31, 2016 compared to the year ended December 31, 2015 primarily as a result of the recognition in March 2015 of the $100.0 million milestone payment received from AstraZeneca as a result of the U.S. commercial launch of MOVANTIK and the $40.0 million milestone payment received from AstraZeneca in August 2015 as a result of the EU commercial launch of MOVENTIG partially offset by the recognition in 2016 of a $28.0 million payment received from AstraZeneca described above.", "type": 2, "words": ["<tag1>", "License,", "collaboration", "and", "other", "revenue", "decreased", "for", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "primarily", "as", "a", "result", "of", "the", "recognition", "in", "March", "2015", "of", "the", "$100.0", "million", "milestone", "payment", "received", "from", "AstraZeneca", "as", "a", "result", "of", "the", "U.S.", "commercial", "launch", "of", "MOVANTIK", "and", "the", "$40.0", "million", "milestone", "payment", "received", "from", "AstraZeneca", "in", "August", "2015", "as", "a", "result", "of", "the", "EU", "commercial", "launch", "of", "MOVENTIG", "partially", "offset", "by", "the", "recognition", "of", "$28.0", "million", "in", "March", "2016", "for", "our", "40%", "share", "of", "the", "$70.0", "million", "sublicense", "payment", "received", "by", "AstraZeneca", "from", "Kirin.", "<tag2>", "License,", "collaboration", "and", "other", "revenue", "decreased", "for", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "primarily", "as", "a", "result", "of", "the", "recognition", "in", "March", "2015", "of", "the", "$100.0", "million", "milestone", "payment", "received", "from", "AstraZeneca", "as", "a", "result", "of", "the", "U.S.", "commercial", "launch", "of", "MOVANTIK", "and", "the", "$40.0", "million", "milestone", "payment", "received", "from", "AstraZeneca", "in", "August", "2015", "as", "a", "result", "of", "the", "EU", "commercial", "launch", "of", "MOVENTIG", "partially", "offset", "by", "the", "recognition", "in", "2016", "of", "a", "$28.0", "million", "payment", "received", "from", "AstraZeneca", "described", "above.", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "revenue", "decreased", "for", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "primarily", "as", "a", "result", "of", "the", "recognition", "in", "March", "2015", "of", "the", "$100.0", "million", "milestone", "payment", "received", "from", "AstraZeneca", "as", "a", "result", "of", "the", "U.S.", "commercial", "launch", "of", "MOVANTIK", "and", "the", "$40.0", "million", "milestone", "payment", "received", "from", "AstraZeneca", "in", "August", "2015", "as", "a", "result", "of", "the", "EU", "commercial", "launch", "of", "MOVENTIG", "partially", "offset", "by", "the", "recognition", "of", "$28.0", "million", "in", "March", "2016", "for", "our", "40%", "share", "of", "the", "$70.0", "million", "sublicense", "payment", "received", "by", "AstraZeneca", "from", "Kirin."], "wordsB": ["License,", "collaboration", "and", "other", "revenue", "decreased", "for", "the", "year", "ended", "December", "31,", "2016", "compared", "to", "the", "year", "ended", "December", "31,", "2015", "primarily", "as", "a", "result", "of", "the", "recognition", "in", "March", "2015", "of", "the", "$100.0", "million", "milestone", "payment", "received", "from", "AstraZeneca", "as", "a", "result", "of", "the", "U.S.", "commercial", "launch", "of", "MOVANTIK", "and", "the", "$40.0", "million", "milestone", "payment", "received", "from", "AstraZeneca", "in", "August", "2015", "as", "a", "result", "of", "the", "EU", "commercial", "launch", "of", "MOVENTIG", "partially", "offset", "by", "the", "recognition", "in", "2016", "of", "a", "$28.0", "million", "payment", "received", "from", "AstraZeneca", "described", "above."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p19_s2", "idA": "906709_17_item7_p8_s3", "sentA": "License, collaboration and other revenue increased for the year ended December 31, 2015 compared to the year ended December 31, 2014 primarily as a result of increased revenue from payments received from AstraZeneca in 2015 as compared to 2014.", "sentB": "License, collaboration and other revenue increased for the year ended December 31, 2017 compared to the year ended December 31, 2016 primarily due to the recognition of $130.1 million of the $150.0 million upfront payment we received in September 2017 from our collaboration agreement with Lilly for NKTR-358 as described in Note 10 to our Consolidated Financial Statements.", "type": 2, "words": ["<tag1>", "License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "as", "a", "result", "of", "increased", "revenue", "from", "payments", "received", "from", "AstraZeneca", "in", "2015", "as", "compared", "to", "2014.", "<tag2>", "License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2017", "compared", "to", "the", "year", "ended", "December", "31,", "2016", "primarily", "due", "to", "the", "recognition", "of", "$130.1", "million", "of", "the", "$150.0", "million", "upfront", "payment", "we", "received", "in", "September", "2017", "from", "our", "collaboration", "agreement", "with", "Lilly", "for", "NKTR-358", "as", "described", "in", "Note", "10", "to", "our", "Consolidated", "Financial", "Statements.", "<tag3>"], "wordsA": ["License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2015", "compared", "to", "the", "year", "ended", "December", "31,", "2014", "primarily", "as", "a", "result", "of", "increased", "revenue", "from", "payments", "received", "from", "AstraZeneca", "in", "2015", "as", "compared", "to", "2014."], "wordsB": ["License,", "collaboration", "and", "other", "revenue", "increased", "for", "the", "year", "ended", "December", "31,", "2017", "compared", "to", "the", "year", "ended", "December", "31,", "2016", "primarily", "due", "to", "the", "recognition", "of", "$130.1", "million", "of", "the", "$150.0", "million", "upfront", "payment", "we", "received", "in", "September", "2017", "from", "our", "collaboration", "agreement", "with", "Lilly", "for", "NKTR-358", "as", "described", "in", "Note", "10", "to", "our", "Consolidated", "Financial", "Statements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p19_s3", "idA": "906709_17_item7_p8_s5", "sentA": "In addition, in 2014, we recognized $8.0 million of milestones received in December 2014 related to positive results from Baxalta s ADYNOVATE Phase 3 study.", "sentB": "In addition, in the three months ended December 31, 2017, we recognized $38.0 million related to the termination of our collaboration agreements with Bayer, Ophthotech, and Daiichi as described in Note 10 to our Consolidated Financial Statements.", "type": 2, "words": ["<tag1>", "In", "addition,", "in", "2014,", "we", "recognized", "$8.0", "million", "of", "milestones", "received", "in", "December", "2014", "related", "to", "positive", "results", "from", "Baxalta", "s", "ADYNOVATE", "Phase", "3", "study.", "<tag2>", "In", "addition,", "in", "the", "three", "months", "ended", "December", "31,", "2017,", "we", "recognized", "$38.0", "million", "related", "to", "the", "termination", "of", "our", "collaboration", "agreements", "with", "Bayer,", "Ophthotech,", "and", "Daiichi", "as", "described", "in", "Note", "10", "to", "our", "Consolidated", "Financial", "Statements.", "<tag3>"], "wordsA": ["In", "addition,", "in", "2014,", "we", "recognized", "$8.0", "million", "of", "milestones", "received", "in", "December", "2014", "related", "to", "positive", "results", "from", "Baxalta", "s", "ADYNOVATE", "Phase", "3", "study."], "wordsB": ["In", "addition,", "in", "the", "three", "months", "ended", "December", "31,", "2017,", "we", "recognized", "$38.0", "million", "related", "to", "the", "termination", "of", "our", "collaboration", "agreements", "with", "Bayer,", "Ophthotech,", "and", "Daiichi", "as", "described", "in", "Note", "10", "to", "our", "Consolidated", "Financial", "Statements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p16_s3", "idA": "906709_17_item7_p8_s6", "sentA": "We expect license, collaboration and other revenue in 2017 to decrease compared to 2016.", "sentB": "We expect product sales in 2018 to decrease compared to 2017 primarily due to the termination of the Ophthotech agreement.", "type": 2, "words": ["<tag1>", "We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2017", "to", "decrease", "compared", "to", "2016.", "<tag2>", "We", "expect", "product", "sales", "in", "2018", "to", "decrease", "compared", "to", "2017", "primarily", "due", "to", "the", "termination", "of", "the", "Ophthotech", "agreement.", "<tag3>"], "wordsA": ["We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2017", "to", "decrease", "compared", "to", "2016."], "wordsB": ["We", "expect", "product", "sales", "in", "2018", "to", "decrease", "compared", "to", "2017", "primarily", "due", "to", "the", "termination", "of", "the", "Ophthotech", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "906709_18_item7_p19_s6", "idA": "906709_17_item7_p8_s6", "sentA": "We expect license, collaboration and other revenue in 2017 to decrease compared to 2016.", "sentB": "We currently expect, subject to our adoption of ASC 606 and completion of our determination of revenue to be recognized related to the BMS Collaboration Agreement executed in February 2018, that our license, collaboration and other revenue from existing collaboration agreements will increase in 2018 compared to 2017.", "type": 2, "words": ["<tag1>", "We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2017", "to", "decrease", "compared", "to", "2016.", "<tag2>", "We", "currently", "expect,", "subject", "to", "our", "adoption", "of", "ASC", "606", "and", "completion", "of", "our", "determination", "of", "revenue", "to", "be", "recognized", "related", "to", "the", "BMS", "Collaboration", "Agreement", "executed", "in", "February", "2018,", "that", "our", "license,", "collaboration", "and", "other", "revenue", "from", "existing", "collaboration", "agreements", "will", "increase", "in", "2018", "compared", "to", "2017.", "<tag3>"], "wordsA": ["We", "expect", "license,", "collaboration", "and", "other", "revenue", "in", "2017", "to", "decrease", "compared", "to", "2016."], "wordsB": ["We", "currently", "expect,", "subject", "to", "our", "adoption", "of", "ASC", "606", "and", "completion", "of", "our", "determination", "of", "revenue", "to", "be", "recognized", "related", "to", "the", "BMS", "Collaboration", "Agreement", "executed", "in", "February", "2018,", "that", "our", "license,", "collaboration", "and", "other", "revenue", "from", "existing", "collaboration", "agreements", "will", "increase", "in", "2018", "compared", "to", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
